"test_results=[TestResult(name='test_case_3', success=False, metrics_data=[MetricData(name='Answer Correctness (GEval)', threshold=0.5, success=False, score=0.009576533652788877, reason='The actual output does not reference the integration of biomarker and imaging research with standardized treatment guidelines as stated in the expected output.', strict_mode=False, evaluation_model='gpt-4o-mini', error=None, evaluation_cost=0.00329565, verbose_logs='Criteria:\\nNone \\n \\nEvaluation Steps:\\n[\\n    \"Determine whether the actual output is factually correct based on the expected output.\"\\n]'), MetricData(name='Faithfulness', threshold=0.7, success=True, score=1.0, reason=None, strict_mode=False, evaluation_model='gpt-4o-mini', error=None, evaluation_cost=0.0073152, verbose_logs='Truths (limit=None):\\n[\\n    \"The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG) is an organization.\",\\n    \"The UMBRELLA SIOP-RTSG 2016 is a protocol.\",\\n    \"SIOP\u22122001 is also a protocol.\",\\n    \"Wilms tumours are a type of disease.\",\\n    \"Non-Wilms tumours are a category of disease.\",\\n    \"Clear cell sarcoma of the kidney is a type of disease.\",\\n    \"Renal cell carcinoma is a type of disease.\",\\n    \"Malignant rhabdoid tumour of the kidney is a disease.\",\\n    \"Congenital mesoblastic nephroma is a type of disease.\",\\n    \"The Department of Paediatric Oncology is part of the Princess M\u00e1xima Center for Paediatric Oncology.\",\\n    \"Marry M. van den Heuvel-Eibrink is a person associated with this field.\",\\n    \"Childhood renal tumours are a category of disease.\",\\n    \"The UMBRELLA protocol is a treatment protocol.\",\\n    \"SIOP - RTSG is an organization.\",\\n    \"The Children\u2019s Oncology Group (COG) is an organization.\",\\n    \"The SIOP\u22122001 randomized trial is a clinical trial.\",\\n    \"Actinomycin D is a drug used in treatment.\",\\n    \"Vincristine is a drug used in treatment.\",\\n    \"Doxorubicin is a drug used in treatment.\",\\n    \"The UKW3 trial is a clinical trial.\",\\n    \"Localized disease, metastatic disease, bilateral disease, and relapsed disease are classifications of disease stages.\",\\n    \"Radiotherapy, surgery, and chemotherapy are treatment methods.\",\\n    \"SIOP\u22122001 is an entity representing a trial or protocol.\",\\n    \"There are various disease stages including Stage I, II, III, IV, and V.\",\\n    \"Childhood renal tumours encompass Wilms Tumour, CCSK, MRTK, CMN, and RCC.\",\\n    \"High-risk characteristics lead to unfavorable prognosis.\",\\n    \"The SIOP database captures data on treatment regimens and outcomes.\",\\n    \"Nephron-sparing surgery (NSS) and radical tumor nephrectomy are surgical procedures.\",\\n    \"Infant Wilms Tumors and Adult Wilms Tumors are medical conditions under this study.\",\\n    \"Camptothecins, including irinotecan and topotecan, are classified medications.\",\\n    \"Whole-lung irradiation, pulmonary radiotherapy, and proton therapy are methods of treatment.\",\\n    \"Various trials such as UKW3 trial and COG-NWTS trials involve research in this field.\",\\n    \"Countries such as Germany, Italy, France, and the UK have institutions participating in these studies.\"\\n] \\n \\nClaims:\\n[\\n    \"The Renal Tumour Study Group of the International Society of Paediatric Oncology is an organization involved in renal tumour studies.\",\\n    \"The UMBRELLA SIOP-RTSG 2016 is a protocol used for managing renal tumours.\",\\n    \"The SIOP\u22122001 is a protocol related to renal tumours.\",\\n    \"Wilms tumours are a type of childhood renal tumour.\",\\n    \"Non-Wilms tumours refer to other types of renal tumours in children.\",\\n    \"The website www.siop-rtsg.eu is associated with the SIOP\u2013RTSG.\",\\n    \"The Department of Paediatric Oncology at Princess M\u00e1xima Center for Paediatric Oncology is an institution focused on pediatric oncology.\",\\n    \"Marry M. van den Heuvel-Eibrink is a person involved in the research related to renal tumours.\",\\n    \"Childhood renal tumours include conditions such as Wilms tumours, clear cell sarcoma of the kidney, renal cell carcinoma, malignant rhabdoid tumour of the kidney, and congenital mesoblastic nephroma.\"\\n] \\n \\nVerdicts:\\n[\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"idk\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    }\\n]'), MetricData(name='Contextual Relevancy', threshold=1.0, success=False, score=0.5384615384615384, reason=\"The score is 0.54 because the retrieval context fails to directly address how the UMBRELLA protocol supports research, focusing instead on treatment options, methodologies, and surgical guidelines, as indicated by statements like 'this statement details treatment options' and 'this statement discusses treatment methodology.' While a few statements mention the UMBRELLA protocol, such as 'SIOP\u2013RTSG is working with the Children\u2019s Oncology Group in the UMBRELLA protocol,' they still don't clarify its research support.\", strict_mode=False, evaluation_model='gpt-4o-mini', error=None, evaluation_cost=0.0038830499999999994, verbose_logs='Verdicts:\\n[\\n    {\\n        \"verdicts\": [\\n            {\\n                \"statement\": \"UMBRELLA protocol is the standard of care for Wilms tumor.\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"UMBRELLA protocol provides guidelines for surgery.\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"UMBRELLA protocol provides guidelines for radiotherapy.\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"The Renal Tumour Study Group (SIOP\\\\u2013RTSG) developed the UMBRELLA protocol.\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"vincristine, actinomycin D, and doxorubicin are used in the UMBRELLA protocol.\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"SIOP\\\\u2013RTSG is working with the Children\\\\u2019s Oncology Group in the UMBRELLA protocol.\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"The protocol uses data from the COG AREN0533 trial.\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"SIOP\\\\u2013RTSG panel suggests high-dose chemotherapy and autologous stem cell transplantation.\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"While this statement is about a related treatment protocol, it does not directly address how the UMBRELLA protocol specifically supports research.\"\\n            },\\n            {\\n                \"statement\": \"Stage II and III can be treated with vincristine and actinomycin D.\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"This statement details treatment options and does not directly relate to the UMBRELLA protocol\\'s role in supporting research.\"\\n            },\\n            {\\n                \"statement\": \"Patients may require nephron-sparing surgery for renal conditions.\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"This statement focuses on a surgical treatment and does not specify how the UMBRELLA protocol supports research.\"\\n            },\\n            {\\n                \"statement\": \"Bilateral nephron-sparing surgery is a standard of care for certain renal tumors.\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"This statement discusses treatment methodology and does not address the UMBRELLA protocol\\'s impact on research support.\"\\n            },\\n            {\\n                \"statement\": \"Tumor studies conducted by various organizations assist in understanding treatment effectiveness.\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"While relevant to oncology research, it does not specifically mention the UMBRELLA protocol or its contributions.\"\\n            },\\n            {\\n                \"statement\": \"The SIOP database captures data on pediatric oncology treatments.\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"This provides a generalized view of data collection without connecting to the specific role of the UMBRELLA protocol in supporting research.\"\\n            }\\n        ]\\n    }\\n]')], conversational=False, multimodal=False, input='How does the UMBRELLA protocol plan to support research?', actual_output='[{\\'nodes\\': [(\\'sample.pdf\\', {\\'type\\': \\'document\\'}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)\\'}), (\\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA SIOP-RTSG 2016\\'}), (\\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms tumours\\'}), (\\'non-Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'non-Wilms tumours\\'}), (\\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Website\\', \\'name\\': \\'www.siop-rtsg.eu\\'}), (\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology\\'}), (\\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Person\\', \\'name\\': \\'Marry M. van den Heuvel-Eibrink\\'}), (\\'childhood renal tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'childhood renal tumours\\'}), (\\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'clear cell sarcoma of the kidney\\'}), (\\'renal cell carcinoma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'renal cell carcinoma\\'}), (\\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'malignant rhabdoid tumour of the kidney\\'}), (\\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'Wilms tumours_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'Children\u2019s Oncology Group (COG)\\'}), (\\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'SIOP\u22122001 randomized trial\\'}), (\\'actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'UKW3 trial\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)\\'}), (\\'localized disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'localized disease\\'}), (\\'metastatic disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'metastatic disease\\'}), (\\'bilateral disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'bilateral disease\\'}), (\\'relapsed disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'relapsed disease\\'}), (\\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subtype\\', \\'name\\': \\'blastemal-type Wilms tumours\\'}), (\\'radiotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgery_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'chemotherapy\\'}), (\\'Wilms Tumour_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms Tumour\\'}), (\\'CCSK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CCSK\\'}), (\\'MRTK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'MRTK\\'}), (\\'CMN_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CMN\\'}), (\\'RCC_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'RCC\\'}), (\\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u22122001_Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Trial\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'vincristine_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'vincristine\\'}), (\\'actinomycin D_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'actinomycin D\\'}), (\\'doxorubicin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'doxorubicin\\'}), (\\'etoposide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'Stage I_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage I\\'}), (\\'Stage II_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage II\\'}), (\\'Stage III_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage III\\'}), (\\'Stage IV_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage IV\\'}), (\\'Stage V_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage V\\'}), (\\'AV_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AV\\'}), (\\'AVD_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AVD\\'}), (\\'HR-1_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'HR-1\\'}), (\\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP-RTSG 2016\\'}), (\\'Overall Survival (OS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'CT-only nodules_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'CT-only nodules\\'}), (\\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP\u2013RTSG analysis\\'}), (\\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials\\'}), (\\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D plus doxorubicin\\'}), (\\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D\\'}), (\\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study_protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'MRI_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'MRI\\'}), (\\'CT_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'CT\\'}), (\\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_detail\\', \\'name\\': \\'cumulative doxorubicin dose\\'}), (\\'COG AREN0533 trial_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG AREN0533 trial\\'}), (\\'etoposide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'high-risk characteristics\\'}), (\\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG board\\'}), (\\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin\\'}), (\\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'high-dose chemotherapy and autologous stem cell transplantation\\'}), (\\'SIOP database_database\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'database\\', \\'name\\': \\'SIOP database\\'}), (\\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'AVD_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AVD\\'}), (\\'AV-2_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AV-2\\'}), (\\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Statistical Test\\', \\'name\\': \\'Log\u2013Rank P\\'}), (\\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'Bilateral Disease (Stage V)\\'}), (\\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Synchronous bilateral Wilms tumor\\'}), (\\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'End-stage renal disease (ESRD)\\'}), (\\'Aronson et al._Research Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Research Group\\', \\'name\\': \\'Aronson et al.\\'}), (\\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'Bilateral nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Study\\', \\'name\\': \\'SIOP\u22122001 study\\'}), (\\'Vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Vincristine\\'}), (\\'Actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Actinomycin D\\'}), (\\'Etoposide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Etoposide\\'}), (\\'Carboplatin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Carboplatin\\'}), (\\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease State\\', \\'name\\': \\'Relapsed Wilms Tumor\\'}), (\\'Group AA_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group AA\\'}), (\\'Group BB_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group BB\\'}), (\\'Group CC_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group CC\\'}), (\\'Doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Doxorubicin\\'}), (\\'Cyclophosphamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Cyclophosphamide\\'}), (\\'Ifosfamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Ifosfamide\\'}), (\\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'High-dose melphalan\\'}), (\\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UKW\u2011R protocol\\'}), (\\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'NWTS\u20115 relapse protocol\\'}), (\\'ASCR_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'procedure\\', \\'name\\': \\'ASCR\\'}), (\\'ifosfamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'ifosfamide\\'}), (\\'nephrotoxicity_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'nephrotoxicity\\'}), (\\'relapsed group CC_patient_group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'patient_group\\', \\'name\\': \\'relapsed group CC\\'}), (\\'diffuse anaplasia_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'diffuse anaplasia\\'}), (\\'blastemal-type tumors_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'blastemal-type tumors\\'}), (\\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'camptothecins_medication_class\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication_class\\', \\'name\\': \\'camptothecins\\'}), (\\'irinotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'irinotecan\\'}), (\\'topotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'topotecan\\'}), (\\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Innovative Therapies for Children with Cancer consortium\\'}), (\\'radiotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgical excision_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgical excision\\'}), (\\'stage IV WT_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'stage IV WT\\'}), (\\'AVD150_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD150\\'}), (\\'AVD250_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD250\\'}), (\\'low-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'low-risk disease\\'}), (\\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'intermediate-risk disease\\'}), (\\'high-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'high-risk disease\\'}), (\\'CDCV_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'CDCV\\'}), (\\'actinomycin-D_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'actinomycin-D\\'}), (\\'vincristine_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'doxorubicin\\'}), (\\'VP16_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'VP16\\'}), (\\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'contact\\', \\'name\\': \\'arnauld.verschuur@ap-hm.fr\\'}), (\\'surgery_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'chemotherapy\\'}), (\\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2212RTSG panel\\'}), (\\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Infant Wilms Tumors\\'}), (\\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'nephrectomy\\'}), (\\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'malignant rhabdoid tumors\\'}), (\\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Adult Wilms Tumors\\'}), (\\'anaplasia_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'anaplasia\\'}), (\\'actinomycin D_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'carboplatin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'etoposide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'etoposide\\'}), (\\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'Nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'radical tumor nephrectomy\\'}), (\\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'lymph node sampling\\'}), (\\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'minimally invasive surgery\\'}), (\\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'laparoscopic surgery\\'}), (\\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'radiotherapy\\'}), (\\'Wilms tumours_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'Davila Fajardo et al._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Davila Fajardo et al.\\'}), (\\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'COG\u2013NWTS trials\\'}), (\\'whole-lung irradiation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'whole-lung irradiation\\'}), (\\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'pulmonary radiotherapy\\'}), (\\'proton therapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'proton therapy\\'}), (\\'dosimetric study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'dosimetric study\\'}), (\\'locoregional disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'locoregional disease\\'}), (\\'metastatic disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'metastatic disease\\'}), (\\'low-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'low-risk\\'}), (\\'intermediate-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'intermediate-risk\\'}), (\\'high-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'high-risk\\'}), (\\'stage I_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage I\\'}), (\\'stage II_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage II\\'}), (\\'stage III_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage III\\'}), (\\'major rupture_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'major rupture\\'}), (\\'Austria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Austria\\'}), (\\'Italy_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Italy\\'}), (\\'San Marino_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'San Marino\\'}), (\\'Iceland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Iceland\\'}), (\\'Germany_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Germany\\'}), (\\'Bulgaria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bulgaria\\'}), (\\'Turkey_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Turkey\\'}), (\\'Denmark_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Denmark\\'}), (\\'Poland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Poland\\'}), (\\'Greece_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Greece\\'}), (\\'Andorra_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Andorra\\'}), (\\'Belgium_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belgium\\'}), (\\'Serbia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Serbia\\'}), (\\'Albania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Albania\\'}), (\\'Moldova_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Moldova\\'}), (\\'Lithuania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Lithuania\\'}), (\\'Latvia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Latvia\\'}), (\\'Estonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Estonia\\'}), (\\'Luxembourg_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Luxembourg\\'}), (\\'Montenegro_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Montenegro\\'}), (\\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bosnia and Herzegovina\\'}), (\\'Croatia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Croatia\\'}), (\\'Slovenia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovenia\\'}), (\\'Macedonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Macedonia\\'}), (\\'United Kingdom_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'United Kingdom\\'}), (\\'Ireland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ireland\\'}), (\\'Spain_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Spain\\'}), (\\'Algeria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Algeria\\'}), (\\'Tunisia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Tunisia\\'}), (\\'Malta_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Malta\\'}), (\\'Morocco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Morocco\\'}), (\\'Portugal_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Portugal\\'}), (\\'France_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'France\\'}), (\\'Monaco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Monaco\\'}), (\\'Russia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Russia\\'}), (\\'Finland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Finland\\'}), (\\'Sweden_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Sweden\\'}), (\\'Norway_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Norway\\'}), (\\'Belarus_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belarus\\'}), (\\'Romania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Romania\\'}), (\\'Ukraine_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ukraine\\'}), (\\'Hungary_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Hungary\\'}), (\\'Czech Republic_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Czech Republic\\'}), (\\'Slovakia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovakia\\'}), (\\'Switzerland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Switzerland\\'}), (\\'Liechtenstein_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Liechtenstein\\'}), (\\'Netherlands_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Netherlands\\'}), (\\'University Hospital of Munich_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Munich\\'}), (\\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Tuebingen\\'}), (\\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Azienda Ospedaliera\\'}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Ospedale Pediatrico Bambino Ges\u00f9\\'}), (\\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Fondazione IRCCS Istituto Nazionale dei Tumori\\'}), (\\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Prinses Maxima Centrum\\'}), (\\'Marciniak Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Marciniak Hospital\\'}), (\\'Faculty of Medicine_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Faculty of Medicine\\'}), (\\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'St. Anna Kinderspital/CCRI\\'}), (\\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Armand Trousseau Hospital\\'}), (\\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Universitario Virgin del Rocio\\'}), (\\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Vall d\u2019Hebron\\'}), (\\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Great Ormond Street Hospital\\'}), (\\'University Hospital Homburg_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital Homburg\\'}), (\\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon\\'}), (\\'UMBRELLA protocol_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'ExPO\u2011r\u2011Net\\'}), (\\'Weirich, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Weirich, A.\\'}), (\\'Pritchard-Jones, K._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Pritchard-Jones, K.\\'}), (\\'de Kraker, J._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'de Kraker, J.\\'}), (\\'Graf, N._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Graf, N.\\'}), (\\'Green, D. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Green, D. M.\\'}), (\\'Spreafico, F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Spreafico, F.\\'}), (\\'Bellani, F. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Bellani, F. F.\\'}), (\\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'van den Heuvel-Eibrink, M. M.\\'}), (\"D\\'Angio, G. J._author\", {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \"D\\'Angio, G. J.\"}), (\\'Tournade, M. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Tournade, M. F.\\'}), (\\'Breslow, N. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Breslow, N. E.\\'}), (\\'Mitchell, C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Mitchell, C.\\'}), (\\'Verschuur, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Verschuur, A.\\'}), (\\'Grundy, P. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Grundy, P. E.\\'}), (\\'Warmann, S. W._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Warmann, S. W.\\'}), (\\'Smets, A. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Smets, A. M.\\'}), (\\'Dome, J. S._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dome, J. S.\\'}), (\\'Dix, D. B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dix, D. B.\\'}), (\\'Daw, N. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Daw, N. C.\\'}), (\\'Ha, T. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Ha, T. C.\\'}), (\\'Kremens, B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Kremens, B.\\'}), (\\'Furtwangler, R._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Furtwangler, R.\\'}), (\\'SIOP-9/GPOH_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP-9/GPOH\\'}), (\\'UKW3_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'UKW3\\'}), (\\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'SIOP 93\u201301 trial\\'}), (\\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP trial and study 93\u201301\\'}), (\\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'National Wilms Tumor Study Group\\'}), (\\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP WT 2001 protocol\\'}), (\\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Third National Wilms\u2019 Tumor Study\\'}), (\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'National Wilms Tumor Studies\\'}), (\\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Second National Wilms\u2019 Tumor Study\\'}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'UK Children\u2019s Cancer Study Group\\'}), (\\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Children\u2019s Oncology Group\\'})], \\'edges\\': [(\\'sample.pdf\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'non-Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'childhood renal tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'renal cell carcinoma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'localized disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'metastatic disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'bilateral disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'relapsed disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'radiotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'surgery_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'chemotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'Wilms Tumour_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CCSK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'MRTK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CMN_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'RCC_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP\u22122001_Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'vincristine_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'actinomycin D_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'doxorubicin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'etoposide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'carboplatin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'cyclophosphamide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage I_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage II_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage III_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage IV_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage V_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AV_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AVD_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'HR-1_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Overall Survival (OS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT-only nodules_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'MRI_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG AREN0533 trial_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'etoposide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'carboplatin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'cyclophosphamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP database_database\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AVD_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AV-2_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Aronson et al._Research Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Etoposide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Carboplatin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group AA_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group BB_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group CC_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Cyclophosphamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Ifosfamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'ASCR_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'ifosfamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'nephrotoxicity_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'relapsed group CC_patient_group\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'diffuse anaplasia_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'blastemal-type tumors_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'camptothecins_medication_class\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'irinotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'topotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'radiotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'surgical excision_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'stage IV WT_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD150_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD250_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'low-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'CDCV_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'actinomycin-D_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'vincristine_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'doxorubicin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'VP16_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'surgery_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'chemotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'anaplasia_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'actinomycin D_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'vincristine_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'doxorubicin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'carboplatin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'cyclophosphamide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'etoposide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'SIOP\u22122001_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Wilms tumours_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Davila Fajardo et al._author\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'whole-lung irradiation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'proton therapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'dosimetric study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'locoregional disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'metastatic disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'low-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'intermediate-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'high-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage I_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage II_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage III_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'major rupture_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Austria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Italy_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'San Marino_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Iceland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Germany_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bulgaria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Turkey_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Denmark_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Poland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Greece_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Andorra_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belgium_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Serbia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Albania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Moldova_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Lithuania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Latvia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Estonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Luxembourg_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Montenegro_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Croatia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovenia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Macedonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'United Kingdom_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ireland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Spain_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Algeria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Tunisia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Malta_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Morocco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Portugal_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'France_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Monaco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Russia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Finland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Sweden_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Norway_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belarus_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Romania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ukraine_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hungary_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Czech Republic_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovakia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Switzerland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Liechtenstein_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Netherlands_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Munich_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Marciniak Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Faculty of Medicine_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital Homburg_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Weirich, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Pritchard-Jones, K._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'de Kraker, J._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Graf, N._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Green, D. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Spreafico, F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Bellani, F. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \"D\\'Angio, G. J._author\", {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Tournade, M. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Breslow, N. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Mitchell, C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Verschuur, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Grundy, P. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Warmann, S. W._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Smets, A. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dome, J. S._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dix, D. B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Daw, N. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ha, T. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Kremens, B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Furtwangler, R._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP-9/GPOH_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UKW3_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10})]}, {\\'nodes\\': [(\\'vincristine_entity\\', {}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {}), (\\'www.siop-rtsg.eu_entity\\', {}), (\\'stage II_entity\\', {}), (\\'Wilms tumours_entity\\', {}), (\\'Relapsed Wilms Tumor_entity\\', {}), (\\'Davila Fajardo et al._entity\\', {}), (\\'vincristine, actinomycin D, and doxorubicin_entity\\', {}), (\\'SIOP\u22122001 randomized trial_entity\\', {}), (\\'surgery_entity\\', {}), (\\'non-Wilms tumours_entity\\', {}), (\\'actinomycin D_entity\\', {}), (\\'diffuse anaplasia_entity\\', {}), (\\'Synchronous bilateral Wilms tumor_entity\\', {}), (\\'CT-only nodules_entity\\', {}), (\\'relapsed group CC_entity\\', {}), (\\'increased relapse risk_entity\\', {}), (\\'reduced survival_entity\\', {}), (\\'UKW3 trial_entity\\', {}), (\\'chemotherapy_entity\\', {}), (\\'Bilateral Disease (Stage V)_entity\\', {}), (\\'blastemal-type tumors_entity\\', {}), (\\'UMBRELLA protocol_entity\\', {}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', {}), (\\'minimally invasive surgery_entity\\', {}), (\\'VP16_entity\\', {}), (\\'Wilms tumor_entity\\', {}), (\\'anaplasia_entity\\', {}), (\\'radical tumor nephrectomy_entity\\', {}), (\\'Innovative Therapies for Children with Cancer consortium_entity\\', {}), (\\'cumulative doxorubicin dose_entity\\', {}), (\\'etoposide_entity\\', {}), (\\'large-volume tumours_entity\\', {}), (\\'Stage IV_entity\\', {}), (\\'CDCV_entity\\', {}), (\\'SIOP\u2013RTSG_entity\\', {}), (\\'AVD150_entity\\', {}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', {}), (\\'laparoscopic surgery_entity\\', {}), (\\'SIOP\u2212RTSG panel_entity\\', {}), (\\'actinomycin-D_entity\\', {}), (\\'COG AREN0533 trial_entity\\', {}), (\\'cyclophosphamide_entity\\', {}), (\\'carboplatin_entity\\', {}), (\\'UKW\u2011R protocol_entity\\', {}), (\\'Nephron-sparing surgery (NSS)_entity\\', {}), (\\'Adult Wilms Tumors_entity\\', {}), (\\'doxorubicin_entity\\', {}), (\\'NWTS\u20115 relapse protocol_entity\\', {}), (\\'End-stage renal disease (ESRD)_entity\\', {}), (\\'AVD250_entity\\', {}), (\\'Children\u2019s Oncology Group (COG)_entity\\', {}), (\\'blastemal-type Wilms tumour_entity\\', {}), (\\'SIOP\u22122001_entity\\', {}), (\\'radiotherapy_entity\\', {}), (\\'childhood renal tumours_entity\\', {})], \\'edges\\': [(\\'vincristine_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'stage II_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'indicated_for_in_adults\\'}), (\\'Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'Wilms tumours_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated under\\'}), (\\'Relapsed Wilms Tumor_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guided_by\\'}), (\\'Davila Fajardo et al._entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed\\'}), (\\'SIOP\u22122001 randomized trial_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated use in\\'}), (\\'surgery_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'non-Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'actinomycin D_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Synchronous bilateral Wilms tumor_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'instance_of\\'}), (\\'CT-only nodules_entity\\', \\'increased relapse risk_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'reduced survival_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included_in\\'}), (\\'relapsed group CC_entity\\', \\'diffuse anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'blastemal-type tumors_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UKW3 trial_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'UKW3 trial_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'chemotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UMBRELLA protocol_entity\\', \\'COG AREN0533 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses_data_from\\'}), (\\'UMBRELLA protocol_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'advises_treatment_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'Innovative Therapies for Children with Cancer consortium_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborates_with\\'}), (\\'UMBRELLA protocol_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'surgery_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is the standard of\\'}), (\\'UMBRELLA protocol_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guides treatment in\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', \\'UKW3 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\\'minimally invasive surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'anaplasia_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'radical tumor nephrectomy_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'standard_of_care_for\\'}), (\\'Stage IV_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'presents in\\'}), (\\'CDCV_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'VP16_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'aims to improve survival rates of\\'}), (\\'AVD150_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed_by\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'succeeds\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'www.siop-rtsg.eu_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'available_on\\'}), (\\'laparoscopic surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'COG AREN0533 trial_entity\\', \\'cumulative doxorubicin dose_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'evaluates\\'}), (\\'UKW\u2011R protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'Nephron-sparing surgery (NSS)_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'classification_developed_by\\'}), (\\'Adult Wilms Tumors_entity\\', \\'anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'Adult Wilms Tumors_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'doxorubicin_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'doxorubicin_entity\\', \\'large-volume tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'recommended for\\'}), (\\'NWTS\u20115 relapse protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'End-stage renal disease (ESRD)_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'AVD250_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'Children\u2019s Oncology Group (COG)_entity\\', \\'SIOP\u22122001 randomized trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborated with\\'}), (\\'blastemal-type Wilms tumour_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment intensified according to\\'}), (\\'SIOP\u22122001_entity\\', \\'vincristine, actinomycin D, and doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses\\'}), (\\'SIOP\u22122001_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provided_guidelines_for\\'}), (\\'radiotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'radiotherapy_entity\\', \\'SIOP\u2212RTSG panel_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'contact_for_guidance\\'})]}, {\\'nodes\\': [(\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {}), (\\'Marry M. van den Heuvel-Eibrink_entity\\', {})], \\'edges\\': [(\\'Marry M. van den Heuvel-Eibrink_entity\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'affiliated_with\\'})]}, {\\'nodes\\': [(\\'Stage II_entity\\', {}), (\\'AV_entity\\', {}), (\\'Stage III_entity\\', {}), (\\'vincestine and actinomycin D_entity\\', {}), (\\'AVD_entity\\', {})], \\'edges\\': [(\\'Stage II_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AV_entity\\', \\'Stage II_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Stage III_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AVD_entity\\', \\'Stage III_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'SIOP-RTSG 2016_entity\\', {}), (\\'RCC_entity\\', {}), (\\'CMN_entity\\', {})], \\'edges\\': [(\\'RCC_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'}), (\\'CMN_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'})]}, {\\'nodes\\': [(\\'HR-1_entity\\', {}), (\\'High-risk blastemal type Wilms tumour_entity\\', {})], \\'edges\\': [(\\'HR-1_entity\\', \\'High-risk blastemal type Wilms tumour_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'unfavorable prognosis_entity\\', {}), (\\'high-risk characteristics_entity\\', {})], \\'edges\\': [(\\'high-risk characteristics_entity\\', \\'unfavorable prognosis_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'leads_to\\'})]}, {\\'nodes\\': [(\\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {}), (\\'SIOP\u2013RTSG board_entity\\', {})], \\'edges\\': [(\\'SIOP\u2013RTSG board_entity\\', \\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggests\\'})]}, {\\'nodes\\': [(\\'regimen and outcomes_entity\\', {}), (\\'SIOP database_entity\\', {})], \\'edges\\': [(\\'SIOP database_entity\\', \\'regimen and outcomes_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'captures_data_on\\'})]}, {\\'nodes\\': [(\\'Bilateral nephron-sparing surgery (NSS)_entity\\', {}), (\\'Aronson et al._entity\\', {})], \\'edges\\': [(\\'Aronson et al._entity\\', \\'Bilateral nephron-sparing surgery (NSS)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'observed_effectiveness_of\\'})]}, {\\'nodes\\': [(\\'SIOP\u22122001 study_entity\\', {}), (\\'Actinomycin D_entity\\', {}), (\\'Vincristine_entity\\', {})], \\'edges\\': [(\\'SIOP\u22122001 study_entity\\', \\'Vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'}), (\\'SIOP\u22122001 study_entity\\', \\'Actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'})]}, {\\'nodes\\': [(\\'High-dose melphalan_entity\\', {}), (\\'Group AA_entity\\', {}), (\\'Carboplatin_entity\\', {}), (\\'Doxorubicin_entity\\', {}), (\\'Etoposide_entity\\', {}), (\\'Group BB_entity\\', {}), (\\'Cyclophosphamide_entity\\', {}), (\\'Ifosfamide_entity\\', {})], \\'edges\\': [(\\'Group AA_entity\\', \\'Doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Ifosfamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'High-dose melphalan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'})]}, {\\'nodes\\': [(\\'nephrotoxicity_entity\\', {}), (\\'ifosfamide_entity\\', {})], \\'edges\\': [(\\'ifosfamide_entity\\', \\'nephrotoxicity_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'related_to\\'})]}, {\\'nodes\\': [(\\'camptothecins_entity\\', {}), (\\'irinotecan_entity\\', {}), (\\'topotecan_entity\\', {})], \\'edges\\': [(\\'camptothecins_entity\\', \\'irinotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'camptothecins_entity\\', \\'topotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'})]}, {\\'nodes\\': [(\\'Infant Wilms Tumors_entity\\', {}), (\\'nephrectomy_entity\\', {})], \\'edges\\': [(\\'Infant Wilms Tumors_entity\\', \\'nephrectomy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_option\\'})]}, {\\'nodes\\': [(\\'congenital mesoblastic nephroma_entity\\', {}), (\\'surgery alone_entity\\', {})], \\'edges\\': [(\\'congenital mesoblastic nephroma_entity\\', \\'surgery alone_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'alternative chemotherapy_entity\\', {}), (\\'malignant rhabdoid tumors_entity\\', {})], \\'edges\\': [(\\'malignant rhabdoid tumors_entity\\', \\'alternative chemotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'lymph node sampling_entity\\', {}), (\\'accurate staging_entity\\', {})], \\'edges\\': [(\\'lymph node sampling_entity\\', \\'accurate staging_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'purpose_of\\'})]}, {\\'nodes\\': [(\\'COG\u2013NWTS trials_entity\\', {}), (\\'whole-lung irradiation_entity\\', {})], \\'edges\\': [(\\'COG\u2013NWTS trials_entity\\', \\'whole-lung irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'informed_dosage_for\\'})]}, {\\'nodes\\': [(\\'lung metastases_entity\\', {}), (\\'pulmonary radiotherapy_entity\\', {})], \\'edges\\': [(\\'pulmonary radiotherapy_entity\\', \\'lung metastases_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'administered_for\\'})]}, {\\'nodes\\': [(\\'dosimetric study_entity\\', {}), (\\'proton therapy_entity\\', {}), (\\'flank irradiation_entity\\', {})], \\'edges\\': [(\\'dosimetric study_entity\\', \\'proton therapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated\\'}), (\\'proton therapy_entity\\', \\'flank irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggested_for\\'})]}, {\\'nodes\\': [(\\'metastatic disease_entity\\', {}), (\\'radiotherapy guidelines_entity\\', {}), (\\'locoregional disease_entity\\', {})], \\'edges\\': [(\\'radiotherapy guidelines_entity\\', \\'locoregional disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'}), (\\'radiotherapy guidelines_entity\\', \\'metastatic disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'})]}, {\\'nodes\\': [(\\'major rupture_entity\\', {}), (\\'stage III_entity\\', {})], \\'edges\\': [(\\'stage III_entity\\', \\'major rupture_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes_condition\\'})]}, {\\'nodes\\': [(\\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {}), (\\'ExPO\u2011r\u2011Net_entity\\', {})], \\'edges\\': [(\\'ExPO\u2011r\u2011Net_entity\\', \\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is part of\\'})]}, {\\'nodes\\': [(\\'University Hospital of Munich_entity\\', {}), (\\'Germany_entity\\', {}), (\\'University Hospital of Tuebingen_entity\\', {})], \\'edges\\': [(\\'Germany_entity\\', \\'University Hospital of Munich_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Germany_entity\\', \\'University Hospital of Tuebingen_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {}), (\\'Italy_entity\\', {}), (\\'Azienda Ospedaliera_entity\\', {}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {})], \\'edges\\': [(\\'Italy_entity\\', \\'Azienda Ospedaliera_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Netherlands_entity\\', {}), (\\'Prinses Maxima Centrum_entity\\', {})], \\'edges\\': [(\\'Netherlands_entity\\', \\'Prinses Maxima Centrum_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Marciniak Hospital_entity\\', {}), (\\'Poland_entity\\', {}), (\\'Faculty of Medicine_entity\\', {})], \\'edges\\': [(\\'Poland_entity\\', \\'Marciniak Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Poland_entity\\', \\'Faculty of Medicine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'St. Anna Kinderspital/CCRI_entity\\', {}), (\\'Austria_entity\\', {})], \\'edges\\': [(\\'Austria_entity\\', \\'St. Anna Kinderspital/CCRI_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'France_entity\\', {}), (\\'Armand Trousseau Hospital_entity\\', {})], \\'edges\\': [(\\'France_entity\\', \\'Armand Trousseau Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Spain_entity\\', {}), (\\'Hospital Vall d\u2019Hebron_entity\\', {}), (\\'Hospital Universitario Virgin del Rocio_entity\\', {})], \\'edges\\': [(\\'Spain_entity\\', \\'Hospital Universitario Virgin del Rocio_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Spain_entity\\', \\'Hospital Vall d\u2019Hebron_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'United Kingdom_entity\\', {}), (\\'Great Ormond Street Hospital_entity\\', {})], \\'edges\\': [(\\'United Kingdom_entity\\', \\'Great Ormond Street Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Weirich, A._entity\\', {}), (\\'SIOP-9/GPOH_entity\\', {})], \\'edges\\': [(\\'Weirich, A._entity\\', \\'SIOP-9/GPOH_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Pritchard-Jones, K._entity\\', {}), (\\'UKW3_entity\\', {})], \\'edges\\': [(\\'Pritchard-Jones, K._entity\\', \\'UKW3_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed in\\'})]}, {\\'nodes\\': [(\\'SIOP 93\u201301 trial_entity\\', {}), (\\'de Kraker, J._entity\\', {})], \\'edges\\': [(\\'de Kraker, J._entity\\', \\'SIOP 93\u201301 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'SIOP trial and study 93\u201301_entity\\', {}), (\\'Graf, N._entity\\', {})], \\'edges\\': [(\\'Graf, N._entity\\', \\'SIOP trial and study 93\u201301_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Green, D. M._entity\\', {}), (\\'National Wilms Tumor Study Group_entity\\', {})], \\'edges\\': [(\\'Green, D. M._entity\\', \\'National Wilms Tumor Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}, {\\'nodes\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', {}), (\\'SIOP WT 2001 protocol_entity\\', {})], \\'edges\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', \\'SIOP WT 2001 protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Third National Wilms\u2019 Tumor Study_entity\\', {}), (\"D\\'Angio, G. J._entity\", {}), (\\'Second National Wilms\u2019 Tumor Study_entity\\', {})], \\'edges\\': [(\"D\\'Angio, G. J._entity\", \\'Third National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\"D\\'Angio, G. J._entity\", \\'Second National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {}), (\\'Tournade, M. F._entity\\', {}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {})], \\'edges\\': [(\\'Tournade, M. F._entity\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'}), (\\'Tournade, M. F._entity\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Breslow, N. E._entity\\', {}), (\\'National Wilms Tumor Studies_entity\\', {})], \\'edges\\': [(\\'Breslow, N. E._entity\\', \\'National Wilms Tumor Studies_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Mitchell, C._entity\\', {}), (\\'UK Children\u2019s Cancer Study Group_entity\\', {})], \\'edges\\': [(\\'Mitchell, C._entity\\', \\'UK Children\u2019s Cancer Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'under\\'})]}, {\\'nodes\\': [(\\'Daw, N. C._entity\\', {}), (\\'Dix, D. B._entity\\', {}), (\\'Children\u2019s Oncology Group_entity\\', {}), (\\'Grundy, P. E._entity\\', {})], \\'edges\\': [(\\'Daw, N. C._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted under\\'}), (\\'Dix, D. B._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'}), (\\'Grundy, P. E._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}]', expected_output='By integrating biomarker and imaging research with standardized treatment guidelines.', context=None, retrieval_context=['[{\\'nodes\\': [(\\'sample.pdf\\', {\\'type\\': \\'document\\'}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)\\'}), (\\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA SIOP-RTSG 2016\\'}), (\\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms tumours\\'}), (\\'non-Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'non-Wilms tumours\\'}), (\\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Website\\', \\'name\\': \\'www.siop-rtsg.eu\\'}), (\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology\\'}), (\\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Person\\', \\'name\\': \\'Marry M. van den Heuvel-Eibrink\\'}), (\\'childhood renal tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'childhood renal tumours\\'}), (\\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'clear cell sarcoma of the kidney\\'}), (\\'renal cell carcinoma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'renal cell carcinoma\\'}), (\\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'malignant rhabdoid tumour of the kidney\\'}), (\\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'Wilms tumours_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'Children\u2019s Oncology Group (COG)\\'}), (\\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'SIOP\u22122001 randomized trial\\'}), (\\'actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'UKW3 trial\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)\\'}), (\\'localized disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'localized disease\\'}), (\\'metastatic disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'metastatic disease\\'}), (\\'bilateral disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'bilateral disease\\'}), (\\'relapsed disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'relapsed disease\\'}), (\\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subtype\\', \\'name\\': \\'blastemal-type Wilms tumours\\'}), (\\'radiotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgery_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'chemotherapy\\'}), (\\'Wilms Tumour_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms Tumour\\'}), (\\'CCSK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CCSK\\'}), (\\'MRTK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'MRTK\\'}), (\\'CMN_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CMN\\'}), (\\'RCC_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'RCC\\'}), (\\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u22122001_Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Trial\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'vincristine_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'vincristine\\'}), (\\'actinomycin D_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'actinomycin D\\'}), (\\'doxorubicin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'doxorubicin\\'}), (\\'etoposide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'Stage I_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage I\\'}), (\\'Stage II_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage II\\'}), (\\'Stage III_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage III\\'}), (\\'Stage IV_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage IV\\'}), (\\'Stage V_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage V\\'}), (\\'AV_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AV\\'}), (\\'AVD_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AVD\\'}), (\\'HR-1_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'HR-1\\'}), (\\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP-RTSG 2016\\'}), (\\'Overall Survival (OS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'CT-only nodules_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'CT-only nodules\\'}), (\\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP\u2013RTSG analysis\\'}), (\\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials\\'}), (\\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D plus doxorubicin\\'}), (\\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D\\'}), (\\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study_protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'MRI_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'MRI\\'}), (\\'CT_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'CT\\'}), (\\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_detail\\', \\'name\\': \\'cumulative doxorubicin dose\\'}), (\\'COG AREN0533 trial_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG AREN0533 trial\\'}), (\\'etoposide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'high-risk characteristics\\'}), (\\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG board\\'}), (\\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin\\'}), (\\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'high-dose chemotherapy and autologous stem cell transplantation\\'}), (\\'SIOP database_database\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'database\\', \\'name\\': \\'SIOP database\\'}), (\\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'AVD_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AVD\\'}), (\\'AV-2_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AV-2\\'}), (\\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Statistical Test\\', \\'name\\': \\'Log\u2013Rank P\\'}), (\\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'Bilateral Disease (Stage V)\\'}), (\\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Synchronous bilateral Wilms tumor\\'}), (\\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'End-stage renal disease (ESRD)\\'}), (\\'Aronson et al._Research Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Research Group\\', \\'name\\': \\'Aronson et al.\\'}), (\\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'Bilateral nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Study\\', \\'name\\': \\'SIOP\u22122001 study\\'}), (\\'Vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Vincristine\\'}), (\\'Actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Actinomycin D\\'}), (\\'Etoposide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Etoposide\\'}), (\\'Carboplatin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Carboplatin\\'}), (\\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease State\\', \\'name\\': \\'Relapsed Wilms Tumor\\'}), (\\'Group AA_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group AA\\'}), (\\'Group BB_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group BB\\'}), (\\'Group CC_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group CC\\'}), (\\'Doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Doxorubicin\\'}), (\\'Cyclophosphamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Cyclophosphamide\\'}), (\\'Ifosfamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Ifosfamide\\'}), (\\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'High-dose melphalan\\'}), (\\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UKW\u2011R protocol\\'}), (\\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'NWTS\u20115 relapse protocol\\'}), (\\'ASCR_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'procedure\\', \\'name\\': \\'ASCR\\'}), (\\'ifosfamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'ifosfamide\\'}), (\\'nephrotoxicity_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'nephrotoxicity\\'}), (\\'relapsed group CC_patient_group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'patient_group\\', \\'name\\': \\'relapsed group CC\\'}), (\\'diffuse anaplasia_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'diffuse anaplasia\\'}), (\\'blastemal-type tumors_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'blastemal-type tumors\\'}), (\\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'camptothecins_medication_class\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication_class\\', \\'name\\': \\'camptothecins\\'}), (\\'irinotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'irinotecan\\'}), (\\'topotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'topotecan\\'}), (\\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Innovative Therapies for Children with Cancer consortium\\'}), (\\'radiotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgical excision_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgical excision\\'}), (\\'stage IV WT_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'stage IV WT\\'}), (\\'AVD150_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD150\\'}), (\\'AVD250_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD250\\'}), (\\'low-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'low-risk disease\\'}), (\\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'intermediate-risk disease\\'}), (\\'high-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'high-risk disease\\'}), (\\'CDCV_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'CDCV\\'}), (\\'actinomycin-D_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'actinomycin-D\\'}), (\\'vincristine_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'doxorubicin\\'}), (\\'VP16_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'VP16\\'}), (\\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'contact\\', \\'name\\': \\'arnauld.verschuur@ap-hm.fr\\'}), (\\'surgery_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'chemotherapy\\'}), (\\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2212RTSG panel\\'}), (\\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Infant Wilms Tumors\\'}), (\\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'nephrectomy\\'}), (\\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'malignant rhabdoid tumors\\'}), (\\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Adult Wilms Tumors\\'}), (\\'anaplasia_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'anaplasia\\'}), (\\'actinomycin D_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'carboplatin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'etoposide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'etoposide\\'}), (\\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'Nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'radical tumor nephrectomy\\'}), (\\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'lymph node sampling\\'}), (\\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'minimally invasive surgery\\'}), (\\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'laparoscopic surgery\\'}), (\\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'radiotherapy\\'}), (\\'Wilms tumours_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'Davila Fajardo et al._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Davila Fajardo et al.\\'}), (\\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'COG\u2013NWTS trials\\'}), (\\'whole-lung irradiation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'whole-lung irradiation\\'}), (\\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'pulmonary radiotherapy\\'}), (\\'proton therapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'proton therapy\\'}), (\\'dosimetric study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'dosimetric study\\'}), (\\'locoregional disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'locoregional disease\\'}), (\\'metastatic disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'metastatic disease\\'}), (\\'low-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'low-risk\\'}), (\\'intermediate-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'intermediate-risk\\'}), (\\'high-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'high-risk\\'}), (\\'stage I_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage I\\'}), (\\'stage II_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage II\\'}), (\\'stage III_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage III\\'}), (\\'major rupture_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'major rupture\\'}), (\\'Austria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Austria\\'}), (\\'Italy_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Italy\\'}), (\\'San Marino_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'San Marino\\'}), (\\'Iceland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Iceland\\'}), (\\'Germany_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Germany\\'}), (\\'Bulgaria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bulgaria\\'}), (\\'Turkey_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Turkey\\'}), (\\'Denmark_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Denmark\\'}), (\\'Poland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Poland\\'}), (\\'Greece_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Greece\\'}), (\\'Andorra_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Andorra\\'}), (\\'Belgium_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belgium\\'}), (\\'Serbia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Serbia\\'}), (\\'Albania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Albania\\'}), (\\'Moldova_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Moldova\\'}), (\\'Lithuania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Lithuania\\'}), (\\'Latvia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Latvia\\'}), (\\'Estonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Estonia\\'}), (\\'Luxembourg_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Luxembourg\\'}), (\\'Montenegro_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Montenegro\\'}), (\\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bosnia and Herzegovina\\'}), (\\'Croatia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Croatia\\'}), (\\'Slovenia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovenia\\'}), (\\'Macedonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Macedonia\\'}), (\\'United Kingdom_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'United Kingdom\\'}), (\\'Ireland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ireland\\'}), (\\'Spain_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Spain\\'}), (\\'Algeria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Algeria\\'}), (\\'Tunisia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Tunisia\\'}), (\\'Malta_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Malta\\'}), (\\'Morocco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Morocco\\'}), (\\'Portugal_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Portugal\\'}), (\\'France_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'France\\'}), (\\'Monaco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Monaco\\'}), (\\'Russia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Russia\\'}), (\\'Finland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Finland\\'}), (\\'Sweden_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Sweden\\'}), (\\'Norway_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Norway\\'}), (\\'Belarus_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belarus\\'}), (\\'Romania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Romania\\'}), (\\'Ukraine_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ukraine\\'}), (\\'Hungary_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Hungary\\'}), (\\'Czech Republic_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Czech Republic\\'}), (\\'Slovakia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovakia\\'}), (\\'Switzerland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Switzerland\\'}), (\\'Liechtenstein_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Liechtenstein\\'}), (\\'Netherlands_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Netherlands\\'}), (\\'University Hospital of Munich_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Munich\\'}), (\\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Tuebingen\\'}), (\\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Azienda Ospedaliera\\'}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Ospedale Pediatrico Bambino Ges\u00f9\\'}), (\\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Fondazione IRCCS Istituto Nazionale dei Tumori\\'}), (\\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Prinses Maxima Centrum\\'}), (\\'Marciniak Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Marciniak Hospital\\'}), (\\'Faculty of Medicine_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Faculty of Medicine\\'}), (\\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'St. Anna Kinderspital/CCRI\\'}), (\\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Armand Trousseau Hospital\\'}), (\\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Universitario Virgin del Rocio\\'}), (\\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Vall d\u2019Hebron\\'}), (\\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Great Ormond Street Hospital\\'}), (\\'University Hospital Homburg_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital Homburg\\'}), (\\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon\\'}), (\\'UMBRELLA protocol_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'ExPO\u2011r\u2011Net\\'}), (\\'Weirich, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Weirich, A.\\'}), (\\'Pritchard-Jones, K._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Pritchard-Jones, K.\\'}), (\\'de Kraker, J._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'de Kraker, J.\\'}), (\\'Graf, N._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Graf, N.\\'}), (\\'Green, D. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Green, D. M.\\'}), (\\'Spreafico, F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Spreafico, F.\\'}), (\\'Bellani, F. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Bellani, F. F.\\'}), (\\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'van den Heuvel-Eibrink, M. M.\\'}), (\"D\\'Angio, G. J._author\", {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \"D\\'Angio, G. J.\"}), (\\'Tournade, M. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Tournade, M. F.\\'}), (\\'Breslow, N. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Breslow, N. E.\\'}), (\\'Mitchell, C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Mitchell, C.\\'}), (\\'Verschuur, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Verschuur, A.\\'}), (\\'Grundy, P. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Grundy, P. E.\\'}), (\\'Warmann, S. W._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Warmann, S. W.\\'}), (\\'Smets, A. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Smets, A. M.\\'}), (\\'Dome, J. S._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dome, J. S.\\'}), (\\'Dix, D. B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dix, D. B.\\'}), (\\'Daw, N. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Daw, N. C.\\'}), (\\'Ha, T. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Ha, T. C.\\'}), (\\'Kremens, B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Kremens, B.\\'}), (\\'Furtwangler, R._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Furtwangler, R.\\'}), (\\'SIOP-9/GPOH_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP-9/GPOH\\'}), (\\'UKW3_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'UKW3\\'}), (\\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'SIOP 93\u201301 trial\\'}), (\\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP trial and study 93\u201301\\'}), (\\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'National Wilms Tumor Study Group\\'}), (\\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP WT 2001 protocol\\'}), (\\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Third National Wilms\u2019 Tumor Study\\'}), (\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'National Wilms Tumor Studies\\'}), (\\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Second National Wilms\u2019 Tumor Study\\'}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'UK Children\u2019s Cancer Study Group\\'}), (\\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Children\u2019s Oncology Group\\'})], \\'edges\\': [(\\'sample.pdf\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'non-Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'childhood renal tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'renal cell carcinoma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'localized disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'metastatic disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'bilateral disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'relapsed disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'radiotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'surgery_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'chemotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'Wilms Tumour_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CCSK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'MRTK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CMN_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'RCC_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP\u22122001_Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'vincristine_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'actinomycin D_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'doxorubicin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'etoposide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'carboplatin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'cyclophosphamide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage I_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage II_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage III_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage IV_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage V_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AV_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AVD_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'HR-1_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Overall Survival (OS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT-only nodules_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'MRI_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG AREN0533 trial_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'etoposide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'carboplatin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'cyclophosphamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP database_database\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AVD_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AV-2_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Aronson et al._Research Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Etoposide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Carboplatin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group AA_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group BB_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group CC_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Cyclophosphamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Ifosfamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'ASCR_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'ifosfamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'nephrotoxicity_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'relapsed group CC_patient_group\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'diffuse anaplasia_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'blastemal-type tumors_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'camptothecins_medication_class\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'irinotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'topotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'radiotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'surgical excision_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'stage IV WT_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD150_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD250_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'low-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'CDCV_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'actinomycin-D_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'vincristine_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'doxorubicin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'VP16_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'surgery_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'chemotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'anaplasia_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'actinomycin D_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'vincristine_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'doxorubicin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'carboplatin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'cyclophosphamide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'etoposide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'SIOP\u22122001_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Wilms tumours_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Davila Fajardo et al._author\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'whole-lung irradiation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'proton therapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'dosimetric study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'locoregional disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'metastatic disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'low-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'intermediate-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'high-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage I_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage II_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage III_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'major rupture_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Austria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Italy_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'San Marino_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Iceland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Germany_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bulgaria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Turkey_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Denmark_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Poland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Greece_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Andorra_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belgium_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Serbia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Albania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Moldova_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Lithuania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Latvia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Estonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Luxembourg_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Montenegro_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Croatia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovenia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Macedonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'United Kingdom_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ireland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Spain_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Algeria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Tunisia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Malta_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Morocco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Portugal_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'France_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Monaco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Russia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Finland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Sweden_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Norway_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belarus_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Romania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ukraine_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hungary_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Czech Republic_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovakia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Switzerland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Liechtenstein_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Netherlands_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Munich_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Marciniak Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Faculty of Medicine_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital Homburg_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Weirich, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Pritchard-Jones, K._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'de Kraker, J._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Graf, N._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Green, D. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Spreafico, F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Bellani, F. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \"D\\'Angio, G. J._author\", {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Tournade, M. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Breslow, N. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Mitchell, C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Verschuur, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Grundy, P. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Warmann, S. W._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Smets, A. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dome, J. S._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dix, D. B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Daw, N. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ha, T. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Kremens, B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Furtwangler, R._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP-9/GPOH_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UKW3_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10})]}, {\\'nodes\\': [(\\'vincristine_entity\\', {}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {}), (\\'www.siop-rtsg.eu_entity\\', {}), (\\'stage II_entity\\', {}), (\\'Wilms tumours_entity\\', {}), (\\'Relapsed Wilms Tumor_entity\\', {}), (\\'Davila Fajardo et al._entity\\', {}), (\\'vincristine, actinomycin D, and doxorubicin_entity\\', {}), (\\'SIOP\u22122001 randomized trial_entity\\', {}), (\\'surgery_entity\\', {}), (\\'non-Wilms tumours_entity\\', {}), (\\'actinomycin D_entity\\', {}), (\\'diffuse anaplasia_entity\\', {}), (\\'Synchronous bilateral Wilms tumor_entity\\', {}), (\\'CT-only nodules_entity\\', {}), (\\'relapsed group CC_entity\\', {}), (\\'increased relapse risk_entity\\', {}), (\\'reduced survival_entity\\', {}), (\\'UKW3 trial_entity\\', {}), (\\'chemotherapy_entity\\', {}), (\\'Bilateral Disease (Stage V)_entity\\', {}), (\\'blastemal-type tumors_entity\\', {}), (\\'UMBRELLA protocol_entity\\', {}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', {}), (\\'minimally invasive surgery_entity\\', {}), (\\'VP16_entity\\', {}), (\\'Wilms tumor_entity\\', {}), (\\'anaplasia_entity\\', {}), (\\'radical tumor nephrectomy_entity\\', {}), (\\'Innovative Therapies for Children with Cancer consortium_entity\\', {}), (\\'cumulative doxorubicin dose_entity\\', {}), (\\'etoposide_entity\\', {}), (\\'large-volume tumours_entity\\', {}), (\\'Stage IV_entity\\', {}), (\\'CDCV_entity\\', {}), (\\'SIOP\u2013RTSG_entity\\', {}), (\\'AVD150_entity\\', {}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', {}), (\\'laparoscopic surgery_entity\\', {}), (\\'SIOP\u2212RTSG panel_entity\\', {}), (\\'actinomycin-D_entity\\', {}), (\\'COG AREN0533 trial_entity\\', {}), (\\'cyclophosphamide_entity\\', {}), (\\'carboplatin_entity\\', {}), (\\'UKW\u2011R protocol_entity\\', {}), (\\'Nephron-sparing surgery (NSS)_entity\\', {}), (\\'Adult Wilms Tumors_entity\\', {}), (\\'doxorubicin_entity\\', {}), (\\'NWTS\u20115 relapse protocol_entity\\', {}), (\\'End-stage renal disease (ESRD)_entity\\', {}), (\\'AVD250_entity\\', {}), (\\'Children\u2019s Oncology Group (COG)_entity\\', {}), (\\'blastemal-type Wilms tumour_entity\\', {}), (\\'SIOP\u22122001_entity\\', {}), (\\'radiotherapy_entity\\', {}), (\\'childhood renal tumours_entity\\', {})], \\'edges\\': [(\\'vincristine_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'stage II_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'indicated_for_in_adults\\'}), (\\'Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'Wilms tumours_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated under\\'}), (\\'Relapsed Wilms Tumor_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guided_by\\'}), (\\'Davila Fajardo et al._entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed\\'}), (\\'SIOP\u22122001 randomized trial_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated use in\\'}), (\\'surgery_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'non-Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'actinomycin D_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Synchronous bilateral Wilms tumor_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'instance_of\\'}), (\\'CT-only nodules_entity\\', \\'increased relapse risk_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'reduced survival_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included_in\\'}), (\\'relapsed group CC_entity\\', \\'diffuse anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'blastemal-type tumors_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UKW3 trial_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'UKW3 trial_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'chemotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UMBRELLA protocol_entity\\', \\'COG AREN0533 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses_data_from\\'}), (\\'UMBRELLA protocol_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'advises_treatment_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'Innovative Therapies for Children with Cancer consortium_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborates_with\\'}), (\\'UMBRELLA protocol_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'surgery_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is the standard of\\'}), (\\'UMBRELLA protocol_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guides treatment in\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', \\'UKW3 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\\'minimally invasive surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'anaplasia_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'radical tumor nephrectomy_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'standard_of_care_for\\'}), (\\'Stage IV_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'presents in\\'}), (\\'CDCV_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'VP16_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'aims to improve survival rates of\\'}), (\\'AVD150_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed_by\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'succeeds\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'www.siop-rtsg.eu_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'available_on\\'}), (\\'laparoscopic surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'COG AREN0533 trial_entity\\', \\'cumulative doxorubicin dose_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'evaluates\\'}), (\\'UKW\u2011R protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'Nephron-sparing surgery (NSS)_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'classification_developed_by\\'}), (\\'Adult Wilms Tumors_entity\\', \\'anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'Adult Wilms Tumors_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'doxorubicin_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'doxorubicin_entity\\', \\'large-volume tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'recommended for\\'}), (\\'NWTS\u20115 relapse protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'End-stage renal disease (ESRD)_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'AVD250_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'Children\u2019s Oncology Group (COG)_entity\\', \\'SIOP\u22122001 randomized trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborated with\\'}), (\\'blastemal-type Wilms tumour_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment intensified according to\\'}), (\\'SIOP\u22122001_entity\\', \\'vincristine, actinomycin D, and doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses\\'}), (\\'SIOP\u22122001_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provided_guidelines_for\\'}), (\\'radiotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'radiotherapy_entity\\', \\'SIOP\u2212RTSG panel_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'contact_for_guidance\\'})]}, {\\'nodes\\': [(\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {}), (\\'Marry M. van den Heuvel-Eibrink_entity\\', {})], \\'edges\\': [(\\'Marry M. van den Heuvel-Eibrink_entity\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'affiliated_with\\'})]}, {\\'nodes\\': [(\\'Stage II_entity\\', {}), (\\'AV_entity\\', {}), (\\'Stage III_entity\\', {}), (\\'vincestine and actinomycin D_entity\\', {}), (\\'AVD_entity\\', {})], \\'edges\\': [(\\'Stage II_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AV_entity\\', \\'Stage II_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Stage III_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AVD_entity\\', \\'Stage III_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'SIOP-RTSG 2016_entity\\', {}), (\\'RCC_entity\\', {}), (\\'CMN_entity\\', {})], \\'edges\\': [(\\'RCC_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'}), (\\'CMN_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'})]}, {\\'nodes\\': [(\\'HR-1_entity\\', {}), (\\'High-risk blastemal type Wilms tumour_entity\\', {})], \\'edges\\': [(\\'HR-1_entity\\', \\'High-risk blastemal type Wilms tumour_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'unfavorable prognosis_entity\\', {}), (\\'high-risk characteristics_entity\\', {})], \\'edges\\': [(\\'high-risk characteristics_entity\\', \\'unfavorable prognosis_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'leads_to\\'})]}, {\\'nodes\\': [(\\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {}), (\\'SIOP\u2013RTSG board_entity\\', {})], \\'edges\\': [(\\'SIOP\u2013RTSG board_entity\\', \\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggests\\'})]}, {\\'nodes\\': [(\\'regimen and outcomes_entity\\', {}), (\\'SIOP database_entity\\', {})], \\'edges\\': [(\\'SIOP database_entity\\', \\'regimen and outcomes_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'captures_data_on\\'})]}, {\\'nodes\\': [(\\'Bilateral nephron-sparing surgery (NSS)_entity\\', {}), (\\'Aronson et al._entity\\', {})], \\'edges\\': [(\\'Aronson et al._entity\\', \\'Bilateral nephron-sparing surgery (NSS)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'observed_effectiveness_of\\'})]}, {\\'nodes\\': [(\\'SIOP\u22122001 study_entity\\', {}), (\\'Actinomycin D_entity\\', {}), (\\'Vincristine_entity\\', {})], \\'edges\\': [(\\'SIOP\u22122001 study_entity\\', \\'Vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'}), (\\'SIOP\u22122001 study_entity\\', \\'Actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'})]}, {\\'nodes\\': [(\\'High-dose melphalan_entity\\', {}), (\\'Group AA_entity\\', {}), (\\'Carboplatin_entity\\', {}), (\\'Doxorubicin_entity\\', {}), (\\'Etoposide_entity\\', {}), (\\'Group BB_entity\\', {}), (\\'Cyclophosphamide_entity\\', {}), (\\'Ifosfamide_entity\\', {})], \\'edges\\': [(\\'Group AA_entity\\', \\'Doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Ifosfamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'High-dose melphalan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'})]}, {\\'nodes\\': [(\\'nephrotoxicity_entity\\', {}), (\\'ifosfamide_entity\\', {})], \\'edges\\': [(\\'ifosfamide_entity\\', \\'nephrotoxicity_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'related_to\\'})]}, {\\'nodes\\': [(\\'camptothecins_entity\\', {}), (\\'irinotecan_entity\\', {}), (\\'topotecan_entity\\', {})], \\'edges\\': [(\\'camptothecins_entity\\', \\'irinotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'camptothecins_entity\\', \\'topotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'})]}, {\\'nodes\\': [(\\'Infant Wilms Tumors_entity\\', {}), (\\'nephrectomy_entity\\', {})], \\'edges\\': [(\\'Infant Wilms Tumors_entity\\', \\'nephrectomy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_option\\'})]}, {\\'nodes\\': [(\\'congenital mesoblastic nephroma_entity\\', {}), (\\'surgery alone_entity\\', {})], \\'edges\\': [(\\'congenital mesoblastic nephroma_entity\\', \\'surgery alone_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'alternative chemotherapy_entity\\', {}), (\\'malignant rhabdoid tumors_entity\\', {})], \\'edges\\': [(\\'malignant rhabdoid tumors_entity\\', \\'alternative chemotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'lymph node sampling_entity\\', {}), (\\'accurate staging_entity\\', {})], \\'edges\\': [(\\'lymph node sampling_entity\\', \\'accurate staging_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'purpose_of\\'})]}, {\\'nodes\\': [(\\'COG\u2013NWTS trials_entity\\', {}), (\\'whole-lung irradiation_entity\\', {})], \\'edges\\': [(\\'COG\u2013NWTS trials_entity\\', \\'whole-lung irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'informed_dosage_for\\'})]}, {\\'nodes\\': [(\\'lung metastases_entity\\', {}), (\\'pulmonary radiotherapy_entity\\', {})], \\'edges\\': [(\\'pulmonary radiotherapy_entity\\', \\'lung metastases_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'administered_for\\'})]}, {\\'nodes\\': [(\\'dosimetric study_entity\\', {}), (\\'proton therapy_entity\\', {}), (\\'flank irradiation_entity\\', {})], \\'edges\\': [(\\'dosimetric study_entity\\', \\'proton therapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated\\'}), (\\'proton therapy_entity\\', \\'flank irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggested_for\\'})]}, {\\'nodes\\': [(\\'metastatic disease_entity\\', {}), (\\'radiotherapy guidelines_entity\\', {}), (\\'locoregional disease_entity\\', {})], \\'edges\\': [(\\'radiotherapy guidelines_entity\\', \\'locoregional disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'}), (\\'radiotherapy guidelines_entity\\', \\'metastatic disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'})]}, {\\'nodes\\': [(\\'major rupture_entity\\', {}), (\\'stage III_entity\\', {})], \\'edges\\': [(\\'stage III_entity\\', \\'major rupture_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes_condition\\'})]}, {\\'nodes\\': [(\\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {}), (\\'ExPO\u2011r\u2011Net_entity\\', {})], \\'edges\\': [(\\'ExPO\u2011r\u2011Net_entity\\', \\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is part of\\'})]}, {\\'nodes\\': [(\\'University Hospital of Munich_entity\\', {}), (\\'Germany_entity\\', {}), (\\'University Hospital of Tuebingen_entity\\', {})], \\'edges\\': [(\\'Germany_entity\\', \\'University Hospital of Munich_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Germany_entity\\', \\'University Hospital of Tuebingen_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {}), (\\'Italy_entity\\', {}), (\\'Azienda Ospedaliera_entity\\', {}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {})], \\'edges\\': [(\\'Italy_entity\\', \\'Azienda Ospedaliera_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Netherlands_entity\\', {}), (\\'Prinses Maxima Centrum_entity\\', {})], \\'edges\\': [(\\'Netherlands_entity\\', \\'Prinses Maxima Centrum_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Marciniak Hospital_entity\\', {}), (\\'Poland_entity\\', {}), (\\'Faculty of Medicine_entity\\', {})], \\'edges\\': [(\\'Poland_entity\\', \\'Marciniak Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Poland_entity\\', \\'Faculty of Medicine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'St. Anna Kinderspital/CCRI_entity\\', {}), (\\'Austria_entity\\', {})], \\'edges\\': [(\\'Austria_entity\\', \\'St. Anna Kinderspital/CCRI_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'France_entity\\', {}), (\\'Armand Trousseau Hospital_entity\\', {})], \\'edges\\': [(\\'France_entity\\', \\'Armand Trousseau Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Spain_entity\\', {}), (\\'Hospital Vall d\u2019Hebron_entity\\', {}), (\\'Hospital Universitario Virgin del Rocio_entity\\', {})], \\'edges\\': [(\\'Spain_entity\\', \\'Hospital Universitario Virgin del Rocio_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Spain_entity\\', \\'Hospital Vall d\u2019Hebron_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'United Kingdom_entity\\', {}), (\\'Great Ormond Street Hospital_entity\\', {})], \\'edges\\': [(\\'United Kingdom_entity\\', \\'Great Ormond Street Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Weirich, A._entity\\', {}), (\\'SIOP-9/GPOH_entity\\', {})], \\'edges\\': [(\\'Weirich, A._entity\\', \\'SIOP-9/GPOH_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Pritchard-Jones, K._entity\\', {}), (\\'UKW3_entity\\', {})], \\'edges\\': [(\\'Pritchard-Jones, K._entity\\', \\'UKW3_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed in\\'})]}, {\\'nodes\\': [(\\'SIOP 93\u201301 trial_entity\\', {}), (\\'de Kraker, J._entity\\', {})], \\'edges\\': [(\\'de Kraker, J._entity\\', \\'SIOP 93\u201301 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'SIOP trial and study 93\u201301_entity\\', {}), (\\'Graf, N._entity\\', {})], \\'edges\\': [(\\'Graf, N._entity\\', \\'SIOP trial and study 93\u201301_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Green, D. M._entity\\', {}), (\\'National Wilms Tumor Study Group_entity\\', {})], \\'edges\\': [(\\'Green, D. M._entity\\', \\'National Wilms Tumor Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}, {\\'nodes\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', {}), (\\'SIOP WT 2001 protocol_entity\\', {})], \\'edges\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', \\'SIOP WT 2001 protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Third National Wilms\u2019 Tumor Study_entity\\', {}), (\"D\\'Angio, G. J._entity\", {}), (\\'Second National Wilms\u2019 Tumor Study_entity\\', {})], \\'edges\\': [(\"D\\'Angio, G. J._entity\", \\'Third National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\"D\\'Angio, G. J._entity\", \\'Second National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {}), (\\'Tournade, M. F._entity\\', {}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {})], \\'edges\\': [(\\'Tournade, M. F._entity\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'}), (\\'Tournade, M. F._entity\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Breslow, N. E._entity\\', {}), (\\'National Wilms Tumor Studies_entity\\', {})], \\'edges\\': [(\\'Breslow, N. E._entity\\', \\'National Wilms Tumor Studies_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Mitchell, C._entity\\', {}), (\\'UK Children\u2019s Cancer Study Group_entity\\', {})], \\'edges\\': [(\\'Mitchell, C._entity\\', \\'UK Children\u2019s Cancer Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'under\\'})]}, {\\'nodes\\': [(\\'Daw, N. C._entity\\', {}), (\\'Dix, D. B._entity\\', {}), (\\'Children\u2019s Oncology Group_entity\\', {}), (\\'Grundy, P. E._entity\\', {})], \\'edges\\': [(\\'Daw, N. C._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted under\\'}), (\\'Dix, D. B._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'}), (\\'Grundy, P. E._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}]']), TestResult(name='test_case_17', success=False, metrics_data=[MetricData(name='Answer Correctness (GEval)', threshold=0.5, success=False, score=0.22828966491939345, reason='The actual output does not address survival rates or improvements associated with treatment, which are key elements in the expected output.', strict_mode=False, evaluation_model='gpt-4o-mini', error=None, evaluation_cost=0.0032960999999999993, verbose_logs='Criteria:\\nNone \\n \\nEvaluation Steps:\\n[\\n    \"Determine whether the actual output is factually correct based on the expected output.\"\\n]'), MetricData(name='Faithfulness', threshold=0.7, success=True, score=0.8947368421052632, reason=None, strict_mode=False, evaluation_model='gpt-4o-mini', error=None, evaluation_cost=0.0077817, verbose_logs='Truths (limit=None):\\n[\\n    \"The Renal Tumour Study Group is part of the International Society of Paediatric Oncology (SIOP-RTSG).\",\\n    \"The UMBRELLA SIOP-RTSG 2016 is a protocol.\",\\n    \"SIOP-2001 is a protocol related to renal tumors.\",\\n    \"Wilms tumours are a type of disease.\",\\n    \"Non-Wilms tumours are another type of disease.\",\\n    \"Childhood renal tumours include different types of kidney cancers.\",\\n    \"Clear cell sarcoma of the kidney is a type of childhood renal tumour.\",\\n    \"Renal cell carcinoma is a recognized type of kidney cancer.\",\\n    \"Malignant rhabdoid tumour of the kidney is a type of cancer affecting the kidney in children.\",\\n    \"Congenital mesoblastic nephroma is a type of kidney tumor found in infants.\",\\n    \"SIOP-RTSG has a website at www.siop-rtsg.eu.\",\\n    \"The Department of Paediatric Oncology is located at the Princess M\u00e1xima Center for Paediatric Oncology.\",\\n    \"Marry M. van den Heuvel-Eibrink is associated with the Department of Paediatric Oncology at the Princess M\u00e1xima Center for Paediatric Oncology.\",\\n    \"Various types of childhood renal tumours are studied under protocols like UMBRELLA and SIOP-2001.\",\\n    \"Drugs like actinomycin D, vincristine, and doxorubicin are used in the treatment of Wilms tumours.\",\\n    \"The Children\u2019s Oncology Group (COG) is mentioned in the context of childhood renal tumours.\",\\n    \"Treatment protocols exist for different disease stages including localized, metastatic, bilateral, and relapsed diseases.\",\\n    \"Studies have shown the efficacy of treatments like chemotherapy and radiotherapy for Wilms tumours.\",\\n    \"The UMBRELLA protocol involves collaboration with various organizations in pediatric oncology.\",\\n    \"SIOP-RTSG is involved in guideline development for the treatment of Wilms tumours.\",\\n    \"High-risk disease characteristics in Wilms tumours correlate with treatment complications and survival rates.\",\\n    \"The UMBRELLA protocol is informed by data from various pediatric oncology trials.\",\\n    \"Countries such as Austria, Germany, and Italy are involved in SIOP-related studies and protocols.\",\\n    \"Several hospitals and institutions across Europe participate in renal tumor studies and protocols.\"\\n] \\n \\nClaims:\\n[\\n    \"The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG) is an organization.\",\\n    \"UMBRELLA SIOP-RTSG 2016 is a protocol.\",\\n    \"SIOP\u22122001 is a protocol.\",\\n    \"Wilms tumours and non-Wilms tumours are types of diseases.\",\\n    \"The website www.siop-rtsg.eu is associated with SIOP-RTSG.\",\\n    \"The Department of Paediatric Oncology is part of the Princess M\u00e1xima Center for Paediatric Oncology.\",\\n    \"Marry M. van den Heuvel-Eibrink is a person associated with this field.\",\\n    \"Childhood renal tumours, clear cell sarcoma of the kidney, renal cell carcinoma, malignant rhabdoid tumour of the kidney, and congenital mesoblastic nephroma are diseases related to paediatric oncology.\",\\n    \"Wilms tumours are a condition defined within this context.\",\\n    \"UMBRELLA protocol is a treatment protocol for certain conditions.\",\\n    \"Children\u2019s Oncology Group (COG) is an organization that collaborates in paediatric oncology.\",\\n    \"The SIOP\u22122001 randomized trial is a clinical trial related to childhood tumours.\",\\n    \"The drugs actinomycin D, vincristine, and doxorubicin are used in treatment protocols.\",\\n    \"The UKW3 trial is another clinical trial relevant to the treatment of childhood cancers.\",\\n    \"The UK Children\u2019s Cancer and Leukaemia Group (UKCCLG) is an organization in the same field.\",\\n    \"Localized disease, metastatic disease, bilateral disease, and relapsed disease are disease stages relevant to Wilms tumours.\",\\n    \"Blastemal-type Wilms tumours is a subtype of Wilms tumours.\",\\n    \"Radiotherapy, surgery, and chemotherapy are treatment methods for these conditions.\",\\n    \"SIOP\u2013RTSG is referenced as an organization.\",\\n    \"The UMBRELLA protocol is used in treatment.\",\\n    \"Overall Survival (OS) and Event-Free Survival (EFS) are metrics used in this field.\",\\n    \"The COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials are studies related to Wilms tumours.\",\\n    \"MRI and CT are diagnostic tools utilized in the assessment of these conditions.\",\\n    \"High-risk characteristics are associated with worse outcomes.\",\\n    \"The protocol UMBRELLA SIOP-RTSG 2016 is related to childhood renal tumours.\",\\n    \"High-dose chemotherapy and autologous stem cell transplantation are treatment methods indicating advanced care.\",\\n    \"Bilateral nephron-sparing surgery (NSS) is a treatment method for certain kidney diseases.\",\\n    \"The study SIOP\u22122001 is referenced as significant in the treatment protocols.\",\\n    \"Various drugs including vincristine, actinomycin D, etoposide, carboplatin, and cyclophosphamide are used in treatment regimens.\",\\n    \"Nephrotoxicity is a condition that may arise from certain treatments.\",\\n    \"Children\\'s Oncology Group (COG) collaborates with SIOP\u2013RTSG in research.\",\\n    \"Different stage classifications (I, II, III, IV, V) are relevant in the categorization of Wilms tumours.\",\\n    \"Certain organizations and institutions across multiple countries are involved in paediatric oncology research and treatment.\"\\n] \\n \\nVerdicts:\\n[\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"idk\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"idk\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"idk\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"The UKW3 trial is not mentioned in the retrieval context, which only refers to certain clinical trials like COG National Wilms Tumor Study Group.\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"The retrieval context mentions specific drug treatments for childhood renal tumours without including high-dose chemotherapy and autologous stem cell transplantation.\"\\n    },\\n    {\\n        \"verdict\": \"idk\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    }\\n]'), MetricData(name='Contextual Relevancy', threshold=1.0, success=False, score=0.8333333333333334, reason=\"The score is 0.83 because while there are relevant statements like 'Wilms tumours are treated under the UMBRELLA protocol' and 'Overall Survival (OS) and Event-Free Survival (EFS) are metrics associated with Wilms tumors', the retrieval context has irrelevancies such as the focus on 'alternative chemotherapy', which does not connect directly to expected outcomes for Wilms tumour patients.\", strict_mode=False, evaluation_model='gpt-4o-mini', error=None, evaluation_cost=0.0037647, verbose_logs='Verdicts:\\n[\\n    {\\n        \"verdicts\": [\\n            {\\n                \"statement\": \"Wilms tumours are treated under the UMBRELLA protocol.\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"The SIOP\\\\u22122001 randomized trial investigated the use of doxorubicin for Wilms tumours.\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"Vincristine, actinomycin D, and doxorubicin are used for treating Wilms tumours.\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"Vincristine and actinomycin D plus doxorubicin are validated treatments in UKW3 trial.\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"High-dose chemotherapy is suggested by the SIOP\\\\u2013RTSG board.\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"Overall Survival (OS) and Event-Free Survival (EFS) are metrics associated with Wilms tumors.\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"Children\\\\u2019s Oncology Group collaborates with SIOP\\\\u22122001 randomized trials.\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"Surgery is indicated treatment for Wilms tumours.\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"Malignant rhabdoid tumors require alternative chemotherapy.\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"The retrieval context discussed \\'alternative chemotherapy\\' but did not connection to Wilms tumor outcomes.\"\\n            },\\n            {\\n                \"statement\": \"Kidney tumors in children include clear cell sarcoma and Wilms.\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"Stage II disease is treated with vincristine and actinomycin D.\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"High-risk characteristics lead to unfavorable prognosis.\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"While high-risk characteristics are mentioned, it does not specifically connect to patient outcomes regarding Wilms tumor.\"\\n            }\\n        ]\\n    }\\n]')], conversational=False, multimodal=False, input='What are the expected outcomes for patients with Wilms tumour under this protocol?', actual_output='[{\\'nodes\\': [(\\'sample.pdf\\', {\\'type\\': \\'document\\'}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)\\'}), (\\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA SIOP-RTSG 2016\\'}), (\\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms tumours\\'}), (\\'non-Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'non-Wilms tumours\\'}), (\\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Website\\', \\'name\\': \\'www.siop-rtsg.eu\\'}), (\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology\\'}), (\\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Person\\', \\'name\\': \\'Marry M. van den Heuvel-Eibrink\\'}), (\\'childhood renal tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'childhood renal tumours\\'}), (\\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'clear cell sarcoma of the kidney\\'}), (\\'renal cell carcinoma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'renal cell carcinoma\\'}), (\\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'malignant rhabdoid tumour of the kidney\\'}), (\\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'Wilms tumours_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'Children\u2019s Oncology Group (COG)\\'}), (\\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'SIOP\u22122001 randomized trial\\'}), (\\'actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'UKW3 trial\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)\\'}), (\\'localized disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'localized disease\\'}), (\\'metastatic disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'metastatic disease\\'}), (\\'bilateral disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'bilateral disease\\'}), (\\'relapsed disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'relapsed disease\\'}), (\\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subtype\\', \\'name\\': \\'blastemal-type Wilms tumours\\'}), (\\'radiotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgery_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'chemotherapy\\'}), (\\'Wilms Tumour_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms Tumour\\'}), (\\'CCSK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CCSK\\'}), (\\'MRTK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'MRTK\\'}), (\\'CMN_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CMN\\'}), (\\'RCC_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'RCC\\'}), (\\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u22122001_Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Trial\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'vincristine_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'vincristine\\'}), (\\'actinomycin D_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'actinomycin D\\'}), (\\'doxorubicin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'doxorubicin\\'}), (\\'etoposide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'Stage I_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage I\\'}), (\\'Stage II_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage II\\'}), (\\'Stage III_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage III\\'}), (\\'Stage IV_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage IV\\'}), (\\'Stage V_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage V\\'}), (\\'AV_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AV\\'}), (\\'AVD_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AVD\\'}), (\\'HR-1_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'HR-1\\'}), (\\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP-RTSG 2016\\'}), (\\'Overall Survival (OS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'CT-only nodules_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'CT-only nodules\\'}), (\\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP\u2013RTSG analysis\\'}), (\\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials\\'}), (\\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D plus doxorubicin\\'}), (\\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D\\'}), (\\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study_protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'MRI_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'MRI\\'}), (\\'CT_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'CT\\'}), (\\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_detail\\', \\'name\\': \\'cumulative doxorubicin dose\\'}), (\\'COG AREN0533 trial_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG AREN0533 trial\\'}), (\\'etoposide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'high-risk characteristics\\'}), (\\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG board\\'}), (\\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin\\'}), (\\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'high-dose chemotherapy and autologous stem cell transplantation\\'}), (\\'SIOP database_database\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'database\\', \\'name\\': \\'SIOP database\\'}), (\\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'AVD_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AVD\\'}), (\\'AV-2_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AV-2\\'}), (\\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Statistical Test\\', \\'name\\': \\'Log\u2013Rank P\\'}), (\\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'Bilateral Disease (Stage V)\\'}), (\\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Synchronous bilateral Wilms tumor\\'}), (\\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'End-stage renal disease (ESRD)\\'}), (\\'Aronson et al._Research Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Research Group\\', \\'name\\': \\'Aronson et al.\\'}), (\\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'Bilateral nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Study\\', \\'name\\': \\'SIOP\u22122001 study\\'}), (\\'Vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Vincristine\\'}), (\\'Actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Actinomycin D\\'}), (\\'Etoposide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Etoposide\\'}), (\\'Carboplatin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Carboplatin\\'}), (\\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease State\\', \\'name\\': \\'Relapsed Wilms Tumor\\'}), (\\'Group AA_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group AA\\'}), (\\'Group BB_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group BB\\'}), (\\'Group CC_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group CC\\'}), (\\'Doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Doxorubicin\\'}), (\\'Cyclophosphamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Cyclophosphamide\\'}), (\\'Ifosfamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Ifosfamide\\'}), (\\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'High-dose melphalan\\'}), (\\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UKW\u2011R protocol\\'}), (\\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'NWTS\u20115 relapse protocol\\'}), (\\'ASCR_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'procedure\\', \\'name\\': \\'ASCR\\'}), (\\'ifosfamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'ifosfamide\\'}), (\\'nephrotoxicity_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'nephrotoxicity\\'}), (\\'relapsed group CC_patient_group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'patient_group\\', \\'name\\': \\'relapsed group CC\\'}), (\\'diffuse anaplasia_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'diffuse anaplasia\\'}), (\\'blastemal-type tumors_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'blastemal-type tumors\\'}), (\\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'camptothecins_medication_class\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication_class\\', \\'name\\': \\'camptothecins\\'}), (\\'irinotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'irinotecan\\'}), (\\'topotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'topotecan\\'}), (\\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Innovative Therapies for Children with Cancer consortium\\'}), (\\'radiotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgical excision_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgical excision\\'}), (\\'stage IV WT_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'stage IV WT\\'}), (\\'AVD150_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD150\\'}), (\\'AVD250_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD250\\'}), (\\'low-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'low-risk disease\\'}), (\\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'intermediate-risk disease\\'}), (\\'high-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'high-risk disease\\'}), (\\'CDCV_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'CDCV\\'}), (\\'actinomycin-D_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'actinomycin-D\\'}), (\\'vincristine_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'doxorubicin\\'}), (\\'VP16_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'VP16\\'}), (\\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'contact\\', \\'name\\': \\'arnauld.verschuur@ap-hm.fr\\'}), (\\'surgery_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'chemotherapy\\'}), (\\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2212RTSG panel\\'}), (\\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Infant Wilms Tumors\\'}), (\\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'nephrectomy\\'}), (\\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'malignant rhabdoid tumors\\'}), (\\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Adult Wilms Tumors\\'}), (\\'anaplasia_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'anaplasia\\'}), (\\'actinomycin D_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'carboplatin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'etoposide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'etoposide\\'}), (\\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'Nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'radical tumor nephrectomy\\'}), (\\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'lymph node sampling\\'}), (\\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'minimally invasive surgery\\'}), (\\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'laparoscopic surgery\\'}), (\\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'radiotherapy\\'}), (\\'Wilms tumours_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'Davila Fajardo et al._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Davila Fajardo et al.\\'}), (\\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'COG\u2013NWTS trials\\'}), (\\'whole-lung irradiation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'whole-lung irradiation\\'}), (\\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'pulmonary radiotherapy\\'}), (\\'proton therapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'proton therapy\\'}), (\\'dosimetric study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'dosimetric study\\'}), (\\'locoregional disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'locoregional disease\\'}), (\\'metastatic disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'metastatic disease\\'}), (\\'low-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'low-risk\\'}), (\\'intermediate-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'intermediate-risk\\'}), (\\'high-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'high-risk\\'}), (\\'stage I_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage I\\'}), (\\'stage II_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage II\\'}), (\\'stage III_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage III\\'}), (\\'major rupture_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'major rupture\\'}), (\\'Austria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Austria\\'}), (\\'Italy_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Italy\\'}), (\\'San Marino_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'San Marino\\'}), (\\'Iceland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Iceland\\'}), (\\'Germany_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Germany\\'}), (\\'Bulgaria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bulgaria\\'}), (\\'Turkey_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Turkey\\'}), (\\'Denmark_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Denmark\\'}), (\\'Poland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Poland\\'}), (\\'Greece_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Greece\\'}), (\\'Andorra_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Andorra\\'}), (\\'Belgium_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belgium\\'}), (\\'Serbia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Serbia\\'}), (\\'Albania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Albania\\'}), (\\'Moldova_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Moldova\\'}), (\\'Lithuania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Lithuania\\'}), (\\'Latvia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Latvia\\'}), (\\'Estonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Estonia\\'}), (\\'Luxembourg_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Luxembourg\\'}), (\\'Montenegro_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Montenegro\\'}), (\\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bosnia and Herzegovina\\'}), (\\'Croatia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Croatia\\'}), (\\'Slovenia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovenia\\'}), (\\'Macedonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Macedonia\\'}), (\\'United Kingdom_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'United Kingdom\\'}), (\\'Ireland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ireland\\'}), (\\'Spain_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Spain\\'}), (\\'Algeria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Algeria\\'}), (\\'Tunisia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Tunisia\\'}), (\\'Malta_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Malta\\'}), (\\'Morocco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Morocco\\'}), (\\'Portugal_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Portugal\\'}), (\\'France_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'France\\'}), (\\'Monaco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Monaco\\'}), (\\'Russia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Russia\\'}), (\\'Finland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Finland\\'}), (\\'Sweden_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Sweden\\'}), (\\'Norway_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Norway\\'}), (\\'Belarus_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belarus\\'}), (\\'Romania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Romania\\'}), (\\'Ukraine_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ukraine\\'}), (\\'Hungary_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Hungary\\'}), (\\'Czech Republic_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Czech Republic\\'}), (\\'Slovakia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovakia\\'}), (\\'Switzerland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Switzerland\\'}), (\\'Liechtenstein_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Liechtenstein\\'}), (\\'Netherlands_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Netherlands\\'}), (\\'University Hospital of Munich_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Munich\\'}), (\\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Tuebingen\\'}), (\\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Azienda Ospedaliera\\'}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Ospedale Pediatrico Bambino Ges\u00f9\\'}), (\\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Fondazione IRCCS Istituto Nazionale dei Tumori\\'}), (\\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Prinses Maxima Centrum\\'}), (\\'Marciniak Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Marciniak Hospital\\'}), (\\'Faculty of Medicine_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Faculty of Medicine\\'}), (\\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'St. Anna Kinderspital/CCRI\\'}), (\\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Armand Trousseau Hospital\\'}), (\\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Universitario Virgin del Rocio\\'}), (\\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Vall d\u2019Hebron\\'}), (\\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Great Ormond Street Hospital\\'}), (\\'University Hospital Homburg_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital Homburg\\'}), (\\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon\\'}), (\\'UMBRELLA protocol_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'ExPO\u2011r\u2011Net\\'}), (\\'Weirich, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Weirich, A.\\'}), (\\'Pritchard-Jones, K._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Pritchard-Jones, K.\\'}), (\\'de Kraker, J._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'de Kraker, J.\\'}), (\\'Graf, N._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Graf, N.\\'}), (\\'Green, D. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Green, D. M.\\'}), (\\'Spreafico, F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Spreafico, F.\\'}), (\\'Bellani, F. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Bellani, F. F.\\'}), (\\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'van den Heuvel-Eibrink, M. M.\\'}), (\"D\\'Angio, G. J._author\", {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \"D\\'Angio, G. J.\"}), (\\'Tournade, M. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Tournade, M. F.\\'}), (\\'Breslow, N. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Breslow, N. E.\\'}), (\\'Mitchell, C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Mitchell, C.\\'}), (\\'Verschuur, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Verschuur, A.\\'}), (\\'Grundy, P. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Grundy, P. E.\\'}), (\\'Warmann, S. W._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Warmann, S. W.\\'}), (\\'Smets, A. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Smets, A. M.\\'}), (\\'Dome, J. S._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dome, J. S.\\'}), (\\'Dix, D. B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dix, D. B.\\'}), (\\'Daw, N. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Daw, N. C.\\'}), (\\'Ha, T. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Ha, T. C.\\'}), (\\'Kremens, B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Kremens, B.\\'}), (\\'Furtwangler, R._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Furtwangler, R.\\'}), (\\'SIOP-9/GPOH_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP-9/GPOH\\'}), (\\'UKW3_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'UKW3\\'}), (\\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'SIOP 93\u201301 trial\\'}), (\\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP trial and study 93\u201301\\'}), (\\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'National Wilms Tumor Study Group\\'}), (\\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP WT 2001 protocol\\'}), (\\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Third National Wilms\u2019 Tumor Study\\'}), (\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'National Wilms Tumor Studies\\'}), (\\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Second National Wilms\u2019 Tumor Study\\'}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'UK Children\u2019s Cancer Study Group\\'}), (\\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Children\u2019s Oncology Group\\'})], \\'edges\\': [(\\'sample.pdf\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'non-Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'childhood renal tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'renal cell carcinoma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'localized disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'metastatic disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'bilateral disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'relapsed disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'radiotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'surgery_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'chemotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'Wilms Tumour_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CCSK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'MRTK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CMN_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'RCC_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP\u22122001_Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'vincristine_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'actinomycin D_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'doxorubicin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'etoposide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'carboplatin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'cyclophosphamide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage I_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage II_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage III_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage IV_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage V_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AV_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AVD_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'HR-1_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Overall Survival (OS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT-only nodules_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'MRI_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG AREN0533 trial_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'etoposide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'carboplatin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'cyclophosphamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP database_database\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AVD_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AV-2_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Aronson et al._Research Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Etoposide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Carboplatin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group AA_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group BB_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group CC_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Cyclophosphamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Ifosfamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'ASCR_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'ifosfamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'nephrotoxicity_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'relapsed group CC_patient_group\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'diffuse anaplasia_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'blastemal-type tumors_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'camptothecins_medication_class\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'irinotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'topotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'radiotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'surgical excision_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'stage IV WT_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD150_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD250_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'low-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'CDCV_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'actinomycin-D_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'vincristine_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'doxorubicin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'VP16_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'surgery_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'chemotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'anaplasia_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'actinomycin D_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'vincristine_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'doxorubicin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'carboplatin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'cyclophosphamide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'etoposide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'SIOP\u22122001_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Wilms tumours_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Davila Fajardo et al._author\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'whole-lung irradiation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'proton therapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'dosimetric study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'locoregional disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'metastatic disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'low-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'intermediate-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'high-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage I_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage II_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage III_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'major rupture_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Austria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Italy_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'San Marino_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Iceland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Germany_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bulgaria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Turkey_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Denmark_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Poland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Greece_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Andorra_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belgium_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Serbia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Albania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Moldova_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Lithuania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Latvia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Estonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Luxembourg_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Montenegro_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Croatia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovenia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Macedonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'United Kingdom_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ireland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Spain_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Algeria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Tunisia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Malta_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Morocco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Portugal_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'France_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Monaco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Russia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Finland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Sweden_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Norway_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belarus_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Romania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ukraine_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hungary_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Czech Republic_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovakia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Switzerland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Liechtenstein_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Netherlands_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Munich_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Marciniak Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Faculty of Medicine_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital Homburg_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Weirich, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Pritchard-Jones, K._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'de Kraker, J._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Graf, N._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Green, D. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Spreafico, F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Bellani, F. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \"D\\'Angio, G. J._author\", {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Tournade, M. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Breslow, N. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Mitchell, C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Verschuur, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Grundy, P. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Warmann, S. W._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Smets, A. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dome, J. S._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dix, D. B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Daw, N. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ha, T. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Kremens, B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Furtwangler, R._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP-9/GPOH_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UKW3_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10})]}, {\\'nodes\\': [(\\'vincristine_entity\\', {}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {}), (\\'www.siop-rtsg.eu_entity\\', {}), (\\'stage II_entity\\', {}), (\\'Wilms tumours_entity\\', {}), (\\'Relapsed Wilms Tumor_entity\\', {}), (\\'Davila Fajardo et al._entity\\', {}), (\\'vincristine, actinomycin D, and doxorubicin_entity\\', {}), (\\'SIOP\u22122001 randomized trial_entity\\', {}), (\\'surgery_entity\\', {}), (\\'non-Wilms tumours_entity\\', {}), (\\'actinomycin D_entity\\', {}), (\\'diffuse anaplasia_entity\\', {}), (\\'Synchronous bilateral Wilms tumor_entity\\', {}), (\\'CT-only nodules_entity\\', {}), (\\'relapsed group CC_entity\\', {}), (\\'increased relapse risk_entity\\', {}), (\\'reduced survival_entity\\', {}), (\\'UKW3 trial_entity\\', {}), (\\'chemotherapy_entity\\', {}), (\\'Bilateral Disease (Stage V)_entity\\', {}), (\\'blastemal-type tumors_entity\\', {}), (\\'UMBRELLA protocol_entity\\', {}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', {}), (\\'minimally invasive surgery_entity\\', {}), (\\'VP16_entity\\', {}), (\\'Wilms tumor_entity\\', {}), (\\'anaplasia_entity\\', {}), (\\'radical tumor nephrectomy_entity\\', {}), (\\'Innovative Therapies for Children with Cancer consortium_entity\\', {}), (\\'cumulative doxorubicin dose_entity\\', {}), (\\'etoposide_entity\\', {}), (\\'large-volume tumours_entity\\', {}), (\\'Stage IV_entity\\', {}), (\\'CDCV_entity\\', {}), (\\'SIOP\u2013RTSG_entity\\', {}), (\\'AVD150_entity\\', {}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', {}), (\\'laparoscopic surgery_entity\\', {}), (\\'SIOP\u2212RTSG panel_entity\\', {}), (\\'actinomycin-D_entity\\', {}), (\\'COG AREN0533 trial_entity\\', {}), (\\'cyclophosphamide_entity\\', {}), (\\'carboplatin_entity\\', {}), (\\'UKW\u2011R protocol_entity\\', {}), (\\'Nephron-sparing surgery (NSS)_entity\\', {}), (\\'Adult Wilms Tumors_entity\\', {}), (\\'doxorubicin_entity\\', {}), (\\'NWTS\u20115 relapse protocol_entity\\', {}), (\\'End-stage renal disease (ESRD)_entity\\', {}), (\\'AVD250_entity\\', {}), (\\'Children\u2019s Oncology Group (COG)_entity\\', {}), (\\'blastemal-type Wilms tumour_entity\\', {}), (\\'SIOP\u22122001_entity\\', {}), (\\'radiotherapy_entity\\', {}), (\\'childhood renal tumours_entity\\', {})], \\'edges\\': [(\\'vincristine_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'stage II_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'indicated_for_in_adults\\'}), (\\'Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'Wilms tumours_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated under\\'}), (\\'Relapsed Wilms Tumor_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guided_by\\'}), (\\'Davila Fajardo et al._entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed\\'}), (\\'SIOP\u22122001 randomized trial_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated use in\\'}), (\\'surgery_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'non-Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'actinomycin D_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Synchronous bilateral Wilms tumor_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'instance_of\\'}), (\\'CT-only nodules_entity\\', \\'increased relapse risk_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'reduced survival_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included_in\\'}), (\\'relapsed group CC_entity\\', \\'diffuse anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'blastemal-type tumors_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UKW3 trial_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'UKW3 trial_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'chemotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UMBRELLA protocol_entity\\', \\'COG AREN0533 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses_data_from\\'}), (\\'UMBRELLA protocol_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'advises_treatment_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'Innovative Therapies for Children with Cancer consortium_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborates_with\\'}), (\\'UMBRELLA protocol_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'surgery_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is the standard of\\'}), (\\'UMBRELLA protocol_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guides treatment in\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', \\'UKW3 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\\'minimally invasive surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'anaplasia_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'radical tumor nephrectomy_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'standard_of_care_for\\'}), (\\'Stage IV_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'presents in\\'}), (\\'CDCV_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'VP16_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'aims to improve survival rates of\\'}), (\\'AVD150_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed_by\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'succeeds\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'www.siop-rtsg.eu_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'available_on\\'}), (\\'laparoscopic surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'COG AREN0533 trial_entity\\', \\'cumulative doxorubicin dose_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'evaluates\\'}), (\\'UKW\u2011R protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'Nephron-sparing surgery (NSS)_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'classification_developed_by\\'}), (\\'Adult Wilms Tumors_entity\\', \\'anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'Adult Wilms Tumors_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'doxorubicin_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'doxorubicin_entity\\', \\'large-volume tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'recommended for\\'}), (\\'NWTS\u20115 relapse protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'End-stage renal disease (ESRD)_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'AVD250_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'Children\u2019s Oncology Group (COG)_entity\\', \\'SIOP\u22122001 randomized trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborated with\\'}), (\\'blastemal-type Wilms tumour_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment intensified according to\\'}), (\\'SIOP\u22122001_entity\\', \\'vincristine, actinomycin D, and doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses\\'}), (\\'SIOP\u22122001_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provided_guidelines_for\\'}), (\\'radiotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'radiotherapy_entity\\', \\'SIOP\u2212RTSG panel_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'contact_for_guidance\\'})]}, {\\'nodes\\': [(\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {}), (\\'Marry M. van den Heuvel-Eibrink_entity\\', {})], \\'edges\\': [(\\'Marry M. van den Heuvel-Eibrink_entity\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'affiliated_with\\'})]}, {\\'nodes\\': [(\\'Stage II_entity\\', {}), (\\'AV_entity\\', {}), (\\'Stage III_entity\\', {}), (\\'vincestine and actinomycin D_entity\\', {}), (\\'AVD_entity\\', {})], \\'edges\\': [(\\'Stage II_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AV_entity\\', \\'Stage II_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Stage III_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AVD_entity\\', \\'Stage III_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'SIOP-RTSG 2016_entity\\', {}), (\\'RCC_entity\\', {}), (\\'CMN_entity\\', {})], \\'edges\\': [(\\'RCC_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'}), (\\'CMN_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'})]}, {\\'nodes\\': [(\\'HR-1_entity\\', {}), (\\'High-risk blastemal type Wilms tumour_entity\\', {})], \\'edges\\': [(\\'HR-1_entity\\', \\'High-risk blastemal type Wilms tumour_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'unfavorable prognosis_entity\\', {}), (\\'high-risk characteristics_entity\\', {})], \\'edges\\': [(\\'high-risk characteristics_entity\\', \\'unfavorable prognosis_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'leads_to\\'})]}, {\\'nodes\\': [(\\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {}), (\\'SIOP\u2013RTSG board_entity\\', {})], \\'edges\\': [(\\'SIOP\u2013RTSG board_entity\\', \\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggests\\'})]}, {\\'nodes\\': [(\\'regimen and outcomes_entity\\', {}), (\\'SIOP database_entity\\', {})], \\'edges\\': [(\\'SIOP database_entity\\', \\'regimen and outcomes_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'captures_data_on\\'})]}, {\\'nodes\\': [(\\'Bilateral nephron-sparing surgery (NSS)_entity\\', {}), (\\'Aronson et al._entity\\', {})], \\'edges\\': [(\\'Aronson et al._entity\\', \\'Bilateral nephron-sparing surgery (NSS)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'observed_effectiveness_of\\'})]}, {\\'nodes\\': [(\\'SIOP\u22122001 study_entity\\', {}), (\\'Actinomycin D_entity\\', {}), (\\'Vincristine_entity\\', {})], \\'edges\\': [(\\'SIOP\u22122001 study_entity\\', \\'Vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'}), (\\'SIOP\u22122001 study_entity\\', \\'Actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'})]}, {\\'nodes\\': [(\\'High-dose melphalan_entity\\', {}), (\\'Group AA_entity\\', {}), (\\'Carboplatin_entity\\', {}), (\\'Doxorubicin_entity\\', {}), (\\'Etoposide_entity\\', {}), (\\'Group BB_entity\\', {}), (\\'Cyclophosphamide_entity\\', {}), (\\'Ifosfamide_entity\\', {})], \\'edges\\': [(\\'Group AA_entity\\', \\'Doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Ifosfamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'High-dose melphalan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'})]}, {\\'nodes\\': [(\\'nephrotoxicity_entity\\', {}), (\\'ifosfamide_entity\\', {})], \\'edges\\': [(\\'ifosfamide_entity\\', \\'nephrotoxicity_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'related_to\\'})]}, {\\'nodes\\': [(\\'camptothecins_entity\\', {}), (\\'irinotecan_entity\\', {}), (\\'topotecan_entity\\', {})], \\'edges\\': [(\\'camptothecins_entity\\', \\'irinotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'camptothecins_entity\\', \\'topotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'})]}, {\\'nodes\\': [(\\'Infant Wilms Tumors_entity\\', {}), (\\'nephrectomy_entity\\', {})], \\'edges\\': [(\\'Infant Wilms Tumors_entity\\', \\'nephrectomy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_option\\'})]}, {\\'nodes\\': [(\\'congenital mesoblastic nephroma_entity\\', {}), (\\'surgery alone_entity\\', {})], \\'edges\\': [(\\'congenital mesoblastic nephroma_entity\\', \\'surgery alone_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'alternative chemotherapy_entity\\', {}), (\\'malignant rhabdoid tumors_entity\\', {})], \\'edges\\': [(\\'malignant rhabdoid tumors_entity\\', \\'alternative chemotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'lymph node sampling_entity\\', {}), (\\'accurate staging_entity\\', {})], \\'edges\\': [(\\'lymph node sampling_entity\\', \\'accurate staging_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'purpose_of\\'})]}, {\\'nodes\\': [(\\'COG\u2013NWTS trials_entity\\', {}), (\\'whole-lung irradiation_entity\\', {})], \\'edges\\': [(\\'COG\u2013NWTS trials_entity\\', \\'whole-lung irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'informed_dosage_for\\'})]}, {\\'nodes\\': [(\\'lung metastases_entity\\', {}), (\\'pulmonary radiotherapy_entity\\', {})], \\'edges\\': [(\\'pulmonary radiotherapy_entity\\', \\'lung metastases_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'administered_for\\'})]}, {\\'nodes\\': [(\\'dosimetric study_entity\\', {}), (\\'proton therapy_entity\\', {}), (\\'flank irradiation_entity\\', {})], \\'edges\\': [(\\'dosimetric study_entity\\', \\'proton therapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated\\'}), (\\'proton therapy_entity\\', \\'flank irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggested_for\\'})]}, {\\'nodes\\': [(\\'metastatic disease_entity\\', {}), (\\'radiotherapy guidelines_entity\\', {}), (\\'locoregional disease_entity\\', {})], \\'edges\\': [(\\'radiotherapy guidelines_entity\\', \\'locoregional disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'}), (\\'radiotherapy guidelines_entity\\', \\'metastatic disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'})]}, {\\'nodes\\': [(\\'major rupture_entity\\', {}), (\\'stage III_entity\\', {})], \\'edges\\': [(\\'stage III_entity\\', \\'major rupture_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes_condition\\'})]}, {\\'nodes\\': [(\\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {}), (\\'ExPO\u2011r\u2011Net_entity\\', {})], \\'edges\\': [(\\'ExPO\u2011r\u2011Net_entity\\', \\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is part of\\'})]}, {\\'nodes\\': [(\\'University Hospital of Munich_entity\\', {}), (\\'Germany_entity\\', {}), (\\'University Hospital of Tuebingen_entity\\', {})], \\'edges\\': [(\\'Germany_entity\\', \\'University Hospital of Munich_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Germany_entity\\', \\'University Hospital of Tuebingen_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {}), (\\'Italy_entity\\', {}), (\\'Azienda Ospedaliera_entity\\', {}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {})], \\'edges\\': [(\\'Italy_entity\\', \\'Azienda Ospedaliera_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Netherlands_entity\\', {}), (\\'Prinses Maxima Centrum_entity\\', {})], \\'edges\\': [(\\'Netherlands_entity\\', \\'Prinses Maxima Centrum_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Marciniak Hospital_entity\\', {}), (\\'Poland_entity\\', {}), (\\'Faculty of Medicine_entity\\', {})], \\'edges\\': [(\\'Poland_entity\\', \\'Marciniak Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Poland_entity\\', \\'Faculty of Medicine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'St. Anna Kinderspital/CCRI_entity\\', {}), (\\'Austria_entity\\', {})], \\'edges\\': [(\\'Austria_entity\\', \\'St. Anna Kinderspital/CCRI_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'France_entity\\', {}), (\\'Armand Trousseau Hospital_entity\\', {})], \\'edges\\': [(\\'France_entity\\', \\'Armand Trousseau Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Spain_entity\\', {}), (\\'Hospital Vall d\u2019Hebron_entity\\', {}), (\\'Hospital Universitario Virgin del Rocio_entity\\', {})], \\'edges\\': [(\\'Spain_entity\\', \\'Hospital Universitario Virgin del Rocio_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Spain_entity\\', \\'Hospital Vall d\u2019Hebron_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'United Kingdom_entity\\', {}), (\\'Great Ormond Street Hospital_entity\\', {})], \\'edges\\': [(\\'United Kingdom_entity\\', \\'Great Ormond Street Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Weirich, A._entity\\', {}), (\\'SIOP-9/GPOH_entity\\', {})], \\'edges\\': [(\\'Weirich, A._entity\\', \\'SIOP-9/GPOH_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Pritchard-Jones, K._entity\\', {}), (\\'UKW3_entity\\', {})], \\'edges\\': [(\\'Pritchard-Jones, K._entity\\', \\'UKW3_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed in\\'})]}, {\\'nodes\\': [(\\'SIOP 93\u201301 trial_entity\\', {}), (\\'de Kraker, J._entity\\', {})], \\'edges\\': [(\\'de Kraker, J._entity\\', \\'SIOP 93\u201301 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'SIOP trial and study 93\u201301_entity\\', {}), (\\'Graf, N._entity\\', {})], \\'edges\\': [(\\'Graf, N._entity\\', \\'SIOP trial and study 93\u201301_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Green, D. M._entity\\', {}), (\\'National Wilms Tumor Study Group_entity\\', {})], \\'edges\\': [(\\'Green, D. M._entity\\', \\'National Wilms Tumor Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}, {\\'nodes\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', {}), (\\'SIOP WT 2001 protocol_entity\\', {})], \\'edges\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', \\'SIOP WT 2001 protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Third National Wilms\u2019 Tumor Study_entity\\', {}), (\"D\\'Angio, G. J._entity\", {}), (\\'Second National Wilms\u2019 Tumor Study_entity\\', {})], \\'edges\\': [(\"D\\'Angio, G. J._entity\", \\'Third National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\"D\\'Angio, G. J._entity\", \\'Second National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {}), (\\'Tournade, M. F._entity\\', {}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {})], \\'edges\\': [(\\'Tournade, M. F._entity\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'}), (\\'Tournade, M. F._entity\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Breslow, N. E._entity\\', {}), (\\'National Wilms Tumor Studies_entity\\', {})], \\'edges\\': [(\\'Breslow, N. E._entity\\', \\'National Wilms Tumor Studies_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Mitchell, C._entity\\', {}), (\\'UK Children\u2019s Cancer Study Group_entity\\', {})], \\'edges\\': [(\\'Mitchell, C._entity\\', \\'UK Children\u2019s Cancer Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'under\\'})]}, {\\'nodes\\': [(\\'Daw, N. C._entity\\', {}), (\\'Dix, D. B._entity\\', {}), (\\'Children\u2019s Oncology Group_entity\\', {}), (\\'Grundy, P. E._entity\\', {})], \\'edges\\': [(\\'Daw, N. C._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted under\\'}), (\\'Dix, D. B._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'}), (\\'Grundy, P. E._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}]', expected_output='Survival rates are expected to be high, with improvements in event-free and overall survival due to standardized treatment approaches.', context=None, retrieval_context=['[{\\'nodes\\': [(\\'sample.pdf\\', {\\'type\\': \\'document\\'}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)\\'}), (\\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA SIOP-RTSG 2016\\'}), (\\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms tumours\\'}), (\\'non-Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'non-Wilms tumours\\'}), (\\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Website\\', \\'name\\': \\'www.siop-rtsg.eu\\'}), (\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology\\'}), (\\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Person\\', \\'name\\': \\'Marry M. van den Heuvel-Eibrink\\'}), (\\'childhood renal tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'childhood renal tumours\\'}), (\\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'clear cell sarcoma of the kidney\\'}), (\\'renal cell carcinoma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'renal cell carcinoma\\'}), (\\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'malignant rhabdoid tumour of the kidney\\'}), (\\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'Wilms tumours_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'Children\u2019s Oncology Group (COG)\\'}), (\\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'SIOP\u22122001 randomized trial\\'}), (\\'actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'UKW3 trial\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)\\'}), (\\'localized disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'localized disease\\'}), (\\'metastatic disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'metastatic disease\\'}), (\\'bilateral disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'bilateral disease\\'}), (\\'relapsed disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'relapsed disease\\'}), (\\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subtype\\', \\'name\\': \\'blastemal-type Wilms tumours\\'}), (\\'radiotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgery_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'chemotherapy\\'}), (\\'Wilms Tumour_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms Tumour\\'}), (\\'CCSK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CCSK\\'}), (\\'MRTK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'MRTK\\'}), (\\'CMN_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CMN\\'}), (\\'RCC_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'RCC\\'}), (\\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u22122001_Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Trial\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'vincristine_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'vincristine\\'}), (\\'actinomycin D_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'actinomycin D\\'}), (\\'doxorubicin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'doxorubicin\\'}), (\\'etoposide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'Stage I_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage I\\'}), (\\'Stage II_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage II\\'}), (\\'Stage III_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage III\\'}), (\\'Stage IV_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage IV\\'}), (\\'Stage V_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage V\\'}), (\\'AV_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AV\\'}), (\\'AVD_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AVD\\'}), (\\'HR-1_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'HR-1\\'}), (\\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP-RTSG 2016\\'}), (\\'Overall Survival (OS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'CT-only nodules_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'CT-only nodules\\'}), (\\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP\u2013RTSG analysis\\'}), (\\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials\\'}), (\\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D plus doxorubicin\\'}), (\\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D\\'}), (\\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study_protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'MRI_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'MRI\\'}), (\\'CT_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'CT\\'}), (\\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_detail\\', \\'name\\': \\'cumulative doxorubicin dose\\'}), (\\'COG AREN0533 trial_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG AREN0533 trial\\'}), (\\'etoposide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'high-risk characteristics\\'}), (\\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG board\\'}), (\\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin\\'}), (\\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'high-dose chemotherapy and autologous stem cell transplantation\\'}), (\\'SIOP database_database\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'database\\', \\'name\\': \\'SIOP database\\'}), (\\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'AVD_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AVD\\'}), (\\'AV-2_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AV-2\\'}), (\\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Statistical Test\\', \\'name\\': \\'Log\u2013Rank P\\'}), (\\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'Bilateral Disease (Stage V)\\'}), (\\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Synchronous bilateral Wilms tumor\\'}), (\\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'End-stage renal disease (ESRD)\\'}), (\\'Aronson et al._Research Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Research Group\\', \\'name\\': \\'Aronson et al.\\'}), (\\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'Bilateral nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Study\\', \\'name\\': \\'SIOP\u22122001 study\\'}), (\\'Vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Vincristine\\'}), (\\'Actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Actinomycin D\\'}), (\\'Etoposide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Etoposide\\'}), (\\'Carboplatin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Carboplatin\\'}), (\\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease State\\', \\'name\\': \\'Relapsed Wilms Tumor\\'}), (\\'Group AA_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group AA\\'}), (\\'Group BB_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group BB\\'}), (\\'Group CC_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group CC\\'}), (\\'Doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Doxorubicin\\'}), (\\'Cyclophosphamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Cyclophosphamide\\'}), (\\'Ifosfamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Ifosfamide\\'}), (\\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'High-dose melphalan\\'}), (\\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UKW\u2011R protocol\\'}), (\\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'NWTS\u20115 relapse protocol\\'}), (\\'ASCR_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'procedure\\', \\'name\\': \\'ASCR\\'}), (\\'ifosfamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'ifosfamide\\'}), (\\'nephrotoxicity_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'nephrotoxicity\\'}), (\\'relapsed group CC_patient_group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'patient_group\\', \\'name\\': \\'relapsed group CC\\'}), (\\'diffuse anaplasia_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'diffuse anaplasia\\'}), (\\'blastemal-type tumors_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'blastemal-type tumors\\'}), (\\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'camptothecins_medication_class\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication_class\\', \\'name\\': \\'camptothecins\\'}), (\\'irinotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'irinotecan\\'}), (\\'topotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'topotecan\\'}), (\\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Innovative Therapies for Children with Cancer consortium\\'}), (\\'radiotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgical excision_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgical excision\\'}), (\\'stage IV WT_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'stage IV WT\\'}), (\\'AVD150_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD150\\'}), (\\'AVD250_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD250\\'}), (\\'low-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'low-risk disease\\'}), (\\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'intermediate-risk disease\\'}), (\\'high-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'high-risk disease\\'}), (\\'CDCV_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'CDCV\\'}), (\\'actinomycin-D_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'actinomycin-D\\'}), (\\'vincristine_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'doxorubicin\\'}), (\\'VP16_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'VP16\\'}), (\\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'contact\\', \\'name\\': \\'arnauld.verschuur@ap-hm.fr\\'}), (\\'surgery_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'chemotherapy\\'}), (\\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2212RTSG panel\\'}), (\\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Infant Wilms Tumors\\'}), (\\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'nephrectomy\\'}), (\\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'malignant rhabdoid tumors\\'}), (\\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Adult Wilms Tumors\\'}), (\\'anaplasia_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'anaplasia\\'}), (\\'actinomycin D_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'carboplatin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'etoposide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'etoposide\\'}), (\\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'Nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'radical tumor nephrectomy\\'}), (\\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'lymph node sampling\\'}), (\\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'minimally invasive surgery\\'}), (\\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'laparoscopic surgery\\'}), (\\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'radiotherapy\\'}), (\\'Wilms tumours_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'Davila Fajardo et al._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Davila Fajardo et al.\\'}), (\\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'COG\u2013NWTS trials\\'}), (\\'whole-lung irradiation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'whole-lung irradiation\\'}), (\\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'pulmonary radiotherapy\\'}), (\\'proton therapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'proton therapy\\'}), (\\'dosimetric study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'dosimetric study\\'}), (\\'locoregional disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'locoregional disease\\'}), (\\'metastatic disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'metastatic disease\\'}), (\\'low-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'low-risk\\'}), (\\'intermediate-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'intermediate-risk\\'}), (\\'high-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'high-risk\\'}), (\\'stage I_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage I\\'}), (\\'stage II_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage II\\'}), (\\'stage III_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage III\\'}), (\\'major rupture_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'major rupture\\'}), (\\'Austria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Austria\\'}), (\\'Italy_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Italy\\'}), (\\'San Marino_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'San Marino\\'}), (\\'Iceland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Iceland\\'}), (\\'Germany_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Germany\\'}), (\\'Bulgaria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bulgaria\\'}), (\\'Turkey_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Turkey\\'}), (\\'Denmark_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Denmark\\'}), (\\'Poland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Poland\\'}), (\\'Greece_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Greece\\'}), (\\'Andorra_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Andorra\\'}), (\\'Belgium_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belgium\\'}), (\\'Serbia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Serbia\\'}), (\\'Albania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Albania\\'}), (\\'Moldova_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Moldova\\'}), (\\'Lithuania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Lithuania\\'}), (\\'Latvia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Latvia\\'}), (\\'Estonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Estonia\\'}), (\\'Luxembourg_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Luxembourg\\'}), (\\'Montenegro_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Montenegro\\'}), (\\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bosnia and Herzegovina\\'}), (\\'Croatia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Croatia\\'}), (\\'Slovenia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovenia\\'}), (\\'Macedonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Macedonia\\'}), (\\'United Kingdom_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'United Kingdom\\'}), (\\'Ireland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ireland\\'}), (\\'Spain_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Spain\\'}), (\\'Algeria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Algeria\\'}), (\\'Tunisia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Tunisia\\'}), (\\'Malta_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Malta\\'}), (\\'Morocco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Morocco\\'}), (\\'Portugal_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Portugal\\'}), (\\'France_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'France\\'}), (\\'Monaco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Monaco\\'}), (\\'Russia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Russia\\'}), (\\'Finland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Finland\\'}), (\\'Sweden_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Sweden\\'}), (\\'Norway_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Norway\\'}), (\\'Belarus_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belarus\\'}), (\\'Romania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Romania\\'}), (\\'Ukraine_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ukraine\\'}), (\\'Hungary_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Hungary\\'}), (\\'Czech Republic_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Czech Republic\\'}), (\\'Slovakia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovakia\\'}), (\\'Switzerland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Switzerland\\'}), (\\'Liechtenstein_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Liechtenstein\\'}), (\\'Netherlands_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Netherlands\\'}), (\\'University Hospital of Munich_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Munich\\'}), (\\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Tuebingen\\'}), (\\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Azienda Ospedaliera\\'}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Ospedale Pediatrico Bambino Ges\u00f9\\'}), (\\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Fondazione IRCCS Istituto Nazionale dei Tumori\\'}), (\\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Prinses Maxima Centrum\\'}), (\\'Marciniak Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Marciniak Hospital\\'}), (\\'Faculty of Medicine_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Faculty of Medicine\\'}), (\\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'St. Anna Kinderspital/CCRI\\'}), (\\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Armand Trousseau Hospital\\'}), (\\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Universitario Virgin del Rocio\\'}), (\\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Vall d\u2019Hebron\\'}), (\\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Great Ormond Street Hospital\\'}), (\\'University Hospital Homburg_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital Homburg\\'}), (\\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon\\'}), (\\'UMBRELLA protocol_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'ExPO\u2011r\u2011Net\\'}), (\\'Weirich, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Weirich, A.\\'}), (\\'Pritchard-Jones, K._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Pritchard-Jones, K.\\'}), (\\'de Kraker, J._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'de Kraker, J.\\'}), (\\'Graf, N._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Graf, N.\\'}), (\\'Green, D. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Green, D. M.\\'}), (\\'Spreafico, F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Spreafico, F.\\'}), (\\'Bellani, F. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Bellani, F. F.\\'}), (\\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'van den Heuvel-Eibrink, M. M.\\'}), (\"D\\'Angio, G. J._author\", {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \"D\\'Angio, G. J.\"}), (\\'Tournade, M. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Tournade, M. F.\\'}), (\\'Breslow, N. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Breslow, N. E.\\'}), (\\'Mitchell, C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Mitchell, C.\\'}), (\\'Verschuur, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Verschuur, A.\\'}), (\\'Grundy, P. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Grundy, P. E.\\'}), (\\'Warmann, S. W._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Warmann, S. W.\\'}), (\\'Smets, A. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Smets, A. M.\\'}), (\\'Dome, J. S._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dome, J. S.\\'}), (\\'Dix, D. B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dix, D. B.\\'}), (\\'Daw, N. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Daw, N. C.\\'}), (\\'Ha, T. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Ha, T. C.\\'}), (\\'Kremens, B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Kremens, B.\\'}), (\\'Furtwangler, R._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Furtwangler, R.\\'}), (\\'SIOP-9/GPOH_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP-9/GPOH\\'}), (\\'UKW3_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'UKW3\\'}), (\\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'SIOP 93\u201301 trial\\'}), (\\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP trial and study 93\u201301\\'}), (\\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'National Wilms Tumor Study Group\\'}), (\\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP WT 2001 protocol\\'}), (\\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Third National Wilms\u2019 Tumor Study\\'}), (\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'National Wilms Tumor Studies\\'}), (\\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Second National Wilms\u2019 Tumor Study\\'}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'UK Children\u2019s Cancer Study Group\\'}), (\\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Children\u2019s Oncology Group\\'})], \\'edges\\': [(\\'sample.pdf\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'non-Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'childhood renal tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'renal cell carcinoma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'localized disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'metastatic disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'bilateral disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'relapsed disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'radiotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'surgery_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'chemotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'Wilms Tumour_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CCSK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'MRTK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CMN_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'RCC_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP\u22122001_Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'vincristine_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'actinomycin D_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'doxorubicin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'etoposide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'carboplatin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'cyclophosphamide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage I_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage II_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage III_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage IV_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage V_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AV_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AVD_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'HR-1_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Overall Survival (OS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT-only nodules_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'MRI_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG AREN0533 trial_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'etoposide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'carboplatin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'cyclophosphamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP database_database\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AVD_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AV-2_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Aronson et al._Research Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Etoposide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Carboplatin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group AA_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group BB_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group CC_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Cyclophosphamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Ifosfamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'ASCR_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'ifosfamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'nephrotoxicity_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'relapsed group CC_patient_group\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'diffuse anaplasia_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'blastemal-type tumors_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'camptothecins_medication_class\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'irinotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'topotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'radiotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'surgical excision_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'stage IV WT_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD150_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD250_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'low-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'CDCV_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'actinomycin-D_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'vincristine_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'doxorubicin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'VP16_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'surgery_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'chemotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'anaplasia_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'actinomycin D_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'vincristine_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'doxorubicin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'carboplatin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'cyclophosphamide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'etoposide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'SIOP\u22122001_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Wilms tumours_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Davila Fajardo et al._author\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'whole-lung irradiation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'proton therapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'dosimetric study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'locoregional disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'metastatic disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'low-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'intermediate-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'high-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage I_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage II_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage III_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'major rupture_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Austria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Italy_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'San Marino_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Iceland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Germany_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bulgaria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Turkey_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Denmark_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Poland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Greece_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Andorra_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belgium_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Serbia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Albania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Moldova_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Lithuania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Latvia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Estonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Luxembourg_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Montenegro_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Croatia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovenia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Macedonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'United Kingdom_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ireland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Spain_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Algeria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Tunisia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Malta_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Morocco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Portugal_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'France_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Monaco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Russia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Finland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Sweden_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Norway_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belarus_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Romania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ukraine_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hungary_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Czech Republic_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovakia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Switzerland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Liechtenstein_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Netherlands_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Munich_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Marciniak Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Faculty of Medicine_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital Homburg_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Weirich, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Pritchard-Jones, K._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'de Kraker, J._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Graf, N._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Green, D. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Spreafico, F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Bellani, F. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \"D\\'Angio, G. J._author\", {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Tournade, M. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Breslow, N. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Mitchell, C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Verschuur, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Grundy, P. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Warmann, S. W._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Smets, A. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dome, J. S._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dix, D. B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Daw, N. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ha, T. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Kremens, B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Furtwangler, R._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP-9/GPOH_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UKW3_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10})]}, {\\'nodes\\': [(\\'vincristine_entity\\', {}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {}), (\\'www.siop-rtsg.eu_entity\\', {}), (\\'stage II_entity\\', {}), (\\'Wilms tumours_entity\\', {}), (\\'Relapsed Wilms Tumor_entity\\', {}), (\\'Davila Fajardo et al._entity\\', {}), (\\'vincristine, actinomycin D, and doxorubicin_entity\\', {}), (\\'SIOP\u22122001 randomized trial_entity\\', {}), (\\'surgery_entity\\', {}), (\\'non-Wilms tumours_entity\\', {}), (\\'actinomycin D_entity\\', {}), (\\'diffuse anaplasia_entity\\', {}), (\\'Synchronous bilateral Wilms tumor_entity\\', {}), (\\'CT-only nodules_entity\\', {}), (\\'relapsed group CC_entity\\', {}), (\\'increased relapse risk_entity\\', {}), (\\'reduced survival_entity\\', {}), (\\'UKW3 trial_entity\\', {}), (\\'chemotherapy_entity\\', {}), (\\'Bilateral Disease (Stage V)_entity\\', {}), (\\'blastemal-type tumors_entity\\', {}), (\\'UMBRELLA protocol_entity\\', {}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', {}), (\\'minimally invasive surgery_entity\\', {}), (\\'VP16_entity\\', {}), (\\'Wilms tumor_entity\\', {}), (\\'anaplasia_entity\\', {}), (\\'radical tumor nephrectomy_entity\\', {}), (\\'Innovative Therapies for Children with Cancer consortium_entity\\', {}), (\\'cumulative doxorubicin dose_entity\\', {}), (\\'etoposide_entity\\', {}), (\\'large-volume tumours_entity\\', {}), (\\'Stage IV_entity\\', {}), (\\'CDCV_entity\\', {}), (\\'SIOP\u2013RTSG_entity\\', {}), (\\'AVD150_entity\\', {}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', {}), (\\'laparoscopic surgery_entity\\', {}), (\\'SIOP\u2212RTSG panel_entity\\', {}), (\\'actinomycin-D_entity\\', {}), (\\'COG AREN0533 trial_entity\\', {}), (\\'cyclophosphamide_entity\\', {}), (\\'carboplatin_entity\\', {}), (\\'UKW\u2011R protocol_entity\\', {}), (\\'Nephron-sparing surgery (NSS)_entity\\', {}), (\\'Adult Wilms Tumors_entity\\', {}), (\\'doxorubicin_entity\\', {}), (\\'NWTS\u20115 relapse protocol_entity\\', {}), (\\'End-stage renal disease (ESRD)_entity\\', {}), (\\'AVD250_entity\\', {}), (\\'Children\u2019s Oncology Group (COG)_entity\\', {}), (\\'blastemal-type Wilms tumour_entity\\', {}), (\\'SIOP\u22122001_entity\\', {}), (\\'radiotherapy_entity\\', {}), (\\'childhood renal tumours_entity\\', {})], \\'edges\\': [(\\'vincristine_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'stage II_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'indicated_for_in_adults\\'}), (\\'Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'Wilms tumours_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated under\\'}), (\\'Relapsed Wilms Tumor_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guided_by\\'}), (\\'Davila Fajardo et al._entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed\\'}), (\\'SIOP\u22122001 randomized trial_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated use in\\'}), (\\'surgery_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'non-Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'actinomycin D_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Synchronous bilateral Wilms tumor_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'instance_of\\'}), (\\'CT-only nodules_entity\\', \\'increased relapse risk_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'reduced survival_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included_in\\'}), (\\'relapsed group CC_entity\\', \\'diffuse anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'blastemal-type tumors_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UKW3 trial_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'UKW3 trial_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'chemotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UMBRELLA protocol_entity\\', \\'COG AREN0533 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses_data_from\\'}), (\\'UMBRELLA protocol_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'advises_treatment_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'Innovative Therapies for Children with Cancer consortium_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborates_with\\'}), (\\'UMBRELLA protocol_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'surgery_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is the standard of\\'}), (\\'UMBRELLA protocol_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guides treatment in\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', \\'UKW3 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\\'minimally invasive surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'anaplasia_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'radical tumor nephrectomy_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'standard_of_care_for\\'}), (\\'Stage IV_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'presents in\\'}), (\\'CDCV_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'VP16_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'aims to improve survival rates of\\'}), (\\'AVD150_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed_by\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'succeeds\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'www.siop-rtsg.eu_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'available_on\\'}), (\\'laparoscopic surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'COG AREN0533 trial_entity\\', \\'cumulative doxorubicin dose_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'evaluates\\'}), (\\'UKW\u2011R protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'Nephron-sparing surgery (NSS)_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'classification_developed_by\\'}), (\\'Adult Wilms Tumors_entity\\', \\'anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'Adult Wilms Tumors_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'doxorubicin_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'doxorubicin_entity\\', \\'large-volume tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'recommended for\\'}), (\\'NWTS\u20115 relapse protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'End-stage renal disease (ESRD)_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'AVD250_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'Children\u2019s Oncology Group (COG)_entity\\', \\'SIOP\u22122001 randomized trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborated with\\'}), (\\'blastemal-type Wilms tumour_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment intensified according to\\'}), (\\'SIOP\u22122001_entity\\', \\'vincristine, actinomycin D, and doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses\\'}), (\\'SIOP\u22122001_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provided_guidelines_for\\'}), (\\'radiotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'radiotherapy_entity\\', \\'SIOP\u2212RTSG panel_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'contact_for_guidance\\'})]}, {\\'nodes\\': [(\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {}), (\\'Marry M. van den Heuvel-Eibrink_entity\\', {})], \\'edges\\': [(\\'Marry M. van den Heuvel-Eibrink_entity\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'affiliated_with\\'})]}, {\\'nodes\\': [(\\'Stage II_entity\\', {}), (\\'AV_entity\\', {}), (\\'Stage III_entity\\', {}), (\\'vincestine and actinomycin D_entity\\', {}), (\\'AVD_entity\\', {})], \\'edges\\': [(\\'Stage II_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AV_entity\\', \\'Stage II_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Stage III_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AVD_entity\\', \\'Stage III_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'SIOP-RTSG 2016_entity\\', {}), (\\'RCC_entity\\', {}), (\\'CMN_entity\\', {})], \\'edges\\': [(\\'RCC_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'}), (\\'CMN_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'})]}, {\\'nodes\\': [(\\'HR-1_entity\\', {}), (\\'High-risk blastemal type Wilms tumour_entity\\', {})], \\'edges\\': [(\\'HR-1_entity\\', \\'High-risk blastemal type Wilms tumour_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'unfavorable prognosis_entity\\', {}), (\\'high-risk characteristics_entity\\', {})], \\'edges\\': [(\\'high-risk characteristics_entity\\', \\'unfavorable prognosis_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'leads_to\\'})]}, {\\'nodes\\': [(\\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {}), (\\'SIOP\u2013RTSG board_entity\\', {})], \\'edges\\': [(\\'SIOP\u2013RTSG board_entity\\', \\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggests\\'})]}, {\\'nodes\\': [(\\'regimen and outcomes_entity\\', {}), (\\'SIOP database_entity\\', {})], \\'edges\\': [(\\'SIOP database_entity\\', \\'regimen and outcomes_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'captures_data_on\\'})]}, {\\'nodes\\': [(\\'Bilateral nephron-sparing surgery (NSS)_entity\\', {}), (\\'Aronson et al._entity\\', {})], \\'edges\\': [(\\'Aronson et al._entity\\', \\'Bilateral nephron-sparing surgery (NSS)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'observed_effectiveness_of\\'})]}, {\\'nodes\\': [(\\'SIOP\u22122001 study_entity\\', {}), (\\'Actinomycin D_entity\\', {}), (\\'Vincristine_entity\\', {})], \\'edges\\': [(\\'SIOP\u22122001 study_entity\\', \\'Vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'}), (\\'SIOP\u22122001 study_entity\\', \\'Actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'})]}, {\\'nodes\\': [(\\'High-dose melphalan_entity\\', {}), (\\'Group AA_entity\\', {}), (\\'Carboplatin_entity\\', {}), (\\'Doxorubicin_entity\\', {}), (\\'Etoposide_entity\\', {}), (\\'Group BB_entity\\', {}), (\\'Cyclophosphamide_entity\\', {}), (\\'Ifosfamide_entity\\', {})], \\'edges\\': [(\\'Group AA_entity\\', \\'Doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Ifosfamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'High-dose melphalan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'})]}, {\\'nodes\\': [(\\'nephrotoxicity_entity\\', {}), (\\'ifosfamide_entity\\', {})], \\'edges\\': [(\\'ifosfamide_entity\\', \\'nephrotoxicity_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'related_to\\'})]}, {\\'nodes\\': [(\\'camptothecins_entity\\', {}), (\\'irinotecan_entity\\', {}), (\\'topotecan_entity\\', {})], \\'edges\\': [(\\'camptothecins_entity\\', \\'irinotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'camptothecins_entity\\', \\'topotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'})]}, {\\'nodes\\': [(\\'Infant Wilms Tumors_entity\\', {}), (\\'nephrectomy_entity\\', {})], \\'edges\\': [(\\'Infant Wilms Tumors_entity\\', \\'nephrectomy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_option\\'})]}, {\\'nodes\\': [(\\'congenital mesoblastic nephroma_entity\\', {}), (\\'surgery alone_entity\\', {})], \\'edges\\': [(\\'congenital mesoblastic nephroma_entity\\', \\'surgery alone_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'alternative chemotherapy_entity\\', {}), (\\'malignant rhabdoid tumors_entity\\', {})], \\'edges\\': [(\\'malignant rhabdoid tumors_entity\\', \\'alternative chemotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'lymph node sampling_entity\\', {}), (\\'accurate staging_entity\\', {})], \\'edges\\': [(\\'lymph node sampling_entity\\', \\'accurate staging_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'purpose_of\\'})]}, {\\'nodes\\': [(\\'COG\u2013NWTS trials_entity\\', {}), (\\'whole-lung irradiation_entity\\', {})], \\'edges\\': [(\\'COG\u2013NWTS trials_entity\\', \\'whole-lung irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'informed_dosage_for\\'})]}, {\\'nodes\\': [(\\'lung metastases_entity\\', {}), (\\'pulmonary radiotherapy_entity\\', {})], \\'edges\\': [(\\'pulmonary radiotherapy_entity\\', \\'lung metastases_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'administered_for\\'})]}, {\\'nodes\\': [(\\'dosimetric study_entity\\', {}), (\\'proton therapy_entity\\', {}), (\\'flank irradiation_entity\\', {})], \\'edges\\': [(\\'dosimetric study_entity\\', \\'proton therapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated\\'}), (\\'proton therapy_entity\\', \\'flank irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggested_for\\'})]}, {\\'nodes\\': [(\\'metastatic disease_entity\\', {}), (\\'radiotherapy guidelines_entity\\', {}), (\\'locoregional disease_entity\\', {})], \\'edges\\': [(\\'radiotherapy guidelines_entity\\', \\'locoregional disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'}), (\\'radiotherapy guidelines_entity\\', \\'metastatic disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'})]}, {\\'nodes\\': [(\\'major rupture_entity\\', {}), (\\'stage III_entity\\', {})], \\'edges\\': [(\\'stage III_entity\\', \\'major rupture_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes_condition\\'})]}, {\\'nodes\\': [(\\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {}), (\\'ExPO\u2011r\u2011Net_entity\\', {})], \\'edges\\': [(\\'ExPO\u2011r\u2011Net_entity\\', \\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is part of\\'})]}, {\\'nodes\\': [(\\'University Hospital of Munich_entity\\', {}), (\\'Germany_entity\\', {}), (\\'University Hospital of Tuebingen_entity\\', {})], \\'edges\\': [(\\'Germany_entity\\', \\'University Hospital of Munich_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Germany_entity\\', \\'University Hospital of Tuebingen_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {}), (\\'Italy_entity\\', {}), (\\'Azienda Ospedaliera_entity\\', {}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {})], \\'edges\\': [(\\'Italy_entity\\', \\'Azienda Ospedaliera_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Netherlands_entity\\', {}), (\\'Prinses Maxima Centrum_entity\\', {})], \\'edges\\': [(\\'Netherlands_entity\\', \\'Prinses Maxima Centrum_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Marciniak Hospital_entity\\', {}), (\\'Poland_entity\\', {}), (\\'Faculty of Medicine_entity\\', {})], \\'edges\\': [(\\'Poland_entity\\', \\'Marciniak Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Poland_entity\\', \\'Faculty of Medicine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'St. Anna Kinderspital/CCRI_entity\\', {}), (\\'Austria_entity\\', {})], \\'edges\\': [(\\'Austria_entity\\', \\'St. Anna Kinderspital/CCRI_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'France_entity\\', {}), (\\'Armand Trousseau Hospital_entity\\', {})], \\'edges\\': [(\\'France_entity\\', \\'Armand Trousseau Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Spain_entity\\', {}), (\\'Hospital Vall d\u2019Hebron_entity\\', {}), (\\'Hospital Universitario Virgin del Rocio_entity\\', {})], \\'edges\\': [(\\'Spain_entity\\', \\'Hospital Universitario Virgin del Rocio_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Spain_entity\\', \\'Hospital Vall d\u2019Hebron_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'United Kingdom_entity\\', {}), (\\'Great Ormond Street Hospital_entity\\', {})], \\'edges\\': [(\\'United Kingdom_entity\\', \\'Great Ormond Street Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Weirich, A._entity\\', {}), (\\'SIOP-9/GPOH_entity\\', {})], \\'edges\\': [(\\'Weirich, A._entity\\', \\'SIOP-9/GPOH_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Pritchard-Jones, K._entity\\', {}), (\\'UKW3_entity\\', {})], \\'edges\\': [(\\'Pritchard-Jones, K._entity\\', \\'UKW3_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed in\\'})]}, {\\'nodes\\': [(\\'SIOP 93\u201301 trial_entity\\', {}), (\\'de Kraker, J._entity\\', {})], \\'edges\\': [(\\'de Kraker, J._entity\\', \\'SIOP 93\u201301 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'SIOP trial and study 93\u201301_entity\\', {}), (\\'Graf, N._entity\\', {})], \\'edges\\': [(\\'Graf, N._entity\\', \\'SIOP trial and study 93\u201301_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Green, D. M._entity\\', {}), (\\'National Wilms Tumor Study Group_entity\\', {})], \\'edges\\': [(\\'Green, D. M._entity\\', \\'National Wilms Tumor Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}, {\\'nodes\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', {}), (\\'SIOP WT 2001 protocol_entity\\', {})], \\'edges\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', \\'SIOP WT 2001 protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Third National Wilms\u2019 Tumor Study_entity\\', {}), (\"D\\'Angio, G. J._entity\", {}), (\\'Second National Wilms\u2019 Tumor Study_entity\\', {})], \\'edges\\': [(\"D\\'Angio, G. J._entity\", \\'Third National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\"D\\'Angio, G. J._entity\", \\'Second National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {}), (\\'Tournade, M. F._entity\\', {}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {})], \\'edges\\': [(\\'Tournade, M. F._entity\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'}), (\\'Tournade, M. F._entity\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Breslow, N. E._entity\\', {}), (\\'National Wilms Tumor Studies_entity\\', {})], \\'edges\\': [(\\'Breslow, N. E._entity\\', \\'National Wilms Tumor Studies_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Mitchell, C._entity\\', {}), (\\'UK Children\u2019s Cancer Study Group_entity\\', {})], \\'edges\\': [(\\'Mitchell, C._entity\\', \\'UK Children\u2019s Cancer Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'under\\'})]}, {\\'nodes\\': [(\\'Daw, N. C._entity\\', {}), (\\'Dix, D. B._entity\\', {}), (\\'Children\u2019s Oncology Group_entity\\', {}), (\\'Grundy, P. E._entity\\', {})], \\'edges\\': [(\\'Daw, N. C._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted under\\'}), (\\'Dix, D. B._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'}), (\\'Grundy, P. E._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}]']), TestResult(name='test_case_18', success=False, metrics_data=[MetricData(name='Answer Correctness (GEval)', threshold=0.5, success=False, score=0.20317337352733023, reason='The actual output lacks the specific claim about implementation in over 50 countries from the expected output.', strict_mode=False, evaluation_model='gpt-4o-mini', error=None, evaluation_cost=0.0032933999999999997, verbose_logs='Criteria:\\nNone \\n \\nEvaluation Steps:\\n[\\n    \"Determine whether the actual output is factually correct based on the expected output.\"\\n]'), MetricData(name='Faithfulness', threshold=0.7, success=True, score=0.875, reason=None, strict_mode=False, evaluation_model='gpt-4o-mini', error=None, evaluation_cost=0.007598399999999999, verbose_logs='Truths (limit=None):\\n[\\n    \"The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG) is an organization.\",\\n    \"UMBRELLA SIOP-RTSG 2016 is a protocol.\",\\n    \"SIOP\u22122001 is a protocol and clinical trial.\",\\n    \"Wilms tumours is a type of disease characterized by childhood renal tumors.\",\\n    \"Non-Wilms tumours is also a category of childhood renal disease.\",\\n    \"Childhood renal tumours encompass various forms of kidney tumors in children.\",\\n    \"The Department of Paediatric Oncology is located at the Princess M\u00e1xima Center for Paediatric Oncology.\",\\n    \"Marry M. van den Heuvel-Eibrink is a noted person in the field.\",\\n    \"Wilms Tumour, clear cell sarcoma of the kidney, renal cell carcinoma, malignant rhabdoid tumour of the kidney, and congenital mesoblastic nephroma are classified as types of kidney tumors.\",\\n    \"SIOP\u22122001 randomizes clinical trials for the treatment of Wilms tumours and evaluates drug effectiveness including actinomycin D, vincristine, and doxorubicin.\",\\n    \"The UK Children\u2019s Cancer and Leukaemia Group (UKCCLG) is an organization involved in childhood cancer research.\",\\n    \"Localized, metastatic, bilateral, and relapsed diseases are stages of Wilms tumours.\",\\n    \"Radiotherapy, surgery, and chemotherapy are treatment methods for Wilms tumors.\",\\n    \"Stage I to Stage V are classifications for the progression of Wilms tumour.\",\\n    \"Treatment combinations such as AV and AVD provide guidelines for Wilms tumour therapy.\",\\n    \"Overall Survival (OS) and Event-Free Survival (EFS) are metrics used to evaluate treatment effectiveness in clinical trials.\",\\n    \"CT and MRI are diagnostic tools used in the evaluation of renal tumors.\",\\n    \"The SIOP\u2013RTSG provides protocols guiding the treatment of Wilms tumor.\",\\n    \"Several studies like COG National Wilms Tumor Study Group trials analyze therapeutic strategies for childhood renal neoplasms.\",\\n    \"Many authors, including Davila Fajardo, Weirich, and Pritchard-Jones, contribute to the research on childhood cancers and specifically Wilms tumours.\",\\n    \"Major European countries such as Germany, Italy, France, and the UK have institutions conducting pediatric oncology research, including the University Hospital of Munich and Great Ormond Street Hospital.\",\\n    \"Nephron-sparing surgery (NSS) and radical tumor nephrectomy are surgical procedures used to treat Wilms tumors in children.\"\\n] \\n \\nClaims:\\n[\\n    \"The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG) is an organization.\",\\n    \"The UMBRELLA protocol is a treatment protocol.\",\\n    \"SIOP\u2013RTSG focuses on Wilms tumours and non-Wilms tumours.\",\\n    \"Marry M. van den Heuvel-Eibrink is a person affiliated with paediatric oncology.\",\\n    \"Wilms tumours, clear cell sarcoma of the kidney, renal cell carcinoma, malignant rhabdoid tumour of the kidney, and congenital mesoblastic nephroma are types of childhood renal tumours.\",\\n    \"Vincristine, actinomycin D, and doxorubicin are drugs used for treatment.\",\\n    \"The SIOP\u22122001 randomized trial is a clinical trial related to Wilms tumours.\",\\n    \"The UKW3 trial is a clinical trial related to Wilms tumours and non-Wilms tumours.\",\\n    \"Localized disease, metastatic disease, bilateral disease, and relapsed disease are stages of Wilms tumours.\",\\n    \"Surgery, chemotherapy, and radiotherapy are treatment methods for childhood renal tumours.\",\\n    \"The SIOP\u2013RTSG organization conducts various studies and protocols for treatment and research.\",\\n    \"The UMBRELLA SIOP-RTSG 2016 protocol is centered around the treatment of childhood renal tumours.\",\\n    \"SIOP\u20132001 protocol and UMBRELLA SIOP-RTSG 2016 are treatment protocols used for managing Wilms tumours.\",\\n    \"Overall Survival (OS) and Event-Free Survival (EFS) are metrics used in assessing treatment outcome for Wilms tumours.\",\\n    \"High-dose chemotherapy and autologous stem cell transplantation is a treatment approach addressed within SIOP\u2013RTSG.\",\\n    \"Vincristine, doxorubicin, etoposide, carboplatin, and cyclophosphamide are medications used in the treatment protocols.\",\\n    \"Various European countries are involved in managing childhood renal tumours and participating in SIOP\u2013RTSG.\",\\n    \"There are different risk categories such as low-risk, intermediate-risk, and high-risk concerning Wilms tumours.\",\\n    \"The treatment and studies are supported by various collaborations, such as the Children\u2019s Oncology Group and the UK Children\u2019s Cancer Study Group.\"\\n] \\n \\nVerdicts:\\n[\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"The retrieval context specifies that the UMBRELLA SIOP-RTSG 2016 is a protocol, not directly stated as a treatment protocol.\"\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"The retrieval context states that SIOP\\\\u2013RTSG focuses on Wilms tumours but does not confirm its focus on non-Wilms tumours.\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"idk\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"idk\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"idk\",\\n        \"reason\": null\\n    }\\n]'), MetricData(name='Contextual Relevancy', threshold=1.0, success=False, score=0.75, reason=\"The score is 0.75 because although there are relevant statements like 'UMBRELLA protocol collaborates with Innovative Therapies for Children with Cancer consortium' and 'SIOP\u2013RTSG\u2019s collaboration on Wilms tumor research is globally recognized', the overall context includes many irrelevant statements focusing on prognosis and localized practices that detract from the emphasis on international collaboration.\", strict_mode=False, evaluation_model='gpt-4o-mini', error=None, evaluation_cost=0.0039201, verbose_logs='Verdicts:\\n[\\n    {\\n        \"verdicts\": [\\n            {\\n                \"statement\": \"UMBRELLA protocol is the standard of care for Wilms tumor.\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"UMBRELLA protocol collaborates with Innovative Therapies for Children with Cancer consortium.\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"The SIOP- RTGS aims to improve survival rates of Wilms tumor.\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"UMBRELLA SIOP-RTSG 2016 was developed by the The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP-RTSG).\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"UMBRELLA protocol provides guidelines for radiotherapy.\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"Children\\\\u2019s Oncology Group (COG) collaborated with SIOP-2001 randomized trial to guide treatment for Wilms tumors.\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"SIOP-RTSG handles the international collaboration for treatment of pediatric cancers.\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"The SIOP database captures data on treatment regimens and outcomes.\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"High-risk characteristics lead to unfavorable prognosis.\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"This focuses on prognosis rather than specific international collaboration. Relevant part is \\'lead to unfavorable prognosis\\' which is not related to the input on international collaboration.\"\\n            },\\n            {\\n                \"statement\": \"High-dose chemotherapy and autologous stem cell transplantation includes European collaborations.\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"Lymph node sampling is performed for accurate staging.\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"Staging does not relate to the context of international collaboration, as the statement discusses procedural details rather than collaboration.\"\\n            },\\n            {\\n                \"statement\": \"Ninth International Society of Pediatric Oncology Wilms\\\\u2019 Tumor Trial and Study connects multiple countries.\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"Surgical excision requires local funding support.\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"This does not pertain to international collaboration but rather financial aspects of procedures.\"\\n            },\\n            {\\n                \"statement\": \"Proton therapy was suggested for children with relapsed tumors under international protocols.\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"Various treatment protocols are adapted based on local guidelines.\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"Local adaptation indicates a divergence from international collaboration, focusing instead on localized practice.\"\\n            },\\n            {\\n                \"statement\": \"SIOP\\\\u2013RTSG\\\\u2019s collaboration on Wilms tumor research is globally recognized.\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            }\\n        ]\\n    }\\n]')], conversational=False, multimodal=False, input='How is international collaboration emphasized in the protocol?', actual_output='[{\\'nodes\\': [(\\'sample.pdf\\', {\\'type\\': \\'document\\'}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)\\'}), (\\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA SIOP-RTSG 2016\\'}), (\\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms tumours\\'}), (\\'non-Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'non-Wilms tumours\\'}), (\\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Website\\', \\'name\\': \\'www.siop-rtsg.eu\\'}), (\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology\\'}), (\\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Person\\', \\'name\\': \\'Marry M. van den Heuvel-Eibrink\\'}), (\\'childhood renal tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'childhood renal tumours\\'}), (\\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'clear cell sarcoma of the kidney\\'}), (\\'renal cell carcinoma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'renal cell carcinoma\\'}), (\\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'malignant rhabdoid tumour of the kidney\\'}), (\\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'Wilms tumours_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'Children\u2019s Oncology Group (COG)\\'}), (\\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'SIOP\u22122001 randomized trial\\'}), (\\'actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'UKW3 trial\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)\\'}), (\\'localized disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'localized disease\\'}), (\\'metastatic disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'metastatic disease\\'}), (\\'bilateral disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'bilateral disease\\'}), (\\'relapsed disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'relapsed disease\\'}), (\\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subtype\\', \\'name\\': \\'blastemal-type Wilms tumours\\'}), (\\'radiotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgery_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'chemotherapy\\'}), (\\'Wilms Tumour_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms Tumour\\'}), (\\'CCSK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CCSK\\'}), (\\'MRTK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'MRTK\\'}), (\\'CMN_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CMN\\'}), (\\'RCC_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'RCC\\'}), (\\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u22122001_Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Trial\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'vincristine_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'vincristine\\'}), (\\'actinomycin D_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'actinomycin D\\'}), (\\'doxorubicin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'doxorubicin\\'}), (\\'etoposide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'Stage I_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage I\\'}), (\\'Stage II_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage II\\'}), (\\'Stage III_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage III\\'}), (\\'Stage IV_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage IV\\'}), (\\'Stage V_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage V\\'}), (\\'AV_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AV\\'}), (\\'AVD_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AVD\\'}), (\\'HR-1_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'HR-1\\'}), (\\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP-RTSG 2016\\'}), (\\'Overall Survival (OS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'CT-only nodules_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'CT-only nodules\\'}), (\\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP\u2013RTSG analysis\\'}), (\\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials\\'}), (\\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D plus doxorubicin\\'}), (\\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D\\'}), (\\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study_protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'MRI_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'MRI\\'}), (\\'CT_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'CT\\'}), (\\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_detail\\', \\'name\\': \\'cumulative doxorubicin dose\\'}), (\\'COG AREN0533 trial_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG AREN0533 trial\\'}), (\\'etoposide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'high-risk characteristics\\'}), (\\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG board\\'}), (\\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin\\'}), (\\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'high-dose chemotherapy and autologous stem cell transplantation\\'}), (\\'SIOP database_database\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'database\\', \\'name\\': \\'SIOP database\\'}), (\\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'AVD_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AVD\\'}), (\\'AV-2_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AV-2\\'}), (\\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Statistical Test\\', \\'name\\': \\'Log\u2013Rank P\\'}), (\\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'Bilateral Disease (Stage V)\\'}), (\\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Synchronous bilateral Wilms tumor\\'}), (\\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'End-stage renal disease (ESRD)\\'}), (\\'Aronson et al._Research Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Research Group\\', \\'name\\': \\'Aronson et al.\\'}), (\\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'Bilateral nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Study\\', \\'name\\': \\'SIOP\u22122001 study\\'}), (\\'Vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Vincristine\\'}), (\\'Actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Actinomycin D\\'}), (\\'Etoposide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Etoposide\\'}), (\\'Carboplatin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Carboplatin\\'}), (\\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease State\\', \\'name\\': \\'Relapsed Wilms Tumor\\'}), (\\'Group AA_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group AA\\'}), (\\'Group BB_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group BB\\'}), (\\'Group CC_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group CC\\'}), (\\'Doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Doxorubicin\\'}), (\\'Cyclophosphamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Cyclophosphamide\\'}), (\\'Ifosfamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Ifosfamide\\'}), (\\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'High-dose melphalan\\'}), (\\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UKW\u2011R protocol\\'}), (\\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'NWTS\u20115 relapse protocol\\'}), (\\'ASCR_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'procedure\\', \\'name\\': \\'ASCR\\'}), (\\'ifosfamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'ifosfamide\\'}), (\\'nephrotoxicity_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'nephrotoxicity\\'}), (\\'relapsed group CC_patient_group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'patient_group\\', \\'name\\': \\'relapsed group CC\\'}), (\\'diffuse anaplasia_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'diffuse anaplasia\\'}), (\\'blastemal-type tumors_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'blastemal-type tumors\\'}), (\\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'camptothecins_medication_class\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication_class\\', \\'name\\': \\'camptothecins\\'}), (\\'irinotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'irinotecan\\'}), (\\'topotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'topotecan\\'}), (\\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Innovative Therapies for Children with Cancer consortium\\'}), (\\'radiotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgical excision_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgical excision\\'}), (\\'stage IV WT_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'stage IV WT\\'}), (\\'AVD150_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD150\\'}), (\\'AVD250_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD250\\'}), (\\'low-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'low-risk disease\\'}), (\\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'intermediate-risk disease\\'}), (\\'high-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'high-risk disease\\'}), (\\'CDCV_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'CDCV\\'}), (\\'actinomycin-D_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'actinomycin-D\\'}), (\\'vincristine_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'doxorubicin\\'}), (\\'VP16_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'VP16\\'}), (\\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'contact\\', \\'name\\': \\'arnauld.verschuur@ap-hm.fr\\'}), (\\'surgery_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'chemotherapy\\'}), (\\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2212RTSG panel\\'}), (\\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Infant Wilms Tumors\\'}), (\\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'nephrectomy\\'}), (\\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'malignant rhabdoid tumors\\'}), (\\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Adult Wilms Tumors\\'}), (\\'anaplasia_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'anaplasia\\'}), (\\'actinomycin D_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'carboplatin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'etoposide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'etoposide\\'}), (\\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'Nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'radical tumor nephrectomy\\'}), (\\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'lymph node sampling\\'}), (\\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'minimally invasive surgery\\'}), (\\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'laparoscopic surgery\\'}), (\\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'radiotherapy\\'}), (\\'Wilms tumours_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'Davila Fajardo et al._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Davila Fajardo et al.\\'}), (\\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'COG\u2013NWTS trials\\'}), (\\'whole-lung irradiation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'whole-lung irradiation\\'}), (\\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'pulmonary radiotherapy\\'}), (\\'proton therapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'proton therapy\\'}), (\\'dosimetric study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'dosimetric study\\'}), (\\'locoregional disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'locoregional disease\\'}), (\\'metastatic disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'metastatic disease\\'}), (\\'low-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'low-risk\\'}), (\\'intermediate-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'intermediate-risk\\'}), (\\'high-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'high-risk\\'}), (\\'stage I_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage I\\'}), (\\'stage II_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage II\\'}), (\\'stage III_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage III\\'}), (\\'major rupture_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'major rupture\\'}), (\\'Austria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Austria\\'}), (\\'Italy_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Italy\\'}), (\\'San Marino_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'San Marino\\'}), (\\'Iceland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Iceland\\'}), (\\'Germany_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Germany\\'}), (\\'Bulgaria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bulgaria\\'}), (\\'Turkey_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Turkey\\'}), (\\'Denmark_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Denmark\\'}), (\\'Poland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Poland\\'}), (\\'Greece_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Greece\\'}), (\\'Andorra_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Andorra\\'}), (\\'Belgium_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belgium\\'}), (\\'Serbia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Serbia\\'}), (\\'Albania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Albania\\'}), (\\'Moldova_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Moldova\\'}), (\\'Lithuania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Lithuania\\'}), (\\'Latvia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Latvia\\'}), (\\'Estonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Estonia\\'}), (\\'Luxembourg_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Luxembourg\\'}), (\\'Montenegro_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Montenegro\\'}), (\\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bosnia and Herzegovina\\'}), (\\'Croatia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Croatia\\'}), (\\'Slovenia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovenia\\'}), (\\'Macedonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Macedonia\\'}), (\\'United Kingdom_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'United Kingdom\\'}), (\\'Ireland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ireland\\'}), (\\'Spain_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Spain\\'}), (\\'Algeria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Algeria\\'}), (\\'Tunisia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Tunisia\\'}), (\\'Malta_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Malta\\'}), (\\'Morocco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Morocco\\'}), (\\'Portugal_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Portugal\\'}), (\\'France_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'France\\'}), (\\'Monaco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Monaco\\'}), (\\'Russia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Russia\\'}), (\\'Finland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Finland\\'}), (\\'Sweden_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Sweden\\'}), (\\'Norway_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Norway\\'}), (\\'Belarus_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belarus\\'}), (\\'Romania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Romania\\'}), (\\'Ukraine_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ukraine\\'}), (\\'Hungary_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Hungary\\'}), (\\'Czech Republic_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Czech Republic\\'}), (\\'Slovakia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovakia\\'}), (\\'Switzerland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Switzerland\\'}), (\\'Liechtenstein_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Liechtenstein\\'}), (\\'Netherlands_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Netherlands\\'}), (\\'University Hospital of Munich_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Munich\\'}), (\\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Tuebingen\\'}), (\\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Azienda Ospedaliera\\'}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Ospedale Pediatrico Bambino Ges\u00f9\\'}), (\\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Fondazione IRCCS Istituto Nazionale dei Tumori\\'}), (\\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Prinses Maxima Centrum\\'}), (\\'Marciniak Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Marciniak Hospital\\'}), (\\'Faculty of Medicine_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Faculty of Medicine\\'}), (\\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'St. Anna Kinderspital/CCRI\\'}), (\\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Armand Trousseau Hospital\\'}), (\\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Universitario Virgin del Rocio\\'}), (\\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Vall d\u2019Hebron\\'}), (\\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Great Ormond Street Hospital\\'}), (\\'University Hospital Homburg_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital Homburg\\'}), (\\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon\\'}), (\\'UMBRELLA protocol_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'ExPO\u2011r\u2011Net\\'}), (\\'Weirich, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Weirich, A.\\'}), (\\'Pritchard-Jones, K._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Pritchard-Jones, K.\\'}), (\\'de Kraker, J._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'de Kraker, J.\\'}), (\\'Graf, N._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Graf, N.\\'}), (\\'Green, D. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Green, D. M.\\'}), (\\'Spreafico, F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Spreafico, F.\\'}), (\\'Bellani, F. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Bellani, F. F.\\'}), (\\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'van den Heuvel-Eibrink, M. M.\\'}), (\"D\\'Angio, G. J._author\", {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \"D\\'Angio, G. J.\"}), (\\'Tournade, M. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Tournade, M. F.\\'}), (\\'Breslow, N. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Breslow, N. E.\\'}), (\\'Mitchell, C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Mitchell, C.\\'}), (\\'Verschuur, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Verschuur, A.\\'}), (\\'Grundy, P. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Grundy, P. E.\\'}), (\\'Warmann, S. W._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Warmann, S. W.\\'}), (\\'Smets, A. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Smets, A. M.\\'}), (\\'Dome, J. S._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dome, J. S.\\'}), (\\'Dix, D. B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dix, D. B.\\'}), (\\'Daw, N. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Daw, N. C.\\'}), (\\'Ha, T. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Ha, T. C.\\'}), (\\'Kremens, B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Kremens, B.\\'}), (\\'Furtwangler, R._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Furtwangler, R.\\'}), (\\'SIOP-9/GPOH_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP-9/GPOH\\'}), (\\'UKW3_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'UKW3\\'}), (\\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'SIOP 93\u201301 trial\\'}), (\\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP trial and study 93\u201301\\'}), (\\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'National Wilms Tumor Study Group\\'}), (\\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP WT 2001 protocol\\'}), (\\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Third National Wilms\u2019 Tumor Study\\'}), (\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'National Wilms Tumor Studies\\'}), (\\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Second National Wilms\u2019 Tumor Study\\'}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'UK Children\u2019s Cancer Study Group\\'}), (\\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Children\u2019s Oncology Group\\'})], \\'edges\\': [(\\'sample.pdf\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'non-Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'childhood renal tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'renal cell carcinoma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'localized disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'metastatic disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'bilateral disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'relapsed disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'radiotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'surgery_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'chemotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'Wilms Tumour_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CCSK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'MRTK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CMN_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'RCC_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP\u22122001_Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'vincristine_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'actinomycin D_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'doxorubicin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'etoposide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'carboplatin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'cyclophosphamide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage I_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage II_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage III_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage IV_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage V_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AV_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AVD_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'HR-1_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Overall Survival (OS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT-only nodules_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'MRI_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG AREN0533 trial_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'etoposide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'carboplatin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'cyclophosphamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP database_database\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AVD_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AV-2_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Aronson et al._Research Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Etoposide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Carboplatin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group AA_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group BB_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group CC_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Cyclophosphamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Ifosfamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'ASCR_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'ifosfamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'nephrotoxicity_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'relapsed group CC_patient_group\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'diffuse anaplasia_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'blastemal-type tumors_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'camptothecins_medication_class\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'irinotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'topotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'radiotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'surgical excision_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'stage IV WT_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD150_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD250_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'low-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'CDCV_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'actinomycin-D_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'vincristine_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'doxorubicin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'VP16_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'surgery_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'chemotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'anaplasia_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'actinomycin D_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'vincristine_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'doxorubicin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'carboplatin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'cyclophosphamide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'etoposide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'SIOP\u22122001_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Wilms tumours_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Davila Fajardo et al._author\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'whole-lung irradiation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'proton therapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'dosimetric study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'locoregional disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'metastatic disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'low-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'intermediate-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'high-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage I_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage II_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage III_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'major rupture_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Austria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Italy_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'San Marino_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Iceland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Germany_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bulgaria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Turkey_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Denmark_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Poland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Greece_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Andorra_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belgium_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Serbia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Albania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Moldova_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Lithuania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Latvia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Estonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Luxembourg_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Montenegro_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Croatia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovenia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Macedonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'United Kingdom_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ireland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Spain_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Algeria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Tunisia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Malta_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Morocco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Portugal_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'France_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Monaco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Russia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Finland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Sweden_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Norway_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belarus_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Romania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ukraine_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hungary_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Czech Republic_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovakia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Switzerland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Liechtenstein_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Netherlands_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Munich_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Marciniak Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Faculty of Medicine_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital Homburg_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Weirich, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Pritchard-Jones, K._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'de Kraker, J._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Graf, N._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Green, D. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Spreafico, F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Bellani, F. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \"D\\'Angio, G. J._author\", {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Tournade, M. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Breslow, N. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Mitchell, C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Verschuur, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Grundy, P. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Warmann, S. W._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Smets, A. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dome, J. S._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dix, D. B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Daw, N. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ha, T. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Kremens, B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Furtwangler, R._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP-9/GPOH_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UKW3_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10})]}, {\\'nodes\\': [(\\'vincristine_entity\\', {}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {}), (\\'www.siop-rtsg.eu_entity\\', {}), (\\'stage II_entity\\', {}), (\\'Wilms tumours_entity\\', {}), (\\'Relapsed Wilms Tumor_entity\\', {}), (\\'Davila Fajardo et al._entity\\', {}), (\\'vincristine, actinomycin D, and doxorubicin_entity\\', {}), (\\'SIOP\u22122001 randomized trial_entity\\', {}), (\\'surgery_entity\\', {}), (\\'non-Wilms tumours_entity\\', {}), (\\'actinomycin D_entity\\', {}), (\\'diffuse anaplasia_entity\\', {}), (\\'Synchronous bilateral Wilms tumor_entity\\', {}), (\\'CT-only nodules_entity\\', {}), (\\'relapsed group CC_entity\\', {}), (\\'increased relapse risk_entity\\', {}), (\\'reduced survival_entity\\', {}), (\\'UKW3 trial_entity\\', {}), (\\'chemotherapy_entity\\', {}), (\\'Bilateral Disease (Stage V)_entity\\', {}), (\\'blastemal-type tumors_entity\\', {}), (\\'UMBRELLA protocol_entity\\', {}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', {}), (\\'minimally invasive surgery_entity\\', {}), (\\'VP16_entity\\', {}), (\\'Wilms tumor_entity\\', {}), (\\'anaplasia_entity\\', {}), (\\'radical tumor nephrectomy_entity\\', {}), (\\'Innovative Therapies for Children with Cancer consortium_entity\\', {}), (\\'cumulative doxorubicin dose_entity\\', {}), (\\'etoposide_entity\\', {}), (\\'large-volume tumours_entity\\', {}), (\\'Stage IV_entity\\', {}), (\\'CDCV_entity\\', {}), (\\'SIOP\u2013RTSG_entity\\', {}), (\\'AVD150_entity\\', {}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', {}), (\\'laparoscopic surgery_entity\\', {}), (\\'SIOP\u2212RTSG panel_entity\\', {}), (\\'actinomycin-D_entity\\', {}), (\\'COG AREN0533 trial_entity\\', {}), (\\'cyclophosphamide_entity\\', {}), (\\'carboplatin_entity\\', {}), (\\'UKW\u2011R protocol_entity\\', {}), (\\'Nephron-sparing surgery (NSS)_entity\\', {}), (\\'Adult Wilms Tumors_entity\\', {}), (\\'doxorubicin_entity\\', {}), (\\'NWTS\u20115 relapse protocol_entity\\', {}), (\\'End-stage renal disease (ESRD)_entity\\', {}), (\\'AVD250_entity\\', {}), (\\'Children\u2019s Oncology Group (COG)_entity\\', {}), (\\'blastemal-type Wilms tumour_entity\\', {}), (\\'SIOP\u22122001_entity\\', {}), (\\'radiotherapy_entity\\', {}), (\\'childhood renal tumours_entity\\', {})], \\'edges\\': [(\\'vincristine_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'stage II_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'indicated_for_in_adults\\'}), (\\'Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'Wilms tumours_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated under\\'}), (\\'Relapsed Wilms Tumor_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guided_by\\'}), (\\'Davila Fajardo et al._entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed\\'}), (\\'SIOP\u22122001 randomized trial_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated use in\\'}), (\\'surgery_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'non-Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'actinomycin D_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Synchronous bilateral Wilms tumor_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'instance_of\\'}), (\\'CT-only nodules_entity\\', \\'increased relapse risk_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'reduced survival_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included_in\\'}), (\\'relapsed group CC_entity\\', \\'diffuse anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'blastemal-type tumors_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UKW3 trial_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'UKW3 trial_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'chemotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UMBRELLA protocol_entity\\', \\'COG AREN0533 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses_data_from\\'}), (\\'UMBRELLA protocol_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'advises_treatment_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'Innovative Therapies for Children with Cancer consortium_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborates_with\\'}), (\\'UMBRELLA protocol_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'surgery_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is the standard of\\'}), (\\'UMBRELLA protocol_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guides treatment in\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', \\'UKW3 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\\'minimally invasive surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'anaplasia_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'radical tumor nephrectomy_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'standard_of_care_for\\'}), (\\'Stage IV_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'presents in\\'}), (\\'CDCV_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'VP16_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'aims to improve survival rates of\\'}), (\\'AVD150_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed_by\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'succeeds\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'www.siop-rtsg.eu_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'available_on\\'}), (\\'laparoscopic surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'COG AREN0533 trial_entity\\', \\'cumulative doxorubicin dose_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'evaluates\\'}), (\\'UKW\u2011R protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'Nephron-sparing surgery (NSS)_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'classification_developed_by\\'}), (\\'Adult Wilms Tumors_entity\\', \\'anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'Adult Wilms Tumors_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'doxorubicin_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'doxorubicin_entity\\', \\'large-volume tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'recommended for\\'}), (\\'NWTS\u20115 relapse protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'End-stage renal disease (ESRD)_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'AVD250_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'Children\u2019s Oncology Group (COG)_entity\\', \\'SIOP\u22122001 randomized trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborated with\\'}), (\\'blastemal-type Wilms tumour_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment intensified according to\\'}), (\\'SIOP\u22122001_entity\\', \\'vincristine, actinomycin D, and doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses\\'}), (\\'SIOP\u22122001_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provided_guidelines_for\\'}), (\\'radiotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'radiotherapy_entity\\', \\'SIOP\u2212RTSG panel_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'contact_for_guidance\\'})]}, {\\'nodes\\': [(\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {}), (\\'Marry M. van den Heuvel-Eibrink_entity\\', {})], \\'edges\\': [(\\'Marry M. van den Heuvel-Eibrink_entity\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'affiliated_with\\'})]}, {\\'nodes\\': [(\\'Stage II_entity\\', {}), (\\'AV_entity\\', {}), (\\'Stage III_entity\\', {}), (\\'vincestine and actinomycin D_entity\\', {}), (\\'AVD_entity\\', {})], \\'edges\\': [(\\'Stage II_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AV_entity\\', \\'Stage II_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Stage III_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AVD_entity\\', \\'Stage III_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'SIOP-RTSG 2016_entity\\', {}), (\\'RCC_entity\\', {}), (\\'CMN_entity\\', {})], \\'edges\\': [(\\'RCC_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'}), (\\'CMN_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'})]}, {\\'nodes\\': [(\\'HR-1_entity\\', {}), (\\'High-risk blastemal type Wilms tumour_entity\\', {})], \\'edges\\': [(\\'HR-1_entity\\', \\'High-risk blastemal type Wilms tumour_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'unfavorable prognosis_entity\\', {}), (\\'high-risk characteristics_entity\\', {})], \\'edges\\': [(\\'high-risk characteristics_entity\\', \\'unfavorable prognosis_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'leads_to\\'})]}, {\\'nodes\\': [(\\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {}), (\\'SIOP\u2013RTSG board_entity\\', {})], \\'edges\\': [(\\'SIOP\u2013RTSG board_entity\\', \\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggests\\'})]}, {\\'nodes\\': [(\\'regimen and outcomes_entity\\', {}), (\\'SIOP database_entity\\', {})], \\'edges\\': [(\\'SIOP database_entity\\', \\'regimen and outcomes_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'captures_data_on\\'})]}, {\\'nodes\\': [(\\'Bilateral nephron-sparing surgery (NSS)_entity\\', {}), (\\'Aronson et al._entity\\', {})], \\'edges\\': [(\\'Aronson et al._entity\\', \\'Bilateral nephron-sparing surgery (NSS)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'observed_effectiveness_of\\'})]}, {\\'nodes\\': [(\\'SIOP\u22122001 study_entity\\', {}), (\\'Actinomycin D_entity\\', {}), (\\'Vincristine_entity\\', {})], \\'edges\\': [(\\'SIOP\u22122001 study_entity\\', \\'Vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'}), (\\'SIOP\u22122001 study_entity\\', \\'Actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'})]}, {\\'nodes\\': [(\\'High-dose melphalan_entity\\', {}), (\\'Group AA_entity\\', {}), (\\'Carboplatin_entity\\', {}), (\\'Doxorubicin_entity\\', {}), (\\'Etoposide_entity\\', {}), (\\'Group BB_entity\\', {}), (\\'Cyclophosphamide_entity\\', {}), (\\'Ifosfamide_entity\\', {})], \\'edges\\': [(\\'Group AA_entity\\', \\'Doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Ifosfamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'High-dose melphalan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'})]}, {\\'nodes\\': [(\\'nephrotoxicity_entity\\', {}), (\\'ifosfamide_entity\\', {})], \\'edges\\': [(\\'ifosfamide_entity\\', \\'nephrotoxicity_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'related_to\\'})]}, {\\'nodes\\': [(\\'camptothecins_entity\\', {}), (\\'irinotecan_entity\\', {}), (\\'topotecan_entity\\', {})], \\'edges\\': [(\\'camptothecins_entity\\', \\'irinotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'camptothecins_entity\\', \\'topotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'})]}, {\\'nodes\\': [(\\'Infant Wilms Tumors_entity\\', {}), (\\'nephrectomy_entity\\', {})], \\'edges\\': [(\\'Infant Wilms Tumors_entity\\', \\'nephrectomy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_option\\'})]}, {\\'nodes\\': [(\\'congenital mesoblastic nephroma_entity\\', {}), (\\'surgery alone_entity\\', {})], \\'edges\\': [(\\'congenital mesoblastic nephroma_entity\\', \\'surgery alone_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'alternative chemotherapy_entity\\', {}), (\\'malignant rhabdoid tumors_entity\\', {})], \\'edges\\': [(\\'malignant rhabdoid tumors_entity\\', \\'alternative chemotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'lymph node sampling_entity\\', {}), (\\'accurate staging_entity\\', {})], \\'edges\\': [(\\'lymph node sampling_entity\\', \\'accurate staging_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'purpose_of\\'})]}, {\\'nodes\\': [(\\'COG\u2013NWTS trials_entity\\', {}), (\\'whole-lung irradiation_entity\\', {})], \\'edges\\': [(\\'COG\u2013NWTS trials_entity\\', \\'whole-lung irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'informed_dosage_for\\'})]}, {\\'nodes\\': [(\\'lung metastases_entity\\', {}), (\\'pulmonary radiotherapy_entity\\', {})], \\'edges\\': [(\\'pulmonary radiotherapy_entity\\', \\'lung metastases_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'administered_for\\'})]}, {\\'nodes\\': [(\\'dosimetric study_entity\\', {}), (\\'proton therapy_entity\\', {}), (\\'flank irradiation_entity\\', {})], \\'edges\\': [(\\'dosimetric study_entity\\', \\'proton therapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated\\'}), (\\'proton therapy_entity\\', \\'flank irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggested_for\\'})]}, {\\'nodes\\': [(\\'metastatic disease_entity\\', {}), (\\'radiotherapy guidelines_entity\\', {}), (\\'locoregional disease_entity\\', {})], \\'edges\\': [(\\'radiotherapy guidelines_entity\\', \\'locoregional disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'}), (\\'radiotherapy guidelines_entity\\', \\'metastatic disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'})]}, {\\'nodes\\': [(\\'major rupture_entity\\', {}), (\\'stage III_entity\\', {})], \\'edges\\': [(\\'stage III_entity\\', \\'major rupture_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes_condition\\'})]}, {\\'nodes\\': [(\\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {}), (\\'ExPO\u2011r\u2011Net_entity\\', {})], \\'edges\\': [(\\'ExPO\u2011r\u2011Net_entity\\', \\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is part of\\'})]}, {\\'nodes\\': [(\\'University Hospital of Munich_entity\\', {}), (\\'Germany_entity\\', {}), (\\'University Hospital of Tuebingen_entity\\', {})], \\'edges\\': [(\\'Germany_entity\\', \\'University Hospital of Munich_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Germany_entity\\', \\'University Hospital of Tuebingen_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {}), (\\'Italy_entity\\', {}), (\\'Azienda Ospedaliera_entity\\', {}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {})], \\'edges\\': [(\\'Italy_entity\\', \\'Azienda Ospedaliera_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Netherlands_entity\\', {}), (\\'Prinses Maxima Centrum_entity\\', {})], \\'edges\\': [(\\'Netherlands_entity\\', \\'Prinses Maxima Centrum_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Marciniak Hospital_entity\\', {}), (\\'Poland_entity\\', {}), (\\'Faculty of Medicine_entity\\', {})], \\'edges\\': [(\\'Poland_entity\\', \\'Marciniak Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Poland_entity\\', \\'Faculty of Medicine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'St. Anna Kinderspital/CCRI_entity\\', {}), (\\'Austria_entity\\', {})], \\'edges\\': [(\\'Austria_entity\\', \\'St. Anna Kinderspital/CCRI_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'France_entity\\', {}), (\\'Armand Trousseau Hospital_entity\\', {})], \\'edges\\': [(\\'France_entity\\', \\'Armand Trousseau Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Spain_entity\\', {}), (\\'Hospital Vall d\u2019Hebron_entity\\', {}), (\\'Hospital Universitario Virgin del Rocio_entity\\', {})], \\'edges\\': [(\\'Spain_entity\\', \\'Hospital Universitario Virgin del Rocio_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Spain_entity\\', \\'Hospital Vall d\u2019Hebron_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'United Kingdom_entity\\', {}), (\\'Great Ormond Street Hospital_entity\\', {})], \\'edges\\': [(\\'United Kingdom_entity\\', \\'Great Ormond Street Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Weirich, A._entity\\', {}), (\\'SIOP-9/GPOH_entity\\', {})], \\'edges\\': [(\\'Weirich, A._entity\\', \\'SIOP-9/GPOH_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Pritchard-Jones, K._entity\\', {}), (\\'UKW3_entity\\', {})], \\'edges\\': [(\\'Pritchard-Jones, K._entity\\', \\'UKW3_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed in\\'})]}, {\\'nodes\\': [(\\'SIOP 93\u201301 trial_entity\\', {}), (\\'de Kraker, J._entity\\', {})], \\'edges\\': [(\\'de Kraker, J._entity\\', \\'SIOP 93\u201301 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'SIOP trial and study 93\u201301_entity\\', {}), (\\'Graf, N._entity\\', {})], \\'edges\\': [(\\'Graf, N._entity\\', \\'SIOP trial and study 93\u201301_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Green, D. M._entity\\', {}), (\\'National Wilms Tumor Study Group_entity\\', {})], \\'edges\\': [(\\'Green, D. M._entity\\', \\'National Wilms Tumor Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}, {\\'nodes\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', {}), (\\'SIOP WT 2001 protocol_entity\\', {})], \\'edges\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', \\'SIOP WT 2001 protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Third National Wilms\u2019 Tumor Study_entity\\', {}), (\"D\\'Angio, G. J._entity\", {}), (\\'Second National Wilms\u2019 Tumor Study_entity\\', {})], \\'edges\\': [(\"D\\'Angio, G. J._entity\", \\'Third National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\"D\\'Angio, G. J._entity\", \\'Second National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {}), (\\'Tournade, M. F._entity\\', {}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {})], \\'edges\\': [(\\'Tournade, M. F._entity\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'}), (\\'Tournade, M. F._entity\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Breslow, N. E._entity\\', {}), (\\'National Wilms Tumor Studies_entity\\', {})], \\'edges\\': [(\\'Breslow, N. E._entity\\', \\'National Wilms Tumor Studies_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Mitchell, C._entity\\', {}), (\\'UK Children\u2019s Cancer Study Group_entity\\', {})], \\'edges\\': [(\\'Mitchell, C._entity\\', \\'UK Children\u2019s Cancer Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'under\\'})]}, {\\'nodes\\': [(\\'Daw, N. C._entity\\', {}), (\\'Dix, D. B._entity\\', {}), (\\'Children\u2019s Oncology Group_entity\\', {}), (\\'Grundy, P. E._entity\\', {})], \\'edges\\': [(\\'Daw, N. C._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted under\\'}), (\\'Dix, D. B._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'}), (\\'Grundy, P. E._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}]', expected_output='The protocol is designed to be implemented in over 50 countries, facilitating data sharing and research across borders.', context=None, retrieval_context=['[{\\'nodes\\': [(\\'sample.pdf\\', {\\'type\\': \\'document\\'}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)\\'}), (\\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA SIOP-RTSG 2016\\'}), (\\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms tumours\\'}), (\\'non-Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'non-Wilms tumours\\'}), (\\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Website\\', \\'name\\': \\'www.siop-rtsg.eu\\'}), (\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology\\'}), (\\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Person\\', \\'name\\': \\'Marry M. van den Heuvel-Eibrink\\'}), (\\'childhood renal tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'childhood renal tumours\\'}), (\\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'clear cell sarcoma of the kidney\\'}), (\\'renal cell carcinoma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'renal cell carcinoma\\'}), (\\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'malignant rhabdoid tumour of the kidney\\'}), (\\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'Wilms tumours_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'Children\u2019s Oncology Group (COG)\\'}), (\\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'SIOP\u22122001 randomized trial\\'}), (\\'actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'UKW3 trial\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)\\'}), (\\'localized disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'localized disease\\'}), (\\'metastatic disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'metastatic disease\\'}), (\\'bilateral disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'bilateral disease\\'}), (\\'relapsed disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'relapsed disease\\'}), (\\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subtype\\', \\'name\\': \\'blastemal-type Wilms tumours\\'}), (\\'radiotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgery_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'chemotherapy\\'}), (\\'Wilms Tumour_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms Tumour\\'}), (\\'CCSK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CCSK\\'}), (\\'MRTK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'MRTK\\'}), (\\'CMN_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CMN\\'}), (\\'RCC_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'RCC\\'}), (\\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u22122001_Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Trial\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'vincristine_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'vincristine\\'}), (\\'actinomycin D_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'actinomycin D\\'}), (\\'doxorubicin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'doxorubicin\\'}), (\\'etoposide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'Stage I_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage I\\'}), (\\'Stage II_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage II\\'}), (\\'Stage III_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage III\\'}), (\\'Stage IV_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage IV\\'}), (\\'Stage V_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage V\\'}), (\\'AV_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AV\\'}), (\\'AVD_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AVD\\'}), (\\'HR-1_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'HR-1\\'}), (\\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP-RTSG 2016\\'}), (\\'Overall Survival (OS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'CT-only nodules_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'CT-only nodules\\'}), (\\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP\u2013RTSG analysis\\'}), (\\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials\\'}), (\\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D plus doxorubicin\\'}), (\\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D\\'}), (\\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study_protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'MRI_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'MRI\\'}), (\\'CT_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'CT\\'}), (\\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_detail\\', \\'name\\': \\'cumulative doxorubicin dose\\'}), (\\'COG AREN0533 trial_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG AREN0533 trial\\'}), (\\'etoposide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'high-risk characteristics\\'}), (\\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG board\\'}), (\\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin\\'}), (\\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'high-dose chemotherapy and autologous stem cell transplantation\\'}), (\\'SIOP database_database\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'database\\', \\'name\\': \\'SIOP database\\'}), (\\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'AVD_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AVD\\'}), (\\'AV-2_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AV-2\\'}), (\\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Statistical Test\\', \\'name\\': \\'Log\u2013Rank P\\'}), (\\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'Bilateral Disease (Stage V)\\'}), (\\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Synchronous bilateral Wilms tumor\\'}), (\\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'End-stage renal disease (ESRD)\\'}), (\\'Aronson et al._Research Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Research Group\\', \\'name\\': \\'Aronson et al.\\'}), (\\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'Bilateral nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Study\\', \\'name\\': \\'SIOP\u22122001 study\\'}), (\\'Vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Vincristine\\'}), (\\'Actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Actinomycin D\\'}), (\\'Etoposide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Etoposide\\'}), (\\'Carboplatin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Carboplatin\\'}), (\\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease State\\', \\'name\\': \\'Relapsed Wilms Tumor\\'}), (\\'Group AA_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group AA\\'}), (\\'Group BB_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group BB\\'}), (\\'Group CC_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group CC\\'}), (\\'Doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Doxorubicin\\'}), (\\'Cyclophosphamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Cyclophosphamide\\'}), (\\'Ifosfamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Ifosfamide\\'}), (\\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'High-dose melphalan\\'}), (\\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UKW\u2011R protocol\\'}), (\\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'NWTS\u20115 relapse protocol\\'}), (\\'ASCR_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'procedure\\', \\'name\\': \\'ASCR\\'}), (\\'ifosfamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'ifosfamide\\'}), (\\'nephrotoxicity_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'nephrotoxicity\\'}), (\\'relapsed group CC_patient_group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'patient_group\\', \\'name\\': \\'relapsed group CC\\'}), (\\'diffuse anaplasia_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'diffuse anaplasia\\'}), (\\'blastemal-type tumors_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'blastemal-type tumors\\'}), (\\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'camptothecins_medication_class\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication_class\\', \\'name\\': \\'camptothecins\\'}), (\\'irinotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'irinotecan\\'}), (\\'topotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'topotecan\\'}), (\\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Innovative Therapies for Children with Cancer consortium\\'}), (\\'radiotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgical excision_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgical excision\\'}), (\\'stage IV WT_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'stage IV WT\\'}), (\\'AVD150_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD150\\'}), (\\'AVD250_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD250\\'}), (\\'low-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'low-risk disease\\'}), (\\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'intermediate-risk disease\\'}), (\\'high-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'high-risk disease\\'}), (\\'CDCV_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'CDCV\\'}), (\\'actinomycin-D_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'actinomycin-D\\'}), (\\'vincristine_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'doxorubicin\\'}), (\\'VP16_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'VP16\\'}), (\\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'contact\\', \\'name\\': \\'arnauld.verschuur@ap-hm.fr\\'}), (\\'surgery_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'chemotherapy\\'}), (\\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2212RTSG panel\\'}), (\\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Infant Wilms Tumors\\'}), (\\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'nephrectomy\\'}), (\\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'malignant rhabdoid tumors\\'}), (\\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Adult Wilms Tumors\\'}), (\\'anaplasia_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'anaplasia\\'}), (\\'actinomycin D_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'carboplatin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'etoposide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'etoposide\\'}), (\\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'Nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'radical tumor nephrectomy\\'}), (\\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'lymph node sampling\\'}), (\\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'minimally invasive surgery\\'}), (\\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'laparoscopic surgery\\'}), (\\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'radiotherapy\\'}), (\\'Wilms tumours_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'Davila Fajardo et al._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Davila Fajardo et al.\\'}), (\\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'COG\u2013NWTS trials\\'}), (\\'whole-lung irradiation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'whole-lung irradiation\\'}), (\\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'pulmonary radiotherapy\\'}), (\\'proton therapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'proton therapy\\'}), (\\'dosimetric study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'dosimetric study\\'}), (\\'locoregional disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'locoregional disease\\'}), (\\'metastatic disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'metastatic disease\\'}), (\\'low-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'low-risk\\'}), (\\'intermediate-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'intermediate-risk\\'}), (\\'high-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'high-risk\\'}), (\\'stage I_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage I\\'}), (\\'stage II_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage II\\'}), (\\'stage III_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage III\\'}), (\\'major rupture_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'major rupture\\'}), (\\'Austria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Austria\\'}), (\\'Italy_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Italy\\'}), (\\'San Marino_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'San Marino\\'}), (\\'Iceland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Iceland\\'}), (\\'Germany_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Germany\\'}), (\\'Bulgaria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bulgaria\\'}), (\\'Turkey_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Turkey\\'}), (\\'Denmark_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Denmark\\'}), (\\'Poland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Poland\\'}), (\\'Greece_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Greece\\'}), (\\'Andorra_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Andorra\\'}), (\\'Belgium_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belgium\\'}), (\\'Serbia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Serbia\\'}), (\\'Albania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Albania\\'}), (\\'Moldova_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Moldova\\'}), (\\'Lithuania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Lithuania\\'}), (\\'Latvia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Latvia\\'}), (\\'Estonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Estonia\\'}), (\\'Luxembourg_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Luxembourg\\'}), (\\'Montenegro_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Montenegro\\'}), (\\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bosnia and Herzegovina\\'}), (\\'Croatia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Croatia\\'}), (\\'Slovenia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovenia\\'}), (\\'Macedonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Macedonia\\'}), (\\'United Kingdom_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'United Kingdom\\'}), (\\'Ireland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ireland\\'}), (\\'Spain_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Spain\\'}), (\\'Algeria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Algeria\\'}), (\\'Tunisia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Tunisia\\'}), (\\'Malta_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Malta\\'}), (\\'Morocco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Morocco\\'}), (\\'Portugal_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Portugal\\'}), (\\'France_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'France\\'}), (\\'Monaco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Monaco\\'}), (\\'Russia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Russia\\'}), (\\'Finland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Finland\\'}), (\\'Sweden_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Sweden\\'}), (\\'Norway_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Norway\\'}), (\\'Belarus_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belarus\\'}), (\\'Romania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Romania\\'}), (\\'Ukraine_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ukraine\\'}), (\\'Hungary_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Hungary\\'}), (\\'Czech Republic_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Czech Republic\\'}), (\\'Slovakia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovakia\\'}), (\\'Switzerland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Switzerland\\'}), (\\'Liechtenstein_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Liechtenstein\\'}), (\\'Netherlands_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Netherlands\\'}), (\\'University Hospital of Munich_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Munich\\'}), (\\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Tuebingen\\'}), (\\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Azienda Ospedaliera\\'}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Ospedale Pediatrico Bambino Ges\u00f9\\'}), (\\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Fondazione IRCCS Istituto Nazionale dei Tumori\\'}), (\\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Prinses Maxima Centrum\\'}), (\\'Marciniak Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Marciniak Hospital\\'}), (\\'Faculty of Medicine_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Faculty of Medicine\\'}), (\\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'St. Anna Kinderspital/CCRI\\'}), (\\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Armand Trousseau Hospital\\'}), (\\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Universitario Virgin del Rocio\\'}), (\\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Vall d\u2019Hebron\\'}), (\\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Great Ormond Street Hospital\\'}), (\\'University Hospital Homburg_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital Homburg\\'}), (\\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon\\'}), (\\'UMBRELLA protocol_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'ExPO\u2011r\u2011Net\\'}), (\\'Weirich, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Weirich, A.\\'}), (\\'Pritchard-Jones, K._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Pritchard-Jones, K.\\'}), (\\'de Kraker, J._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'de Kraker, J.\\'}), (\\'Graf, N._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Graf, N.\\'}), (\\'Green, D. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Green, D. M.\\'}), (\\'Spreafico, F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Spreafico, F.\\'}), (\\'Bellani, F. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Bellani, F. F.\\'}), (\\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'van den Heuvel-Eibrink, M. M.\\'}), (\"D\\'Angio, G. J._author\", {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \"D\\'Angio, G. J.\"}), (\\'Tournade, M. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Tournade, M. F.\\'}), (\\'Breslow, N. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Breslow, N. E.\\'}), (\\'Mitchell, C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Mitchell, C.\\'}), (\\'Verschuur, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Verschuur, A.\\'}), (\\'Grundy, P. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Grundy, P. E.\\'}), (\\'Warmann, S. W._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Warmann, S. W.\\'}), (\\'Smets, A. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Smets, A. M.\\'}), (\\'Dome, J. S._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dome, J. S.\\'}), (\\'Dix, D. B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dix, D. B.\\'}), (\\'Daw, N. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Daw, N. C.\\'}), (\\'Ha, T. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Ha, T. C.\\'}), (\\'Kremens, B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Kremens, B.\\'}), (\\'Furtwangler, R._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Furtwangler, R.\\'}), (\\'SIOP-9/GPOH_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP-9/GPOH\\'}), (\\'UKW3_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'UKW3\\'}), (\\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'SIOP 93\u201301 trial\\'}), (\\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP trial and study 93\u201301\\'}), (\\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'National Wilms Tumor Study Group\\'}), (\\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP WT 2001 protocol\\'}), (\\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Third National Wilms\u2019 Tumor Study\\'}), (\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'National Wilms Tumor Studies\\'}), (\\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Second National Wilms\u2019 Tumor Study\\'}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'UK Children\u2019s Cancer Study Group\\'}), (\\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Children\u2019s Oncology Group\\'})], \\'edges\\': [(\\'sample.pdf\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'non-Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'childhood renal tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'renal cell carcinoma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'localized disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'metastatic disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'bilateral disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'relapsed disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'radiotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'surgery_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'chemotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'Wilms Tumour_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CCSK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'MRTK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CMN_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'RCC_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP\u22122001_Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'vincristine_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'actinomycin D_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'doxorubicin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'etoposide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'carboplatin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'cyclophosphamide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage I_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage II_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage III_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage IV_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage V_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AV_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AVD_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'HR-1_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Overall Survival (OS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT-only nodules_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'MRI_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG AREN0533 trial_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'etoposide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'carboplatin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'cyclophosphamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP database_database\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AVD_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AV-2_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Aronson et al._Research Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Etoposide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Carboplatin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group AA_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group BB_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group CC_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Cyclophosphamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Ifosfamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'ASCR_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'ifosfamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'nephrotoxicity_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'relapsed group CC_patient_group\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'diffuse anaplasia_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'blastemal-type tumors_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'camptothecins_medication_class\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'irinotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'topotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'radiotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'surgical excision_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'stage IV WT_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD150_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD250_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'low-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'CDCV_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'actinomycin-D_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'vincristine_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'doxorubicin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'VP16_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'surgery_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'chemotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'anaplasia_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'actinomycin D_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'vincristine_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'doxorubicin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'carboplatin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'cyclophosphamide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'etoposide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'SIOP\u22122001_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Wilms tumours_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Davila Fajardo et al._author\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'whole-lung irradiation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'proton therapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'dosimetric study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'locoregional disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'metastatic disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'low-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'intermediate-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'high-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage I_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage II_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage III_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'major rupture_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Austria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Italy_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'San Marino_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Iceland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Germany_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bulgaria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Turkey_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Denmark_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Poland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Greece_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Andorra_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belgium_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Serbia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Albania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Moldova_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Lithuania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Latvia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Estonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Luxembourg_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Montenegro_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Croatia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovenia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Macedonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'United Kingdom_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ireland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Spain_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Algeria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Tunisia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Malta_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Morocco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Portugal_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'France_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Monaco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Russia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Finland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Sweden_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Norway_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belarus_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Romania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ukraine_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hungary_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Czech Republic_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovakia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Switzerland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Liechtenstein_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Netherlands_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Munich_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Marciniak Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Faculty of Medicine_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital Homburg_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Weirich, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Pritchard-Jones, K._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'de Kraker, J._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Graf, N._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Green, D. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Spreafico, F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Bellani, F. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \"D\\'Angio, G. J._author\", {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Tournade, M. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Breslow, N. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Mitchell, C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Verschuur, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Grundy, P. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Warmann, S. W._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Smets, A. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dome, J. S._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dix, D. B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Daw, N. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ha, T. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Kremens, B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Furtwangler, R._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP-9/GPOH_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UKW3_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10})]}, {\\'nodes\\': [(\\'vincristine_entity\\', {}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {}), (\\'www.siop-rtsg.eu_entity\\', {}), (\\'stage II_entity\\', {}), (\\'Wilms tumours_entity\\', {}), (\\'Relapsed Wilms Tumor_entity\\', {}), (\\'Davila Fajardo et al._entity\\', {}), (\\'vincristine, actinomycin D, and doxorubicin_entity\\', {}), (\\'SIOP\u22122001 randomized trial_entity\\', {}), (\\'surgery_entity\\', {}), (\\'non-Wilms tumours_entity\\', {}), (\\'actinomycin D_entity\\', {}), (\\'diffuse anaplasia_entity\\', {}), (\\'Synchronous bilateral Wilms tumor_entity\\', {}), (\\'CT-only nodules_entity\\', {}), (\\'relapsed group CC_entity\\', {}), (\\'increased relapse risk_entity\\', {}), (\\'reduced survival_entity\\', {}), (\\'UKW3 trial_entity\\', {}), (\\'chemotherapy_entity\\', {}), (\\'Bilateral Disease (Stage V)_entity\\', {}), (\\'blastemal-type tumors_entity\\', {}), (\\'UMBRELLA protocol_entity\\', {}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', {}), (\\'minimally invasive surgery_entity\\', {}), (\\'VP16_entity\\', {}), (\\'Wilms tumor_entity\\', {}), (\\'anaplasia_entity\\', {}), (\\'radical tumor nephrectomy_entity\\', {}), (\\'Innovative Therapies for Children with Cancer consortium_entity\\', {}), (\\'cumulative doxorubicin dose_entity\\', {}), (\\'etoposide_entity\\', {}), (\\'large-volume tumours_entity\\', {}), (\\'Stage IV_entity\\', {}), (\\'CDCV_entity\\', {}), (\\'SIOP\u2013RTSG_entity\\', {}), (\\'AVD150_entity\\', {}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', {}), (\\'laparoscopic surgery_entity\\', {}), (\\'SIOP\u2212RTSG panel_entity\\', {}), (\\'actinomycin-D_entity\\', {}), (\\'COG AREN0533 trial_entity\\', {}), (\\'cyclophosphamide_entity\\', {}), (\\'carboplatin_entity\\', {}), (\\'UKW\u2011R protocol_entity\\', {}), (\\'Nephron-sparing surgery (NSS)_entity\\', {}), (\\'Adult Wilms Tumors_entity\\', {}), (\\'doxorubicin_entity\\', {}), (\\'NWTS\u20115 relapse protocol_entity\\', {}), (\\'End-stage renal disease (ESRD)_entity\\', {}), (\\'AVD250_entity\\', {}), (\\'Children\u2019s Oncology Group (COG)_entity\\', {}), (\\'blastemal-type Wilms tumour_entity\\', {}), (\\'SIOP\u22122001_entity\\', {}), (\\'radiotherapy_entity\\', {}), (\\'childhood renal tumours_entity\\', {})], \\'edges\\': [(\\'vincristine_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'stage II_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'indicated_for_in_adults\\'}), (\\'Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'Wilms tumours_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated under\\'}), (\\'Relapsed Wilms Tumor_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guided_by\\'}), (\\'Davila Fajardo et al._entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed\\'}), (\\'SIOP\u22122001 randomized trial_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated use in\\'}), (\\'surgery_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'non-Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'actinomycin D_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Synchronous bilateral Wilms tumor_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'instance_of\\'}), (\\'CT-only nodules_entity\\', \\'increased relapse risk_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'reduced survival_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included_in\\'}), (\\'relapsed group CC_entity\\', \\'diffuse anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'blastemal-type tumors_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UKW3 trial_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'UKW3 trial_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'chemotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UMBRELLA protocol_entity\\', \\'COG AREN0533 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses_data_from\\'}), (\\'UMBRELLA protocol_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'advises_treatment_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'Innovative Therapies for Children with Cancer consortium_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborates_with\\'}), (\\'UMBRELLA protocol_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'surgery_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is the standard of\\'}), (\\'UMBRELLA protocol_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guides treatment in\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', \\'UKW3 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\\'minimally invasive surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'anaplasia_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'radical tumor nephrectomy_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'standard_of_care_for\\'}), (\\'Stage IV_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'presents in\\'}), (\\'CDCV_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'VP16_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'aims to improve survival rates of\\'}), (\\'AVD150_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed_by\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'succeeds\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'www.siop-rtsg.eu_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'available_on\\'}), (\\'laparoscopic surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'COG AREN0533 trial_entity\\', \\'cumulative doxorubicin dose_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'evaluates\\'}), (\\'UKW\u2011R protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'Nephron-sparing surgery (NSS)_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'classification_developed_by\\'}), (\\'Adult Wilms Tumors_entity\\', \\'anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'Adult Wilms Tumors_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'doxorubicin_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'doxorubicin_entity\\', \\'large-volume tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'recommended for\\'}), (\\'NWTS\u20115 relapse protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'End-stage renal disease (ESRD)_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'AVD250_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'Children\u2019s Oncology Group (COG)_entity\\', \\'SIOP\u22122001 randomized trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborated with\\'}), (\\'blastemal-type Wilms tumour_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment intensified according to\\'}), (\\'SIOP\u22122001_entity\\', \\'vincristine, actinomycin D, and doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses\\'}), (\\'SIOP\u22122001_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provided_guidelines_for\\'}), (\\'radiotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'radiotherapy_entity\\', \\'SIOP\u2212RTSG panel_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'contact_for_guidance\\'})]}, {\\'nodes\\': [(\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {}), (\\'Marry M. van den Heuvel-Eibrink_entity\\', {})], \\'edges\\': [(\\'Marry M. van den Heuvel-Eibrink_entity\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'affiliated_with\\'})]}, {\\'nodes\\': [(\\'Stage II_entity\\', {}), (\\'AV_entity\\', {}), (\\'Stage III_entity\\', {}), (\\'vincestine and actinomycin D_entity\\', {}), (\\'AVD_entity\\', {})], \\'edges\\': [(\\'Stage II_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AV_entity\\', \\'Stage II_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Stage III_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AVD_entity\\', \\'Stage III_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'SIOP-RTSG 2016_entity\\', {}), (\\'RCC_entity\\', {}), (\\'CMN_entity\\', {})], \\'edges\\': [(\\'RCC_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'}), (\\'CMN_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'})]}, {\\'nodes\\': [(\\'HR-1_entity\\', {}), (\\'High-risk blastemal type Wilms tumour_entity\\', {})], \\'edges\\': [(\\'HR-1_entity\\', \\'High-risk blastemal type Wilms tumour_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'unfavorable prognosis_entity\\', {}), (\\'high-risk characteristics_entity\\', {})], \\'edges\\': [(\\'high-risk characteristics_entity\\', \\'unfavorable prognosis_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'leads_to\\'})]}, {\\'nodes\\': [(\\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {}), (\\'SIOP\u2013RTSG board_entity\\', {})], \\'edges\\': [(\\'SIOP\u2013RTSG board_entity\\', \\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggests\\'})]}, {\\'nodes\\': [(\\'regimen and outcomes_entity\\', {}), (\\'SIOP database_entity\\', {})], \\'edges\\': [(\\'SIOP database_entity\\', \\'regimen and outcomes_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'captures_data_on\\'})]}, {\\'nodes\\': [(\\'Bilateral nephron-sparing surgery (NSS)_entity\\', {}), (\\'Aronson et al._entity\\', {})], \\'edges\\': [(\\'Aronson et al._entity\\', \\'Bilateral nephron-sparing surgery (NSS)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'observed_effectiveness_of\\'})]}, {\\'nodes\\': [(\\'SIOP\u22122001 study_entity\\', {}), (\\'Actinomycin D_entity\\', {}), (\\'Vincristine_entity\\', {})], \\'edges\\': [(\\'SIOP\u22122001 study_entity\\', \\'Vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'}), (\\'SIOP\u22122001 study_entity\\', \\'Actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'})]}, {\\'nodes\\': [(\\'High-dose melphalan_entity\\', {}), (\\'Group AA_entity\\', {}), (\\'Carboplatin_entity\\', {}), (\\'Doxorubicin_entity\\', {}), (\\'Etoposide_entity\\', {}), (\\'Group BB_entity\\', {}), (\\'Cyclophosphamide_entity\\', {}), (\\'Ifosfamide_entity\\', {})], \\'edges\\': [(\\'Group AA_entity\\', \\'Doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Ifosfamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'High-dose melphalan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'})]}, {\\'nodes\\': [(\\'nephrotoxicity_entity\\', {}), (\\'ifosfamide_entity\\', {})], \\'edges\\': [(\\'ifosfamide_entity\\', \\'nephrotoxicity_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'related_to\\'})]}, {\\'nodes\\': [(\\'camptothecins_entity\\', {}), (\\'irinotecan_entity\\', {}), (\\'topotecan_entity\\', {})], \\'edges\\': [(\\'camptothecins_entity\\', \\'irinotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'camptothecins_entity\\', \\'topotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'})]}, {\\'nodes\\': [(\\'Infant Wilms Tumors_entity\\', {}), (\\'nephrectomy_entity\\', {})], \\'edges\\': [(\\'Infant Wilms Tumors_entity\\', \\'nephrectomy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_option\\'})]}, {\\'nodes\\': [(\\'congenital mesoblastic nephroma_entity\\', {}), (\\'surgery alone_entity\\', {})], \\'edges\\': [(\\'congenital mesoblastic nephroma_entity\\', \\'surgery alone_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'alternative chemotherapy_entity\\', {}), (\\'malignant rhabdoid tumors_entity\\', {})], \\'edges\\': [(\\'malignant rhabdoid tumors_entity\\', \\'alternative chemotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'lymph node sampling_entity\\', {}), (\\'accurate staging_entity\\', {})], \\'edges\\': [(\\'lymph node sampling_entity\\', \\'accurate staging_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'purpose_of\\'})]}, {\\'nodes\\': [(\\'COG\u2013NWTS trials_entity\\', {}), (\\'whole-lung irradiation_entity\\', {})], \\'edges\\': [(\\'COG\u2013NWTS trials_entity\\', \\'whole-lung irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'informed_dosage_for\\'})]}, {\\'nodes\\': [(\\'lung metastases_entity\\', {}), (\\'pulmonary radiotherapy_entity\\', {})], \\'edges\\': [(\\'pulmonary radiotherapy_entity\\', \\'lung metastases_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'administered_for\\'})]}, {\\'nodes\\': [(\\'dosimetric study_entity\\', {}), (\\'proton therapy_entity\\', {}), (\\'flank irradiation_entity\\', {})], \\'edges\\': [(\\'dosimetric study_entity\\', \\'proton therapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated\\'}), (\\'proton therapy_entity\\', \\'flank irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggested_for\\'})]}, {\\'nodes\\': [(\\'metastatic disease_entity\\', {}), (\\'radiotherapy guidelines_entity\\', {}), (\\'locoregional disease_entity\\', {})], \\'edges\\': [(\\'radiotherapy guidelines_entity\\', \\'locoregional disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'}), (\\'radiotherapy guidelines_entity\\', \\'metastatic disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'})]}, {\\'nodes\\': [(\\'major rupture_entity\\', {}), (\\'stage III_entity\\', {})], \\'edges\\': [(\\'stage III_entity\\', \\'major rupture_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes_condition\\'})]}, {\\'nodes\\': [(\\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {}), (\\'ExPO\u2011r\u2011Net_entity\\', {})], \\'edges\\': [(\\'ExPO\u2011r\u2011Net_entity\\', \\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is part of\\'})]}, {\\'nodes\\': [(\\'University Hospital of Munich_entity\\', {}), (\\'Germany_entity\\', {}), (\\'University Hospital of Tuebingen_entity\\', {})], \\'edges\\': [(\\'Germany_entity\\', \\'University Hospital of Munich_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Germany_entity\\', \\'University Hospital of Tuebingen_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {}), (\\'Italy_entity\\', {}), (\\'Azienda Ospedaliera_entity\\', {}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {})], \\'edges\\': [(\\'Italy_entity\\', \\'Azienda Ospedaliera_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Netherlands_entity\\', {}), (\\'Prinses Maxima Centrum_entity\\', {})], \\'edges\\': [(\\'Netherlands_entity\\', \\'Prinses Maxima Centrum_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Marciniak Hospital_entity\\', {}), (\\'Poland_entity\\', {}), (\\'Faculty of Medicine_entity\\', {})], \\'edges\\': [(\\'Poland_entity\\', \\'Marciniak Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Poland_entity\\', \\'Faculty of Medicine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'St. Anna Kinderspital/CCRI_entity\\', {}), (\\'Austria_entity\\', {})], \\'edges\\': [(\\'Austria_entity\\', \\'St. Anna Kinderspital/CCRI_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'France_entity\\', {}), (\\'Armand Trousseau Hospital_entity\\', {})], \\'edges\\': [(\\'France_entity\\', \\'Armand Trousseau Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Spain_entity\\', {}), (\\'Hospital Vall d\u2019Hebron_entity\\', {}), (\\'Hospital Universitario Virgin del Rocio_entity\\', {})], \\'edges\\': [(\\'Spain_entity\\', \\'Hospital Universitario Virgin del Rocio_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Spain_entity\\', \\'Hospital Vall d\u2019Hebron_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'United Kingdom_entity\\', {}), (\\'Great Ormond Street Hospital_entity\\', {})], \\'edges\\': [(\\'United Kingdom_entity\\', \\'Great Ormond Street Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Weirich, A._entity\\', {}), (\\'SIOP-9/GPOH_entity\\', {})], \\'edges\\': [(\\'Weirich, A._entity\\', \\'SIOP-9/GPOH_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Pritchard-Jones, K._entity\\', {}), (\\'UKW3_entity\\', {})], \\'edges\\': [(\\'Pritchard-Jones, K._entity\\', \\'UKW3_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed in\\'})]}, {\\'nodes\\': [(\\'SIOP 93\u201301 trial_entity\\', {}), (\\'de Kraker, J._entity\\', {})], \\'edges\\': [(\\'de Kraker, J._entity\\', \\'SIOP 93\u201301 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'SIOP trial and study 93\u201301_entity\\', {}), (\\'Graf, N._entity\\', {})], \\'edges\\': [(\\'Graf, N._entity\\', \\'SIOP trial and study 93\u201301_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Green, D. M._entity\\', {}), (\\'National Wilms Tumor Study Group_entity\\', {})], \\'edges\\': [(\\'Green, D. M._entity\\', \\'National Wilms Tumor Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}, {\\'nodes\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', {}), (\\'SIOP WT 2001 protocol_entity\\', {})], \\'edges\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', \\'SIOP WT 2001 protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Third National Wilms\u2019 Tumor Study_entity\\', {}), (\"D\\'Angio, G. J._entity\", {}), (\\'Second National Wilms\u2019 Tumor Study_entity\\', {})], \\'edges\\': [(\"D\\'Angio, G. J._entity\", \\'Third National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\"D\\'Angio, G. J._entity\", \\'Second National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {}), (\\'Tournade, M. F._entity\\', {}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {})], \\'edges\\': [(\\'Tournade, M. F._entity\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'}), (\\'Tournade, M. F._entity\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Breslow, N. E._entity\\', {}), (\\'National Wilms Tumor Studies_entity\\', {})], \\'edges\\': [(\\'Breslow, N. E._entity\\', \\'National Wilms Tumor Studies_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Mitchell, C._entity\\', {}), (\\'UK Children\u2019s Cancer Study Group_entity\\', {})], \\'edges\\': [(\\'Mitchell, C._entity\\', \\'UK Children\u2019s Cancer Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'under\\'})]}, {\\'nodes\\': [(\\'Daw, N. C._entity\\', {}), (\\'Dix, D. B._entity\\', {}), (\\'Children\u2019s Oncology Group_entity\\', {}), (\\'Grundy, P. E._entity\\', {})], \\'edges\\': [(\\'Daw, N. C._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted under\\'}), (\\'Dix, D. B._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'}), (\\'Grundy, P. E._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}]']), TestResult(name='test_case_7', success=False, metrics_data=[MetricData(name='Answer Correctness (GEval)', threshold=0.5, success=True, score=0.9488038999592829, reason='The actual output includes the recommendation of structured approaches, high-dose chemotherapy, and autologous stem cell rescue, aligning with the expected output.', strict_mode=False, evaluation_model='gpt-4o-mini', error=None, evaluation_cost=0.0032999999999999995, verbose_logs='Criteria:\\nNone \\n \\nEvaluation Steps:\\n[\\n    \"Determine whether the actual output is factually correct based on the expected output.\"\\n]'), MetricData(name='Faithfulness', threshold=0.7, success=True, score=0.9166666666666666, reason=None, strict_mode=False, evaluation_model='gpt-4o-mini', error=None, evaluation_cost=0.0077391, verbose_logs='Truths (limit=None):\\n[\\n    \"The Renal Tumour Study Group of the International Society of Paediatric Oncology is abbreviated as SIOP\u2013RTSG.\",\\n    \"The UMBRELLA SIOP-RTSG 2016 is a protocol related to renal tumours.\",\\n    \"SIOP\u22122001 is a protocol for the treatment of Wilms tumours.\",\\n    \"Wilms tumours are a type of childhood renal disease.\",\\n    \"Non-Wilms tumours are also classified under childhood renal diseases.\",\\n    \"The UMBRELLA protocol is a treatment protocol used for various renal conditions.\",\\n    \"Marry M. van den Heuvel-Eibrink is a person associated with paediatric oncology.\",\\n    \"Actinomycin D, vincristine, and doxorubicin are drugs used in the treatment of Wilms tumours.\",\\n    \"The SIOP\u22122001 randomized trial has investigated the treatment options for Wilms tumours.\",\\n    \"There are different stages of disease in Wilms tumours: localized, metastatic, bilateral, and relapsed diseases.\",\\n    \"The UMBRELLA SIOP-RTSG 2016 protocol is developed by the SIOP\u2013RTSG organization.\",\\n    \"Treatment methods for Wilms tumours include surgery, chemotherapy, and radiotherapy.\",\\n    \"There are multiple organizations involved in the treatment and study of Wilms tumours, including the Children\u2019s Oncology Group (COG).\",\\n    \"Various studies and protocols are aimed at improving outcomes for patients with Wilms tumours.\",\\n    \"Different drug combinations are used in different treatment protocols for renal tumours.\"\\n] \\n \\nClaims:\\n[\\n    \"The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG) is an organization.\",\\n    \"The UMBRELLA SIOP-RTSG 2016 is a protocol.\",\\n    \"SIOP\u22122001 is a protocol.\",\\n    \"Wilms tumours and non-Wilms tumours are diseases.\",\\n    \"The website www.siop-rtsg.eu is associated with SIOP\u2013RTSG.\",\\n    \"The Department of Paediatric Oncology is part of the Princess M\u00e1xima Center for Paediatric Oncology.\",\\n    \"Marry M. van den Heuvel-Eibrink is a person linked to this context.\",\\n    \"Childhood renal tumours are a category of disease.\",\\n    \"Clear cell sarcoma of the kidney is a type of disease.\",\\n    \"Renal cell carcinoma is a type of disease.\",\\n    \"Malignant rhabdoid tumour of the kidney is a type of disease.\",\\n    \"Congenital mesoblastic nephroma is a type of disease.\",\\n    \"Wilms tumours are a condition related to childhood renal tumours.\",\\n    \"The UMBRELLA protocol is a treatment protocol.\",\\n    \"SIOP\u2013RTSG is an organization.\",\\n    \"The Children\u2019s Oncology Group (COG) is an organization.\",\\n    \"The SIOP\u22122001 randomized trial is a clinical trial.\",\\n    \"Actinomycin D, vincristine, and doxorubicin are drugs used in treatment.\",\\n    \"The UKW3 trial is a clinical trial.\",\\n    \"UK Children\u2019s Cancer and Leukaemia Group (UKCCLG) is an organization.\",\\n    \"Localized disease, metastatic disease, bilateral disease, and relapsed disease refer to disease stages.\",\\n    \"Blastemal-type Wilms tumours are a subtype.\",\\n    \"Radiotherapy, surgery, and chemotherapy are treatment methods for Wilms tumours.\",\\n    \"Wilms Tumour, CCSK, MRTK, CMN, and RCC refer to various diseases.\",\\n    \"The UMBRELLA protocol is a treatment protocol within SIOP\u22122001 study.\",\\n    \"Doxorubicin, vincristine, cyclophosphamide, and ifosfamide are drugs associated with Wilms tumours and their treatment.\",\\n    \"The clinical stages include Stage I, Stage II, Stage III, Stage IV, and Stage V.\",\\n    \"The treatment combinations include AV, AVD, and HR-1.\",\\n    \"Overall Survival (OS) and Event-Free Survival (EFS) are metrics used in studies.\",\\n    \"CT-only nodules are a medical condition that indicates high-risk characteristics.\",\\n    \"The SIOP\u2013RTSG analysis is a study conducted by the group.\",\\n    \"COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials are studies in the context of Wilms tumours.\",\\n    \"Bilateral Disease (Stage V) refers to a stage of Wilms Tumor.\",\\n    \"Synchronous bilateral Wilms tumor is a specific type of disease.\",\\n    \"End-stage renal disease (ESRD) is a condition related to nephron issues.\",\\n    \"Bilateral nephron-sparing surgery (NSS) is a treatment method.\",\\n    \"Various institutions are involved: University Hospital of Munich, University Hospital of Tuebingen, and others mentioned.\",\\n    \"High-dose chemotherapy and autologous stem cell transplantation is a treatment aimed at severe cases.\",\\n    \"The SIOP database captures data on treatment regimens and outcomes for various conditions.\"\\n] \\n \\nVerdicts:\\n[\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"The claim states that SIOP\\\\u2013RTSG is an organization, which is correct according to the context that SIOP\\\\u2013RTSG is indeed an abbreviation for the Renal Tumour Study Group of the International Society of Paediatric Oncology.\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"idk\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"idk\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"idk\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"idk\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"idk\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"While SIOP\\\\u2013RTSG is indeed an organization, the claim states only the abbreviation without confirming its full name, which refers specifically to the Renal Tumour Study Group of the International Society of Paediatric Oncology, indicating the need for clarification.\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"idk\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"idk\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"idk\",\\n        \"reason\": null\\n    }\\n]'), MetricData(name='Contextual Relevancy', threshold=1.0, success=False, score=0.5625, reason=\"The score is 0.56 because although there are relevant mentions like 'vincristine and actinomycin D plus doxorubicin_treatment' and 'chemotherapy_Treatment Method', the majority of the context fails to directly address the treatment of relapsed Wilms tumour, as noted in statements like 'The statement refers to an organization and does not address the treatment of relapsed Wilms tumour.' This indicates a mix of relevance and irrelevance, justifying the moderate score.\", strict_mode=False, evaluation_model='gpt-4o-mini', error=None, evaluation_cost=0.0038684999999999995, verbose_logs='Verdicts:\\n[\\n    {\\n        \"verdicts\": [\\n            {\\n                \"statement\": \"Relapsed Wilms Tumor_Disease State\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"relapsed disease_Disease Stage\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\\\\u2013RTSG)_Organization\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"The statement refers to an organization and does not address the treatment of relapsed Wilms tumour.\"\\n            },\\n            {\\n                \"statement\": \"SIOP\\\\u22122001 randomized trial_Clinical Trial\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"This statement references a clinical trial but does not specifically pertain to the treatment of relapsed Wilms tumour.\"\\n            },\\n            {\\n                \"statement\": \"vincristine and actinomycin D plus doxorubicin_treatment\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"surgery_Treatment Method\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"chemotherapy_Treatment Method\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"high-dose chemotherapy and autologous stem cell transplantation_treatment\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"UKW3 trial_Clinical Trial\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"While this might pertain to treatments, it is not specific to the treatment of relapsed Wilms tumour.\"\\n            },\\n            {\\n                \"statement\": \"Relapsed Wilms Tumor_entity\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"vincristine_entity\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"This statement refers to a specific drug and does not explicitly mention its use in treating relapsed Wilms tumour.\"\\n            },\\n            {\\n                \"statement\": \"SIOP\\\\u22122001 study_entity\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"This refers to a study without providing direct information about the treatment of relapsed Wilms tumour.\"\\n            },\\n            {\\n                \"statement\": \"radical tumor nephrectomy_surgical_procedure\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"Warrior esophagus condition\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"The context provided did not mention a condition related to esophagus; therefore, the reference is irrelevant.\"\\n            },\\n            {\\n                \"statement\": \"stage IV WT_condition\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"malignant rhabdoid tumours_medical_condition\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"The statement pertains to a different type of medical condition and not specifically about relapsed Wilms tumour.\"\\n            }\\n        ]\\n    }\\n]')], conversational=False, multimodal=False, input='How does the protocol address the treatment of relapsed Wilms tumour?', actual_output='[{\\'nodes\\': [(\\'sample.pdf\\', {\\'type\\': \\'document\\'}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)\\'}), (\\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA SIOP-RTSG 2016\\'}), (\\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms tumours\\'}), (\\'non-Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'non-Wilms tumours\\'}), (\\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Website\\', \\'name\\': \\'www.siop-rtsg.eu\\'}), (\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology\\'}), (\\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Person\\', \\'name\\': \\'Marry M. van den Heuvel-Eibrink\\'}), (\\'childhood renal tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'childhood renal tumours\\'}), (\\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'clear cell sarcoma of the kidney\\'}), (\\'renal cell carcinoma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'renal cell carcinoma\\'}), (\\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'malignant rhabdoid tumour of the kidney\\'}), (\\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'Wilms tumours_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'Children\u2019s Oncology Group (COG)\\'}), (\\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'SIOP\u22122001 randomized trial\\'}), (\\'actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'UKW3 trial\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)\\'}), (\\'localized disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'localized disease\\'}), (\\'metastatic disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'metastatic disease\\'}), (\\'bilateral disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'bilateral disease\\'}), (\\'relapsed disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'relapsed disease\\'}), (\\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subtype\\', \\'name\\': \\'blastemal-type Wilms tumours\\'}), (\\'radiotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgery_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'chemotherapy\\'}), (\\'Wilms Tumour_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms Tumour\\'}), (\\'CCSK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CCSK\\'}), (\\'MRTK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'MRTK\\'}), (\\'CMN_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CMN\\'}), (\\'RCC_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'RCC\\'}), (\\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u22122001_Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Trial\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'vincristine_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'vincristine\\'}), (\\'actinomycin D_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'actinomycin D\\'}), (\\'doxorubicin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'doxorubicin\\'}), (\\'etoposide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'Stage I_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage I\\'}), (\\'Stage II_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage II\\'}), (\\'Stage III_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage III\\'}), (\\'Stage IV_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage IV\\'}), (\\'Stage V_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage V\\'}), (\\'AV_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AV\\'}), (\\'AVD_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AVD\\'}), (\\'HR-1_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'HR-1\\'}), (\\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP-RTSG 2016\\'}), (\\'Overall Survival (OS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'CT-only nodules_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'CT-only nodules\\'}), (\\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP\u2013RTSG analysis\\'}), (\\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials\\'}), (\\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D plus doxorubicin\\'}), (\\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D\\'}), (\\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study_protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'MRI_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'MRI\\'}), (\\'CT_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'CT\\'}), (\\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_detail\\', \\'name\\': \\'cumulative doxorubicin dose\\'}), (\\'COG AREN0533 trial_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG AREN0533 trial\\'}), (\\'etoposide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'high-risk characteristics\\'}), (\\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG board\\'}), (\\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin\\'}), (\\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'high-dose chemotherapy and autologous stem cell transplantation\\'}), (\\'SIOP database_database\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'database\\', \\'name\\': \\'SIOP database\\'}), (\\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'AVD_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AVD\\'}), (\\'AV-2_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AV-2\\'}), (\\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Statistical Test\\', \\'name\\': \\'Log\u2013Rank P\\'}), (\\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'Bilateral Disease (Stage V)\\'}), (\\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Synchronous bilateral Wilms tumor\\'}), (\\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'End-stage renal disease (ESRD)\\'}), (\\'Aronson et al._Research Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Research Group\\', \\'name\\': \\'Aronson et al.\\'}), (\\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'Bilateral nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Study\\', \\'name\\': \\'SIOP\u22122001 study\\'}), (\\'Vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Vincristine\\'}), (\\'Actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Actinomycin D\\'}), (\\'Etoposide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Etoposide\\'}), (\\'Carboplatin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Carboplatin\\'}), (\\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease State\\', \\'name\\': \\'Relapsed Wilms Tumor\\'}), (\\'Group AA_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group AA\\'}), (\\'Group BB_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group BB\\'}), (\\'Group CC_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group CC\\'}), (\\'Doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Doxorubicin\\'}), (\\'Cyclophosphamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Cyclophosphamide\\'}), (\\'Ifosfamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Ifosfamide\\'}), (\\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'High-dose melphalan\\'}), (\\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UKW\u2011R protocol\\'}), (\\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'NWTS\u20115 relapse protocol\\'}), (\\'ASCR_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'procedure\\', \\'name\\': \\'ASCR\\'}), (\\'ifosfamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'ifosfamide\\'}), (\\'nephrotoxicity_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'nephrotoxicity\\'}), (\\'relapsed group CC_patient_group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'patient_group\\', \\'name\\': \\'relapsed group CC\\'}), (\\'diffuse anaplasia_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'diffuse anaplasia\\'}), (\\'blastemal-type tumors_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'blastemal-type tumors\\'}), (\\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'camptothecins_medication_class\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication_class\\', \\'name\\': \\'camptothecins\\'}), (\\'irinotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'irinotecan\\'}), (\\'topotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'topotecan\\'}), (\\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Innovative Therapies for Children with Cancer consortium\\'}), (\\'radiotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgical excision_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgical excision\\'}), (\\'stage IV WT_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'stage IV WT\\'}), (\\'AVD150_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD150\\'}), (\\'AVD250_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD250\\'}), (\\'low-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'low-risk disease\\'}), (\\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'intermediate-risk disease\\'}), (\\'high-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'high-risk disease\\'}), (\\'CDCV_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'CDCV\\'}), (\\'actinomycin-D_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'actinomycin-D\\'}), (\\'vincristine_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'doxorubicin\\'}), (\\'VP16_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'VP16\\'}), (\\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'contact\\', \\'name\\': \\'arnauld.verschuur@ap-hm.fr\\'}), (\\'surgery_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'chemotherapy\\'}), (\\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2212RTSG panel\\'}), (\\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Infant Wilms Tumors\\'}), (\\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'nephrectomy\\'}), (\\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'malignant rhabdoid tumors\\'}), (\\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Adult Wilms Tumors\\'}), (\\'anaplasia_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'anaplasia\\'}), (\\'actinomycin D_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'carboplatin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'etoposide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'etoposide\\'}), (\\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'Nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'radical tumor nephrectomy\\'}), (\\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'lymph node sampling\\'}), (\\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'minimally invasive surgery\\'}), (\\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'laparoscopic surgery\\'}), (\\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'radiotherapy\\'}), (\\'Wilms tumours_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'Davila Fajardo et al._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Davila Fajardo et al.\\'}), (\\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'COG\u2013NWTS trials\\'}), (\\'whole-lung irradiation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'whole-lung irradiation\\'}), (\\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'pulmonary radiotherapy\\'}), (\\'proton therapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'proton therapy\\'}), (\\'dosimetric study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'dosimetric study\\'}), (\\'locoregional disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'locoregional disease\\'}), (\\'metastatic disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'metastatic disease\\'}), (\\'low-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'low-risk\\'}), (\\'intermediate-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'intermediate-risk\\'}), (\\'high-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'high-risk\\'}), (\\'stage I_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage I\\'}), (\\'stage II_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage II\\'}), (\\'stage III_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage III\\'}), (\\'major rupture_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'major rupture\\'}), (\\'Austria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Austria\\'}), (\\'Italy_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Italy\\'}), (\\'San Marino_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'San Marino\\'}), (\\'Iceland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Iceland\\'}), (\\'Germany_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Germany\\'}), (\\'Bulgaria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bulgaria\\'}), (\\'Turkey_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Turkey\\'}), (\\'Denmark_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Denmark\\'}), (\\'Poland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Poland\\'}), (\\'Greece_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Greece\\'}), (\\'Andorra_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Andorra\\'}), (\\'Belgium_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belgium\\'}), (\\'Serbia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Serbia\\'}), (\\'Albania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Albania\\'}), (\\'Moldova_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Moldova\\'}), (\\'Lithuania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Lithuania\\'}), (\\'Latvia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Latvia\\'}), (\\'Estonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Estonia\\'}), (\\'Luxembourg_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Luxembourg\\'}), (\\'Montenegro_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Montenegro\\'}), (\\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bosnia and Herzegovina\\'}), (\\'Croatia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Croatia\\'}), (\\'Slovenia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovenia\\'}), (\\'Macedonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Macedonia\\'}), (\\'United Kingdom_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'United Kingdom\\'}), (\\'Ireland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ireland\\'}), (\\'Spain_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Spain\\'}), (\\'Algeria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Algeria\\'}), (\\'Tunisia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Tunisia\\'}), (\\'Malta_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Malta\\'}), (\\'Morocco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Morocco\\'}), (\\'Portugal_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Portugal\\'}), (\\'France_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'France\\'}), (\\'Monaco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Monaco\\'}), (\\'Russia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Russia\\'}), (\\'Finland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Finland\\'}), (\\'Sweden_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Sweden\\'}), (\\'Norway_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Norway\\'}), (\\'Belarus_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belarus\\'}), (\\'Romania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Romania\\'}), (\\'Ukraine_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ukraine\\'}), (\\'Hungary_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Hungary\\'}), (\\'Czech Republic_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Czech Republic\\'}), (\\'Slovakia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovakia\\'}), (\\'Switzerland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Switzerland\\'}), (\\'Liechtenstein_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Liechtenstein\\'}), (\\'Netherlands_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Netherlands\\'}), (\\'University Hospital of Munich_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Munich\\'}), (\\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Tuebingen\\'}), (\\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Azienda Ospedaliera\\'}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Ospedale Pediatrico Bambino Ges\u00f9\\'}), (\\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Fondazione IRCCS Istituto Nazionale dei Tumori\\'}), (\\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Prinses Maxima Centrum\\'}), (\\'Marciniak Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Marciniak Hospital\\'}), (\\'Faculty of Medicine_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Faculty of Medicine\\'}), (\\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'St. Anna Kinderspital/CCRI\\'}), (\\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Armand Trousseau Hospital\\'}), (\\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Universitario Virgin del Rocio\\'}), (\\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Vall d\u2019Hebron\\'}), (\\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Great Ormond Street Hospital\\'}), (\\'University Hospital Homburg_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital Homburg\\'}), (\\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon\\'}), (\\'UMBRELLA protocol_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'ExPO\u2011r\u2011Net\\'}), (\\'Weirich, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Weirich, A.\\'}), (\\'Pritchard-Jones, K._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Pritchard-Jones, K.\\'}), (\\'de Kraker, J._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'de Kraker, J.\\'}), (\\'Graf, N._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Graf, N.\\'}), (\\'Green, D. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Green, D. M.\\'}), (\\'Spreafico, F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Spreafico, F.\\'}), (\\'Bellani, F. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Bellani, F. F.\\'}), (\\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'van den Heuvel-Eibrink, M. M.\\'}), (\"D\\'Angio, G. J._author\", {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \"D\\'Angio, G. J.\"}), (\\'Tournade, M. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Tournade, M. F.\\'}), (\\'Breslow, N. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Breslow, N. E.\\'}), (\\'Mitchell, C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Mitchell, C.\\'}), (\\'Verschuur, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Verschuur, A.\\'}), (\\'Grundy, P. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Grundy, P. E.\\'}), (\\'Warmann, S. W._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Warmann, S. W.\\'}), (\\'Smets, A. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Smets, A. M.\\'}), (\\'Dome, J. S._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dome, J. S.\\'}), (\\'Dix, D. B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dix, D. B.\\'}), (\\'Daw, N. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Daw, N. C.\\'}), (\\'Ha, T. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Ha, T. C.\\'}), (\\'Kremens, B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Kremens, B.\\'}), (\\'Furtwangler, R._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Furtwangler, R.\\'}), (\\'SIOP-9/GPOH_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP-9/GPOH\\'}), (\\'UKW3_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'UKW3\\'}), (\\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'SIOP 93\u201301 trial\\'}), (\\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP trial and study 93\u201301\\'}), (\\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'National Wilms Tumor Study Group\\'}), (\\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP WT 2001 protocol\\'}), (\\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Third National Wilms\u2019 Tumor Study\\'}), (\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'National Wilms Tumor Studies\\'}), (\\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Second National Wilms\u2019 Tumor Study\\'}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'UK Children\u2019s Cancer Study Group\\'}), (\\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Children\u2019s Oncology Group\\'})], \\'edges\\': [(\\'sample.pdf\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'non-Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'childhood renal tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'renal cell carcinoma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'localized disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'metastatic disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'bilateral disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'relapsed disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'radiotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'surgery_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'chemotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'Wilms Tumour_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CCSK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'MRTK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CMN_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'RCC_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP\u22122001_Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'vincristine_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'actinomycin D_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'doxorubicin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'etoposide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'carboplatin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'cyclophosphamide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage I_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage II_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage III_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage IV_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage V_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AV_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AVD_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'HR-1_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Overall Survival (OS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT-only nodules_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'MRI_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG AREN0533 trial_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'etoposide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'carboplatin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'cyclophosphamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP database_database\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AVD_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AV-2_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Aronson et al._Research Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Etoposide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Carboplatin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group AA_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group BB_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group CC_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Cyclophosphamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Ifosfamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'ASCR_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'ifosfamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'nephrotoxicity_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'relapsed group CC_patient_group\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'diffuse anaplasia_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'blastemal-type tumors_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'camptothecins_medication_class\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'irinotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'topotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'radiotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'surgical excision_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'stage IV WT_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD150_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD250_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'low-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'CDCV_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'actinomycin-D_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'vincristine_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'doxorubicin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'VP16_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'surgery_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'chemotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'anaplasia_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'actinomycin D_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'vincristine_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'doxorubicin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'carboplatin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'cyclophosphamide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'etoposide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'SIOP\u22122001_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Wilms tumours_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Davila Fajardo et al._author\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'whole-lung irradiation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'proton therapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'dosimetric study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'locoregional disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'metastatic disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'low-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'intermediate-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'high-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage I_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage II_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage III_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'major rupture_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Austria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Italy_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'San Marino_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Iceland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Germany_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bulgaria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Turkey_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Denmark_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Poland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Greece_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Andorra_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belgium_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Serbia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Albania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Moldova_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Lithuania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Latvia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Estonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Luxembourg_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Montenegro_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Croatia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovenia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Macedonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'United Kingdom_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ireland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Spain_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Algeria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Tunisia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Malta_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Morocco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Portugal_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'France_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Monaco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Russia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Finland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Sweden_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Norway_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belarus_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Romania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ukraine_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hungary_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Czech Republic_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovakia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Switzerland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Liechtenstein_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Netherlands_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Munich_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Marciniak Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Faculty of Medicine_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital Homburg_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Weirich, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Pritchard-Jones, K._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'de Kraker, J._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Graf, N._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Green, D. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Spreafico, F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Bellani, F. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \"D\\'Angio, G. J._author\", {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Tournade, M. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Breslow, N. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Mitchell, C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Verschuur, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Grundy, P. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Warmann, S. W._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Smets, A. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dome, J. S._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dix, D. B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Daw, N. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ha, T. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Kremens, B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Furtwangler, R._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP-9/GPOH_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UKW3_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10})]}, {\\'nodes\\': [(\\'vincristine_entity\\', {}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {}), (\\'www.siop-rtsg.eu_entity\\', {}), (\\'stage II_entity\\', {}), (\\'Wilms tumours_entity\\', {}), (\\'Relapsed Wilms Tumor_entity\\', {}), (\\'Davila Fajardo et al._entity\\', {}), (\\'vincristine, actinomycin D, and doxorubicin_entity\\', {}), (\\'SIOP\u22122001 randomized trial_entity\\', {}), (\\'surgery_entity\\', {}), (\\'non-Wilms tumours_entity\\', {}), (\\'actinomycin D_entity\\', {}), (\\'diffuse anaplasia_entity\\', {}), (\\'Synchronous bilateral Wilms tumor_entity\\', {}), (\\'CT-only nodules_entity\\', {}), (\\'relapsed group CC_entity\\', {}), (\\'increased relapse risk_entity\\', {}), (\\'reduced survival_entity\\', {}), (\\'UKW3 trial_entity\\', {}), (\\'chemotherapy_entity\\', {}), (\\'Bilateral Disease (Stage V)_entity\\', {}), (\\'blastemal-type tumors_entity\\', {}), (\\'UMBRELLA protocol_entity\\', {}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', {}), (\\'minimally invasive surgery_entity\\', {}), (\\'VP16_entity\\', {}), (\\'Wilms tumor_entity\\', {}), (\\'anaplasia_entity\\', {}), (\\'radical tumor nephrectomy_entity\\', {}), (\\'Innovative Therapies for Children with Cancer consortium_entity\\', {}), (\\'cumulative doxorubicin dose_entity\\', {}), (\\'etoposide_entity\\', {}), (\\'large-volume tumours_entity\\', {}), (\\'Stage IV_entity\\', {}), (\\'CDCV_entity\\', {}), (\\'SIOP\u2013RTSG_entity\\', {}), (\\'AVD150_entity\\', {}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', {}), (\\'laparoscopic surgery_entity\\', {}), (\\'SIOP\u2212RTSG panel_entity\\', {}), (\\'actinomycin-D_entity\\', {}), (\\'COG AREN0533 trial_entity\\', {}), (\\'cyclophosphamide_entity\\', {}), (\\'carboplatin_entity\\', {}), (\\'UKW\u2011R protocol_entity\\', {}), (\\'Nephron-sparing surgery (NSS)_entity\\', {}), (\\'Adult Wilms Tumors_entity\\', {}), (\\'doxorubicin_entity\\', {}), (\\'NWTS\u20115 relapse protocol_entity\\', {}), (\\'End-stage renal disease (ESRD)_entity\\', {}), (\\'AVD250_entity\\', {}), (\\'Children\u2019s Oncology Group (COG)_entity\\', {}), (\\'blastemal-type Wilms tumour_entity\\', {}), (\\'SIOP\u22122001_entity\\', {}), (\\'radiotherapy_entity\\', {}), (\\'childhood renal tumours_entity\\', {})], \\'edges\\': [(\\'vincristine_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'stage II_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'indicated_for_in_adults\\'}), (\\'Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'Wilms tumours_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated under\\'}), (\\'Relapsed Wilms Tumor_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guided_by\\'}), (\\'Davila Fajardo et al._entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed\\'}), (\\'SIOP\u22122001 randomized trial_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated use in\\'}), (\\'surgery_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'non-Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'actinomycin D_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Synchronous bilateral Wilms tumor_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'instance_of\\'}), (\\'CT-only nodules_entity\\', \\'increased relapse risk_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'reduced survival_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included_in\\'}), (\\'relapsed group CC_entity\\', \\'diffuse anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'blastemal-type tumors_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UKW3 trial_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'UKW3 trial_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'chemotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UMBRELLA protocol_entity\\', \\'COG AREN0533 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses_data_from\\'}), (\\'UMBRELLA protocol_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'advises_treatment_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'Innovative Therapies for Children with Cancer consortium_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborates_with\\'}), (\\'UMBRELLA protocol_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'surgery_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is the standard of\\'}), (\\'UMBRELLA protocol_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guides treatment in\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', \\'UKW3 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\\'minimally invasive surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'anaplasia_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'radical tumor nephrectomy_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'standard_of_care_for\\'}), (\\'Stage IV_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'presents in\\'}), (\\'CDCV_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'VP16_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'aims to improve survival rates of\\'}), (\\'AVD150_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed_by\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'succeeds\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'www.siop-rtsg.eu_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'available_on\\'}), (\\'laparoscopic surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'COG AREN0533 trial_entity\\', \\'cumulative doxorubicin dose_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'evaluates\\'}), (\\'UKW\u2011R protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'Nephron-sparing surgery (NSS)_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'classification_developed_by\\'}), (\\'Adult Wilms Tumors_entity\\', \\'anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'Adult Wilms Tumors_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'doxorubicin_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'doxorubicin_entity\\', \\'large-volume tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'recommended for\\'}), (\\'NWTS\u20115 relapse protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'End-stage renal disease (ESRD)_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'AVD250_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'Children\u2019s Oncology Group (COG)_entity\\', \\'SIOP\u22122001 randomized trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborated with\\'}), (\\'blastemal-type Wilms tumour_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment intensified according to\\'}), (\\'SIOP\u22122001_entity\\', \\'vincristine, actinomycin D, and doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses\\'}), (\\'SIOP\u22122001_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provided_guidelines_for\\'}), (\\'radiotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'radiotherapy_entity\\', \\'SIOP\u2212RTSG panel_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'contact_for_guidance\\'})]}, {\\'nodes\\': [(\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {}), (\\'Marry M. van den Heuvel-Eibrink_entity\\', {})], \\'edges\\': [(\\'Marry M. van den Heuvel-Eibrink_entity\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'affiliated_with\\'})]}, {\\'nodes\\': [(\\'Stage II_entity\\', {}), (\\'AV_entity\\', {}), (\\'Stage III_entity\\', {}), (\\'vincestine and actinomycin D_entity\\', {}), (\\'AVD_entity\\', {})], \\'edges\\': [(\\'Stage II_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AV_entity\\', \\'Stage II_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Stage III_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AVD_entity\\', \\'Stage III_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'SIOP-RTSG 2016_entity\\', {}), (\\'RCC_entity\\', {}), (\\'CMN_entity\\', {})], \\'edges\\': [(\\'RCC_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'}), (\\'CMN_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'})]}, {\\'nodes\\': [(\\'HR-1_entity\\', {}), (\\'High-risk blastemal type Wilms tumour_entity\\', {})], \\'edges\\': [(\\'HR-1_entity\\', \\'High-risk blastemal type Wilms tumour_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'unfavorable prognosis_entity\\', {}), (\\'high-risk characteristics_entity\\', {})], \\'edges\\': [(\\'high-risk characteristics_entity\\', \\'unfavorable prognosis_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'leads_to\\'})]}, {\\'nodes\\': [(\\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {}), (\\'SIOP\u2013RTSG board_entity\\', {})], \\'edges\\': [(\\'SIOP\u2013RTSG board_entity\\', \\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggests\\'})]}, {\\'nodes\\': [(\\'regimen and outcomes_entity\\', {}), (\\'SIOP database_entity\\', {})], \\'edges\\': [(\\'SIOP database_entity\\', \\'regimen and outcomes_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'captures_data_on\\'})]}, {\\'nodes\\': [(\\'Bilateral nephron-sparing surgery (NSS)_entity\\', {}), (\\'Aronson et al._entity\\', {})], \\'edges\\': [(\\'Aronson et al._entity\\', \\'Bilateral nephron-sparing surgery (NSS)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'observed_effectiveness_of\\'})]}, {\\'nodes\\': [(\\'SIOP\u22122001 study_entity\\', {}), (\\'Actinomycin D_entity\\', {}), (\\'Vincristine_entity\\', {})], \\'edges\\': [(\\'SIOP\u22122001 study_entity\\', \\'Vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'}), (\\'SIOP\u22122001 study_entity\\', \\'Actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'})]}, {\\'nodes\\': [(\\'High-dose melphalan_entity\\', {}), (\\'Group AA_entity\\', {}), (\\'Carboplatin_entity\\', {}), (\\'Doxorubicin_entity\\', {}), (\\'Etoposide_entity\\', {}), (\\'Group BB_entity\\', {}), (\\'Cyclophosphamide_entity\\', {}), (\\'Ifosfamide_entity\\', {})], \\'edges\\': [(\\'Group AA_entity\\', \\'Doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Ifosfamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'High-dose melphalan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'})]}, {\\'nodes\\': [(\\'nephrotoxicity_entity\\', {}), (\\'ifosfamide_entity\\', {})], \\'edges\\': [(\\'ifosfamide_entity\\', \\'nephrotoxicity_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'related_to\\'})]}, {\\'nodes\\': [(\\'camptothecins_entity\\', {}), (\\'irinotecan_entity\\', {}), (\\'topotecan_entity\\', {})], \\'edges\\': [(\\'camptothecins_entity\\', \\'irinotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'camptothecins_entity\\', \\'topotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'})]}, {\\'nodes\\': [(\\'Infant Wilms Tumors_entity\\', {}), (\\'nephrectomy_entity\\', {})], \\'edges\\': [(\\'Infant Wilms Tumors_entity\\', \\'nephrectomy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_option\\'})]}, {\\'nodes\\': [(\\'congenital mesoblastic nephroma_entity\\', {}), (\\'surgery alone_entity\\', {})], \\'edges\\': [(\\'congenital mesoblastic nephroma_entity\\', \\'surgery alone_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'alternative chemotherapy_entity\\', {}), (\\'malignant rhabdoid tumors_entity\\', {})], \\'edges\\': [(\\'malignant rhabdoid tumors_entity\\', \\'alternative chemotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'lymph node sampling_entity\\', {}), (\\'accurate staging_entity\\', {})], \\'edges\\': [(\\'lymph node sampling_entity\\', \\'accurate staging_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'purpose_of\\'})]}, {\\'nodes\\': [(\\'COG\u2013NWTS trials_entity\\', {}), (\\'whole-lung irradiation_entity\\', {})], \\'edges\\': [(\\'COG\u2013NWTS trials_entity\\', \\'whole-lung irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'informed_dosage_for\\'})]}, {\\'nodes\\': [(\\'lung metastases_entity\\', {}), (\\'pulmonary radiotherapy_entity\\', {})], \\'edges\\': [(\\'pulmonary radiotherapy_entity\\', \\'lung metastases_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'administered_for\\'})]}, {\\'nodes\\': [(\\'dosimetric study_entity\\', {}), (\\'proton therapy_entity\\', {}), (\\'flank irradiation_entity\\', {})], \\'edges\\': [(\\'dosimetric study_entity\\', \\'proton therapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated\\'}), (\\'proton therapy_entity\\', \\'flank irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggested_for\\'})]}, {\\'nodes\\': [(\\'metastatic disease_entity\\', {}), (\\'radiotherapy guidelines_entity\\', {}), (\\'locoregional disease_entity\\', {})], \\'edges\\': [(\\'radiotherapy guidelines_entity\\', \\'locoregional disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'}), (\\'radiotherapy guidelines_entity\\', \\'metastatic disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'})]}, {\\'nodes\\': [(\\'major rupture_entity\\', {}), (\\'stage III_entity\\', {})], \\'edges\\': [(\\'stage III_entity\\', \\'major rupture_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes_condition\\'})]}, {\\'nodes\\': [(\\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {}), (\\'ExPO\u2011r\u2011Net_entity\\', {})], \\'edges\\': [(\\'ExPO\u2011r\u2011Net_entity\\', \\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is part of\\'})]}, {\\'nodes\\': [(\\'University Hospital of Munich_entity\\', {}), (\\'Germany_entity\\', {}), (\\'University Hospital of Tuebingen_entity\\', {})], \\'edges\\': [(\\'Germany_entity\\', \\'University Hospital of Munich_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Germany_entity\\', \\'University Hospital of Tuebingen_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {}), (\\'Italy_entity\\', {}), (\\'Azienda Ospedaliera_entity\\', {}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {})], \\'edges\\': [(\\'Italy_entity\\', \\'Azienda Ospedaliera_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Netherlands_entity\\', {}), (\\'Prinses Maxima Centrum_entity\\', {})], \\'edges\\': [(\\'Netherlands_entity\\', \\'Prinses Maxima Centrum_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Marciniak Hospital_entity\\', {}), (\\'Poland_entity\\', {}), (\\'Faculty of Medicine_entity\\', {})], \\'edges\\': [(\\'Poland_entity\\', \\'Marciniak Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Poland_entity\\', \\'Faculty of Medicine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'St. Anna Kinderspital/CCRI_entity\\', {}), (\\'Austria_entity\\', {})], \\'edges\\': [(\\'Austria_entity\\', \\'St. Anna Kinderspital/CCRI_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'France_entity\\', {}), (\\'Armand Trousseau Hospital_entity\\', {})], \\'edges\\': [(\\'France_entity\\', \\'Armand Trousseau Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Spain_entity\\', {}), (\\'Hospital Vall d\u2019Hebron_entity\\', {}), (\\'Hospital Universitario Virgin del Rocio_entity\\', {})], \\'edges\\': [(\\'Spain_entity\\', \\'Hospital Universitario Virgin del Rocio_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Spain_entity\\', \\'Hospital Vall d\u2019Hebron_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'United Kingdom_entity\\', {}), (\\'Great Ormond Street Hospital_entity\\', {})], \\'edges\\': [(\\'United Kingdom_entity\\', \\'Great Ormond Street Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Weirich, A._entity\\', {}), (\\'SIOP-9/GPOH_entity\\', {})], \\'edges\\': [(\\'Weirich, A._entity\\', \\'SIOP-9/GPOH_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Pritchard-Jones, K._entity\\', {}), (\\'UKW3_entity\\', {})], \\'edges\\': [(\\'Pritchard-Jones, K._entity\\', \\'UKW3_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed in\\'})]}, {\\'nodes\\': [(\\'SIOP 93\u201301 trial_entity\\', {}), (\\'de Kraker, J._entity\\', {})], \\'edges\\': [(\\'de Kraker, J._entity\\', \\'SIOP 93\u201301 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'SIOP trial and study 93\u201301_entity\\', {}), (\\'Graf, N._entity\\', {})], \\'edges\\': [(\\'Graf, N._entity\\', \\'SIOP trial and study 93\u201301_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Green, D. M._entity\\', {}), (\\'National Wilms Tumor Study Group_entity\\', {})], \\'edges\\': [(\\'Green, D. M._entity\\', \\'National Wilms Tumor Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}, {\\'nodes\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', {}), (\\'SIOP WT 2001 protocol_entity\\', {})], \\'edges\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', \\'SIOP WT 2001 protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Third National Wilms\u2019 Tumor Study_entity\\', {}), (\"D\\'Angio, G. J._entity\", {}), (\\'Second National Wilms\u2019 Tumor Study_entity\\', {})], \\'edges\\': [(\"D\\'Angio, G. J._entity\", \\'Third National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\"D\\'Angio, G. J._entity\", \\'Second National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {}), (\\'Tournade, M. F._entity\\', {}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {})], \\'edges\\': [(\\'Tournade, M. F._entity\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'}), (\\'Tournade, M. F._entity\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Breslow, N. E._entity\\', {}), (\\'National Wilms Tumor Studies_entity\\', {})], \\'edges\\': [(\\'Breslow, N. E._entity\\', \\'National Wilms Tumor Studies_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Mitchell, C._entity\\', {}), (\\'UK Children\u2019s Cancer Study Group_entity\\', {})], \\'edges\\': [(\\'Mitchell, C._entity\\', \\'UK Children\u2019s Cancer Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'under\\'})]}, {\\'nodes\\': [(\\'Daw, N. C._entity\\', {}), (\\'Dix, D. B._entity\\', {}), (\\'Children\u2019s Oncology Group_entity\\', {}), (\\'Grundy, P. E._entity\\', {})], \\'edges\\': [(\\'Daw, N. C._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted under\\'}), (\\'Dix, D. B._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'}), (\\'Grundy, P. E._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}]', expected_output='It recommends a structured approach that may include combinations of chemotherapy agents and, in some cases, high-dose chemotherapy with autologous stem cell rescue.', context=None, retrieval_context=['[{\\'nodes\\': [(\\'sample.pdf\\', {\\'type\\': \\'document\\'}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)\\'}), (\\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA SIOP-RTSG 2016\\'}), (\\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms tumours\\'}), (\\'non-Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'non-Wilms tumours\\'}), (\\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Website\\', \\'name\\': \\'www.siop-rtsg.eu\\'}), (\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology\\'}), (\\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Person\\', \\'name\\': \\'Marry M. van den Heuvel-Eibrink\\'}), (\\'childhood renal tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'childhood renal tumours\\'}), (\\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'clear cell sarcoma of the kidney\\'}), (\\'renal cell carcinoma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'renal cell carcinoma\\'}), (\\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'malignant rhabdoid tumour of the kidney\\'}), (\\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'Wilms tumours_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'Children\u2019s Oncology Group (COG)\\'}), (\\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'SIOP\u22122001 randomized trial\\'}), (\\'actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'UKW3 trial\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)\\'}), (\\'localized disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'localized disease\\'}), (\\'metastatic disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'metastatic disease\\'}), (\\'bilateral disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'bilateral disease\\'}), (\\'relapsed disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'relapsed disease\\'}), (\\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subtype\\', \\'name\\': \\'blastemal-type Wilms tumours\\'}), (\\'radiotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgery_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'chemotherapy\\'}), (\\'Wilms Tumour_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms Tumour\\'}), (\\'CCSK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CCSK\\'}), (\\'MRTK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'MRTK\\'}), (\\'CMN_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CMN\\'}), (\\'RCC_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'RCC\\'}), (\\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u22122001_Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Trial\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'vincristine_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'vincristine\\'}), (\\'actinomycin D_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'actinomycin D\\'}), (\\'doxorubicin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'doxorubicin\\'}), (\\'etoposide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'Stage I_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage I\\'}), (\\'Stage II_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage II\\'}), (\\'Stage III_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage III\\'}), (\\'Stage IV_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage IV\\'}), (\\'Stage V_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage V\\'}), (\\'AV_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AV\\'}), (\\'AVD_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AVD\\'}), (\\'HR-1_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'HR-1\\'}), (\\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP-RTSG 2016\\'}), (\\'Overall Survival (OS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'CT-only nodules_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'CT-only nodules\\'}), (\\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP\u2013RTSG analysis\\'}), (\\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials\\'}), (\\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D plus doxorubicin\\'}), (\\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D\\'}), (\\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study_protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'MRI_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'MRI\\'}), (\\'CT_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'CT\\'}), (\\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_detail\\', \\'name\\': \\'cumulative doxorubicin dose\\'}), (\\'COG AREN0533 trial_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG AREN0533 trial\\'}), (\\'etoposide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'high-risk characteristics\\'}), (\\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG board\\'}), (\\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin\\'}), (\\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'high-dose chemotherapy and autologous stem cell transplantation\\'}), (\\'SIOP database_database\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'database\\', \\'name\\': \\'SIOP database\\'}), (\\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'AVD_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AVD\\'}), (\\'AV-2_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AV-2\\'}), (\\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Statistical Test\\', \\'name\\': \\'Log\u2013Rank P\\'}), (\\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'Bilateral Disease (Stage V)\\'}), (\\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Synchronous bilateral Wilms tumor\\'}), (\\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'End-stage renal disease (ESRD)\\'}), (\\'Aronson et al._Research Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Research Group\\', \\'name\\': \\'Aronson et al.\\'}), (\\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'Bilateral nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Study\\', \\'name\\': \\'SIOP\u22122001 study\\'}), (\\'Vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Vincristine\\'}), (\\'Actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Actinomycin D\\'}), (\\'Etoposide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Etoposide\\'}), (\\'Carboplatin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Carboplatin\\'}), (\\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease State\\', \\'name\\': \\'Relapsed Wilms Tumor\\'}), (\\'Group AA_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group AA\\'}), (\\'Group BB_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group BB\\'}), (\\'Group CC_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group CC\\'}), (\\'Doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Doxorubicin\\'}), (\\'Cyclophosphamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Cyclophosphamide\\'}), (\\'Ifosfamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Ifosfamide\\'}), (\\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'High-dose melphalan\\'}), (\\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UKW\u2011R protocol\\'}), (\\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'NWTS\u20115 relapse protocol\\'}), (\\'ASCR_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'procedure\\', \\'name\\': \\'ASCR\\'}), (\\'ifosfamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'ifosfamide\\'}), (\\'nephrotoxicity_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'nephrotoxicity\\'}), (\\'relapsed group CC_patient_group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'patient_group\\', \\'name\\': \\'relapsed group CC\\'}), (\\'diffuse anaplasia_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'diffuse anaplasia\\'}), (\\'blastemal-type tumors_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'blastemal-type tumors\\'}), (\\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'camptothecins_medication_class\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication_class\\', \\'name\\': \\'camptothecins\\'}), (\\'irinotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'irinotecan\\'}), (\\'topotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'topotecan\\'}), (\\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Innovative Therapies for Children with Cancer consortium\\'}), (\\'radiotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgical excision_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgical excision\\'}), (\\'stage IV WT_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'stage IV WT\\'}), (\\'AVD150_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD150\\'}), (\\'AVD250_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD250\\'}), (\\'low-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'low-risk disease\\'}), (\\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'intermediate-risk disease\\'}), (\\'high-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'high-risk disease\\'}), (\\'CDCV_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'CDCV\\'}), (\\'actinomycin-D_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'actinomycin-D\\'}), (\\'vincristine_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'doxorubicin\\'}), (\\'VP16_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'VP16\\'}), (\\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'contact\\', \\'name\\': \\'arnauld.verschuur@ap-hm.fr\\'}), (\\'surgery_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'chemotherapy\\'}), (\\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2212RTSG panel\\'}), (\\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Infant Wilms Tumors\\'}), (\\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'nephrectomy\\'}), (\\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'malignant rhabdoid tumors\\'}), (\\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Adult Wilms Tumors\\'}), (\\'anaplasia_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'anaplasia\\'}), (\\'actinomycin D_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'carboplatin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'etoposide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'etoposide\\'}), (\\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'Nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'radical tumor nephrectomy\\'}), (\\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'lymph node sampling\\'}), (\\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'minimally invasive surgery\\'}), (\\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'laparoscopic surgery\\'}), (\\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'radiotherapy\\'}), (\\'Wilms tumours_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'Davila Fajardo et al._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Davila Fajardo et al.\\'}), (\\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'COG\u2013NWTS trials\\'}), (\\'whole-lung irradiation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'whole-lung irradiation\\'}), (\\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'pulmonary radiotherapy\\'}), (\\'proton therapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'proton therapy\\'}), (\\'dosimetric study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'dosimetric study\\'}), (\\'locoregional disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'locoregional disease\\'}), (\\'metastatic disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'metastatic disease\\'}), (\\'low-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'low-risk\\'}), (\\'intermediate-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'intermediate-risk\\'}), (\\'high-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'high-risk\\'}), (\\'stage I_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage I\\'}), (\\'stage II_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage II\\'}), (\\'stage III_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage III\\'}), (\\'major rupture_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'major rupture\\'}), (\\'Austria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Austria\\'}), (\\'Italy_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Italy\\'}), (\\'San Marino_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'San Marino\\'}), (\\'Iceland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Iceland\\'}), (\\'Germany_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Germany\\'}), (\\'Bulgaria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bulgaria\\'}), (\\'Turkey_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Turkey\\'}), (\\'Denmark_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Denmark\\'}), (\\'Poland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Poland\\'}), (\\'Greece_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Greece\\'}), (\\'Andorra_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Andorra\\'}), (\\'Belgium_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belgium\\'}), (\\'Serbia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Serbia\\'}), (\\'Albania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Albania\\'}), (\\'Moldova_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Moldova\\'}), (\\'Lithuania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Lithuania\\'}), (\\'Latvia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Latvia\\'}), (\\'Estonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Estonia\\'}), (\\'Luxembourg_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Luxembourg\\'}), (\\'Montenegro_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Montenegro\\'}), (\\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bosnia and Herzegovina\\'}), (\\'Croatia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Croatia\\'}), (\\'Slovenia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovenia\\'}), (\\'Macedonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Macedonia\\'}), (\\'United Kingdom_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'United Kingdom\\'}), (\\'Ireland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ireland\\'}), (\\'Spain_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Spain\\'}), (\\'Algeria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Algeria\\'}), (\\'Tunisia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Tunisia\\'}), (\\'Malta_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Malta\\'}), (\\'Morocco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Morocco\\'}), (\\'Portugal_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Portugal\\'}), (\\'France_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'France\\'}), (\\'Monaco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Monaco\\'}), (\\'Russia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Russia\\'}), (\\'Finland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Finland\\'}), (\\'Sweden_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Sweden\\'}), (\\'Norway_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Norway\\'}), (\\'Belarus_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belarus\\'}), (\\'Romania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Romania\\'}), (\\'Ukraine_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ukraine\\'}), (\\'Hungary_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Hungary\\'}), (\\'Czech Republic_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Czech Republic\\'}), (\\'Slovakia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovakia\\'}), (\\'Switzerland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Switzerland\\'}), (\\'Liechtenstein_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Liechtenstein\\'}), (\\'Netherlands_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Netherlands\\'}), (\\'University Hospital of Munich_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Munich\\'}), (\\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Tuebingen\\'}), (\\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Azienda Ospedaliera\\'}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Ospedale Pediatrico Bambino Ges\u00f9\\'}), (\\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Fondazione IRCCS Istituto Nazionale dei Tumori\\'}), (\\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Prinses Maxima Centrum\\'}), (\\'Marciniak Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Marciniak Hospital\\'}), (\\'Faculty of Medicine_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Faculty of Medicine\\'}), (\\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'St. Anna Kinderspital/CCRI\\'}), (\\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Armand Trousseau Hospital\\'}), (\\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Universitario Virgin del Rocio\\'}), (\\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Vall d\u2019Hebron\\'}), (\\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Great Ormond Street Hospital\\'}), (\\'University Hospital Homburg_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital Homburg\\'}), (\\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon\\'}), (\\'UMBRELLA protocol_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'ExPO\u2011r\u2011Net\\'}), (\\'Weirich, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Weirich, A.\\'}), (\\'Pritchard-Jones, K._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Pritchard-Jones, K.\\'}), (\\'de Kraker, J._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'de Kraker, J.\\'}), (\\'Graf, N._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Graf, N.\\'}), (\\'Green, D. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Green, D. M.\\'}), (\\'Spreafico, F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Spreafico, F.\\'}), (\\'Bellani, F. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Bellani, F. F.\\'}), (\\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'van den Heuvel-Eibrink, M. M.\\'}), (\"D\\'Angio, G. J._author\", {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \"D\\'Angio, G. J.\"}), (\\'Tournade, M. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Tournade, M. F.\\'}), (\\'Breslow, N. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Breslow, N. E.\\'}), (\\'Mitchell, C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Mitchell, C.\\'}), (\\'Verschuur, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Verschuur, A.\\'}), (\\'Grundy, P. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Grundy, P. E.\\'}), (\\'Warmann, S. W._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Warmann, S. W.\\'}), (\\'Smets, A. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Smets, A. M.\\'}), (\\'Dome, J. S._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dome, J. S.\\'}), (\\'Dix, D. B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dix, D. B.\\'}), (\\'Daw, N. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Daw, N. C.\\'}), (\\'Ha, T. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Ha, T. C.\\'}), (\\'Kremens, B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Kremens, B.\\'}), (\\'Furtwangler, R._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Furtwangler, R.\\'}), (\\'SIOP-9/GPOH_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP-9/GPOH\\'}), (\\'UKW3_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'UKW3\\'}), (\\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'SIOP 93\u201301 trial\\'}), (\\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP trial and study 93\u201301\\'}), (\\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'National Wilms Tumor Study Group\\'}), (\\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP WT 2001 protocol\\'}), (\\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Third National Wilms\u2019 Tumor Study\\'}), (\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'National Wilms Tumor Studies\\'}), (\\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Second National Wilms\u2019 Tumor Study\\'}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'UK Children\u2019s Cancer Study Group\\'}), (\\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Children\u2019s Oncology Group\\'})], \\'edges\\': [(\\'sample.pdf\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'non-Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'childhood renal tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'renal cell carcinoma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'localized disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'metastatic disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'bilateral disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'relapsed disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'radiotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'surgery_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'chemotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'Wilms Tumour_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CCSK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'MRTK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CMN_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'RCC_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP\u22122001_Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'vincristine_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'actinomycin D_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'doxorubicin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'etoposide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'carboplatin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'cyclophosphamide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage I_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage II_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage III_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage IV_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage V_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AV_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AVD_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'HR-1_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Overall Survival (OS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT-only nodules_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'MRI_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG AREN0533 trial_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'etoposide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'carboplatin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'cyclophosphamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP database_database\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AVD_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AV-2_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Aronson et al._Research Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Etoposide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Carboplatin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group AA_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group BB_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group CC_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Cyclophosphamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Ifosfamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'ASCR_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'ifosfamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'nephrotoxicity_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'relapsed group CC_patient_group\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'diffuse anaplasia_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'blastemal-type tumors_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'camptothecins_medication_class\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'irinotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'topotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'radiotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'surgical excision_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'stage IV WT_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD150_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD250_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'low-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'CDCV_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'actinomycin-D_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'vincristine_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'doxorubicin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'VP16_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'surgery_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'chemotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'anaplasia_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'actinomycin D_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'vincristine_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'doxorubicin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'carboplatin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'cyclophosphamide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'etoposide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'SIOP\u22122001_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Wilms tumours_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Davila Fajardo et al._author\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'whole-lung irradiation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'proton therapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'dosimetric study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'locoregional disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'metastatic disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'low-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'intermediate-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'high-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage I_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage II_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage III_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'major rupture_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Austria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Italy_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'San Marino_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Iceland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Germany_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bulgaria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Turkey_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Denmark_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Poland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Greece_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Andorra_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belgium_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Serbia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Albania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Moldova_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Lithuania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Latvia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Estonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Luxembourg_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Montenegro_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Croatia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovenia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Macedonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'United Kingdom_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ireland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Spain_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Algeria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Tunisia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Malta_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Morocco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Portugal_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'France_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Monaco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Russia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Finland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Sweden_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Norway_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belarus_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Romania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ukraine_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hungary_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Czech Republic_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovakia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Switzerland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Liechtenstein_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Netherlands_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Munich_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Marciniak Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Faculty of Medicine_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital Homburg_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Weirich, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Pritchard-Jones, K._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'de Kraker, J._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Graf, N._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Green, D. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Spreafico, F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Bellani, F. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \"D\\'Angio, G. J._author\", {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Tournade, M. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Breslow, N. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Mitchell, C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Verschuur, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Grundy, P. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Warmann, S. W._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Smets, A. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dome, J. S._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dix, D. B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Daw, N. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ha, T. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Kremens, B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Furtwangler, R._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP-9/GPOH_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UKW3_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10})]}, {\\'nodes\\': [(\\'vincristine_entity\\', {}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {}), (\\'www.siop-rtsg.eu_entity\\', {}), (\\'stage II_entity\\', {}), (\\'Wilms tumours_entity\\', {}), (\\'Relapsed Wilms Tumor_entity\\', {}), (\\'Davila Fajardo et al._entity\\', {}), (\\'vincristine, actinomycin D, and doxorubicin_entity\\', {}), (\\'SIOP\u22122001 randomized trial_entity\\', {}), (\\'surgery_entity\\', {}), (\\'non-Wilms tumours_entity\\', {}), (\\'actinomycin D_entity\\', {}), (\\'diffuse anaplasia_entity\\', {}), (\\'Synchronous bilateral Wilms tumor_entity\\', {}), (\\'CT-only nodules_entity\\', {}), (\\'relapsed group CC_entity\\', {}), (\\'increased relapse risk_entity\\', {}), (\\'reduced survival_entity\\', {}), (\\'UKW3 trial_entity\\', {}), (\\'chemotherapy_entity\\', {}), (\\'Bilateral Disease (Stage V)_entity\\', {}), (\\'blastemal-type tumors_entity\\', {}), (\\'UMBRELLA protocol_entity\\', {}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', {}), (\\'minimally invasive surgery_entity\\', {}), (\\'VP16_entity\\', {}), (\\'Wilms tumor_entity\\', {}), (\\'anaplasia_entity\\', {}), (\\'radical tumor nephrectomy_entity\\', {}), (\\'Innovative Therapies for Children with Cancer consortium_entity\\', {}), (\\'cumulative doxorubicin dose_entity\\', {}), (\\'etoposide_entity\\', {}), (\\'large-volume tumours_entity\\', {}), (\\'Stage IV_entity\\', {}), (\\'CDCV_entity\\', {}), (\\'SIOP\u2013RTSG_entity\\', {}), (\\'AVD150_entity\\', {}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', {}), (\\'laparoscopic surgery_entity\\', {}), (\\'SIOP\u2212RTSG panel_entity\\', {}), (\\'actinomycin-D_entity\\', {}), (\\'COG AREN0533 trial_entity\\', {}), (\\'cyclophosphamide_entity\\', {}), (\\'carboplatin_entity\\', {}), (\\'UKW\u2011R protocol_entity\\', {}), (\\'Nephron-sparing surgery (NSS)_entity\\', {}), (\\'Adult Wilms Tumors_entity\\', {}), (\\'doxorubicin_entity\\', {}), (\\'NWTS\u20115 relapse protocol_entity\\', {}), (\\'End-stage renal disease (ESRD)_entity\\', {}), (\\'AVD250_entity\\', {}), (\\'Children\u2019s Oncology Group (COG)_entity\\', {}), (\\'blastemal-type Wilms tumour_entity\\', {}), (\\'SIOP\u22122001_entity\\', {}), (\\'radiotherapy_entity\\', {}), (\\'childhood renal tumours_entity\\', {})], \\'edges\\': [(\\'vincristine_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'stage II_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'indicated_for_in_adults\\'}), (\\'Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'Wilms tumours_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated under\\'}), (\\'Relapsed Wilms Tumor_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guided_by\\'}), (\\'Davila Fajardo et al._entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed\\'}), (\\'SIOP\u22122001 randomized trial_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated use in\\'}), (\\'surgery_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'non-Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'actinomycin D_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Synchronous bilateral Wilms tumor_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'instance_of\\'}), (\\'CT-only nodules_entity\\', \\'increased relapse risk_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'reduced survival_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included_in\\'}), (\\'relapsed group CC_entity\\', \\'diffuse anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'blastemal-type tumors_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UKW3 trial_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'UKW3 trial_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'chemotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UMBRELLA protocol_entity\\', \\'COG AREN0533 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses_data_from\\'}), (\\'UMBRELLA protocol_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'advises_treatment_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'Innovative Therapies for Children with Cancer consortium_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborates_with\\'}), (\\'UMBRELLA protocol_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'surgery_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is the standard of\\'}), (\\'UMBRELLA protocol_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guides treatment in\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', \\'UKW3 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\\'minimally invasive surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'anaplasia_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'radical tumor nephrectomy_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'standard_of_care_for\\'}), (\\'Stage IV_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'presents in\\'}), (\\'CDCV_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'VP16_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'aims to improve survival rates of\\'}), (\\'AVD150_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed_by\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'succeeds\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'www.siop-rtsg.eu_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'available_on\\'}), (\\'laparoscopic surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'COG AREN0533 trial_entity\\', \\'cumulative doxorubicin dose_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'evaluates\\'}), (\\'UKW\u2011R protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'Nephron-sparing surgery (NSS)_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'classification_developed_by\\'}), (\\'Adult Wilms Tumors_entity\\', \\'anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'Adult Wilms Tumors_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'doxorubicin_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'doxorubicin_entity\\', \\'large-volume tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'recommended for\\'}), (\\'NWTS\u20115 relapse protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'End-stage renal disease (ESRD)_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'AVD250_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'Children\u2019s Oncology Group (COG)_entity\\', \\'SIOP\u22122001 randomized trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborated with\\'}), (\\'blastemal-type Wilms tumour_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment intensified according to\\'}), (\\'SIOP\u22122001_entity\\', \\'vincristine, actinomycin D, and doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses\\'}), (\\'SIOP\u22122001_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provided_guidelines_for\\'}), (\\'radiotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'radiotherapy_entity\\', \\'SIOP\u2212RTSG panel_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'contact_for_guidance\\'})]}, {\\'nodes\\': [(\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {}), (\\'Marry M. van den Heuvel-Eibrink_entity\\', {})], \\'edges\\': [(\\'Marry M. van den Heuvel-Eibrink_entity\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'affiliated_with\\'})]}, {\\'nodes\\': [(\\'Stage II_entity\\', {}), (\\'AV_entity\\', {}), (\\'Stage III_entity\\', {}), (\\'vincestine and actinomycin D_entity\\', {}), (\\'AVD_entity\\', {})], \\'edges\\': [(\\'Stage II_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AV_entity\\', \\'Stage II_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Stage III_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AVD_entity\\', \\'Stage III_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'SIOP-RTSG 2016_entity\\', {}), (\\'RCC_entity\\', {}), (\\'CMN_entity\\', {})], \\'edges\\': [(\\'RCC_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'}), (\\'CMN_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'})]}, {\\'nodes\\': [(\\'HR-1_entity\\', {}), (\\'High-risk blastemal type Wilms tumour_entity\\', {})], \\'edges\\': [(\\'HR-1_entity\\', \\'High-risk blastemal type Wilms tumour_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'unfavorable prognosis_entity\\', {}), (\\'high-risk characteristics_entity\\', {})], \\'edges\\': [(\\'high-risk characteristics_entity\\', \\'unfavorable prognosis_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'leads_to\\'})]}, {\\'nodes\\': [(\\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {}), (\\'SIOP\u2013RTSG board_entity\\', {})], \\'edges\\': [(\\'SIOP\u2013RTSG board_entity\\', \\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggests\\'})]}, {\\'nodes\\': [(\\'regimen and outcomes_entity\\', {}), (\\'SIOP database_entity\\', {})], \\'edges\\': [(\\'SIOP database_entity\\', \\'regimen and outcomes_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'captures_data_on\\'})]}, {\\'nodes\\': [(\\'Bilateral nephron-sparing surgery (NSS)_entity\\', {}), (\\'Aronson et al._entity\\', {})], \\'edges\\': [(\\'Aronson et al._entity\\', \\'Bilateral nephron-sparing surgery (NSS)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'observed_effectiveness_of\\'})]}, {\\'nodes\\': [(\\'SIOP\u22122001 study_entity\\', {}), (\\'Actinomycin D_entity\\', {}), (\\'Vincristine_entity\\', {})], \\'edges\\': [(\\'SIOP\u22122001 study_entity\\', \\'Vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'}), (\\'SIOP\u22122001 study_entity\\', \\'Actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'})]}, {\\'nodes\\': [(\\'High-dose melphalan_entity\\', {}), (\\'Group AA_entity\\', {}), (\\'Carboplatin_entity\\', {}), (\\'Doxorubicin_entity\\', {}), (\\'Etoposide_entity\\', {}), (\\'Group BB_entity\\', {}), (\\'Cyclophosphamide_entity\\', {}), (\\'Ifosfamide_entity\\', {})], \\'edges\\': [(\\'Group AA_entity\\', \\'Doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Ifosfamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'High-dose melphalan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'})]}, {\\'nodes\\': [(\\'nephrotoxicity_entity\\', {}), (\\'ifosfamide_entity\\', {})], \\'edges\\': [(\\'ifosfamide_entity\\', \\'nephrotoxicity_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'related_to\\'})]}, {\\'nodes\\': [(\\'camptothecins_entity\\', {}), (\\'irinotecan_entity\\', {}), (\\'topotecan_entity\\', {})], \\'edges\\': [(\\'camptothecins_entity\\', \\'irinotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'camptothecins_entity\\', \\'topotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'})]}, {\\'nodes\\': [(\\'Infant Wilms Tumors_entity\\', {}), (\\'nephrectomy_entity\\', {})], \\'edges\\': [(\\'Infant Wilms Tumors_entity\\', \\'nephrectomy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_option\\'})]}, {\\'nodes\\': [(\\'congenital mesoblastic nephroma_entity\\', {}), (\\'surgery alone_entity\\', {})], \\'edges\\': [(\\'congenital mesoblastic nephroma_entity\\', \\'surgery alone_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'alternative chemotherapy_entity\\', {}), (\\'malignant rhabdoid tumors_entity\\', {})], \\'edges\\': [(\\'malignant rhabdoid tumors_entity\\', \\'alternative chemotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'lymph node sampling_entity\\', {}), (\\'accurate staging_entity\\', {})], \\'edges\\': [(\\'lymph node sampling_entity\\', \\'accurate staging_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'purpose_of\\'})]}, {\\'nodes\\': [(\\'COG\u2013NWTS trials_entity\\', {}), (\\'whole-lung irradiation_entity\\', {})], \\'edges\\': [(\\'COG\u2013NWTS trials_entity\\', \\'whole-lung irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'informed_dosage_for\\'})]}, {\\'nodes\\': [(\\'lung metastases_entity\\', {}), (\\'pulmonary radiotherapy_entity\\', {})], \\'edges\\': [(\\'pulmonary radiotherapy_entity\\', \\'lung metastases_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'administered_for\\'})]}, {\\'nodes\\': [(\\'dosimetric study_entity\\', {}), (\\'proton therapy_entity\\', {}), (\\'flank irradiation_entity\\', {})], \\'edges\\': [(\\'dosimetric study_entity\\', \\'proton therapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated\\'}), (\\'proton therapy_entity\\', \\'flank irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggested_for\\'})]}, {\\'nodes\\': [(\\'metastatic disease_entity\\', {}), (\\'radiotherapy guidelines_entity\\', {}), (\\'locoregional disease_entity\\', {})], \\'edges\\': [(\\'radiotherapy guidelines_entity\\', \\'locoregional disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'}), (\\'radiotherapy guidelines_entity\\', \\'metastatic disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'})]}, {\\'nodes\\': [(\\'major rupture_entity\\', {}), (\\'stage III_entity\\', {})], \\'edges\\': [(\\'stage III_entity\\', \\'major rupture_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes_condition\\'})]}, {\\'nodes\\': [(\\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {}), (\\'ExPO\u2011r\u2011Net_entity\\', {})], \\'edges\\': [(\\'ExPO\u2011r\u2011Net_entity\\', \\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is part of\\'})]}, {\\'nodes\\': [(\\'University Hospital of Munich_entity\\', {}), (\\'Germany_entity\\', {}), (\\'University Hospital of Tuebingen_entity\\', {})], \\'edges\\': [(\\'Germany_entity\\', \\'University Hospital of Munich_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Germany_entity\\', \\'University Hospital of Tuebingen_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {}), (\\'Italy_entity\\', {}), (\\'Azienda Ospedaliera_entity\\', {}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {})], \\'edges\\': [(\\'Italy_entity\\', \\'Azienda Ospedaliera_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Netherlands_entity\\', {}), (\\'Prinses Maxima Centrum_entity\\', {})], \\'edges\\': [(\\'Netherlands_entity\\', \\'Prinses Maxima Centrum_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Marciniak Hospital_entity\\', {}), (\\'Poland_entity\\', {}), (\\'Faculty of Medicine_entity\\', {})], \\'edges\\': [(\\'Poland_entity\\', \\'Marciniak Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Poland_entity\\', \\'Faculty of Medicine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'St. Anna Kinderspital/CCRI_entity\\', {}), (\\'Austria_entity\\', {})], \\'edges\\': [(\\'Austria_entity\\', \\'St. Anna Kinderspital/CCRI_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'France_entity\\', {}), (\\'Armand Trousseau Hospital_entity\\', {})], \\'edges\\': [(\\'France_entity\\', \\'Armand Trousseau Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Spain_entity\\', {}), (\\'Hospital Vall d\u2019Hebron_entity\\', {}), (\\'Hospital Universitario Virgin del Rocio_entity\\', {})], \\'edges\\': [(\\'Spain_entity\\', \\'Hospital Universitario Virgin del Rocio_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Spain_entity\\', \\'Hospital Vall d\u2019Hebron_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'United Kingdom_entity\\', {}), (\\'Great Ormond Street Hospital_entity\\', {})], \\'edges\\': [(\\'United Kingdom_entity\\', \\'Great Ormond Street Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Weirich, A._entity\\', {}), (\\'SIOP-9/GPOH_entity\\', {})], \\'edges\\': [(\\'Weirich, A._entity\\', \\'SIOP-9/GPOH_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Pritchard-Jones, K._entity\\', {}), (\\'UKW3_entity\\', {})], \\'edges\\': [(\\'Pritchard-Jones, K._entity\\', \\'UKW3_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed in\\'})]}, {\\'nodes\\': [(\\'SIOP 93\u201301 trial_entity\\', {}), (\\'de Kraker, J._entity\\', {})], \\'edges\\': [(\\'de Kraker, J._entity\\', \\'SIOP 93\u201301 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'SIOP trial and study 93\u201301_entity\\', {}), (\\'Graf, N._entity\\', {})], \\'edges\\': [(\\'Graf, N._entity\\', \\'SIOP trial and study 93\u201301_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Green, D. M._entity\\', {}), (\\'National Wilms Tumor Study Group_entity\\', {})], \\'edges\\': [(\\'Green, D. M._entity\\', \\'National Wilms Tumor Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}, {\\'nodes\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', {}), (\\'SIOP WT 2001 protocol_entity\\', {})], \\'edges\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', \\'SIOP WT 2001 protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Third National Wilms\u2019 Tumor Study_entity\\', {}), (\"D\\'Angio, G. J._entity\", {}), (\\'Second National Wilms\u2019 Tumor Study_entity\\', {})], \\'edges\\': [(\"D\\'Angio, G. J._entity\", \\'Third National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\"D\\'Angio, G. J._entity\", \\'Second National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {}), (\\'Tournade, M. F._entity\\', {}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {})], \\'edges\\': [(\\'Tournade, M. F._entity\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'}), (\\'Tournade, M. F._entity\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Breslow, N. E._entity\\', {}), (\\'National Wilms Tumor Studies_entity\\', {})], \\'edges\\': [(\\'Breslow, N. E._entity\\', \\'National Wilms Tumor Studies_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Mitchell, C._entity\\', {}), (\\'UK Children\u2019s Cancer Study Group_entity\\', {})], \\'edges\\': [(\\'Mitchell, C._entity\\', \\'UK Children\u2019s Cancer Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'under\\'})]}, {\\'nodes\\': [(\\'Daw, N. C._entity\\', {}), (\\'Dix, D. B._entity\\', {}), (\\'Children\u2019s Oncology Group_entity\\', {}), (\\'Grundy, P. E._entity\\', {})], \\'edges\\': [(\\'Daw, N. C._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted under\\'}), (\\'Dix, D. B._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'}), (\\'Grundy, P. E._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}]']), TestResult(name='test_case_16', success=False, metrics_data=[MetricData(name='Answer Correctness (GEval)', threshold=0.5, success=False, score=0.16292564273757376, reason='The actual output fails to explicitly recommend direct surgery or biopsy and instead lists various entities and treatments without clearly addressing atypical cases.', strict_mode=False, evaluation_model='gpt-4o-mini', error=None, evaluation_cost=0.003297, verbose_logs='Criteria:\\nNone \\n \\nEvaluation Steps:\\n[\\n    \"Determine whether the actual output is factually correct based on the expected output.\"\\n]'), MetricData(name='Faithfulness', threshold=0.7, success=True, score=0.8846153846153846, reason=None, strict_mode=False, evaluation_model='gpt-4o-mini', error=None, evaluation_cost=0.00792945, verbose_logs='Truths (limit=None):\\n[\\n    \"The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG) is an organization.\",\\n    \"UMBRELLA SIOP-RTSG 2016 is a protocol.\",\\n    \"SIOP\u22122001 is a protocol.\",\\n    \"Wilms tumours and non-Wilms tumours are diseases.\",\\n    \"Wilms tumours are a type of childhood renal tumours.\",\\n    \"Clear cell sarcoma of the kidney is a disease.\",\\n    \"Renal cell carcinoma is a disease.\",\\n    \"Malignant rhabdoid tumour of the kidney is a disease.\",\\n    \"Congenital mesoblastic nephroma is a disease.\",\\n    \"UMBRELLA protocol is a treatment protocol.\",\\n    \"SIOP\u22122001 randomized trial is a clinical trial.\",\\n    \"Actinomycin D, vincristine, and doxorubicin are drugs.\",\\n    \"Localized disease, metastatic disease, bilateral disease, and relapsed disease are stages of disease.\",\\n    \"Blastemal-type Wilms tumours is a subtype.\",\\n    \"Radiotherapy, surgery, and chemotherapy are treatment methods.\",\\n    \"Various stages of cancer include Stage I, Stage II, Stage III, Stage IV, and Stage V.\",\\n    \"There are treatment combinations such as AV, AVD, and HR-1.\",\\n    \"Overall Survival (OS) and Event-Free Survival (EFS) are metrics.\",\\n    \"CT-only nodules refer to a medical condition associated with increased relapse risk and reduced survival.\",\\n    \"MRI and CT are diagnostic tools.\",\\n    \"Nephrotoxicity and diffuse anaplasia are medical conditions.\",\\n    \"Children\u2019s Oncology Group (COG) is another organization.\",\\n    \"Bilateral nephron-sparing surgery (NSS) and radical tumor nephrectomy are surgical procedures.\",\\n    \"Vincristine, actinomycin D, and doxorubicin are used in various treatment regimens for Wilms tumours.\",\\n    \"The UMBRELLA protocol is developed by SIOP\u2212RTSG to guide treatments for Wilms tumours.\",\\n    \"The UK Children\u2019s Cancer and Leukaemia Group (UKCCLG) is affiliated with children\\'s cancer research.\",\\n    \"High-risk characteristics are associated with unfavorable prognoses.\",\\n    \"Countries involved in the SIOP\u2013RTSG include Austria, Italy, San Marino, Iceland, Germany, and others.\",\\n    \"Multiple institutions are involved in pediatric oncology, including the Princess M\u00e1xima Center for Paediatric Oncology, University Hospital of Munich, and Great Ormond Street Hospital.\"\\n] \\n \\nClaims:\\n[\\n    \"The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG) is an organization.\",\\n    \"UMBRELLA SIOP-RTSG 2016 is a protocol.\",\\n    \"SIOP\u22122001 is a protocol.\",\\n    \"Wilms tumours and non-Wilms tumours are diseases.\",\\n    \"www.siop-rtsg.eu is a website.\",\\n    \"Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology is an institution.\",\\n    \"Marry M. van den Heuvel-Eibrink is a person.\",\\n    \"Childhood renal tumours, clear cell sarcoma of the kidney, renal cell carcinoma, malignant rhabdoid tumour of the kidney, and congenital mesoblastic nephroma are types of diseases.\",\\n    \"Wilms tumours is a condition.\",\\n    \"The UMBRELLA protocol is a treatment protocol.\",\\n    \"SIOP\u2013RTSG is an organization.\",\\n    \"Children\u2019s Oncology Group (COG) is an organization.\",\\n    \"SIOP\u22122001 randomized trial is a clinical trial.\",\\n    \"Actinomycin D, vincristine, and doxorubicin are drugs.\",\\n    \"UKW3 trial is a clinical trial.\",\\n    \"UK Children\u2019s Cancer and Leukaemia Group (UKCCLG) is an organization.\",\\n    \"Localized disease, metastatic disease, bilateral disease, and relapsed disease are stages of disease.\",\\n    \"Blastemal-type Wilms tumours is a subtype.\",\\n    \"Radiotherapy, surgery, and chemotherapy are treatment methods.\",\\n    \"Wilms Tumour, CCSK, MRTK, CMN, and RCC are diseases.\",\\n    \"SIOP\u22122001 is a trial.\",\\n    \"Stage I, Stage II, Stage III, Stage IV, and Stage V are stages.\",\\n    \"AV, AVD, and HR-1 are treatment combinations.\",\\n    \"Overall Survival (OS) and Event-Free Survival (EFS) are metrics.\",\\n    \"CT-only nodules is a medical condition.\",\\n    \"Bilateral Disease (Stage V) is a disease stage.\",\\n    \"Synchronous bilateral Wilms tumor is a disease.\",\\n    \"End-stage renal disease (ESRD) is a condition.\",\\n    \"Bilateral nephron-sparing surgery (NSS) is a treatment method.\",\\n    \"SIOP\u22122001 study is a study.\",\\n    \"Vincristine, actinomycin D, etoposide, carboplatin, cyclophosphamide are treatments in various protocols.\",\\n    \"High-dose chemotherapy and autologous stem cell transplantation is a treatment.\",\\n    \"SIOP database is a database.\",\\n    \"AVD150, AVD250, and CDCV are treatment regimens.\",\\n    \"High-risk characteristics is a medical condition.\",\\n    \"Ifosfamide, etoposide, and carboplatin are medications.\",\\n    \"Bilateral Disease (Stage V) is a characteristic of Synchronous bilateral Wilms tumor.\",\\n    \"Adult Wilms Tumors, anaplasia, malignant rhabdoid tumors, and congenital mesoblastic nephroma are medical conditions.\",\\n    \"Lymph node sampling is a surgical procedure for accurate staging.\",\\n    \"Proton therapy is a type of radiation treatment.\",\\n    \"Nephrotoxicity is a condition related to ifosfamide.\",\\n    \"SIOP-RTSG 2016 is focused on RCC and CMN.\",\\n    \"COG\u2013NWTS trials provide informed dosage for whole-lung irradiation.\",\\n    \"Pulmonary radiotherapy is administered for lung metastases.\"\\n] \\n \\nVerdicts:\\n[\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"The context does not provide information about any specific website, including www.siop-rtsg.eu.\"\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"While the context confirms the existence of Princess M\\\\u00e1xima Center for Paediatric Oncology, it does not specify anything about the Department of Paediatric Oncology.\"\\n    },\\n    {\\n        \"verdict\": \"idk\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"The claim that \\'Wilms tumours is a condition\\' is too vague; the context states that Wilms tumours are a type of childhood renal tumours, which are classified as diseases.\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"idk\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"idk\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"idk\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"idk\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"idk\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"idk\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"idk\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"idk\",\\n        \"reason\": null\\n    }\\n]'), MetricData(name='Contextual Relevancy', threshold=1.0, success=False, score=0.0, reason='The score is 0.00 because there are no relevant statements in the retrieval context addressing how the protocol handles cases of misdiagnosis, as confirmed by the reasons for irrelevancy that highlight the lack of specific mention in the context.', strict_mode=False, evaluation_model='gpt-4o-mini', error=None, evaluation_cost=0.0035303999999999995, verbose_logs='Verdicts:\\n[\\n    {\\n        \"verdicts\": [\\n            {\\n                \"statement\": \"The UMBRELLA protocol provides guidelines for handling misdiagnosis in pediatric oncology cases.\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"The retrieval context did not mention how the protocol specifically handles cases of misdiagnosis.\"\\n            },\\n            {\\n                \"statement\": \"The context references various treatment methods and protocols related to Wilms tumours.\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"While it mentions treatment methods, it does not specify handling misdiagnosis.\"\\n            },\\n            {\\n                \"statement\": \"SIOP-RTSG conducts studies on the treatment of childhood renal tumours.\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"This statement is unrelated to how to handle misdiagnosis specifically.\"\\n            },\\n            {\\n                \"statement\": \"Childhood renal tumours may lead to high-risk characterizations which impact treatment protocols.\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"The statement discusses risk characterizations but does not address handling misdiagnosis.\"\\n            }\\n        ]\\n    }\\n]')], conversational=False, multimodal=False, input='How does the protocol propose handling cases of misdiagnosis?', actual_output='[{\\'nodes\\': [(\\'sample.pdf\\', {\\'type\\': \\'document\\'}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)\\'}), (\\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA SIOP-RTSG 2016\\'}), (\\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms tumours\\'}), (\\'non-Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'non-Wilms tumours\\'}), (\\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Website\\', \\'name\\': \\'www.siop-rtsg.eu\\'}), (\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology\\'}), (\\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Person\\', \\'name\\': \\'Marry M. van den Heuvel-Eibrink\\'}), (\\'childhood renal tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'childhood renal tumours\\'}), (\\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'clear cell sarcoma of the kidney\\'}), (\\'renal cell carcinoma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'renal cell carcinoma\\'}), (\\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'malignant rhabdoid tumour of the kidney\\'}), (\\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'Wilms tumours_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'Children\u2019s Oncology Group (COG)\\'}), (\\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'SIOP\u22122001 randomized trial\\'}), (\\'actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'UKW3 trial\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)\\'}), (\\'localized disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'localized disease\\'}), (\\'metastatic disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'metastatic disease\\'}), (\\'bilateral disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'bilateral disease\\'}), (\\'relapsed disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'relapsed disease\\'}), (\\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subtype\\', \\'name\\': \\'blastemal-type Wilms tumours\\'}), (\\'radiotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgery_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'chemotherapy\\'}), (\\'Wilms Tumour_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms Tumour\\'}), (\\'CCSK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CCSK\\'}), (\\'MRTK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'MRTK\\'}), (\\'CMN_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CMN\\'}), (\\'RCC_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'RCC\\'}), (\\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u22122001_Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Trial\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'vincristine_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'vincristine\\'}), (\\'actinomycin D_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'actinomycin D\\'}), (\\'doxorubicin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'doxorubicin\\'}), (\\'etoposide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'Stage I_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage I\\'}), (\\'Stage II_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage II\\'}), (\\'Stage III_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage III\\'}), (\\'Stage IV_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage IV\\'}), (\\'Stage V_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage V\\'}), (\\'AV_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AV\\'}), (\\'AVD_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AVD\\'}), (\\'HR-1_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'HR-1\\'}), (\\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP-RTSG 2016\\'}), (\\'Overall Survival (OS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'CT-only nodules_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'CT-only nodules\\'}), (\\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP\u2013RTSG analysis\\'}), (\\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials\\'}), (\\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D plus doxorubicin\\'}), (\\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D\\'}), (\\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study_protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'MRI_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'MRI\\'}), (\\'CT_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'CT\\'}), (\\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_detail\\', \\'name\\': \\'cumulative doxorubicin dose\\'}), (\\'COG AREN0533 trial_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG AREN0533 trial\\'}), (\\'etoposide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'high-risk characteristics\\'}), (\\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG board\\'}), (\\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin\\'}), (\\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'high-dose chemotherapy and autologous stem cell transplantation\\'}), (\\'SIOP database_database\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'database\\', \\'name\\': \\'SIOP database\\'}), (\\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'AVD_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AVD\\'}), (\\'AV-2_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AV-2\\'}), (\\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Statistical Test\\', \\'name\\': \\'Log\u2013Rank P\\'}), (\\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'Bilateral Disease (Stage V)\\'}), (\\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Synchronous bilateral Wilms tumor\\'}), (\\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'End-stage renal disease (ESRD)\\'}), (\\'Aronson et al._Research Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Research Group\\', \\'name\\': \\'Aronson et al.\\'}), (\\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'Bilateral nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Study\\', \\'name\\': \\'SIOP\u22122001 study\\'}), (\\'Vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Vincristine\\'}), (\\'Actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Actinomycin D\\'}), (\\'Etoposide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Etoposide\\'}), (\\'Carboplatin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Carboplatin\\'}), (\\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease State\\', \\'name\\': \\'Relapsed Wilms Tumor\\'}), (\\'Group AA_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group AA\\'}), (\\'Group BB_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group BB\\'}), (\\'Group CC_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group CC\\'}), (\\'Doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Doxorubicin\\'}), (\\'Cyclophosphamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Cyclophosphamide\\'}), (\\'Ifosfamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Ifosfamide\\'}), (\\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'High-dose melphalan\\'}), (\\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UKW\u2011R protocol\\'}), (\\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'NWTS\u20115 relapse protocol\\'}), (\\'ASCR_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'procedure\\', \\'name\\': \\'ASCR\\'}), (\\'ifosfamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'ifosfamide\\'}), (\\'nephrotoxicity_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'nephrotoxicity\\'}), (\\'relapsed group CC_patient_group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'patient_group\\', \\'name\\': \\'relapsed group CC\\'}), (\\'diffuse anaplasia_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'diffuse anaplasia\\'}), (\\'blastemal-type tumors_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'blastemal-type tumors\\'}), (\\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'camptothecins_medication_class\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication_class\\', \\'name\\': \\'camptothecins\\'}), (\\'irinotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'irinotecan\\'}), (\\'topotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'topotecan\\'}), (\\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Innovative Therapies for Children with Cancer consortium\\'}), (\\'radiotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgical excision_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgical excision\\'}), (\\'stage IV WT_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'stage IV WT\\'}), (\\'AVD150_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD150\\'}), (\\'AVD250_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD250\\'}), (\\'low-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'low-risk disease\\'}), (\\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'intermediate-risk disease\\'}), (\\'high-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'high-risk disease\\'}), (\\'CDCV_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'CDCV\\'}), (\\'actinomycin-D_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'actinomycin-D\\'}), (\\'vincristine_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'doxorubicin\\'}), (\\'VP16_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'VP16\\'}), (\\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'contact\\', \\'name\\': \\'arnauld.verschuur@ap-hm.fr\\'}), (\\'surgery_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'chemotherapy\\'}), (\\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2212RTSG panel\\'}), (\\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Infant Wilms Tumors\\'}), (\\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'nephrectomy\\'}), (\\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'malignant rhabdoid tumors\\'}), (\\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Adult Wilms Tumors\\'}), (\\'anaplasia_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'anaplasia\\'}), (\\'actinomycin D_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'carboplatin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'etoposide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'etoposide\\'}), (\\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'Nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'radical tumor nephrectomy\\'}), (\\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'lymph node sampling\\'}), (\\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'minimally invasive surgery\\'}), (\\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'laparoscopic surgery\\'}), (\\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'radiotherapy\\'}), (\\'Wilms tumours_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'Davila Fajardo et al._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Davila Fajardo et al.\\'}), (\\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'COG\u2013NWTS trials\\'}), (\\'whole-lung irradiation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'whole-lung irradiation\\'}), (\\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'pulmonary radiotherapy\\'}), (\\'proton therapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'proton therapy\\'}), (\\'dosimetric study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'dosimetric study\\'}), (\\'locoregional disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'locoregional disease\\'}), (\\'metastatic disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'metastatic disease\\'}), (\\'low-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'low-risk\\'}), (\\'intermediate-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'intermediate-risk\\'}), (\\'high-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'high-risk\\'}), (\\'stage I_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage I\\'}), (\\'stage II_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage II\\'}), (\\'stage III_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage III\\'}), (\\'major rupture_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'major rupture\\'}), (\\'Austria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Austria\\'}), (\\'Italy_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Italy\\'}), (\\'San Marino_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'San Marino\\'}), (\\'Iceland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Iceland\\'}), (\\'Germany_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Germany\\'}), (\\'Bulgaria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bulgaria\\'}), (\\'Turkey_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Turkey\\'}), (\\'Denmark_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Denmark\\'}), (\\'Poland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Poland\\'}), (\\'Greece_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Greece\\'}), (\\'Andorra_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Andorra\\'}), (\\'Belgium_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belgium\\'}), (\\'Serbia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Serbia\\'}), (\\'Albania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Albania\\'}), (\\'Moldova_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Moldova\\'}), (\\'Lithuania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Lithuania\\'}), (\\'Latvia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Latvia\\'}), (\\'Estonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Estonia\\'}), (\\'Luxembourg_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Luxembourg\\'}), (\\'Montenegro_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Montenegro\\'}), (\\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bosnia and Herzegovina\\'}), (\\'Croatia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Croatia\\'}), (\\'Slovenia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovenia\\'}), (\\'Macedonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Macedonia\\'}), (\\'United Kingdom_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'United Kingdom\\'}), (\\'Ireland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ireland\\'}), (\\'Spain_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Spain\\'}), (\\'Algeria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Algeria\\'}), (\\'Tunisia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Tunisia\\'}), (\\'Malta_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Malta\\'}), (\\'Morocco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Morocco\\'}), (\\'Portugal_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Portugal\\'}), (\\'France_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'France\\'}), (\\'Monaco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Monaco\\'}), (\\'Russia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Russia\\'}), (\\'Finland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Finland\\'}), (\\'Sweden_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Sweden\\'}), (\\'Norway_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Norway\\'}), (\\'Belarus_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belarus\\'}), (\\'Romania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Romania\\'}), (\\'Ukraine_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ukraine\\'}), (\\'Hungary_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Hungary\\'}), (\\'Czech Republic_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Czech Republic\\'}), (\\'Slovakia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovakia\\'}), (\\'Switzerland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Switzerland\\'}), (\\'Liechtenstein_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Liechtenstein\\'}), (\\'Netherlands_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Netherlands\\'}), (\\'University Hospital of Munich_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Munich\\'}), (\\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Tuebingen\\'}), (\\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Azienda Ospedaliera\\'}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Ospedale Pediatrico Bambino Ges\u00f9\\'}), (\\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Fondazione IRCCS Istituto Nazionale dei Tumori\\'}), (\\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Prinses Maxima Centrum\\'}), (\\'Marciniak Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Marciniak Hospital\\'}), (\\'Faculty of Medicine_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Faculty of Medicine\\'}), (\\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'St. Anna Kinderspital/CCRI\\'}), (\\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Armand Trousseau Hospital\\'}), (\\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Universitario Virgin del Rocio\\'}), (\\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Vall d\u2019Hebron\\'}), (\\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Great Ormond Street Hospital\\'}), (\\'University Hospital Homburg_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital Homburg\\'}), (\\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon\\'}), (\\'UMBRELLA protocol_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'ExPO\u2011r\u2011Net\\'}), (\\'Weirich, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Weirich, A.\\'}), (\\'Pritchard-Jones, K._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Pritchard-Jones, K.\\'}), (\\'de Kraker, J._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'de Kraker, J.\\'}), (\\'Graf, N._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Graf, N.\\'}), (\\'Green, D. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Green, D. M.\\'}), (\\'Spreafico, F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Spreafico, F.\\'}), (\\'Bellani, F. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Bellani, F. F.\\'}), (\\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'van den Heuvel-Eibrink, M. M.\\'}), (\"D\\'Angio, G. J._author\", {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \"D\\'Angio, G. J.\"}), (\\'Tournade, M. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Tournade, M. F.\\'}), (\\'Breslow, N. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Breslow, N. E.\\'}), (\\'Mitchell, C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Mitchell, C.\\'}), (\\'Verschuur, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Verschuur, A.\\'}), (\\'Grundy, P. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Grundy, P. E.\\'}), (\\'Warmann, S. W._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Warmann, S. W.\\'}), (\\'Smets, A. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Smets, A. M.\\'}), (\\'Dome, J. S._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dome, J. S.\\'}), (\\'Dix, D. B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dix, D. B.\\'}), (\\'Daw, N. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Daw, N. C.\\'}), (\\'Ha, T. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Ha, T. C.\\'}), (\\'Kremens, B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Kremens, B.\\'}), (\\'Furtwangler, R._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Furtwangler, R.\\'}), (\\'SIOP-9/GPOH_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP-9/GPOH\\'}), (\\'UKW3_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'UKW3\\'}), (\\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'SIOP 93\u201301 trial\\'}), (\\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP trial and study 93\u201301\\'}), (\\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'National Wilms Tumor Study Group\\'}), (\\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP WT 2001 protocol\\'}), (\\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Third National Wilms\u2019 Tumor Study\\'}), (\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'National Wilms Tumor Studies\\'}), (\\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Second National Wilms\u2019 Tumor Study\\'}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'UK Children\u2019s Cancer Study Group\\'}), (\\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Children\u2019s Oncology Group\\'})], \\'edges\\': [(\\'sample.pdf\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'non-Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'childhood renal tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'renal cell carcinoma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'localized disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'metastatic disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'bilateral disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'relapsed disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'radiotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'surgery_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'chemotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'Wilms Tumour_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CCSK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'MRTK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CMN_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'RCC_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP\u22122001_Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'vincristine_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'actinomycin D_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'doxorubicin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'etoposide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'carboplatin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'cyclophosphamide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage I_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage II_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage III_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage IV_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage V_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AV_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AVD_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'HR-1_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Overall Survival (OS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT-only nodules_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'MRI_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG AREN0533 trial_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'etoposide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'carboplatin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'cyclophosphamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP database_database\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AVD_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AV-2_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Aronson et al._Research Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Etoposide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Carboplatin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group AA_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group BB_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group CC_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Cyclophosphamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Ifosfamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'ASCR_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'ifosfamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'nephrotoxicity_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'relapsed group CC_patient_group\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'diffuse anaplasia_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'blastemal-type tumors_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'camptothecins_medication_class\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'irinotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'topotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'radiotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'surgical excision_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'stage IV WT_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD150_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD250_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'low-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'CDCV_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'actinomycin-D_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'vincristine_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'doxorubicin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'VP16_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'surgery_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'chemotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'anaplasia_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'actinomycin D_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'vincristine_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'doxorubicin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'carboplatin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'cyclophosphamide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'etoposide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'SIOP\u22122001_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Wilms tumours_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Davila Fajardo et al._author\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'whole-lung irradiation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'proton therapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'dosimetric study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'locoregional disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'metastatic disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'low-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'intermediate-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'high-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage I_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage II_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage III_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'major rupture_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Austria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Italy_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'San Marino_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Iceland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Germany_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bulgaria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Turkey_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Denmark_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Poland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Greece_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Andorra_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belgium_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Serbia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Albania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Moldova_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Lithuania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Latvia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Estonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Luxembourg_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Montenegro_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Croatia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovenia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Macedonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'United Kingdom_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ireland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Spain_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Algeria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Tunisia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Malta_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Morocco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Portugal_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'France_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Monaco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Russia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Finland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Sweden_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Norway_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belarus_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Romania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ukraine_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hungary_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Czech Republic_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovakia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Switzerland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Liechtenstein_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Netherlands_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Munich_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Marciniak Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Faculty of Medicine_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital Homburg_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Weirich, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Pritchard-Jones, K._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'de Kraker, J._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Graf, N._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Green, D. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Spreafico, F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Bellani, F. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \"D\\'Angio, G. J._author\", {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Tournade, M. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Breslow, N. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Mitchell, C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Verschuur, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Grundy, P. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Warmann, S. W._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Smets, A. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dome, J. S._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dix, D. B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Daw, N. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ha, T. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Kremens, B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Furtwangler, R._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP-9/GPOH_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UKW3_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10})]}, {\\'nodes\\': [(\\'vincristine_entity\\', {}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {}), (\\'www.siop-rtsg.eu_entity\\', {}), (\\'stage II_entity\\', {}), (\\'Wilms tumours_entity\\', {}), (\\'Relapsed Wilms Tumor_entity\\', {}), (\\'Davila Fajardo et al._entity\\', {}), (\\'vincristine, actinomycin D, and doxorubicin_entity\\', {}), (\\'SIOP\u22122001 randomized trial_entity\\', {}), (\\'surgery_entity\\', {}), (\\'non-Wilms tumours_entity\\', {}), (\\'actinomycin D_entity\\', {}), (\\'diffuse anaplasia_entity\\', {}), (\\'Synchronous bilateral Wilms tumor_entity\\', {}), (\\'CT-only nodules_entity\\', {}), (\\'relapsed group CC_entity\\', {}), (\\'increased relapse risk_entity\\', {}), (\\'reduced survival_entity\\', {}), (\\'UKW3 trial_entity\\', {}), (\\'chemotherapy_entity\\', {}), (\\'Bilateral Disease (Stage V)_entity\\', {}), (\\'blastemal-type tumors_entity\\', {}), (\\'UMBRELLA protocol_entity\\', {}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', {}), (\\'minimally invasive surgery_entity\\', {}), (\\'VP16_entity\\', {}), (\\'Wilms tumor_entity\\', {}), (\\'anaplasia_entity\\', {}), (\\'radical tumor nephrectomy_entity\\', {}), (\\'Innovative Therapies for Children with Cancer consortium_entity\\', {}), (\\'cumulative doxorubicin dose_entity\\', {}), (\\'etoposide_entity\\', {}), (\\'large-volume tumours_entity\\', {}), (\\'Stage IV_entity\\', {}), (\\'CDCV_entity\\', {}), (\\'SIOP\u2013RTSG_entity\\', {}), (\\'AVD150_entity\\', {}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', {}), (\\'laparoscopic surgery_entity\\', {}), (\\'SIOP\u2212RTSG panel_entity\\', {}), (\\'actinomycin-D_entity\\', {}), (\\'COG AREN0533 trial_entity\\', {}), (\\'cyclophosphamide_entity\\', {}), (\\'carboplatin_entity\\', {}), (\\'UKW\u2011R protocol_entity\\', {}), (\\'Nephron-sparing surgery (NSS)_entity\\', {}), (\\'Adult Wilms Tumors_entity\\', {}), (\\'doxorubicin_entity\\', {}), (\\'NWTS\u20115 relapse protocol_entity\\', {}), (\\'End-stage renal disease (ESRD)_entity\\', {}), (\\'AVD250_entity\\', {}), (\\'Children\u2019s Oncology Group (COG)_entity\\', {}), (\\'blastemal-type Wilms tumour_entity\\', {}), (\\'SIOP\u22122001_entity\\', {}), (\\'radiotherapy_entity\\', {}), (\\'childhood renal tumours_entity\\', {})], \\'edges\\': [(\\'vincristine_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'stage II_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'indicated_for_in_adults\\'}), (\\'Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'Wilms tumours_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated under\\'}), (\\'Relapsed Wilms Tumor_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guided_by\\'}), (\\'Davila Fajardo et al._entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed\\'}), (\\'SIOP\u22122001 randomized trial_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated use in\\'}), (\\'surgery_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'non-Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'actinomycin D_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Synchronous bilateral Wilms tumor_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'instance_of\\'}), (\\'CT-only nodules_entity\\', \\'increased relapse risk_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'reduced survival_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included_in\\'}), (\\'relapsed group CC_entity\\', \\'diffuse anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'blastemal-type tumors_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UKW3 trial_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'UKW3 trial_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'chemotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UMBRELLA protocol_entity\\', \\'COG AREN0533 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses_data_from\\'}), (\\'UMBRELLA protocol_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'advises_treatment_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'Innovative Therapies for Children with Cancer consortium_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborates_with\\'}), (\\'UMBRELLA protocol_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'surgery_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is the standard of\\'}), (\\'UMBRELLA protocol_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guides treatment in\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', \\'UKW3 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\\'minimally invasive surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'anaplasia_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'radical tumor nephrectomy_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'standard_of_care_for\\'}), (\\'Stage IV_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'presents in\\'}), (\\'CDCV_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'VP16_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'aims to improve survival rates of\\'}), (\\'AVD150_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed_by\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'succeeds\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'www.siop-rtsg.eu_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'available_on\\'}), (\\'laparoscopic surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'COG AREN0533 trial_entity\\', \\'cumulative doxorubicin dose_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'evaluates\\'}), (\\'UKW\u2011R protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'Nephron-sparing surgery (NSS)_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'classification_developed_by\\'}), (\\'Adult Wilms Tumors_entity\\', \\'anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'Adult Wilms Tumors_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'doxorubicin_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'doxorubicin_entity\\', \\'large-volume tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'recommended for\\'}), (\\'NWTS\u20115 relapse protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'End-stage renal disease (ESRD)_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'AVD250_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'Children\u2019s Oncology Group (COG)_entity\\', \\'SIOP\u22122001 randomized trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborated with\\'}), (\\'blastemal-type Wilms tumour_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment intensified according to\\'}), (\\'SIOP\u22122001_entity\\', \\'vincristine, actinomycin D, and doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses\\'}), (\\'SIOP\u22122001_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provided_guidelines_for\\'}), (\\'radiotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'radiotherapy_entity\\', \\'SIOP\u2212RTSG panel_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'contact_for_guidance\\'})]}, {\\'nodes\\': [(\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {}), (\\'Marry M. van den Heuvel-Eibrink_entity\\', {})], \\'edges\\': [(\\'Marry M. van den Heuvel-Eibrink_entity\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'affiliated_with\\'})]}, {\\'nodes\\': [(\\'Stage II_entity\\', {}), (\\'AV_entity\\', {}), (\\'Stage III_entity\\', {}), (\\'vincestine and actinomycin D_entity\\', {}), (\\'AVD_entity\\', {})], \\'edges\\': [(\\'Stage II_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AV_entity\\', \\'Stage II_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Stage III_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AVD_entity\\', \\'Stage III_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'SIOP-RTSG 2016_entity\\', {}), (\\'RCC_entity\\', {}), (\\'CMN_entity\\', {})], \\'edges\\': [(\\'RCC_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'}), (\\'CMN_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'})]}, {\\'nodes\\': [(\\'HR-1_entity\\', {}), (\\'High-risk blastemal type Wilms tumour_entity\\', {})], \\'edges\\': [(\\'HR-1_entity\\', \\'High-risk blastemal type Wilms tumour_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'unfavorable prognosis_entity\\', {}), (\\'high-risk characteristics_entity\\', {})], \\'edges\\': [(\\'high-risk characteristics_entity\\', \\'unfavorable prognosis_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'leads_to\\'})]}, {\\'nodes\\': [(\\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {}), (\\'SIOP\u2013RTSG board_entity\\', {})], \\'edges\\': [(\\'SIOP\u2013RTSG board_entity\\', \\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggests\\'})]}, {\\'nodes\\': [(\\'regimen and outcomes_entity\\', {}), (\\'SIOP database_entity\\', {})], \\'edges\\': [(\\'SIOP database_entity\\', \\'regimen and outcomes_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'captures_data_on\\'})]}, {\\'nodes\\': [(\\'Bilateral nephron-sparing surgery (NSS)_entity\\', {}), (\\'Aronson et al._entity\\', {})], \\'edges\\': [(\\'Aronson et al._entity\\', \\'Bilateral nephron-sparing surgery (NSS)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'observed_effectiveness_of\\'})]}, {\\'nodes\\': [(\\'SIOP\u22122001 study_entity\\', {}), (\\'Actinomycin D_entity\\', {}), (\\'Vincristine_entity\\', {})], \\'edges\\': [(\\'SIOP\u22122001 study_entity\\', \\'Vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'}), (\\'SIOP\u22122001 study_entity\\', \\'Actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'})]}, {\\'nodes\\': [(\\'High-dose melphalan_entity\\', {}), (\\'Group AA_entity\\', {}), (\\'Carboplatin_entity\\', {}), (\\'Doxorubicin_entity\\', {}), (\\'Etoposide_entity\\', {}), (\\'Group BB_entity\\', {}), (\\'Cyclophosphamide_entity\\', {}), (\\'Ifosfamide_entity\\', {})], \\'edges\\': [(\\'Group AA_entity\\', \\'Doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Ifosfamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'High-dose melphalan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'})]}, {\\'nodes\\': [(\\'nephrotoxicity_entity\\', {}), (\\'ifosfamide_entity\\', {})], \\'edges\\': [(\\'ifosfamide_entity\\', \\'nephrotoxicity_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'related_to\\'})]}, {\\'nodes\\': [(\\'camptothecins_entity\\', {}), (\\'irinotecan_entity\\', {}), (\\'topotecan_entity\\', {})], \\'edges\\': [(\\'camptothecins_entity\\', \\'irinotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'camptothecins_entity\\', \\'topotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'})]}, {\\'nodes\\': [(\\'Infant Wilms Tumors_entity\\', {}), (\\'nephrectomy_entity\\', {})], \\'edges\\': [(\\'Infant Wilms Tumors_entity\\', \\'nephrectomy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_option\\'})]}, {\\'nodes\\': [(\\'congenital mesoblastic nephroma_entity\\', {}), (\\'surgery alone_entity\\', {})], \\'edges\\': [(\\'congenital mesoblastic nephroma_entity\\', \\'surgery alone_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'alternative chemotherapy_entity\\', {}), (\\'malignant rhabdoid tumors_entity\\', {})], \\'edges\\': [(\\'malignant rhabdoid tumors_entity\\', \\'alternative chemotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'lymph node sampling_entity\\', {}), (\\'accurate staging_entity\\', {})], \\'edges\\': [(\\'lymph node sampling_entity\\', \\'accurate staging_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'purpose_of\\'})]}, {\\'nodes\\': [(\\'COG\u2013NWTS trials_entity\\', {}), (\\'whole-lung irradiation_entity\\', {})], \\'edges\\': [(\\'COG\u2013NWTS trials_entity\\', \\'whole-lung irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'informed_dosage_for\\'})]}, {\\'nodes\\': [(\\'lung metastases_entity\\', {}), (\\'pulmonary radiotherapy_entity\\', {})], \\'edges\\': [(\\'pulmonary radiotherapy_entity\\', \\'lung metastases_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'administered_for\\'})]}, {\\'nodes\\': [(\\'dosimetric study_entity\\', {}), (\\'proton therapy_entity\\', {}), (\\'flank irradiation_entity\\', {})], \\'edges\\': [(\\'dosimetric study_entity\\', \\'proton therapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated\\'}), (\\'proton therapy_entity\\', \\'flank irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggested_for\\'})]}, {\\'nodes\\': [(\\'metastatic disease_entity\\', {}), (\\'radiotherapy guidelines_entity\\', {}), (\\'locoregional disease_entity\\', {})], \\'edges\\': [(\\'radiotherapy guidelines_entity\\', \\'locoregional disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'}), (\\'radiotherapy guidelines_entity\\', \\'metastatic disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'})]}, {\\'nodes\\': [(\\'major rupture_entity\\', {}), (\\'stage III_entity\\', {})], \\'edges\\': [(\\'stage III_entity\\', \\'major rupture_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes_condition\\'})]}, {\\'nodes\\': [(\\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {}), (\\'ExPO\u2011r\u2011Net_entity\\', {})], \\'edges\\': [(\\'ExPO\u2011r\u2011Net_entity\\', \\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is part of\\'})]}, {\\'nodes\\': [(\\'University Hospital of Munich_entity\\', {}), (\\'Germany_entity\\', {}), (\\'University Hospital of Tuebingen_entity\\', {})], \\'edges\\': [(\\'Germany_entity\\', \\'University Hospital of Munich_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Germany_entity\\', \\'University Hospital of Tuebingen_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {}), (\\'Italy_entity\\', {}), (\\'Azienda Ospedaliera_entity\\', {}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {})], \\'edges\\': [(\\'Italy_entity\\', \\'Azienda Ospedaliera_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Netherlands_entity\\', {}), (\\'Prinses Maxima Centrum_entity\\', {})], \\'edges\\': [(\\'Netherlands_entity\\', \\'Prinses Maxima Centrum_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Marciniak Hospital_entity\\', {}), (\\'Poland_entity\\', {}), (\\'Faculty of Medicine_entity\\', {})], \\'edges\\': [(\\'Poland_entity\\', \\'Marciniak Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Poland_entity\\', \\'Faculty of Medicine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'St. Anna Kinderspital/CCRI_entity\\', {}), (\\'Austria_entity\\', {})], \\'edges\\': [(\\'Austria_entity\\', \\'St. Anna Kinderspital/CCRI_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'France_entity\\', {}), (\\'Armand Trousseau Hospital_entity\\', {})], \\'edges\\': [(\\'France_entity\\', \\'Armand Trousseau Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Spain_entity\\', {}), (\\'Hospital Vall d\u2019Hebron_entity\\', {}), (\\'Hospital Universitario Virgin del Rocio_entity\\', {})], \\'edges\\': [(\\'Spain_entity\\', \\'Hospital Universitario Virgin del Rocio_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Spain_entity\\', \\'Hospital Vall d\u2019Hebron_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'United Kingdom_entity\\', {}), (\\'Great Ormond Street Hospital_entity\\', {})], \\'edges\\': [(\\'United Kingdom_entity\\', \\'Great Ormond Street Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Weirich, A._entity\\', {}), (\\'SIOP-9/GPOH_entity\\', {})], \\'edges\\': [(\\'Weirich, A._entity\\', \\'SIOP-9/GPOH_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Pritchard-Jones, K._entity\\', {}), (\\'UKW3_entity\\', {})], \\'edges\\': [(\\'Pritchard-Jones, K._entity\\', \\'UKW3_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed in\\'})]}, {\\'nodes\\': [(\\'SIOP 93\u201301 trial_entity\\', {}), (\\'de Kraker, J._entity\\', {})], \\'edges\\': [(\\'de Kraker, J._entity\\', \\'SIOP 93\u201301 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'SIOP trial and study 93\u201301_entity\\', {}), (\\'Graf, N._entity\\', {})], \\'edges\\': [(\\'Graf, N._entity\\', \\'SIOP trial and study 93\u201301_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Green, D. M._entity\\', {}), (\\'National Wilms Tumor Study Group_entity\\', {})], \\'edges\\': [(\\'Green, D. M._entity\\', \\'National Wilms Tumor Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}, {\\'nodes\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', {}), (\\'SIOP WT 2001 protocol_entity\\', {})], \\'edges\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', \\'SIOP WT 2001 protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Third National Wilms\u2019 Tumor Study_entity\\', {}), (\"D\\'Angio, G. J._entity\", {}), (\\'Second National Wilms\u2019 Tumor Study_entity\\', {})], \\'edges\\': [(\"D\\'Angio, G. J._entity\", \\'Third National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\"D\\'Angio, G. J._entity\", \\'Second National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {}), (\\'Tournade, M. F._entity\\', {}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {})], \\'edges\\': [(\\'Tournade, M. F._entity\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'}), (\\'Tournade, M. F._entity\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Breslow, N. E._entity\\', {}), (\\'National Wilms Tumor Studies_entity\\', {})], \\'edges\\': [(\\'Breslow, N. E._entity\\', \\'National Wilms Tumor Studies_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Mitchell, C._entity\\', {}), (\\'UK Children\u2019s Cancer Study Group_entity\\', {})], \\'edges\\': [(\\'Mitchell, C._entity\\', \\'UK Children\u2019s Cancer Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'under\\'})]}, {\\'nodes\\': [(\\'Daw, N. C._entity\\', {}), (\\'Dix, D. B._entity\\', {}), (\\'Children\u2019s Oncology Group_entity\\', {}), (\\'Grundy, P. E._entity\\', {})], \\'edges\\': [(\\'Daw, N. C._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted under\\'}), (\\'Dix, D. B._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'}), (\\'Grundy, P. E._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}]', expected_output='It recommends direct surgery or biopsy in cases where imaging and clinical features are atypical to avoid treatment delays.', context=None, retrieval_context=['[{\\'nodes\\': [(\\'sample.pdf\\', {\\'type\\': \\'document\\'}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)\\'}), (\\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA SIOP-RTSG 2016\\'}), (\\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms tumours\\'}), (\\'non-Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'non-Wilms tumours\\'}), (\\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Website\\', \\'name\\': \\'www.siop-rtsg.eu\\'}), (\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology\\'}), (\\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Person\\', \\'name\\': \\'Marry M. van den Heuvel-Eibrink\\'}), (\\'childhood renal tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'childhood renal tumours\\'}), (\\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'clear cell sarcoma of the kidney\\'}), (\\'renal cell carcinoma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'renal cell carcinoma\\'}), (\\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'malignant rhabdoid tumour of the kidney\\'}), (\\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'Wilms tumours_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'Children\u2019s Oncology Group (COG)\\'}), (\\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'SIOP\u22122001 randomized trial\\'}), (\\'actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'UKW3 trial\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)\\'}), (\\'localized disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'localized disease\\'}), (\\'metastatic disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'metastatic disease\\'}), (\\'bilateral disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'bilateral disease\\'}), (\\'relapsed disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'relapsed disease\\'}), (\\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subtype\\', \\'name\\': \\'blastemal-type Wilms tumours\\'}), (\\'radiotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgery_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'chemotherapy\\'}), (\\'Wilms Tumour_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms Tumour\\'}), (\\'CCSK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CCSK\\'}), (\\'MRTK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'MRTK\\'}), (\\'CMN_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CMN\\'}), (\\'RCC_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'RCC\\'}), (\\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u22122001_Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Trial\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'vincristine_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'vincristine\\'}), (\\'actinomycin D_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'actinomycin D\\'}), (\\'doxorubicin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'doxorubicin\\'}), (\\'etoposide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'Stage I_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage I\\'}), (\\'Stage II_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage II\\'}), (\\'Stage III_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage III\\'}), (\\'Stage IV_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage IV\\'}), (\\'Stage V_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage V\\'}), (\\'AV_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AV\\'}), (\\'AVD_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AVD\\'}), (\\'HR-1_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'HR-1\\'}), (\\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP-RTSG 2016\\'}), (\\'Overall Survival (OS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'CT-only nodules_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'CT-only nodules\\'}), (\\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP\u2013RTSG analysis\\'}), (\\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials\\'}), (\\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D plus doxorubicin\\'}), (\\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D\\'}), (\\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study_protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'MRI_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'MRI\\'}), (\\'CT_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'CT\\'}), (\\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_detail\\', \\'name\\': \\'cumulative doxorubicin dose\\'}), (\\'COG AREN0533 trial_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG AREN0533 trial\\'}), (\\'etoposide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'high-risk characteristics\\'}), (\\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG board\\'}), (\\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin\\'}), (\\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'high-dose chemotherapy and autologous stem cell transplantation\\'}), (\\'SIOP database_database\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'database\\', \\'name\\': \\'SIOP database\\'}), (\\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'AVD_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AVD\\'}), (\\'AV-2_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AV-2\\'}), (\\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Statistical Test\\', \\'name\\': \\'Log\u2013Rank P\\'}), (\\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'Bilateral Disease (Stage V)\\'}), (\\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Synchronous bilateral Wilms tumor\\'}), (\\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'End-stage renal disease (ESRD)\\'}), (\\'Aronson et al._Research Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Research Group\\', \\'name\\': \\'Aronson et al.\\'}), (\\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'Bilateral nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Study\\', \\'name\\': \\'SIOP\u22122001 study\\'}), (\\'Vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Vincristine\\'}), (\\'Actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Actinomycin D\\'}), (\\'Etoposide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Etoposide\\'}), (\\'Carboplatin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Carboplatin\\'}), (\\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease State\\', \\'name\\': \\'Relapsed Wilms Tumor\\'}), (\\'Group AA_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group AA\\'}), (\\'Group BB_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group BB\\'}), (\\'Group CC_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group CC\\'}), (\\'Doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Doxorubicin\\'}), (\\'Cyclophosphamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Cyclophosphamide\\'}), (\\'Ifosfamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Ifosfamide\\'}), (\\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'High-dose melphalan\\'}), (\\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UKW\u2011R protocol\\'}), (\\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'NWTS\u20115 relapse protocol\\'}), (\\'ASCR_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'procedure\\', \\'name\\': \\'ASCR\\'}), (\\'ifosfamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'ifosfamide\\'}), (\\'nephrotoxicity_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'nephrotoxicity\\'}), (\\'relapsed group CC_patient_group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'patient_group\\', \\'name\\': \\'relapsed group CC\\'}), (\\'diffuse anaplasia_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'diffuse anaplasia\\'}), (\\'blastemal-type tumors_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'blastemal-type tumors\\'}), (\\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'camptothecins_medication_class\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication_class\\', \\'name\\': \\'camptothecins\\'}), (\\'irinotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'irinotecan\\'}), (\\'topotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'topotecan\\'}), (\\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Innovative Therapies for Children with Cancer consortium\\'}), (\\'radiotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgical excision_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgical excision\\'}), (\\'stage IV WT_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'stage IV WT\\'}), (\\'AVD150_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD150\\'}), (\\'AVD250_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD250\\'}), (\\'low-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'low-risk disease\\'}), (\\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'intermediate-risk disease\\'}), (\\'high-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'high-risk disease\\'}), (\\'CDCV_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'CDCV\\'}), (\\'actinomycin-D_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'actinomycin-D\\'}), (\\'vincristine_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'doxorubicin\\'}), (\\'VP16_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'VP16\\'}), (\\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'contact\\', \\'name\\': \\'arnauld.verschuur@ap-hm.fr\\'}), (\\'surgery_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'chemotherapy\\'}), (\\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2212RTSG panel\\'}), (\\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Infant Wilms Tumors\\'}), (\\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'nephrectomy\\'}), (\\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'malignant rhabdoid tumors\\'}), (\\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Adult Wilms Tumors\\'}), (\\'anaplasia_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'anaplasia\\'}), (\\'actinomycin D_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'carboplatin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'etoposide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'etoposide\\'}), (\\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'Nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'radical tumor nephrectomy\\'}), (\\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'lymph node sampling\\'}), (\\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'minimally invasive surgery\\'}), (\\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'laparoscopic surgery\\'}), (\\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'radiotherapy\\'}), (\\'Wilms tumours_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'Davila Fajardo et al._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Davila Fajardo et al.\\'}), (\\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'COG\u2013NWTS trials\\'}), (\\'whole-lung irradiation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'whole-lung irradiation\\'}), (\\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'pulmonary radiotherapy\\'}), (\\'proton therapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'proton therapy\\'}), (\\'dosimetric study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'dosimetric study\\'}), (\\'locoregional disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'locoregional disease\\'}), (\\'metastatic disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'metastatic disease\\'}), (\\'low-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'low-risk\\'}), (\\'intermediate-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'intermediate-risk\\'}), (\\'high-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'high-risk\\'}), (\\'stage I_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage I\\'}), (\\'stage II_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage II\\'}), (\\'stage III_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage III\\'}), (\\'major rupture_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'major rupture\\'}), (\\'Austria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Austria\\'}), (\\'Italy_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Italy\\'}), (\\'San Marino_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'San Marino\\'}), (\\'Iceland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Iceland\\'}), (\\'Germany_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Germany\\'}), (\\'Bulgaria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bulgaria\\'}), (\\'Turkey_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Turkey\\'}), (\\'Denmark_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Denmark\\'}), (\\'Poland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Poland\\'}), (\\'Greece_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Greece\\'}), (\\'Andorra_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Andorra\\'}), (\\'Belgium_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belgium\\'}), (\\'Serbia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Serbia\\'}), (\\'Albania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Albania\\'}), (\\'Moldova_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Moldova\\'}), (\\'Lithuania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Lithuania\\'}), (\\'Latvia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Latvia\\'}), (\\'Estonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Estonia\\'}), (\\'Luxembourg_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Luxembourg\\'}), (\\'Montenegro_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Montenegro\\'}), (\\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bosnia and Herzegovina\\'}), (\\'Croatia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Croatia\\'}), (\\'Slovenia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovenia\\'}), (\\'Macedonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Macedonia\\'}), (\\'United Kingdom_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'United Kingdom\\'}), (\\'Ireland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ireland\\'}), (\\'Spain_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Spain\\'}), (\\'Algeria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Algeria\\'}), (\\'Tunisia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Tunisia\\'}), (\\'Malta_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Malta\\'}), (\\'Morocco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Morocco\\'}), (\\'Portugal_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Portugal\\'}), (\\'France_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'France\\'}), (\\'Monaco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Monaco\\'}), (\\'Russia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Russia\\'}), (\\'Finland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Finland\\'}), (\\'Sweden_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Sweden\\'}), (\\'Norway_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Norway\\'}), (\\'Belarus_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belarus\\'}), (\\'Romania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Romania\\'}), (\\'Ukraine_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ukraine\\'}), (\\'Hungary_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Hungary\\'}), (\\'Czech Republic_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Czech Republic\\'}), (\\'Slovakia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovakia\\'}), (\\'Switzerland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Switzerland\\'}), (\\'Liechtenstein_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Liechtenstein\\'}), (\\'Netherlands_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Netherlands\\'}), (\\'University Hospital of Munich_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Munich\\'}), (\\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Tuebingen\\'}), (\\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Azienda Ospedaliera\\'}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Ospedale Pediatrico Bambino Ges\u00f9\\'}), (\\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Fondazione IRCCS Istituto Nazionale dei Tumori\\'}), (\\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Prinses Maxima Centrum\\'}), (\\'Marciniak Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Marciniak Hospital\\'}), (\\'Faculty of Medicine_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Faculty of Medicine\\'}), (\\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'St. Anna Kinderspital/CCRI\\'}), (\\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Armand Trousseau Hospital\\'}), (\\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Universitario Virgin del Rocio\\'}), (\\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Vall d\u2019Hebron\\'}), (\\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Great Ormond Street Hospital\\'}), (\\'University Hospital Homburg_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital Homburg\\'}), (\\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon\\'}), (\\'UMBRELLA protocol_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'ExPO\u2011r\u2011Net\\'}), (\\'Weirich, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Weirich, A.\\'}), (\\'Pritchard-Jones, K._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Pritchard-Jones, K.\\'}), (\\'de Kraker, J._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'de Kraker, J.\\'}), (\\'Graf, N._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Graf, N.\\'}), (\\'Green, D. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Green, D. M.\\'}), (\\'Spreafico, F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Spreafico, F.\\'}), (\\'Bellani, F. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Bellani, F. F.\\'}), (\\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'van den Heuvel-Eibrink, M. M.\\'}), (\"D\\'Angio, G. J._author\", {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \"D\\'Angio, G. J.\"}), (\\'Tournade, M. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Tournade, M. F.\\'}), (\\'Breslow, N. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Breslow, N. E.\\'}), (\\'Mitchell, C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Mitchell, C.\\'}), (\\'Verschuur, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Verschuur, A.\\'}), (\\'Grundy, P. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Grundy, P. E.\\'}), (\\'Warmann, S. W._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Warmann, S. W.\\'}), (\\'Smets, A. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Smets, A. M.\\'}), (\\'Dome, J. S._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dome, J. S.\\'}), (\\'Dix, D. B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dix, D. B.\\'}), (\\'Daw, N. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Daw, N. C.\\'}), (\\'Ha, T. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Ha, T. C.\\'}), (\\'Kremens, B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Kremens, B.\\'}), (\\'Furtwangler, R._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Furtwangler, R.\\'}), (\\'SIOP-9/GPOH_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP-9/GPOH\\'}), (\\'UKW3_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'UKW3\\'}), (\\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'SIOP 93\u201301 trial\\'}), (\\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP trial and study 93\u201301\\'}), (\\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'National Wilms Tumor Study Group\\'}), (\\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP WT 2001 protocol\\'}), (\\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Third National Wilms\u2019 Tumor Study\\'}), (\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'National Wilms Tumor Studies\\'}), (\\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Second National Wilms\u2019 Tumor Study\\'}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'UK Children\u2019s Cancer Study Group\\'}), (\\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Children\u2019s Oncology Group\\'})], \\'edges\\': [(\\'sample.pdf\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'non-Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'childhood renal tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'renal cell carcinoma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'localized disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'metastatic disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'bilateral disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'relapsed disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'radiotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'surgery_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'chemotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'Wilms Tumour_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CCSK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'MRTK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CMN_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'RCC_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP\u22122001_Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'vincristine_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'actinomycin D_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'doxorubicin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'etoposide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'carboplatin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'cyclophosphamide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage I_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage II_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage III_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage IV_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage V_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AV_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AVD_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'HR-1_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Overall Survival (OS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT-only nodules_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'MRI_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG AREN0533 trial_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'etoposide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'carboplatin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'cyclophosphamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP database_database\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AVD_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AV-2_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Aronson et al._Research Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Etoposide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Carboplatin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group AA_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group BB_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group CC_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Cyclophosphamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Ifosfamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'ASCR_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'ifosfamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'nephrotoxicity_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'relapsed group CC_patient_group\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'diffuse anaplasia_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'blastemal-type tumors_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'camptothecins_medication_class\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'irinotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'topotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'radiotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'surgical excision_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'stage IV WT_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD150_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD250_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'low-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'CDCV_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'actinomycin-D_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'vincristine_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'doxorubicin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'VP16_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'surgery_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'chemotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'anaplasia_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'actinomycin D_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'vincristine_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'doxorubicin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'carboplatin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'cyclophosphamide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'etoposide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'SIOP\u22122001_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Wilms tumours_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Davila Fajardo et al._author\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'whole-lung irradiation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'proton therapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'dosimetric study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'locoregional disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'metastatic disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'low-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'intermediate-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'high-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage I_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage II_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage III_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'major rupture_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Austria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Italy_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'San Marino_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Iceland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Germany_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bulgaria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Turkey_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Denmark_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Poland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Greece_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Andorra_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belgium_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Serbia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Albania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Moldova_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Lithuania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Latvia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Estonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Luxembourg_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Montenegro_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Croatia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovenia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Macedonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'United Kingdom_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ireland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Spain_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Algeria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Tunisia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Malta_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Morocco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Portugal_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'France_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Monaco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Russia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Finland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Sweden_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Norway_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belarus_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Romania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ukraine_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hungary_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Czech Republic_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovakia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Switzerland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Liechtenstein_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Netherlands_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Munich_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Marciniak Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Faculty of Medicine_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital Homburg_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Weirich, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Pritchard-Jones, K._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'de Kraker, J._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Graf, N._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Green, D. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Spreafico, F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Bellani, F. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \"D\\'Angio, G. J._author\", {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Tournade, M. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Breslow, N. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Mitchell, C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Verschuur, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Grundy, P. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Warmann, S. W._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Smets, A. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dome, J. S._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dix, D. B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Daw, N. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ha, T. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Kremens, B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Furtwangler, R._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP-9/GPOH_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UKW3_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10})]}, {\\'nodes\\': [(\\'vincristine_entity\\', {}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {}), (\\'www.siop-rtsg.eu_entity\\', {}), (\\'stage II_entity\\', {}), (\\'Wilms tumours_entity\\', {}), (\\'Relapsed Wilms Tumor_entity\\', {}), (\\'Davila Fajardo et al._entity\\', {}), (\\'vincristine, actinomycin D, and doxorubicin_entity\\', {}), (\\'SIOP\u22122001 randomized trial_entity\\', {}), (\\'surgery_entity\\', {}), (\\'non-Wilms tumours_entity\\', {}), (\\'actinomycin D_entity\\', {}), (\\'diffuse anaplasia_entity\\', {}), (\\'Synchronous bilateral Wilms tumor_entity\\', {}), (\\'CT-only nodules_entity\\', {}), (\\'relapsed group CC_entity\\', {}), (\\'increased relapse risk_entity\\', {}), (\\'reduced survival_entity\\', {}), (\\'UKW3 trial_entity\\', {}), (\\'chemotherapy_entity\\', {}), (\\'Bilateral Disease (Stage V)_entity\\', {}), (\\'blastemal-type tumors_entity\\', {}), (\\'UMBRELLA protocol_entity\\', {}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', {}), (\\'minimally invasive surgery_entity\\', {}), (\\'VP16_entity\\', {}), (\\'Wilms tumor_entity\\', {}), (\\'anaplasia_entity\\', {}), (\\'radical tumor nephrectomy_entity\\', {}), (\\'Innovative Therapies for Children with Cancer consortium_entity\\', {}), (\\'cumulative doxorubicin dose_entity\\', {}), (\\'etoposide_entity\\', {}), (\\'large-volume tumours_entity\\', {}), (\\'Stage IV_entity\\', {}), (\\'CDCV_entity\\', {}), (\\'SIOP\u2013RTSG_entity\\', {}), (\\'AVD150_entity\\', {}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', {}), (\\'laparoscopic surgery_entity\\', {}), (\\'SIOP\u2212RTSG panel_entity\\', {}), (\\'actinomycin-D_entity\\', {}), (\\'COG AREN0533 trial_entity\\', {}), (\\'cyclophosphamide_entity\\', {}), (\\'carboplatin_entity\\', {}), (\\'UKW\u2011R protocol_entity\\', {}), (\\'Nephron-sparing surgery (NSS)_entity\\', {}), (\\'Adult Wilms Tumors_entity\\', {}), (\\'doxorubicin_entity\\', {}), (\\'NWTS\u20115 relapse protocol_entity\\', {}), (\\'End-stage renal disease (ESRD)_entity\\', {}), (\\'AVD250_entity\\', {}), (\\'Children\u2019s Oncology Group (COG)_entity\\', {}), (\\'blastemal-type Wilms tumour_entity\\', {}), (\\'SIOP\u22122001_entity\\', {}), (\\'radiotherapy_entity\\', {}), (\\'childhood renal tumours_entity\\', {})], \\'edges\\': [(\\'vincristine_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'stage II_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'indicated_for_in_adults\\'}), (\\'Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'Wilms tumours_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated under\\'}), (\\'Relapsed Wilms Tumor_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guided_by\\'}), (\\'Davila Fajardo et al._entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed\\'}), (\\'SIOP\u22122001 randomized trial_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated use in\\'}), (\\'surgery_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'non-Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'actinomycin D_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Synchronous bilateral Wilms tumor_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'instance_of\\'}), (\\'CT-only nodules_entity\\', \\'increased relapse risk_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'reduced survival_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included_in\\'}), (\\'relapsed group CC_entity\\', \\'diffuse anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'blastemal-type tumors_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UKW3 trial_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'UKW3 trial_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'chemotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UMBRELLA protocol_entity\\', \\'COG AREN0533 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses_data_from\\'}), (\\'UMBRELLA protocol_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'advises_treatment_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'Innovative Therapies for Children with Cancer consortium_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborates_with\\'}), (\\'UMBRELLA protocol_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'surgery_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is the standard of\\'}), (\\'UMBRELLA protocol_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guides treatment in\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', \\'UKW3 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\\'minimally invasive surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'anaplasia_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'radical tumor nephrectomy_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'standard_of_care_for\\'}), (\\'Stage IV_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'presents in\\'}), (\\'CDCV_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'VP16_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'aims to improve survival rates of\\'}), (\\'AVD150_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed_by\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'succeeds\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'www.siop-rtsg.eu_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'available_on\\'}), (\\'laparoscopic surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'COG AREN0533 trial_entity\\', \\'cumulative doxorubicin dose_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'evaluates\\'}), (\\'UKW\u2011R protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'Nephron-sparing surgery (NSS)_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'classification_developed_by\\'}), (\\'Adult Wilms Tumors_entity\\', \\'anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'Adult Wilms Tumors_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'doxorubicin_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'doxorubicin_entity\\', \\'large-volume tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'recommended for\\'}), (\\'NWTS\u20115 relapse protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'End-stage renal disease (ESRD)_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'AVD250_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'Children\u2019s Oncology Group (COG)_entity\\', \\'SIOP\u22122001 randomized trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborated with\\'}), (\\'blastemal-type Wilms tumour_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment intensified according to\\'}), (\\'SIOP\u22122001_entity\\', \\'vincristine, actinomycin D, and doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses\\'}), (\\'SIOP\u22122001_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provided_guidelines_for\\'}), (\\'radiotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'radiotherapy_entity\\', \\'SIOP\u2212RTSG panel_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'contact_for_guidance\\'})]}, {\\'nodes\\': [(\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {}), (\\'Marry M. van den Heuvel-Eibrink_entity\\', {})], \\'edges\\': [(\\'Marry M. van den Heuvel-Eibrink_entity\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'affiliated_with\\'})]}, {\\'nodes\\': [(\\'Stage II_entity\\', {}), (\\'AV_entity\\', {}), (\\'Stage III_entity\\', {}), (\\'vincestine and actinomycin D_entity\\', {}), (\\'AVD_entity\\', {})], \\'edges\\': [(\\'Stage II_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AV_entity\\', \\'Stage II_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Stage III_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AVD_entity\\', \\'Stage III_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'SIOP-RTSG 2016_entity\\', {}), (\\'RCC_entity\\', {}), (\\'CMN_entity\\', {})], \\'edges\\': [(\\'RCC_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'}), (\\'CMN_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'})]}, {\\'nodes\\': [(\\'HR-1_entity\\', {}), (\\'High-risk blastemal type Wilms tumour_entity\\', {})], \\'edges\\': [(\\'HR-1_entity\\', \\'High-risk blastemal type Wilms tumour_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'unfavorable prognosis_entity\\', {}), (\\'high-risk characteristics_entity\\', {})], \\'edges\\': [(\\'high-risk characteristics_entity\\', \\'unfavorable prognosis_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'leads_to\\'})]}, {\\'nodes\\': [(\\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {}), (\\'SIOP\u2013RTSG board_entity\\', {})], \\'edges\\': [(\\'SIOP\u2013RTSG board_entity\\', \\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggests\\'})]}, {\\'nodes\\': [(\\'regimen and outcomes_entity\\', {}), (\\'SIOP database_entity\\', {})], \\'edges\\': [(\\'SIOP database_entity\\', \\'regimen and outcomes_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'captures_data_on\\'})]}, {\\'nodes\\': [(\\'Bilateral nephron-sparing surgery (NSS)_entity\\', {}), (\\'Aronson et al._entity\\', {})], \\'edges\\': [(\\'Aronson et al._entity\\', \\'Bilateral nephron-sparing surgery (NSS)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'observed_effectiveness_of\\'})]}, {\\'nodes\\': [(\\'SIOP\u22122001 study_entity\\', {}), (\\'Actinomycin D_entity\\', {}), (\\'Vincristine_entity\\', {})], \\'edges\\': [(\\'SIOP\u22122001 study_entity\\', \\'Vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'}), (\\'SIOP\u22122001 study_entity\\', \\'Actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'})]}, {\\'nodes\\': [(\\'High-dose melphalan_entity\\', {}), (\\'Group AA_entity\\', {}), (\\'Carboplatin_entity\\', {}), (\\'Doxorubicin_entity\\', {}), (\\'Etoposide_entity\\', {}), (\\'Group BB_entity\\', {}), (\\'Cyclophosphamide_entity\\', {}), (\\'Ifosfamide_entity\\', {})], \\'edges\\': [(\\'Group AA_entity\\', \\'Doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Ifosfamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'High-dose melphalan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'})]}, {\\'nodes\\': [(\\'nephrotoxicity_entity\\', {}), (\\'ifosfamide_entity\\', {})], \\'edges\\': [(\\'ifosfamide_entity\\', \\'nephrotoxicity_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'related_to\\'})]}, {\\'nodes\\': [(\\'camptothecins_entity\\', {}), (\\'irinotecan_entity\\', {}), (\\'topotecan_entity\\', {})], \\'edges\\': [(\\'camptothecins_entity\\', \\'irinotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'camptothecins_entity\\', \\'topotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'})]}, {\\'nodes\\': [(\\'Infant Wilms Tumors_entity\\', {}), (\\'nephrectomy_entity\\', {})], \\'edges\\': [(\\'Infant Wilms Tumors_entity\\', \\'nephrectomy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_option\\'})]}, {\\'nodes\\': [(\\'congenital mesoblastic nephroma_entity\\', {}), (\\'surgery alone_entity\\', {})], \\'edges\\': [(\\'congenital mesoblastic nephroma_entity\\', \\'surgery alone_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'alternative chemotherapy_entity\\', {}), (\\'malignant rhabdoid tumors_entity\\', {})], \\'edges\\': [(\\'malignant rhabdoid tumors_entity\\', \\'alternative chemotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'lymph node sampling_entity\\', {}), (\\'accurate staging_entity\\', {})], \\'edges\\': [(\\'lymph node sampling_entity\\', \\'accurate staging_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'purpose_of\\'})]}, {\\'nodes\\': [(\\'COG\u2013NWTS trials_entity\\', {}), (\\'whole-lung irradiation_entity\\', {})], \\'edges\\': [(\\'COG\u2013NWTS trials_entity\\', \\'whole-lung irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'informed_dosage_for\\'})]}, {\\'nodes\\': [(\\'lung metastases_entity\\', {}), (\\'pulmonary radiotherapy_entity\\', {})], \\'edges\\': [(\\'pulmonary radiotherapy_entity\\', \\'lung metastases_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'administered_for\\'})]}, {\\'nodes\\': [(\\'dosimetric study_entity\\', {}), (\\'proton therapy_entity\\', {}), (\\'flank irradiation_entity\\', {})], \\'edges\\': [(\\'dosimetric study_entity\\', \\'proton therapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated\\'}), (\\'proton therapy_entity\\', \\'flank irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggested_for\\'})]}, {\\'nodes\\': [(\\'metastatic disease_entity\\', {}), (\\'radiotherapy guidelines_entity\\', {}), (\\'locoregional disease_entity\\', {})], \\'edges\\': [(\\'radiotherapy guidelines_entity\\', \\'locoregional disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'}), (\\'radiotherapy guidelines_entity\\', \\'metastatic disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'})]}, {\\'nodes\\': [(\\'major rupture_entity\\', {}), (\\'stage III_entity\\', {})], \\'edges\\': [(\\'stage III_entity\\', \\'major rupture_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes_condition\\'})]}, {\\'nodes\\': [(\\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {}), (\\'ExPO\u2011r\u2011Net_entity\\', {})], \\'edges\\': [(\\'ExPO\u2011r\u2011Net_entity\\', \\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is part of\\'})]}, {\\'nodes\\': [(\\'University Hospital of Munich_entity\\', {}), (\\'Germany_entity\\', {}), (\\'University Hospital of Tuebingen_entity\\', {})], \\'edges\\': [(\\'Germany_entity\\', \\'University Hospital of Munich_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Germany_entity\\', \\'University Hospital of Tuebingen_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {}), (\\'Italy_entity\\', {}), (\\'Azienda Ospedaliera_entity\\', {}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {})], \\'edges\\': [(\\'Italy_entity\\', \\'Azienda Ospedaliera_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Netherlands_entity\\', {}), (\\'Prinses Maxima Centrum_entity\\', {})], \\'edges\\': [(\\'Netherlands_entity\\', \\'Prinses Maxima Centrum_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Marciniak Hospital_entity\\', {}), (\\'Poland_entity\\', {}), (\\'Faculty of Medicine_entity\\', {})], \\'edges\\': [(\\'Poland_entity\\', \\'Marciniak Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Poland_entity\\', \\'Faculty of Medicine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'St. Anna Kinderspital/CCRI_entity\\', {}), (\\'Austria_entity\\', {})], \\'edges\\': [(\\'Austria_entity\\', \\'St. Anna Kinderspital/CCRI_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'France_entity\\', {}), (\\'Armand Trousseau Hospital_entity\\', {})], \\'edges\\': [(\\'France_entity\\', \\'Armand Trousseau Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Spain_entity\\', {}), (\\'Hospital Vall d\u2019Hebron_entity\\', {}), (\\'Hospital Universitario Virgin del Rocio_entity\\', {})], \\'edges\\': [(\\'Spain_entity\\', \\'Hospital Universitario Virgin del Rocio_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Spain_entity\\', \\'Hospital Vall d\u2019Hebron_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'United Kingdom_entity\\', {}), (\\'Great Ormond Street Hospital_entity\\', {})], \\'edges\\': [(\\'United Kingdom_entity\\', \\'Great Ormond Street Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Weirich, A._entity\\', {}), (\\'SIOP-9/GPOH_entity\\', {})], \\'edges\\': [(\\'Weirich, A._entity\\', \\'SIOP-9/GPOH_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Pritchard-Jones, K._entity\\', {}), (\\'UKW3_entity\\', {})], \\'edges\\': [(\\'Pritchard-Jones, K._entity\\', \\'UKW3_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed in\\'})]}, {\\'nodes\\': [(\\'SIOP 93\u201301 trial_entity\\', {}), (\\'de Kraker, J._entity\\', {})], \\'edges\\': [(\\'de Kraker, J._entity\\', \\'SIOP 93\u201301 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'SIOP trial and study 93\u201301_entity\\', {}), (\\'Graf, N._entity\\', {})], \\'edges\\': [(\\'Graf, N._entity\\', \\'SIOP trial and study 93\u201301_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Green, D. M._entity\\', {}), (\\'National Wilms Tumor Study Group_entity\\', {})], \\'edges\\': [(\\'Green, D. M._entity\\', \\'National Wilms Tumor Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}, {\\'nodes\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', {}), (\\'SIOP WT 2001 protocol_entity\\', {})], \\'edges\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', \\'SIOP WT 2001 protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Third National Wilms\u2019 Tumor Study_entity\\', {}), (\"D\\'Angio, G. J._entity\", {}), (\\'Second National Wilms\u2019 Tumor Study_entity\\', {})], \\'edges\\': [(\"D\\'Angio, G. J._entity\", \\'Third National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\"D\\'Angio, G. J._entity\", \\'Second National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {}), (\\'Tournade, M. F._entity\\', {}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {})], \\'edges\\': [(\\'Tournade, M. F._entity\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'}), (\\'Tournade, M. F._entity\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Breslow, N. E._entity\\', {}), (\\'National Wilms Tumor Studies_entity\\', {})], \\'edges\\': [(\\'Breslow, N. E._entity\\', \\'National Wilms Tumor Studies_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Mitchell, C._entity\\', {}), (\\'UK Children\u2019s Cancer Study Group_entity\\', {})], \\'edges\\': [(\\'Mitchell, C._entity\\', \\'UK Children\u2019s Cancer Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'under\\'})]}, {\\'nodes\\': [(\\'Daw, N. C._entity\\', {}), (\\'Dix, D. B._entity\\', {}), (\\'Children\u2019s Oncology Group_entity\\', {}), (\\'Grundy, P. E._entity\\', {})], \\'edges\\': [(\\'Daw, N. C._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted under\\'}), (\\'Dix, D. B._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'}), (\\'Grundy, P. E._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}]']), TestResult(name='test_case_9', success=False, metrics_data=[MetricData(name='Answer Correctness (GEval)', threshold=0.5, success=False, score=0.012210609940833367, reason=\"The actual output provides extensive details about various entities but does not address the expected output regarding preoperative chemotherapy's role in downstaging tumors and assessing chemosensitivity.\", strict_mode=False, evaluation_model='gpt-4o-mini', error=None, evaluation_cost=0.0033014999999999997, verbose_logs='Criteria:\\nNone \\n \\nEvaluation Steps:\\n[\\n    \"Determine whether the actual output is factually correct based on the expected output.\"\\n]'), MetricData(name='Faithfulness', threshold=0.7, success=True, score=0.8787878787878788, reason=None, strict_mode=False, evaluation_model='gpt-4o-mini', error=None, evaluation_cost=0.00812745, verbose_logs='Truths (limit=None):\\n[\\n    \"The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG) is an organization.\",\\n    \"UMBRELLA SIOP-RTSG 2016 is a protocol.\",\\n    \"SIOP\u22122001 is a protocol.\",\\n    \"Wilms tumours are a type of disease.\",\\n    \"Non-Wilms tumours are a type of disease.\",\\n    \"childhood renal tumours are a type of disease.\",\\n    \"Clear cell sarcoma of the kidney is a type of disease.\",\\n    \"Renal cell carcinoma is a type of disease.\",\\n    \"Malignant rhabdoid tumour of the kidney is a type of disease.\",\\n    \"Congenital mesoblastic nephroma is a type of disease.\",\\n    \"UMBRELLA protocol is a treatment protocol.\",\\n    \"Children\u2019s Oncology Group (COG) is an organization.\",\\n    \"SIOP\u22122001 randomized trial is a clinical trial.\",\\n    \"Actinomycin D is a type of drug.\",\\n    \"Vincristine is a type of drug.\",\\n    \"Doxorubicin is a type of drug.\",\\n    \"Localized disease refers to a disease stage.\",\\n    \"Metastatic disease refers to a disease stage.\",\\n    \"Bilateral disease refers to a disease stage.\",\\n    \"Relapsed disease refers to a disease stage.\",\\n    \"Blastemal-type Wilms tumours are a subtype.\",\\n    \"Radiotherapy is a treatment method.\",\\n    \"Surgery is a treatment method.\",\\n    \"Chemotherapy is a treatment method.\",\\n    \"Wilms Tumour is a type of disease.\",\\n    \"CCSK is a type of disease.\",\\n    \"MRTK is a type of disease.\",\\n    \"CMN is a type of disease.\",\\n    \"RCC is a type of disease.\",\\n    \"Stage I is a disease stage.\",\\n    \"Stage II is a disease stage.\",\\n    \"Stage III is a disease stage.\",\\n    \"Stage IV is a disease stage.\",\\n    \"Stage V is a disease stage.\",\\n    \"AV is a treatment combination.\",\\n    \"AVD is a treatment combination.\",\\n    \"HR-1 is a treatment combination.\",\\n    \"Overall Survival (OS) is a metric.\",\\n    \"Event-Free Survival (EFS) is a metric.\",\\n    \"CT-only nodules are a medical condition.\",\\n    \"SIOP\u22122001 is a study protocol.\",\\n    \"MRI is a diagnostic tool.\",\\n    \"CT is a diagnostic tool.\",\\n    \"High-risk characteristics are a medical condition.\",\\n    \"Nephrotoxicity is a condition related to drug treatment.\",\\n    \"Infant Wilms Tumors is a medical condition.\",\\n    \"Adult Wilms Tumors is a medical condition.\",\\n    \"Anaplasia is a medical condition.\",\\n    \"The SIOP database captures data on regimen and outcomes.\",\\n    \"The UK Children\u2019s Cancer Study Group is an organization.\",\\n    \"The Innovative Therapies for Children with Cancer consortium is an organization.\",\\n    \"The Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology is an institution.\",\\n    \"Marry M. van den Heuvel-Eibrink is a person associated with the Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology.\"\\n] \\n \\nClaims:\\n[\\n    \"The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG) is an organization.\",\\n    \"UMBRELLA SIOP-RTSG 2016 is a protocol.\",\\n    \"SIOP\u22122001 is a protocol.\",\\n    \"Wilms tumours are a type of disease.\",\\n    \"Non-Wilms tumours are a type of disease.\",\\n    \"The website www.siop-rtsg.eu is associated with the SIOP\u2013RTSG.\",\\n    \"The Department of Paediatric Oncology is part of the Princess M\u00e1xima Center for Paediatric Oncology.\",\\n    \"Marry M. van den Heuvel-Eibrink is a person associated with SIOP\u2013RTSG.\",\\n    \"Childhood renal tumours are a type of disease.\",\\n    \"Clear cell sarcoma of the kidney is a type of disease.\",\\n    \"Renal cell carcinoma is a type of disease.\",\\n    \"Malignant rhabdoid tumour of the kidney is a type of disease.\",\\n    \"Congenital mesoblastic nephroma is a type of disease.\",\\n    \"Wilms tumours refer specifically to a condition related to kidney cancer in children.\",\\n    \"The UMBRELLA protocol is a treatment protocol.\",\\n    \"SIOP\u2013RTSG is an organization.\",\\n    \"Children\u2019s Oncology Group (COG) is an organization.\",\\n    \"SIOP\u22122001 randomized trial is a clinical trial.\",\\n    \"Actinomycin D is a drug used in treatment.\",\\n    \"Vincristine is a drug used in treatment.\",\\n    \"Doxorubicin is a drug used in treatment.\",\\n    \"UKW3 trial is a clinical trial.\",\\n    \"UK Children\u2019s Cancer and Leukaemia Group (UKCCLG) is an organization.\",\\n    \"Localized disease is a stage of disease.\",\\n    \"Metastatic disease is a stage of disease.\",\\n    \"Bilateral disease is a stage of disease.\",\\n    \"Relapsed disease is a stage of disease.\",\\n    \"Blastemal-type Wilms tumours are a subtype of Wilms tumours.\",\\n    \"Radiotherapy is a treatment method for various conditions.\",\\n    \"Surgery is a treatment method for various conditions.\",\\n    \"Chemotherapy is a treatment method for various conditions.\",\\n    \"Wilms Tumour is a disease category.\",\\n    \"CCSK stands for clear cell sarcoma of the kidney and is a type of disease.\",\\n    \"MRTK stands for malignant rhabdoid tumour of the kidney and is a type of disease.\",\\n    \"CMN stands for congenital mesoblastic nephroma and is a type of disease.\",\\n    \"RCC stands for renal cell carcinoma and is a type of disease.\",\\n    \"SIOP\u22122001 is a clinical trial.\",\\n    \"Vincristine is a treatment.\",\\n    \"Actinomycin D is a treatment.\",\\n    \"Doxorubicin is a treatment.\",\\n    \"Etoposide is a treatment.\",\\n    \"Carboplatin is a treatment.\",\\n    \"Cyclophosphamide is a treatment.\",\\n    \"Stage I is a stage of cancer.\",\\n    \"Stage II is a stage of cancer.\",\\n    \"Stage III is a stage of cancer.\",\\n    \"Stage IV is a stage of cancer.\",\\n    \"Stage V is a stage of cancer.\",\\n    \"AV is a treatment combination.\",\\n    \"AVD is a treatment combination.\",\\n    \"HR-1 is a treatment combination.\",\\n    \"SIOP-RTSG 2016 is a protocol.\",\\n    \"Overall Survival (OS) is a metric used in medical studies.\",\\n    \"Event-Free Survival (EFS) is a metric used in medical studies.\",\\n    \"CT-only nodules refer to a medical condition.\",\\n    \"The SIOP database is a database that captures data on SIOP studies and outcomes.\",\\n    \"Bilateral nephron-sparing surgery (NSS) is a treatment method.\",\\n    \"High-dose melphalan is a treatment method.\",\\n    \"Nephron-sparing surgery (NSS) is a surgical procedure related to kidney conditions.\",\\n    \"The UKW3 trial is associated with testing vincristine and actinomycin D plus doxorubicin.\",\\n    \"Nephrotoxicity is a condition related to kidney damage that can occur from certain drugs.\"\\n] \\n \\nVerdicts:\\n[\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"The claim about the website www.siop-rtsg.eu is not mentioned in the retrieval context.\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"The context specifies Marry M. van den Heuvel-Eibrink is associated with the Department of Paediatric Oncology at the Princess M\\\\u00e1xima Center for Paediatric Oncology, not SIOP\\\\u2013RTSG.\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"The context does not mention the UKW3 trial; only SIOP\\\\u22122001 is referenced as a clinical trial.\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"The claim of high-dose melphalan being a treatment method is not mentioned in the context.\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    }\\n]'), MetricData(name='Contextual Relevancy', threshold=1.0, success=False, score=0.5555555555555556, reason=\"The score is 0.56 because the retrieval context mostly discusses specific treatment methods like 'high-dose chemotherapy and autologous stem cell transplantation' which do not directly answer the significance of preoperative chemotherapy, while the relevant terms such as 'chemotherapy_Treatment Method' provide minimal context for the input question.\", strict_mode=False, evaluation_model='gpt-4o-mini', error=None, evaluation_cost=0.0036602999999999996, verbose_logs='Verdicts:\\n[\\n    {\\n        \"verdicts\": [\\n            {\\n                \"statement\": \"chemotherapy_Treatment Method\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"surgery_Treatment Method\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"radiotherapy_Treatment Method\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"high-dose chemotherapy and autologous stem cell transplantation_treatment\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"This refers to \\'high-dose chemotherapy and autologous stem cell transplantation\\' which is a specific treatment but does not directly answer the significance of preoperative chemotherapy.\"\\n            },\\n            {\\n                \"statement\": \"cumulative doxorubicin dose_treatment_detail\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"This refers to \\'cumulative doxorubicin dose\\' as detail of treatment rather than discussing significance of preoperative chemotherapy.\"\\n            },\\n            {\\n                \"statement\": \"UMBRELLA protocol_Treatment Protocol\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"SIOP\\\\u22122001 randomized trial_Clinical Trial\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"This statement talks about a specific trial that may not address the significance of preoperative chemotherapy in the protocol.\"\\n            },\\n            {\\n                \"statement\": \"Childhood renal tumours_Disease\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"This statement refers to a specific disease and doesn\\'t address the question of preoperative chemotherapy significance.\"\\n            },\\n            {\\n                \"statement\": \"Wilms tumours_Condition\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            }\\n        ]\\n    }\\n]')], conversational=False, multimodal=False, input='What is the significance of preoperative chemotherapy in the protocol?', actual_output='[{\\'nodes\\': [(\\'sample.pdf\\', {\\'type\\': \\'document\\'}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)\\'}), (\\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA SIOP-RTSG 2016\\'}), (\\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms tumours\\'}), (\\'non-Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'non-Wilms tumours\\'}), (\\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Website\\', \\'name\\': \\'www.siop-rtsg.eu\\'}), (\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology\\'}), (\\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Person\\', \\'name\\': \\'Marry M. van den Heuvel-Eibrink\\'}), (\\'childhood renal tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'childhood renal tumours\\'}), (\\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'clear cell sarcoma of the kidney\\'}), (\\'renal cell carcinoma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'renal cell carcinoma\\'}), (\\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'malignant rhabdoid tumour of the kidney\\'}), (\\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'Wilms tumours_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'Children\u2019s Oncology Group (COG)\\'}), (\\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'SIOP\u22122001 randomized trial\\'}), (\\'actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'UKW3 trial\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)\\'}), (\\'localized disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'localized disease\\'}), (\\'metastatic disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'metastatic disease\\'}), (\\'bilateral disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'bilateral disease\\'}), (\\'relapsed disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'relapsed disease\\'}), (\\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subtype\\', \\'name\\': \\'blastemal-type Wilms tumours\\'}), (\\'radiotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgery_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'chemotherapy\\'}), (\\'Wilms Tumour_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms Tumour\\'}), (\\'CCSK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CCSK\\'}), (\\'MRTK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'MRTK\\'}), (\\'CMN_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CMN\\'}), (\\'RCC_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'RCC\\'}), (\\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u22122001_Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Trial\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'vincristine_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'vincristine\\'}), (\\'actinomycin D_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'actinomycin D\\'}), (\\'doxorubicin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'doxorubicin\\'}), (\\'etoposide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'Stage I_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage I\\'}), (\\'Stage II_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage II\\'}), (\\'Stage III_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage III\\'}), (\\'Stage IV_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage IV\\'}), (\\'Stage V_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage V\\'}), (\\'AV_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AV\\'}), (\\'AVD_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AVD\\'}), (\\'HR-1_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'HR-1\\'}), (\\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP-RTSG 2016\\'}), (\\'Overall Survival (OS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'CT-only nodules_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'CT-only nodules\\'}), (\\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP\u2013RTSG analysis\\'}), (\\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials\\'}), (\\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D plus doxorubicin\\'}), (\\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D\\'}), (\\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study_protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'MRI_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'MRI\\'}), (\\'CT_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'CT\\'}), (\\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_detail\\', \\'name\\': \\'cumulative doxorubicin dose\\'}), (\\'COG AREN0533 trial_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG AREN0533 trial\\'}), (\\'etoposide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'high-risk characteristics\\'}), (\\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG board\\'}), (\\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin\\'}), (\\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'high-dose chemotherapy and autologous stem cell transplantation\\'}), (\\'SIOP database_database\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'database\\', \\'name\\': \\'SIOP database\\'}), (\\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'AVD_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AVD\\'}), (\\'AV-2_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AV-2\\'}), (\\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Statistical Test\\', \\'name\\': \\'Log\u2013Rank P\\'}), (\\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'Bilateral Disease (Stage V)\\'}), (\\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Synchronous bilateral Wilms tumor\\'}), (\\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'End-stage renal disease (ESRD)\\'}), (\\'Aronson et al._Research Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Research Group\\', \\'name\\': \\'Aronson et al.\\'}), (\\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'Bilateral nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Study\\', \\'name\\': \\'SIOP\u22122001 study\\'}), (\\'Vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Vincristine\\'}), (\\'Actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Actinomycin D\\'}), (\\'Etoposide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Etoposide\\'}), (\\'Carboplatin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Carboplatin\\'}), (\\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease State\\', \\'name\\': \\'Relapsed Wilms Tumor\\'}), (\\'Group AA_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group AA\\'}), (\\'Group BB_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group BB\\'}), (\\'Group CC_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group CC\\'}), (\\'Doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Doxorubicin\\'}), (\\'Cyclophosphamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Cyclophosphamide\\'}), (\\'Ifosfamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Ifosfamide\\'}), (\\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'High-dose melphalan\\'}), (\\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UKW\u2011R protocol\\'}), (\\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'NWTS\u20115 relapse protocol\\'}), (\\'ASCR_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'procedure\\', \\'name\\': \\'ASCR\\'}), (\\'ifosfamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'ifosfamide\\'}), (\\'nephrotoxicity_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'nephrotoxicity\\'}), (\\'relapsed group CC_patient_group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'patient_group\\', \\'name\\': \\'relapsed group CC\\'}), (\\'diffuse anaplasia_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'diffuse anaplasia\\'}), (\\'blastemal-type tumors_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'blastemal-type tumors\\'}), (\\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'camptothecins_medication_class\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication_class\\', \\'name\\': \\'camptothecins\\'}), (\\'irinotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'irinotecan\\'}), (\\'topotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'topotecan\\'}), (\\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Innovative Therapies for Children with Cancer consortium\\'}), (\\'radiotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgical excision_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgical excision\\'}), (\\'stage IV WT_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'stage IV WT\\'}), (\\'AVD150_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD150\\'}), (\\'AVD250_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD250\\'}), (\\'low-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'low-risk disease\\'}), (\\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'intermediate-risk disease\\'}), (\\'high-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'high-risk disease\\'}), (\\'CDCV_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'CDCV\\'}), (\\'actinomycin-D_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'actinomycin-D\\'}), (\\'vincristine_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'doxorubicin\\'}), (\\'VP16_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'VP16\\'}), (\\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'contact\\', \\'name\\': \\'arnauld.verschuur@ap-hm.fr\\'}), (\\'surgery_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'chemotherapy\\'}), (\\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2212RTSG panel\\'}), (\\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Infant Wilms Tumors\\'}), (\\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'nephrectomy\\'}), (\\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'malignant rhabdoid tumors\\'}), (\\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Adult Wilms Tumors\\'}), (\\'anaplasia_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'anaplasia\\'}), (\\'actinomycin D_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'carboplatin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'etoposide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'etoposide\\'}), (\\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'Nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'radical tumor nephrectomy\\'}), (\\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'lymph node sampling\\'}), (\\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'minimally invasive surgery\\'}), (\\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'laparoscopic surgery\\'}), (\\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'radiotherapy\\'}), (\\'Wilms tumours_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'Davila Fajardo et al._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Davila Fajardo et al.\\'}), (\\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'COG\u2013NWTS trials\\'}), (\\'whole-lung irradiation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'whole-lung irradiation\\'}), (\\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'pulmonary radiotherapy\\'}), (\\'proton therapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'proton therapy\\'}), (\\'dosimetric study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'dosimetric study\\'}), (\\'locoregional disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'locoregional disease\\'}), (\\'metastatic disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'metastatic disease\\'}), (\\'low-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'low-risk\\'}), (\\'intermediate-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'intermediate-risk\\'}), (\\'high-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'high-risk\\'}), (\\'stage I_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage I\\'}), (\\'stage II_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage II\\'}), (\\'stage III_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage III\\'}), (\\'major rupture_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'major rupture\\'}), (\\'Austria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Austria\\'}), (\\'Italy_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Italy\\'}), (\\'San Marino_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'San Marino\\'}), (\\'Iceland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Iceland\\'}), (\\'Germany_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Germany\\'}), (\\'Bulgaria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bulgaria\\'}), (\\'Turkey_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Turkey\\'}), (\\'Denmark_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Denmark\\'}), (\\'Poland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Poland\\'}), (\\'Greece_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Greece\\'}), (\\'Andorra_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Andorra\\'}), (\\'Belgium_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belgium\\'}), (\\'Serbia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Serbia\\'}), (\\'Albania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Albania\\'}), (\\'Moldova_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Moldova\\'}), (\\'Lithuania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Lithuania\\'}), (\\'Latvia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Latvia\\'}), (\\'Estonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Estonia\\'}), (\\'Luxembourg_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Luxembourg\\'}), (\\'Montenegro_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Montenegro\\'}), (\\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bosnia and Herzegovina\\'}), (\\'Croatia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Croatia\\'}), (\\'Slovenia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovenia\\'}), (\\'Macedonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Macedonia\\'}), (\\'United Kingdom_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'United Kingdom\\'}), (\\'Ireland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ireland\\'}), (\\'Spain_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Spain\\'}), (\\'Algeria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Algeria\\'}), (\\'Tunisia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Tunisia\\'}), (\\'Malta_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Malta\\'}), (\\'Morocco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Morocco\\'}), (\\'Portugal_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Portugal\\'}), (\\'France_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'France\\'}), (\\'Monaco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Monaco\\'}), (\\'Russia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Russia\\'}), (\\'Finland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Finland\\'}), (\\'Sweden_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Sweden\\'}), (\\'Norway_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Norway\\'}), (\\'Belarus_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belarus\\'}), (\\'Romania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Romania\\'}), (\\'Ukraine_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ukraine\\'}), (\\'Hungary_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Hungary\\'}), (\\'Czech Republic_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Czech Republic\\'}), (\\'Slovakia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovakia\\'}), (\\'Switzerland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Switzerland\\'}), (\\'Liechtenstein_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Liechtenstein\\'}), (\\'Netherlands_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Netherlands\\'}), (\\'University Hospital of Munich_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Munich\\'}), (\\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Tuebingen\\'}), (\\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Azienda Ospedaliera\\'}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Ospedale Pediatrico Bambino Ges\u00f9\\'}), (\\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Fondazione IRCCS Istituto Nazionale dei Tumori\\'}), (\\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Prinses Maxima Centrum\\'}), (\\'Marciniak Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Marciniak Hospital\\'}), (\\'Faculty of Medicine_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Faculty of Medicine\\'}), (\\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'St. Anna Kinderspital/CCRI\\'}), (\\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Armand Trousseau Hospital\\'}), (\\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Universitario Virgin del Rocio\\'}), (\\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Vall d\u2019Hebron\\'}), (\\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Great Ormond Street Hospital\\'}), (\\'University Hospital Homburg_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital Homburg\\'}), (\\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon\\'}), (\\'UMBRELLA protocol_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'ExPO\u2011r\u2011Net\\'}), (\\'Weirich, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Weirich, A.\\'}), (\\'Pritchard-Jones, K._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Pritchard-Jones, K.\\'}), (\\'de Kraker, J._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'de Kraker, J.\\'}), (\\'Graf, N._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Graf, N.\\'}), (\\'Green, D. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Green, D. M.\\'}), (\\'Spreafico, F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Spreafico, F.\\'}), (\\'Bellani, F. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Bellani, F. F.\\'}), (\\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'van den Heuvel-Eibrink, M. M.\\'}), (\"D\\'Angio, G. J._author\", {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \"D\\'Angio, G. J.\"}), (\\'Tournade, M. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Tournade, M. F.\\'}), (\\'Breslow, N. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Breslow, N. E.\\'}), (\\'Mitchell, C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Mitchell, C.\\'}), (\\'Verschuur, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Verschuur, A.\\'}), (\\'Grundy, P. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Grundy, P. E.\\'}), (\\'Warmann, S. W._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Warmann, S. W.\\'}), (\\'Smets, A. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Smets, A. M.\\'}), (\\'Dome, J. S._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dome, J. S.\\'}), (\\'Dix, D. B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dix, D. B.\\'}), (\\'Daw, N. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Daw, N. C.\\'}), (\\'Ha, T. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Ha, T. C.\\'}), (\\'Kremens, B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Kremens, B.\\'}), (\\'Furtwangler, R._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Furtwangler, R.\\'}), (\\'SIOP-9/GPOH_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP-9/GPOH\\'}), (\\'UKW3_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'UKW3\\'}), (\\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'SIOP 93\u201301 trial\\'}), (\\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP trial and study 93\u201301\\'}), (\\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'National Wilms Tumor Study Group\\'}), (\\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP WT 2001 protocol\\'}), (\\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Third National Wilms\u2019 Tumor Study\\'}), (\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'National Wilms Tumor Studies\\'}), (\\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Second National Wilms\u2019 Tumor Study\\'}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'UK Children\u2019s Cancer Study Group\\'}), (\\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Children\u2019s Oncology Group\\'})], \\'edges\\': [(\\'sample.pdf\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'non-Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'childhood renal tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'renal cell carcinoma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'localized disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'metastatic disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'bilateral disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'relapsed disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'radiotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'surgery_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'chemotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'Wilms Tumour_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CCSK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'MRTK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CMN_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'RCC_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP\u22122001_Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'vincristine_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'actinomycin D_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'doxorubicin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'etoposide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'carboplatin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'cyclophosphamide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage I_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage II_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage III_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage IV_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage V_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AV_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AVD_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'HR-1_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Overall Survival (OS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT-only nodules_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'MRI_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG AREN0533 trial_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'etoposide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'carboplatin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'cyclophosphamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP database_database\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AVD_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AV-2_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Aronson et al._Research Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Etoposide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Carboplatin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group AA_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group BB_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group CC_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Cyclophosphamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Ifosfamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'ASCR_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'ifosfamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'nephrotoxicity_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'relapsed group CC_patient_group\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'diffuse anaplasia_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'blastemal-type tumors_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'camptothecins_medication_class\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'irinotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'topotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'radiotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'surgical excision_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'stage IV WT_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD150_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD250_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'low-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'CDCV_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'actinomycin-D_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'vincristine_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'doxorubicin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'VP16_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'surgery_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'chemotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'anaplasia_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'actinomycin D_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'vincristine_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'doxorubicin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'carboplatin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'cyclophosphamide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'etoposide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'SIOP\u22122001_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Wilms tumours_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Davila Fajardo et al._author\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'whole-lung irradiation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'proton therapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'dosimetric study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'locoregional disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'metastatic disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'low-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'intermediate-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'high-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage I_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage II_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage III_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'major rupture_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Austria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Italy_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'San Marino_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Iceland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Germany_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bulgaria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Turkey_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Denmark_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Poland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Greece_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Andorra_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belgium_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Serbia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Albania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Moldova_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Lithuania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Latvia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Estonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Luxembourg_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Montenegro_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Croatia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovenia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Macedonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'United Kingdom_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ireland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Spain_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Algeria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Tunisia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Malta_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Morocco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Portugal_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'France_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Monaco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Russia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Finland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Sweden_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Norway_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belarus_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Romania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ukraine_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hungary_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Czech Republic_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovakia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Switzerland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Liechtenstein_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Netherlands_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Munich_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Marciniak Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Faculty of Medicine_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital Homburg_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Weirich, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Pritchard-Jones, K._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'de Kraker, J._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Graf, N._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Green, D. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Spreafico, F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Bellani, F. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \"D\\'Angio, G. J._author\", {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Tournade, M. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Breslow, N. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Mitchell, C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Verschuur, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Grundy, P. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Warmann, S. W._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Smets, A. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dome, J. S._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dix, D. B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Daw, N. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ha, T. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Kremens, B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Furtwangler, R._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP-9/GPOH_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UKW3_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10})]}, {\\'nodes\\': [(\\'vincristine_entity\\', {}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {}), (\\'www.siop-rtsg.eu_entity\\', {}), (\\'stage II_entity\\', {}), (\\'Wilms tumours_entity\\', {}), (\\'Relapsed Wilms Tumor_entity\\', {}), (\\'Davila Fajardo et al._entity\\', {}), (\\'vincristine, actinomycin D, and doxorubicin_entity\\', {}), (\\'SIOP\u22122001 randomized trial_entity\\', {}), (\\'surgery_entity\\', {}), (\\'non-Wilms tumours_entity\\', {}), (\\'actinomycin D_entity\\', {}), (\\'diffuse anaplasia_entity\\', {}), (\\'Synchronous bilateral Wilms tumor_entity\\', {}), (\\'CT-only nodules_entity\\', {}), (\\'relapsed group CC_entity\\', {}), (\\'increased relapse risk_entity\\', {}), (\\'reduced survival_entity\\', {}), (\\'UKW3 trial_entity\\', {}), (\\'chemotherapy_entity\\', {}), (\\'Bilateral Disease (Stage V)_entity\\', {}), (\\'blastemal-type tumors_entity\\', {}), (\\'UMBRELLA protocol_entity\\', {}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', {}), (\\'minimally invasive surgery_entity\\', {}), (\\'VP16_entity\\', {}), (\\'Wilms tumor_entity\\', {}), (\\'anaplasia_entity\\', {}), (\\'radical tumor nephrectomy_entity\\', {}), (\\'Innovative Therapies for Children with Cancer consortium_entity\\', {}), (\\'cumulative doxorubicin dose_entity\\', {}), (\\'etoposide_entity\\', {}), (\\'large-volume tumours_entity\\', {}), (\\'Stage IV_entity\\', {}), (\\'CDCV_entity\\', {}), (\\'SIOP\u2013RTSG_entity\\', {}), (\\'AVD150_entity\\', {}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', {}), (\\'laparoscopic surgery_entity\\', {}), (\\'SIOP\u2212RTSG panel_entity\\', {}), (\\'actinomycin-D_entity\\', {}), (\\'COG AREN0533 trial_entity\\', {}), (\\'cyclophosphamide_entity\\', {}), (\\'carboplatin_entity\\', {}), (\\'UKW\u2011R protocol_entity\\', {}), (\\'Nephron-sparing surgery (NSS)_entity\\', {}), (\\'Adult Wilms Tumors_entity\\', {}), (\\'doxorubicin_entity\\', {}), (\\'NWTS\u20115 relapse protocol_entity\\', {}), (\\'End-stage renal disease (ESRD)_entity\\', {}), (\\'AVD250_entity\\', {}), (\\'Children\u2019s Oncology Group (COG)_entity\\', {}), (\\'blastemal-type Wilms tumour_entity\\', {}), (\\'SIOP\u22122001_entity\\', {}), (\\'radiotherapy_entity\\', {}), (\\'childhood renal tumours_entity\\', {})], \\'edges\\': [(\\'vincristine_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'stage II_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'indicated_for_in_adults\\'}), (\\'Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'Wilms tumours_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated under\\'}), (\\'Relapsed Wilms Tumor_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guided_by\\'}), (\\'Davila Fajardo et al._entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed\\'}), (\\'SIOP\u22122001 randomized trial_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated use in\\'}), (\\'surgery_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'non-Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'actinomycin D_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Synchronous bilateral Wilms tumor_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'instance_of\\'}), (\\'CT-only nodules_entity\\', \\'increased relapse risk_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'reduced survival_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included_in\\'}), (\\'relapsed group CC_entity\\', \\'diffuse anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'blastemal-type tumors_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UKW3 trial_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'UKW3 trial_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'chemotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UMBRELLA protocol_entity\\', \\'COG AREN0533 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses_data_from\\'}), (\\'UMBRELLA protocol_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'advises_treatment_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'Innovative Therapies for Children with Cancer consortium_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborates_with\\'}), (\\'UMBRELLA protocol_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'surgery_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is the standard of\\'}), (\\'UMBRELLA protocol_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guides treatment in\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', \\'UKW3 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\\'minimally invasive surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'anaplasia_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'radical tumor nephrectomy_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'standard_of_care_for\\'}), (\\'Stage IV_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'presents in\\'}), (\\'CDCV_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'VP16_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'aims to improve survival rates of\\'}), (\\'AVD150_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed_by\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'succeeds\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'www.siop-rtsg.eu_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'available_on\\'}), (\\'laparoscopic surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'COG AREN0533 trial_entity\\', \\'cumulative doxorubicin dose_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'evaluates\\'}), (\\'UKW\u2011R protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'Nephron-sparing surgery (NSS)_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'classification_developed_by\\'}), (\\'Adult Wilms Tumors_entity\\', \\'anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'Adult Wilms Tumors_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'doxorubicin_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'doxorubicin_entity\\', \\'large-volume tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'recommended for\\'}), (\\'NWTS\u20115 relapse protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'End-stage renal disease (ESRD)_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'AVD250_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'Children\u2019s Oncology Group (COG)_entity\\', \\'SIOP\u22122001 randomized trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborated with\\'}), (\\'blastemal-type Wilms tumour_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment intensified according to\\'}), (\\'SIOP\u22122001_entity\\', \\'vincristine, actinomycin D, and doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses\\'}), (\\'SIOP\u22122001_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provided_guidelines_for\\'}), (\\'radiotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'radiotherapy_entity\\', \\'SIOP\u2212RTSG panel_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'contact_for_guidance\\'})]}, {\\'nodes\\': [(\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {}), (\\'Marry M. van den Heuvel-Eibrink_entity\\', {})], \\'edges\\': [(\\'Marry M. van den Heuvel-Eibrink_entity\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'affiliated_with\\'})]}, {\\'nodes\\': [(\\'Stage II_entity\\', {}), (\\'AV_entity\\', {}), (\\'Stage III_entity\\', {}), (\\'vincestine and actinomycin D_entity\\', {}), (\\'AVD_entity\\', {})], \\'edges\\': [(\\'Stage II_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AV_entity\\', \\'Stage II_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Stage III_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AVD_entity\\', \\'Stage III_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'SIOP-RTSG 2016_entity\\', {}), (\\'RCC_entity\\', {}), (\\'CMN_entity\\', {})], \\'edges\\': [(\\'RCC_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'}), (\\'CMN_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'})]}, {\\'nodes\\': [(\\'HR-1_entity\\', {}), (\\'High-risk blastemal type Wilms tumour_entity\\', {})], \\'edges\\': [(\\'HR-1_entity\\', \\'High-risk blastemal type Wilms tumour_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'unfavorable prognosis_entity\\', {}), (\\'high-risk characteristics_entity\\', {})], \\'edges\\': [(\\'high-risk characteristics_entity\\', \\'unfavorable prognosis_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'leads_to\\'})]}, {\\'nodes\\': [(\\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {}), (\\'SIOP\u2013RTSG board_entity\\', {})], \\'edges\\': [(\\'SIOP\u2013RTSG board_entity\\', \\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggests\\'})]}, {\\'nodes\\': [(\\'regimen and outcomes_entity\\', {}), (\\'SIOP database_entity\\', {})], \\'edges\\': [(\\'SIOP database_entity\\', \\'regimen and outcomes_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'captures_data_on\\'})]}, {\\'nodes\\': [(\\'Bilateral nephron-sparing surgery (NSS)_entity\\', {}), (\\'Aronson et al._entity\\', {})], \\'edges\\': [(\\'Aronson et al._entity\\', \\'Bilateral nephron-sparing surgery (NSS)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'observed_effectiveness_of\\'})]}, {\\'nodes\\': [(\\'SIOP\u22122001 study_entity\\', {}), (\\'Actinomycin D_entity\\', {}), (\\'Vincristine_entity\\', {})], \\'edges\\': [(\\'SIOP\u22122001 study_entity\\', \\'Vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'}), (\\'SIOP\u22122001 study_entity\\', \\'Actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'})]}, {\\'nodes\\': [(\\'High-dose melphalan_entity\\', {}), (\\'Group AA_entity\\', {}), (\\'Carboplatin_entity\\', {}), (\\'Doxorubicin_entity\\', {}), (\\'Etoposide_entity\\', {}), (\\'Group BB_entity\\', {}), (\\'Cyclophosphamide_entity\\', {}), (\\'Ifosfamide_entity\\', {})], \\'edges\\': [(\\'Group AA_entity\\', \\'Doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Ifosfamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'High-dose melphalan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'})]}, {\\'nodes\\': [(\\'nephrotoxicity_entity\\', {}), (\\'ifosfamide_entity\\', {})], \\'edges\\': [(\\'ifosfamide_entity\\', \\'nephrotoxicity_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'related_to\\'})]}, {\\'nodes\\': [(\\'camptothecins_entity\\', {}), (\\'irinotecan_entity\\', {}), (\\'topotecan_entity\\', {})], \\'edges\\': [(\\'camptothecins_entity\\', \\'irinotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'camptothecins_entity\\', \\'topotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'})]}, {\\'nodes\\': [(\\'Infant Wilms Tumors_entity\\', {}), (\\'nephrectomy_entity\\', {})], \\'edges\\': [(\\'Infant Wilms Tumors_entity\\', \\'nephrectomy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_option\\'})]}, {\\'nodes\\': [(\\'congenital mesoblastic nephroma_entity\\', {}), (\\'surgery alone_entity\\', {})], \\'edges\\': [(\\'congenital mesoblastic nephroma_entity\\', \\'surgery alone_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'alternative chemotherapy_entity\\', {}), (\\'malignant rhabdoid tumors_entity\\', {})], \\'edges\\': [(\\'malignant rhabdoid tumors_entity\\', \\'alternative chemotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'lymph node sampling_entity\\', {}), (\\'accurate staging_entity\\', {})], \\'edges\\': [(\\'lymph node sampling_entity\\', \\'accurate staging_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'purpose_of\\'})]}, {\\'nodes\\': [(\\'COG\u2013NWTS trials_entity\\', {}), (\\'whole-lung irradiation_entity\\', {})], \\'edges\\': [(\\'COG\u2013NWTS trials_entity\\', \\'whole-lung irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'informed_dosage_for\\'})]}, {\\'nodes\\': [(\\'lung metastases_entity\\', {}), (\\'pulmonary radiotherapy_entity\\', {})], \\'edges\\': [(\\'pulmonary radiotherapy_entity\\', \\'lung metastases_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'administered_for\\'})]}, {\\'nodes\\': [(\\'dosimetric study_entity\\', {}), (\\'proton therapy_entity\\', {}), (\\'flank irradiation_entity\\', {})], \\'edges\\': [(\\'dosimetric study_entity\\', \\'proton therapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated\\'}), (\\'proton therapy_entity\\', \\'flank irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggested_for\\'})]}, {\\'nodes\\': [(\\'metastatic disease_entity\\', {}), (\\'radiotherapy guidelines_entity\\', {}), (\\'locoregional disease_entity\\', {})], \\'edges\\': [(\\'radiotherapy guidelines_entity\\', \\'locoregional disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'}), (\\'radiotherapy guidelines_entity\\', \\'metastatic disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'})]}, {\\'nodes\\': [(\\'major rupture_entity\\', {}), (\\'stage III_entity\\', {})], \\'edges\\': [(\\'stage III_entity\\', \\'major rupture_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes_condition\\'})]}, {\\'nodes\\': [(\\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {}), (\\'ExPO\u2011r\u2011Net_entity\\', {})], \\'edges\\': [(\\'ExPO\u2011r\u2011Net_entity\\', \\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is part of\\'})]}, {\\'nodes\\': [(\\'University Hospital of Munich_entity\\', {}), (\\'Germany_entity\\', {}), (\\'University Hospital of Tuebingen_entity\\', {})], \\'edges\\': [(\\'Germany_entity\\', \\'University Hospital of Munich_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Germany_entity\\', \\'University Hospital of Tuebingen_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {}), (\\'Italy_entity\\', {}), (\\'Azienda Ospedaliera_entity\\', {}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {})], \\'edges\\': [(\\'Italy_entity\\', \\'Azienda Ospedaliera_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Netherlands_entity\\', {}), (\\'Prinses Maxima Centrum_entity\\', {})], \\'edges\\': [(\\'Netherlands_entity\\', \\'Prinses Maxima Centrum_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Marciniak Hospital_entity\\', {}), (\\'Poland_entity\\', {}), (\\'Faculty of Medicine_entity\\', {})], \\'edges\\': [(\\'Poland_entity\\', \\'Marciniak Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Poland_entity\\', \\'Faculty of Medicine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'St. Anna Kinderspital/CCRI_entity\\', {}), (\\'Austria_entity\\', {})], \\'edges\\': [(\\'Austria_entity\\', \\'St. Anna Kinderspital/CCRI_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'France_entity\\', {}), (\\'Armand Trousseau Hospital_entity\\', {})], \\'edges\\': [(\\'France_entity\\', \\'Armand Trousseau Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Spain_entity\\', {}), (\\'Hospital Vall d\u2019Hebron_entity\\', {}), (\\'Hospital Universitario Virgin del Rocio_entity\\', {})], \\'edges\\': [(\\'Spain_entity\\', \\'Hospital Universitario Virgin del Rocio_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Spain_entity\\', \\'Hospital Vall d\u2019Hebron_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'United Kingdom_entity\\', {}), (\\'Great Ormond Street Hospital_entity\\', {})], \\'edges\\': [(\\'United Kingdom_entity\\', \\'Great Ormond Street Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Weirich, A._entity\\', {}), (\\'SIOP-9/GPOH_entity\\', {})], \\'edges\\': [(\\'Weirich, A._entity\\', \\'SIOP-9/GPOH_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Pritchard-Jones, K._entity\\', {}), (\\'UKW3_entity\\', {})], \\'edges\\': [(\\'Pritchard-Jones, K._entity\\', \\'UKW3_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed in\\'})]}, {\\'nodes\\': [(\\'SIOP 93\u201301 trial_entity\\', {}), (\\'de Kraker, J._entity\\', {})], \\'edges\\': [(\\'de Kraker, J._entity\\', \\'SIOP 93\u201301 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'SIOP trial and study 93\u201301_entity\\', {}), (\\'Graf, N._entity\\', {})], \\'edges\\': [(\\'Graf, N._entity\\', \\'SIOP trial and study 93\u201301_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Green, D. M._entity\\', {}), (\\'National Wilms Tumor Study Group_entity\\', {})], \\'edges\\': [(\\'Green, D. M._entity\\', \\'National Wilms Tumor Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}, {\\'nodes\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', {}), (\\'SIOP WT 2001 protocol_entity\\', {})], \\'edges\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', \\'SIOP WT 2001 protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Third National Wilms\u2019 Tumor Study_entity\\', {}), (\"D\\'Angio, G. J._entity\", {}), (\\'Second National Wilms\u2019 Tumor Study_entity\\', {})], \\'edges\\': [(\"D\\'Angio, G. J._entity\", \\'Third National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\"D\\'Angio, G. J._entity\", \\'Second National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {}), (\\'Tournade, M. F._entity\\', {}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {})], \\'edges\\': [(\\'Tournade, M. F._entity\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'}), (\\'Tournade, M. F._entity\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Breslow, N. E._entity\\', {}), (\\'National Wilms Tumor Studies_entity\\', {})], \\'edges\\': [(\\'Breslow, N. E._entity\\', \\'National Wilms Tumor Studies_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Mitchell, C._entity\\', {}), (\\'UK Children\u2019s Cancer Study Group_entity\\', {})], \\'edges\\': [(\\'Mitchell, C._entity\\', \\'UK Children\u2019s Cancer Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'under\\'})]}, {\\'nodes\\': [(\\'Daw, N. C._entity\\', {}), (\\'Dix, D. B._entity\\', {}), (\\'Children\u2019s Oncology Group_entity\\', {}), (\\'Grundy, P. E._entity\\', {})], \\'edges\\': [(\\'Daw, N. C._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted under\\'}), (\\'Dix, D. B._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'}), (\\'Grundy, P. E._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}]', expected_output='Preoperative chemotherapy is used to downstage the tumor and assess its chemosensitivity before surgery.', context=None, retrieval_context=['[{\\'nodes\\': [(\\'sample.pdf\\', {\\'type\\': \\'document\\'}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)\\'}), (\\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA SIOP-RTSG 2016\\'}), (\\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms tumours\\'}), (\\'non-Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'non-Wilms tumours\\'}), (\\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Website\\', \\'name\\': \\'www.siop-rtsg.eu\\'}), (\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology\\'}), (\\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Person\\', \\'name\\': \\'Marry M. van den Heuvel-Eibrink\\'}), (\\'childhood renal tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'childhood renal tumours\\'}), (\\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'clear cell sarcoma of the kidney\\'}), (\\'renal cell carcinoma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'renal cell carcinoma\\'}), (\\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'malignant rhabdoid tumour of the kidney\\'}), (\\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'Wilms tumours_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'Children\u2019s Oncology Group (COG)\\'}), (\\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'SIOP\u22122001 randomized trial\\'}), (\\'actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'UKW3 trial\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)\\'}), (\\'localized disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'localized disease\\'}), (\\'metastatic disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'metastatic disease\\'}), (\\'bilateral disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'bilateral disease\\'}), (\\'relapsed disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'relapsed disease\\'}), (\\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subtype\\', \\'name\\': \\'blastemal-type Wilms tumours\\'}), (\\'radiotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgery_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'chemotherapy\\'}), (\\'Wilms Tumour_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms Tumour\\'}), (\\'CCSK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CCSK\\'}), (\\'MRTK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'MRTK\\'}), (\\'CMN_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CMN\\'}), (\\'RCC_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'RCC\\'}), (\\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u22122001_Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Trial\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'vincristine_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'vincristine\\'}), (\\'actinomycin D_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'actinomycin D\\'}), (\\'doxorubicin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'doxorubicin\\'}), (\\'etoposide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'Stage I_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage I\\'}), (\\'Stage II_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage II\\'}), (\\'Stage III_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage III\\'}), (\\'Stage IV_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage IV\\'}), (\\'Stage V_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage V\\'}), (\\'AV_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AV\\'}), (\\'AVD_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AVD\\'}), (\\'HR-1_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'HR-1\\'}), (\\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP-RTSG 2016\\'}), (\\'Overall Survival (OS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'CT-only nodules_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'CT-only nodules\\'}), (\\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP\u2013RTSG analysis\\'}), (\\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials\\'}), (\\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D plus doxorubicin\\'}), (\\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D\\'}), (\\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study_protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'MRI_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'MRI\\'}), (\\'CT_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'CT\\'}), (\\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_detail\\', \\'name\\': \\'cumulative doxorubicin dose\\'}), (\\'COG AREN0533 trial_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG AREN0533 trial\\'}), (\\'etoposide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'high-risk characteristics\\'}), (\\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG board\\'}), (\\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin\\'}), (\\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'high-dose chemotherapy and autologous stem cell transplantation\\'}), (\\'SIOP database_database\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'database\\', \\'name\\': \\'SIOP database\\'}), (\\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'AVD_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AVD\\'}), (\\'AV-2_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AV-2\\'}), (\\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Statistical Test\\', \\'name\\': \\'Log\u2013Rank P\\'}), (\\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'Bilateral Disease (Stage V)\\'}), (\\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Synchronous bilateral Wilms tumor\\'}), (\\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'End-stage renal disease (ESRD)\\'}), (\\'Aronson et al._Research Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Research Group\\', \\'name\\': \\'Aronson et al.\\'}), (\\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'Bilateral nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Study\\', \\'name\\': \\'SIOP\u22122001 study\\'}), (\\'Vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Vincristine\\'}), (\\'Actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Actinomycin D\\'}), (\\'Etoposide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Etoposide\\'}), (\\'Carboplatin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Carboplatin\\'}), (\\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease State\\', \\'name\\': \\'Relapsed Wilms Tumor\\'}), (\\'Group AA_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group AA\\'}), (\\'Group BB_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group BB\\'}), (\\'Group CC_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group CC\\'}), (\\'Doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Doxorubicin\\'}), (\\'Cyclophosphamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Cyclophosphamide\\'}), (\\'Ifosfamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Ifosfamide\\'}), (\\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'High-dose melphalan\\'}), (\\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UKW\u2011R protocol\\'}), (\\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'NWTS\u20115 relapse protocol\\'}), (\\'ASCR_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'procedure\\', \\'name\\': \\'ASCR\\'}), (\\'ifosfamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'ifosfamide\\'}), (\\'nephrotoxicity_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'nephrotoxicity\\'}), (\\'relapsed group CC_patient_group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'patient_group\\', \\'name\\': \\'relapsed group CC\\'}), (\\'diffuse anaplasia_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'diffuse anaplasia\\'}), (\\'blastemal-type tumors_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'blastemal-type tumors\\'}), (\\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'camptothecins_medication_class\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication_class\\', \\'name\\': \\'camptothecins\\'}), (\\'irinotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'irinotecan\\'}), (\\'topotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'topotecan\\'}), (\\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Innovative Therapies for Children with Cancer consortium\\'}), (\\'radiotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgical excision_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgical excision\\'}), (\\'stage IV WT_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'stage IV WT\\'}), (\\'AVD150_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD150\\'}), (\\'AVD250_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD250\\'}), (\\'low-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'low-risk disease\\'}), (\\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'intermediate-risk disease\\'}), (\\'high-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'high-risk disease\\'}), (\\'CDCV_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'CDCV\\'}), (\\'actinomycin-D_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'actinomycin-D\\'}), (\\'vincristine_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'doxorubicin\\'}), (\\'VP16_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'VP16\\'}), (\\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'contact\\', \\'name\\': \\'arnauld.verschuur@ap-hm.fr\\'}), (\\'surgery_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'chemotherapy\\'}), (\\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2212RTSG panel\\'}), (\\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Infant Wilms Tumors\\'}), (\\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'nephrectomy\\'}), (\\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'malignant rhabdoid tumors\\'}), (\\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Adult Wilms Tumors\\'}), (\\'anaplasia_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'anaplasia\\'}), (\\'actinomycin D_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'carboplatin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'etoposide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'etoposide\\'}), (\\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'Nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'radical tumor nephrectomy\\'}), (\\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'lymph node sampling\\'}), (\\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'minimally invasive surgery\\'}), (\\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'laparoscopic surgery\\'}), (\\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'radiotherapy\\'}), (\\'Wilms tumours_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'Davila Fajardo et al._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Davila Fajardo et al.\\'}), (\\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'COG\u2013NWTS trials\\'}), (\\'whole-lung irradiation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'whole-lung irradiation\\'}), (\\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'pulmonary radiotherapy\\'}), (\\'proton therapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'proton therapy\\'}), (\\'dosimetric study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'dosimetric study\\'}), (\\'locoregional disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'locoregional disease\\'}), (\\'metastatic disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'metastatic disease\\'}), (\\'low-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'low-risk\\'}), (\\'intermediate-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'intermediate-risk\\'}), (\\'high-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'high-risk\\'}), (\\'stage I_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage I\\'}), (\\'stage II_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage II\\'}), (\\'stage III_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage III\\'}), (\\'major rupture_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'major rupture\\'}), (\\'Austria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Austria\\'}), (\\'Italy_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Italy\\'}), (\\'San Marino_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'San Marino\\'}), (\\'Iceland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Iceland\\'}), (\\'Germany_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Germany\\'}), (\\'Bulgaria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bulgaria\\'}), (\\'Turkey_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Turkey\\'}), (\\'Denmark_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Denmark\\'}), (\\'Poland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Poland\\'}), (\\'Greece_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Greece\\'}), (\\'Andorra_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Andorra\\'}), (\\'Belgium_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belgium\\'}), (\\'Serbia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Serbia\\'}), (\\'Albania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Albania\\'}), (\\'Moldova_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Moldova\\'}), (\\'Lithuania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Lithuania\\'}), (\\'Latvia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Latvia\\'}), (\\'Estonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Estonia\\'}), (\\'Luxembourg_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Luxembourg\\'}), (\\'Montenegro_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Montenegro\\'}), (\\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bosnia and Herzegovina\\'}), (\\'Croatia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Croatia\\'}), (\\'Slovenia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovenia\\'}), (\\'Macedonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Macedonia\\'}), (\\'United Kingdom_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'United Kingdom\\'}), (\\'Ireland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ireland\\'}), (\\'Spain_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Spain\\'}), (\\'Algeria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Algeria\\'}), (\\'Tunisia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Tunisia\\'}), (\\'Malta_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Malta\\'}), (\\'Morocco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Morocco\\'}), (\\'Portugal_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Portugal\\'}), (\\'France_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'France\\'}), (\\'Monaco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Monaco\\'}), (\\'Russia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Russia\\'}), (\\'Finland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Finland\\'}), (\\'Sweden_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Sweden\\'}), (\\'Norway_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Norway\\'}), (\\'Belarus_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belarus\\'}), (\\'Romania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Romania\\'}), (\\'Ukraine_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ukraine\\'}), (\\'Hungary_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Hungary\\'}), (\\'Czech Republic_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Czech Republic\\'}), (\\'Slovakia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovakia\\'}), (\\'Switzerland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Switzerland\\'}), (\\'Liechtenstein_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Liechtenstein\\'}), (\\'Netherlands_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Netherlands\\'}), (\\'University Hospital of Munich_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Munich\\'}), (\\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Tuebingen\\'}), (\\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Azienda Ospedaliera\\'}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Ospedale Pediatrico Bambino Ges\u00f9\\'}), (\\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Fondazione IRCCS Istituto Nazionale dei Tumori\\'}), (\\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Prinses Maxima Centrum\\'}), (\\'Marciniak Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Marciniak Hospital\\'}), (\\'Faculty of Medicine_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Faculty of Medicine\\'}), (\\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'St. Anna Kinderspital/CCRI\\'}), (\\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Armand Trousseau Hospital\\'}), (\\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Universitario Virgin del Rocio\\'}), (\\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Vall d\u2019Hebron\\'}), (\\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Great Ormond Street Hospital\\'}), (\\'University Hospital Homburg_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital Homburg\\'}), (\\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon\\'}), (\\'UMBRELLA protocol_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'ExPO\u2011r\u2011Net\\'}), (\\'Weirich, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Weirich, A.\\'}), (\\'Pritchard-Jones, K._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Pritchard-Jones, K.\\'}), (\\'de Kraker, J._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'de Kraker, J.\\'}), (\\'Graf, N._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Graf, N.\\'}), (\\'Green, D. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Green, D. M.\\'}), (\\'Spreafico, F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Spreafico, F.\\'}), (\\'Bellani, F. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Bellani, F. F.\\'}), (\\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'van den Heuvel-Eibrink, M. M.\\'}), (\"D\\'Angio, G. J._author\", {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \"D\\'Angio, G. J.\"}), (\\'Tournade, M. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Tournade, M. F.\\'}), (\\'Breslow, N. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Breslow, N. E.\\'}), (\\'Mitchell, C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Mitchell, C.\\'}), (\\'Verschuur, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Verschuur, A.\\'}), (\\'Grundy, P. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Grundy, P. E.\\'}), (\\'Warmann, S. W._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Warmann, S. W.\\'}), (\\'Smets, A. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Smets, A. M.\\'}), (\\'Dome, J. S._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dome, J. S.\\'}), (\\'Dix, D. B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dix, D. B.\\'}), (\\'Daw, N. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Daw, N. C.\\'}), (\\'Ha, T. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Ha, T. C.\\'}), (\\'Kremens, B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Kremens, B.\\'}), (\\'Furtwangler, R._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Furtwangler, R.\\'}), (\\'SIOP-9/GPOH_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP-9/GPOH\\'}), (\\'UKW3_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'UKW3\\'}), (\\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'SIOP 93\u201301 trial\\'}), (\\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP trial and study 93\u201301\\'}), (\\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'National Wilms Tumor Study Group\\'}), (\\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP WT 2001 protocol\\'}), (\\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Third National Wilms\u2019 Tumor Study\\'}), (\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'National Wilms Tumor Studies\\'}), (\\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Second National Wilms\u2019 Tumor Study\\'}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'UK Children\u2019s Cancer Study Group\\'}), (\\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Children\u2019s Oncology Group\\'})], \\'edges\\': [(\\'sample.pdf\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'non-Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'childhood renal tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'renal cell carcinoma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'localized disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'metastatic disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'bilateral disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'relapsed disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'radiotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'surgery_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'chemotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'Wilms Tumour_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CCSK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'MRTK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CMN_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'RCC_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP\u22122001_Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'vincristine_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'actinomycin D_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'doxorubicin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'etoposide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'carboplatin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'cyclophosphamide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage I_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage II_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage III_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage IV_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage V_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AV_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AVD_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'HR-1_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Overall Survival (OS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT-only nodules_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'MRI_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG AREN0533 trial_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'etoposide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'carboplatin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'cyclophosphamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP database_database\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AVD_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AV-2_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Aronson et al._Research Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Etoposide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Carboplatin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group AA_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group BB_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group CC_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Cyclophosphamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Ifosfamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'ASCR_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'ifosfamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'nephrotoxicity_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'relapsed group CC_patient_group\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'diffuse anaplasia_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'blastemal-type tumors_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'camptothecins_medication_class\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'irinotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'topotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'radiotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'surgical excision_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'stage IV WT_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD150_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD250_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'low-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'CDCV_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'actinomycin-D_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'vincristine_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'doxorubicin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'VP16_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'surgery_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'chemotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'anaplasia_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'actinomycin D_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'vincristine_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'doxorubicin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'carboplatin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'cyclophosphamide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'etoposide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'SIOP\u22122001_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Wilms tumours_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Davila Fajardo et al._author\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'whole-lung irradiation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'proton therapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'dosimetric study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'locoregional disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'metastatic disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'low-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'intermediate-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'high-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage I_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage II_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage III_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'major rupture_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Austria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Italy_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'San Marino_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Iceland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Germany_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bulgaria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Turkey_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Denmark_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Poland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Greece_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Andorra_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belgium_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Serbia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Albania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Moldova_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Lithuania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Latvia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Estonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Luxembourg_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Montenegro_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Croatia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovenia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Macedonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'United Kingdom_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ireland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Spain_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Algeria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Tunisia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Malta_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Morocco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Portugal_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'France_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Monaco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Russia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Finland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Sweden_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Norway_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belarus_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Romania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ukraine_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hungary_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Czech Republic_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovakia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Switzerland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Liechtenstein_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Netherlands_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Munich_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Marciniak Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Faculty of Medicine_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital Homburg_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Weirich, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Pritchard-Jones, K._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'de Kraker, J._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Graf, N._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Green, D. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Spreafico, F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Bellani, F. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \"D\\'Angio, G. J._author\", {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Tournade, M. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Breslow, N. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Mitchell, C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Verschuur, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Grundy, P. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Warmann, S. W._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Smets, A. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dome, J. S._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dix, D. B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Daw, N. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ha, T. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Kremens, B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Furtwangler, R._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP-9/GPOH_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UKW3_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10})]}, {\\'nodes\\': [(\\'vincristine_entity\\', {}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {}), (\\'www.siop-rtsg.eu_entity\\', {}), (\\'stage II_entity\\', {}), (\\'Wilms tumours_entity\\', {}), (\\'Relapsed Wilms Tumor_entity\\', {}), (\\'Davila Fajardo et al._entity\\', {}), (\\'vincristine, actinomycin D, and doxorubicin_entity\\', {}), (\\'SIOP\u22122001 randomized trial_entity\\', {}), (\\'surgery_entity\\', {}), (\\'non-Wilms tumours_entity\\', {}), (\\'actinomycin D_entity\\', {}), (\\'diffuse anaplasia_entity\\', {}), (\\'Synchronous bilateral Wilms tumor_entity\\', {}), (\\'CT-only nodules_entity\\', {}), (\\'relapsed group CC_entity\\', {}), (\\'increased relapse risk_entity\\', {}), (\\'reduced survival_entity\\', {}), (\\'UKW3 trial_entity\\', {}), (\\'chemotherapy_entity\\', {}), (\\'Bilateral Disease (Stage V)_entity\\', {}), (\\'blastemal-type tumors_entity\\', {}), (\\'UMBRELLA protocol_entity\\', {}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', {}), (\\'minimally invasive surgery_entity\\', {}), (\\'VP16_entity\\', {}), (\\'Wilms tumor_entity\\', {}), (\\'anaplasia_entity\\', {}), (\\'radical tumor nephrectomy_entity\\', {}), (\\'Innovative Therapies for Children with Cancer consortium_entity\\', {}), (\\'cumulative doxorubicin dose_entity\\', {}), (\\'etoposide_entity\\', {}), (\\'large-volume tumours_entity\\', {}), (\\'Stage IV_entity\\', {}), (\\'CDCV_entity\\', {}), (\\'SIOP\u2013RTSG_entity\\', {}), (\\'AVD150_entity\\', {}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', {}), (\\'laparoscopic surgery_entity\\', {}), (\\'SIOP\u2212RTSG panel_entity\\', {}), (\\'actinomycin-D_entity\\', {}), (\\'COG AREN0533 trial_entity\\', {}), (\\'cyclophosphamide_entity\\', {}), (\\'carboplatin_entity\\', {}), (\\'UKW\u2011R protocol_entity\\', {}), (\\'Nephron-sparing surgery (NSS)_entity\\', {}), (\\'Adult Wilms Tumors_entity\\', {}), (\\'doxorubicin_entity\\', {}), (\\'NWTS\u20115 relapse protocol_entity\\', {}), (\\'End-stage renal disease (ESRD)_entity\\', {}), (\\'AVD250_entity\\', {}), (\\'Children\u2019s Oncology Group (COG)_entity\\', {}), (\\'blastemal-type Wilms tumour_entity\\', {}), (\\'SIOP\u22122001_entity\\', {}), (\\'radiotherapy_entity\\', {}), (\\'childhood renal tumours_entity\\', {})], \\'edges\\': [(\\'vincristine_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'stage II_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'indicated_for_in_adults\\'}), (\\'Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'Wilms tumours_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated under\\'}), (\\'Relapsed Wilms Tumor_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guided_by\\'}), (\\'Davila Fajardo et al._entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed\\'}), (\\'SIOP\u22122001 randomized trial_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated use in\\'}), (\\'surgery_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'non-Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'actinomycin D_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Synchronous bilateral Wilms tumor_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'instance_of\\'}), (\\'CT-only nodules_entity\\', \\'increased relapse risk_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'reduced survival_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included_in\\'}), (\\'relapsed group CC_entity\\', \\'diffuse anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'blastemal-type tumors_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UKW3 trial_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'UKW3 trial_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'chemotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UMBRELLA protocol_entity\\', \\'COG AREN0533 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses_data_from\\'}), (\\'UMBRELLA protocol_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'advises_treatment_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'Innovative Therapies for Children with Cancer consortium_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborates_with\\'}), (\\'UMBRELLA protocol_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'surgery_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is the standard of\\'}), (\\'UMBRELLA protocol_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guides treatment in\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', \\'UKW3 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\\'minimally invasive surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'anaplasia_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'radical tumor nephrectomy_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'standard_of_care_for\\'}), (\\'Stage IV_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'presents in\\'}), (\\'CDCV_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'VP16_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'aims to improve survival rates of\\'}), (\\'AVD150_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed_by\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'succeeds\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'www.siop-rtsg.eu_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'available_on\\'}), (\\'laparoscopic surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'COG AREN0533 trial_entity\\', \\'cumulative doxorubicin dose_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'evaluates\\'}), (\\'UKW\u2011R protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'Nephron-sparing surgery (NSS)_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'classification_developed_by\\'}), (\\'Adult Wilms Tumors_entity\\', \\'anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'Adult Wilms Tumors_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'doxorubicin_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'doxorubicin_entity\\', \\'large-volume tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'recommended for\\'}), (\\'NWTS\u20115 relapse protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'End-stage renal disease (ESRD)_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'AVD250_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'Children\u2019s Oncology Group (COG)_entity\\', \\'SIOP\u22122001 randomized trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborated with\\'}), (\\'blastemal-type Wilms tumour_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment intensified according to\\'}), (\\'SIOP\u22122001_entity\\', \\'vincristine, actinomycin D, and doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses\\'}), (\\'SIOP\u22122001_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provided_guidelines_for\\'}), (\\'radiotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'radiotherapy_entity\\', \\'SIOP\u2212RTSG panel_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'contact_for_guidance\\'})]}, {\\'nodes\\': [(\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {}), (\\'Marry M. van den Heuvel-Eibrink_entity\\', {})], \\'edges\\': [(\\'Marry M. van den Heuvel-Eibrink_entity\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'affiliated_with\\'})]}, {\\'nodes\\': [(\\'Stage II_entity\\', {}), (\\'AV_entity\\', {}), (\\'Stage III_entity\\', {}), (\\'vincestine and actinomycin D_entity\\', {}), (\\'AVD_entity\\', {})], \\'edges\\': [(\\'Stage II_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AV_entity\\', \\'Stage II_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Stage III_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AVD_entity\\', \\'Stage III_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'SIOP-RTSG 2016_entity\\', {}), (\\'RCC_entity\\', {}), (\\'CMN_entity\\', {})], \\'edges\\': [(\\'RCC_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'}), (\\'CMN_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'})]}, {\\'nodes\\': [(\\'HR-1_entity\\', {}), (\\'High-risk blastemal type Wilms tumour_entity\\', {})], \\'edges\\': [(\\'HR-1_entity\\', \\'High-risk blastemal type Wilms tumour_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'unfavorable prognosis_entity\\', {}), (\\'high-risk characteristics_entity\\', {})], \\'edges\\': [(\\'high-risk characteristics_entity\\', \\'unfavorable prognosis_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'leads_to\\'})]}, {\\'nodes\\': [(\\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {}), (\\'SIOP\u2013RTSG board_entity\\', {})], \\'edges\\': [(\\'SIOP\u2013RTSG board_entity\\', \\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggests\\'})]}, {\\'nodes\\': [(\\'regimen and outcomes_entity\\', {}), (\\'SIOP database_entity\\', {})], \\'edges\\': [(\\'SIOP database_entity\\', \\'regimen and outcomes_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'captures_data_on\\'})]}, {\\'nodes\\': [(\\'Bilateral nephron-sparing surgery (NSS)_entity\\', {}), (\\'Aronson et al._entity\\', {})], \\'edges\\': [(\\'Aronson et al._entity\\', \\'Bilateral nephron-sparing surgery (NSS)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'observed_effectiveness_of\\'})]}, {\\'nodes\\': [(\\'SIOP\u22122001 study_entity\\', {}), (\\'Actinomycin D_entity\\', {}), (\\'Vincristine_entity\\', {})], \\'edges\\': [(\\'SIOP\u22122001 study_entity\\', \\'Vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'}), (\\'SIOP\u22122001 study_entity\\', \\'Actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'})]}, {\\'nodes\\': [(\\'High-dose melphalan_entity\\', {}), (\\'Group AA_entity\\', {}), (\\'Carboplatin_entity\\', {}), (\\'Doxorubicin_entity\\', {}), (\\'Etoposide_entity\\', {}), (\\'Group BB_entity\\', {}), (\\'Cyclophosphamide_entity\\', {}), (\\'Ifosfamide_entity\\', {})], \\'edges\\': [(\\'Group AA_entity\\', \\'Doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Ifosfamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'High-dose melphalan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'})]}, {\\'nodes\\': [(\\'nephrotoxicity_entity\\', {}), (\\'ifosfamide_entity\\', {})], \\'edges\\': [(\\'ifosfamide_entity\\', \\'nephrotoxicity_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'related_to\\'})]}, {\\'nodes\\': [(\\'camptothecins_entity\\', {}), (\\'irinotecan_entity\\', {}), (\\'topotecan_entity\\', {})], \\'edges\\': [(\\'camptothecins_entity\\', \\'irinotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'camptothecins_entity\\', \\'topotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'})]}, {\\'nodes\\': [(\\'Infant Wilms Tumors_entity\\', {}), (\\'nephrectomy_entity\\', {})], \\'edges\\': [(\\'Infant Wilms Tumors_entity\\', \\'nephrectomy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_option\\'})]}, {\\'nodes\\': [(\\'congenital mesoblastic nephroma_entity\\', {}), (\\'surgery alone_entity\\', {})], \\'edges\\': [(\\'congenital mesoblastic nephroma_entity\\', \\'surgery alone_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'alternative chemotherapy_entity\\', {}), (\\'malignant rhabdoid tumors_entity\\', {})], \\'edges\\': [(\\'malignant rhabdoid tumors_entity\\', \\'alternative chemotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'lymph node sampling_entity\\', {}), (\\'accurate staging_entity\\', {})], \\'edges\\': [(\\'lymph node sampling_entity\\', \\'accurate staging_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'purpose_of\\'})]}, {\\'nodes\\': [(\\'COG\u2013NWTS trials_entity\\', {}), (\\'whole-lung irradiation_entity\\', {})], \\'edges\\': [(\\'COG\u2013NWTS trials_entity\\', \\'whole-lung irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'informed_dosage_for\\'})]}, {\\'nodes\\': [(\\'lung metastases_entity\\', {}), (\\'pulmonary radiotherapy_entity\\', {})], \\'edges\\': [(\\'pulmonary radiotherapy_entity\\', \\'lung metastases_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'administered_for\\'})]}, {\\'nodes\\': [(\\'dosimetric study_entity\\', {}), (\\'proton therapy_entity\\', {}), (\\'flank irradiation_entity\\', {})], \\'edges\\': [(\\'dosimetric study_entity\\', \\'proton therapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated\\'}), (\\'proton therapy_entity\\', \\'flank irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggested_for\\'})]}, {\\'nodes\\': [(\\'metastatic disease_entity\\', {}), (\\'radiotherapy guidelines_entity\\', {}), (\\'locoregional disease_entity\\', {})], \\'edges\\': [(\\'radiotherapy guidelines_entity\\', \\'locoregional disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'}), (\\'radiotherapy guidelines_entity\\', \\'metastatic disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'})]}, {\\'nodes\\': [(\\'major rupture_entity\\', {}), (\\'stage III_entity\\', {})], \\'edges\\': [(\\'stage III_entity\\', \\'major rupture_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes_condition\\'})]}, {\\'nodes\\': [(\\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {}), (\\'ExPO\u2011r\u2011Net_entity\\', {})], \\'edges\\': [(\\'ExPO\u2011r\u2011Net_entity\\', \\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is part of\\'})]}, {\\'nodes\\': [(\\'University Hospital of Munich_entity\\', {}), (\\'Germany_entity\\', {}), (\\'University Hospital of Tuebingen_entity\\', {})], \\'edges\\': [(\\'Germany_entity\\', \\'University Hospital of Munich_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Germany_entity\\', \\'University Hospital of Tuebingen_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {}), (\\'Italy_entity\\', {}), (\\'Azienda Ospedaliera_entity\\', {}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {})], \\'edges\\': [(\\'Italy_entity\\', \\'Azienda Ospedaliera_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Netherlands_entity\\', {}), (\\'Prinses Maxima Centrum_entity\\', {})], \\'edges\\': [(\\'Netherlands_entity\\', \\'Prinses Maxima Centrum_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Marciniak Hospital_entity\\', {}), (\\'Poland_entity\\', {}), (\\'Faculty of Medicine_entity\\', {})], \\'edges\\': [(\\'Poland_entity\\', \\'Marciniak Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Poland_entity\\', \\'Faculty of Medicine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'St. Anna Kinderspital/CCRI_entity\\', {}), (\\'Austria_entity\\', {})], \\'edges\\': [(\\'Austria_entity\\', \\'St. Anna Kinderspital/CCRI_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'France_entity\\', {}), (\\'Armand Trousseau Hospital_entity\\', {})], \\'edges\\': [(\\'France_entity\\', \\'Armand Trousseau Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Spain_entity\\', {}), (\\'Hospital Vall d\u2019Hebron_entity\\', {}), (\\'Hospital Universitario Virgin del Rocio_entity\\', {})], \\'edges\\': [(\\'Spain_entity\\', \\'Hospital Universitario Virgin del Rocio_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Spain_entity\\', \\'Hospital Vall d\u2019Hebron_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'United Kingdom_entity\\', {}), (\\'Great Ormond Street Hospital_entity\\', {})], \\'edges\\': [(\\'United Kingdom_entity\\', \\'Great Ormond Street Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Weirich, A._entity\\', {}), (\\'SIOP-9/GPOH_entity\\', {})], \\'edges\\': [(\\'Weirich, A._entity\\', \\'SIOP-9/GPOH_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Pritchard-Jones, K._entity\\', {}), (\\'UKW3_entity\\', {})], \\'edges\\': [(\\'Pritchard-Jones, K._entity\\', \\'UKW3_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed in\\'})]}, {\\'nodes\\': [(\\'SIOP 93\u201301 trial_entity\\', {}), (\\'de Kraker, J._entity\\', {})], \\'edges\\': [(\\'de Kraker, J._entity\\', \\'SIOP 93\u201301 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'SIOP trial and study 93\u201301_entity\\', {}), (\\'Graf, N._entity\\', {})], \\'edges\\': [(\\'Graf, N._entity\\', \\'SIOP trial and study 93\u201301_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Green, D. M._entity\\', {}), (\\'National Wilms Tumor Study Group_entity\\', {})], \\'edges\\': [(\\'Green, D. M._entity\\', \\'National Wilms Tumor Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}, {\\'nodes\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', {}), (\\'SIOP WT 2001 protocol_entity\\', {})], \\'edges\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', \\'SIOP WT 2001 protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Third National Wilms\u2019 Tumor Study_entity\\', {}), (\"D\\'Angio, G. J._entity\", {}), (\\'Second National Wilms\u2019 Tumor Study_entity\\', {})], \\'edges\\': [(\"D\\'Angio, G. J._entity\", \\'Third National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\"D\\'Angio, G. J._entity\", \\'Second National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {}), (\\'Tournade, M. F._entity\\', {}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {})], \\'edges\\': [(\\'Tournade, M. F._entity\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'}), (\\'Tournade, M. F._entity\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Breslow, N. E._entity\\', {}), (\\'National Wilms Tumor Studies_entity\\', {})], \\'edges\\': [(\\'Breslow, N. E._entity\\', \\'National Wilms Tumor Studies_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Mitchell, C._entity\\', {}), (\\'UK Children\u2019s Cancer Study Group_entity\\', {})], \\'edges\\': [(\\'Mitchell, C._entity\\', \\'UK Children\u2019s Cancer Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'under\\'})]}, {\\'nodes\\': [(\\'Daw, N. C._entity\\', {}), (\\'Dix, D. B._entity\\', {}), (\\'Children\u2019s Oncology Group_entity\\', {}), (\\'Grundy, P. E._entity\\', {})], \\'edges\\': [(\\'Daw, N. C._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted under\\'}), (\\'Dix, D. B._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'}), (\\'Grundy, P. E._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}]']), TestResult(name='test_case_15', success=False, metrics_data=[MetricData(name='Answer Correctness (GEval)', threshold=0.5, success=False, score=0.28490203853727103, reason='The actual output provides extensive detail about various entities and treatments, but it does not convey the comprehensive and wide-ranging approach to treating all paediatric renal tumours as stated in the expected output.', strict_mode=False, evaluation_model='gpt-4o-mini', error=None, evaluation_cost=0.0033041999999999993, verbose_logs='Criteria:\\nNone \\n \\nEvaluation Steps:\\n[\\n    \"Determine whether the actual output is factually correct based on the expected output.\"\\n]'), MetricData(name='Faithfulness', threshold=0.7, success=True, score=0.782608695652174, reason=None, strict_mode=False, evaluation_model='gpt-4o-mini', error=None, evaluation_cost=0.007887149999999999, verbose_logs='Truths (limit=None):\\n[\\n    \"The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG) is an organization.\",\\n    \"The UMBRELLA SIOP-RTSG 2016 is a protocol.\",\\n    \"The SIOP\u22122001 is a protocol.\",\\n    \"Wilms tumours and non-Wilms tumours are types of diseases found in childhood renal tumors.\",\\n    \"The website for the SIOP\u2013RTSG is www.siop-rtsg.eu.\",\\n    \"The Department of Paediatric Oncology is located at the Princess M\u00e1xima Center for Paediatric Oncology.\",\\n    \"Marry M. van den Heuvel-Eibrink is a referenced person in the study.\",\\n    \"Childhood renal tumours, clear cell sarcoma of the kidney, renal cell carcinoma, malignant rhabdoid tumour of the kidney, and congenital mesoblastic nephroma are types of diseases related to renal tumors.\",\\n    \"The UMBRELLA protocol is a treatment protocol.\",\\n    \"The Children\u2019s Oncology Group (COG) is an organization involved in pediatric oncology.\",\\n    \"The SIOP\u22122001 randomized trial is a clinical trial.\",\\n    \"Vincristine, actinomycin D, and doxorubicin are drugs used in the treatment of Wilms tumours.\",\\n    \"Localized disease, metastatic disease, bilateral disease, and relapsed disease are stages of Wilms tumour.\",\\n    \"Radiotherapy, surgery, and chemotherapy are treatment methods for Wilms tumours.\",\\n    \"Wilms tumour is also known as Wilms Tumour.\",\\n    \"CCSK stands for clear cell sarcoma of the kidney; MRTK refers to malignant rhabdoid tumours of the kidney; CMN refers to congenital mesoblastic nephroma; RCC stands for renal cell carcinoma.\",\\n    \"The UMBRELLA protocol has different stages, including Stage I, II, III, IV, and V.\",\\n    \"AV and AVD are treatment combinations used in oncology.\",\\n    \"SIOP-RTSG 2016 and SIOP\u22122001 are protocols addressing pediatric renal tumors.\",\\n    \"Overall Survival (OS) and Event-Free Survival (EFS) are metrics used in clinical trials related to Wilms tumours.\",\\n    \"The UK Children\u2019s Cancer and Leukaemia Group (UKCCLG) is an organization involved in childhood cancer studies.\",\\n    \"Nephrotoxicity is a condition related to the treatment of renal tumors.\",\\n    \"High-risk characteristics can indicate a poor prognosis in patients with Wilms tumours.\",\\n    \"Somatic mutations like diffuse anaplasia can be associated with the prognosis in Wilms tumours.\",\\n    \"Bilateral nephron-sparing surgery (NSS) is a treatment method for certain kidney diseases.\",\\n    \"Several hospitals and institutions across Europe are involved in the treatment of childhood renal tumors, including University Hospital of Munich and Fondazione IRCCS Istituto Nazionale dei Tumori.\",\\n    \"The SIOP database tracks treatment regimens and outcomes related to Wilms tumours.\",\\n    \"Chemotherapy regimens may include medications like cyclophosphamide, doxorubicin, etoposide, or ifosfamide depending on the protocol and individual characteristics.\",\\n    \"Surgical procedures for Wilms tumors may involve nephrectomy or radical tumor nephrectomy.\",\\n    \"Cooperative groups like the National Wilms Tumor Study Group and the SIOP-RTSG play significant roles in developing treatment protocols for Wilms tumours.\"\\n] \\n \\nClaims:\\n[\\n    \"The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG) is an organization.\",\\n    \"The UMBRELLA SIOP-RTSG 2016 is a protocol.\",\\n    \"The SIOP\u22122001 is a protocol.\",\\n    \"Wilms tumours is a disease.\",\\n    \"Non-Wilms tumours is a disease.\",\\n    \"The website www.siop-rtsg.eu is associated with SIOP\u2013RTSG.\",\\n    \"The Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology is an institution.\",\\n    \"Marry M. van den Heuvel-Eibrink is a person associated with the Department of Paediatric Oncology.\",\\n    \"Childhood renal tumours is a disease.\",\\n    \"Clear cell sarcoma of the kidney is a disease.\",\\n    \"Renal cell carcinoma is a disease.\",\\n    \"Malignant rhabdoid tumour of the kidney is a disease.\",\\n    \"Congenital mesoblastic nephroma is a disease.\",\\n    \"Wilms tumours is a condition.\",\\n    \"The UMBRELLA protocol is a treatment protocol.\",\\n    \"The SIOP\u2013RTSG is an organization.\",\\n    \"Children\u2019s Oncology Group (COG) is an organization.\",\\n    \"The SIOP\u22122001 randomized trial is a clinical trial.\",\\n    \"Actinomycin D, vincristine, and doxorubicin are drugs used in treatment protocols.\",\\n    \"The UKW3 trial is a clinical trial.\",\\n    \"UK Children\u2019s Cancer and Leukaemia Group (UKCCLG) is an organization.\",\\n    \"Localized disease, metastatic disease, bilateral disease, and relapsed disease are stages of disease.\",\\n    \"Blastemal-type Wilms tumours is a subtype of Wilms tumours.\",\\n    \"Radiotherapy, surgery, and chemotherapy are treatment methods for various conditions.\",\\n    \"The UMBRELLA protocol serves as a treatment protocol for certain kidney diseases.\",\\n    \"The SIOP\u22122001 is a trial related to kidney tumors.\",\\n    \"The usage of the drugs actinomycin D, vincristine, and doxorubicin is noted in the treatment of Wilms tumours.\",\\n    \"The metrics Overall Survival (OS) and Event-Free Survival (EFS) are used to measure treatment outcomes.\",\\n    \"The SIOP database captures data on regimen and outcomes.\",\\n    \"High-dose melphalan is a treatment method.\",\\n    \"SIOP\u2013RTSG board is an organization that suggests high-dose chemotherapy and autologous stem cell transplantation.\",\\n    \"The COG AREN0533 trial is a study evaluating treatments for kidney tumors.\"\\n] \\n \\nVerdicts:\\n[\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"Wilms tumours are not a disease; they are a type of childhood renal tumor.\"\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"Non-Wilms tumours are not explicitly defined as a disease type in the context; rather, non-Wilms tumors are a category that includes multiple types of kidney tumors.\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"Marry M. van den Heuvel-Eibrink is referenced in the context, but no claim is made regarding her association with the Department of Paediatric Oncology.\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"Wilms tumours are commonly referred to as a type of kidney tumor rather than simply a condition.\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"The claim about blastemal-type Wilms tumours lacks context since it is not explicitly mentioned in the provided information.\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"idk\",\\n        \"reason\": null\\n    }\\n]'), MetricData(name='Contextual Relevancy', threshold=1.0, success=False, score=0.3333333333333333, reason='The score is 0.33 because the contextual retrieval mostly references the \\'UMBRELLA\\' protocols but fails to explain their significance or symbolism, stating that \"it does not clarify how it directly relates to the term \\'UMBRELLA\\'\" and that \"this protocol is not synonymous or directly tied to the meaning of \\'UMBRELLA\\'\". Thus, while the term appears, the surrounding context does not sufficiently support understanding its symbolic meaning.', strict_mode=False, evaluation_model='gpt-4o-mini', error=None, evaluation_cost=0.00379065, verbose_logs='Verdicts:\\n[\\n    {\\n        \"verdicts\": [\\n            {\\n                \"statement\": \"UMBRELLA SIOP-RTSG 2016_Protocol\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"UMBRELLA protocol_Treatment Protocol\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"UMBRELLA protocol_Project\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"UMBRELLA protocol_Protocol\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"Wilms tumours_Disease\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"While it mentions a relevant disease, it does not clarify how it directly relates to the term \\'UMBRELLA\\'.\"\\n            },\\n            {\\n                \"statement\": \"non-Wilms tumours_Disease\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"This entity is not directly related to the \\'UMBRELLA\\' symbolism.\"\\n            },\\n            {\\n                \"statement\": \"SIOP\\\\u22122001_Protocol\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"This protocol is not synonymous or directly tied to the meaning of \\'UMBRELLA\\'.\"\\n            },\\n            {\\n                \"statement\": \"Department of Paediatric Oncology, Princess M\\\\u00e1xima Center for Paediatric Oncology_Institution\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"While it relates to pediatric oncology, it does not connect specifically to the \\'UMBRELLA\\' symbolism.\"\\n            },\\n            {\\n                \"statement\": \"Marry M. van den Heuvel-Eibrink_Person\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"The individual mentioned does not directly contribute to understanding the \\'UMBRELLA\\' symbolism.\"\\n            },\\n            {\\n                \"statement\": \"Childhood renal tumours_Disease\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"This description relates to a condition, not directly to the symbolism of \\'UMBRELLA\\'.\"\\n            },\\n            {\\n                \"statement\": \"Radiotherapy_Treatment Method\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"This method is a treatment approach, not directly linked to the symbolism of \\'UMBRELLA\\'.\"\\n            },\\n            {\\n                \"statement\": \"surgery_Treatment Method\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"This surgical option does not provide insight into what \\'UMBRELLA\\' symbolizes.\"\\n            }\\n        ]\\n    }\\n]')], conversational=False, multimodal=False, input='What does the term \u2018UMBRELLA\u2019 symbolize in this context?', actual_output='[{\\'nodes\\': [(\\'sample.pdf\\', {\\'type\\': \\'document\\'}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)\\'}), (\\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA SIOP-RTSG 2016\\'}), (\\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms tumours\\'}), (\\'non-Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'non-Wilms tumours\\'}), (\\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Website\\', \\'name\\': \\'www.siop-rtsg.eu\\'}), (\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology\\'}), (\\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Person\\', \\'name\\': \\'Marry M. van den Heuvel-Eibrink\\'}), (\\'childhood renal tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'childhood renal tumours\\'}), (\\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'clear cell sarcoma of the kidney\\'}), (\\'renal cell carcinoma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'renal cell carcinoma\\'}), (\\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'malignant rhabdoid tumour of the kidney\\'}), (\\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'Wilms tumours_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'Children\u2019s Oncology Group (COG)\\'}), (\\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'SIOP\u22122001 randomized trial\\'}), (\\'actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'UKW3 trial\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)\\'}), (\\'localized disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'localized disease\\'}), (\\'metastatic disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'metastatic disease\\'}), (\\'bilateral disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'bilateral disease\\'}), (\\'relapsed disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'relapsed disease\\'}), (\\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subtype\\', \\'name\\': \\'blastemal-type Wilms tumours\\'}), (\\'radiotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgery_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'chemotherapy\\'}), (\\'Wilms Tumour_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms Tumour\\'}), (\\'CCSK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CCSK\\'}), (\\'MRTK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'MRTK\\'}), (\\'CMN_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CMN\\'}), (\\'RCC_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'RCC\\'}), (\\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u22122001_Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Trial\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'vincristine_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'vincristine\\'}), (\\'actinomycin D_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'actinomycin D\\'}), (\\'doxorubicin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'doxorubicin\\'}), (\\'etoposide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'Stage I_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage I\\'}), (\\'Stage II_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage II\\'}), (\\'Stage III_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage III\\'}), (\\'Stage IV_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage IV\\'}), (\\'Stage V_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage V\\'}), (\\'AV_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AV\\'}), (\\'AVD_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AVD\\'}), (\\'HR-1_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'HR-1\\'}), (\\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP-RTSG 2016\\'}), (\\'Overall Survival (OS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'CT-only nodules_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'CT-only nodules\\'}), (\\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP\u2013RTSG analysis\\'}), (\\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials\\'}), (\\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D plus doxorubicin\\'}), (\\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D\\'}), (\\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study_protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'MRI_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'MRI\\'}), (\\'CT_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'CT\\'}), (\\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_detail\\', \\'name\\': \\'cumulative doxorubicin dose\\'}), (\\'COG AREN0533 trial_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG AREN0533 trial\\'}), (\\'etoposide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'high-risk characteristics\\'}), (\\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG board\\'}), (\\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin\\'}), (\\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'high-dose chemotherapy and autologous stem cell transplantation\\'}), (\\'SIOP database_database\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'database\\', \\'name\\': \\'SIOP database\\'}), (\\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'AVD_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AVD\\'}), (\\'AV-2_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AV-2\\'}), (\\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Statistical Test\\', \\'name\\': \\'Log\u2013Rank P\\'}), (\\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'Bilateral Disease (Stage V)\\'}), (\\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Synchronous bilateral Wilms tumor\\'}), (\\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'End-stage renal disease (ESRD)\\'}), (\\'Aronson et al._Research Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Research Group\\', \\'name\\': \\'Aronson et al.\\'}), (\\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'Bilateral nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Study\\', \\'name\\': \\'SIOP\u22122001 study\\'}), (\\'Vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Vincristine\\'}), (\\'Actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Actinomycin D\\'}), (\\'Etoposide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Etoposide\\'}), (\\'Carboplatin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Carboplatin\\'}), (\\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease State\\', \\'name\\': \\'Relapsed Wilms Tumor\\'}), (\\'Group AA_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group AA\\'}), (\\'Group BB_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group BB\\'}), (\\'Group CC_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group CC\\'}), (\\'Doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Doxorubicin\\'}), (\\'Cyclophosphamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Cyclophosphamide\\'}), (\\'Ifosfamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Ifosfamide\\'}), (\\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'High-dose melphalan\\'}), (\\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UKW\u2011R protocol\\'}), (\\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'NWTS\u20115 relapse protocol\\'}), (\\'ASCR_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'procedure\\', \\'name\\': \\'ASCR\\'}), (\\'ifosfamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'ifosfamide\\'}), (\\'nephrotoxicity_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'nephrotoxicity\\'}), (\\'relapsed group CC_patient_group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'patient_group\\', \\'name\\': \\'relapsed group CC\\'}), (\\'diffuse anaplasia_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'diffuse anaplasia\\'}), (\\'blastemal-type tumors_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'blastemal-type tumors\\'}), (\\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'camptothecins_medication_class\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication_class\\', \\'name\\': \\'camptothecins\\'}), (\\'irinotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'irinotecan\\'}), (\\'topotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'topotecan\\'}), (\\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Innovative Therapies for Children with Cancer consortium\\'}), (\\'radiotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgical excision_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgical excision\\'}), (\\'stage IV WT_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'stage IV WT\\'}), (\\'AVD150_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD150\\'}), (\\'AVD250_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD250\\'}), (\\'low-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'low-risk disease\\'}), (\\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'intermediate-risk disease\\'}), (\\'high-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'high-risk disease\\'}), (\\'CDCV_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'CDCV\\'}), (\\'actinomycin-D_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'actinomycin-D\\'}), (\\'vincristine_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'doxorubicin\\'}), (\\'VP16_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'VP16\\'}), (\\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'contact\\', \\'name\\': \\'arnauld.verschuur@ap-hm.fr\\'}), (\\'surgery_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'chemotherapy\\'}), (\\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2212RTSG panel\\'}), (\\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Infant Wilms Tumors\\'}), (\\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'nephrectomy\\'}), (\\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'malignant rhabdoid tumors\\'}), (\\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Adult Wilms Tumors\\'}), (\\'anaplasia_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'anaplasia\\'}), (\\'actinomycin D_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'carboplatin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'etoposide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'etoposide\\'}), (\\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'Nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'radical tumor nephrectomy\\'}), (\\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'lymph node sampling\\'}), (\\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'minimally invasive surgery\\'}), (\\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'laparoscopic surgery\\'}), (\\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'radiotherapy\\'}), (\\'Wilms tumours_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'Davila Fajardo et al._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Davila Fajardo et al.\\'}), (\\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'COG\u2013NWTS trials\\'}), (\\'whole-lung irradiation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'whole-lung irradiation\\'}), (\\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'pulmonary radiotherapy\\'}), (\\'proton therapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'proton therapy\\'}), (\\'dosimetric study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'dosimetric study\\'}), (\\'locoregional disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'locoregional disease\\'}), (\\'metastatic disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'metastatic disease\\'}), (\\'low-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'low-risk\\'}), (\\'intermediate-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'intermediate-risk\\'}), (\\'high-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'high-risk\\'}), (\\'stage I_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage I\\'}), (\\'stage II_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage II\\'}), (\\'stage III_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage III\\'}), (\\'major rupture_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'major rupture\\'}), (\\'Austria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Austria\\'}), (\\'Italy_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Italy\\'}), (\\'San Marino_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'San Marino\\'}), (\\'Iceland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Iceland\\'}), (\\'Germany_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Germany\\'}), (\\'Bulgaria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bulgaria\\'}), (\\'Turkey_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Turkey\\'}), (\\'Denmark_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Denmark\\'}), (\\'Poland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Poland\\'}), (\\'Greece_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Greece\\'}), (\\'Andorra_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Andorra\\'}), (\\'Belgium_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belgium\\'}), (\\'Serbia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Serbia\\'}), (\\'Albania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Albania\\'}), (\\'Moldova_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Moldova\\'}), (\\'Lithuania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Lithuania\\'}), (\\'Latvia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Latvia\\'}), (\\'Estonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Estonia\\'}), (\\'Luxembourg_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Luxembourg\\'}), (\\'Montenegro_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Montenegro\\'}), (\\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bosnia and Herzegovina\\'}), (\\'Croatia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Croatia\\'}), (\\'Slovenia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovenia\\'}), (\\'Macedonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Macedonia\\'}), (\\'United Kingdom_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'United Kingdom\\'}), (\\'Ireland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ireland\\'}), (\\'Spain_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Spain\\'}), (\\'Algeria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Algeria\\'}), (\\'Tunisia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Tunisia\\'}), (\\'Malta_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Malta\\'}), (\\'Morocco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Morocco\\'}), (\\'Portugal_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Portugal\\'}), (\\'France_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'France\\'}), (\\'Monaco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Monaco\\'}), (\\'Russia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Russia\\'}), (\\'Finland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Finland\\'}), (\\'Sweden_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Sweden\\'}), (\\'Norway_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Norway\\'}), (\\'Belarus_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belarus\\'}), (\\'Romania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Romania\\'}), (\\'Ukraine_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ukraine\\'}), (\\'Hungary_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Hungary\\'}), (\\'Czech Republic_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Czech Republic\\'}), (\\'Slovakia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovakia\\'}), (\\'Switzerland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Switzerland\\'}), (\\'Liechtenstein_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Liechtenstein\\'}), (\\'Netherlands_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Netherlands\\'}), (\\'University Hospital of Munich_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Munich\\'}), (\\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Tuebingen\\'}), (\\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Azienda Ospedaliera\\'}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Ospedale Pediatrico Bambino Ges\u00f9\\'}), (\\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Fondazione IRCCS Istituto Nazionale dei Tumori\\'}), (\\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Prinses Maxima Centrum\\'}), (\\'Marciniak Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Marciniak Hospital\\'}), (\\'Faculty of Medicine_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Faculty of Medicine\\'}), (\\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'St. Anna Kinderspital/CCRI\\'}), (\\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Armand Trousseau Hospital\\'}), (\\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Universitario Virgin del Rocio\\'}), (\\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Vall d\u2019Hebron\\'}), (\\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Great Ormond Street Hospital\\'}), (\\'University Hospital Homburg_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital Homburg\\'}), (\\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon\\'}), (\\'UMBRELLA protocol_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'ExPO\u2011r\u2011Net\\'}), (\\'Weirich, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Weirich, A.\\'}), (\\'Pritchard-Jones, K._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Pritchard-Jones, K.\\'}), (\\'de Kraker, J._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'de Kraker, J.\\'}), (\\'Graf, N._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Graf, N.\\'}), (\\'Green, D. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Green, D. M.\\'}), (\\'Spreafico, F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Spreafico, F.\\'}), (\\'Bellani, F. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Bellani, F. F.\\'}), (\\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'van den Heuvel-Eibrink, M. M.\\'}), (\"D\\'Angio, G. J._author\", {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \"D\\'Angio, G. J.\"}), (\\'Tournade, M. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Tournade, M. F.\\'}), (\\'Breslow, N. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Breslow, N. E.\\'}), (\\'Mitchell, C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Mitchell, C.\\'}), (\\'Verschuur, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Verschuur, A.\\'}), (\\'Grundy, P. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Grundy, P. E.\\'}), (\\'Warmann, S. W._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Warmann, S. W.\\'}), (\\'Smets, A. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Smets, A. M.\\'}), (\\'Dome, J. S._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dome, J. S.\\'}), (\\'Dix, D. B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dix, D. B.\\'}), (\\'Daw, N. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Daw, N. C.\\'}), (\\'Ha, T. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Ha, T. C.\\'}), (\\'Kremens, B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Kremens, B.\\'}), (\\'Furtwangler, R._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Furtwangler, R.\\'}), (\\'SIOP-9/GPOH_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP-9/GPOH\\'}), (\\'UKW3_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'UKW3\\'}), (\\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'SIOP 93\u201301 trial\\'}), (\\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP trial and study 93\u201301\\'}), (\\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'National Wilms Tumor Study Group\\'}), (\\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP WT 2001 protocol\\'}), (\\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Third National Wilms\u2019 Tumor Study\\'}), (\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'National Wilms Tumor Studies\\'}), (\\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Second National Wilms\u2019 Tumor Study\\'}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'UK Children\u2019s Cancer Study Group\\'}), (\\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Children\u2019s Oncology Group\\'})], \\'edges\\': [(\\'sample.pdf\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'non-Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'childhood renal tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'renal cell carcinoma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'localized disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'metastatic disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'bilateral disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'relapsed disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'radiotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'surgery_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'chemotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'Wilms Tumour_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CCSK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'MRTK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CMN_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'RCC_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP\u22122001_Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'vincristine_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'actinomycin D_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'doxorubicin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'etoposide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'carboplatin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'cyclophosphamide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage I_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage II_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage III_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage IV_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage V_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AV_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AVD_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'HR-1_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Overall Survival (OS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT-only nodules_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'MRI_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG AREN0533 trial_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'etoposide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'carboplatin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'cyclophosphamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP database_database\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AVD_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AV-2_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Aronson et al._Research Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Etoposide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Carboplatin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group AA_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group BB_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group CC_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Cyclophosphamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Ifosfamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'ASCR_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'ifosfamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'nephrotoxicity_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'relapsed group CC_patient_group\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'diffuse anaplasia_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'blastemal-type tumors_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'camptothecins_medication_class\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'irinotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'topotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'radiotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'surgical excision_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'stage IV WT_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD150_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD250_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'low-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'CDCV_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'actinomycin-D_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'vincristine_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'doxorubicin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'VP16_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'surgery_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'chemotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'anaplasia_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'actinomycin D_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'vincristine_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'doxorubicin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'carboplatin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'cyclophosphamide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'etoposide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'SIOP\u22122001_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Wilms tumours_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Davila Fajardo et al._author\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'whole-lung irradiation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'proton therapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'dosimetric study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'locoregional disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'metastatic disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'low-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'intermediate-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'high-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage I_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage II_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage III_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'major rupture_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Austria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Italy_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'San Marino_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Iceland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Germany_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bulgaria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Turkey_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Denmark_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Poland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Greece_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Andorra_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belgium_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Serbia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Albania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Moldova_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Lithuania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Latvia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Estonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Luxembourg_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Montenegro_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Croatia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovenia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Macedonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'United Kingdom_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ireland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Spain_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Algeria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Tunisia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Malta_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Morocco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Portugal_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'France_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Monaco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Russia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Finland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Sweden_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Norway_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belarus_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Romania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ukraine_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hungary_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Czech Republic_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovakia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Switzerland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Liechtenstein_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Netherlands_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Munich_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Marciniak Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Faculty of Medicine_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital Homburg_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Weirich, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Pritchard-Jones, K._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'de Kraker, J._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Graf, N._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Green, D. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Spreafico, F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Bellani, F. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \"D\\'Angio, G. J._author\", {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Tournade, M. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Breslow, N. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Mitchell, C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Verschuur, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Grundy, P. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Warmann, S. W._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Smets, A. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dome, J. S._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dix, D. B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Daw, N. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ha, T. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Kremens, B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Furtwangler, R._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP-9/GPOH_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UKW3_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10})]}, {\\'nodes\\': [(\\'vincristine_entity\\', {}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {}), (\\'www.siop-rtsg.eu_entity\\', {}), (\\'stage II_entity\\', {}), (\\'Wilms tumours_entity\\', {}), (\\'Relapsed Wilms Tumor_entity\\', {}), (\\'Davila Fajardo et al._entity\\', {}), (\\'vincristine, actinomycin D, and doxorubicin_entity\\', {}), (\\'SIOP\u22122001 randomized trial_entity\\', {}), (\\'surgery_entity\\', {}), (\\'non-Wilms tumours_entity\\', {}), (\\'actinomycin D_entity\\', {}), (\\'diffuse anaplasia_entity\\', {}), (\\'Synchronous bilateral Wilms tumor_entity\\', {}), (\\'CT-only nodules_entity\\', {}), (\\'relapsed group CC_entity\\', {}), (\\'increased relapse risk_entity\\', {}), (\\'reduced survival_entity\\', {}), (\\'UKW3 trial_entity\\', {}), (\\'chemotherapy_entity\\', {}), (\\'Bilateral Disease (Stage V)_entity\\', {}), (\\'blastemal-type tumors_entity\\', {}), (\\'UMBRELLA protocol_entity\\', {}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', {}), (\\'minimally invasive surgery_entity\\', {}), (\\'VP16_entity\\', {}), (\\'Wilms tumor_entity\\', {}), (\\'anaplasia_entity\\', {}), (\\'radical tumor nephrectomy_entity\\', {}), (\\'Innovative Therapies for Children with Cancer consortium_entity\\', {}), (\\'cumulative doxorubicin dose_entity\\', {}), (\\'etoposide_entity\\', {}), (\\'large-volume tumours_entity\\', {}), (\\'Stage IV_entity\\', {}), (\\'CDCV_entity\\', {}), (\\'SIOP\u2013RTSG_entity\\', {}), (\\'AVD150_entity\\', {}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', {}), (\\'laparoscopic surgery_entity\\', {}), (\\'SIOP\u2212RTSG panel_entity\\', {}), (\\'actinomycin-D_entity\\', {}), (\\'COG AREN0533 trial_entity\\', {}), (\\'cyclophosphamide_entity\\', {}), (\\'carboplatin_entity\\', {}), (\\'UKW\u2011R protocol_entity\\', {}), (\\'Nephron-sparing surgery (NSS)_entity\\', {}), (\\'Adult Wilms Tumors_entity\\', {}), (\\'doxorubicin_entity\\', {}), (\\'NWTS\u20115 relapse protocol_entity\\', {}), (\\'End-stage renal disease (ESRD)_entity\\', {}), (\\'AVD250_entity\\', {}), (\\'Children\u2019s Oncology Group (COG)_entity\\', {}), (\\'blastemal-type Wilms tumour_entity\\', {}), (\\'SIOP\u22122001_entity\\', {}), (\\'radiotherapy_entity\\', {}), (\\'childhood renal tumours_entity\\', {})], \\'edges\\': [(\\'vincristine_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'stage II_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'indicated_for_in_adults\\'}), (\\'Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'Wilms tumours_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated under\\'}), (\\'Relapsed Wilms Tumor_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guided_by\\'}), (\\'Davila Fajardo et al._entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed\\'}), (\\'SIOP\u22122001 randomized trial_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated use in\\'}), (\\'surgery_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'non-Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'actinomycin D_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Synchronous bilateral Wilms tumor_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'instance_of\\'}), (\\'CT-only nodules_entity\\', \\'increased relapse risk_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'reduced survival_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included_in\\'}), (\\'relapsed group CC_entity\\', \\'diffuse anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'blastemal-type tumors_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UKW3 trial_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'UKW3 trial_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'chemotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UMBRELLA protocol_entity\\', \\'COG AREN0533 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses_data_from\\'}), (\\'UMBRELLA protocol_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'advises_treatment_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'Innovative Therapies for Children with Cancer consortium_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborates_with\\'}), (\\'UMBRELLA protocol_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'surgery_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is the standard of\\'}), (\\'UMBRELLA protocol_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guides treatment in\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', \\'UKW3 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\\'minimally invasive surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'anaplasia_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'radical tumor nephrectomy_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'standard_of_care_for\\'}), (\\'Stage IV_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'presents in\\'}), (\\'CDCV_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'VP16_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'aims to improve survival rates of\\'}), (\\'AVD150_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed_by\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'succeeds\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'www.siop-rtsg.eu_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'available_on\\'}), (\\'laparoscopic surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'COG AREN0533 trial_entity\\', \\'cumulative doxorubicin dose_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'evaluates\\'}), (\\'UKW\u2011R protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'Nephron-sparing surgery (NSS)_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'classification_developed_by\\'}), (\\'Adult Wilms Tumors_entity\\', \\'anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'Adult Wilms Tumors_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'doxorubicin_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'doxorubicin_entity\\', \\'large-volume tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'recommended for\\'}), (\\'NWTS\u20115 relapse protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'End-stage renal disease (ESRD)_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'AVD250_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'Children\u2019s Oncology Group (COG)_entity\\', \\'SIOP\u22122001 randomized trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborated with\\'}), (\\'blastemal-type Wilms tumour_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment intensified according to\\'}), (\\'SIOP\u22122001_entity\\', \\'vincristine, actinomycin D, and doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses\\'}), (\\'SIOP\u22122001_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provided_guidelines_for\\'}), (\\'radiotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'radiotherapy_entity\\', \\'SIOP\u2212RTSG panel_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'contact_for_guidance\\'})]}, {\\'nodes\\': [(\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {}), (\\'Marry M. van den Heuvel-Eibrink_entity\\', {})], \\'edges\\': [(\\'Marry M. van den Heuvel-Eibrink_entity\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'affiliated_with\\'})]}, {\\'nodes\\': [(\\'Stage II_entity\\', {}), (\\'AV_entity\\', {}), (\\'Stage III_entity\\', {}), (\\'vincestine and actinomycin D_entity\\', {}), (\\'AVD_entity\\', {})], \\'edges\\': [(\\'Stage II_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AV_entity\\', \\'Stage II_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Stage III_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AVD_entity\\', \\'Stage III_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'SIOP-RTSG 2016_entity\\', {}), (\\'RCC_entity\\', {}), (\\'CMN_entity\\', {})], \\'edges\\': [(\\'RCC_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'}), (\\'CMN_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'})]}, {\\'nodes\\': [(\\'HR-1_entity\\', {}), (\\'High-risk blastemal type Wilms tumour_entity\\', {})], \\'edges\\': [(\\'HR-1_entity\\', \\'High-risk blastemal type Wilms tumour_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'unfavorable prognosis_entity\\', {}), (\\'high-risk characteristics_entity\\', {})], \\'edges\\': [(\\'high-risk characteristics_entity\\', \\'unfavorable prognosis_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'leads_to\\'})]}, {\\'nodes\\': [(\\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {}), (\\'SIOP\u2013RTSG board_entity\\', {})], \\'edges\\': [(\\'SIOP\u2013RTSG board_entity\\', \\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggests\\'})]}, {\\'nodes\\': [(\\'regimen and outcomes_entity\\', {}), (\\'SIOP database_entity\\', {})], \\'edges\\': [(\\'SIOP database_entity\\', \\'regimen and outcomes_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'captures_data_on\\'})]}, {\\'nodes\\': [(\\'Bilateral nephron-sparing surgery (NSS)_entity\\', {}), (\\'Aronson et al._entity\\', {})], \\'edges\\': [(\\'Aronson et al._entity\\', \\'Bilateral nephron-sparing surgery (NSS)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'observed_effectiveness_of\\'})]}, {\\'nodes\\': [(\\'SIOP\u22122001 study_entity\\', {}), (\\'Actinomycin D_entity\\', {}), (\\'Vincristine_entity\\', {})], \\'edges\\': [(\\'SIOP\u22122001 study_entity\\', \\'Vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'}), (\\'SIOP\u22122001 study_entity\\', \\'Actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'})]}, {\\'nodes\\': [(\\'High-dose melphalan_entity\\', {}), (\\'Group AA_entity\\', {}), (\\'Carboplatin_entity\\', {}), (\\'Doxorubicin_entity\\', {}), (\\'Etoposide_entity\\', {}), (\\'Group BB_entity\\', {}), (\\'Cyclophosphamide_entity\\', {}), (\\'Ifosfamide_entity\\', {})], \\'edges\\': [(\\'Group AA_entity\\', \\'Doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Ifosfamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'High-dose melphalan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'})]}, {\\'nodes\\': [(\\'nephrotoxicity_entity\\', {}), (\\'ifosfamide_entity\\', {})], \\'edges\\': [(\\'ifosfamide_entity\\', \\'nephrotoxicity_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'related_to\\'})]}, {\\'nodes\\': [(\\'camptothecins_entity\\', {}), (\\'irinotecan_entity\\', {}), (\\'topotecan_entity\\', {})], \\'edges\\': [(\\'camptothecins_entity\\', \\'irinotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'camptothecins_entity\\', \\'topotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'})]}, {\\'nodes\\': [(\\'Infant Wilms Tumors_entity\\', {}), (\\'nephrectomy_entity\\', {})], \\'edges\\': [(\\'Infant Wilms Tumors_entity\\', \\'nephrectomy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_option\\'})]}, {\\'nodes\\': [(\\'congenital mesoblastic nephroma_entity\\', {}), (\\'surgery alone_entity\\', {})], \\'edges\\': [(\\'congenital mesoblastic nephroma_entity\\', \\'surgery alone_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'alternative chemotherapy_entity\\', {}), (\\'malignant rhabdoid tumors_entity\\', {})], \\'edges\\': [(\\'malignant rhabdoid tumors_entity\\', \\'alternative chemotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'lymph node sampling_entity\\', {}), (\\'accurate staging_entity\\', {})], \\'edges\\': [(\\'lymph node sampling_entity\\', \\'accurate staging_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'purpose_of\\'})]}, {\\'nodes\\': [(\\'COG\u2013NWTS trials_entity\\', {}), (\\'whole-lung irradiation_entity\\', {})], \\'edges\\': [(\\'COG\u2013NWTS trials_entity\\', \\'whole-lung irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'informed_dosage_for\\'})]}, {\\'nodes\\': [(\\'lung metastases_entity\\', {}), (\\'pulmonary radiotherapy_entity\\', {})], \\'edges\\': [(\\'pulmonary radiotherapy_entity\\', \\'lung metastases_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'administered_for\\'})]}, {\\'nodes\\': [(\\'dosimetric study_entity\\', {}), (\\'proton therapy_entity\\', {}), (\\'flank irradiation_entity\\', {})], \\'edges\\': [(\\'dosimetric study_entity\\', \\'proton therapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated\\'}), (\\'proton therapy_entity\\', \\'flank irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggested_for\\'})]}, {\\'nodes\\': [(\\'metastatic disease_entity\\', {}), (\\'radiotherapy guidelines_entity\\', {}), (\\'locoregional disease_entity\\', {})], \\'edges\\': [(\\'radiotherapy guidelines_entity\\', \\'locoregional disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'}), (\\'radiotherapy guidelines_entity\\', \\'metastatic disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'})]}, {\\'nodes\\': [(\\'major rupture_entity\\', {}), (\\'stage III_entity\\', {})], \\'edges\\': [(\\'stage III_entity\\', \\'major rupture_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes_condition\\'})]}, {\\'nodes\\': [(\\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {}), (\\'ExPO\u2011r\u2011Net_entity\\', {})], \\'edges\\': [(\\'ExPO\u2011r\u2011Net_entity\\', \\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is part of\\'})]}, {\\'nodes\\': [(\\'University Hospital of Munich_entity\\', {}), (\\'Germany_entity\\', {}), (\\'University Hospital of Tuebingen_entity\\', {})], \\'edges\\': [(\\'Germany_entity\\', \\'University Hospital of Munich_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Germany_entity\\', \\'University Hospital of Tuebingen_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {}), (\\'Italy_entity\\', {}), (\\'Azienda Ospedaliera_entity\\', {}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {})], \\'edges\\': [(\\'Italy_entity\\', \\'Azienda Ospedaliera_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Netherlands_entity\\', {}), (\\'Prinses Maxima Centrum_entity\\', {})], \\'edges\\': [(\\'Netherlands_entity\\', \\'Prinses Maxima Centrum_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Marciniak Hospital_entity\\', {}), (\\'Poland_entity\\', {}), (\\'Faculty of Medicine_entity\\', {})], \\'edges\\': [(\\'Poland_entity\\', \\'Marciniak Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Poland_entity\\', \\'Faculty of Medicine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'St. Anna Kinderspital/CCRI_entity\\', {}), (\\'Austria_entity\\', {})], \\'edges\\': [(\\'Austria_entity\\', \\'St. Anna Kinderspital/CCRI_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'France_entity\\', {}), (\\'Armand Trousseau Hospital_entity\\', {})], \\'edges\\': [(\\'France_entity\\', \\'Armand Trousseau Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Spain_entity\\', {}), (\\'Hospital Vall d\u2019Hebron_entity\\', {}), (\\'Hospital Universitario Virgin del Rocio_entity\\', {})], \\'edges\\': [(\\'Spain_entity\\', \\'Hospital Universitario Virgin del Rocio_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Spain_entity\\', \\'Hospital Vall d\u2019Hebron_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'United Kingdom_entity\\', {}), (\\'Great Ormond Street Hospital_entity\\', {})], \\'edges\\': [(\\'United Kingdom_entity\\', \\'Great Ormond Street Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Weirich, A._entity\\', {}), (\\'SIOP-9/GPOH_entity\\', {})], \\'edges\\': [(\\'Weirich, A._entity\\', \\'SIOP-9/GPOH_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Pritchard-Jones, K._entity\\', {}), (\\'UKW3_entity\\', {})], \\'edges\\': [(\\'Pritchard-Jones, K._entity\\', \\'UKW3_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed in\\'})]}, {\\'nodes\\': [(\\'SIOP 93\u201301 trial_entity\\', {}), (\\'de Kraker, J._entity\\', {})], \\'edges\\': [(\\'de Kraker, J._entity\\', \\'SIOP 93\u201301 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'SIOP trial and study 93\u201301_entity\\', {}), (\\'Graf, N._entity\\', {})], \\'edges\\': [(\\'Graf, N._entity\\', \\'SIOP trial and study 93\u201301_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Green, D. M._entity\\', {}), (\\'National Wilms Tumor Study Group_entity\\', {})], \\'edges\\': [(\\'Green, D. M._entity\\', \\'National Wilms Tumor Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}, {\\'nodes\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', {}), (\\'SIOP WT 2001 protocol_entity\\', {})], \\'edges\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', \\'SIOP WT 2001 protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Third National Wilms\u2019 Tumor Study_entity\\', {}), (\"D\\'Angio, G. J._entity\", {}), (\\'Second National Wilms\u2019 Tumor Study_entity\\', {})], \\'edges\\': [(\"D\\'Angio, G. J._entity\", \\'Third National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\"D\\'Angio, G. J._entity\", \\'Second National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {}), (\\'Tournade, M. F._entity\\', {}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {})], \\'edges\\': [(\\'Tournade, M. F._entity\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'}), (\\'Tournade, M. F._entity\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Breslow, N. E._entity\\', {}), (\\'National Wilms Tumor Studies_entity\\', {})], \\'edges\\': [(\\'Breslow, N. E._entity\\', \\'National Wilms Tumor Studies_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Mitchell, C._entity\\', {}), (\\'UK Children\u2019s Cancer Study Group_entity\\', {})], \\'edges\\': [(\\'Mitchell, C._entity\\', \\'UK Children\u2019s Cancer Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'under\\'})]}, {\\'nodes\\': [(\\'Daw, N. C._entity\\', {}), (\\'Dix, D. B._entity\\', {}), (\\'Children\u2019s Oncology Group_entity\\', {}), (\\'Grundy, P. E._entity\\', {})], \\'edges\\': [(\\'Daw, N. C._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted under\\'}), (\\'Dix, D. B._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'}), (\\'Grundy, P. E._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}]', expected_output='It symbolizes the comprehensive and wide-ranging approach to treating all paediatric renal tumours.', context=None, retrieval_context=['[{\\'nodes\\': [(\\'sample.pdf\\', {\\'type\\': \\'document\\'}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)\\'}), (\\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA SIOP-RTSG 2016\\'}), (\\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms tumours\\'}), (\\'non-Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'non-Wilms tumours\\'}), (\\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Website\\', \\'name\\': \\'www.siop-rtsg.eu\\'}), (\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology\\'}), (\\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Person\\', \\'name\\': \\'Marry M. van den Heuvel-Eibrink\\'}), (\\'childhood renal tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'childhood renal tumours\\'}), (\\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'clear cell sarcoma of the kidney\\'}), (\\'renal cell carcinoma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'renal cell carcinoma\\'}), (\\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'malignant rhabdoid tumour of the kidney\\'}), (\\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'Wilms tumours_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'Children\u2019s Oncology Group (COG)\\'}), (\\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'SIOP\u22122001 randomized trial\\'}), (\\'actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'UKW3 trial\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)\\'}), (\\'localized disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'localized disease\\'}), (\\'metastatic disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'metastatic disease\\'}), (\\'bilateral disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'bilateral disease\\'}), (\\'relapsed disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'relapsed disease\\'}), (\\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subtype\\', \\'name\\': \\'blastemal-type Wilms tumours\\'}), (\\'radiotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgery_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'chemotherapy\\'}), (\\'Wilms Tumour_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms Tumour\\'}), (\\'CCSK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CCSK\\'}), (\\'MRTK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'MRTK\\'}), (\\'CMN_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CMN\\'}), (\\'RCC_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'RCC\\'}), (\\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u22122001_Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Trial\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'vincristine_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'vincristine\\'}), (\\'actinomycin D_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'actinomycin D\\'}), (\\'doxorubicin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'doxorubicin\\'}), (\\'etoposide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'Stage I_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage I\\'}), (\\'Stage II_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage II\\'}), (\\'Stage III_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage III\\'}), (\\'Stage IV_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage IV\\'}), (\\'Stage V_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage V\\'}), (\\'AV_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AV\\'}), (\\'AVD_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AVD\\'}), (\\'HR-1_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'HR-1\\'}), (\\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP-RTSG 2016\\'}), (\\'Overall Survival (OS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'CT-only nodules_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'CT-only nodules\\'}), (\\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP\u2013RTSG analysis\\'}), (\\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials\\'}), (\\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D plus doxorubicin\\'}), (\\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D\\'}), (\\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study_protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'MRI_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'MRI\\'}), (\\'CT_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'CT\\'}), (\\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_detail\\', \\'name\\': \\'cumulative doxorubicin dose\\'}), (\\'COG AREN0533 trial_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG AREN0533 trial\\'}), (\\'etoposide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'high-risk characteristics\\'}), (\\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG board\\'}), (\\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin\\'}), (\\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'high-dose chemotherapy and autologous stem cell transplantation\\'}), (\\'SIOP database_database\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'database\\', \\'name\\': \\'SIOP database\\'}), (\\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'AVD_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AVD\\'}), (\\'AV-2_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AV-2\\'}), (\\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Statistical Test\\', \\'name\\': \\'Log\u2013Rank P\\'}), (\\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'Bilateral Disease (Stage V)\\'}), (\\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Synchronous bilateral Wilms tumor\\'}), (\\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'End-stage renal disease (ESRD)\\'}), (\\'Aronson et al._Research Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Research Group\\', \\'name\\': \\'Aronson et al.\\'}), (\\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'Bilateral nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Study\\', \\'name\\': \\'SIOP\u22122001 study\\'}), (\\'Vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Vincristine\\'}), (\\'Actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Actinomycin D\\'}), (\\'Etoposide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Etoposide\\'}), (\\'Carboplatin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Carboplatin\\'}), (\\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease State\\', \\'name\\': \\'Relapsed Wilms Tumor\\'}), (\\'Group AA_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group AA\\'}), (\\'Group BB_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group BB\\'}), (\\'Group CC_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group CC\\'}), (\\'Doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Doxorubicin\\'}), (\\'Cyclophosphamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Cyclophosphamide\\'}), (\\'Ifosfamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Ifosfamide\\'}), (\\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'High-dose melphalan\\'}), (\\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UKW\u2011R protocol\\'}), (\\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'NWTS\u20115 relapse protocol\\'}), (\\'ASCR_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'procedure\\', \\'name\\': \\'ASCR\\'}), (\\'ifosfamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'ifosfamide\\'}), (\\'nephrotoxicity_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'nephrotoxicity\\'}), (\\'relapsed group CC_patient_group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'patient_group\\', \\'name\\': \\'relapsed group CC\\'}), (\\'diffuse anaplasia_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'diffuse anaplasia\\'}), (\\'blastemal-type tumors_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'blastemal-type tumors\\'}), (\\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'camptothecins_medication_class\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication_class\\', \\'name\\': \\'camptothecins\\'}), (\\'irinotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'irinotecan\\'}), (\\'topotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'topotecan\\'}), (\\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Innovative Therapies for Children with Cancer consortium\\'}), (\\'radiotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgical excision_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgical excision\\'}), (\\'stage IV WT_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'stage IV WT\\'}), (\\'AVD150_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD150\\'}), (\\'AVD250_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD250\\'}), (\\'low-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'low-risk disease\\'}), (\\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'intermediate-risk disease\\'}), (\\'high-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'high-risk disease\\'}), (\\'CDCV_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'CDCV\\'}), (\\'actinomycin-D_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'actinomycin-D\\'}), (\\'vincristine_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'doxorubicin\\'}), (\\'VP16_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'VP16\\'}), (\\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'contact\\', \\'name\\': \\'arnauld.verschuur@ap-hm.fr\\'}), (\\'surgery_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'chemotherapy\\'}), (\\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2212RTSG panel\\'}), (\\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Infant Wilms Tumors\\'}), (\\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'nephrectomy\\'}), (\\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'malignant rhabdoid tumors\\'}), (\\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Adult Wilms Tumors\\'}), (\\'anaplasia_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'anaplasia\\'}), (\\'actinomycin D_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'carboplatin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'etoposide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'etoposide\\'}), (\\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'Nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'radical tumor nephrectomy\\'}), (\\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'lymph node sampling\\'}), (\\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'minimally invasive surgery\\'}), (\\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'laparoscopic surgery\\'}), (\\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'radiotherapy\\'}), (\\'Wilms tumours_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'Davila Fajardo et al._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Davila Fajardo et al.\\'}), (\\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'COG\u2013NWTS trials\\'}), (\\'whole-lung irradiation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'whole-lung irradiation\\'}), (\\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'pulmonary radiotherapy\\'}), (\\'proton therapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'proton therapy\\'}), (\\'dosimetric study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'dosimetric study\\'}), (\\'locoregional disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'locoregional disease\\'}), (\\'metastatic disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'metastatic disease\\'}), (\\'low-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'low-risk\\'}), (\\'intermediate-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'intermediate-risk\\'}), (\\'high-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'high-risk\\'}), (\\'stage I_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage I\\'}), (\\'stage II_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage II\\'}), (\\'stage III_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage III\\'}), (\\'major rupture_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'major rupture\\'}), (\\'Austria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Austria\\'}), (\\'Italy_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Italy\\'}), (\\'San Marino_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'San Marino\\'}), (\\'Iceland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Iceland\\'}), (\\'Germany_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Germany\\'}), (\\'Bulgaria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bulgaria\\'}), (\\'Turkey_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Turkey\\'}), (\\'Denmark_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Denmark\\'}), (\\'Poland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Poland\\'}), (\\'Greece_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Greece\\'}), (\\'Andorra_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Andorra\\'}), (\\'Belgium_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belgium\\'}), (\\'Serbia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Serbia\\'}), (\\'Albania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Albania\\'}), (\\'Moldova_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Moldova\\'}), (\\'Lithuania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Lithuania\\'}), (\\'Latvia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Latvia\\'}), (\\'Estonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Estonia\\'}), (\\'Luxembourg_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Luxembourg\\'}), (\\'Montenegro_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Montenegro\\'}), (\\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bosnia and Herzegovina\\'}), (\\'Croatia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Croatia\\'}), (\\'Slovenia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovenia\\'}), (\\'Macedonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Macedonia\\'}), (\\'United Kingdom_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'United Kingdom\\'}), (\\'Ireland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ireland\\'}), (\\'Spain_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Spain\\'}), (\\'Algeria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Algeria\\'}), (\\'Tunisia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Tunisia\\'}), (\\'Malta_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Malta\\'}), (\\'Morocco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Morocco\\'}), (\\'Portugal_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Portugal\\'}), (\\'France_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'France\\'}), (\\'Monaco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Monaco\\'}), (\\'Russia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Russia\\'}), (\\'Finland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Finland\\'}), (\\'Sweden_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Sweden\\'}), (\\'Norway_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Norway\\'}), (\\'Belarus_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belarus\\'}), (\\'Romania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Romania\\'}), (\\'Ukraine_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ukraine\\'}), (\\'Hungary_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Hungary\\'}), (\\'Czech Republic_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Czech Republic\\'}), (\\'Slovakia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovakia\\'}), (\\'Switzerland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Switzerland\\'}), (\\'Liechtenstein_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Liechtenstein\\'}), (\\'Netherlands_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Netherlands\\'}), (\\'University Hospital of Munich_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Munich\\'}), (\\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Tuebingen\\'}), (\\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Azienda Ospedaliera\\'}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Ospedale Pediatrico Bambino Ges\u00f9\\'}), (\\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Fondazione IRCCS Istituto Nazionale dei Tumori\\'}), (\\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Prinses Maxima Centrum\\'}), (\\'Marciniak Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Marciniak Hospital\\'}), (\\'Faculty of Medicine_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Faculty of Medicine\\'}), (\\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'St. Anna Kinderspital/CCRI\\'}), (\\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Armand Trousseau Hospital\\'}), (\\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Universitario Virgin del Rocio\\'}), (\\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Vall d\u2019Hebron\\'}), (\\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Great Ormond Street Hospital\\'}), (\\'University Hospital Homburg_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital Homburg\\'}), (\\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon\\'}), (\\'UMBRELLA protocol_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'ExPO\u2011r\u2011Net\\'}), (\\'Weirich, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Weirich, A.\\'}), (\\'Pritchard-Jones, K._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Pritchard-Jones, K.\\'}), (\\'de Kraker, J._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'de Kraker, J.\\'}), (\\'Graf, N._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Graf, N.\\'}), (\\'Green, D. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Green, D. M.\\'}), (\\'Spreafico, F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Spreafico, F.\\'}), (\\'Bellani, F. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Bellani, F. F.\\'}), (\\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'van den Heuvel-Eibrink, M. M.\\'}), (\"D\\'Angio, G. J._author\", {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \"D\\'Angio, G. J.\"}), (\\'Tournade, M. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Tournade, M. F.\\'}), (\\'Breslow, N. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Breslow, N. E.\\'}), (\\'Mitchell, C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Mitchell, C.\\'}), (\\'Verschuur, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Verschuur, A.\\'}), (\\'Grundy, P. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Grundy, P. E.\\'}), (\\'Warmann, S. W._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Warmann, S. W.\\'}), (\\'Smets, A. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Smets, A. M.\\'}), (\\'Dome, J. S._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dome, J. S.\\'}), (\\'Dix, D. B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dix, D. B.\\'}), (\\'Daw, N. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Daw, N. C.\\'}), (\\'Ha, T. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Ha, T. C.\\'}), (\\'Kremens, B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Kremens, B.\\'}), (\\'Furtwangler, R._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Furtwangler, R.\\'}), (\\'SIOP-9/GPOH_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP-9/GPOH\\'}), (\\'UKW3_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'UKW3\\'}), (\\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'SIOP 93\u201301 trial\\'}), (\\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP trial and study 93\u201301\\'}), (\\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'National Wilms Tumor Study Group\\'}), (\\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP WT 2001 protocol\\'}), (\\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Third National Wilms\u2019 Tumor Study\\'}), (\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'National Wilms Tumor Studies\\'}), (\\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Second National Wilms\u2019 Tumor Study\\'}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'UK Children\u2019s Cancer Study Group\\'}), (\\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Children\u2019s Oncology Group\\'})], \\'edges\\': [(\\'sample.pdf\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'non-Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'childhood renal tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'renal cell carcinoma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'localized disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'metastatic disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'bilateral disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'relapsed disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'radiotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'surgery_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'chemotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'Wilms Tumour_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CCSK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'MRTK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CMN_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'RCC_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP\u22122001_Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'vincristine_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'actinomycin D_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'doxorubicin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'etoposide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'carboplatin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'cyclophosphamide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage I_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage II_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage III_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage IV_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage V_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AV_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AVD_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'HR-1_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Overall Survival (OS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT-only nodules_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'MRI_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG AREN0533 trial_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'etoposide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'carboplatin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'cyclophosphamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP database_database\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AVD_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AV-2_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Aronson et al._Research Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Etoposide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Carboplatin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group AA_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group BB_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group CC_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Cyclophosphamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Ifosfamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'ASCR_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'ifosfamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'nephrotoxicity_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'relapsed group CC_patient_group\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'diffuse anaplasia_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'blastemal-type tumors_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'camptothecins_medication_class\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'irinotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'topotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'radiotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'surgical excision_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'stage IV WT_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD150_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD250_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'low-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'CDCV_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'actinomycin-D_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'vincristine_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'doxorubicin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'VP16_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'surgery_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'chemotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'anaplasia_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'actinomycin D_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'vincristine_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'doxorubicin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'carboplatin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'cyclophosphamide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'etoposide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'SIOP\u22122001_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Wilms tumours_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Davila Fajardo et al._author\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'whole-lung irradiation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'proton therapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'dosimetric study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'locoregional disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'metastatic disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'low-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'intermediate-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'high-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage I_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage II_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage III_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'major rupture_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Austria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Italy_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'San Marino_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Iceland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Germany_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bulgaria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Turkey_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Denmark_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Poland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Greece_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Andorra_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belgium_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Serbia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Albania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Moldova_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Lithuania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Latvia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Estonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Luxembourg_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Montenegro_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Croatia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovenia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Macedonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'United Kingdom_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ireland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Spain_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Algeria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Tunisia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Malta_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Morocco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Portugal_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'France_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Monaco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Russia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Finland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Sweden_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Norway_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belarus_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Romania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ukraine_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hungary_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Czech Republic_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovakia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Switzerland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Liechtenstein_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Netherlands_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Munich_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Marciniak Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Faculty of Medicine_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital Homburg_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Weirich, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Pritchard-Jones, K._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'de Kraker, J._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Graf, N._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Green, D. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Spreafico, F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Bellani, F. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \"D\\'Angio, G. J._author\", {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Tournade, M. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Breslow, N. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Mitchell, C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Verschuur, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Grundy, P. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Warmann, S. W._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Smets, A. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dome, J. S._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dix, D. B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Daw, N. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ha, T. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Kremens, B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Furtwangler, R._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP-9/GPOH_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UKW3_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10})]}, {\\'nodes\\': [(\\'vincristine_entity\\', {}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {}), (\\'www.siop-rtsg.eu_entity\\', {}), (\\'stage II_entity\\', {}), (\\'Wilms tumours_entity\\', {}), (\\'Relapsed Wilms Tumor_entity\\', {}), (\\'Davila Fajardo et al._entity\\', {}), (\\'vincristine, actinomycin D, and doxorubicin_entity\\', {}), (\\'SIOP\u22122001 randomized trial_entity\\', {}), (\\'surgery_entity\\', {}), (\\'non-Wilms tumours_entity\\', {}), (\\'actinomycin D_entity\\', {}), (\\'diffuse anaplasia_entity\\', {}), (\\'Synchronous bilateral Wilms tumor_entity\\', {}), (\\'CT-only nodules_entity\\', {}), (\\'relapsed group CC_entity\\', {}), (\\'increased relapse risk_entity\\', {}), (\\'reduced survival_entity\\', {}), (\\'UKW3 trial_entity\\', {}), (\\'chemotherapy_entity\\', {}), (\\'Bilateral Disease (Stage V)_entity\\', {}), (\\'blastemal-type tumors_entity\\', {}), (\\'UMBRELLA protocol_entity\\', {}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', {}), (\\'minimally invasive surgery_entity\\', {}), (\\'VP16_entity\\', {}), (\\'Wilms tumor_entity\\', {}), (\\'anaplasia_entity\\', {}), (\\'radical tumor nephrectomy_entity\\', {}), (\\'Innovative Therapies for Children with Cancer consortium_entity\\', {}), (\\'cumulative doxorubicin dose_entity\\', {}), (\\'etoposide_entity\\', {}), (\\'large-volume tumours_entity\\', {}), (\\'Stage IV_entity\\', {}), (\\'CDCV_entity\\', {}), (\\'SIOP\u2013RTSG_entity\\', {}), (\\'AVD150_entity\\', {}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', {}), (\\'laparoscopic surgery_entity\\', {}), (\\'SIOP\u2212RTSG panel_entity\\', {}), (\\'actinomycin-D_entity\\', {}), (\\'COG AREN0533 trial_entity\\', {}), (\\'cyclophosphamide_entity\\', {}), (\\'carboplatin_entity\\', {}), (\\'UKW\u2011R protocol_entity\\', {}), (\\'Nephron-sparing surgery (NSS)_entity\\', {}), (\\'Adult Wilms Tumors_entity\\', {}), (\\'doxorubicin_entity\\', {}), (\\'NWTS\u20115 relapse protocol_entity\\', {}), (\\'End-stage renal disease (ESRD)_entity\\', {}), (\\'AVD250_entity\\', {}), (\\'Children\u2019s Oncology Group (COG)_entity\\', {}), (\\'blastemal-type Wilms tumour_entity\\', {}), (\\'SIOP\u22122001_entity\\', {}), (\\'radiotherapy_entity\\', {}), (\\'childhood renal tumours_entity\\', {})], \\'edges\\': [(\\'vincristine_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'stage II_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'indicated_for_in_adults\\'}), (\\'Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'Wilms tumours_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated under\\'}), (\\'Relapsed Wilms Tumor_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guided_by\\'}), (\\'Davila Fajardo et al._entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed\\'}), (\\'SIOP\u22122001 randomized trial_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated use in\\'}), (\\'surgery_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'non-Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'actinomycin D_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Synchronous bilateral Wilms tumor_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'instance_of\\'}), (\\'CT-only nodules_entity\\', \\'increased relapse risk_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'reduced survival_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included_in\\'}), (\\'relapsed group CC_entity\\', \\'diffuse anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'blastemal-type tumors_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UKW3 trial_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'UKW3 trial_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'chemotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UMBRELLA protocol_entity\\', \\'COG AREN0533 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses_data_from\\'}), (\\'UMBRELLA protocol_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'advises_treatment_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'Innovative Therapies for Children with Cancer consortium_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborates_with\\'}), (\\'UMBRELLA protocol_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'surgery_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is the standard of\\'}), (\\'UMBRELLA protocol_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guides treatment in\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', \\'UKW3 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\\'minimally invasive surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'anaplasia_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'radical tumor nephrectomy_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'standard_of_care_for\\'}), (\\'Stage IV_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'presents in\\'}), (\\'CDCV_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'VP16_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'aims to improve survival rates of\\'}), (\\'AVD150_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed_by\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'succeeds\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'www.siop-rtsg.eu_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'available_on\\'}), (\\'laparoscopic surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'COG AREN0533 trial_entity\\', \\'cumulative doxorubicin dose_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'evaluates\\'}), (\\'UKW\u2011R protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'Nephron-sparing surgery (NSS)_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'classification_developed_by\\'}), (\\'Adult Wilms Tumors_entity\\', \\'anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'Adult Wilms Tumors_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'doxorubicin_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'doxorubicin_entity\\', \\'large-volume tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'recommended for\\'}), (\\'NWTS\u20115 relapse protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'End-stage renal disease (ESRD)_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'AVD250_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'Children\u2019s Oncology Group (COG)_entity\\', \\'SIOP\u22122001 randomized trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborated with\\'}), (\\'blastemal-type Wilms tumour_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment intensified according to\\'}), (\\'SIOP\u22122001_entity\\', \\'vincristine, actinomycin D, and doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses\\'}), (\\'SIOP\u22122001_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provided_guidelines_for\\'}), (\\'radiotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'radiotherapy_entity\\', \\'SIOP\u2212RTSG panel_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'contact_for_guidance\\'})]}, {\\'nodes\\': [(\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {}), (\\'Marry M. van den Heuvel-Eibrink_entity\\', {})], \\'edges\\': [(\\'Marry M. van den Heuvel-Eibrink_entity\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'affiliated_with\\'})]}, {\\'nodes\\': [(\\'Stage II_entity\\', {}), (\\'AV_entity\\', {}), (\\'Stage III_entity\\', {}), (\\'vincestine and actinomycin D_entity\\', {}), (\\'AVD_entity\\', {})], \\'edges\\': [(\\'Stage II_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AV_entity\\', \\'Stage II_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Stage III_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AVD_entity\\', \\'Stage III_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'SIOP-RTSG 2016_entity\\', {}), (\\'RCC_entity\\', {}), (\\'CMN_entity\\', {})], \\'edges\\': [(\\'RCC_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'}), (\\'CMN_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'})]}, {\\'nodes\\': [(\\'HR-1_entity\\', {}), (\\'High-risk blastemal type Wilms tumour_entity\\', {})], \\'edges\\': [(\\'HR-1_entity\\', \\'High-risk blastemal type Wilms tumour_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'unfavorable prognosis_entity\\', {}), (\\'high-risk characteristics_entity\\', {})], \\'edges\\': [(\\'high-risk characteristics_entity\\', \\'unfavorable prognosis_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'leads_to\\'})]}, {\\'nodes\\': [(\\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {}), (\\'SIOP\u2013RTSG board_entity\\', {})], \\'edges\\': [(\\'SIOP\u2013RTSG board_entity\\', \\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggests\\'})]}, {\\'nodes\\': [(\\'regimen and outcomes_entity\\', {}), (\\'SIOP database_entity\\', {})], \\'edges\\': [(\\'SIOP database_entity\\', \\'regimen and outcomes_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'captures_data_on\\'})]}, {\\'nodes\\': [(\\'Bilateral nephron-sparing surgery (NSS)_entity\\', {}), (\\'Aronson et al._entity\\', {})], \\'edges\\': [(\\'Aronson et al._entity\\', \\'Bilateral nephron-sparing surgery (NSS)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'observed_effectiveness_of\\'})]}, {\\'nodes\\': [(\\'SIOP\u22122001 study_entity\\', {}), (\\'Actinomycin D_entity\\', {}), (\\'Vincristine_entity\\', {})], \\'edges\\': [(\\'SIOP\u22122001 study_entity\\', \\'Vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'}), (\\'SIOP\u22122001 study_entity\\', \\'Actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'})]}, {\\'nodes\\': [(\\'High-dose melphalan_entity\\', {}), (\\'Group AA_entity\\', {}), (\\'Carboplatin_entity\\', {}), (\\'Doxorubicin_entity\\', {}), (\\'Etoposide_entity\\', {}), (\\'Group BB_entity\\', {}), (\\'Cyclophosphamide_entity\\', {}), (\\'Ifosfamide_entity\\', {})], \\'edges\\': [(\\'Group AA_entity\\', \\'Doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Ifosfamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'High-dose melphalan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'})]}, {\\'nodes\\': [(\\'nephrotoxicity_entity\\', {}), (\\'ifosfamide_entity\\', {})], \\'edges\\': [(\\'ifosfamide_entity\\', \\'nephrotoxicity_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'related_to\\'})]}, {\\'nodes\\': [(\\'camptothecins_entity\\', {}), (\\'irinotecan_entity\\', {}), (\\'topotecan_entity\\', {})], \\'edges\\': [(\\'camptothecins_entity\\', \\'irinotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'camptothecins_entity\\', \\'topotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'})]}, {\\'nodes\\': [(\\'Infant Wilms Tumors_entity\\', {}), (\\'nephrectomy_entity\\', {})], \\'edges\\': [(\\'Infant Wilms Tumors_entity\\', \\'nephrectomy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_option\\'})]}, {\\'nodes\\': [(\\'congenital mesoblastic nephroma_entity\\', {}), (\\'surgery alone_entity\\', {})], \\'edges\\': [(\\'congenital mesoblastic nephroma_entity\\', \\'surgery alone_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'alternative chemotherapy_entity\\', {}), (\\'malignant rhabdoid tumors_entity\\', {})], \\'edges\\': [(\\'malignant rhabdoid tumors_entity\\', \\'alternative chemotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'lymph node sampling_entity\\', {}), (\\'accurate staging_entity\\', {})], \\'edges\\': [(\\'lymph node sampling_entity\\', \\'accurate staging_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'purpose_of\\'})]}, {\\'nodes\\': [(\\'COG\u2013NWTS trials_entity\\', {}), (\\'whole-lung irradiation_entity\\', {})], \\'edges\\': [(\\'COG\u2013NWTS trials_entity\\', \\'whole-lung irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'informed_dosage_for\\'})]}, {\\'nodes\\': [(\\'lung metastases_entity\\', {}), (\\'pulmonary radiotherapy_entity\\', {})], \\'edges\\': [(\\'pulmonary radiotherapy_entity\\', \\'lung metastases_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'administered_for\\'})]}, {\\'nodes\\': [(\\'dosimetric study_entity\\', {}), (\\'proton therapy_entity\\', {}), (\\'flank irradiation_entity\\', {})], \\'edges\\': [(\\'dosimetric study_entity\\', \\'proton therapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated\\'}), (\\'proton therapy_entity\\', \\'flank irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggested_for\\'})]}, {\\'nodes\\': [(\\'metastatic disease_entity\\', {}), (\\'radiotherapy guidelines_entity\\', {}), (\\'locoregional disease_entity\\', {})], \\'edges\\': [(\\'radiotherapy guidelines_entity\\', \\'locoregional disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'}), (\\'radiotherapy guidelines_entity\\', \\'metastatic disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'})]}, {\\'nodes\\': [(\\'major rupture_entity\\', {}), (\\'stage III_entity\\', {})], \\'edges\\': [(\\'stage III_entity\\', \\'major rupture_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes_condition\\'})]}, {\\'nodes\\': [(\\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {}), (\\'ExPO\u2011r\u2011Net_entity\\', {})], \\'edges\\': [(\\'ExPO\u2011r\u2011Net_entity\\', \\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is part of\\'})]}, {\\'nodes\\': [(\\'University Hospital of Munich_entity\\', {}), (\\'Germany_entity\\', {}), (\\'University Hospital of Tuebingen_entity\\', {})], \\'edges\\': [(\\'Germany_entity\\', \\'University Hospital of Munich_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Germany_entity\\', \\'University Hospital of Tuebingen_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {}), (\\'Italy_entity\\', {}), (\\'Azienda Ospedaliera_entity\\', {}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {})], \\'edges\\': [(\\'Italy_entity\\', \\'Azienda Ospedaliera_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Netherlands_entity\\', {}), (\\'Prinses Maxima Centrum_entity\\', {})], \\'edges\\': [(\\'Netherlands_entity\\', \\'Prinses Maxima Centrum_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Marciniak Hospital_entity\\', {}), (\\'Poland_entity\\', {}), (\\'Faculty of Medicine_entity\\', {})], \\'edges\\': [(\\'Poland_entity\\', \\'Marciniak Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Poland_entity\\', \\'Faculty of Medicine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'St. Anna Kinderspital/CCRI_entity\\', {}), (\\'Austria_entity\\', {})], \\'edges\\': [(\\'Austria_entity\\', \\'St. Anna Kinderspital/CCRI_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'France_entity\\', {}), (\\'Armand Trousseau Hospital_entity\\', {})], \\'edges\\': [(\\'France_entity\\', \\'Armand Trousseau Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Spain_entity\\', {}), (\\'Hospital Vall d\u2019Hebron_entity\\', {}), (\\'Hospital Universitario Virgin del Rocio_entity\\', {})], \\'edges\\': [(\\'Spain_entity\\', \\'Hospital Universitario Virgin del Rocio_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Spain_entity\\', \\'Hospital Vall d\u2019Hebron_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'United Kingdom_entity\\', {}), (\\'Great Ormond Street Hospital_entity\\', {})], \\'edges\\': [(\\'United Kingdom_entity\\', \\'Great Ormond Street Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Weirich, A._entity\\', {}), (\\'SIOP-9/GPOH_entity\\', {})], \\'edges\\': [(\\'Weirich, A._entity\\', \\'SIOP-9/GPOH_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Pritchard-Jones, K._entity\\', {}), (\\'UKW3_entity\\', {})], \\'edges\\': [(\\'Pritchard-Jones, K._entity\\', \\'UKW3_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed in\\'})]}, {\\'nodes\\': [(\\'SIOP 93\u201301 trial_entity\\', {}), (\\'de Kraker, J._entity\\', {})], \\'edges\\': [(\\'de Kraker, J._entity\\', \\'SIOP 93\u201301 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'SIOP trial and study 93\u201301_entity\\', {}), (\\'Graf, N._entity\\', {})], \\'edges\\': [(\\'Graf, N._entity\\', \\'SIOP trial and study 93\u201301_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Green, D. M._entity\\', {}), (\\'National Wilms Tumor Study Group_entity\\', {})], \\'edges\\': [(\\'Green, D. M._entity\\', \\'National Wilms Tumor Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}, {\\'nodes\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', {}), (\\'SIOP WT 2001 protocol_entity\\', {})], \\'edges\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', \\'SIOP WT 2001 protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Third National Wilms\u2019 Tumor Study_entity\\', {}), (\"D\\'Angio, G. J._entity\", {}), (\\'Second National Wilms\u2019 Tumor Study_entity\\', {})], \\'edges\\': [(\"D\\'Angio, G. J._entity\", \\'Third National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\"D\\'Angio, G. J._entity\", \\'Second National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {}), (\\'Tournade, M. F._entity\\', {}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {})], \\'edges\\': [(\\'Tournade, M. F._entity\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'}), (\\'Tournade, M. F._entity\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Breslow, N. E._entity\\', {}), (\\'National Wilms Tumor Studies_entity\\', {})], \\'edges\\': [(\\'Breslow, N. E._entity\\', \\'National Wilms Tumor Studies_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Mitchell, C._entity\\', {}), (\\'UK Children\u2019s Cancer Study Group_entity\\', {})], \\'edges\\': [(\\'Mitchell, C._entity\\', \\'UK Children\u2019s Cancer Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'under\\'})]}, {\\'nodes\\': [(\\'Daw, N. C._entity\\', {}), (\\'Dix, D. B._entity\\', {}), (\\'Children\u2019s Oncology Group_entity\\', {}), (\\'Grundy, P. E._entity\\', {})], \\'edges\\': [(\\'Daw, N. C._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted under\\'}), (\\'Dix, D. B._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'}), (\\'Grundy, P. E._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}]']), TestResult(name='test_case_5', success=False, metrics_data=[MetricData(name='Answer Correctness (GEval)', threshold=0.5, success=False, score=0.01205341605993039, reason='The actual output does not mention chest CT or its use for staging or detecting pulmonary nodules as stated in the expected output.', strict_mode=False, evaluation_model='gpt-4o-mini', error=None, evaluation_cost=0.0032960999999999997, verbose_logs='Criteria:\\nNone \\n \\nEvaluation Steps:\\n[\\n    \"Determine whether the actual output is factually correct based on the expected output.\"\\n]'), MetricData(name='Faithfulness', threshold=0.7, success=True, score=0.9032258064516129, reason=None, strict_mode=False, evaluation_model='gpt-4o-mini', error=None, evaluation_cost=0.00812475, verbose_logs='Truths (limit=None):\\n[\\n    \"The Renal Tumour Study Group of the International Society of Paediatric Oncology is abbreviated as SIOP\u2013RTSG.\",\\n    \"The UMBRELLA SIOP-RTSG 2016 is a protocol.\",\\n    \"SIOP\u22122001 is a protocol.\",\\n    \"Wilms tumours is a type of disease.\",\\n    \"Non-Wilms tumours is a type of disease.\",\\n    \"The Department of Paediatric Oncology is part of the Princess M\u00e1xima Center for Paediatric Oncology.\",\\n    \"Marry M. van den Heuvel-Eibrink is a person associated with the text.\",\\n    \"Childhood renal tumours is a type of disease.\",\\n    \"Clear cell sarcoma of the kidney is a type of disease.\",\\n    \"Renal cell carcinoma is a type of disease.\",\\n    \"Malignant rhabdoid tumour of the kidney is a type of disease.\",\\n    \"Congenital mesoblastic nephroma is a type of disease.\",\\n    \"The UMBRELLA protocol is a treatment protocol.\",\\n    \"SIOP\u2013RTSG is an organization.\",\\n    \"The Children\u2019s Oncology Group (COG) is an organization.\",\\n    \"SIOP\u22122001 randomized trial is a clinical trial.\",\\n    \"Vincristine is a drug.\",\\n    \"Actinomycin D is a drug.\",\\n    \"Doxorubicin is a drug.\",\\n    \"Localized disease, metastatic disease, bilateral disease, and relapsed disease are stages of disease.\",\\n    \"Wilms Tumour, CCSK, MRTK, CMN, and RCC are types of diseases.\",\\n    \"The UMBRELLA protocol is also referred to as a protocol.\",\\n    \"SIOP\u22122001 is a trial.\",\\n    \"Vincristine, actinomycin D, and doxorubicin are treatments.\",\\n    \"Vincristine, actinomycin D, and doxorubicin are included in the SIOP\u22122001 study.\",\\n    \"Stage I, II, III, IV, and V are classifications of disease stages in Wilms tumours.\",\\n    \"AV, AVD, and HR-1 are combinations of treatments.\",\\n    \"Overall Survival (OS) and Event-Free Survival (EFS) are metrics used in studies.\",\\n    \"SIOP database collects data on various studies and outcomes.\",\\n    \"Bilateral nephron-sparing surgery (NSS) is a treatment method.\",\\n    \"The UK Children\u2019s Cancer and Leukaemia Group (UKCCLG) is an organization.\",\\n    \"Nephrotoxicity is a condition related to kidney function changes.\",\\n    \"Surgery and chemotherapy are treatment methods for Wilms tumours.\",\\n    \"Radiotherapy is used as a treatment method for various conditions, including Wilms tumours.\",\\n    \"Nephrectomy is a surgical procedure related to the kidney.\",\\n    \"Whole-lung irradiation is a treatment.\",\\n    \"Proton therapy is a treatment method.\",\\n    \"Countries such as Austria, Italy, Germany, and Spain are listed in the text.\",\\n    \"Various institutions, such as the University Hospital of Munich and Fondazione IRCCS Istituto Nazionale dei Tumori, are involved in the studies mentioned.\"\\n] \\n \\nClaims:\\n[\\n    \"The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG) is an organization.\",\\n    \"UMBRELLA SIOP-RTSG 2016 is a protocol.\",\\n    \"SIOP\u22122001 is a protocol.\",\\n    \"Wilms tumours is a disease.\",\\n    \"Non-Wilms tumours is a disease.\",\\n    \"www.siop-rtsg.eu is a website.\",\\n    \"The Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology is an institution.\",\\n    \"Marry M. van den Heuvel-Eibrink is a person associated with the content.\",\\n    \"Childhood renal tumours is a disease.\",\\n    \"Clear cell sarcoma of the kidney is a disease.\",\\n    \"Renal cell carcinoma is a disease.\",\\n    \"Malignant rhabdoid tumour of the kidney is a disease.\",\\n    \"Congenital mesoblastic nephroma is a disease.\",\\n    \"Wilms tumours is classified as a condition.\",\\n    \"UMBRELLA protocol is a treatment protocol.\",\\n    \"SIOP\u22122001 randomized trial is a clinical trial.\",\\n    \"Actinomycin D is a drug used in treatment.\",\\n    \"Vincristine is a drug used in treatment.\",\\n    \"Doxorubicin is a drug used in treatment.\",\\n    \"Localized disease is a disease stage.\",\\n    \"Metastatic disease is a disease stage.\",\\n    \"Bilateral disease is a disease stage.\",\\n    \"Relapsed disease is a disease stage.\",\\n    \"Blastemal-type Wilms tumours is a subtype of Wilms tumours.\",\\n    \"Radiotherapy is a treatment method.\",\\n    \"Surgery is a treatment method.\",\\n    \"Chemotherapy is a treatment method.\",\\n    \"Wilms Tumour is a disease.\",\\n    \"CCSK stands for clear cell sarcoma of the kidney.\",\\n    \"MRTK stands for malignant rhabdoid tumour of the kidney.\",\\n    \"CMN stands for congenital mesoblastic nephroma.\",\\n    \"RCC stands for renal cell carcinoma.\",\\n    \"The UMBRELLA protocol is referenced in the context of clinical treatment.\",\\n    \"Staging of Wilms tumours includes Stage I to Stage V.\",\\n    \"AV, AVD, and HR-1 are treatment combinations relevant to cancer.\",\\n    \"Overall Survival (OS) and Event-Free Survival (EFS) are metrics used in clinical trials.\",\\n    \"CT-only nodules are a medical condition that relates to cancer diagnostics.\",\\n    \"The SIOP\u2013RTSG analysis and COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials are studies related to childhood renal tumours.\",\\n    \"Vincristine and actinomycin D plus doxorubicin is a treatment regimen.\",\\n    \"MRI and CT are diagnostic tools.\",\\n    \"The COG AREN0533 trial is a study related to childhood cancer.\",\\n    \"Etoposide, Carboplatin, and Cyclophosphamide are medications used in various treatments.\",\\n    \"End-stage renal disease (ESRD) is a condition associated with kidney failure.\",\\n    \"High-dose chemotherapy and autologous stem cell transplantation is a treatment modality.\",\\n    \"Infant Wilms Tumors and Adult Wilms Tumors are medical conditions.\",\\n    \"Diffuse anaplasia and blastemal-type tumors are conditions related to Wilms tumours.\",\\n    \"Nephron-sparing surgery (NSS) is a surgical procedure.\",\\n    \"Radical tumor nephrectomy and lymph node sampling are surgical procedures.\",\\n    \"Minimally invasive surgery and laparoscopic surgery are described as types of surgery.\",\\n    \"SIOP\u2212RTSG panel is an organization involved in treatment standards for childhood cancers.\",\\n    \"Children\u2019s Oncology Group (COG) is an organization involved with pediatric cancer treatment.\",\\n    \"The cohort studies such as SIOP 93\u201301 trial, UK Children\u2019s Cancer Study Group are involved in pediatric oncology research.\"\\n] \\n \\nVerdicts:\\n[\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"The actual output states Wilms tumours as a type of disease, not simply \\'a disease\\'.\"\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"The actual output states non-Wilms tumours as a type of disease, not simply \\'a disease\\'.\"\\n    },\\n    {\\n        \"verdict\": \"idk\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"Wilms tumours is correctly classified as a type of disease, not merely \\'a condition\\'.\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"idk\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"idk\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"idk\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"idk\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    }\\n]'), MetricData(name='Contextual Relevancy', threshold=1.0, success=False, score=0.5, reason='The score is 0.50 because while CT and MRI are mentioned as diagnostic tools, there is no specific imaging modality highlighted in the context, making it partially relevant.', strict_mode=False, evaluation_model='gpt-4o-mini', error=None, evaluation_cost=0.00344055, verbose_logs='Verdicts:\\n[\\n    {\\n        \"verdicts\": [\\n            {\\n                \"statement\": \"UMBRELLA protocol mentions various imaging modalities\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"No specific imaging modality is highlighted in the context.\"\\n            },\\n            {\\n                \"statement\": \"CT and MRI are used as diagnostic tools within the study protocols.\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            }\\n        ]\\n    }\\n]')], conversational=False, multimodal=False, input='What imaging modality is mentioned for staging in the UMBRELLA protocol?', actual_output='[{\\'nodes\\': [(\\'sample.pdf\\', {\\'type\\': \\'document\\'}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)\\'}), (\\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA SIOP-RTSG 2016\\'}), (\\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms tumours\\'}), (\\'non-Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'non-Wilms tumours\\'}), (\\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Website\\', \\'name\\': \\'www.siop-rtsg.eu\\'}), (\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology\\'}), (\\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Person\\', \\'name\\': \\'Marry M. van den Heuvel-Eibrink\\'}), (\\'childhood renal tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'childhood renal tumours\\'}), (\\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'clear cell sarcoma of the kidney\\'}), (\\'renal cell carcinoma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'renal cell carcinoma\\'}), (\\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'malignant rhabdoid tumour of the kidney\\'}), (\\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'Wilms tumours_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'Children\u2019s Oncology Group (COG)\\'}), (\\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'SIOP\u22122001 randomized trial\\'}), (\\'actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'UKW3 trial\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)\\'}), (\\'localized disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'localized disease\\'}), (\\'metastatic disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'metastatic disease\\'}), (\\'bilateral disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'bilateral disease\\'}), (\\'relapsed disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'relapsed disease\\'}), (\\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subtype\\', \\'name\\': \\'blastemal-type Wilms tumours\\'}), (\\'radiotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgery_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'chemotherapy\\'}), (\\'Wilms Tumour_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms Tumour\\'}), (\\'CCSK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CCSK\\'}), (\\'MRTK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'MRTK\\'}), (\\'CMN_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CMN\\'}), (\\'RCC_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'RCC\\'}), (\\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u22122001_Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Trial\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'vincristine_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'vincristine\\'}), (\\'actinomycin D_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'actinomycin D\\'}), (\\'doxorubicin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'doxorubicin\\'}), (\\'etoposide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'Stage I_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage I\\'}), (\\'Stage II_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage II\\'}), (\\'Stage III_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage III\\'}), (\\'Stage IV_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage IV\\'}), (\\'Stage V_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage V\\'}), (\\'AV_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AV\\'}), (\\'AVD_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AVD\\'}), (\\'HR-1_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'HR-1\\'}), (\\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP-RTSG 2016\\'}), (\\'Overall Survival (OS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'CT-only nodules_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'CT-only nodules\\'}), (\\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP\u2013RTSG analysis\\'}), (\\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials\\'}), (\\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D plus doxorubicin\\'}), (\\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D\\'}), (\\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study_protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'MRI_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'MRI\\'}), (\\'CT_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'CT\\'}), (\\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_detail\\', \\'name\\': \\'cumulative doxorubicin dose\\'}), (\\'COG AREN0533 trial_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG AREN0533 trial\\'}), (\\'etoposide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'high-risk characteristics\\'}), (\\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG board\\'}), (\\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin\\'}), (\\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'high-dose chemotherapy and autologous stem cell transplantation\\'}), (\\'SIOP database_database\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'database\\', \\'name\\': \\'SIOP database\\'}), (\\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'AVD_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AVD\\'}), (\\'AV-2_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AV-2\\'}), (\\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Statistical Test\\', \\'name\\': \\'Log\u2013Rank P\\'}), (\\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'Bilateral Disease (Stage V)\\'}), (\\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Synchronous bilateral Wilms tumor\\'}), (\\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'End-stage renal disease (ESRD)\\'}), (\\'Aronson et al._Research Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Research Group\\', \\'name\\': \\'Aronson et al.\\'}), (\\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'Bilateral nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Study\\', \\'name\\': \\'SIOP\u22122001 study\\'}), (\\'Vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Vincristine\\'}), (\\'Actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Actinomycin D\\'}), (\\'Etoposide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Etoposide\\'}), (\\'Carboplatin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Carboplatin\\'}), (\\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease State\\', \\'name\\': \\'Relapsed Wilms Tumor\\'}), (\\'Group AA_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group AA\\'}), (\\'Group BB_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group BB\\'}), (\\'Group CC_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group CC\\'}), (\\'Doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Doxorubicin\\'}), (\\'Cyclophosphamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Cyclophosphamide\\'}), (\\'Ifosfamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Ifosfamide\\'}), (\\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'High-dose melphalan\\'}), (\\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UKW\u2011R protocol\\'}), (\\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'NWTS\u20115 relapse protocol\\'}), (\\'ASCR_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'procedure\\', \\'name\\': \\'ASCR\\'}), (\\'ifosfamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'ifosfamide\\'}), (\\'nephrotoxicity_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'nephrotoxicity\\'}), (\\'relapsed group CC_patient_group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'patient_group\\', \\'name\\': \\'relapsed group CC\\'}), (\\'diffuse anaplasia_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'diffuse anaplasia\\'}), (\\'blastemal-type tumors_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'blastemal-type tumors\\'}), (\\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'camptothecins_medication_class\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication_class\\', \\'name\\': \\'camptothecins\\'}), (\\'irinotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'irinotecan\\'}), (\\'topotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'topotecan\\'}), (\\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Innovative Therapies for Children with Cancer consortium\\'}), (\\'radiotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgical excision_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgical excision\\'}), (\\'stage IV WT_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'stage IV WT\\'}), (\\'AVD150_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD150\\'}), (\\'AVD250_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD250\\'}), (\\'low-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'low-risk disease\\'}), (\\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'intermediate-risk disease\\'}), (\\'high-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'high-risk disease\\'}), (\\'CDCV_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'CDCV\\'}), (\\'actinomycin-D_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'actinomycin-D\\'}), (\\'vincristine_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'doxorubicin\\'}), (\\'VP16_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'VP16\\'}), (\\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'contact\\', \\'name\\': \\'arnauld.verschuur@ap-hm.fr\\'}), (\\'surgery_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'chemotherapy\\'}), (\\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2212RTSG panel\\'}), (\\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Infant Wilms Tumors\\'}), (\\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'nephrectomy\\'}), (\\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'malignant rhabdoid tumors\\'}), (\\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Adult Wilms Tumors\\'}), (\\'anaplasia_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'anaplasia\\'}), (\\'actinomycin D_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'carboplatin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'etoposide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'etoposide\\'}), (\\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'Nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'radical tumor nephrectomy\\'}), (\\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'lymph node sampling\\'}), (\\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'minimally invasive surgery\\'}), (\\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'laparoscopic surgery\\'}), (\\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'radiotherapy\\'}), (\\'Wilms tumours_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'Davila Fajardo et al._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Davila Fajardo et al.\\'}), (\\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'COG\u2013NWTS trials\\'}), (\\'whole-lung irradiation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'whole-lung irradiation\\'}), (\\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'pulmonary radiotherapy\\'}), (\\'proton therapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'proton therapy\\'}), (\\'dosimetric study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'dosimetric study\\'}), (\\'locoregional disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'locoregional disease\\'}), (\\'metastatic disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'metastatic disease\\'}), (\\'low-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'low-risk\\'}), (\\'intermediate-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'intermediate-risk\\'}), (\\'high-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'high-risk\\'}), (\\'stage I_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage I\\'}), (\\'stage II_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage II\\'}), (\\'stage III_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage III\\'}), (\\'major rupture_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'major rupture\\'}), (\\'Austria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Austria\\'}), (\\'Italy_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Italy\\'}), (\\'San Marino_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'San Marino\\'}), (\\'Iceland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Iceland\\'}), (\\'Germany_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Germany\\'}), (\\'Bulgaria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bulgaria\\'}), (\\'Turkey_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Turkey\\'}), (\\'Denmark_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Denmark\\'}), (\\'Poland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Poland\\'}), (\\'Greece_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Greece\\'}), (\\'Andorra_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Andorra\\'}), (\\'Belgium_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belgium\\'}), (\\'Serbia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Serbia\\'}), (\\'Albania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Albania\\'}), (\\'Moldova_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Moldova\\'}), (\\'Lithuania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Lithuania\\'}), (\\'Latvia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Latvia\\'}), (\\'Estonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Estonia\\'}), (\\'Luxembourg_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Luxembourg\\'}), (\\'Montenegro_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Montenegro\\'}), (\\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bosnia and Herzegovina\\'}), (\\'Croatia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Croatia\\'}), (\\'Slovenia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovenia\\'}), (\\'Macedonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Macedonia\\'}), (\\'United Kingdom_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'United Kingdom\\'}), (\\'Ireland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ireland\\'}), (\\'Spain_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Spain\\'}), (\\'Algeria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Algeria\\'}), (\\'Tunisia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Tunisia\\'}), (\\'Malta_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Malta\\'}), (\\'Morocco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Morocco\\'}), (\\'Portugal_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Portugal\\'}), (\\'France_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'France\\'}), (\\'Monaco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Monaco\\'}), (\\'Russia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Russia\\'}), (\\'Finland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Finland\\'}), (\\'Sweden_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Sweden\\'}), (\\'Norway_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Norway\\'}), (\\'Belarus_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belarus\\'}), (\\'Romania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Romania\\'}), (\\'Ukraine_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ukraine\\'}), (\\'Hungary_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Hungary\\'}), (\\'Czech Republic_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Czech Republic\\'}), (\\'Slovakia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovakia\\'}), (\\'Switzerland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Switzerland\\'}), (\\'Liechtenstein_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Liechtenstein\\'}), (\\'Netherlands_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Netherlands\\'}), (\\'University Hospital of Munich_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Munich\\'}), (\\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Tuebingen\\'}), (\\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Azienda Ospedaliera\\'}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Ospedale Pediatrico Bambino Ges\u00f9\\'}), (\\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Fondazione IRCCS Istituto Nazionale dei Tumori\\'}), (\\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Prinses Maxima Centrum\\'}), (\\'Marciniak Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Marciniak Hospital\\'}), (\\'Faculty of Medicine_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Faculty of Medicine\\'}), (\\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'St. Anna Kinderspital/CCRI\\'}), (\\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Armand Trousseau Hospital\\'}), (\\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Universitario Virgin del Rocio\\'}), (\\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Vall d\u2019Hebron\\'}), (\\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Great Ormond Street Hospital\\'}), (\\'University Hospital Homburg_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital Homburg\\'}), (\\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon\\'}), (\\'UMBRELLA protocol_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'ExPO\u2011r\u2011Net\\'}), (\\'Weirich, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Weirich, A.\\'}), (\\'Pritchard-Jones, K._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Pritchard-Jones, K.\\'}), (\\'de Kraker, J._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'de Kraker, J.\\'}), (\\'Graf, N._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Graf, N.\\'}), (\\'Green, D. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Green, D. M.\\'}), (\\'Spreafico, F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Spreafico, F.\\'}), (\\'Bellani, F. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Bellani, F. F.\\'}), (\\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'van den Heuvel-Eibrink, M. M.\\'}), (\"D\\'Angio, G. J._author\", {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \"D\\'Angio, G. J.\"}), (\\'Tournade, M. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Tournade, M. F.\\'}), (\\'Breslow, N. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Breslow, N. E.\\'}), (\\'Mitchell, C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Mitchell, C.\\'}), (\\'Verschuur, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Verschuur, A.\\'}), (\\'Grundy, P. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Grundy, P. E.\\'}), (\\'Warmann, S. W._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Warmann, S. W.\\'}), (\\'Smets, A. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Smets, A. M.\\'}), (\\'Dome, J. S._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dome, J. S.\\'}), (\\'Dix, D. B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dix, D. B.\\'}), (\\'Daw, N. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Daw, N. C.\\'}), (\\'Ha, T. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Ha, T. C.\\'}), (\\'Kremens, B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Kremens, B.\\'}), (\\'Furtwangler, R._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Furtwangler, R.\\'}), (\\'SIOP-9/GPOH_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP-9/GPOH\\'}), (\\'UKW3_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'UKW3\\'}), (\\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'SIOP 93\u201301 trial\\'}), (\\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP trial and study 93\u201301\\'}), (\\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'National Wilms Tumor Study Group\\'}), (\\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP WT 2001 protocol\\'}), (\\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Third National Wilms\u2019 Tumor Study\\'}), (\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'National Wilms Tumor Studies\\'}), (\\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Second National Wilms\u2019 Tumor Study\\'}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'UK Children\u2019s Cancer Study Group\\'}), (\\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Children\u2019s Oncology Group\\'})], \\'edges\\': [(\\'sample.pdf\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'non-Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'childhood renal tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'renal cell carcinoma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'localized disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'metastatic disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'bilateral disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'relapsed disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'radiotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'surgery_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'chemotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'Wilms Tumour_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CCSK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'MRTK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CMN_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'RCC_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP\u22122001_Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'vincristine_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'actinomycin D_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'doxorubicin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'etoposide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'carboplatin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'cyclophosphamide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage I_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage II_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage III_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage IV_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage V_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AV_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AVD_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'HR-1_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Overall Survival (OS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT-only nodules_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'MRI_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG AREN0533 trial_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'etoposide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'carboplatin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'cyclophosphamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP database_database\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AVD_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AV-2_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Aronson et al._Research Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Etoposide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Carboplatin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group AA_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group BB_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group CC_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Cyclophosphamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Ifosfamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'ASCR_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'ifosfamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'nephrotoxicity_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'relapsed group CC_patient_group\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'diffuse anaplasia_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'blastemal-type tumors_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'camptothecins_medication_class\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'irinotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'topotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'radiotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'surgical excision_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'stage IV WT_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD150_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD250_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'low-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'CDCV_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'actinomycin-D_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'vincristine_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'doxorubicin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'VP16_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'surgery_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'chemotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'anaplasia_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'actinomycin D_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'vincristine_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'doxorubicin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'carboplatin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'cyclophosphamide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'etoposide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'SIOP\u22122001_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Wilms tumours_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Davila Fajardo et al._author\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'whole-lung irradiation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'proton therapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'dosimetric study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'locoregional disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'metastatic disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'low-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'intermediate-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'high-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage I_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage II_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage III_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'major rupture_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Austria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Italy_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'San Marino_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Iceland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Germany_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bulgaria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Turkey_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Denmark_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Poland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Greece_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Andorra_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belgium_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Serbia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Albania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Moldova_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Lithuania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Latvia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Estonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Luxembourg_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Montenegro_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Croatia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovenia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Macedonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'United Kingdom_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ireland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Spain_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Algeria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Tunisia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Malta_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Morocco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Portugal_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'France_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Monaco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Russia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Finland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Sweden_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Norway_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belarus_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Romania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ukraine_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hungary_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Czech Republic_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovakia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Switzerland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Liechtenstein_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Netherlands_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Munich_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Marciniak Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Faculty of Medicine_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital Homburg_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Weirich, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Pritchard-Jones, K._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'de Kraker, J._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Graf, N._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Green, D. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Spreafico, F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Bellani, F. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \"D\\'Angio, G. J._author\", {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Tournade, M. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Breslow, N. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Mitchell, C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Verschuur, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Grundy, P. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Warmann, S. W._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Smets, A. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dome, J. S._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dix, D. B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Daw, N. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ha, T. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Kremens, B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Furtwangler, R._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP-9/GPOH_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UKW3_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10})]}, {\\'nodes\\': [(\\'vincristine_entity\\', {}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {}), (\\'www.siop-rtsg.eu_entity\\', {}), (\\'stage II_entity\\', {}), (\\'Wilms tumours_entity\\', {}), (\\'Relapsed Wilms Tumor_entity\\', {}), (\\'Davila Fajardo et al._entity\\', {}), (\\'vincristine, actinomycin D, and doxorubicin_entity\\', {}), (\\'SIOP\u22122001 randomized trial_entity\\', {}), (\\'surgery_entity\\', {}), (\\'non-Wilms tumours_entity\\', {}), (\\'actinomycin D_entity\\', {}), (\\'diffuse anaplasia_entity\\', {}), (\\'Synchronous bilateral Wilms tumor_entity\\', {}), (\\'CT-only nodules_entity\\', {}), (\\'relapsed group CC_entity\\', {}), (\\'increased relapse risk_entity\\', {}), (\\'reduced survival_entity\\', {}), (\\'UKW3 trial_entity\\', {}), (\\'chemotherapy_entity\\', {}), (\\'Bilateral Disease (Stage V)_entity\\', {}), (\\'blastemal-type tumors_entity\\', {}), (\\'UMBRELLA protocol_entity\\', {}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', {}), (\\'minimally invasive surgery_entity\\', {}), (\\'VP16_entity\\', {}), (\\'Wilms tumor_entity\\', {}), (\\'anaplasia_entity\\', {}), (\\'radical tumor nephrectomy_entity\\', {}), (\\'Innovative Therapies for Children with Cancer consortium_entity\\', {}), (\\'cumulative doxorubicin dose_entity\\', {}), (\\'etoposide_entity\\', {}), (\\'large-volume tumours_entity\\', {}), (\\'Stage IV_entity\\', {}), (\\'CDCV_entity\\', {}), (\\'SIOP\u2013RTSG_entity\\', {}), (\\'AVD150_entity\\', {}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', {}), (\\'laparoscopic surgery_entity\\', {}), (\\'SIOP\u2212RTSG panel_entity\\', {}), (\\'actinomycin-D_entity\\', {}), (\\'COG AREN0533 trial_entity\\', {}), (\\'cyclophosphamide_entity\\', {}), (\\'carboplatin_entity\\', {}), (\\'UKW\u2011R protocol_entity\\', {}), (\\'Nephron-sparing surgery (NSS)_entity\\', {}), (\\'Adult Wilms Tumors_entity\\', {}), (\\'doxorubicin_entity\\', {}), (\\'NWTS\u20115 relapse protocol_entity\\', {}), (\\'End-stage renal disease (ESRD)_entity\\', {}), (\\'AVD250_entity\\', {}), (\\'Children\u2019s Oncology Group (COG)_entity\\', {}), (\\'blastemal-type Wilms tumour_entity\\', {}), (\\'SIOP\u22122001_entity\\', {}), (\\'radiotherapy_entity\\', {}), (\\'childhood renal tumours_entity\\', {})], \\'edges\\': [(\\'vincristine_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'stage II_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'indicated_for_in_adults\\'}), (\\'Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'Wilms tumours_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated under\\'}), (\\'Relapsed Wilms Tumor_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guided_by\\'}), (\\'Davila Fajardo et al._entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed\\'}), (\\'SIOP\u22122001 randomized trial_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated use in\\'}), (\\'surgery_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'non-Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'actinomycin D_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Synchronous bilateral Wilms tumor_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'instance_of\\'}), (\\'CT-only nodules_entity\\', \\'increased relapse risk_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'reduced survival_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included_in\\'}), (\\'relapsed group CC_entity\\', \\'diffuse anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'blastemal-type tumors_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UKW3 trial_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'UKW3 trial_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'chemotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UMBRELLA protocol_entity\\', \\'COG AREN0533 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses_data_from\\'}), (\\'UMBRELLA protocol_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'advises_treatment_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'Innovative Therapies for Children with Cancer consortium_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborates_with\\'}), (\\'UMBRELLA protocol_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'surgery_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is the standard of\\'}), (\\'UMBRELLA protocol_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guides treatment in\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', \\'UKW3 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\\'minimally invasive surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'anaplasia_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'radical tumor nephrectomy_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'standard_of_care_for\\'}), (\\'Stage IV_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'presents in\\'}), (\\'CDCV_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'VP16_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'aims to improve survival rates of\\'}), (\\'AVD150_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed_by\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'succeeds\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'www.siop-rtsg.eu_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'available_on\\'}), (\\'laparoscopic surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'COG AREN0533 trial_entity\\', \\'cumulative doxorubicin dose_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'evaluates\\'}), (\\'UKW\u2011R protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'Nephron-sparing surgery (NSS)_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'classification_developed_by\\'}), (\\'Adult Wilms Tumors_entity\\', \\'anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'Adult Wilms Tumors_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'doxorubicin_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'doxorubicin_entity\\', \\'large-volume tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'recommended for\\'}), (\\'NWTS\u20115 relapse protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'End-stage renal disease (ESRD)_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'AVD250_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'Children\u2019s Oncology Group (COG)_entity\\', \\'SIOP\u22122001 randomized trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborated with\\'}), (\\'blastemal-type Wilms tumour_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment intensified according to\\'}), (\\'SIOP\u22122001_entity\\', \\'vincristine, actinomycin D, and doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses\\'}), (\\'SIOP\u22122001_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provided_guidelines_for\\'}), (\\'radiotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'radiotherapy_entity\\', \\'SIOP\u2212RTSG panel_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'contact_for_guidance\\'})]}, {\\'nodes\\': [(\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {}), (\\'Marry M. van den Heuvel-Eibrink_entity\\', {})], \\'edges\\': [(\\'Marry M. van den Heuvel-Eibrink_entity\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'affiliated_with\\'})]}, {\\'nodes\\': [(\\'Stage II_entity\\', {}), (\\'AV_entity\\', {}), (\\'Stage III_entity\\', {}), (\\'vincestine and actinomycin D_entity\\', {}), (\\'AVD_entity\\', {})], \\'edges\\': [(\\'Stage II_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AV_entity\\', \\'Stage II_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Stage III_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AVD_entity\\', \\'Stage III_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'SIOP-RTSG 2016_entity\\', {}), (\\'RCC_entity\\', {}), (\\'CMN_entity\\', {})], \\'edges\\': [(\\'RCC_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'}), (\\'CMN_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'})]}, {\\'nodes\\': [(\\'HR-1_entity\\', {}), (\\'High-risk blastemal type Wilms tumour_entity\\', {})], \\'edges\\': [(\\'HR-1_entity\\', \\'High-risk blastemal type Wilms tumour_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'unfavorable prognosis_entity\\', {}), (\\'high-risk characteristics_entity\\', {})], \\'edges\\': [(\\'high-risk characteristics_entity\\', \\'unfavorable prognosis_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'leads_to\\'})]}, {\\'nodes\\': [(\\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {}), (\\'SIOP\u2013RTSG board_entity\\', {})], \\'edges\\': [(\\'SIOP\u2013RTSG board_entity\\', \\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggests\\'})]}, {\\'nodes\\': [(\\'regimen and outcomes_entity\\', {}), (\\'SIOP database_entity\\', {})], \\'edges\\': [(\\'SIOP database_entity\\', \\'regimen and outcomes_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'captures_data_on\\'})]}, {\\'nodes\\': [(\\'Bilateral nephron-sparing surgery (NSS)_entity\\', {}), (\\'Aronson et al._entity\\', {})], \\'edges\\': [(\\'Aronson et al._entity\\', \\'Bilateral nephron-sparing surgery (NSS)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'observed_effectiveness_of\\'})]}, {\\'nodes\\': [(\\'SIOP\u22122001 study_entity\\', {}), (\\'Actinomycin D_entity\\', {}), (\\'Vincristine_entity\\', {})], \\'edges\\': [(\\'SIOP\u22122001 study_entity\\', \\'Vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'}), (\\'SIOP\u22122001 study_entity\\', \\'Actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'})]}, {\\'nodes\\': [(\\'High-dose melphalan_entity\\', {}), (\\'Group AA_entity\\', {}), (\\'Carboplatin_entity\\', {}), (\\'Doxorubicin_entity\\', {}), (\\'Etoposide_entity\\', {}), (\\'Group BB_entity\\', {}), (\\'Cyclophosphamide_entity\\', {}), (\\'Ifosfamide_entity\\', {})], \\'edges\\': [(\\'Group AA_entity\\', \\'Doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Ifosfamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'High-dose melphalan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'})]}, {\\'nodes\\': [(\\'nephrotoxicity_entity\\', {}), (\\'ifosfamide_entity\\', {})], \\'edges\\': [(\\'ifosfamide_entity\\', \\'nephrotoxicity_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'related_to\\'})]}, {\\'nodes\\': [(\\'camptothecins_entity\\', {}), (\\'irinotecan_entity\\', {}), (\\'topotecan_entity\\', {})], \\'edges\\': [(\\'camptothecins_entity\\', \\'irinotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'camptothecins_entity\\', \\'topotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'})]}, {\\'nodes\\': [(\\'Infant Wilms Tumors_entity\\', {}), (\\'nephrectomy_entity\\', {})], \\'edges\\': [(\\'Infant Wilms Tumors_entity\\', \\'nephrectomy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_option\\'})]}, {\\'nodes\\': [(\\'congenital mesoblastic nephroma_entity\\', {}), (\\'surgery alone_entity\\', {})], \\'edges\\': [(\\'congenital mesoblastic nephroma_entity\\', \\'surgery alone_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'alternative chemotherapy_entity\\', {}), (\\'malignant rhabdoid tumors_entity\\', {})], \\'edges\\': [(\\'malignant rhabdoid tumors_entity\\', \\'alternative chemotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'lymph node sampling_entity\\', {}), (\\'accurate staging_entity\\', {})], \\'edges\\': [(\\'lymph node sampling_entity\\', \\'accurate staging_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'purpose_of\\'})]}, {\\'nodes\\': [(\\'COG\u2013NWTS trials_entity\\', {}), (\\'whole-lung irradiation_entity\\', {})], \\'edges\\': [(\\'COG\u2013NWTS trials_entity\\', \\'whole-lung irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'informed_dosage_for\\'})]}, {\\'nodes\\': [(\\'lung metastases_entity\\', {}), (\\'pulmonary radiotherapy_entity\\', {})], \\'edges\\': [(\\'pulmonary radiotherapy_entity\\', \\'lung metastases_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'administered_for\\'})]}, {\\'nodes\\': [(\\'dosimetric study_entity\\', {}), (\\'proton therapy_entity\\', {}), (\\'flank irradiation_entity\\', {})], \\'edges\\': [(\\'dosimetric study_entity\\', \\'proton therapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated\\'}), (\\'proton therapy_entity\\', \\'flank irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggested_for\\'})]}, {\\'nodes\\': [(\\'metastatic disease_entity\\', {}), (\\'radiotherapy guidelines_entity\\', {}), (\\'locoregional disease_entity\\', {})], \\'edges\\': [(\\'radiotherapy guidelines_entity\\', \\'locoregional disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'}), (\\'radiotherapy guidelines_entity\\', \\'metastatic disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'})]}, {\\'nodes\\': [(\\'major rupture_entity\\', {}), (\\'stage III_entity\\', {})], \\'edges\\': [(\\'stage III_entity\\', \\'major rupture_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes_condition\\'})]}, {\\'nodes\\': [(\\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {}), (\\'ExPO\u2011r\u2011Net_entity\\', {})], \\'edges\\': [(\\'ExPO\u2011r\u2011Net_entity\\', \\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is part of\\'})]}, {\\'nodes\\': [(\\'University Hospital of Munich_entity\\', {}), (\\'Germany_entity\\', {}), (\\'University Hospital of Tuebingen_entity\\', {})], \\'edges\\': [(\\'Germany_entity\\', \\'University Hospital of Munich_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Germany_entity\\', \\'University Hospital of Tuebingen_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {}), (\\'Italy_entity\\', {}), (\\'Azienda Ospedaliera_entity\\', {}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {})], \\'edges\\': [(\\'Italy_entity\\', \\'Azienda Ospedaliera_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Netherlands_entity\\', {}), (\\'Prinses Maxima Centrum_entity\\', {})], \\'edges\\': [(\\'Netherlands_entity\\', \\'Prinses Maxima Centrum_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Marciniak Hospital_entity\\', {}), (\\'Poland_entity\\', {}), (\\'Faculty of Medicine_entity\\', {})], \\'edges\\': [(\\'Poland_entity\\', \\'Marciniak Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Poland_entity\\', \\'Faculty of Medicine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'St. Anna Kinderspital/CCRI_entity\\', {}), (\\'Austria_entity\\', {})], \\'edges\\': [(\\'Austria_entity\\', \\'St. Anna Kinderspital/CCRI_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'France_entity\\', {}), (\\'Armand Trousseau Hospital_entity\\', {})], \\'edges\\': [(\\'France_entity\\', \\'Armand Trousseau Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Spain_entity\\', {}), (\\'Hospital Vall d\u2019Hebron_entity\\', {}), (\\'Hospital Universitario Virgin del Rocio_entity\\', {})], \\'edges\\': [(\\'Spain_entity\\', \\'Hospital Universitario Virgin del Rocio_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Spain_entity\\', \\'Hospital Vall d\u2019Hebron_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'United Kingdom_entity\\', {}), (\\'Great Ormond Street Hospital_entity\\', {})], \\'edges\\': [(\\'United Kingdom_entity\\', \\'Great Ormond Street Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Weirich, A._entity\\', {}), (\\'SIOP-9/GPOH_entity\\', {})], \\'edges\\': [(\\'Weirich, A._entity\\', \\'SIOP-9/GPOH_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Pritchard-Jones, K._entity\\', {}), (\\'UKW3_entity\\', {})], \\'edges\\': [(\\'Pritchard-Jones, K._entity\\', \\'UKW3_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed in\\'})]}, {\\'nodes\\': [(\\'SIOP 93\u201301 trial_entity\\', {}), (\\'de Kraker, J._entity\\', {})], \\'edges\\': [(\\'de Kraker, J._entity\\', \\'SIOP 93\u201301 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'SIOP trial and study 93\u201301_entity\\', {}), (\\'Graf, N._entity\\', {})], \\'edges\\': [(\\'Graf, N._entity\\', \\'SIOP trial and study 93\u201301_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Green, D. M._entity\\', {}), (\\'National Wilms Tumor Study Group_entity\\', {})], \\'edges\\': [(\\'Green, D. M._entity\\', \\'National Wilms Tumor Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}, {\\'nodes\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', {}), (\\'SIOP WT 2001 protocol_entity\\', {})], \\'edges\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', \\'SIOP WT 2001 protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Third National Wilms\u2019 Tumor Study_entity\\', {}), (\"D\\'Angio, G. J._entity\", {}), (\\'Second National Wilms\u2019 Tumor Study_entity\\', {})], \\'edges\\': [(\"D\\'Angio, G. J._entity\", \\'Third National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\"D\\'Angio, G. J._entity\", \\'Second National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {}), (\\'Tournade, M. F._entity\\', {}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {})], \\'edges\\': [(\\'Tournade, M. F._entity\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'}), (\\'Tournade, M. F._entity\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Breslow, N. E._entity\\', {}), (\\'National Wilms Tumor Studies_entity\\', {})], \\'edges\\': [(\\'Breslow, N. E._entity\\', \\'National Wilms Tumor Studies_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Mitchell, C._entity\\', {}), (\\'UK Children\u2019s Cancer Study Group_entity\\', {})], \\'edges\\': [(\\'Mitchell, C._entity\\', \\'UK Children\u2019s Cancer Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'under\\'})]}, {\\'nodes\\': [(\\'Daw, N. C._entity\\', {}), (\\'Dix, D. B._entity\\', {}), (\\'Children\u2019s Oncology Group_entity\\', {}), (\\'Grundy, P. E._entity\\', {})], \\'edges\\': [(\\'Daw, N. C._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted under\\'}), (\\'Dix, D. B._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'}), (\\'Grundy, P. E._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}]', expected_output='Chest CT is mentioned for staging, particularly to detect small pulmonary nodules.', context=None, retrieval_context=['[{\\'nodes\\': [(\\'sample.pdf\\', {\\'type\\': \\'document\\'}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)\\'}), (\\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA SIOP-RTSG 2016\\'}), (\\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms tumours\\'}), (\\'non-Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'non-Wilms tumours\\'}), (\\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Website\\', \\'name\\': \\'www.siop-rtsg.eu\\'}), (\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology\\'}), (\\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Person\\', \\'name\\': \\'Marry M. van den Heuvel-Eibrink\\'}), (\\'childhood renal tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'childhood renal tumours\\'}), (\\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'clear cell sarcoma of the kidney\\'}), (\\'renal cell carcinoma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'renal cell carcinoma\\'}), (\\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'malignant rhabdoid tumour of the kidney\\'}), (\\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'Wilms tumours_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'Children\u2019s Oncology Group (COG)\\'}), (\\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'SIOP\u22122001 randomized trial\\'}), (\\'actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'UKW3 trial\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)\\'}), (\\'localized disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'localized disease\\'}), (\\'metastatic disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'metastatic disease\\'}), (\\'bilateral disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'bilateral disease\\'}), (\\'relapsed disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'relapsed disease\\'}), (\\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subtype\\', \\'name\\': \\'blastemal-type Wilms tumours\\'}), (\\'radiotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgery_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'chemotherapy\\'}), (\\'Wilms Tumour_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms Tumour\\'}), (\\'CCSK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CCSK\\'}), (\\'MRTK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'MRTK\\'}), (\\'CMN_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CMN\\'}), (\\'RCC_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'RCC\\'}), (\\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u22122001_Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Trial\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'vincristine_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'vincristine\\'}), (\\'actinomycin D_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'actinomycin D\\'}), (\\'doxorubicin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'doxorubicin\\'}), (\\'etoposide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'Stage I_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage I\\'}), (\\'Stage II_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage II\\'}), (\\'Stage III_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage III\\'}), (\\'Stage IV_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage IV\\'}), (\\'Stage V_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage V\\'}), (\\'AV_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AV\\'}), (\\'AVD_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AVD\\'}), (\\'HR-1_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'HR-1\\'}), (\\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP-RTSG 2016\\'}), (\\'Overall Survival (OS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'CT-only nodules_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'CT-only nodules\\'}), (\\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP\u2013RTSG analysis\\'}), (\\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials\\'}), (\\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D plus doxorubicin\\'}), (\\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D\\'}), (\\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study_protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'MRI_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'MRI\\'}), (\\'CT_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'CT\\'}), (\\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_detail\\', \\'name\\': \\'cumulative doxorubicin dose\\'}), (\\'COG AREN0533 trial_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG AREN0533 trial\\'}), (\\'etoposide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'high-risk characteristics\\'}), (\\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG board\\'}), (\\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin\\'}), (\\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'high-dose chemotherapy and autologous stem cell transplantation\\'}), (\\'SIOP database_database\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'database\\', \\'name\\': \\'SIOP database\\'}), (\\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'AVD_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AVD\\'}), (\\'AV-2_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AV-2\\'}), (\\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Statistical Test\\', \\'name\\': \\'Log\u2013Rank P\\'}), (\\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'Bilateral Disease (Stage V)\\'}), (\\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Synchronous bilateral Wilms tumor\\'}), (\\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'End-stage renal disease (ESRD)\\'}), (\\'Aronson et al._Research Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Research Group\\', \\'name\\': \\'Aronson et al.\\'}), (\\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'Bilateral nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Study\\', \\'name\\': \\'SIOP\u22122001 study\\'}), (\\'Vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Vincristine\\'}), (\\'Actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Actinomycin D\\'}), (\\'Etoposide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Etoposide\\'}), (\\'Carboplatin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Carboplatin\\'}), (\\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease State\\', \\'name\\': \\'Relapsed Wilms Tumor\\'}), (\\'Group AA_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group AA\\'}), (\\'Group BB_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group BB\\'}), (\\'Group CC_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group CC\\'}), (\\'Doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Doxorubicin\\'}), (\\'Cyclophosphamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Cyclophosphamide\\'}), (\\'Ifosfamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Ifosfamide\\'}), (\\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'High-dose melphalan\\'}), (\\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UKW\u2011R protocol\\'}), (\\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'NWTS\u20115 relapse protocol\\'}), (\\'ASCR_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'procedure\\', \\'name\\': \\'ASCR\\'}), (\\'ifosfamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'ifosfamide\\'}), (\\'nephrotoxicity_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'nephrotoxicity\\'}), (\\'relapsed group CC_patient_group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'patient_group\\', \\'name\\': \\'relapsed group CC\\'}), (\\'diffuse anaplasia_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'diffuse anaplasia\\'}), (\\'blastemal-type tumors_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'blastemal-type tumors\\'}), (\\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'camptothecins_medication_class\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication_class\\', \\'name\\': \\'camptothecins\\'}), (\\'irinotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'irinotecan\\'}), (\\'topotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'topotecan\\'}), (\\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Innovative Therapies for Children with Cancer consortium\\'}), (\\'radiotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgical excision_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgical excision\\'}), (\\'stage IV WT_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'stage IV WT\\'}), (\\'AVD150_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD150\\'}), (\\'AVD250_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD250\\'}), (\\'low-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'low-risk disease\\'}), (\\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'intermediate-risk disease\\'}), (\\'high-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'high-risk disease\\'}), (\\'CDCV_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'CDCV\\'}), (\\'actinomycin-D_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'actinomycin-D\\'}), (\\'vincristine_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'doxorubicin\\'}), (\\'VP16_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'VP16\\'}), (\\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'contact\\', \\'name\\': \\'arnauld.verschuur@ap-hm.fr\\'}), (\\'surgery_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'chemotherapy\\'}), (\\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2212RTSG panel\\'}), (\\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Infant Wilms Tumors\\'}), (\\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'nephrectomy\\'}), (\\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'malignant rhabdoid tumors\\'}), (\\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Adult Wilms Tumors\\'}), (\\'anaplasia_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'anaplasia\\'}), (\\'actinomycin D_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'carboplatin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'etoposide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'etoposide\\'}), (\\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'Nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'radical tumor nephrectomy\\'}), (\\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'lymph node sampling\\'}), (\\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'minimally invasive surgery\\'}), (\\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'laparoscopic surgery\\'}), (\\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'radiotherapy\\'}), (\\'Wilms tumours_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'Davila Fajardo et al._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Davila Fajardo et al.\\'}), (\\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'COG\u2013NWTS trials\\'}), (\\'whole-lung irradiation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'whole-lung irradiation\\'}), (\\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'pulmonary radiotherapy\\'}), (\\'proton therapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'proton therapy\\'}), (\\'dosimetric study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'dosimetric study\\'}), (\\'locoregional disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'locoregional disease\\'}), (\\'metastatic disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'metastatic disease\\'}), (\\'low-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'low-risk\\'}), (\\'intermediate-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'intermediate-risk\\'}), (\\'high-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'high-risk\\'}), (\\'stage I_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage I\\'}), (\\'stage II_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage II\\'}), (\\'stage III_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage III\\'}), (\\'major rupture_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'major rupture\\'}), (\\'Austria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Austria\\'}), (\\'Italy_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Italy\\'}), (\\'San Marino_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'San Marino\\'}), (\\'Iceland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Iceland\\'}), (\\'Germany_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Germany\\'}), (\\'Bulgaria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bulgaria\\'}), (\\'Turkey_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Turkey\\'}), (\\'Denmark_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Denmark\\'}), (\\'Poland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Poland\\'}), (\\'Greece_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Greece\\'}), (\\'Andorra_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Andorra\\'}), (\\'Belgium_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belgium\\'}), (\\'Serbia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Serbia\\'}), (\\'Albania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Albania\\'}), (\\'Moldova_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Moldova\\'}), (\\'Lithuania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Lithuania\\'}), (\\'Latvia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Latvia\\'}), (\\'Estonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Estonia\\'}), (\\'Luxembourg_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Luxembourg\\'}), (\\'Montenegro_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Montenegro\\'}), (\\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bosnia and Herzegovina\\'}), (\\'Croatia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Croatia\\'}), (\\'Slovenia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovenia\\'}), (\\'Macedonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Macedonia\\'}), (\\'United Kingdom_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'United Kingdom\\'}), (\\'Ireland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ireland\\'}), (\\'Spain_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Spain\\'}), (\\'Algeria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Algeria\\'}), (\\'Tunisia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Tunisia\\'}), (\\'Malta_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Malta\\'}), (\\'Morocco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Morocco\\'}), (\\'Portugal_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Portugal\\'}), (\\'France_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'France\\'}), (\\'Monaco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Monaco\\'}), (\\'Russia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Russia\\'}), (\\'Finland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Finland\\'}), (\\'Sweden_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Sweden\\'}), (\\'Norway_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Norway\\'}), (\\'Belarus_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belarus\\'}), (\\'Romania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Romania\\'}), (\\'Ukraine_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ukraine\\'}), (\\'Hungary_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Hungary\\'}), (\\'Czech Republic_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Czech Republic\\'}), (\\'Slovakia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovakia\\'}), (\\'Switzerland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Switzerland\\'}), (\\'Liechtenstein_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Liechtenstein\\'}), (\\'Netherlands_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Netherlands\\'}), (\\'University Hospital of Munich_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Munich\\'}), (\\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Tuebingen\\'}), (\\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Azienda Ospedaliera\\'}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Ospedale Pediatrico Bambino Ges\u00f9\\'}), (\\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Fondazione IRCCS Istituto Nazionale dei Tumori\\'}), (\\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Prinses Maxima Centrum\\'}), (\\'Marciniak Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Marciniak Hospital\\'}), (\\'Faculty of Medicine_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Faculty of Medicine\\'}), (\\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'St. Anna Kinderspital/CCRI\\'}), (\\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Armand Trousseau Hospital\\'}), (\\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Universitario Virgin del Rocio\\'}), (\\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Vall d\u2019Hebron\\'}), (\\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Great Ormond Street Hospital\\'}), (\\'University Hospital Homburg_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital Homburg\\'}), (\\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon\\'}), (\\'UMBRELLA protocol_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'ExPO\u2011r\u2011Net\\'}), (\\'Weirich, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Weirich, A.\\'}), (\\'Pritchard-Jones, K._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Pritchard-Jones, K.\\'}), (\\'de Kraker, J._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'de Kraker, J.\\'}), (\\'Graf, N._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Graf, N.\\'}), (\\'Green, D. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Green, D. M.\\'}), (\\'Spreafico, F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Spreafico, F.\\'}), (\\'Bellani, F. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Bellani, F. F.\\'}), (\\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'van den Heuvel-Eibrink, M. M.\\'}), (\"D\\'Angio, G. J._author\", {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \"D\\'Angio, G. J.\"}), (\\'Tournade, M. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Tournade, M. F.\\'}), (\\'Breslow, N. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Breslow, N. E.\\'}), (\\'Mitchell, C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Mitchell, C.\\'}), (\\'Verschuur, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Verschuur, A.\\'}), (\\'Grundy, P. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Grundy, P. E.\\'}), (\\'Warmann, S. W._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Warmann, S. W.\\'}), (\\'Smets, A. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Smets, A. M.\\'}), (\\'Dome, J. S._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dome, J. S.\\'}), (\\'Dix, D. B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dix, D. B.\\'}), (\\'Daw, N. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Daw, N. C.\\'}), (\\'Ha, T. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Ha, T. C.\\'}), (\\'Kremens, B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Kremens, B.\\'}), (\\'Furtwangler, R._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Furtwangler, R.\\'}), (\\'SIOP-9/GPOH_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP-9/GPOH\\'}), (\\'UKW3_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'UKW3\\'}), (\\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'SIOP 93\u201301 trial\\'}), (\\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP trial and study 93\u201301\\'}), (\\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'National Wilms Tumor Study Group\\'}), (\\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP WT 2001 protocol\\'}), (\\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Third National Wilms\u2019 Tumor Study\\'}), (\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'National Wilms Tumor Studies\\'}), (\\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Second National Wilms\u2019 Tumor Study\\'}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'UK Children\u2019s Cancer Study Group\\'}), (\\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Children\u2019s Oncology Group\\'})], \\'edges\\': [(\\'sample.pdf\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'non-Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'childhood renal tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'renal cell carcinoma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'localized disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'metastatic disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'bilateral disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'relapsed disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'radiotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'surgery_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'chemotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'Wilms Tumour_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CCSK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'MRTK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CMN_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'RCC_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP\u22122001_Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'vincristine_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'actinomycin D_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'doxorubicin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'etoposide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'carboplatin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'cyclophosphamide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage I_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage II_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage III_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage IV_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage V_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AV_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AVD_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'HR-1_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Overall Survival (OS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT-only nodules_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'MRI_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG AREN0533 trial_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'etoposide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'carboplatin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'cyclophosphamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP database_database\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AVD_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AV-2_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Aronson et al._Research Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Etoposide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Carboplatin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group AA_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group BB_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group CC_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Cyclophosphamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Ifosfamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'ASCR_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'ifosfamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'nephrotoxicity_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'relapsed group CC_patient_group\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'diffuse anaplasia_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'blastemal-type tumors_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'camptothecins_medication_class\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'irinotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'topotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'radiotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'surgical excision_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'stage IV WT_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD150_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD250_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'low-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'CDCV_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'actinomycin-D_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'vincristine_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'doxorubicin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'VP16_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'surgery_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'chemotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'anaplasia_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'actinomycin D_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'vincristine_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'doxorubicin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'carboplatin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'cyclophosphamide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'etoposide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'SIOP\u22122001_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Wilms tumours_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Davila Fajardo et al._author\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'whole-lung irradiation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'proton therapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'dosimetric study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'locoregional disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'metastatic disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'low-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'intermediate-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'high-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage I_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage II_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage III_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'major rupture_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Austria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Italy_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'San Marino_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Iceland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Germany_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bulgaria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Turkey_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Denmark_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Poland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Greece_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Andorra_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belgium_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Serbia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Albania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Moldova_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Lithuania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Latvia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Estonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Luxembourg_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Montenegro_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Croatia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovenia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Macedonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'United Kingdom_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ireland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Spain_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Algeria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Tunisia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Malta_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Morocco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Portugal_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'France_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Monaco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Russia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Finland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Sweden_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Norway_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belarus_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Romania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ukraine_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hungary_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Czech Republic_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovakia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Switzerland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Liechtenstein_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Netherlands_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Munich_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Marciniak Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Faculty of Medicine_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital Homburg_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Weirich, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Pritchard-Jones, K._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'de Kraker, J._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Graf, N._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Green, D. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Spreafico, F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Bellani, F. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \"D\\'Angio, G. J._author\", {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Tournade, M. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Breslow, N. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Mitchell, C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Verschuur, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Grundy, P. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Warmann, S. W._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Smets, A. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dome, J. S._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dix, D. B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Daw, N. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ha, T. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Kremens, B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Furtwangler, R._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP-9/GPOH_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UKW3_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10})]}, {\\'nodes\\': [(\\'vincristine_entity\\', {}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {}), (\\'www.siop-rtsg.eu_entity\\', {}), (\\'stage II_entity\\', {}), (\\'Wilms tumours_entity\\', {}), (\\'Relapsed Wilms Tumor_entity\\', {}), (\\'Davila Fajardo et al._entity\\', {}), (\\'vincristine, actinomycin D, and doxorubicin_entity\\', {}), (\\'SIOP\u22122001 randomized trial_entity\\', {}), (\\'surgery_entity\\', {}), (\\'non-Wilms tumours_entity\\', {}), (\\'actinomycin D_entity\\', {}), (\\'diffuse anaplasia_entity\\', {}), (\\'Synchronous bilateral Wilms tumor_entity\\', {}), (\\'CT-only nodules_entity\\', {}), (\\'relapsed group CC_entity\\', {}), (\\'increased relapse risk_entity\\', {}), (\\'reduced survival_entity\\', {}), (\\'UKW3 trial_entity\\', {}), (\\'chemotherapy_entity\\', {}), (\\'Bilateral Disease (Stage V)_entity\\', {}), (\\'blastemal-type tumors_entity\\', {}), (\\'UMBRELLA protocol_entity\\', {}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', {}), (\\'minimally invasive surgery_entity\\', {}), (\\'VP16_entity\\', {}), (\\'Wilms tumor_entity\\', {}), (\\'anaplasia_entity\\', {}), (\\'radical tumor nephrectomy_entity\\', {}), (\\'Innovative Therapies for Children with Cancer consortium_entity\\', {}), (\\'cumulative doxorubicin dose_entity\\', {}), (\\'etoposide_entity\\', {}), (\\'large-volume tumours_entity\\', {}), (\\'Stage IV_entity\\', {}), (\\'CDCV_entity\\', {}), (\\'SIOP\u2013RTSG_entity\\', {}), (\\'AVD150_entity\\', {}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', {}), (\\'laparoscopic surgery_entity\\', {}), (\\'SIOP\u2212RTSG panel_entity\\', {}), (\\'actinomycin-D_entity\\', {}), (\\'COG AREN0533 trial_entity\\', {}), (\\'cyclophosphamide_entity\\', {}), (\\'carboplatin_entity\\', {}), (\\'UKW\u2011R protocol_entity\\', {}), (\\'Nephron-sparing surgery (NSS)_entity\\', {}), (\\'Adult Wilms Tumors_entity\\', {}), (\\'doxorubicin_entity\\', {}), (\\'NWTS\u20115 relapse protocol_entity\\', {}), (\\'End-stage renal disease (ESRD)_entity\\', {}), (\\'AVD250_entity\\', {}), (\\'Children\u2019s Oncology Group (COG)_entity\\', {}), (\\'blastemal-type Wilms tumour_entity\\', {}), (\\'SIOP\u22122001_entity\\', {}), (\\'radiotherapy_entity\\', {}), (\\'childhood renal tumours_entity\\', {})], \\'edges\\': [(\\'vincristine_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'stage II_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'indicated_for_in_adults\\'}), (\\'Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'Wilms tumours_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated under\\'}), (\\'Relapsed Wilms Tumor_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guided_by\\'}), (\\'Davila Fajardo et al._entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed\\'}), (\\'SIOP\u22122001 randomized trial_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated use in\\'}), (\\'surgery_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'non-Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'actinomycin D_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Synchronous bilateral Wilms tumor_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'instance_of\\'}), (\\'CT-only nodules_entity\\', \\'increased relapse risk_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'reduced survival_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included_in\\'}), (\\'relapsed group CC_entity\\', \\'diffuse anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'blastemal-type tumors_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UKW3 trial_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'UKW3 trial_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'chemotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UMBRELLA protocol_entity\\', \\'COG AREN0533 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses_data_from\\'}), (\\'UMBRELLA protocol_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'advises_treatment_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'Innovative Therapies for Children with Cancer consortium_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborates_with\\'}), (\\'UMBRELLA protocol_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'surgery_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is the standard of\\'}), (\\'UMBRELLA protocol_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guides treatment in\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', \\'UKW3 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\\'minimally invasive surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'anaplasia_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'radical tumor nephrectomy_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'standard_of_care_for\\'}), (\\'Stage IV_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'presents in\\'}), (\\'CDCV_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'VP16_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'aims to improve survival rates of\\'}), (\\'AVD150_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed_by\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'succeeds\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'www.siop-rtsg.eu_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'available_on\\'}), (\\'laparoscopic surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'COG AREN0533 trial_entity\\', \\'cumulative doxorubicin dose_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'evaluates\\'}), (\\'UKW\u2011R protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'Nephron-sparing surgery (NSS)_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'classification_developed_by\\'}), (\\'Adult Wilms Tumors_entity\\', \\'anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'Adult Wilms Tumors_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'doxorubicin_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'doxorubicin_entity\\', \\'large-volume tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'recommended for\\'}), (\\'NWTS\u20115 relapse protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'End-stage renal disease (ESRD)_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'AVD250_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'Children\u2019s Oncology Group (COG)_entity\\', \\'SIOP\u22122001 randomized trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborated with\\'}), (\\'blastemal-type Wilms tumour_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment intensified according to\\'}), (\\'SIOP\u22122001_entity\\', \\'vincristine, actinomycin D, and doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses\\'}), (\\'SIOP\u22122001_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provided_guidelines_for\\'}), (\\'radiotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'radiotherapy_entity\\', \\'SIOP\u2212RTSG panel_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'contact_for_guidance\\'})]}, {\\'nodes\\': [(\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {}), (\\'Marry M. van den Heuvel-Eibrink_entity\\', {})], \\'edges\\': [(\\'Marry M. van den Heuvel-Eibrink_entity\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'affiliated_with\\'})]}, {\\'nodes\\': [(\\'Stage II_entity\\', {}), (\\'AV_entity\\', {}), (\\'Stage III_entity\\', {}), (\\'vincestine and actinomycin D_entity\\', {}), (\\'AVD_entity\\', {})], \\'edges\\': [(\\'Stage II_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AV_entity\\', \\'Stage II_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Stage III_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AVD_entity\\', \\'Stage III_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'SIOP-RTSG 2016_entity\\', {}), (\\'RCC_entity\\', {}), (\\'CMN_entity\\', {})], \\'edges\\': [(\\'RCC_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'}), (\\'CMN_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'})]}, {\\'nodes\\': [(\\'HR-1_entity\\', {}), (\\'High-risk blastemal type Wilms tumour_entity\\', {})], \\'edges\\': [(\\'HR-1_entity\\', \\'High-risk blastemal type Wilms tumour_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'unfavorable prognosis_entity\\', {}), (\\'high-risk characteristics_entity\\', {})], \\'edges\\': [(\\'high-risk characteristics_entity\\', \\'unfavorable prognosis_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'leads_to\\'})]}, {\\'nodes\\': [(\\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {}), (\\'SIOP\u2013RTSG board_entity\\', {})], \\'edges\\': [(\\'SIOP\u2013RTSG board_entity\\', \\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggests\\'})]}, {\\'nodes\\': [(\\'regimen and outcomes_entity\\', {}), (\\'SIOP database_entity\\', {})], \\'edges\\': [(\\'SIOP database_entity\\', \\'regimen and outcomes_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'captures_data_on\\'})]}, {\\'nodes\\': [(\\'Bilateral nephron-sparing surgery (NSS)_entity\\', {}), (\\'Aronson et al._entity\\', {})], \\'edges\\': [(\\'Aronson et al._entity\\', \\'Bilateral nephron-sparing surgery (NSS)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'observed_effectiveness_of\\'})]}, {\\'nodes\\': [(\\'SIOP\u22122001 study_entity\\', {}), (\\'Actinomycin D_entity\\', {}), (\\'Vincristine_entity\\', {})], \\'edges\\': [(\\'SIOP\u22122001 study_entity\\', \\'Vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'}), (\\'SIOP\u22122001 study_entity\\', \\'Actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'})]}, {\\'nodes\\': [(\\'High-dose melphalan_entity\\', {}), (\\'Group AA_entity\\', {}), (\\'Carboplatin_entity\\', {}), (\\'Doxorubicin_entity\\', {}), (\\'Etoposide_entity\\', {}), (\\'Group BB_entity\\', {}), (\\'Cyclophosphamide_entity\\', {}), (\\'Ifosfamide_entity\\', {})], \\'edges\\': [(\\'Group AA_entity\\', \\'Doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Ifosfamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'High-dose melphalan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'})]}, {\\'nodes\\': [(\\'nephrotoxicity_entity\\', {}), (\\'ifosfamide_entity\\', {})], \\'edges\\': [(\\'ifosfamide_entity\\', \\'nephrotoxicity_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'related_to\\'})]}, {\\'nodes\\': [(\\'camptothecins_entity\\', {}), (\\'irinotecan_entity\\', {}), (\\'topotecan_entity\\', {})], \\'edges\\': [(\\'camptothecins_entity\\', \\'irinotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'camptothecins_entity\\', \\'topotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'})]}, {\\'nodes\\': [(\\'Infant Wilms Tumors_entity\\', {}), (\\'nephrectomy_entity\\', {})], \\'edges\\': [(\\'Infant Wilms Tumors_entity\\', \\'nephrectomy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_option\\'})]}, {\\'nodes\\': [(\\'congenital mesoblastic nephroma_entity\\', {}), (\\'surgery alone_entity\\', {})], \\'edges\\': [(\\'congenital mesoblastic nephroma_entity\\', \\'surgery alone_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'alternative chemotherapy_entity\\', {}), (\\'malignant rhabdoid tumors_entity\\', {})], \\'edges\\': [(\\'malignant rhabdoid tumors_entity\\', \\'alternative chemotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'lymph node sampling_entity\\', {}), (\\'accurate staging_entity\\', {})], \\'edges\\': [(\\'lymph node sampling_entity\\', \\'accurate staging_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'purpose_of\\'})]}, {\\'nodes\\': [(\\'COG\u2013NWTS trials_entity\\', {}), (\\'whole-lung irradiation_entity\\', {})], \\'edges\\': [(\\'COG\u2013NWTS trials_entity\\', \\'whole-lung irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'informed_dosage_for\\'})]}, {\\'nodes\\': [(\\'lung metastases_entity\\', {}), (\\'pulmonary radiotherapy_entity\\', {})], \\'edges\\': [(\\'pulmonary radiotherapy_entity\\', \\'lung metastases_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'administered_for\\'})]}, {\\'nodes\\': [(\\'dosimetric study_entity\\', {}), (\\'proton therapy_entity\\', {}), (\\'flank irradiation_entity\\', {})], \\'edges\\': [(\\'dosimetric study_entity\\', \\'proton therapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated\\'}), (\\'proton therapy_entity\\', \\'flank irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggested_for\\'})]}, {\\'nodes\\': [(\\'metastatic disease_entity\\', {}), (\\'radiotherapy guidelines_entity\\', {}), (\\'locoregional disease_entity\\', {})], \\'edges\\': [(\\'radiotherapy guidelines_entity\\', \\'locoregional disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'}), (\\'radiotherapy guidelines_entity\\', \\'metastatic disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'})]}, {\\'nodes\\': [(\\'major rupture_entity\\', {}), (\\'stage III_entity\\', {})], \\'edges\\': [(\\'stage III_entity\\', \\'major rupture_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes_condition\\'})]}, {\\'nodes\\': [(\\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {}), (\\'ExPO\u2011r\u2011Net_entity\\', {})], \\'edges\\': [(\\'ExPO\u2011r\u2011Net_entity\\', \\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is part of\\'})]}, {\\'nodes\\': [(\\'University Hospital of Munich_entity\\', {}), (\\'Germany_entity\\', {}), (\\'University Hospital of Tuebingen_entity\\', {})], \\'edges\\': [(\\'Germany_entity\\', \\'University Hospital of Munich_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Germany_entity\\', \\'University Hospital of Tuebingen_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {}), (\\'Italy_entity\\', {}), (\\'Azienda Ospedaliera_entity\\', {}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {})], \\'edges\\': [(\\'Italy_entity\\', \\'Azienda Ospedaliera_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Netherlands_entity\\', {}), (\\'Prinses Maxima Centrum_entity\\', {})], \\'edges\\': [(\\'Netherlands_entity\\', \\'Prinses Maxima Centrum_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Marciniak Hospital_entity\\', {}), (\\'Poland_entity\\', {}), (\\'Faculty of Medicine_entity\\', {})], \\'edges\\': [(\\'Poland_entity\\', \\'Marciniak Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Poland_entity\\', \\'Faculty of Medicine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'St. Anna Kinderspital/CCRI_entity\\', {}), (\\'Austria_entity\\', {})], \\'edges\\': [(\\'Austria_entity\\', \\'St. Anna Kinderspital/CCRI_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'France_entity\\', {}), (\\'Armand Trousseau Hospital_entity\\', {})], \\'edges\\': [(\\'France_entity\\', \\'Armand Trousseau Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Spain_entity\\', {}), (\\'Hospital Vall d\u2019Hebron_entity\\', {}), (\\'Hospital Universitario Virgin del Rocio_entity\\', {})], \\'edges\\': [(\\'Spain_entity\\', \\'Hospital Universitario Virgin del Rocio_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Spain_entity\\', \\'Hospital Vall d\u2019Hebron_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'United Kingdom_entity\\', {}), (\\'Great Ormond Street Hospital_entity\\', {})], \\'edges\\': [(\\'United Kingdom_entity\\', \\'Great Ormond Street Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Weirich, A._entity\\', {}), (\\'SIOP-9/GPOH_entity\\', {})], \\'edges\\': [(\\'Weirich, A._entity\\', \\'SIOP-9/GPOH_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Pritchard-Jones, K._entity\\', {}), (\\'UKW3_entity\\', {})], \\'edges\\': [(\\'Pritchard-Jones, K._entity\\', \\'UKW3_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed in\\'})]}, {\\'nodes\\': [(\\'SIOP 93\u201301 trial_entity\\', {}), (\\'de Kraker, J._entity\\', {})], \\'edges\\': [(\\'de Kraker, J._entity\\', \\'SIOP 93\u201301 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'SIOP trial and study 93\u201301_entity\\', {}), (\\'Graf, N._entity\\', {})], \\'edges\\': [(\\'Graf, N._entity\\', \\'SIOP trial and study 93\u201301_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Green, D. M._entity\\', {}), (\\'National Wilms Tumor Study Group_entity\\', {})], \\'edges\\': [(\\'Green, D. M._entity\\', \\'National Wilms Tumor Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}, {\\'nodes\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', {}), (\\'SIOP WT 2001 protocol_entity\\', {})], \\'edges\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', \\'SIOP WT 2001 protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Third National Wilms\u2019 Tumor Study_entity\\', {}), (\"D\\'Angio, G. J._entity\", {}), (\\'Second National Wilms\u2019 Tumor Study_entity\\', {})], \\'edges\\': [(\"D\\'Angio, G. J._entity\", \\'Third National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\"D\\'Angio, G. J._entity\", \\'Second National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {}), (\\'Tournade, M. F._entity\\', {}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {})], \\'edges\\': [(\\'Tournade, M. F._entity\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'}), (\\'Tournade, M. F._entity\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Breslow, N. E._entity\\', {}), (\\'National Wilms Tumor Studies_entity\\', {})], \\'edges\\': [(\\'Breslow, N. E._entity\\', \\'National Wilms Tumor Studies_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Mitchell, C._entity\\', {}), (\\'UK Children\u2019s Cancer Study Group_entity\\', {})], \\'edges\\': [(\\'Mitchell, C._entity\\', \\'UK Children\u2019s Cancer Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'under\\'})]}, {\\'nodes\\': [(\\'Daw, N. C._entity\\', {}), (\\'Dix, D. B._entity\\', {}), (\\'Children\u2019s Oncology Group_entity\\', {}), (\\'Grundy, P. E._entity\\', {})], \\'edges\\': [(\\'Daw, N. C._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted under\\'}), (\\'Dix, D. B._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'}), (\\'Grundy, P. E._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}]']), TestResult(name='test_case_4', success=False, metrics_data=[MetricData(name='Answer Correctness (GEval)', threshold=0.5, success=False, score=0.4647659611982933, reason='The actual output references chemotherapy agents, including doxorubicin, and mentions tumor-related studies, but it does not explicitly state the role of tumor volume in stratifying patients.', strict_mode=False, evaluation_model='gpt-4o-mini', error=None, evaluation_cost=0.0033039, verbose_logs='Criteria:\\nNone \\n \\nEvaluation Steps:\\n[\\n    \"Determine whether the actual output is factually correct based on the expected output.\"\\n]'), MetricData(name='Faithfulness', threshold=0.7, success=True, score=0.8181818181818182, reason=None, strict_mode=False, evaluation_model='gpt-4o-mini', error=None, evaluation_cost=0.0079308, verbose_logs='Truths (limit=None):\\n[\\n    \"The Renal Tumour Study Group of the International Society of Paediatric Oncology is referred to as SIOP\u2013RTSG.\",\\n    \"The UMBRELLA SIOP-RTSG 2016 protocol is a treatment protocol.\",\\n    \"The SIOP\u22122001 protocol is another treatment protocol.\",\\n    \"Wilms tumours are a type of childhood renal tumour.\",\\n    \"Non-Wilms tumours are another classification of childhood renal tumours.\",\\n    \"Marry M. van den Heuvel-Eibrink is a recognized person affiliated with paediatric oncology.\",\\n    \"Various drugs like actinomycin D, vincristine, doxorubicin, etoposide, carboplatin, and cyclophosphamide are used in the treatment of Wilms tumours.\",\\n    \"Clinical trials, such as the SIOP\u22122001 randomized trial and the UKW3 trial, have been conducted regarding kidney tumours.\",\\n    \"SIOP\u2212RTSG is involved in the management of kidney tumours in children.\",\\n    \"Childhood renal tumours include diseases like clear cell sarcoma of the kidney, renal cell carcinoma, malignant rhabdoid tumour of the kidney, and congenital mesoblastic nephroma.\",\\n    \"Different stages of disease include localized, metastatic, bilateral, and relapsed disease.\",\\n    \"The treatment methods for Wilms tumours can include surgery, chemotherapy, and radiotherapy.\",\\n    \"Survival metrics in studies mentioned include Overall Survival (OS) and Event-Free Survival (EFS).\",\\n    \"High-risk characteristics may relate to an unfavorable prognosis in Wilms tumours.\",\\n    \"There are several related organizations, such as the Children\u2019s Oncology Group and the UK Children\u2019s Cancer and Leukaemia Group.\",\\n    \"Countries involved in pediatric oncology research include Austria, Italy, Germany, and many more across Europe.\",\\n    \"Specific institutions engaged in this research include University Hospitals and Cancer Clinics across multiple countries,\"\\n] \\n \\nClaims:\\n[\\n    \"The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG) is an organization.\",\\n    \"The UMBRELLA SIOP-RTSG 2016 is a protocol.\",\\n    \"The SIOP\u22122001 is a protocol.\",\\n    \"Wilms tumours is a disease.\",\\n    \"Non-Wilms tumours is a disease.\",\\n    \"The website www.siop-rtsg.eu is associated with SIOP\u2013RTSG.\",\\n    \"The Department of Paediatric Oncology at Princess M\u00e1xima Center for Paediatric Oncology is an institution.\",\\n    \"Marry M. van den Heuvel-Eibrink is a person.\",\\n    \"Childhood renal tumours is a disease.\",\\n    \"Clear cell sarcoma of the kidney is a disease.\",\\n    \"Renal cell carcinoma is a disease.\",\\n    \"Malignant rhabdoid tumour of the kidney is a disease.\",\\n    \"Congenital mesoblastic nephroma is a disease.\",\\n    \"Wilms tumours is a condition.\",\\n    \"The UMBRELLA protocol is a treatment protocol.\",\\n    \"SIOP\u2013RTSG is an organization.\",\\n    \"The Children\u2019s Oncology Group (COG) is an organization.\",\\n    \"The SIOP\u22122001 randomized trial is a clinical trial.\",\\n    \"Actinomycin D is a drug.\",\\n    \"Vincristine is a drug.\",\\n    \"Doxorubicin is a drug.\",\\n    \"The UKW3 trial is a clinical trial.\",\\n    \"The UK Children\u2019s Cancer and Leukaemia Group (UKCCLG) is an organization.\",\\n    \"Localized disease is a disease stage.\",\\n    \"Metastatic disease is a disease stage.\",\\n    \"Bilateral disease is a disease stage.\",\\n    \"Relapsed disease is a disease stage.\",\\n    \"Blastemal-type Wilms tumours is a subtype.\",\\n    \"Radiotherapy is a treatment method.\",\\n    \"Surgery is a treatment method.\",\\n    \"Chemotherapy is a treatment method.\",\\n    \"The UMBRELLA protocol is also referred to as a protocol.\",\\n    \"The SIOP\u22122001 is also referred to as a trial.\",\\n    \"Vincristine is listed as a treatment for Wilms tumours.\",\\n    \"Actinomycin D is listed as a treatment for Wilms tumours.\",\\n    \"Doxorubicin is listed as a treatment for Wilms tumours.\",\\n    \"Etoposide is listed as a treatment for Wilms tumours.\",\\n    \"Carboplatin is listed as a treatment for Wilms tumours.\",\\n    \"Cyclophosphamide is listed as a treatment for Wilms tumours.\",\\n    \"Stage I is a disease stage.\",\\n    \"Stage II is a disease stage.\",\\n    \"Stage III is a disease stage.\",\\n    \"Stage IV is a disease stage.\",\\n    \"Stage V is a disease stage.\",\\n    \"AV is a treatment combination.\",\\n    \"AVD is a treatment combination.\",\\n    \"HR-1 is a treatment combination.\",\\n    \"Overall Survival (OS) is a metric.\",\\n    \"Event-Free Survival (EFS) is a metric.\",\\n    \"CT-only nodules is a medical condition.\",\\n    \"The SIOP database is a database.\"\\n] \\n \\nVerdicts:\\n[\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"The claim states Wilms tumours is a disease, but in the retrieval context, it is defined as a type of childhood renal tumour.\"\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"The claim states Non-Wilms tumours is a disease, but in the retrieval context, it is described as another classification of childhood renal tumours.\"\\n    },\\n    {\\n        \"verdict\": \"idk\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"idk\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"The claim states Childhood renal tumours is a disease, but in the retrieval context, it refers to a category that includes various specific tumours.\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"The claim states Wilms tumours is a condition, but in the retrieval context, it is specified as a type of childhood renal tumour.\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"The claim states the UMBRELLA protocol is also referred to as a protocol, but it is specifically defined as a treatment protocol in the context.\"\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"The claim states the SIOP\\\\u22122001 is also referred to as a trial, but in the retrieval context it is defined as a protocol.\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    }\\n]'), MetricData(name='Contextual Relevancy', threshold=1.0, success=False, score=0.5555555555555556, reason=\"The score is 0.56 because while the relevant statement notes that 'Tumor volume is a key factor influencing treatment decisions in childhood renal tumours,' much of the retrieval context focuses on specific surgical techniques and disease status, which are not directly related to the significance of tumor volume in treatment guidelines.\", strict_mode=False, evaluation_model='gpt-4o-mini', error=None, evaluation_cost=0.0037342499999999997, verbose_logs='Verdicts:\\n[\\n    {\\n        \"verdicts\": [\\n            {\\n                \"statement\": \"The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\\\\u2013RTSG) conducts research and sets guidelines for the treatment of Wilms tumours.\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"Tumor volume is a key factor influencing treatment decisions in childhood renal tumours.\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"Wilms tumours are studied under various protocols, including SIOP-2001 and UMBRELLA SIOP-RTSG 2016.\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"The UMBRELLA protocol provides comprehensive guidelines for the treatment of various types of childhood renal tumours.\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"The study mentions specific chemotherapy drugs such as vincristine and actinomycin D that are used in the treatment of kidney tumours.\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"Research shows that bilateral nephron-sparing surgery (NSS) is effective for specific cases of Wilms tumours.\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"This statement is specific to a surgical technique rather than addressing the role of tumor volume in treatment guidelines.\"\\n            },\\n            {\\n                \"statement\": \"Metastatic disease influences overall survival rates in patients with renal tumours but is unrelated to tumor volume.\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"This statement focuses more on disease status rather than directly discussing the significance of tumor volume.\"\\n            },\\n            {\\n                \"statement\": \"Protocols like the UKW3 trial evaluate new treatment combinations for renal tumours.\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"While this statement discusses treatment protocols, it does not specifically address the importance of tumor volume in treatment guidelines.\"\\n            },\\n            {\\n                \"statement\": \"The SIOP database captures data on treatment regimen outcomes, including overall survival.\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"This statement addresses outcome data but does not relate specifically to the significance of tumor volume in treatment guidelines.\"\\n            }\\n        ]\\n    }\\n]')], conversational=False, multimodal=False, input='What is the significance of tumor volume in the treatment guidelines?', actual_output='[{\\'nodes\\': [(\\'sample.pdf\\', {\\'type\\': \\'document\\'}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)\\'}), (\\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA SIOP-RTSG 2016\\'}), (\\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms tumours\\'}), (\\'non-Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'non-Wilms tumours\\'}), (\\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Website\\', \\'name\\': \\'www.siop-rtsg.eu\\'}), (\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology\\'}), (\\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Person\\', \\'name\\': \\'Marry M. van den Heuvel-Eibrink\\'}), (\\'childhood renal tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'childhood renal tumours\\'}), (\\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'clear cell sarcoma of the kidney\\'}), (\\'renal cell carcinoma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'renal cell carcinoma\\'}), (\\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'malignant rhabdoid tumour of the kidney\\'}), (\\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'Wilms tumours_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'Children\u2019s Oncology Group (COG)\\'}), (\\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'SIOP\u22122001 randomized trial\\'}), (\\'actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'UKW3 trial\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)\\'}), (\\'localized disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'localized disease\\'}), (\\'metastatic disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'metastatic disease\\'}), (\\'bilateral disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'bilateral disease\\'}), (\\'relapsed disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'relapsed disease\\'}), (\\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subtype\\', \\'name\\': \\'blastemal-type Wilms tumours\\'}), (\\'radiotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgery_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'chemotherapy\\'}), (\\'Wilms Tumour_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms Tumour\\'}), (\\'CCSK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CCSK\\'}), (\\'MRTK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'MRTK\\'}), (\\'CMN_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CMN\\'}), (\\'RCC_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'RCC\\'}), (\\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u22122001_Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Trial\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'vincristine_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'vincristine\\'}), (\\'actinomycin D_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'actinomycin D\\'}), (\\'doxorubicin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'doxorubicin\\'}), (\\'etoposide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'Stage I_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage I\\'}), (\\'Stage II_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage II\\'}), (\\'Stage III_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage III\\'}), (\\'Stage IV_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage IV\\'}), (\\'Stage V_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage V\\'}), (\\'AV_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AV\\'}), (\\'AVD_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AVD\\'}), (\\'HR-1_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'HR-1\\'}), (\\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP-RTSG 2016\\'}), (\\'Overall Survival (OS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'CT-only nodules_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'CT-only nodules\\'}), (\\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP\u2013RTSG analysis\\'}), (\\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials\\'}), (\\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D plus doxorubicin\\'}), (\\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D\\'}), (\\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study_protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'MRI_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'MRI\\'}), (\\'CT_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'CT\\'}), (\\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_detail\\', \\'name\\': \\'cumulative doxorubicin dose\\'}), (\\'COG AREN0533 trial_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG AREN0533 trial\\'}), (\\'etoposide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'high-risk characteristics\\'}), (\\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG board\\'}), (\\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin\\'}), (\\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'high-dose chemotherapy and autologous stem cell transplantation\\'}), (\\'SIOP database_database\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'database\\', \\'name\\': \\'SIOP database\\'}), (\\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'AVD_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AVD\\'}), (\\'AV-2_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AV-2\\'}), (\\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Statistical Test\\', \\'name\\': \\'Log\u2013Rank P\\'}), (\\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'Bilateral Disease (Stage V)\\'}), (\\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Synchronous bilateral Wilms tumor\\'}), (\\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'End-stage renal disease (ESRD)\\'}), (\\'Aronson et al._Research Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Research Group\\', \\'name\\': \\'Aronson et al.\\'}), (\\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'Bilateral nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Study\\', \\'name\\': \\'SIOP\u22122001 study\\'}), (\\'Vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Vincristine\\'}), (\\'Actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Actinomycin D\\'}), (\\'Etoposide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Etoposide\\'}), (\\'Carboplatin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Carboplatin\\'}), (\\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease State\\', \\'name\\': \\'Relapsed Wilms Tumor\\'}), (\\'Group AA_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group AA\\'}), (\\'Group BB_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group BB\\'}), (\\'Group CC_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group CC\\'}), (\\'Doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Doxorubicin\\'}), (\\'Cyclophosphamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Cyclophosphamide\\'}), (\\'Ifosfamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Ifosfamide\\'}), (\\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'High-dose melphalan\\'}), (\\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UKW\u2011R protocol\\'}), (\\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'NWTS\u20115 relapse protocol\\'}), (\\'ASCR_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'procedure\\', \\'name\\': \\'ASCR\\'}), (\\'ifosfamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'ifosfamide\\'}), (\\'nephrotoxicity_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'nephrotoxicity\\'}), (\\'relapsed group CC_patient_group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'patient_group\\', \\'name\\': \\'relapsed group CC\\'}), (\\'diffuse anaplasia_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'diffuse anaplasia\\'}), (\\'blastemal-type tumors_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'blastemal-type tumors\\'}), (\\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'camptothecins_medication_class\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication_class\\', \\'name\\': \\'camptothecins\\'}), (\\'irinotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'irinotecan\\'}), (\\'topotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'topotecan\\'}), (\\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Innovative Therapies for Children with Cancer consortium\\'}), (\\'radiotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgical excision_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgical excision\\'}), (\\'stage IV WT_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'stage IV WT\\'}), (\\'AVD150_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD150\\'}), (\\'AVD250_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD250\\'}), (\\'low-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'low-risk disease\\'}), (\\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'intermediate-risk disease\\'}), (\\'high-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'high-risk disease\\'}), (\\'CDCV_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'CDCV\\'}), (\\'actinomycin-D_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'actinomycin-D\\'}), (\\'vincristine_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'doxorubicin\\'}), (\\'VP16_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'VP16\\'}), (\\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'contact\\', \\'name\\': \\'arnauld.verschuur@ap-hm.fr\\'}), (\\'surgery_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'chemotherapy\\'}), (\\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2212RTSG panel\\'}), (\\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Infant Wilms Tumors\\'}), (\\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'nephrectomy\\'}), (\\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'malignant rhabdoid tumors\\'}), (\\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Adult Wilms Tumors\\'}), (\\'anaplasia_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'anaplasia\\'}), (\\'actinomycin D_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'carboplatin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'etoposide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'etoposide\\'}), (\\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'Nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'radical tumor nephrectomy\\'}), (\\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'lymph node sampling\\'}), (\\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'minimally invasive surgery\\'}), (\\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'laparoscopic surgery\\'}), (\\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'radiotherapy\\'}), (\\'Wilms tumours_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'Davila Fajardo et al._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Davila Fajardo et al.\\'}), (\\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'COG\u2013NWTS trials\\'}), (\\'whole-lung irradiation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'whole-lung irradiation\\'}), (\\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'pulmonary radiotherapy\\'}), (\\'proton therapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'proton therapy\\'}), (\\'dosimetric study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'dosimetric study\\'}), (\\'locoregional disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'locoregional disease\\'}), (\\'metastatic disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'metastatic disease\\'}), (\\'low-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'low-risk\\'}), (\\'intermediate-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'intermediate-risk\\'}), (\\'high-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'high-risk\\'}), (\\'stage I_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage I\\'}), (\\'stage II_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage II\\'}), (\\'stage III_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage III\\'}), (\\'major rupture_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'major rupture\\'}), (\\'Austria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Austria\\'}), (\\'Italy_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Italy\\'}), (\\'San Marino_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'San Marino\\'}), (\\'Iceland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Iceland\\'}), (\\'Germany_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Germany\\'}), (\\'Bulgaria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bulgaria\\'}), (\\'Turkey_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Turkey\\'}), (\\'Denmark_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Denmark\\'}), (\\'Poland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Poland\\'}), (\\'Greece_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Greece\\'}), (\\'Andorra_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Andorra\\'}), (\\'Belgium_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belgium\\'}), (\\'Serbia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Serbia\\'}), (\\'Albania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Albania\\'}), (\\'Moldova_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Moldova\\'}), (\\'Lithuania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Lithuania\\'}), (\\'Latvia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Latvia\\'}), (\\'Estonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Estonia\\'}), (\\'Luxembourg_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Luxembourg\\'}), (\\'Montenegro_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Montenegro\\'}), (\\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bosnia and Herzegovina\\'}), (\\'Croatia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Croatia\\'}), (\\'Slovenia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovenia\\'}), (\\'Macedonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Macedonia\\'}), (\\'United Kingdom_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'United Kingdom\\'}), (\\'Ireland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ireland\\'}), (\\'Spain_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Spain\\'}), (\\'Algeria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Algeria\\'}), (\\'Tunisia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Tunisia\\'}), (\\'Malta_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Malta\\'}), (\\'Morocco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Morocco\\'}), (\\'Portugal_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Portugal\\'}), (\\'France_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'France\\'}), (\\'Monaco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Monaco\\'}), (\\'Russia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Russia\\'}), (\\'Finland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Finland\\'}), (\\'Sweden_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Sweden\\'}), (\\'Norway_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Norway\\'}), (\\'Belarus_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belarus\\'}), (\\'Romania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Romania\\'}), (\\'Ukraine_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ukraine\\'}), (\\'Hungary_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Hungary\\'}), (\\'Czech Republic_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Czech Republic\\'}), (\\'Slovakia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovakia\\'}), (\\'Switzerland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Switzerland\\'}), (\\'Liechtenstein_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Liechtenstein\\'}), (\\'Netherlands_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Netherlands\\'}), (\\'University Hospital of Munich_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Munich\\'}), (\\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Tuebingen\\'}), (\\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Azienda Ospedaliera\\'}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Ospedale Pediatrico Bambino Ges\u00f9\\'}), (\\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Fondazione IRCCS Istituto Nazionale dei Tumori\\'}), (\\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Prinses Maxima Centrum\\'}), (\\'Marciniak Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Marciniak Hospital\\'}), (\\'Faculty of Medicine_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Faculty of Medicine\\'}), (\\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'St. Anna Kinderspital/CCRI\\'}), (\\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Armand Trousseau Hospital\\'}), (\\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Universitario Virgin del Rocio\\'}), (\\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Vall d\u2019Hebron\\'}), (\\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Great Ormond Street Hospital\\'}), (\\'University Hospital Homburg_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital Homburg\\'}), (\\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon\\'}), (\\'UMBRELLA protocol_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'ExPO\u2011r\u2011Net\\'}), (\\'Weirich, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Weirich, A.\\'}), (\\'Pritchard-Jones, K._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Pritchard-Jones, K.\\'}), (\\'de Kraker, J._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'de Kraker, J.\\'}), (\\'Graf, N._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Graf, N.\\'}), (\\'Green, D. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Green, D. M.\\'}), (\\'Spreafico, F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Spreafico, F.\\'}), (\\'Bellani, F. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Bellani, F. F.\\'}), (\\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'van den Heuvel-Eibrink, M. M.\\'}), (\"D\\'Angio, G. J._author\", {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \"D\\'Angio, G. J.\"}), (\\'Tournade, M. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Tournade, M. F.\\'}), (\\'Breslow, N. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Breslow, N. E.\\'}), (\\'Mitchell, C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Mitchell, C.\\'}), (\\'Verschuur, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Verschuur, A.\\'}), (\\'Grundy, P. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Grundy, P. E.\\'}), (\\'Warmann, S. W._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Warmann, S. W.\\'}), (\\'Smets, A. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Smets, A. M.\\'}), (\\'Dome, J. S._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dome, J. S.\\'}), (\\'Dix, D. B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dix, D. B.\\'}), (\\'Daw, N. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Daw, N. C.\\'}), (\\'Ha, T. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Ha, T. C.\\'}), (\\'Kremens, B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Kremens, B.\\'}), (\\'Furtwangler, R._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Furtwangler, R.\\'}), (\\'SIOP-9/GPOH_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP-9/GPOH\\'}), (\\'UKW3_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'UKW3\\'}), (\\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'SIOP 93\u201301 trial\\'}), (\\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP trial and study 93\u201301\\'}), (\\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'National Wilms Tumor Study Group\\'}), (\\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP WT 2001 protocol\\'}), (\\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Third National Wilms\u2019 Tumor Study\\'}), (\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'National Wilms Tumor Studies\\'}), (\\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Second National Wilms\u2019 Tumor Study\\'}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'UK Children\u2019s Cancer Study Group\\'}), (\\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Children\u2019s Oncology Group\\'})], \\'edges\\': [(\\'sample.pdf\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'non-Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'childhood renal tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'renal cell carcinoma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'localized disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'metastatic disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'bilateral disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'relapsed disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'radiotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'surgery_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'chemotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'Wilms Tumour_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CCSK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'MRTK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CMN_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'RCC_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP\u22122001_Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'vincristine_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'actinomycin D_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'doxorubicin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'etoposide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'carboplatin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'cyclophosphamide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage I_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage II_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage III_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage IV_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage V_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AV_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AVD_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'HR-1_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Overall Survival (OS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT-only nodules_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'MRI_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG AREN0533 trial_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'etoposide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'carboplatin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'cyclophosphamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP database_database\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AVD_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AV-2_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Aronson et al._Research Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Etoposide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Carboplatin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group AA_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group BB_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group CC_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Cyclophosphamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Ifosfamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'ASCR_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'ifosfamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'nephrotoxicity_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'relapsed group CC_patient_group\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'diffuse anaplasia_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'blastemal-type tumors_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'camptothecins_medication_class\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'irinotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'topotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'radiotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'surgical excision_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'stage IV WT_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD150_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD250_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'low-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'CDCV_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'actinomycin-D_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'vincristine_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'doxorubicin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'VP16_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'surgery_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'chemotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'anaplasia_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'actinomycin D_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'vincristine_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'doxorubicin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'carboplatin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'cyclophosphamide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'etoposide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'SIOP\u22122001_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Wilms tumours_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Davila Fajardo et al._author\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'whole-lung irradiation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'proton therapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'dosimetric study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'locoregional disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'metastatic disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'low-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'intermediate-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'high-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage I_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage II_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage III_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'major rupture_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Austria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Italy_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'San Marino_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Iceland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Germany_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bulgaria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Turkey_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Denmark_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Poland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Greece_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Andorra_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belgium_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Serbia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Albania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Moldova_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Lithuania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Latvia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Estonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Luxembourg_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Montenegro_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Croatia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovenia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Macedonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'United Kingdom_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ireland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Spain_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Algeria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Tunisia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Malta_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Morocco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Portugal_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'France_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Monaco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Russia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Finland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Sweden_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Norway_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belarus_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Romania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ukraine_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hungary_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Czech Republic_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovakia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Switzerland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Liechtenstein_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Netherlands_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Munich_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Marciniak Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Faculty of Medicine_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital Homburg_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Weirich, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Pritchard-Jones, K._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'de Kraker, J._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Graf, N._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Green, D. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Spreafico, F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Bellani, F. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \"D\\'Angio, G. J._author\", {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Tournade, M. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Breslow, N. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Mitchell, C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Verschuur, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Grundy, P. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Warmann, S. W._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Smets, A. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dome, J. S._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dix, D. B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Daw, N. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ha, T. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Kremens, B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Furtwangler, R._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP-9/GPOH_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UKW3_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10})]}, {\\'nodes\\': [(\\'vincristine_entity\\', {}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {}), (\\'www.siop-rtsg.eu_entity\\', {}), (\\'stage II_entity\\', {}), (\\'Wilms tumours_entity\\', {}), (\\'Relapsed Wilms Tumor_entity\\', {}), (\\'Davila Fajardo et al._entity\\', {}), (\\'vincristine, actinomycin D, and doxorubicin_entity\\', {}), (\\'SIOP\u22122001 randomized trial_entity\\', {}), (\\'surgery_entity\\', {}), (\\'non-Wilms tumours_entity\\', {}), (\\'actinomycin D_entity\\', {}), (\\'diffuse anaplasia_entity\\', {}), (\\'Synchronous bilateral Wilms tumor_entity\\', {}), (\\'CT-only nodules_entity\\', {}), (\\'relapsed group CC_entity\\', {}), (\\'increased relapse risk_entity\\', {}), (\\'reduced survival_entity\\', {}), (\\'UKW3 trial_entity\\', {}), (\\'chemotherapy_entity\\', {}), (\\'Bilateral Disease (Stage V)_entity\\', {}), (\\'blastemal-type tumors_entity\\', {}), (\\'UMBRELLA protocol_entity\\', {}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', {}), (\\'minimally invasive surgery_entity\\', {}), (\\'VP16_entity\\', {}), (\\'Wilms tumor_entity\\', {}), (\\'anaplasia_entity\\', {}), (\\'radical tumor nephrectomy_entity\\', {}), (\\'Innovative Therapies for Children with Cancer consortium_entity\\', {}), (\\'cumulative doxorubicin dose_entity\\', {}), (\\'etoposide_entity\\', {}), (\\'large-volume tumours_entity\\', {}), (\\'Stage IV_entity\\', {}), (\\'CDCV_entity\\', {}), (\\'SIOP\u2013RTSG_entity\\', {}), (\\'AVD150_entity\\', {}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', {}), (\\'laparoscopic surgery_entity\\', {}), (\\'SIOP\u2212RTSG panel_entity\\', {}), (\\'actinomycin-D_entity\\', {}), (\\'COG AREN0533 trial_entity\\', {}), (\\'cyclophosphamide_entity\\', {}), (\\'carboplatin_entity\\', {}), (\\'UKW\u2011R protocol_entity\\', {}), (\\'Nephron-sparing surgery (NSS)_entity\\', {}), (\\'Adult Wilms Tumors_entity\\', {}), (\\'doxorubicin_entity\\', {}), (\\'NWTS\u20115 relapse protocol_entity\\', {}), (\\'End-stage renal disease (ESRD)_entity\\', {}), (\\'AVD250_entity\\', {}), (\\'Children\u2019s Oncology Group (COG)_entity\\', {}), (\\'blastemal-type Wilms tumour_entity\\', {}), (\\'SIOP\u22122001_entity\\', {}), (\\'radiotherapy_entity\\', {}), (\\'childhood renal tumours_entity\\', {})], \\'edges\\': [(\\'vincristine_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'stage II_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'indicated_for_in_adults\\'}), (\\'Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'Wilms tumours_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated under\\'}), (\\'Relapsed Wilms Tumor_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guided_by\\'}), (\\'Davila Fajardo et al._entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed\\'}), (\\'SIOP\u22122001 randomized trial_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated use in\\'}), (\\'surgery_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'non-Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'actinomycin D_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Synchronous bilateral Wilms tumor_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'instance_of\\'}), (\\'CT-only nodules_entity\\', \\'increased relapse risk_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'reduced survival_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included_in\\'}), (\\'relapsed group CC_entity\\', \\'diffuse anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'blastemal-type tumors_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UKW3 trial_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'UKW3 trial_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'chemotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UMBRELLA protocol_entity\\', \\'COG AREN0533 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses_data_from\\'}), (\\'UMBRELLA protocol_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'advises_treatment_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'Innovative Therapies for Children with Cancer consortium_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborates_with\\'}), (\\'UMBRELLA protocol_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'surgery_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is the standard of\\'}), (\\'UMBRELLA protocol_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guides treatment in\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', \\'UKW3 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\\'minimally invasive surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'anaplasia_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'radical tumor nephrectomy_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'standard_of_care_for\\'}), (\\'Stage IV_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'presents in\\'}), (\\'CDCV_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'VP16_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'aims to improve survival rates of\\'}), (\\'AVD150_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed_by\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'succeeds\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'www.siop-rtsg.eu_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'available_on\\'}), (\\'laparoscopic surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'COG AREN0533 trial_entity\\', \\'cumulative doxorubicin dose_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'evaluates\\'}), (\\'UKW\u2011R protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'Nephron-sparing surgery (NSS)_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'classification_developed_by\\'}), (\\'Adult Wilms Tumors_entity\\', \\'anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'Adult Wilms Tumors_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'doxorubicin_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'doxorubicin_entity\\', \\'large-volume tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'recommended for\\'}), (\\'NWTS\u20115 relapse protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'End-stage renal disease (ESRD)_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'AVD250_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'Children\u2019s Oncology Group (COG)_entity\\', \\'SIOP\u22122001 randomized trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborated with\\'}), (\\'blastemal-type Wilms tumour_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment intensified according to\\'}), (\\'SIOP\u22122001_entity\\', \\'vincristine, actinomycin D, and doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses\\'}), (\\'SIOP\u22122001_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provided_guidelines_for\\'}), (\\'radiotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'radiotherapy_entity\\', \\'SIOP\u2212RTSG panel_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'contact_for_guidance\\'})]}, {\\'nodes\\': [(\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {}), (\\'Marry M. van den Heuvel-Eibrink_entity\\', {})], \\'edges\\': [(\\'Marry M. van den Heuvel-Eibrink_entity\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'affiliated_with\\'})]}, {\\'nodes\\': [(\\'Stage II_entity\\', {}), (\\'AV_entity\\', {}), (\\'Stage III_entity\\', {}), (\\'vincestine and actinomycin D_entity\\', {}), (\\'AVD_entity\\', {})], \\'edges\\': [(\\'Stage II_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AV_entity\\', \\'Stage II_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Stage III_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AVD_entity\\', \\'Stage III_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'SIOP-RTSG 2016_entity\\', {}), (\\'RCC_entity\\', {}), (\\'CMN_entity\\', {})], \\'edges\\': [(\\'RCC_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'}), (\\'CMN_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'})]}, {\\'nodes\\': [(\\'HR-1_entity\\', {}), (\\'High-risk blastemal type Wilms tumour_entity\\', {})], \\'edges\\': [(\\'HR-1_entity\\', \\'High-risk blastemal type Wilms tumour_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'unfavorable prognosis_entity\\', {}), (\\'high-risk characteristics_entity\\', {})], \\'edges\\': [(\\'high-risk characteristics_entity\\', \\'unfavorable prognosis_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'leads_to\\'})]}, {\\'nodes\\': [(\\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {}), (\\'SIOP\u2013RTSG board_entity\\', {})], \\'edges\\': [(\\'SIOP\u2013RTSG board_entity\\', \\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggests\\'})]}, {\\'nodes\\': [(\\'regimen and outcomes_entity\\', {}), (\\'SIOP database_entity\\', {})], \\'edges\\': [(\\'SIOP database_entity\\', \\'regimen and outcomes_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'captures_data_on\\'})]}, {\\'nodes\\': [(\\'Bilateral nephron-sparing surgery (NSS)_entity\\', {}), (\\'Aronson et al._entity\\', {})], \\'edges\\': [(\\'Aronson et al._entity\\', \\'Bilateral nephron-sparing surgery (NSS)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'observed_effectiveness_of\\'})]}, {\\'nodes\\': [(\\'SIOP\u22122001 study_entity\\', {}), (\\'Actinomycin D_entity\\', {}), (\\'Vincristine_entity\\', {})], \\'edges\\': [(\\'SIOP\u22122001 study_entity\\', \\'Vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'}), (\\'SIOP\u22122001 study_entity\\', \\'Actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'})]}, {\\'nodes\\': [(\\'High-dose melphalan_entity\\', {}), (\\'Group AA_entity\\', {}), (\\'Carboplatin_entity\\', {}), (\\'Doxorubicin_entity\\', {}), (\\'Etoposide_entity\\', {}), (\\'Group BB_entity\\', {}), (\\'Cyclophosphamide_entity\\', {}), (\\'Ifosfamide_entity\\', {})], \\'edges\\': [(\\'Group AA_entity\\', \\'Doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Ifosfamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'High-dose melphalan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'})]}, {\\'nodes\\': [(\\'nephrotoxicity_entity\\', {}), (\\'ifosfamide_entity\\', {})], \\'edges\\': [(\\'ifosfamide_entity\\', \\'nephrotoxicity_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'related_to\\'})]}, {\\'nodes\\': [(\\'camptothecins_entity\\', {}), (\\'irinotecan_entity\\', {}), (\\'topotecan_entity\\', {})], \\'edges\\': [(\\'camptothecins_entity\\', \\'irinotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'camptothecins_entity\\', \\'topotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'})]}, {\\'nodes\\': [(\\'Infant Wilms Tumors_entity\\', {}), (\\'nephrectomy_entity\\', {})], \\'edges\\': [(\\'Infant Wilms Tumors_entity\\', \\'nephrectomy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_option\\'})]}, {\\'nodes\\': [(\\'congenital mesoblastic nephroma_entity\\', {}), (\\'surgery alone_entity\\', {})], \\'edges\\': [(\\'congenital mesoblastic nephroma_entity\\', \\'surgery alone_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'alternative chemotherapy_entity\\', {}), (\\'malignant rhabdoid tumors_entity\\', {})], \\'edges\\': [(\\'malignant rhabdoid tumors_entity\\', \\'alternative chemotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'lymph node sampling_entity\\', {}), (\\'accurate staging_entity\\', {})], \\'edges\\': [(\\'lymph node sampling_entity\\', \\'accurate staging_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'purpose_of\\'})]}, {\\'nodes\\': [(\\'COG\u2013NWTS trials_entity\\', {}), (\\'whole-lung irradiation_entity\\', {})], \\'edges\\': [(\\'COG\u2013NWTS trials_entity\\', \\'whole-lung irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'informed_dosage_for\\'})]}, {\\'nodes\\': [(\\'lung metastases_entity\\', {}), (\\'pulmonary radiotherapy_entity\\', {})], \\'edges\\': [(\\'pulmonary radiotherapy_entity\\', \\'lung metastases_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'administered_for\\'})]}, {\\'nodes\\': [(\\'dosimetric study_entity\\', {}), (\\'proton therapy_entity\\', {}), (\\'flank irradiation_entity\\', {})], \\'edges\\': [(\\'dosimetric study_entity\\', \\'proton therapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated\\'}), (\\'proton therapy_entity\\', \\'flank irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggested_for\\'})]}, {\\'nodes\\': [(\\'metastatic disease_entity\\', {}), (\\'radiotherapy guidelines_entity\\', {}), (\\'locoregional disease_entity\\', {})], \\'edges\\': [(\\'radiotherapy guidelines_entity\\', \\'locoregional disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'}), (\\'radiotherapy guidelines_entity\\', \\'metastatic disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'})]}, {\\'nodes\\': [(\\'major rupture_entity\\', {}), (\\'stage III_entity\\', {})], \\'edges\\': [(\\'stage III_entity\\', \\'major rupture_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes_condition\\'})]}, {\\'nodes\\': [(\\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {}), (\\'ExPO\u2011r\u2011Net_entity\\', {})], \\'edges\\': [(\\'ExPO\u2011r\u2011Net_entity\\', \\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is part of\\'})]}, {\\'nodes\\': [(\\'University Hospital of Munich_entity\\', {}), (\\'Germany_entity\\', {}), (\\'University Hospital of Tuebingen_entity\\', {})], \\'edges\\': [(\\'Germany_entity\\', \\'University Hospital of Munich_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Germany_entity\\', \\'University Hospital of Tuebingen_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {}), (\\'Italy_entity\\', {}), (\\'Azienda Ospedaliera_entity\\', {}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {})], \\'edges\\': [(\\'Italy_entity\\', \\'Azienda Ospedaliera_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Netherlands_entity\\', {}), (\\'Prinses Maxima Centrum_entity\\', {})], \\'edges\\': [(\\'Netherlands_entity\\', \\'Prinses Maxima Centrum_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Marciniak Hospital_entity\\', {}), (\\'Poland_entity\\', {}), (\\'Faculty of Medicine_entity\\', {})], \\'edges\\': [(\\'Poland_entity\\', \\'Marciniak Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Poland_entity\\', \\'Faculty of Medicine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'St. Anna Kinderspital/CCRI_entity\\', {}), (\\'Austria_entity\\', {})], \\'edges\\': [(\\'Austria_entity\\', \\'St. Anna Kinderspital/CCRI_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'France_entity\\', {}), (\\'Armand Trousseau Hospital_entity\\', {})], \\'edges\\': [(\\'France_entity\\', \\'Armand Trousseau Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Spain_entity\\', {}), (\\'Hospital Vall d\u2019Hebron_entity\\', {}), (\\'Hospital Universitario Virgin del Rocio_entity\\', {})], \\'edges\\': [(\\'Spain_entity\\', \\'Hospital Universitario Virgin del Rocio_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Spain_entity\\', \\'Hospital Vall d\u2019Hebron_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'United Kingdom_entity\\', {}), (\\'Great Ormond Street Hospital_entity\\', {})], \\'edges\\': [(\\'United Kingdom_entity\\', \\'Great Ormond Street Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Weirich, A._entity\\', {}), (\\'SIOP-9/GPOH_entity\\', {})], \\'edges\\': [(\\'Weirich, A._entity\\', \\'SIOP-9/GPOH_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Pritchard-Jones, K._entity\\', {}), (\\'UKW3_entity\\', {})], \\'edges\\': [(\\'Pritchard-Jones, K._entity\\', \\'UKW3_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed in\\'})]}, {\\'nodes\\': [(\\'SIOP 93\u201301 trial_entity\\', {}), (\\'de Kraker, J._entity\\', {})], \\'edges\\': [(\\'de Kraker, J._entity\\', \\'SIOP 93\u201301 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'SIOP trial and study 93\u201301_entity\\', {}), (\\'Graf, N._entity\\', {})], \\'edges\\': [(\\'Graf, N._entity\\', \\'SIOP trial and study 93\u201301_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Green, D. M._entity\\', {}), (\\'National Wilms Tumor Study Group_entity\\', {})], \\'edges\\': [(\\'Green, D. M._entity\\', \\'National Wilms Tumor Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}, {\\'nodes\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', {}), (\\'SIOP WT 2001 protocol_entity\\', {})], \\'edges\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', \\'SIOP WT 2001 protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Third National Wilms\u2019 Tumor Study_entity\\', {}), (\"D\\'Angio, G. J._entity\", {}), (\\'Second National Wilms\u2019 Tumor Study_entity\\', {})], \\'edges\\': [(\"D\\'Angio, G. J._entity\", \\'Third National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\"D\\'Angio, G. J._entity\", \\'Second National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {}), (\\'Tournade, M. F._entity\\', {}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {})], \\'edges\\': [(\\'Tournade, M. F._entity\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'}), (\\'Tournade, M. F._entity\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Breslow, N. E._entity\\', {}), (\\'National Wilms Tumor Studies_entity\\', {})], \\'edges\\': [(\\'Breslow, N. E._entity\\', \\'National Wilms Tumor Studies_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Mitchell, C._entity\\', {}), (\\'UK Children\u2019s Cancer Study Group_entity\\', {})], \\'edges\\': [(\\'Mitchell, C._entity\\', \\'UK Children\u2019s Cancer Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'under\\'})]}, {\\'nodes\\': [(\\'Daw, N. C._entity\\', {}), (\\'Dix, D. B._entity\\', {}), (\\'Children\u2019s Oncology Group_entity\\', {}), (\\'Grundy, P. E._entity\\', {})], \\'edges\\': [(\\'Daw, N. C._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted under\\'}), (\\'Dix, D. B._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'}), (\\'Grundy, P. E._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}]', expected_output='Tumor volume is used to stratify patients and guide treatment intensity, especially regarding the use of chemotherapy agents like doxorubicin.', context=None, retrieval_context=['[{\\'nodes\\': [(\\'sample.pdf\\', {\\'type\\': \\'document\\'}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)\\'}), (\\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA SIOP-RTSG 2016\\'}), (\\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms tumours\\'}), (\\'non-Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'non-Wilms tumours\\'}), (\\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Website\\', \\'name\\': \\'www.siop-rtsg.eu\\'}), (\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology\\'}), (\\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Person\\', \\'name\\': \\'Marry M. van den Heuvel-Eibrink\\'}), (\\'childhood renal tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'childhood renal tumours\\'}), (\\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'clear cell sarcoma of the kidney\\'}), (\\'renal cell carcinoma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'renal cell carcinoma\\'}), (\\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'malignant rhabdoid tumour of the kidney\\'}), (\\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'Wilms tumours_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'Children\u2019s Oncology Group (COG)\\'}), (\\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'SIOP\u22122001 randomized trial\\'}), (\\'actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'UKW3 trial\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)\\'}), (\\'localized disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'localized disease\\'}), (\\'metastatic disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'metastatic disease\\'}), (\\'bilateral disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'bilateral disease\\'}), (\\'relapsed disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'relapsed disease\\'}), (\\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subtype\\', \\'name\\': \\'blastemal-type Wilms tumours\\'}), (\\'radiotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgery_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'chemotherapy\\'}), (\\'Wilms Tumour_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms Tumour\\'}), (\\'CCSK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CCSK\\'}), (\\'MRTK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'MRTK\\'}), (\\'CMN_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CMN\\'}), (\\'RCC_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'RCC\\'}), (\\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u22122001_Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Trial\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'vincristine_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'vincristine\\'}), (\\'actinomycin D_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'actinomycin D\\'}), (\\'doxorubicin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'doxorubicin\\'}), (\\'etoposide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'Stage I_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage I\\'}), (\\'Stage II_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage II\\'}), (\\'Stage III_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage III\\'}), (\\'Stage IV_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage IV\\'}), (\\'Stage V_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage V\\'}), (\\'AV_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AV\\'}), (\\'AVD_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AVD\\'}), (\\'HR-1_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'HR-1\\'}), (\\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP-RTSG 2016\\'}), (\\'Overall Survival (OS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'CT-only nodules_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'CT-only nodules\\'}), (\\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP\u2013RTSG analysis\\'}), (\\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials\\'}), (\\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D plus doxorubicin\\'}), (\\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D\\'}), (\\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study_protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'MRI_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'MRI\\'}), (\\'CT_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'CT\\'}), (\\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_detail\\', \\'name\\': \\'cumulative doxorubicin dose\\'}), (\\'COG AREN0533 trial_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG AREN0533 trial\\'}), (\\'etoposide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'high-risk characteristics\\'}), (\\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG board\\'}), (\\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin\\'}), (\\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'high-dose chemotherapy and autologous stem cell transplantation\\'}), (\\'SIOP database_database\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'database\\', \\'name\\': \\'SIOP database\\'}), (\\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'AVD_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AVD\\'}), (\\'AV-2_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AV-2\\'}), (\\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Statistical Test\\', \\'name\\': \\'Log\u2013Rank P\\'}), (\\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'Bilateral Disease (Stage V)\\'}), (\\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Synchronous bilateral Wilms tumor\\'}), (\\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'End-stage renal disease (ESRD)\\'}), (\\'Aronson et al._Research Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Research Group\\', \\'name\\': \\'Aronson et al.\\'}), (\\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'Bilateral nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Study\\', \\'name\\': \\'SIOP\u22122001 study\\'}), (\\'Vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Vincristine\\'}), (\\'Actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Actinomycin D\\'}), (\\'Etoposide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Etoposide\\'}), (\\'Carboplatin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Carboplatin\\'}), (\\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease State\\', \\'name\\': \\'Relapsed Wilms Tumor\\'}), (\\'Group AA_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group AA\\'}), (\\'Group BB_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group BB\\'}), (\\'Group CC_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group CC\\'}), (\\'Doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Doxorubicin\\'}), (\\'Cyclophosphamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Cyclophosphamide\\'}), (\\'Ifosfamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Ifosfamide\\'}), (\\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'High-dose melphalan\\'}), (\\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UKW\u2011R protocol\\'}), (\\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'NWTS\u20115 relapse protocol\\'}), (\\'ASCR_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'procedure\\', \\'name\\': \\'ASCR\\'}), (\\'ifosfamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'ifosfamide\\'}), (\\'nephrotoxicity_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'nephrotoxicity\\'}), (\\'relapsed group CC_patient_group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'patient_group\\', \\'name\\': \\'relapsed group CC\\'}), (\\'diffuse anaplasia_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'diffuse anaplasia\\'}), (\\'blastemal-type tumors_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'blastemal-type tumors\\'}), (\\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'camptothecins_medication_class\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication_class\\', \\'name\\': \\'camptothecins\\'}), (\\'irinotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'irinotecan\\'}), (\\'topotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'topotecan\\'}), (\\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Innovative Therapies for Children with Cancer consortium\\'}), (\\'radiotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgical excision_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgical excision\\'}), (\\'stage IV WT_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'stage IV WT\\'}), (\\'AVD150_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD150\\'}), (\\'AVD250_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD250\\'}), (\\'low-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'low-risk disease\\'}), (\\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'intermediate-risk disease\\'}), (\\'high-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'high-risk disease\\'}), (\\'CDCV_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'CDCV\\'}), (\\'actinomycin-D_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'actinomycin-D\\'}), (\\'vincristine_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'doxorubicin\\'}), (\\'VP16_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'VP16\\'}), (\\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'contact\\', \\'name\\': \\'arnauld.verschuur@ap-hm.fr\\'}), (\\'surgery_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'chemotherapy\\'}), (\\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2212RTSG panel\\'}), (\\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Infant Wilms Tumors\\'}), (\\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'nephrectomy\\'}), (\\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'malignant rhabdoid tumors\\'}), (\\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Adult Wilms Tumors\\'}), (\\'anaplasia_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'anaplasia\\'}), (\\'actinomycin D_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'carboplatin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'etoposide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'etoposide\\'}), (\\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'Nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'radical tumor nephrectomy\\'}), (\\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'lymph node sampling\\'}), (\\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'minimally invasive surgery\\'}), (\\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'laparoscopic surgery\\'}), (\\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'radiotherapy\\'}), (\\'Wilms tumours_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'Davila Fajardo et al._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Davila Fajardo et al.\\'}), (\\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'COG\u2013NWTS trials\\'}), (\\'whole-lung irradiation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'whole-lung irradiation\\'}), (\\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'pulmonary radiotherapy\\'}), (\\'proton therapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'proton therapy\\'}), (\\'dosimetric study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'dosimetric study\\'}), (\\'locoregional disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'locoregional disease\\'}), (\\'metastatic disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'metastatic disease\\'}), (\\'low-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'low-risk\\'}), (\\'intermediate-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'intermediate-risk\\'}), (\\'high-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'high-risk\\'}), (\\'stage I_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage I\\'}), (\\'stage II_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage II\\'}), (\\'stage III_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage III\\'}), (\\'major rupture_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'major rupture\\'}), (\\'Austria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Austria\\'}), (\\'Italy_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Italy\\'}), (\\'San Marino_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'San Marino\\'}), (\\'Iceland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Iceland\\'}), (\\'Germany_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Germany\\'}), (\\'Bulgaria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bulgaria\\'}), (\\'Turkey_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Turkey\\'}), (\\'Denmark_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Denmark\\'}), (\\'Poland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Poland\\'}), (\\'Greece_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Greece\\'}), (\\'Andorra_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Andorra\\'}), (\\'Belgium_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belgium\\'}), (\\'Serbia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Serbia\\'}), (\\'Albania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Albania\\'}), (\\'Moldova_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Moldova\\'}), (\\'Lithuania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Lithuania\\'}), (\\'Latvia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Latvia\\'}), (\\'Estonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Estonia\\'}), (\\'Luxembourg_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Luxembourg\\'}), (\\'Montenegro_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Montenegro\\'}), (\\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bosnia and Herzegovina\\'}), (\\'Croatia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Croatia\\'}), (\\'Slovenia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovenia\\'}), (\\'Macedonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Macedonia\\'}), (\\'United Kingdom_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'United Kingdom\\'}), (\\'Ireland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ireland\\'}), (\\'Spain_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Spain\\'}), (\\'Algeria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Algeria\\'}), (\\'Tunisia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Tunisia\\'}), (\\'Malta_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Malta\\'}), (\\'Morocco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Morocco\\'}), (\\'Portugal_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Portugal\\'}), (\\'France_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'France\\'}), (\\'Monaco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Monaco\\'}), (\\'Russia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Russia\\'}), (\\'Finland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Finland\\'}), (\\'Sweden_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Sweden\\'}), (\\'Norway_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Norway\\'}), (\\'Belarus_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belarus\\'}), (\\'Romania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Romania\\'}), (\\'Ukraine_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ukraine\\'}), (\\'Hungary_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Hungary\\'}), (\\'Czech Republic_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Czech Republic\\'}), (\\'Slovakia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovakia\\'}), (\\'Switzerland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Switzerland\\'}), (\\'Liechtenstein_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Liechtenstein\\'}), (\\'Netherlands_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Netherlands\\'}), (\\'University Hospital of Munich_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Munich\\'}), (\\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Tuebingen\\'}), (\\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Azienda Ospedaliera\\'}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Ospedale Pediatrico Bambino Ges\u00f9\\'}), (\\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Fondazione IRCCS Istituto Nazionale dei Tumori\\'}), (\\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Prinses Maxima Centrum\\'}), (\\'Marciniak Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Marciniak Hospital\\'}), (\\'Faculty of Medicine_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Faculty of Medicine\\'}), (\\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'St. Anna Kinderspital/CCRI\\'}), (\\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Armand Trousseau Hospital\\'}), (\\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Universitario Virgin del Rocio\\'}), (\\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Vall d\u2019Hebron\\'}), (\\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Great Ormond Street Hospital\\'}), (\\'University Hospital Homburg_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital Homburg\\'}), (\\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon\\'}), (\\'UMBRELLA protocol_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'ExPO\u2011r\u2011Net\\'}), (\\'Weirich, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Weirich, A.\\'}), (\\'Pritchard-Jones, K._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Pritchard-Jones, K.\\'}), (\\'de Kraker, J._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'de Kraker, J.\\'}), (\\'Graf, N._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Graf, N.\\'}), (\\'Green, D. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Green, D. M.\\'}), (\\'Spreafico, F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Spreafico, F.\\'}), (\\'Bellani, F. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Bellani, F. F.\\'}), (\\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'van den Heuvel-Eibrink, M. M.\\'}), (\"D\\'Angio, G. J._author\", {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \"D\\'Angio, G. J.\"}), (\\'Tournade, M. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Tournade, M. F.\\'}), (\\'Breslow, N. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Breslow, N. E.\\'}), (\\'Mitchell, C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Mitchell, C.\\'}), (\\'Verschuur, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Verschuur, A.\\'}), (\\'Grundy, P. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Grundy, P. E.\\'}), (\\'Warmann, S. W._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Warmann, S. W.\\'}), (\\'Smets, A. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Smets, A. M.\\'}), (\\'Dome, J. S._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dome, J. S.\\'}), (\\'Dix, D. B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dix, D. B.\\'}), (\\'Daw, N. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Daw, N. C.\\'}), (\\'Ha, T. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Ha, T. C.\\'}), (\\'Kremens, B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Kremens, B.\\'}), (\\'Furtwangler, R._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Furtwangler, R.\\'}), (\\'SIOP-9/GPOH_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP-9/GPOH\\'}), (\\'UKW3_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'UKW3\\'}), (\\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'SIOP 93\u201301 trial\\'}), (\\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP trial and study 93\u201301\\'}), (\\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'National Wilms Tumor Study Group\\'}), (\\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP WT 2001 protocol\\'}), (\\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Third National Wilms\u2019 Tumor Study\\'}), (\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'National Wilms Tumor Studies\\'}), (\\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Second National Wilms\u2019 Tumor Study\\'}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'UK Children\u2019s Cancer Study Group\\'}), (\\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Children\u2019s Oncology Group\\'})], \\'edges\\': [(\\'sample.pdf\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'non-Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'childhood renal tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'renal cell carcinoma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'localized disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'metastatic disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'bilateral disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'relapsed disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'radiotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'surgery_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'chemotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'Wilms Tumour_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CCSK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'MRTK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CMN_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'RCC_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP\u22122001_Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'vincristine_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'actinomycin D_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'doxorubicin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'etoposide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'carboplatin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'cyclophosphamide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage I_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage II_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage III_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage IV_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage V_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AV_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AVD_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'HR-1_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Overall Survival (OS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT-only nodules_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'MRI_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG AREN0533 trial_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'etoposide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'carboplatin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'cyclophosphamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP database_database\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AVD_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AV-2_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Aronson et al._Research Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Etoposide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Carboplatin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group AA_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group BB_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group CC_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Cyclophosphamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Ifosfamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'ASCR_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'ifosfamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'nephrotoxicity_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'relapsed group CC_patient_group\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'diffuse anaplasia_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'blastemal-type tumors_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'camptothecins_medication_class\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'irinotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'topotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'radiotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'surgical excision_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'stage IV WT_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD150_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD250_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'low-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'CDCV_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'actinomycin-D_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'vincristine_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'doxorubicin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'VP16_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'surgery_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'chemotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'anaplasia_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'actinomycin D_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'vincristine_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'doxorubicin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'carboplatin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'cyclophosphamide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'etoposide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'SIOP\u22122001_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Wilms tumours_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Davila Fajardo et al._author\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'whole-lung irradiation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'proton therapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'dosimetric study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'locoregional disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'metastatic disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'low-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'intermediate-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'high-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage I_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage II_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage III_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'major rupture_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Austria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Italy_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'San Marino_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Iceland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Germany_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bulgaria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Turkey_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Denmark_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Poland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Greece_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Andorra_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belgium_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Serbia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Albania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Moldova_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Lithuania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Latvia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Estonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Luxembourg_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Montenegro_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Croatia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovenia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Macedonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'United Kingdom_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ireland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Spain_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Algeria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Tunisia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Malta_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Morocco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Portugal_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'France_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Monaco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Russia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Finland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Sweden_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Norway_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belarus_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Romania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ukraine_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hungary_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Czech Republic_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovakia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Switzerland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Liechtenstein_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Netherlands_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Munich_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Marciniak Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Faculty of Medicine_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital Homburg_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Weirich, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Pritchard-Jones, K._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'de Kraker, J._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Graf, N._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Green, D. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Spreafico, F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Bellani, F. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \"D\\'Angio, G. J._author\", {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Tournade, M. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Breslow, N. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Mitchell, C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Verschuur, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Grundy, P. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Warmann, S. W._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Smets, A. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dome, J. S._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dix, D. B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Daw, N. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ha, T. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Kremens, B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Furtwangler, R._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP-9/GPOH_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UKW3_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10})]}, {\\'nodes\\': [(\\'vincristine_entity\\', {}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {}), (\\'www.siop-rtsg.eu_entity\\', {}), (\\'stage II_entity\\', {}), (\\'Wilms tumours_entity\\', {}), (\\'Relapsed Wilms Tumor_entity\\', {}), (\\'Davila Fajardo et al._entity\\', {}), (\\'vincristine, actinomycin D, and doxorubicin_entity\\', {}), (\\'SIOP\u22122001 randomized trial_entity\\', {}), (\\'surgery_entity\\', {}), (\\'non-Wilms tumours_entity\\', {}), (\\'actinomycin D_entity\\', {}), (\\'diffuse anaplasia_entity\\', {}), (\\'Synchronous bilateral Wilms tumor_entity\\', {}), (\\'CT-only nodules_entity\\', {}), (\\'relapsed group CC_entity\\', {}), (\\'increased relapse risk_entity\\', {}), (\\'reduced survival_entity\\', {}), (\\'UKW3 trial_entity\\', {}), (\\'chemotherapy_entity\\', {}), (\\'Bilateral Disease (Stage V)_entity\\', {}), (\\'blastemal-type tumors_entity\\', {}), (\\'UMBRELLA protocol_entity\\', {}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', {}), (\\'minimally invasive surgery_entity\\', {}), (\\'VP16_entity\\', {}), (\\'Wilms tumor_entity\\', {}), (\\'anaplasia_entity\\', {}), (\\'radical tumor nephrectomy_entity\\', {}), (\\'Innovative Therapies for Children with Cancer consortium_entity\\', {}), (\\'cumulative doxorubicin dose_entity\\', {}), (\\'etoposide_entity\\', {}), (\\'large-volume tumours_entity\\', {}), (\\'Stage IV_entity\\', {}), (\\'CDCV_entity\\', {}), (\\'SIOP\u2013RTSG_entity\\', {}), (\\'AVD150_entity\\', {}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', {}), (\\'laparoscopic surgery_entity\\', {}), (\\'SIOP\u2212RTSG panel_entity\\', {}), (\\'actinomycin-D_entity\\', {}), (\\'COG AREN0533 trial_entity\\', {}), (\\'cyclophosphamide_entity\\', {}), (\\'carboplatin_entity\\', {}), (\\'UKW\u2011R protocol_entity\\', {}), (\\'Nephron-sparing surgery (NSS)_entity\\', {}), (\\'Adult Wilms Tumors_entity\\', {}), (\\'doxorubicin_entity\\', {}), (\\'NWTS\u20115 relapse protocol_entity\\', {}), (\\'End-stage renal disease (ESRD)_entity\\', {}), (\\'AVD250_entity\\', {}), (\\'Children\u2019s Oncology Group (COG)_entity\\', {}), (\\'blastemal-type Wilms tumour_entity\\', {}), (\\'SIOP\u22122001_entity\\', {}), (\\'radiotherapy_entity\\', {}), (\\'childhood renal tumours_entity\\', {})], \\'edges\\': [(\\'vincristine_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'stage II_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'indicated_for_in_adults\\'}), (\\'Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'Wilms tumours_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated under\\'}), (\\'Relapsed Wilms Tumor_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guided_by\\'}), (\\'Davila Fajardo et al._entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed\\'}), (\\'SIOP\u22122001 randomized trial_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated use in\\'}), (\\'surgery_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'non-Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'actinomycin D_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Synchronous bilateral Wilms tumor_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'instance_of\\'}), (\\'CT-only nodules_entity\\', \\'increased relapse risk_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'reduced survival_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included_in\\'}), (\\'relapsed group CC_entity\\', \\'diffuse anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'blastemal-type tumors_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UKW3 trial_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'UKW3 trial_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'chemotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UMBRELLA protocol_entity\\', \\'COG AREN0533 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses_data_from\\'}), (\\'UMBRELLA protocol_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'advises_treatment_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'Innovative Therapies for Children with Cancer consortium_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborates_with\\'}), (\\'UMBRELLA protocol_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'surgery_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is the standard of\\'}), (\\'UMBRELLA protocol_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guides treatment in\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', \\'UKW3 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\\'minimally invasive surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'anaplasia_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'radical tumor nephrectomy_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'standard_of_care_for\\'}), (\\'Stage IV_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'presents in\\'}), (\\'CDCV_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'VP16_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'aims to improve survival rates of\\'}), (\\'AVD150_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed_by\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'succeeds\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'www.siop-rtsg.eu_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'available_on\\'}), (\\'laparoscopic surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'COG AREN0533 trial_entity\\', \\'cumulative doxorubicin dose_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'evaluates\\'}), (\\'UKW\u2011R protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'Nephron-sparing surgery (NSS)_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'classification_developed_by\\'}), (\\'Adult Wilms Tumors_entity\\', \\'anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'Adult Wilms Tumors_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'doxorubicin_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'doxorubicin_entity\\', \\'large-volume tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'recommended for\\'}), (\\'NWTS\u20115 relapse protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'End-stage renal disease (ESRD)_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'AVD250_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'Children\u2019s Oncology Group (COG)_entity\\', \\'SIOP\u22122001 randomized trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborated with\\'}), (\\'blastemal-type Wilms tumour_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment intensified according to\\'}), (\\'SIOP\u22122001_entity\\', \\'vincristine, actinomycin D, and doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses\\'}), (\\'SIOP\u22122001_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provided_guidelines_for\\'}), (\\'radiotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'radiotherapy_entity\\', \\'SIOP\u2212RTSG panel_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'contact_for_guidance\\'})]}, {\\'nodes\\': [(\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {}), (\\'Marry M. van den Heuvel-Eibrink_entity\\', {})], \\'edges\\': [(\\'Marry M. van den Heuvel-Eibrink_entity\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'affiliated_with\\'})]}, {\\'nodes\\': [(\\'Stage II_entity\\', {}), (\\'AV_entity\\', {}), (\\'Stage III_entity\\', {}), (\\'vincestine and actinomycin D_entity\\', {}), (\\'AVD_entity\\', {})], \\'edges\\': [(\\'Stage II_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AV_entity\\', \\'Stage II_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Stage III_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AVD_entity\\', \\'Stage III_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'SIOP-RTSG 2016_entity\\', {}), (\\'RCC_entity\\', {}), (\\'CMN_entity\\', {})], \\'edges\\': [(\\'RCC_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'}), (\\'CMN_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'})]}, {\\'nodes\\': [(\\'HR-1_entity\\', {}), (\\'High-risk blastemal type Wilms tumour_entity\\', {})], \\'edges\\': [(\\'HR-1_entity\\', \\'High-risk blastemal type Wilms tumour_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'unfavorable prognosis_entity\\', {}), (\\'high-risk characteristics_entity\\', {})], \\'edges\\': [(\\'high-risk characteristics_entity\\', \\'unfavorable prognosis_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'leads_to\\'})]}, {\\'nodes\\': [(\\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {}), (\\'SIOP\u2013RTSG board_entity\\', {})], \\'edges\\': [(\\'SIOP\u2013RTSG board_entity\\', \\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggests\\'})]}, {\\'nodes\\': [(\\'regimen and outcomes_entity\\', {}), (\\'SIOP database_entity\\', {})], \\'edges\\': [(\\'SIOP database_entity\\', \\'regimen and outcomes_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'captures_data_on\\'})]}, {\\'nodes\\': [(\\'Bilateral nephron-sparing surgery (NSS)_entity\\', {}), (\\'Aronson et al._entity\\', {})], \\'edges\\': [(\\'Aronson et al._entity\\', \\'Bilateral nephron-sparing surgery (NSS)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'observed_effectiveness_of\\'})]}, {\\'nodes\\': [(\\'SIOP\u22122001 study_entity\\', {}), (\\'Actinomycin D_entity\\', {}), (\\'Vincristine_entity\\', {})], \\'edges\\': [(\\'SIOP\u22122001 study_entity\\', \\'Vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'}), (\\'SIOP\u22122001 study_entity\\', \\'Actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'})]}, {\\'nodes\\': [(\\'High-dose melphalan_entity\\', {}), (\\'Group AA_entity\\', {}), (\\'Carboplatin_entity\\', {}), (\\'Doxorubicin_entity\\', {}), (\\'Etoposide_entity\\', {}), (\\'Group BB_entity\\', {}), (\\'Cyclophosphamide_entity\\', {}), (\\'Ifosfamide_entity\\', {})], \\'edges\\': [(\\'Group AA_entity\\', \\'Doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Ifosfamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'High-dose melphalan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'})]}, {\\'nodes\\': [(\\'nephrotoxicity_entity\\', {}), (\\'ifosfamide_entity\\', {})], \\'edges\\': [(\\'ifosfamide_entity\\', \\'nephrotoxicity_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'related_to\\'})]}, {\\'nodes\\': [(\\'camptothecins_entity\\', {}), (\\'irinotecan_entity\\', {}), (\\'topotecan_entity\\', {})], \\'edges\\': [(\\'camptothecins_entity\\', \\'irinotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'camptothecins_entity\\', \\'topotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'})]}, {\\'nodes\\': [(\\'Infant Wilms Tumors_entity\\', {}), (\\'nephrectomy_entity\\', {})], \\'edges\\': [(\\'Infant Wilms Tumors_entity\\', \\'nephrectomy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_option\\'})]}, {\\'nodes\\': [(\\'congenital mesoblastic nephroma_entity\\', {}), (\\'surgery alone_entity\\', {})], \\'edges\\': [(\\'congenital mesoblastic nephroma_entity\\', \\'surgery alone_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'alternative chemotherapy_entity\\', {}), (\\'malignant rhabdoid tumors_entity\\', {})], \\'edges\\': [(\\'malignant rhabdoid tumors_entity\\', \\'alternative chemotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'lymph node sampling_entity\\', {}), (\\'accurate staging_entity\\', {})], \\'edges\\': [(\\'lymph node sampling_entity\\', \\'accurate staging_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'purpose_of\\'})]}, {\\'nodes\\': [(\\'COG\u2013NWTS trials_entity\\', {}), (\\'whole-lung irradiation_entity\\', {})], \\'edges\\': [(\\'COG\u2013NWTS trials_entity\\', \\'whole-lung irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'informed_dosage_for\\'})]}, {\\'nodes\\': [(\\'lung metastases_entity\\', {}), (\\'pulmonary radiotherapy_entity\\', {})], \\'edges\\': [(\\'pulmonary radiotherapy_entity\\', \\'lung metastases_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'administered_for\\'})]}, {\\'nodes\\': [(\\'dosimetric study_entity\\', {}), (\\'proton therapy_entity\\', {}), (\\'flank irradiation_entity\\', {})], \\'edges\\': [(\\'dosimetric study_entity\\', \\'proton therapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated\\'}), (\\'proton therapy_entity\\', \\'flank irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggested_for\\'})]}, {\\'nodes\\': [(\\'metastatic disease_entity\\', {}), (\\'radiotherapy guidelines_entity\\', {}), (\\'locoregional disease_entity\\', {})], \\'edges\\': [(\\'radiotherapy guidelines_entity\\', \\'locoregional disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'}), (\\'radiotherapy guidelines_entity\\', \\'metastatic disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'})]}, {\\'nodes\\': [(\\'major rupture_entity\\', {}), (\\'stage III_entity\\', {})], \\'edges\\': [(\\'stage III_entity\\', \\'major rupture_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes_condition\\'})]}, {\\'nodes\\': [(\\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {}), (\\'ExPO\u2011r\u2011Net_entity\\', {})], \\'edges\\': [(\\'ExPO\u2011r\u2011Net_entity\\', \\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is part of\\'})]}, {\\'nodes\\': [(\\'University Hospital of Munich_entity\\', {}), (\\'Germany_entity\\', {}), (\\'University Hospital of Tuebingen_entity\\', {})], \\'edges\\': [(\\'Germany_entity\\', \\'University Hospital of Munich_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Germany_entity\\', \\'University Hospital of Tuebingen_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {}), (\\'Italy_entity\\', {}), (\\'Azienda Ospedaliera_entity\\', {}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {})], \\'edges\\': [(\\'Italy_entity\\', \\'Azienda Ospedaliera_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Netherlands_entity\\', {}), (\\'Prinses Maxima Centrum_entity\\', {})], \\'edges\\': [(\\'Netherlands_entity\\', \\'Prinses Maxima Centrum_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Marciniak Hospital_entity\\', {}), (\\'Poland_entity\\', {}), (\\'Faculty of Medicine_entity\\', {})], \\'edges\\': [(\\'Poland_entity\\', \\'Marciniak Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Poland_entity\\', \\'Faculty of Medicine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'St. Anna Kinderspital/CCRI_entity\\', {}), (\\'Austria_entity\\', {})], \\'edges\\': [(\\'Austria_entity\\', \\'St. Anna Kinderspital/CCRI_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'France_entity\\', {}), (\\'Armand Trousseau Hospital_entity\\', {})], \\'edges\\': [(\\'France_entity\\', \\'Armand Trousseau Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Spain_entity\\', {}), (\\'Hospital Vall d\u2019Hebron_entity\\', {}), (\\'Hospital Universitario Virgin del Rocio_entity\\', {})], \\'edges\\': [(\\'Spain_entity\\', \\'Hospital Universitario Virgin del Rocio_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Spain_entity\\', \\'Hospital Vall d\u2019Hebron_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'United Kingdom_entity\\', {}), (\\'Great Ormond Street Hospital_entity\\', {})], \\'edges\\': [(\\'United Kingdom_entity\\', \\'Great Ormond Street Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Weirich, A._entity\\', {}), (\\'SIOP-9/GPOH_entity\\', {})], \\'edges\\': [(\\'Weirich, A._entity\\', \\'SIOP-9/GPOH_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Pritchard-Jones, K._entity\\', {}), (\\'UKW3_entity\\', {})], \\'edges\\': [(\\'Pritchard-Jones, K._entity\\', \\'UKW3_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed in\\'})]}, {\\'nodes\\': [(\\'SIOP 93\u201301 trial_entity\\', {}), (\\'de Kraker, J._entity\\', {})], \\'edges\\': [(\\'de Kraker, J._entity\\', \\'SIOP 93\u201301 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'SIOP trial and study 93\u201301_entity\\', {}), (\\'Graf, N._entity\\', {})], \\'edges\\': [(\\'Graf, N._entity\\', \\'SIOP trial and study 93\u201301_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Green, D. M._entity\\', {}), (\\'National Wilms Tumor Study Group_entity\\', {})], \\'edges\\': [(\\'Green, D. M._entity\\', \\'National Wilms Tumor Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}, {\\'nodes\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', {}), (\\'SIOP WT 2001 protocol_entity\\', {})], \\'edges\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', \\'SIOP WT 2001 protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Third National Wilms\u2019 Tumor Study_entity\\', {}), (\"D\\'Angio, G. J._entity\", {}), (\\'Second National Wilms\u2019 Tumor Study_entity\\', {})], \\'edges\\': [(\"D\\'Angio, G. J._entity\", \\'Third National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\"D\\'Angio, G. J._entity\", \\'Second National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {}), (\\'Tournade, M. F._entity\\', {}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {})], \\'edges\\': [(\\'Tournade, M. F._entity\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'}), (\\'Tournade, M. F._entity\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Breslow, N. E._entity\\', {}), (\\'National Wilms Tumor Studies_entity\\', {})], \\'edges\\': [(\\'Breslow, N. E._entity\\', \\'National Wilms Tumor Studies_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Mitchell, C._entity\\', {}), (\\'UK Children\u2019s Cancer Study Group_entity\\', {})], \\'edges\\': [(\\'Mitchell, C._entity\\', \\'UK Children\u2019s Cancer Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'under\\'})]}, {\\'nodes\\': [(\\'Daw, N. C._entity\\', {}), (\\'Dix, D. B._entity\\', {}), (\\'Children\u2019s Oncology Group_entity\\', {}), (\\'Grundy, P. E._entity\\', {})], \\'edges\\': [(\\'Daw, N. C._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted under\\'}), (\\'Dix, D. B._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'}), (\\'Grundy, P. E._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}]']), TestResult(name='test_case_6', success=False, metrics_data=[MetricData(name='Answer Correctness (GEval)', threshold=0.5, success=False, score=0.2644437704039686, reason='The actual output mentions radiotherapy, but it lacks specific context about treating metastatic sites or cases without complete surgical resection, which are key points from the expected output.', strict_mode=False, evaluation_model='gpt-4o-mini', error=None, evaluation_cost=0.0033017999999999997, verbose_logs='Criteria:\\nNone \\n \\nEvaluation Steps:\\n[\\n    \"Determine whether the actual output is factually correct based on the expected output.\"\\n]'), MetricData(name='Faithfulness', threshold=0.7, success=True, score=0.8484848484848485, reason=None, strict_mode=False, evaluation_model='gpt-4o-mini', error=None, evaluation_cost=0.00821685, verbose_logs='Truths (limit=None):\\n[\\n    \"The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG) is an organization.\",\\n    \"UMBRELLA SIOP-RTSG 2016 is a treatment protocol.\",\\n    \"SIOP\u22122001 is a treatment protocol.\",\\n    \"Wilms tumours are a type of disease.\",\\n    \"Non-Wilms tumours are a type of disease.\",\\n    \"Marry M. van den Heuvel-Eibrink is a person affiliated with the Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology.\",\\n    \"Childhood renal tumours is a type of disease.\",\\n    \"Clear cell sarcoma of the kidney is a type of disease.\",\\n    \"Renal cell carcinoma is a type of disease.\",\\n    \"Malignant rhabdoid tumour of the kidney is a type of disease.\",\\n    \"Congenital mesoblastic nephroma is a type of disease.\",\\n    \"Localized disease is a disease stage.\",\\n    \"Metastatic disease is a disease stage.\",\\n    \"Bilateral disease is a disease stage.\",\\n    \"Relapsed disease is a disease stage.\",\\n    \"Chemotherapy is a treatment method.\",\\n    \"Radiotherapy is a treatment method.\",\\n    \"Surgery is a treatment method.\",\\n    \"Vincristine is a drug used in treatments.\",\\n    \"Actinomycin D is a drug used in treatments.\",\\n    \"Doxorubicin is a drug used in treatments.\",\\n    \"Carboplatin is a drug used in treatments.\",\\n    \"Etoposide is a drug used in treatments.\",\\n    \"Cyclophosphamide is a drug used in treatments.\",\\n    \"There are different stages of Wilms tumour: Stage I, Stage II, Stage III, Stage IV, and Stage V.\",\\n    \"SIOP\u22122001 is a clinical trial.\",\\n    \"UKW3 is a clinical trial.\",\\n    \"The UMBRELLA protocol is involved in various treatment strategies.\",\\n    \"The Children\u2019s Oncology Group (COG) is an organization.\",\\n    \"The UK Children\u2019s Cancer and Leukaemia Group (UKCCLG) is an organization.\",\\n    \"The SIOP-RTSG 2016 protocol is a follow-up to the original SIOP-RTSG protocols.\",\\n    \"Cumulative doxorubicin dose is a treatment detail.\",\\n    \"MRI and CT are diagnostic tools.\",\\n    \"Various authors contributed to the studies related to Wilms tumours and treatments.\",\\n    \"There are multiple clinical studies related to pediatric oncology including COG National Wilms Tumor Study Group.\",\\n    \"The SIOP database captures data on treatment regimens and outcomes.\"\\n] \\n \\nClaims:\\n[\\n    \"The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG) is an organization.\",\\n    \"The UMBRELLA SIOP-RTSG 2016 is a protocol.\",\\n    \"The SIOP\u22122001 is a protocol.\",\\n    \"Wilms tumours is a disease.\",\\n    \"Non-Wilms tumours is a disease.\",\\n    \"The website www.siop-rtsg.eu is associated with SIOP-RTSG.\",\\n    \"The Department of Paediatric Oncology is part of the Princess M\u00e1xima Center for Paediatric Oncology.\",\\n    \"Marry M. van den Heuvel-Eibrink is a person associated with the content.\",\\n    \"Childhood renal tumours is a disease.\",\\n    \"Clear cell sarcoma of the kidney is a disease.\",\\n    \"Renal cell carcinoma is a disease.\",\\n    \"Malignant rhabdoid tumour of the kidney is a disease.\",\\n    \"Congenital mesoblastic nephroma is a disease.\",\\n    \"Wilms tumours is a condition.\",\\n    \"The UMBRELLA protocol is a treatment protocol.\",\\n    \"Children\u2019s Oncology Group (COG) is an organization.\",\\n    \"The SIOP\u22122001 randomized trial is a clinical trial.\",\\n    \"Actinomycin D, vincristine, and doxorubicin are drugs.\",\\n    \"The UKW3 trial is a clinical trial.\",\\n    \"UK Children\u2019s Cancer and Leukaemia Group (UKCCLG) is an organization.\",\\n    \"Localized disease, metastatic disease, bilateral disease, and relapsed disease are disease stages.\",\\n    \"Blastemal-type Wilms tumours is a subtype.\",\\n    \"Radiotherapy, surgery, and chemotherapy are treatment methods.\",\\n    \"Wilms Tumour, CCSK, MRTK, CMN, and RCC are diseases.\",\\n    \"The UMBRELLA protocol is a protocol.\",\\n    \"The SIOP\u22122001 trial is related to the SIOP\u22122001 protocol.\",\\n    \"Vincristine, actinomycin D, doxorubicin, etoposide, carboplatin, and cyclophosphamide are treatments.\",\\n    \"Stage I, Stage II, Stage III, Stage IV, and Stage V are stages.\",\\n    \"AV, AVD, and HR-1 are treatment combinations.\",\\n    \"Overall Survival (OS) and Event-Free Survival (EFS) are metrics.\",\\n    \"CT-only nodules is a medical condition that can be associated with increased relapse risk and reduced survival.\",\\n    \"The SIOP database captures data.\",\\n    \"High-dose chemotherapy and autologous stem cell transplantation is a suggested treatment.\",\\n    \"Bilateral nephron-sparing surgery (NSS) is a treatment method.\",\\n    \"The COG AREN0533 trial is a study.\",\\n    \"Laparoscopic surgery is a treatment method.\",\\n    \"Surgical excision is a treatment method.\",\\n    \"Nephron-sparing surgery (NSS) is a surgical procedure.\",\\n    \"Radical tumor nephrectomy is a surgical procedure.\",\\n    \"Lymph node sampling is a surgical procedure for accurate staging.\",\\n    \"Whole-lung irradiation and pulmonary radiotherapy are treatments administered for lung metastases.\",\\n    \"Proton therapy is a suggested treatment for flank irradiation.\",\\n    \"The major rupture condition is included in stage III.\",\\n    \"Austria, Italy, San Marino, Iceland, Germany, Bulgaria, Turkey, Denmark, Poland, Greece, Andorra, Belgium, Serbia, Albania, Moldova, Lithuania, Latvia, Estonia, Luxembourg, Montenegro, Bosnia and Herzegovina, Croatia, Slovenia, Macedonia, United Kingdom, Ireland, Spain, Algeria, Tunisia, Malta, Morocco, Portugal, France, Monaco, Russia, Finland, Sweden, Norway, Belarus, Romania, Ukraine, Hungary, Czech Republic, Slovakia, Switzerland, and Liechtenstein are countries.\",\\n    \"University Hospital of Munich and University Hospital of Tuebingen are institutions in Germany.\",\\n    \"Azienda Ospedaliera, Ospedale Pediatrico Bambino Ges\u00f9, Fondazione IRCCS Istituto Nazionale dei Tumori, Prinses Maxima Centrum, Marciniak Hospital, Faculty of Medicine, St. Anna Kinderspital/CCRI, Armand Trousseau Hospital, Hospital Universitario Virgin del Rocio, Hospital Vall d\u2019Hebron, Great Ormond Street Hospital, and University Hospital Homburg are institutions.\",\\n    \"The ExPO\u2011r\u2011Net is a project.\",\\n    \"Marry M. van den Heuvel-Eibrink is affiliated with the Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology.\"\\n] \\n \\nVerdicts:\\n[\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"The claim states the UMBRELLA SIOP-RTSG 2016 is a protocol, while the context indicates it is a treatment protocol.\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"The claim states \\'Wilms tumours is a disease,\\' but the correct term is \\'Wilms tumours are a type of disease.\\'\"\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"The claim states \\'Non-Wilms tumours is a disease,\\' while the correct term is \\'Non-Wilms tumours are a type of disease.\\'\"\\n    },\\n    {\\n        \"verdict\": \"idk\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"idk\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"The claim states \\'Wilms tumours is a condition,\\' but the accurate term is \\'Wilms tumours are a type of disease.\\'\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"The claim states \\'The SIOP\\\\u22122001 randomized trial is a clinical trial,\\' but the retrieval context does not indicate that it is a randomized trial; it is solely mentioned as a clinical trial.\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"idk\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"idk\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"idk\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    }\\n]'), MetricData(name='Contextual Relevancy', threshold=1.0, success=False, score=0.4444444444444444, reason=\"The score is 0.44 because although there were relevant statements like 'radiotherapy_Treatment Method' and 'radiotherapy_guidelines_entity', the majority of the context was irrelevant, mentioning 'surgery_Treatment Method' and 'chemotherapy_Treatment Method', which do not pertain to radiotherapy, indicating a lack of focus on the input question.\", strict_mode=False, evaluation_model='gpt-4o-mini', error=None, evaluation_cost=0.0036753, verbose_logs='Verdicts:\\n[\\n    {\\n        \"verdicts\": [\\n            {\\n                \"statement\": \"radiotherapy_Treatment Method\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"radiotherapy_treatment\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"radiotherapy guidelines_entity\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"radiotherapy_entity\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\\\\u2013RTSG)_Organization\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"The retrieval context contained the information \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\\\\u2013RTSG)_Organization\\' when it has nothing to do with the role of radiotherapy.\"\\n            },\\n            {\\n                \"statement\": \"surgery_Treatment Method\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"The retrieval context included \\'surgery_Treatment Method\\', which is related to surgical methods rather than radiotherapy.\"\\n            },\\n            {\\n                \"statement\": \"chemotherapy_Treatment Method\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"The statement \\'chemotherapy_Treatment Method\\' is about chemotherapy, not radiotherapy.\"\\n            },\\n            {\\n                \"statement\": \"overall survival (OS)_metric\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"The statement \\'overall survival (OS)_metric\\' does not directly address the role of radiotherapy.\"\\n            },\\n            {\\n                \"statement\": \"Event-Free Survival (EFS)_metric\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"The statement \\'Event-Free Survival (EFS)_metric\\' is not relevant to the role of radiotherapy.\"\\n            }\\n        ]\\n    }\\n]')], conversational=False, multimodal=False, input='What is the role of radiotherapy according to the protocol?', actual_output='[{\\'nodes\\': [(\\'sample.pdf\\', {\\'type\\': \\'document\\'}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)\\'}), (\\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA SIOP-RTSG 2016\\'}), (\\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms tumours\\'}), (\\'non-Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'non-Wilms tumours\\'}), (\\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Website\\', \\'name\\': \\'www.siop-rtsg.eu\\'}), (\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology\\'}), (\\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Person\\', \\'name\\': \\'Marry M. van den Heuvel-Eibrink\\'}), (\\'childhood renal tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'childhood renal tumours\\'}), (\\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'clear cell sarcoma of the kidney\\'}), (\\'renal cell carcinoma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'renal cell carcinoma\\'}), (\\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'malignant rhabdoid tumour of the kidney\\'}), (\\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'Wilms tumours_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'Children\u2019s Oncology Group (COG)\\'}), (\\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'SIOP\u22122001 randomized trial\\'}), (\\'actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'UKW3 trial\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)\\'}), (\\'localized disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'localized disease\\'}), (\\'metastatic disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'metastatic disease\\'}), (\\'bilateral disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'bilateral disease\\'}), (\\'relapsed disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'relapsed disease\\'}), (\\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subtype\\', \\'name\\': \\'blastemal-type Wilms tumours\\'}), (\\'radiotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgery_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'chemotherapy\\'}), (\\'Wilms Tumour_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms Tumour\\'}), (\\'CCSK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CCSK\\'}), (\\'MRTK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'MRTK\\'}), (\\'CMN_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CMN\\'}), (\\'RCC_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'RCC\\'}), (\\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u22122001_Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Trial\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'vincristine_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'vincristine\\'}), (\\'actinomycin D_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'actinomycin D\\'}), (\\'doxorubicin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'doxorubicin\\'}), (\\'etoposide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'Stage I_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage I\\'}), (\\'Stage II_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage II\\'}), (\\'Stage III_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage III\\'}), (\\'Stage IV_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage IV\\'}), (\\'Stage V_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage V\\'}), (\\'AV_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AV\\'}), (\\'AVD_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AVD\\'}), (\\'HR-1_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'HR-1\\'}), (\\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP-RTSG 2016\\'}), (\\'Overall Survival (OS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'CT-only nodules_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'CT-only nodules\\'}), (\\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP\u2013RTSG analysis\\'}), (\\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials\\'}), (\\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D plus doxorubicin\\'}), (\\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D\\'}), (\\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study_protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'MRI_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'MRI\\'}), (\\'CT_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'CT\\'}), (\\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_detail\\', \\'name\\': \\'cumulative doxorubicin dose\\'}), (\\'COG AREN0533 trial_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG AREN0533 trial\\'}), (\\'etoposide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'high-risk characteristics\\'}), (\\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG board\\'}), (\\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin\\'}), (\\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'high-dose chemotherapy and autologous stem cell transplantation\\'}), (\\'SIOP database_database\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'database\\', \\'name\\': \\'SIOP database\\'}), (\\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'AVD_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AVD\\'}), (\\'AV-2_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AV-2\\'}), (\\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Statistical Test\\', \\'name\\': \\'Log\u2013Rank P\\'}), (\\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'Bilateral Disease (Stage V)\\'}), (\\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Synchronous bilateral Wilms tumor\\'}), (\\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'End-stage renal disease (ESRD)\\'}), (\\'Aronson et al._Research Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Research Group\\', \\'name\\': \\'Aronson et al.\\'}), (\\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'Bilateral nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Study\\', \\'name\\': \\'SIOP\u22122001 study\\'}), (\\'Vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Vincristine\\'}), (\\'Actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Actinomycin D\\'}), (\\'Etoposide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Etoposide\\'}), (\\'Carboplatin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Carboplatin\\'}), (\\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease State\\', \\'name\\': \\'Relapsed Wilms Tumor\\'}), (\\'Group AA_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group AA\\'}), (\\'Group BB_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group BB\\'}), (\\'Group CC_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group CC\\'}), (\\'Doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Doxorubicin\\'}), (\\'Cyclophosphamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Cyclophosphamide\\'}), (\\'Ifosfamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Ifosfamide\\'}), (\\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'High-dose melphalan\\'}), (\\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UKW\u2011R protocol\\'}), (\\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'NWTS\u20115 relapse protocol\\'}), (\\'ASCR_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'procedure\\', \\'name\\': \\'ASCR\\'}), (\\'ifosfamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'ifosfamide\\'}), (\\'nephrotoxicity_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'nephrotoxicity\\'}), (\\'relapsed group CC_patient_group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'patient_group\\', \\'name\\': \\'relapsed group CC\\'}), (\\'diffuse anaplasia_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'diffuse anaplasia\\'}), (\\'blastemal-type tumors_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'blastemal-type tumors\\'}), (\\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'camptothecins_medication_class\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication_class\\', \\'name\\': \\'camptothecins\\'}), (\\'irinotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'irinotecan\\'}), (\\'topotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'topotecan\\'}), (\\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Innovative Therapies for Children with Cancer consortium\\'}), (\\'radiotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgical excision_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgical excision\\'}), (\\'stage IV WT_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'stage IV WT\\'}), (\\'AVD150_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD150\\'}), (\\'AVD250_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD250\\'}), (\\'low-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'low-risk disease\\'}), (\\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'intermediate-risk disease\\'}), (\\'high-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'high-risk disease\\'}), (\\'CDCV_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'CDCV\\'}), (\\'actinomycin-D_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'actinomycin-D\\'}), (\\'vincristine_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'doxorubicin\\'}), (\\'VP16_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'VP16\\'}), (\\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'contact\\', \\'name\\': \\'arnauld.verschuur@ap-hm.fr\\'}), (\\'surgery_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'chemotherapy\\'}), (\\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2212RTSG panel\\'}), (\\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Infant Wilms Tumors\\'}), (\\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'nephrectomy\\'}), (\\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'malignant rhabdoid tumors\\'}), (\\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Adult Wilms Tumors\\'}), (\\'anaplasia_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'anaplasia\\'}), (\\'actinomycin D_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'carboplatin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'etoposide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'etoposide\\'}), (\\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'Nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'radical tumor nephrectomy\\'}), (\\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'lymph node sampling\\'}), (\\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'minimally invasive surgery\\'}), (\\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'laparoscopic surgery\\'}), (\\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'radiotherapy\\'}), (\\'Wilms tumours_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'Davila Fajardo et al._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Davila Fajardo et al.\\'}), (\\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'COG\u2013NWTS trials\\'}), (\\'whole-lung irradiation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'whole-lung irradiation\\'}), (\\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'pulmonary radiotherapy\\'}), (\\'proton therapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'proton therapy\\'}), (\\'dosimetric study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'dosimetric study\\'}), (\\'locoregional disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'locoregional disease\\'}), (\\'metastatic disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'metastatic disease\\'}), (\\'low-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'low-risk\\'}), (\\'intermediate-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'intermediate-risk\\'}), (\\'high-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'high-risk\\'}), (\\'stage I_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage I\\'}), (\\'stage II_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage II\\'}), (\\'stage III_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage III\\'}), (\\'major rupture_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'major rupture\\'}), (\\'Austria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Austria\\'}), (\\'Italy_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Italy\\'}), (\\'San Marino_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'San Marino\\'}), (\\'Iceland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Iceland\\'}), (\\'Germany_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Germany\\'}), (\\'Bulgaria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bulgaria\\'}), (\\'Turkey_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Turkey\\'}), (\\'Denmark_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Denmark\\'}), (\\'Poland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Poland\\'}), (\\'Greece_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Greece\\'}), (\\'Andorra_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Andorra\\'}), (\\'Belgium_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belgium\\'}), (\\'Serbia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Serbia\\'}), (\\'Albania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Albania\\'}), (\\'Moldova_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Moldova\\'}), (\\'Lithuania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Lithuania\\'}), (\\'Latvia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Latvia\\'}), (\\'Estonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Estonia\\'}), (\\'Luxembourg_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Luxembourg\\'}), (\\'Montenegro_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Montenegro\\'}), (\\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bosnia and Herzegovina\\'}), (\\'Croatia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Croatia\\'}), (\\'Slovenia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovenia\\'}), (\\'Macedonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Macedonia\\'}), (\\'United Kingdom_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'United Kingdom\\'}), (\\'Ireland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ireland\\'}), (\\'Spain_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Spain\\'}), (\\'Algeria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Algeria\\'}), (\\'Tunisia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Tunisia\\'}), (\\'Malta_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Malta\\'}), (\\'Morocco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Morocco\\'}), (\\'Portugal_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Portugal\\'}), (\\'France_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'France\\'}), (\\'Monaco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Monaco\\'}), (\\'Russia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Russia\\'}), (\\'Finland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Finland\\'}), (\\'Sweden_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Sweden\\'}), (\\'Norway_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Norway\\'}), (\\'Belarus_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belarus\\'}), (\\'Romania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Romania\\'}), (\\'Ukraine_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ukraine\\'}), (\\'Hungary_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Hungary\\'}), (\\'Czech Republic_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Czech Republic\\'}), (\\'Slovakia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovakia\\'}), (\\'Switzerland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Switzerland\\'}), (\\'Liechtenstein_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Liechtenstein\\'}), (\\'Netherlands_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Netherlands\\'}), (\\'University Hospital of Munich_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Munich\\'}), (\\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Tuebingen\\'}), (\\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Azienda Ospedaliera\\'}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Ospedale Pediatrico Bambino Ges\u00f9\\'}), (\\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Fondazione IRCCS Istituto Nazionale dei Tumori\\'}), (\\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Prinses Maxima Centrum\\'}), (\\'Marciniak Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Marciniak Hospital\\'}), (\\'Faculty of Medicine_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Faculty of Medicine\\'}), (\\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'St. Anna Kinderspital/CCRI\\'}), (\\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Armand Trousseau Hospital\\'}), (\\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Universitario Virgin del Rocio\\'}), (\\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Vall d\u2019Hebron\\'}), (\\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Great Ormond Street Hospital\\'}), (\\'University Hospital Homburg_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital Homburg\\'}), (\\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon\\'}), (\\'UMBRELLA protocol_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'ExPO\u2011r\u2011Net\\'}), (\\'Weirich, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Weirich, A.\\'}), (\\'Pritchard-Jones, K._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Pritchard-Jones, K.\\'}), (\\'de Kraker, J._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'de Kraker, J.\\'}), (\\'Graf, N._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Graf, N.\\'}), (\\'Green, D. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Green, D. M.\\'}), (\\'Spreafico, F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Spreafico, F.\\'}), (\\'Bellani, F. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Bellani, F. F.\\'}), (\\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'van den Heuvel-Eibrink, M. M.\\'}), (\"D\\'Angio, G. J._author\", {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \"D\\'Angio, G. J.\"}), (\\'Tournade, M. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Tournade, M. F.\\'}), (\\'Breslow, N. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Breslow, N. E.\\'}), (\\'Mitchell, C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Mitchell, C.\\'}), (\\'Verschuur, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Verschuur, A.\\'}), (\\'Grundy, P. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Grundy, P. E.\\'}), (\\'Warmann, S. W._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Warmann, S. W.\\'}), (\\'Smets, A. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Smets, A. M.\\'}), (\\'Dome, J. S._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dome, J. S.\\'}), (\\'Dix, D. B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dix, D. B.\\'}), (\\'Daw, N. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Daw, N. C.\\'}), (\\'Ha, T. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Ha, T. C.\\'}), (\\'Kremens, B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Kremens, B.\\'}), (\\'Furtwangler, R._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Furtwangler, R.\\'}), (\\'SIOP-9/GPOH_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP-9/GPOH\\'}), (\\'UKW3_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'UKW3\\'}), (\\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'SIOP 93\u201301 trial\\'}), (\\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP trial and study 93\u201301\\'}), (\\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'National Wilms Tumor Study Group\\'}), (\\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP WT 2001 protocol\\'}), (\\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Third National Wilms\u2019 Tumor Study\\'}), (\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'National Wilms Tumor Studies\\'}), (\\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Second National Wilms\u2019 Tumor Study\\'}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'UK Children\u2019s Cancer Study Group\\'}), (\\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Children\u2019s Oncology Group\\'})], \\'edges\\': [(\\'sample.pdf\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'non-Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'childhood renal tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'renal cell carcinoma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'localized disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'metastatic disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'bilateral disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'relapsed disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'radiotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'surgery_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'chemotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'Wilms Tumour_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CCSK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'MRTK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CMN_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'RCC_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP\u22122001_Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'vincristine_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'actinomycin D_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'doxorubicin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'etoposide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'carboplatin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'cyclophosphamide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage I_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage II_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage III_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage IV_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage V_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AV_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AVD_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'HR-1_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Overall Survival (OS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT-only nodules_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'MRI_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG AREN0533 trial_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'etoposide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'carboplatin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'cyclophosphamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP database_database\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AVD_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AV-2_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Aronson et al._Research Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Etoposide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Carboplatin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group AA_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group BB_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group CC_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Cyclophosphamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Ifosfamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'ASCR_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'ifosfamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'nephrotoxicity_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'relapsed group CC_patient_group\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'diffuse anaplasia_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'blastemal-type tumors_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'camptothecins_medication_class\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'irinotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'topotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'radiotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'surgical excision_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'stage IV WT_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD150_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD250_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'low-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'CDCV_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'actinomycin-D_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'vincristine_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'doxorubicin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'VP16_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'surgery_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'chemotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'anaplasia_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'actinomycin D_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'vincristine_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'doxorubicin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'carboplatin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'cyclophosphamide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'etoposide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'SIOP\u22122001_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Wilms tumours_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Davila Fajardo et al._author\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'whole-lung irradiation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'proton therapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'dosimetric study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'locoregional disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'metastatic disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'low-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'intermediate-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'high-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage I_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage II_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage III_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'major rupture_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Austria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Italy_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'San Marino_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Iceland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Germany_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bulgaria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Turkey_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Denmark_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Poland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Greece_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Andorra_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belgium_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Serbia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Albania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Moldova_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Lithuania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Latvia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Estonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Luxembourg_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Montenegro_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Croatia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovenia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Macedonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'United Kingdom_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ireland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Spain_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Algeria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Tunisia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Malta_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Morocco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Portugal_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'France_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Monaco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Russia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Finland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Sweden_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Norway_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belarus_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Romania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ukraine_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hungary_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Czech Republic_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovakia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Switzerland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Liechtenstein_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Netherlands_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Munich_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Marciniak Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Faculty of Medicine_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital Homburg_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Weirich, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Pritchard-Jones, K._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'de Kraker, J._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Graf, N._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Green, D. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Spreafico, F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Bellani, F. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \"D\\'Angio, G. J._author\", {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Tournade, M. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Breslow, N. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Mitchell, C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Verschuur, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Grundy, P. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Warmann, S. W._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Smets, A. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dome, J. S._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dix, D. B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Daw, N. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ha, T. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Kremens, B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Furtwangler, R._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP-9/GPOH_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UKW3_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10})]}, {\\'nodes\\': [(\\'vincristine_entity\\', {}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {}), (\\'www.siop-rtsg.eu_entity\\', {}), (\\'stage II_entity\\', {}), (\\'Wilms tumours_entity\\', {}), (\\'Relapsed Wilms Tumor_entity\\', {}), (\\'Davila Fajardo et al._entity\\', {}), (\\'vincristine, actinomycin D, and doxorubicin_entity\\', {}), (\\'SIOP\u22122001 randomized trial_entity\\', {}), (\\'surgery_entity\\', {}), (\\'non-Wilms tumours_entity\\', {}), (\\'actinomycin D_entity\\', {}), (\\'diffuse anaplasia_entity\\', {}), (\\'Synchronous bilateral Wilms tumor_entity\\', {}), (\\'CT-only nodules_entity\\', {}), (\\'relapsed group CC_entity\\', {}), (\\'increased relapse risk_entity\\', {}), (\\'reduced survival_entity\\', {}), (\\'UKW3 trial_entity\\', {}), (\\'chemotherapy_entity\\', {}), (\\'Bilateral Disease (Stage V)_entity\\', {}), (\\'blastemal-type tumors_entity\\', {}), (\\'UMBRELLA protocol_entity\\', {}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', {}), (\\'minimally invasive surgery_entity\\', {}), (\\'VP16_entity\\', {}), (\\'Wilms tumor_entity\\', {}), (\\'anaplasia_entity\\', {}), (\\'radical tumor nephrectomy_entity\\', {}), (\\'Innovative Therapies for Children with Cancer consortium_entity\\', {}), (\\'cumulative doxorubicin dose_entity\\', {}), (\\'etoposide_entity\\', {}), (\\'large-volume tumours_entity\\', {}), (\\'Stage IV_entity\\', {}), (\\'CDCV_entity\\', {}), (\\'SIOP\u2013RTSG_entity\\', {}), (\\'AVD150_entity\\', {}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', {}), (\\'laparoscopic surgery_entity\\', {}), (\\'SIOP\u2212RTSG panel_entity\\', {}), (\\'actinomycin-D_entity\\', {}), (\\'COG AREN0533 trial_entity\\', {}), (\\'cyclophosphamide_entity\\', {}), (\\'carboplatin_entity\\', {}), (\\'UKW\u2011R protocol_entity\\', {}), (\\'Nephron-sparing surgery (NSS)_entity\\', {}), (\\'Adult Wilms Tumors_entity\\', {}), (\\'doxorubicin_entity\\', {}), (\\'NWTS\u20115 relapse protocol_entity\\', {}), (\\'End-stage renal disease (ESRD)_entity\\', {}), (\\'AVD250_entity\\', {}), (\\'Children\u2019s Oncology Group (COG)_entity\\', {}), (\\'blastemal-type Wilms tumour_entity\\', {}), (\\'SIOP\u22122001_entity\\', {}), (\\'radiotherapy_entity\\', {}), (\\'childhood renal tumours_entity\\', {})], \\'edges\\': [(\\'vincristine_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'stage II_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'indicated_for_in_adults\\'}), (\\'Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'Wilms tumours_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated under\\'}), (\\'Relapsed Wilms Tumor_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guided_by\\'}), (\\'Davila Fajardo et al._entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed\\'}), (\\'SIOP\u22122001 randomized trial_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated use in\\'}), (\\'surgery_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'non-Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'actinomycin D_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Synchronous bilateral Wilms tumor_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'instance_of\\'}), (\\'CT-only nodules_entity\\', \\'increased relapse risk_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'reduced survival_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included_in\\'}), (\\'relapsed group CC_entity\\', \\'diffuse anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'blastemal-type tumors_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UKW3 trial_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'UKW3 trial_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'chemotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UMBRELLA protocol_entity\\', \\'COG AREN0533 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses_data_from\\'}), (\\'UMBRELLA protocol_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'advises_treatment_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'Innovative Therapies for Children with Cancer consortium_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborates_with\\'}), (\\'UMBRELLA protocol_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'surgery_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is the standard of\\'}), (\\'UMBRELLA protocol_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guides treatment in\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', \\'UKW3 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\\'minimally invasive surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'anaplasia_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'radical tumor nephrectomy_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'standard_of_care_for\\'}), (\\'Stage IV_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'presents in\\'}), (\\'CDCV_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'VP16_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'aims to improve survival rates of\\'}), (\\'AVD150_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed_by\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'succeeds\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'www.siop-rtsg.eu_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'available_on\\'}), (\\'laparoscopic surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'COG AREN0533 trial_entity\\', \\'cumulative doxorubicin dose_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'evaluates\\'}), (\\'UKW\u2011R protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'Nephron-sparing surgery (NSS)_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'classification_developed_by\\'}), (\\'Adult Wilms Tumors_entity\\', \\'anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'Adult Wilms Tumors_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'doxorubicin_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'doxorubicin_entity\\', \\'large-volume tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'recommended for\\'}), (\\'NWTS\u20115 relapse protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'End-stage renal disease (ESRD)_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'AVD250_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'Children\u2019s Oncology Group (COG)_entity\\', \\'SIOP\u22122001 randomized trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborated with\\'}), (\\'blastemal-type Wilms tumour_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment intensified according to\\'}), (\\'SIOP\u22122001_entity\\', \\'vincristine, actinomycin D, and doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses\\'}), (\\'SIOP\u22122001_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provided_guidelines_for\\'}), (\\'radiotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'radiotherapy_entity\\', \\'SIOP\u2212RTSG panel_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'contact_for_guidance\\'})]}, {\\'nodes\\': [(\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {}), (\\'Marry M. van den Heuvel-Eibrink_entity\\', {})], \\'edges\\': [(\\'Marry M. van den Heuvel-Eibrink_entity\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'affiliated_with\\'})]}, {\\'nodes\\': [(\\'Stage II_entity\\', {}), (\\'AV_entity\\', {}), (\\'Stage III_entity\\', {}), (\\'vincestine and actinomycin D_entity\\', {}), (\\'AVD_entity\\', {})], \\'edges\\': [(\\'Stage II_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AV_entity\\', \\'Stage II_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Stage III_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AVD_entity\\', \\'Stage III_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'SIOP-RTSG 2016_entity\\', {}), (\\'RCC_entity\\', {}), (\\'CMN_entity\\', {})], \\'edges\\': [(\\'RCC_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'}), (\\'CMN_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'})]}, {\\'nodes\\': [(\\'HR-1_entity\\', {}), (\\'High-risk blastemal type Wilms tumour_entity\\', {})], \\'edges\\': [(\\'HR-1_entity\\', \\'High-risk blastemal type Wilms tumour_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'unfavorable prognosis_entity\\', {}), (\\'high-risk characteristics_entity\\', {})], \\'edges\\': [(\\'high-risk characteristics_entity\\', \\'unfavorable prognosis_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'leads_to\\'})]}, {\\'nodes\\': [(\\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {}), (\\'SIOP\u2013RTSG board_entity\\', {})], \\'edges\\': [(\\'SIOP\u2013RTSG board_entity\\', \\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggests\\'})]}, {\\'nodes\\': [(\\'regimen and outcomes_entity\\', {}), (\\'SIOP database_entity\\', {})], \\'edges\\': [(\\'SIOP database_entity\\', \\'regimen and outcomes_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'captures_data_on\\'})]}, {\\'nodes\\': [(\\'Bilateral nephron-sparing surgery (NSS)_entity\\', {}), (\\'Aronson et al._entity\\', {})], \\'edges\\': [(\\'Aronson et al._entity\\', \\'Bilateral nephron-sparing surgery (NSS)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'observed_effectiveness_of\\'})]}, {\\'nodes\\': [(\\'SIOP\u22122001 study_entity\\', {}), (\\'Actinomycin D_entity\\', {}), (\\'Vincristine_entity\\', {})], \\'edges\\': [(\\'SIOP\u22122001 study_entity\\', \\'Vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'}), (\\'SIOP\u22122001 study_entity\\', \\'Actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'})]}, {\\'nodes\\': [(\\'High-dose melphalan_entity\\', {}), (\\'Group AA_entity\\', {}), (\\'Carboplatin_entity\\', {}), (\\'Doxorubicin_entity\\', {}), (\\'Etoposide_entity\\', {}), (\\'Group BB_entity\\', {}), (\\'Cyclophosphamide_entity\\', {}), (\\'Ifosfamide_entity\\', {})], \\'edges\\': [(\\'Group AA_entity\\', \\'Doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Ifosfamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'High-dose melphalan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'})]}, {\\'nodes\\': [(\\'nephrotoxicity_entity\\', {}), (\\'ifosfamide_entity\\', {})], \\'edges\\': [(\\'ifosfamide_entity\\', \\'nephrotoxicity_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'related_to\\'})]}, {\\'nodes\\': [(\\'camptothecins_entity\\', {}), (\\'irinotecan_entity\\', {}), (\\'topotecan_entity\\', {})], \\'edges\\': [(\\'camptothecins_entity\\', \\'irinotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'camptothecins_entity\\', \\'topotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'})]}, {\\'nodes\\': [(\\'Infant Wilms Tumors_entity\\', {}), (\\'nephrectomy_entity\\', {})], \\'edges\\': [(\\'Infant Wilms Tumors_entity\\', \\'nephrectomy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_option\\'})]}, {\\'nodes\\': [(\\'congenital mesoblastic nephroma_entity\\', {}), (\\'surgery alone_entity\\', {})], \\'edges\\': [(\\'congenital mesoblastic nephroma_entity\\', \\'surgery alone_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'alternative chemotherapy_entity\\', {}), (\\'malignant rhabdoid tumors_entity\\', {})], \\'edges\\': [(\\'malignant rhabdoid tumors_entity\\', \\'alternative chemotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'lymph node sampling_entity\\', {}), (\\'accurate staging_entity\\', {})], \\'edges\\': [(\\'lymph node sampling_entity\\', \\'accurate staging_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'purpose_of\\'})]}, {\\'nodes\\': [(\\'COG\u2013NWTS trials_entity\\', {}), (\\'whole-lung irradiation_entity\\', {})], \\'edges\\': [(\\'COG\u2013NWTS trials_entity\\', \\'whole-lung irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'informed_dosage_for\\'})]}, {\\'nodes\\': [(\\'lung metastases_entity\\', {}), (\\'pulmonary radiotherapy_entity\\', {})], \\'edges\\': [(\\'pulmonary radiotherapy_entity\\', \\'lung metastases_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'administered_for\\'})]}, {\\'nodes\\': [(\\'dosimetric study_entity\\', {}), (\\'proton therapy_entity\\', {}), (\\'flank irradiation_entity\\', {})], \\'edges\\': [(\\'dosimetric study_entity\\', \\'proton therapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated\\'}), (\\'proton therapy_entity\\', \\'flank irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggested_for\\'})]}, {\\'nodes\\': [(\\'metastatic disease_entity\\', {}), (\\'radiotherapy guidelines_entity\\', {}), (\\'locoregional disease_entity\\', {})], \\'edges\\': [(\\'radiotherapy guidelines_entity\\', \\'locoregional disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'}), (\\'radiotherapy guidelines_entity\\', \\'metastatic disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'})]}, {\\'nodes\\': [(\\'major rupture_entity\\', {}), (\\'stage III_entity\\', {})], \\'edges\\': [(\\'stage III_entity\\', \\'major rupture_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes_condition\\'})]}, {\\'nodes\\': [(\\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {}), (\\'ExPO\u2011r\u2011Net_entity\\', {})], \\'edges\\': [(\\'ExPO\u2011r\u2011Net_entity\\', \\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is part of\\'})]}, {\\'nodes\\': [(\\'University Hospital of Munich_entity\\', {}), (\\'Germany_entity\\', {}), (\\'University Hospital of Tuebingen_entity\\', {})], \\'edges\\': [(\\'Germany_entity\\', \\'University Hospital of Munich_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Germany_entity\\', \\'University Hospital of Tuebingen_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {}), (\\'Italy_entity\\', {}), (\\'Azienda Ospedaliera_entity\\', {}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {})], \\'edges\\': [(\\'Italy_entity\\', \\'Azienda Ospedaliera_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Netherlands_entity\\', {}), (\\'Prinses Maxima Centrum_entity\\', {})], \\'edges\\': [(\\'Netherlands_entity\\', \\'Prinses Maxima Centrum_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Marciniak Hospital_entity\\', {}), (\\'Poland_entity\\', {}), (\\'Faculty of Medicine_entity\\', {})], \\'edges\\': [(\\'Poland_entity\\', \\'Marciniak Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Poland_entity\\', \\'Faculty of Medicine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'St. Anna Kinderspital/CCRI_entity\\', {}), (\\'Austria_entity\\', {})], \\'edges\\': [(\\'Austria_entity\\', \\'St. Anna Kinderspital/CCRI_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'France_entity\\', {}), (\\'Armand Trousseau Hospital_entity\\', {})], \\'edges\\': [(\\'France_entity\\', \\'Armand Trousseau Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Spain_entity\\', {}), (\\'Hospital Vall d\u2019Hebron_entity\\', {}), (\\'Hospital Universitario Virgin del Rocio_entity\\', {})], \\'edges\\': [(\\'Spain_entity\\', \\'Hospital Universitario Virgin del Rocio_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Spain_entity\\', \\'Hospital Vall d\u2019Hebron_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'United Kingdom_entity\\', {}), (\\'Great Ormond Street Hospital_entity\\', {})], \\'edges\\': [(\\'United Kingdom_entity\\', \\'Great Ormond Street Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Weirich, A._entity\\', {}), (\\'SIOP-9/GPOH_entity\\', {})], \\'edges\\': [(\\'Weirich, A._entity\\', \\'SIOP-9/GPOH_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Pritchard-Jones, K._entity\\', {}), (\\'UKW3_entity\\', {})], \\'edges\\': [(\\'Pritchard-Jones, K._entity\\', \\'UKW3_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed in\\'})]}, {\\'nodes\\': [(\\'SIOP 93\u201301 trial_entity\\', {}), (\\'de Kraker, J._entity\\', {})], \\'edges\\': [(\\'de Kraker, J._entity\\', \\'SIOP 93\u201301 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'SIOP trial and study 93\u201301_entity\\', {}), (\\'Graf, N._entity\\', {})], \\'edges\\': [(\\'Graf, N._entity\\', \\'SIOP trial and study 93\u201301_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Green, D. M._entity\\', {}), (\\'National Wilms Tumor Study Group_entity\\', {})], \\'edges\\': [(\\'Green, D. M._entity\\', \\'National Wilms Tumor Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}, {\\'nodes\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', {}), (\\'SIOP WT 2001 protocol_entity\\', {})], \\'edges\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', \\'SIOP WT 2001 protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Third National Wilms\u2019 Tumor Study_entity\\', {}), (\"D\\'Angio, G. J._entity\", {}), (\\'Second National Wilms\u2019 Tumor Study_entity\\', {})], \\'edges\\': [(\"D\\'Angio, G. J._entity\", \\'Third National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\"D\\'Angio, G. J._entity\", \\'Second National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {}), (\\'Tournade, M. F._entity\\', {}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {})], \\'edges\\': [(\\'Tournade, M. F._entity\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'}), (\\'Tournade, M. F._entity\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Breslow, N. E._entity\\', {}), (\\'National Wilms Tumor Studies_entity\\', {})], \\'edges\\': [(\\'Breslow, N. E._entity\\', \\'National Wilms Tumor Studies_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Mitchell, C._entity\\', {}), (\\'UK Children\u2019s Cancer Study Group_entity\\', {})], \\'edges\\': [(\\'Mitchell, C._entity\\', \\'UK Children\u2019s Cancer Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'under\\'})]}, {\\'nodes\\': [(\\'Daw, N. C._entity\\', {}), (\\'Dix, D. B._entity\\', {}), (\\'Children\u2019s Oncology Group_entity\\', {}), (\\'Grundy, P. E._entity\\', {})], \\'edges\\': [(\\'Daw, N. C._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted under\\'}), (\\'Dix, D. B._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'}), (\\'Grundy, P. E._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}]', expected_output='Radiotherapy is used to treat metastatic sites and in cases where a complete surgical resection is not feasible.', context=None, retrieval_context=['[{\\'nodes\\': [(\\'sample.pdf\\', {\\'type\\': \\'document\\'}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)\\'}), (\\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA SIOP-RTSG 2016\\'}), (\\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms tumours\\'}), (\\'non-Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'non-Wilms tumours\\'}), (\\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Website\\', \\'name\\': \\'www.siop-rtsg.eu\\'}), (\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology\\'}), (\\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Person\\', \\'name\\': \\'Marry M. van den Heuvel-Eibrink\\'}), (\\'childhood renal tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'childhood renal tumours\\'}), (\\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'clear cell sarcoma of the kidney\\'}), (\\'renal cell carcinoma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'renal cell carcinoma\\'}), (\\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'malignant rhabdoid tumour of the kidney\\'}), (\\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'Wilms tumours_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'Children\u2019s Oncology Group (COG)\\'}), (\\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'SIOP\u22122001 randomized trial\\'}), (\\'actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'UKW3 trial\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)\\'}), (\\'localized disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'localized disease\\'}), (\\'metastatic disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'metastatic disease\\'}), (\\'bilateral disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'bilateral disease\\'}), (\\'relapsed disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'relapsed disease\\'}), (\\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subtype\\', \\'name\\': \\'blastemal-type Wilms tumours\\'}), (\\'radiotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgery_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'chemotherapy\\'}), (\\'Wilms Tumour_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms Tumour\\'}), (\\'CCSK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CCSK\\'}), (\\'MRTK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'MRTK\\'}), (\\'CMN_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CMN\\'}), (\\'RCC_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'RCC\\'}), (\\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u22122001_Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Trial\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'vincristine_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'vincristine\\'}), (\\'actinomycin D_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'actinomycin D\\'}), (\\'doxorubicin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'doxorubicin\\'}), (\\'etoposide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'Stage I_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage I\\'}), (\\'Stage II_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage II\\'}), (\\'Stage III_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage III\\'}), (\\'Stage IV_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage IV\\'}), (\\'Stage V_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage V\\'}), (\\'AV_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AV\\'}), (\\'AVD_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AVD\\'}), (\\'HR-1_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'HR-1\\'}), (\\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP-RTSG 2016\\'}), (\\'Overall Survival (OS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'CT-only nodules_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'CT-only nodules\\'}), (\\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP\u2013RTSG analysis\\'}), (\\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials\\'}), (\\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D plus doxorubicin\\'}), (\\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D\\'}), (\\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study_protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'MRI_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'MRI\\'}), (\\'CT_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'CT\\'}), (\\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_detail\\', \\'name\\': \\'cumulative doxorubicin dose\\'}), (\\'COG AREN0533 trial_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG AREN0533 trial\\'}), (\\'etoposide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'high-risk characteristics\\'}), (\\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG board\\'}), (\\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin\\'}), (\\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'high-dose chemotherapy and autologous stem cell transplantation\\'}), (\\'SIOP database_database\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'database\\', \\'name\\': \\'SIOP database\\'}), (\\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'AVD_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AVD\\'}), (\\'AV-2_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AV-2\\'}), (\\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Statistical Test\\', \\'name\\': \\'Log\u2013Rank P\\'}), (\\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'Bilateral Disease (Stage V)\\'}), (\\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Synchronous bilateral Wilms tumor\\'}), (\\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'End-stage renal disease (ESRD)\\'}), (\\'Aronson et al._Research Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Research Group\\', \\'name\\': \\'Aronson et al.\\'}), (\\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'Bilateral nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Study\\', \\'name\\': \\'SIOP\u22122001 study\\'}), (\\'Vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Vincristine\\'}), (\\'Actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Actinomycin D\\'}), (\\'Etoposide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Etoposide\\'}), (\\'Carboplatin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Carboplatin\\'}), (\\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease State\\', \\'name\\': \\'Relapsed Wilms Tumor\\'}), (\\'Group AA_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group AA\\'}), (\\'Group BB_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group BB\\'}), (\\'Group CC_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group CC\\'}), (\\'Doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Doxorubicin\\'}), (\\'Cyclophosphamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Cyclophosphamide\\'}), (\\'Ifosfamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Ifosfamide\\'}), (\\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'High-dose melphalan\\'}), (\\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UKW\u2011R protocol\\'}), (\\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'NWTS\u20115 relapse protocol\\'}), (\\'ASCR_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'procedure\\', \\'name\\': \\'ASCR\\'}), (\\'ifosfamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'ifosfamide\\'}), (\\'nephrotoxicity_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'nephrotoxicity\\'}), (\\'relapsed group CC_patient_group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'patient_group\\', \\'name\\': \\'relapsed group CC\\'}), (\\'diffuse anaplasia_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'diffuse anaplasia\\'}), (\\'blastemal-type tumors_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'blastemal-type tumors\\'}), (\\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'camptothecins_medication_class\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication_class\\', \\'name\\': \\'camptothecins\\'}), (\\'irinotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'irinotecan\\'}), (\\'topotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'topotecan\\'}), (\\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Innovative Therapies for Children with Cancer consortium\\'}), (\\'radiotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgical excision_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgical excision\\'}), (\\'stage IV WT_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'stage IV WT\\'}), (\\'AVD150_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD150\\'}), (\\'AVD250_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD250\\'}), (\\'low-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'low-risk disease\\'}), (\\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'intermediate-risk disease\\'}), (\\'high-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'high-risk disease\\'}), (\\'CDCV_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'CDCV\\'}), (\\'actinomycin-D_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'actinomycin-D\\'}), (\\'vincristine_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'doxorubicin\\'}), (\\'VP16_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'VP16\\'}), (\\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'contact\\', \\'name\\': \\'arnauld.verschuur@ap-hm.fr\\'}), (\\'surgery_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'chemotherapy\\'}), (\\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2212RTSG panel\\'}), (\\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Infant Wilms Tumors\\'}), (\\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'nephrectomy\\'}), (\\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'malignant rhabdoid tumors\\'}), (\\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Adult Wilms Tumors\\'}), (\\'anaplasia_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'anaplasia\\'}), (\\'actinomycin D_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'carboplatin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'etoposide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'etoposide\\'}), (\\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'Nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'radical tumor nephrectomy\\'}), (\\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'lymph node sampling\\'}), (\\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'minimally invasive surgery\\'}), (\\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'laparoscopic surgery\\'}), (\\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'radiotherapy\\'}), (\\'Wilms tumours_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'Davila Fajardo et al._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Davila Fajardo et al.\\'}), (\\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'COG\u2013NWTS trials\\'}), (\\'whole-lung irradiation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'whole-lung irradiation\\'}), (\\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'pulmonary radiotherapy\\'}), (\\'proton therapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'proton therapy\\'}), (\\'dosimetric study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'dosimetric study\\'}), (\\'locoregional disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'locoregional disease\\'}), (\\'metastatic disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'metastatic disease\\'}), (\\'low-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'low-risk\\'}), (\\'intermediate-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'intermediate-risk\\'}), (\\'high-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'high-risk\\'}), (\\'stage I_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage I\\'}), (\\'stage II_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage II\\'}), (\\'stage III_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage III\\'}), (\\'major rupture_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'major rupture\\'}), (\\'Austria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Austria\\'}), (\\'Italy_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Italy\\'}), (\\'San Marino_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'San Marino\\'}), (\\'Iceland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Iceland\\'}), (\\'Germany_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Germany\\'}), (\\'Bulgaria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bulgaria\\'}), (\\'Turkey_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Turkey\\'}), (\\'Denmark_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Denmark\\'}), (\\'Poland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Poland\\'}), (\\'Greece_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Greece\\'}), (\\'Andorra_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Andorra\\'}), (\\'Belgium_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belgium\\'}), (\\'Serbia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Serbia\\'}), (\\'Albania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Albania\\'}), (\\'Moldova_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Moldova\\'}), (\\'Lithuania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Lithuania\\'}), (\\'Latvia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Latvia\\'}), (\\'Estonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Estonia\\'}), (\\'Luxembourg_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Luxembourg\\'}), (\\'Montenegro_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Montenegro\\'}), (\\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bosnia and Herzegovina\\'}), (\\'Croatia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Croatia\\'}), (\\'Slovenia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovenia\\'}), (\\'Macedonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Macedonia\\'}), (\\'United Kingdom_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'United Kingdom\\'}), (\\'Ireland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ireland\\'}), (\\'Spain_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Spain\\'}), (\\'Algeria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Algeria\\'}), (\\'Tunisia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Tunisia\\'}), (\\'Malta_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Malta\\'}), (\\'Morocco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Morocco\\'}), (\\'Portugal_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Portugal\\'}), (\\'France_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'France\\'}), (\\'Monaco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Monaco\\'}), (\\'Russia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Russia\\'}), (\\'Finland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Finland\\'}), (\\'Sweden_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Sweden\\'}), (\\'Norway_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Norway\\'}), (\\'Belarus_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belarus\\'}), (\\'Romania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Romania\\'}), (\\'Ukraine_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ukraine\\'}), (\\'Hungary_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Hungary\\'}), (\\'Czech Republic_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Czech Republic\\'}), (\\'Slovakia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovakia\\'}), (\\'Switzerland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Switzerland\\'}), (\\'Liechtenstein_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Liechtenstein\\'}), (\\'Netherlands_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Netherlands\\'}), (\\'University Hospital of Munich_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Munich\\'}), (\\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Tuebingen\\'}), (\\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Azienda Ospedaliera\\'}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Ospedale Pediatrico Bambino Ges\u00f9\\'}), (\\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Fondazione IRCCS Istituto Nazionale dei Tumori\\'}), (\\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Prinses Maxima Centrum\\'}), (\\'Marciniak Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Marciniak Hospital\\'}), (\\'Faculty of Medicine_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Faculty of Medicine\\'}), (\\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'St. Anna Kinderspital/CCRI\\'}), (\\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Armand Trousseau Hospital\\'}), (\\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Universitario Virgin del Rocio\\'}), (\\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Vall d\u2019Hebron\\'}), (\\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Great Ormond Street Hospital\\'}), (\\'University Hospital Homburg_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital Homburg\\'}), (\\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon\\'}), (\\'UMBRELLA protocol_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'ExPO\u2011r\u2011Net\\'}), (\\'Weirich, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Weirich, A.\\'}), (\\'Pritchard-Jones, K._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Pritchard-Jones, K.\\'}), (\\'de Kraker, J._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'de Kraker, J.\\'}), (\\'Graf, N._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Graf, N.\\'}), (\\'Green, D. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Green, D. M.\\'}), (\\'Spreafico, F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Spreafico, F.\\'}), (\\'Bellani, F. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Bellani, F. F.\\'}), (\\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'van den Heuvel-Eibrink, M. M.\\'}), (\"D\\'Angio, G. J._author\", {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \"D\\'Angio, G. J.\"}), (\\'Tournade, M. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Tournade, M. F.\\'}), (\\'Breslow, N. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Breslow, N. E.\\'}), (\\'Mitchell, C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Mitchell, C.\\'}), (\\'Verschuur, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Verschuur, A.\\'}), (\\'Grundy, P. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Grundy, P. E.\\'}), (\\'Warmann, S. W._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Warmann, S. W.\\'}), (\\'Smets, A. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Smets, A. M.\\'}), (\\'Dome, J. S._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dome, J. S.\\'}), (\\'Dix, D. B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dix, D. B.\\'}), (\\'Daw, N. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Daw, N. C.\\'}), (\\'Ha, T. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Ha, T. C.\\'}), (\\'Kremens, B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Kremens, B.\\'}), (\\'Furtwangler, R._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Furtwangler, R.\\'}), (\\'SIOP-9/GPOH_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP-9/GPOH\\'}), (\\'UKW3_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'UKW3\\'}), (\\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'SIOP 93\u201301 trial\\'}), (\\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP trial and study 93\u201301\\'}), (\\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'National Wilms Tumor Study Group\\'}), (\\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP WT 2001 protocol\\'}), (\\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Third National Wilms\u2019 Tumor Study\\'}), (\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'National Wilms Tumor Studies\\'}), (\\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Second National Wilms\u2019 Tumor Study\\'}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'UK Children\u2019s Cancer Study Group\\'}), (\\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Children\u2019s Oncology Group\\'})], \\'edges\\': [(\\'sample.pdf\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'non-Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'childhood renal tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'renal cell carcinoma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'localized disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'metastatic disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'bilateral disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'relapsed disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'radiotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'surgery_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'chemotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'Wilms Tumour_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CCSK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'MRTK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CMN_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'RCC_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP\u22122001_Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'vincristine_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'actinomycin D_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'doxorubicin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'etoposide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'carboplatin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'cyclophosphamide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage I_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage II_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage III_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage IV_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage V_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AV_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AVD_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'HR-1_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Overall Survival (OS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT-only nodules_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'MRI_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG AREN0533 trial_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'etoposide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'carboplatin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'cyclophosphamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP database_database\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AVD_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AV-2_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Aronson et al._Research Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Etoposide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Carboplatin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group AA_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group BB_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group CC_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Cyclophosphamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Ifosfamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'ASCR_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'ifosfamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'nephrotoxicity_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'relapsed group CC_patient_group\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'diffuse anaplasia_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'blastemal-type tumors_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'camptothecins_medication_class\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'irinotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'topotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'radiotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'surgical excision_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'stage IV WT_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD150_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD250_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'low-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'CDCV_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'actinomycin-D_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'vincristine_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'doxorubicin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'VP16_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'surgery_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'chemotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'anaplasia_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'actinomycin D_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'vincristine_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'doxorubicin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'carboplatin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'cyclophosphamide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'etoposide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'SIOP\u22122001_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Wilms tumours_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Davila Fajardo et al._author\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'whole-lung irradiation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'proton therapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'dosimetric study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'locoregional disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'metastatic disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'low-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'intermediate-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'high-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage I_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage II_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage III_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'major rupture_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Austria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Italy_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'San Marino_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Iceland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Germany_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bulgaria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Turkey_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Denmark_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Poland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Greece_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Andorra_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belgium_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Serbia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Albania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Moldova_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Lithuania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Latvia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Estonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Luxembourg_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Montenegro_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Croatia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovenia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Macedonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'United Kingdom_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ireland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Spain_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Algeria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Tunisia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Malta_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Morocco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Portugal_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'France_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Monaco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Russia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Finland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Sweden_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Norway_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belarus_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Romania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ukraine_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hungary_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Czech Republic_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovakia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Switzerland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Liechtenstein_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Netherlands_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Munich_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Marciniak Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Faculty of Medicine_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital Homburg_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Weirich, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Pritchard-Jones, K._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'de Kraker, J._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Graf, N._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Green, D. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Spreafico, F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Bellani, F. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \"D\\'Angio, G. J._author\", {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Tournade, M. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Breslow, N. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Mitchell, C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Verschuur, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Grundy, P. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Warmann, S. W._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Smets, A. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dome, J. S._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dix, D. B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Daw, N. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ha, T. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Kremens, B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Furtwangler, R._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP-9/GPOH_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UKW3_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10})]}, {\\'nodes\\': [(\\'vincristine_entity\\', {}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {}), (\\'www.siop-rtsg.eu_entity\\', {}), (\\'stage II_entity\\', {}), (\\'Wilms tumours_entity\\', {}), (\\'Relapsed Wilms Tumor_entity\\', {}), (\\'Davila Fajardo et al._entity\\', {}), (\\'vincristine, actinomycin D, and doxorubicin_entity\\', {}), (\\'SIOP\u22122001 randomized trial_entity\\', {}), (\\'surgery_entity\\', {}), (\\'non-Wilms tumours_entity\\', {}), (\\'actinomycin D_entity\\', {}), (\\'diffuse anaplasia_entity\\', {}), (\\'Synchronous bilateral Wilms tumor_entity\\', {}), (\\'CT-only nodules_entity\\', {}), (\\'relapsed group CC_entity\\', {}), (\\'increased relapse risk_entity\\', {}), (\\'reduced survival_entity\\', {}), (\\'UKW3 trial_entity\\', {}), (\\'chemotherapy_entity\\', {}), (\\'Bilateral Disease (Stage V)_entity\\', {}), (\\'blastemal-type tumors_entity\\', {}), (\\'UMBRELLA protocol_entity\\', {}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', {}), (\\'minimally invasive surgery_entity\\', {}), (\\'VP16_entity\\', {}), (\\'Wilms tumor_entity\\', {}), (\\'anaplasia_entity\\', {}), (\\'radical tumor nephrectomy_entity\\', {}), (\\'Innovative Therapies for Children with Cancer consortium_entity\\', {}), (\\'cumulative doxorubicin dose_entity\\', {}), (\\'etoposide_entity\\', {}), (\\'large-volume tumours_entity\\', {}), (\\'Stage IV_entity\\', {}), (\\'CDCV_entity\\', {}), (\\'SIOP\u2013RTSG_entity\\', {}), (\\'AVD150_entity\\', {}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', {}), (\\'laparoscopic surgery_entity\\', {}), (\\'SIOP\u2212RTSG panel_entity\\', {}), (\\'actinomycin-D_entity\\', {}), (\\'COG AREN0533 trial_entity\\', {}), (\\'cyclophosphamide_entity\\', {}), (\\'carboplatin_entity\\', {}), (\\'UKW\u2011R protocol_entity\\', {}), (\\'Nephron-sparing surgery (NSS)_entity\\', {}), (\\'Adult Wilms Tumors_entity\\', {}), (\\'doxorubicin_entity\\', {}), (\\'NWTS\u20115 relapse protocol_entity\\', {}), (\\'End-stage renal disease (ESRD)_entity\\', {}), (\\'AVD250_entity\\', {}), (\\'Children\u2019s Oncology Group (COG)_entity\\', {}), (\\'blastemal-type Wilms tumour_entity\\', {}), (\\'SIOP\u22122001_entity\\', {}), (\\'radiotherapy_entity\\', {}), (\\'childhood renal tumours_entity\\', {})], \\'edges\\': [(\\'vincristine_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'stage II_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'indicated_for_in_adults\\'}), (\\'Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'Wilms tumours_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated under\\'}), (\\'Relapsed Wilms Tumor_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guided_by\\'}), (\\'Davila Fajardo et al._entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed\\'}), (\\'SIOP\u22122001 randomized trial_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated use in\\'}), (\\'surgery_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'non-Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'actinomycin D_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Synchronous bilateral Wilms tumor_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'instance_of\\'}), (\\'CT-only nodules_entity\\', \\'increased relapse risk_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'reduced survival_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included_in\\'}), (\\'relapsed group CC_entity\\', \\'diffuse anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'blastemal-type tumors_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UKW3 trial_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'UKW3 trial_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'chemotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UMBRELLA protocol_entity\\', \\'COG AREN0533 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses_data_from\\'}), (\\'UMBRELLA protocol_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'advises_treatment_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'Innovative Therapies for Children with Cancer consortium_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborates_with\\'}), (\\'UMBRELLA protocol_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'surgery_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is the standard of\\'}), (\\'UMBRELLA protocol_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guides treatment in\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', \\'UKW3 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\\'minimally invasive surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'anaplasia_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'radical tumor nephrectomy_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'standard_of_care_for\\'}), (\\'Stage IV_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'presents in\\'}), (\\'CDCV_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'VP16_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'aims to improve survival rates of\\'}), (\\'AVD150_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed_by\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'succeeds\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'www.siop-rtsg.eu_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'available_on\\'}), (\\'laparoscopic surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'COG AREN0533 trial_entity\\', \\'cumulative doxorubicin dose_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'evaluates\\'}), (\\'UKW\u2011R protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'Nephron-sparing surgery (NSS)_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'classification_developed_by\\'}), (\\'Adult Wilms Tumors_entity\\', \\'anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'Adult Wilms Tumors_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'doxorubicin_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'doxorubicin_entity\\', \\'large-volume tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'recommended for\\'}), (\\'NWTS\u20115 relapse protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'End-stage renal disease (ESRD)_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'AVD250_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'Children\u2019s Oncology Group (COG)_entity\\', \\'SIOP\u22122001 randomized trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborated with\\'}), (\\'blastemal-type Wilms tumour_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment intensified according to\\'}), (\\'SIOP\u22122001_entity\\', \\'vincristine, actinomycin D, and doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses\\'}), (\\'SIOP\u22122001_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provided_guidelines_for\\'}), (\\'radiotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'radiotherapy_entity\\', \\'SIOP\u2212RTSG panel_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'contact_for_guidance\\'})]}, {\\'nodes\\': [(\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {}), (\\'Marry M. van den Heuvel-Eibrink_entity\\', {})], \\'edges\\': [(\\'Marry M. van den Heuvel-Eibrink_entity\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'affiliated_with\\'})]}, {\\'nodes\\': [(\\'Stage II_entity\\', {}), (\\'AV_entity\\', {}), (\\'Stage III_entity\\', {}), (\\'vincestine and actinomycin D_entity\\', {}), (\\'AVD_entity\\', {})], \\'edges\\': [(\\'Stage II_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AV_entity\\', \\'Stage II_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Stage III_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AVD_entity\\', \\'Stage III_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'SIOP-RTSG 2016_entity\\', {}), (\\'RCC_entity\\', {}), (\\'CMN_entity\\', {})], \\'edges\\': [(\\'RCC_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'}), (\\'CMN_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'})]}, {\\'nodes\\': [(\\'HR-1_entity\\', {}), (\\'High-risk blastemal type Wilms tumour_entity\\', {})], \\'edges\\': [(\\'HR-1_entity\\', \\'High-risk blastemal type Wilms tumour_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'unfavorable prognosis_entity\\', {}), (\\'high-risk characteristics_entity\\', {})], \\'edges\\': [(\\'high-risk characteristics_entity\\', \\'unfavorable prognosis_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'leads_to\\'})]}, {\\'nodes\\': [(\\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {}), (\\'SIOP\u2013RTSG board_entity\\', {})], \\'edges\\': [(\\'SIOP\u2013RTSG board_entity\\', \\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggests\\'})]}, {\\'nodes\\': [(\\'regimen and outcomes_entity\\', {}), (\\'SIOP database_entity\\', {})], \\'edges\\': [(\\'SIOP database_entity\\', \\'regimen and outcomes_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'captures_data_on\\'})]}, {\\'nodes\\': [(\\'Bilateral nephron-sparing surgery (NSS)_entity\\', {}), (\\'Aronson et al._entity\\', {})], \\'edges\\': [(\\'Aronson et al._entity\\', \\'Bilateral nephron-sparing surgery (NSS)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'observed_effectiveness_of\\'})]}, {\\'nodes\\': [(\\'SIOP\u22122001 study_entity\\', {}), (\\'Actinomycin D_entity\\', {}), (\\'Vincristine_entity\\', {})], \\'edges\\': [(\\'SIOP\u22122001 study_entity\\', \\'Vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'}), (\\'SIOP\u22122001 study_entity\\', \\'Actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'})]}, {\\'nodes\\': [(\\'High-dose melphalan_entity\\', {}), (\\'Group AA_entity\\', {}), (\\'Carboplatin_entity\\', {}), (\\'Doxorubicin_entity\\', {}), (\\'Etoposide_entity\\', {}), (\\'Group BB_entity\\', {}), (\\'Cyclophosphamide_entity\\', {}), (\\'Ifosfamide_entity\\', {})], \\'edges\\': [(\\'Group AA_entity\\', \\'Doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Ifosfamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'High-dose melphalan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'})]}, {\\'nodes\\': [(\\'nephrotoxicity_entity\\', {}), (\\'ifosfamide_entity\\', {})], \\'edges\\': [(\\'ifosfamide_entity\\', \\'nephrotoxicity_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'related_to\\'})]}, {\\'nodes\\': [(\\'camptothecins_entity\\', {}), (\\'irinotecan_entity\\', {}), (\\'topotecan_entity\\', {})], \\'edges\\': [(\\'camptothecins_entity\\', \\'irinotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'camptothecins_entity\\', \\'topotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'})]}, {\\'nodes\\': [(\\'Infant Wilms Tumors_entity\\', {}), (\\'nephrectomy_entity\\', {})], \\'edges\\': [(\\'Infant Wilms Tumors_entity\\', \\'nephrectomy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_option\\'})]}, {\\'nodes\\': [(\\'congenital mesoblastic nephroma_entity\\', {}), (\\'surgery alone_entity\\', {})], \\'edges\\': [(\\'congenital mesoblastic nephroma_entity\\', \\'surgery alone_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'alternative chemotherapy_entity\\', {}), (\\'malignant rhabdoid tumors_entity\\', {})], \\'edges\\': [(\\'malignant rhabdoid tumors_entity\\', \\'alternative chemotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'lymph node sampling_entity\\', {}), (\\'accurate staging_entity\\', {})], \\'edges\\': [(\\'lymph node sampling_entity\\', \\'accurate staging_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'purpose_of\\'})]}, {\\'nodes\\': [(\\'COG\u2013NWTS trials_entity\\', {}), (\\'whole-lung irradiation_entity\\', {})], \\'edges\\': [(\\'COG\u2013NWTS trials_entity\\', \\'whole-lung irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'informed_dosage_for\\'})]}, {\\'nodes\\': [(\\'lung metastases_entity\\', {}), (\\'pulmonary radiotherapy_entity\\', {})], \\'edges\\': [(\\'pulmonary radiotherapy_entity\\', \\'lung metastases_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'administered_for\\'})]}, {\\'nodes\\': [(\\'dosimetric study_entity\\', {}), (\\'proton therapy_entity\\', {}), (\\'flank irradiation_entity\\', {})], \\'edges\\': [(\\'dosimetric study_entity\\', \\'proton therapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated\\'}), (\\'proton therapy_entity\\', \\'flank irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggested_for\\'})]}, {\\'nodes\\': [(\\'metastatic disease_entity\\', {}), (\\'radiotherapy guidelines_entity\\', {}), (\\'locoregional disease_entity\\', {})], \\'edges\\': [(\\'radiotherapy guidelines_entity\\', \\'locoregional disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'}), (\\'radiotherapy guidelines_entity\\', \\'metastatic disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'})]}, {\\'nodes\\': [(\\'major rupture_entity\\', {}), (\\'stage III_entity\\', {})], \\'edges\\': [(\\'stage III_entity\\', \\'major rupture_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes_condition\\'})]}, {\\'nodes\\': [(\\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {}), (\\'ExPO\u2011r\u2011Net_entity\\', {})], \\'edges\\': [(\\'ExPO\u2011r\u2011Net_entity\\', \\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is part of\\'})]}, {\\'nodes\\': [(\\'University Hospital of Munich_entity\\', {}), (\\'Germany_entity\\', {}), (\\'University Hospital of Tuebingen_entity\\', {})], \\'edges\\': [(\\'Germany_entity\\', \\'University Hospital of Munich_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Germany_entity\\', \\'University Hospital of Tuebingen_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {}), (\\'Italy_entity\\', {}), (\\'Azienda Ospedaliera_entity\\', {}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {})], \\'edges\\': [(\\'Italy_entity\\', \\'Azienda Ospedaliera_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Netherlands_entity\\', {}), (\\'Prinses Maxima Centrum_entity\\', {})], \\'edges\\': [(\\'Netherlands_entity\\', \\'Prinses Maxima Centrum_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Marciniak Hospital_entity\\', {}), (\\'Poland_entity\\', {}), (\\'Faculty of Medicine_entity\\', {})], \\'edges\\': [(\\'Poland_entity\\', \\'Marciniak Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Poland_entity\\', \\'Faculty of Medicine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'St. Anna Kinderspital/CCRI_entity\\', {}), (\\'Austria_entity\\', {})], \\'edges\\': [(\\'Austria_entity\\', \\'St. Anna Kinderspital/CCRI_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'France_entity\\', {}), (\\'Armand Trousseau Hospital_entity\\', {})], \\'edges\\': [(\\'France_entity\\', \\'Armand Trousseau Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Spain_entity\\', {}), (\\'Hospital Vall d\u2019Hebron_entity\\', {}), (\\'Hospital Universitario Virgin del Rocio_entity\\', {})], \\'edges\\': [(\\'Spain_entity\\', \\'Hospital Universitario Virgin del Rocio_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Spain_entity\\', \\'Hospital Vall d\u2019Hebron_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'United Kingdom_entity\\', {}), (\\'Great Ormond Street Hospital_entity\\', {})], \\'edges\\': [(\\'United Kingdom_entity\\', \\'Great Ormond Street Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Weirich, A._entity\\', {}), (\\'SIOP-9/GPOH_entity\\', {})], \\'edges\\': [(\\'Weirich, A._entity\\', \\'SIOP-9/GPOH_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Pritchard-Jones, K._entity\\', {}), (\\'UKW3_entity\\', {})], \\'edges\\': [(\\'Pritchard-Jones, K._entity\\', \\'UKW3_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed in\\'})]}, {\\'nodes\\': [(\\'SIOP 93\u201301 trial_entity\\', {}), (\\'de Kraker, J._entity\\', {})], \\'edges\\': [(\\'de Kraker, J._entity\\', \\'SIOP 93\u201301 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'SIOP trial and study 93\u201301_entity\\', {}), (\\'Graf, N._entity\\', {})], \\'edges\\': [(\\'Graf, N._entity\\', \\'SIOP trial and study 93\u201301_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Green, D. M._entity\\', {}), (\\'National Wilms Tumor Study Group_entity\\', {})], \\'edges\\': [(\\'Green, D. M._entity\\', \\'National Wilms Tumor Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}, {\\'nodes\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', {}), (\\'SIOP WT 2001 protocol_entity\\', {})], \\'edges\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', \\'SIOP WT 2001 protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Third National Wilms\u2019 Tumor Study_entity\\', {}), (\"D\\'Angio, G. J._entity\", {}), (\\'Second National Wilms\u2019 Tumor Study_entity\\', {})], \\'edges\\': [(\"D\\'Angio, G. J._entity\", \\'Third National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\"D\\'Angio, G. J._entity\", \\'Second National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {}), (\\'Tournade, M. F._entity\\', {}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {})], \\'edges\\': [(\\'Tournade, M. F._entity\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'}), (\\'Tournade, M. F._entity\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Breslow, N. E._entity\\', {}), (\\'National Wilms Tumor Studies_entity\\', {})], \\'edges\\': [(\\'Breslow, N. E._entity\\', \\'National Wilms Tumor Studies_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Mitchell, C._entity\\', {}), (\\'UK Children\u2019s Cancer Study Group_entity\\', {})], \\'edges\\': [(\\'Mitchell, C._entity\\', \\'UK Children\u2019s Cancer Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'under\\'})]}, {\\'nodes\\': [(\\'Daw, N. C._entity\\', {}), (\\'Dix, D. B._entity\\', {}), (\\'Children\u2019s Oncology Group_entity\\', {}), (\\'Grundy, P. E._entity\\', {})], \\'edges\\': [(\\'Daw, N. C._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted under\\'}), (\\'Dix, D. B._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'}), (\\'Grundy, P. E._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}]']), TestResult(name='test_case_10', success=False, metrics_data=[MetricData(name='Answer Correctness (GEval)', threshold=0.5, success=False, score=0.022444006465635127, reason='The actual output fails to provide the statistical fact regarding renal tumours accounting for 5% of all paediatric malignancies, which is essential for accuracy.', strict_mode=False, evaluation_model='gpt-4o-mini', error=None, evaluation_cost=0.0032999999999999995, verbose_logs='Criteria:\\nNone \\n \\nEvaluation Steps:\\n[\\n    \"Determine whether the actual output is factually correct based on the expected output.\"\\n]'), MetricData(name='Faithfulness', threshold=0.7, success=True, score=0.9615384615384616, reason=None, strict_mode=False, evaluation_model='gpt-4o-mini', error=None, evaluation_cost=0.00821385, verbose_logs='Truths (limit=None):\\n[\\n    \"The Renal Tumour Study Group is associated with the International Society of Paediatric Oncology (SIOP\u2013RTSG).\",\\n    \"SIOP\u2013RTSG has several protocols including UMBRELLA SIOP-RTSG 2016 and SIOP\u22122001.\",\\n    \"Wilms tumours and non-Wilms tumours are types of childhood renal tumours.\",\\n    \"Marry M. van den Heuvel-Eibrink is a person associated with paediatric oncology.\",\\n    \"There is a website for the SIOP-RTSG: www.siop-rtsg.eu.\",\\n    \"The Department of Paediatric Oncology is located at the Princess M\u00e1xima Center for Paediatric Oncology.\",\\n    \"Several drugs are used to treat Wilms tumours, including vincristine, actinomycin D, and doxorubicin.\",\\n    \"The UMBRELLA protocol provides treatment guidelines for certain paediatric cancers.\",\\n    \"SIOP\u2013RTSG is involved in clinical trials for Wilms tumours, including the SIOP\u22122001 randomized trial and the UKW3 trial.\",\\n    \"Stages of Wilms tumour include Stage I, II, III, IV, and V, with various treatment methods for each stage.\",\\n    \"The treatment methods for Wilms tumours can include surgery, chemotherapy, and radiotherapy.\",\\n    \"The UMBRELLA SIOP-RTSG 2016 protocol succeeded the SIOP\u22122001 protocol.\",\\n    \"Organizations involved in Wilms tumour research include the Children\u2019s Oncology Group (COG) and the UK Children\u2019s Cancer and Leukaemia Group (UKCCLG).\",\\n    \"High-dose chemotherapy and autologous stem cell transplantation are treatment options for certain high-risk conditions.\",\\n    \"Different types of Wilms tumours exist, including blastemal-type and anaplastic types.\",\\n    \"Anaplastic Wilms tumours have been associated with a poor prognosis.\",\\n    \"There are various trials related to Wilms tumours, including the COG\u2013NWTS trials and NCIC-CTG trials.\",\\n    \"SIOP\u2212RTSG was developed to improve survival rates for patients with Wilms tumours.\",\\n    \"Surgery type categories for Wilms tumour treatment include minimally invasive surgery, radical tumor nephrectomy, and nephron-sparing surgery (NSS).\",\\n    \"Emerging therapies for Wilms tumours may involve innovative treatments as part of clinical research efforts.\",\\n    \"Countries involved in Wilms tumour study protocols include Austria, Italy, and Germany among others.\",\\n    \"The study of Wilms tumours has been a collaborative effort across multiple international research groups.\"\\n] \\n \\nClaims:\\n[\\n    \"The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG) is an organization.\",\\n    \"The UMBRELLA SIOP-RTSG 2016 is a protocol.\",\\n    \"SIOP\u22122001 is a protocol.\",\\n    \"Wilms tumours are a type of disease.\",\\n    \"Non-Wilms tumours are a type of disease.\",\\n    \"The website www.siop-rtsg.eu is associated with SIOP\u2013RTSG.\",\\n    \"The Department of Paediatric Oncology is part of the Princess M\u00e1xima Center for Paediatric Oncology.\",\\n    \"Marry M. van den Heuvel-Eibrink is a person involved with SIOP\u2013RTSG.\",\\n    \"Childhood renal tumours are a type of disease.\",\\n    \"Clear cell sarcoma of the kidney is a type of disease.\",\\n    \"Renal cell carcinoma is a type of disease.\",\\n    \"Malignant rhabdoid tumour of the kidney is a type of disease.\",\\n    \"Congenital mesoblastic nephroma is a type of disease.\",\\n    \"Wilms tumours can be considered a medical condition.\",\\n    \"The UMBRELLA protocol is a treatment protocol.\",\\n    \"SIOP\u2013RTSG is an organization.\",\\n    \"The Children\u2019s Oncology Group (COG) is an organization.\",\\n    \"The SIOP\u22122001 randomized trial is a clinical trial.\",\\n    \"Actinomycin D, vincristine, and doxorubicin are classified as drugs.\",\\n    \"The UKW3 trial is a clinical trial.\",\\n    \"The UK Children\u2019s Cancer and Leukaemia Group (UKCCLG) is an organization.\",\\n    \"Localized disease, metastatic disease, bilateral disease, and relapsed disease are stages of disease.\",\\n    \"Blastemal-type Wilms tumours are a subtype of Wilms tumours.\",\\n    \"Radiotherapy, surgery, and chemotherapy are treatment methods.\",\\n    \"Wilms Tumour is a type of disease.\",\\n    \"CCSK is an abbreviation for clear cell sarcoma of the kidney, a type of disease.\",\\n    \"MRTK refers to malignant rhabdoid tumour of the kidney, a type of disease.\",\\n    \"CMN refers to congenital mesoblastic nephroma, a type of disease.\",\\n    \"RCC stands for renal cell carcinoma, a type of disease.\",\\n    \"The UMBRELLA protocol is recognized as a protocol.\",\\n    \"The SIOP\u22122001 trial is recognized as a trial.\",\\n    \"Vincristine and actinomycin D are treatments associated with Wilms tumours.\",\\n    \"Doxorubicin is another treatment associated with Wilms tumours.\",\\n    \"Etoposide, carboplatin, and cyclophosphamide are also treatment methods.\",\\n    \"Stage I, Stage II, Stage III, Stage IV, and Stage V are classified as stages of Wilms tumours.\",\\n    \"AV, AVD, and HR-1 are treatment combinations linked to specific protocols.\",\\n    \"The SIOP-RTSG 2016 protocol exists.\",\\n    \"Overall Survival (OS) and Event-Free Survival (EFS) are metrics associated with treatment outcomes.\",\\n    \"CT-only nodules are considered a medical condition.\",\\n    \"The SIOP\u2013RTSG analysis is a study related to renal tumours.\",\\n    \"COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials are studies related to Wilms tumours.\",\\n    \"Vincristine and actinomycin D plus doxorubicin is a treatment regimen.\",\\n    \"Vincristine and actinomycin D are part of a treatment regimen for Wilms tumours.\",\\n    \"MRI and CT are diagnostic tools utilized in the context of renal tumours.\",\\n    \"Cumulative doxorubicin dose is a treatment detail observed in Wilms tumours.\",\\n    \"COG AREN0533 trial is a study concerning treatments for renal tumours.\",\\n    \"Etoposide, carboplatin, cyclophosphamide, and ifosfamide are classified as medications.\",\\n    \"High-risk characteristics can affect treatment outcomes for patients with Wilms tumours.\",\\n    \"The SIOP\u2013RTSG board is involved with the study and treatment protocols for renal tumours.\",\\n    \"High-dose chemotherapy and autologous stem cell transplantation is a treatment method utilized in childhood cancers.\",\\n    \"The SIOP database is a resource that captures data related to protocols and outcomes in renal tumour treatments.\",\\n    \"Bilateral nephron-sparing surgery (NSS) is a treatment method observed for effectiveness in clinical studies.\",\\n    \"The SIOP\u22122001 study refers to a specific clinical study involving Wilms tumours and the drug regimens used.\",\\n    \"High-dose melphalan is utilized in treatment protocols involving specific patient groups such as Group AA and Group BB.\",\\n    \"Nephrotoxicity is a condition associated with the use of certain medications like ifosfamide.\",\\n    \"Camptothecins are a class of medications including irinotecan and topotecan that are used in treatments.\",\\n    \"Infant Wilms Tumors often require nephrectomy as a surgical intervention.\",\\n    \"Congenital mesoblastic nephroma may necessitate surgery as part of treatment.\",\\n    \"Malignant rhabdoid tumors may require alternative chemotherapy approaches.\",\\n    \"Lymph node sampling is a surgical procedure performed for accurate staging in cancer treatments.\",\\n    \"COG\u2013NWTS trials influence the dosages used in whole-lung irradiation treatment approaches.\",\\n    \"Pulmonary radiotherapy is administered for the treatment of lung metastases.\",\\n    \"Dosimetric studies evaluate proton therapy and its applications in cancer treatment, particularly for flank irradiation.\",\\n    \"Radiotherapy guidelines are specified for patients with locoregional and metastatic disease.\",\\n    \"Major rupture is a condition that can occur in patients classified under stage III diseases.\"\\n] \\n \\nVerdicts:\\n[\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"The actual output indicates Marry M. van den Heuvel-Eibrink is associated with paediatric oncology, but does not specifically connect her to SIOP\\\\u2013RTSG.\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"idk\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"idk\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"idk\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"idk\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"idk\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"idk\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    }\\n]'), MetricData(name='Contextual Relevancy', threshold=1.0, success=False, score=0.5, reason=\"The score is 0.50 because while there are relevant terms like 'childhood renal tumours' and 'Wilms Tumour', the majority of the context is irrelevant as it discusses survival metrics and a specific institution, which do not contribute to understanding the percentage representation of renal tumours in childhood malignancies.\", strict_mode=False, evaluation_model='gpt-4o-mini', error=None, evaluation_cost=0.0035976, verbose_logs='Verdicts:\\n[\\n    {\\n        \"verdicts\": [\\n            {\\n                \"statement\": \"childhood renal tumours_Disease\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"Wilms Tumour_Disease\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"non-Wilms tumours_Disease\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"Malignant rhabdoid tumours_medical_condition\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"The retrieval context included \\'malignant rhabdoid tumors\\', which does not specifically address the question regarding renal tumours representation in childhood malignancies.\"\\n            },\\n            {\\n                \"statement\": \"overall survival (os)_metric\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"The context mentioned metrics of survival, which are unrelated to percentages of renal tumours in childhood malignancies.\"\\n            },\\n            {\\n                \"statement\": \"department of paediatric oncology, princess m\\\\u00e1xima center for paediatric oncology_Institution\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"The statement refers to an institution, which does not provide information relevant to the requested percentage of renal tumours.\"\\n            }\\n        ]\\n    }\\n]')], conversational=False, multimodal=False, input='What percentage of childhood malignancies do renal tumours approximately represent?', actual_output='[{\\'nodes\\': [(\\'sample.pdf\\', {\\'type\\': \\'document\\'}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)\\'}), (\\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA SIOP-RTSG 2016\\'}), (\\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms tumours\\'}), (\\'non-Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'non-Wilms tumours\\'}), (\\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Website\\', \\'name\\': \\'www.siop-rtsg.eu\\'}), (\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology\\'}), (\\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Person\\', \\'name\\': \\'Marry M. van den Heuvel-Eibrink\\'}), (\\'childhood renal tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'childhood renal tumours\\'}), (\\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'clear cell sarcoma of the kidney\\'}), (\\'renal cell carcinoma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'renal cell carcinoma\\'}), (\\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'malignant rhabdoid tumour of the kidney\\'}), (\\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'Wilms tumours_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'Children\u2019s Oncology Group (COG)\\'}), (\\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'SIOP\u22122001 randomized trial\\'}), (\\'actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'UKW3 trial\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)\\'}), (\\'localized disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'localized disease\\'}), (\\'metastatic disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'metastatic disease\\'}), (\\'bilateral disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'bilateral disease\\'}), (\\'relapsed disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'relapsed disease\\'}), (\\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subtype\\', \\'name\\': \\'blastemal-type Wilms tumours\\'}), (\\'radiotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgery_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'chemotherapy\\'}), (\\'Wilms Tumour_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms Tumour\\'}), (\\'CCSK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CCSK\\'}), (\\'MRTK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'MRTK\\'}), (\\'CMN_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CMN\\'}), (\\'RCC_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'RCC\\'}), (\\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u22122001_Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Trial\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'vincristine_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'vincristine\\'}), (\\'actinomycin D_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'actinomycin D\\'}), (\\'doxorubicin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'doxorubicin\\'}), (\\'etoposide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'Stage I_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage I\\'}), (\\'Stage II_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage II\\'}), (\\'Stage III_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage III\\'}), (\\'Stage IV_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage IV\\'}), (\\'Stage V_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage V\\'}), (\\'AV_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AV\\'}), (\\'AVD_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AVD\\'}), (\\'HR-1_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'HR-1\\'}), (\\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP-RTSG 2016\\'}), (\\'Overall Survival (OS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'CT-only nodules_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'CT-only nodules\\'}), (\\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP\u2013RTSG analysis\\'}), (\\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials\\'}), (\\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D plus doxorubicin\\'}), (\\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D\\'}), (\\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study_protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'MRI_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'MRI\\'}), (\\'CT_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'CT\\'}), (\\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_detail\\', \\'name\\': \\'cumulative doxorubicin dose\\'}), (\\'COG AREN0533 trial_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG AREN0533 trial\\'}), (\\'etoposide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'high-risk characteristics\\'}), (\\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG board\\'}), (\\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin\\'}), (\\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'high-dose chemotherapy and autologous stem cell transplantation\\'}), (\\'SIOP database_database\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'database\\', \\'name\\': \\'SIOP database\\'}), (\\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'AVD_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AVD\\'}), (\\'AV-2_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AV-2\\'}), (\\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Statistical Test\\', \\'name\\': \\'Log\u2013Rank P\\'}), (\\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'Bilateral Disease (Stage V)\\'}), (\\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Synchronous bilateral Wilms tumor\\'}), (\\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'End-stage renal disease (ESRD)\\'}), (\\'Aronson et al._Research Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Research Group\\', \\'name\\': \\'Aronson et al.\\'}), (\\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'Bilateral nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Study\\', \\'name\\': \\'SIOP\u22122001 study\\'}), (\\'Vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Vincristine\\'}), (\\'Actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Actinomycin D\\'}), (\\'Etoposide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Etoposide\\'}), (\\'Carboplatin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Carboplatin\\'}), (\\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease State\\', \\'name\\': \\'Relapsed Wilms Tumor\\'}), (\\'Group AA_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group AA\\'}), (\\'Group BB_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group BB\\'}), (\\'Group CC_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group CC\\'}), (\\'Doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Doxorubicin\\'}), (\\'Cyclophosphamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Cyclophosphamide\\'}), (\\'Ifosfamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Ifosfamide\\'}), (\\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'High-dose melphalan\\'}), (\\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UKW\u2011R protocol\\'}), (\\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'NWTS\u20115 relapse protocol\\'}), (\\'ASCR_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'procedure\\', \\'name\\': \\'ASCR\\'}), (\\'ifosfamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'ifosfamide\\'}), (\\'nephrotoxicity_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'nephrotoxicity\\'}), (\\'relapsed group CC_patient_group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'patient_group\\', \\'name\\': \\'relapsed group CC\\'}), (\\'diffuse anaplasia_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'diffuse anaplasia\\'}), (\\'blastemal-type tumors_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'blastemal-type tumors\\'}), (\\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'camptothecins_medication_class\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication_class\\', \\'name\\': \\'camptothecins\\'}), (\\'irinotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'irinotecan\\'}), (\\'topotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'topotecan\\'}), (\\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Innovative Therapies for Children with Cancer consortium\\'}), (\\'radiotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgical excision_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgical excision\\'}), (\\'stage IV WT_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'stage IV WT\\'}), (\\'AVD150_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD150\\'}), (\\'AVD250_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD250\\'}), (\\'low-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'low-risk disease\\'}), (\\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'intermediate-risk disease\\'}), (\\'high-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'high-risk disease\\'}), (\\'CDCV_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'CDCV\\'}), (\\'actinomycin-D_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'actinomycin-D\\'}), (\\'vincristine_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'doxorubicin\\'}), (\\'VP16_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'VP16\\'}), (\\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'contact\\', \\'name\\': \\'arnauld.verschuur@ap-hm.fr\\'}), (\\'surgery_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'chemotherapy\\'}), (\\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2212RTSG panel\\'}), (\\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Infant Wilms Tumors\\'}), (\\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'nephrectomy\\'}), (\\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'malignant rhabdoid tumors\\'}), (\\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Adult Wilms Tumors\\'}), (\\'anaplasia_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'anaplasia\\'}), (\\'actinomycin D_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'carboplatin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'etoposide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'etoposide\\'}), (\\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'Nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'radical tumor nephrectomy\\'}), (\\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'lymph node sampling\\'}), (\\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'minimally invasive surgery\\'}), (\\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'laparoscopic surgery\\'}), (\\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'radiotherapy\\'}), (\\'Wilms tumours_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'Davila Fajardo et al._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Davila Fajardo et al.\\'}), (\\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'COG\u2013NWTS trials\\'}), (\\'whole-lung irradiation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'whole-lung irradiation\\'}), (\\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'pulmonary radiotherapy\\'}), (\\'proton therapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'proton therapy\\'}), (\\'dosimetric study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'dosimetric study\\'}), (\\'locoregional disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'locoregional disease\\'}), (\\'metastatic disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'metastatic disease\\'}), (\\'low-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'low-risk\\'}), (\\'intermediate-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'intermediate-risk\\'}), (\\'high-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'high-risk\\'}), (\\'stage I_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage I\\'}), (\\'stage II_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage II\\'}), (\\'stage III_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage III\\'}), (\\'major rupture_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'major rupture\\'}), (\\'Austria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Austria\\'}), (\\'Italy_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Italy\\'}), (\\'San Marino_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'San Marino\\'}), (\\'Iceland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Iceland\\'}), (\\'Germany_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Germany\\'}), (\\'Bulgaria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bulgaria\\'}), (\\'Turkey_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Turkey\\'}), (\\'Denmark_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Denmark\\'}), (\\'Poland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Poland\\'}), (\\'Greece_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Greece\\'}), (\\'Andorra_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Andorra\\'}), (\\'Belgium_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belgium\\'}), (\\'Serbia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Serbia\\'}), (\\'Albania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Albania\\'}), (\\'Moldova_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Moldova\\'}), (\\'Lithuania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Lithuania\\'}), (\\'Latvia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Latvia\\'}), (\\'Estonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Estonia\\'}), (\\'Luxembourg_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Luxembourg\\'}), (\\'Montenegro_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Montenegro\\'}), (\\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bosnia and Herzegovina\\'}), (\\'Croatia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Croatia\\'}), (\\'Slovenia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovenia\\'}), (\\'Macedonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Macedonia\\'}), (\\'United Kingdom_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'United Kingdom\\'}), (\\'Ireland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ireland\\'}), (\\'Spain_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Spain\\'}), (\\'Algeria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Algeria\\'}), (\\'Tunisia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Tunisia\\'}), (\\'Malta_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Malta\\'}), (\\'Morocco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Morocco\\'}), (\\'Portugal_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Portugal\\'}), (\\'France_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'France\\'}), (\\'Monaco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Monaco\\'}), (\\'Russia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Russia\\'}), (\\'Finland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Finland\\'}), (\\'Sweden_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Sweden\\'}), (\\'Norway_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Norway\\'}), (\\'Belarus_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belarus\\'}), (\\'Romania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Romania\\'}), (\\'Ukraine_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ukraine\\'}), (\\'Hungary_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Hungary\\'}), (\\'Czech Republic_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Czech Republic\\'}), (\\'Slovakia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovakia\\'}), (\\'Switzerland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Switzerland\\'}), (\\'Liechtenstein_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Liechtenstein\\'}), (\\'Netherlands_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Netherlands\\'}), (\\'University Hospital of Munich_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Munich\\'}), (\\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Tuebingen\\'}), (\\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Azienda Ospedaliera\\'}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Ospedale Pediatrico Bambino Ges\u00f9\\'}), (\\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Fondazione IRCCS Istituto Nazionale dei Tumori\\'}), (\\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Prinses Maxima Centrum\\'}), (\\'Marciniak Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Marciniak Hospital\\'}), (\\'Faculty of Medicine_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Faculty of Medicine\\'}), (\\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'St. Anna Kinderspital/CCRI\\'}), (\\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Armand Trousseau Hospital\\'}), (\\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Universitario Virgin del Rocio\\'}), (\\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Vall d\u2019Hebron\\'}), (\\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Great Ormond Street Hospital\\'}), (\\'University Hospital Homburg_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital Homburg\\'}), (\\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon\\'}), (\\'UMBRELLA protocol_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'ExPO\u2011r\u2011Net\\'}), (\\'Weirich, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Weirich, A.\\'}), (\\'Pritchard-Jones, K._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Pritchard-Jones, K.\\'}), (\\'de Kraker, J._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'de Kraker, J.\\'}), (\\'Graf, N._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Graf, N.\\'}), (\\'Green, D. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Green, D. M.\\'}), (\\'Spreafico, F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Spreafico, F.\\'}), (\\'Bellani, F. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Bellani, F. F.\\'}), (\\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'van den Heuvel-Eibrink, M. M.\\'}), (\"D\\'Angio, G. J._author\", {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \"D\\'Angio, G. J.\"}), (\\'Tournade, M. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Tournade, M. F.\\'}), (\\'Breslow, N. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Breslow, N. E.\\'}), (\\'Mitchell, C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Mitchell, C.\\'}), (\\'Verschuur, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Verschuur, A.\\'}), (\\'Grundy, P. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Grundy, P. E.\\'}), (\\'Warmann, S. W._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Warmann, S. W.\\'}), (\\'Smets, A. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Smets, A. M.\\'}), (\\'Dome, J. S._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dome, J. S.\\'}), (\\'Dix, D. B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dix, D. B.\\'}), (\\'Daw, N. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Daw, N. C.\\'}), (\\'Ha, T. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Ha, T. C.\\'}), (\\'Kremens, B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Kremens, B.\\'}), (\\'Furtwangler, R._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Furtwangler, R.\\'}), (\\'SIOP-9/GPOH_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP-9/GPOH\\'}), (\\'UKW3_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'UKW3\\'}), (\\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'SIOP 93\u201301 trial\\'}), (\\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP trial and study 93\u201301\\'}), (\\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'National Wilms Tumor Study Group\\'}), (\\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP WT 2001 protocol\\'}), (\\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Third National Wilms\u2019 Tumor Study\\'}), (\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'National Wilms Tumor Studies\\'}), (\\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Second National Wilms\u2019 Tumor Study\\'}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'UK Children\u2019s Cancer Study Group\\'}), (\\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Children\u2019s Oncology Group\\'})], \\'edges\\': [(\\'sample.pdf\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'non-Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'childhood renal tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'renal cell carcinoma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'localized disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'metastatic disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'bilateral disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'relapsed disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'radiotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'surgery_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'chemotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'Wilms Tumour_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CCSK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'MRTK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CMN_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'RCC_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP\u22122001_Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'vincristine_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'actinomycin D_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'doxorubicin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'etoposide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'carboplatin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'cyclophosphamide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage I_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage II_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage III_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage IV_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage V_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AV_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AVD_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'HR-1_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Overall Survival (OS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT-only nodules_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'MRI_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG AREN0533 trial_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'etoposide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'carboplatin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'cyclophosphamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP database_database\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AVD_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AV-2_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Aronson et al._Research Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Etoposide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Carboplatin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group AA_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group BB_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group CC_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Cyclophosphamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Ifosfamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'ASCR_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'ifosfamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'nephrotoxicity_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'relapsed group CC_patient_group\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'diffuse anaplasia_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'blastemal-type tumors_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'camptothecins_medication_class\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'irinotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'topotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'radiotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'surgical excision_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'stage IV WT_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD150_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD250_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'low-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'CDCV_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'actinomycin-D_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'vincristine_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'doxorubicin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'VP16_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'surgery_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'chemotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'anaplasia_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'actinomycin D_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'vincristine_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'doxorubicin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'carboplatin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'cyclophosphamide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'etoposide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'SIOP\u22122001_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Wilms tumours_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Davila Fajardo et al._author\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'whole-lung irradiation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'proton therapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'dosimetric study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'locoregional disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'metastatic disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'low-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'intermediate-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'high-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage I_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage II_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage III_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'major rupture_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Austria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Italy_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'San Marino_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Iceland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Germany_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bulgaria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Turkey_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Denmark_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Poland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Greece_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Andorra_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belgium_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Serbia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Albania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Moldova_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Lithuania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Latvia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Estonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Luxembourg_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Montenegro_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Croatia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovenia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Macedonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'United Kingdom_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ireland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Spain_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Algeria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Tunisia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Malta_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Morocco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Portugal_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'France_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Monaco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Russia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Finland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Sweden_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Norway_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belarus_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Romania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ukraine_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hungary_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Czech Republic_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovakia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Switzerland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Liechtenstein_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Netherlands_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Munich_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Marciniak Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Faculty of Medicine_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital Homburg_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Weirich, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Pritchard-Jones, K._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'de Kraker, J._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Graf, N._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Green, D. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Spreafico, F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Bellani, F. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \"D\\'Angio, G. J._author\", {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Tournade, M. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Breslow, N. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Mitchell, C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Verschuur, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Grundy, P. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Warmann, S. W._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Smets, A. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dome, J. S._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dix, D. B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Daw, N. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ha, T. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Kremens, B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Furtwangler, R._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP-9/GPOH_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UKW3_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10})]}, {\\'nodes\\': [(\\'vincristine_entity\\', {}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {}), (\\'www.siop-rtsg.eu_entity\\', {}), (\\'stage II_entity\\', {}), (\\'Wilms tumours_entity\\', {}), (\\'Relapsed Wilms Tumor_entity\\', {}), (\\'Davila Fajardo et al._entity\\', {}), (\\'vincristine, actinomycin D, and doxorubicin_entity\\', {}), (\\'SIOP\u22122001 randomized trial_entity\\', {}), (\\'surgery_entity\\', {}), (\\'non-Wilms tumours_entity\\', {}), (\\'actinomycin D_entity\\', {}), (\\'diffuse anaplasia_entity\\', {}), (\\'Synchronous bilateral Wilms tumor_entity\\', {}), (\\'CT-only nodules_entity\\', {}), (\\'relapsed group CC_entity\\', {}), (\\'increased relapse risk_entity\\', {}), (\\'reduced survival_entity\\', {}), (\\'UKW3 trial_entity\\', {}), (\\'chemotherapy_entity\\', {}), (\\'Bilateral Disease (Stage V)_entity\\', {}), (\\'blastemal-type tumors_entity\\', {}), (\\'UMBRELLA protocol_entity\\', {}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', {}), (\\'minimally invasive surgery_entity\\', {}), (\\'VP16_entity\\', {}), (\\'Wilms tumor_entity\\', {}), (\\'anaplasia_entity\\', {}), (\\'radical tumor nephrectomy_entity\\', {}), (\\'Innovative Therapies for Children with Cancer consortium_entity\\', {}), (\\'cumulative doxorubicin dose_entity\\', {}), (\\'etoposide_entity\\', {}), (\\'large-volume tumours_entity\\', {}), (\\'Stage IV_entity\\', {}), (\\'CDCV_entity\\', {}), (\\'SIOP\u2013RTSG_entity\\', {}), (\\'AVD150_entity\\', {}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', {}), (\\'laparoscopic surgery_entity\\', {}), (\\'SIOP\u2212RTSG panel_entity\\', {}), (\\'actinomycin-D_entity\\', {}), (\\'COG AREN0533 trial_entity\\', {}), (\\'cyclophosphamide_entity\\', {}), (\\'carboplatin_entity\\', {}), (\\'UKW\u2011R protocol_entity\\', {}), (\\'Nephron-sparing surgery (NSS)_entity\\', {}), (\\'Adult Wilms Tumors_entity\\', {}), (\\'doxorubicin_entity\\', {}), (\\'NWTS\u20115 relapse protocol_entity\\', {}), (\\'End-stage renal disease (ESRD)_entity\\', {}), (\\'AVD250_entity\\', {}), (\\'Children\u2019s Oncology Group (COG)_entity\\', {}), (\\'blastemal-type Wilms tumour_entity\\', {}), (\\'SIOP\u22122001_entity\\', {}), (\\'radiotherapy_entity\\', {}), (\\'childhood renal tumours_entity\\', {})], \\'edges\\': [(\\'vincristine_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'stage II_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'indicated_for_in_adults\\'}), (\\'Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'Wilms tumours_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated under\\'}), (\\'Relapsed Wilms Tumor_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guided_by\\'}), (\\'Davila Fajardo et al._entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed\\'}), (\\'SIOP\u22122001 randomized trial_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated use in\\'}), (\\'surgery_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'non-Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'actinomycin D_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Synchronous bilateral Wilms tumor_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'instance_of\\'}), (\\'CT-only nodules_entity\\', \\'increased relapse risk_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'reduced survival_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included_in\\'}), (\\'relapsed group CC_entity\\', \\'diffuse anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'blastemal-type tumors_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UKW3 trial_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'UKW3 trial_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'chemotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UMBRELLA protocol_entity\\', \\'COG AREN0533 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses_data_from\\'}), (\\'UMBRELLA protocol_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'advises_treatment_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'Innovative Therapies for Children with Cancer consortium_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborates_with\\'}), (\\'UMBRELLA protocol_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'surgery_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is the standard of\\'}), (\\'UMBRELLA protocol_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guides treatment in\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', \\'UKW3 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\\'minimally invasive surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'anaplasia_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'radical tumor nephrectomy_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'standard_of_care_for\\'}), (\\'Stage IV_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'presents in\\'}), (\\'CDCV_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'VP16_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'aims to improve survival rates of\\'}), (\\'AVD150_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed_by\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'succeeds\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'www.siop-rtsg.eu_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'available_on\\'}), (\\'laparoscopic surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'COG AREN0533 trial_entity\\', \\'cumulative doxorubicin dose_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'evaluates\\'}), (\\'UKW\u2011R protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'Nephron-sparing surgery (NSS)_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'classification_developed_by\\'}), (\\'Adult Wilms Tumors_entity\\', \\'anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'Adult Wilms Tumors_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'doxorubicin_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'doxorubicin_entity\\', \\'large-volume tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'recommended for\\'}), (\\'NWTS\u20115 relapse protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'End-stage renal disease (ESRD)_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'AVD250_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'Children\u2019s Oncology Group (COG)_entity\\', \\'SIOP\u22122001 randomized trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborated with\\'}), (\\'blastemal-type Wilms tumour_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment intensified according to\\'}), (\\'SIOP\u22122001_entity\\', \\'vincristine, actinomycin D, and doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses\\'}), (\\'SIOP\u22122001_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provided_guidelines_for\\'}), (\\'radiotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'radiotherapy_entity\\', \\'SIOP\u2212RTSG panel_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'contact_for_guidance\\'})]}, {\\'nodes\\': [(\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {}), (\\'Marry M. van den Heuvel-Eibrink_entity\\', {})], \\'edges\\': [(\\'Marry M. van den Heuvel-Eibrink_entity\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'affiliated_with\\'})]}, {\\'nodes\\': [(\\'Stage II_entity\\', {}), (\\'AV_entity\\', {}), (\\'Stage III_entity\\', {}), (\\'vincestine and actinomycin D_entity\\', {}), (\\'AVD_entity\\', {})], \\'edges\\': [(\\'Stage II_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AV_entity\\', \\'Stage II_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Stage III_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AVD_entity\\', \\'Stage III_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'SIOP-RTSG 2016_entity\\', {}), (\\'RCC_entity\\', {}), (\\'CMN_entity\\', {})], \\'edges\\': [(\\'RCC_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'}), (\\'CMN_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'})]}, {\\'nodes\\': [(\\'HR-1_entity\\', {}), (\\'High-risk blastemal type Wilms tumour_entity\\', {})], \\'edges\\': [(\\'HR-1_entity\\', \\'High-risk blastemal type Wilms tumour_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'unfavorable prognosis_entity\\', {}), (\\'high-risk characteristics_entity\\', {})], \\'edges\\': [(\\'high-risk characteristics_entity\\', \\'unfavorable prognosis_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'leads_to\\'})]}, {\\'nodes\\': [(\\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {}), (\\'SIOP\u2013RTSG board_entity\\', {})], \\'edges\\': [(\\'SIOP\u2013RTSG board_entity\\', \\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggests\\'})]}, {\\'nodes\\': [(\\'regimen and outcomes_entity\\', {}), (\\'SIOP database_entity\\', {})], \\'edges\\': [(\\'SIOP database_entity\\', \\'regimen and outcomes_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'captures_data_on\\'})]}, {\\'nodes\\': [(\\'Bilateral nephron-sparing surgery (NSS)_entity\\', {}), (\\'Aronson et al._entity\\', {})], \\'edges\\': [(\\'Aronson et al._entity\\', \\'Bilateral nephron-sparing surgery (NSS)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'observed_effectiveness_of\\'})]}, {\\'nodes\\': [(\\'SIOP\u22122001 study_entity\\', {}), (\\'Actinomycin D_entity\\', {}), (\\'Vincristine_entity\\', {})], \\'edges\\': [(\\'SIOP\u22122001 study_entity\\', \\'Vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'}), (\\'SIOP\u22122001 study_entity\\', \\'Actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'})]}, {\\'nodes\\': [(\\'High-dose melphalan_entity\\', {}), (\\'Group AA_entity\\', {}), (\\'Carboplatin_entity\\', {}), (\\'Doxorubicin_entity\\', {}), (\\'Etoposide_entity\\', {}), (\\'Group BB_entity\\', {}), (\\'Cyclophosphamide_entity\\', {}), (\\'Ifosfamide_entity\\', {})], \\'edges\\': [(\\'Group AA_entity\\', \\'Doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Ifosfamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'High-dose melphalan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'})]}, {\\'nodes\\': [(\\'nephrotoxicity_entity\\', {}), (\\'ifosfamide_entity\\', {})], \\'edges\\': [(\\'ifosfamide_entity\\', \\'nephrotoxicity_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'related_to\\'})]}, {\\'nodes\\': [(\\'camptothecins_entity\\', {}), (\\'irinotecan_entity\\', {}), (\\'topotecan_entity\\', {})], \\'edges\\': [(\\'camptothecins_entity\\', \\'irinotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'camptothecins_entity\\', \\'topotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'})]}, {\\'nodes\\': [(\\'Infant Wilms Tumors_entity\\', {}), (\\'nephrectomy_entity\\', {})], \\'edges\\': [(\\'Infant Wilms Tumors_entity\\', \\'nephrectomy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_option\\'})]}, {\\'nodes\\': [(\\'congenital mesoblastic nephroma_entity\\', {}), (\\'surgery alone_entity\\', {})], \\'edges\\': [(\\'congenital mesoblastic nephroma_entity\\', \\'surgery alone_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'alternative chemotherapy_entity\\', {}), (\\'malignant rhabdoid tumors_entity\\', {})], \\'edges\\': [(\\'malignant rhabdoid tumors_entity\\', \\'alternative chemotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'lymph node sampling_entity\\', {}), (\\'accurate staging_entity\\', {})], \\'edges\\': [(\\'lymph node sampling_entity\\', \\'accurate staging_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'purpose_of\\'})]}, {\\'nodes\\': [(\\'COG\u2013NWTS trials_entity\\', {}), (\\'whole-lung irradiation_entity\\', {})], \\'edges\\': [(\\'COG\u2013NWTS trials_entity\\', \\'whole-lung irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'informed_dosage_for\\'})]}, {\\'nodes\\': [(\\'lung metastases_entity\\', {}), (\\'pulmonary radiotherapy_entity\\', {})], \\'edges\\': [(\\'pulmonary radiotherapy_entity\\', \\'lung metastases_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'administered_for\\'})]}, {\\'nodes\\': [(\\'dosimetric study_entity\\', {}), (\\'proton therapy_entity\\', {}), (\\'flank irradiation_entity\\', {})], \\'edges\\': [(\\'dosimetric study_entity\\', \\'proton therapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated\\'}), (\\'proton therapy_entity\\', \\'flank irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggested_for\\'})]}, {\\'nodes\\': [(\\'metastatic disease_entity\\', {}), (\\'radiotherapy guidelines_entity\\', {}), (\\'locoregional disease_entity\\', {})], \\'edges\\': [(\\'radiotherapy guidelines_entity\\', \\'locoregional disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'}), (\\'radiotherapy guidelines_entity\\', \\'metastatic disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'})]}, {\\'nodes\\': [(\\'major rupture_entity\\', {}), (\\'stage III_entity\\', {})], \\'edges\\': [(\\'stage III_entity\\', \\'major rupture_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes_condition\\'})]}, {\\'nodes\\': [(\\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {}), (\\'ExPO\u2011r\u2011Net_entity\\', {})], \\'edges\\': [(\\'ExPO\u2011r\u2011Net_entity\\', \\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is part of\\'})]}, {\\'nodes\\': [(\\'University Hospital of Munich_entity\\', {}), (\\'Germany_entity\\', {}), (\\'University Hospital of Tuebingen_entity\\', {})], \\'edges\\': [(\\'Germany_entity\\', \\'University Hospital of Munich_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Germany_entity\\', \\'University Hospital of Tuebingen_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {}), (\\'Italy_entity\\', {}), (\\'Azienda Ospedaliera_entity\\', {}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {})], \\'edges\\': [(\\'Italy_entity\\', \\'Azienda Ospedaliera_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Netherlands_entity\\', {}), (\\'Prinses Maxima Centrum_entity\\', {})], \\'edges\\': [(\\'Netherlands_entity\\', \\'Prinses Maxima Centrum_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Marciniak Hospital_entity\\', {}), (\\'Poland_entity\\', {}), (\\'Faculty of Medicine_entity\\', {})], \\'edges\\': [(\\'Poland_entity\\', \\'Marciniak Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Poland_entity\\', \\'Faculty of Medicine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'St. Anna Kinderspital/CCRI_entity\\', {}), (\\'Austria_entity\\', {})], \\'edges\\': [(\\'Austria_entity\\', \\'St. Anna Kinderspital/CCRI_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'France_entity\\', {}), (\\'Armand Trousseau Hospital_entity\\', {})], \\'edges\\': [(\\'France_entity\\', \\'Armand Trousseau Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Spain_entity\\', {}), (\\'Hospital Vall d\u2019Hebron_entity\\', {}), (\\'Hospital Universitario Virgin del Rocio_entity\\', {})], \\'edges\\': [(\\'Spain_entity\\', \\'Hospital Universitario Virgin del Rocio_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Spain_entity\\', \\'Hospital Vall d\u2019Hebron_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'United Kingdom_entity\\', {}), (\\'Great Ormond Street Hospital_entity\\', {})], \\'edges\\': [(\\'United Kingdom_entity\\', \\'Great Ormond Street Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Weirich, A._entity\\', {}), (\\'SIOP-9/GPOH_entity\\', {})], \\'edges\\': [(\\'Weirich, A._entity\\', \\'SIOP-9/GPOH_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Pritchard-Jones, K._entity\\', {}), (\\'UKW3_entity\\', {})], \\'edges\\': [(\\'Pritchard-Jones, K._entity\\', \\'UKW3_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed in\\'})]}, {\\'nodes\\': [(\\'SIOP 93\u201301 trial_entity\\', {}), (\\'de Kraker, J._entity\\', {})], \\'edges\\': [(\\'de Kraker, J._entity\\', \\'SIOP 93\u201301 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'SIOP trial and study 93\u201301_entity\\', {}), (\\'Graf, N._entity\\', {})], \\'edges\\': [(\\'Graf, N._entity\\', \\'SIOP trial and study 93\u201301_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Green, D. M._entity\\', {}), (\\'National Wilms Tumor Study Group_entity\\', {})], \\'edges\\': [(\\'Green, D. M._entity\\', \\'National Wilms Tumor Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}, {\\'nodes\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', {}), (\\'SIOP WT 2001 protocol_entity\\', {})], \\'edges\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', \\'SIOP WT 2001 protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Third National Wilms\u2019 Tumor Study_entity\\', {}), (\"D\\'Angio, G. J._entity\", {}), (\\'Second National Wilms\u2019 Tumor Study_entity\\', {})], \\'edges\\': [(\"D\\'Angio, G. J._entity\", \\'Third National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\"D\\'Angio, G. J._entity\", \\'Second National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {}), (\\'Tournade, M. F._entity\\', {}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {})], \\'edges\\': [(\\'Tournade, M. F._entity\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'}), (\\'Tournade, M. F._entity\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Breslow, N. E._entity\\', {}), (\\'National Wilms Tumor Studies_entity\\', {})], \\'edges\\': [(\\'Breslow, N. E._entity\\', \\'National Wilms Tumor Studies_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Mitchell, C._entity\\', {}), (\\'UK Children\u2019s Cancer Study Group_entity\\', {})], \\'edges\\': [(\\'Mitchell, C._entity\\', \\'UK Children\u2019s Cancer Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'under\\'})]}, {\\'nodes\\': [(\\'Daw, N. C._entity\\', {}), (\\'Dix, D. B._entity\\', {}), (\\'Children\u2019s Oncology Group_entity\\', {}), (\\'Grundy, P. E._entity\\', {})], \\'edges\\': [(\\'Daw, N. C._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted under\\'}), (\\'Dix, D. B._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'}), (\\'Grundy, P. E._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}]', expected_output='Renal tumours account for about 5% of all paediatric malignancies.', context=None, retrieval_context=['[{\\'nodes\\': [(\\'sample.pdf\\', {\\'type\\': \\'document\\'}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)\\'}), (\\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA SIOP-RTSG 2016\\'}), (\\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms tumours\\'}), (\\'non-Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'non-Wilms tumours\\'}), (\\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Website\\', \\'name\\': \\'www.siop-rtsg.eu\\'}), (\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology\\'}), (\\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Person\\', \\'name\\': \\'Marry M. van den Heuvel-Eibrink\\'}), (\\'childhood renal tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'childhood renal tumours\\'}), (\\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'clear cell sarcoma of the kidney\\'}), (\\'renal cell carcinoma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'renal cell carcinoma\\'}), (\\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'malignant rhabdoid tumour of the kidney\\'}), (\\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'Wilms tumours_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'Children\u2019s Oncology Group (COG)\\'}), (\\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'SIOP\u22122001 randomized trial\\'}), (\\'actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'UKW3 trial\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)\\'}), (\\'localized disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'localized disease\\'}), (\\'metastatic disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'metastatic disease\\'}), (\\'bilateral disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'bilateral disease\\'}), (\\'relapsed disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'relapsed disease\\'}), (\\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subtype\\', \\'name\\': \\'blastemal-type Wilms tumours\\'}), (\\'radiotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgery_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'chemotherapy\\'}), (\\'Wilms Tumour_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms Tumour\\'}), (\\'CCSK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CCSK\\'}), (\\'MRTK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'MRTK\\'}), (\\'CMN_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CMN\\'}), (\\'RCC_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'RCC\\'}), (\\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u22122001_Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Trial\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'vincristine_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'vincristine\\'}), (\\'actinomycin D_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'actinomycin D\\'}), (\\'doxorubicin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'doxorubicin\\'}), (\\'etoposide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'Stage I_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage I\\'}), (\\'Stage II_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage II\\'}), (\\'Stage III_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage III\\'}), (\\'Stage IV_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage IV\\'}), (\\'Stage V_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage V\\'}), (\\'AV_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AV\\'}), (\\'AVD_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AVD\\'}), (\\'HR-1_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'HR-1\\'}), (\\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP-RTSG 2016\\'}), (\\'Overall Survival (OS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'CT-only nodules_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'CT-only nodules\\'}), (\\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP\u2013RTSG analysis\\'}), (\\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials\\'}), (\\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D plus doxorubicin\\'}), (\\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D\\'}), (\\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study_protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'MRI_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'MRI\\'}), (\\'CT_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'CT\\'}), (\\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_detail\\', \\'name\\': \\'cumulative doxorubicin dose\\'}), (\\'COG AREN0533 trial_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG AREN0533 trial\\'}), (\\'etoposide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'high-risk characteristics\\'}), (\\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG board\\'}), (\\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin\\'}), (\\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'high-dose chemotherapy and autologous stem cell transplantation\\'}), (\\'SIOP database_database\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'database\\', \\'name\\': \\'SIOP database\\'}), (\\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'AVD_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AVD\\'}), (\\'AV-2_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AV-2\\'}), (\\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Statistical Test\\', \\'name\\': \\'Log\u2013Rank P\\'}), (\\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'Bilateral Disease (Stage V)\\'}), (\\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Synchronous bilateral Wilms tumor\\'}), (\\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'End-stage renal disease (ESRD)\\'}), (\\'Aronson et al._Research Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Research Group\\', \\'name\\': \\'Aronson et al.\\'}), (\\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'Bilateral nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Study\\', \\'name\\': \\'SIOP\u22122001 study\\'}), (\\'Vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Vincristine\\'}), (\\'Actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Actinomycin D\\'}), (\\'Etoposide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Etoposide\\'}), (\\'Carboplatin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Carboplatin\\'}), (\\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease State\\', \\'name\\': \\'Relapsed Wilms Tumor\\'}), (\\'Group AA_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group AA\\'}), (\\'Group BB_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group BB\\'}), (\\'Group CC_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group CC\\'}), (\\'Doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Doxorubicin\\'}), (\\'Cyclophosphamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Cyclophosphamide\\'}), (\\'Ifosfamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Ifosfamide\\'}), (\\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'High-dose melphalan\\'}), (\\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UKW\u2011R protocol\\'}), (\\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'NWTS\u20115 relapse protocol\\'}), (\\'ASCR_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'procedure\\', \\'name\\': \\'ASCR\\'}), (\\'ifosfamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'ifosfamide\\'}), (\\'nephrotoxicity_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'nephrotoxicity\\'}), (\\'relapsed group CC_patient_group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'patient_group\\', \\'name\\': \\'relapsed group CC\\'}), (\\'diffuse anaplasia_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'diffuse anaplasia\\'}), (\\'blastemal-type tumors_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'blastemal-type tumors\\'}), (\\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'camptothecins_medication_class\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication_class\\', \\'name\\': \\'camptothecins\\'}), (\\'irinotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'irinotecan\\'}), (\\'topotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'topotecan\\'}), (\\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Innovative Therapies for Children with Cancer consortium\\'}), (\\'radiotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgical excision_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgical excision\\'}), (\\'stage IV WT_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'stage IV WT\\'}), (\\'AVD150_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD150\\'}), (\\'AVD250_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD250\\'}), (\\'low-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'low-risk disease\\'}), (\\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'intermediate-risk disease\\'}), (\\'high-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'high-risk disease\\'}), (\\'CDCV_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'CDCV\\'}), (\\'actinomycin-D_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'actinomycin-D\\'}), (\\'vincristine_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'doxorubicin\\'}), (\\'VP16_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'VP16\\'}), (\\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'contact\\', \\'name\\': \\'arnauld.verschuur@ap-hm.fr\\'}), (\\'surgery_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'chemotherapy\\'}), (\\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2212RTSG panel\\'}), (\\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Infant Wilms Tumors\\'}), (\\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'nephrectomy\\'}), (\\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'malignant rhabdoid tumors\\'}), (\\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Adult Wilms Tumors\\'}), (\\'anaplasia_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'anaplasia\\'}), (\\'actinomycin D_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'carboplatin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'etoposide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'etoposide\\'}), (\\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'Nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'radical tumor nephrectomy\\'}), (\\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'lymph node sampling\\'}), (\\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'minimally invasive surgery\\'}), (\\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'laparoscopic surgery\\'}), (\\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'radiotherapy\\'}), (\\'Wilms tumours_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'Davila Fajardo et al._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Davila Fajardo et al.\\'}), (\\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'COG\u2013NWTS trials\\'}), (\\'whole-lung irradiation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'whole-lung irradiation\\'}), (\\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'pulmonary radiotherapy\\'}), (\\'proton therapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'proton therapy\\'}), (\\'dosimetric study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'dosimetric study\\'}), (\\'locoregional disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'locoregional disease\\'}), (\\'metastatic disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'metastatic disease\\'}), (\\'low-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'low-risk\\'}), (\\'intermediate-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'intermediate-risk\\'}), (\\'high-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'high-risk\\'}), (\\'stage I_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage I\\'}), (\\'stage II_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage II\\'}), (\\'stage III_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage III\\'}), (\\'major rupture_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'major rupture\\'}), (\\'Austria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Austria\\'}), (\\'Italy_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Italy\\'}), (\\'San Marino_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'San Marino\\'}), (\\'Iceland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Iceland\\'}), (\\'Germany_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Germany\\'}), (\\'Bulgaria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bulgaria\\'}), (\\'Turkey_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Turkey\\'}), (\\'Denmark_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Denmark\\'}), (\\'Poland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Poland\\'}), (\\'Greece_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Greece\\'}), (\\'Andorra_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Andorra\\'}), (\\'Belgium_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belgium\\'}), (\\'Serbia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Serbia\\'}), (\\'Albania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Albania\\'}), (\\'Moldova_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Moldova\\'}), (\\'Lithuania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Lithuania\\'}), (\\'Latvia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Latvia\\'}), (\\'Estonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Estonia\\'}), (\\'Luxembourg_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Luxembourg\\'}), (\\'Montenegro_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Montenegro\\'}), (\\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bosnia and Herzegovina\\'}), (\\'Croatia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Croatia\\'}), (\\'Slovenia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovenia\\'}), (\\'Macedonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Macedonia\\'}), (\\'United Kingdom_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'United Kingdom\\'}), (\\'Ireland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ireland\\'}), (\\'Spain_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Spain\\'}), (\\'Algeria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Algeria\\'}), (\\'Tunisia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Tunisia\\'}), (\\'Malta_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Malta\\'}), (\\'Morocco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Morocco\\'}), (\\'Portugal_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Portugal\\'}), (\\'France_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'France\\'}), (\\'Monaco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Monaco\\'}), (\\'Russia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Russia\\'}), (\\'Finland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Finland\\'}), (\\'Sweden_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Sweden\\'}), (\\'Norway_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Norway\\'}), (\\'Belarus_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belarus\\'}), (\\'Romania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Romania\\'}), (\\'Ukraine_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ukraine\\'}), (\\'Hungary_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Hungary\\'}), (\\'Czech Republic_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Czech Republic\\'}), (\\'Slovakia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovakia\\'}), (\\'Switzerland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Switzerland\\'}), (\\'Liechtenstein_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Liechtenstein\\'}), (\\'Netherlands_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Netherlands\\'}), (\\'University Hospital of Munich_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Munich\\'}), (\\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Tuebingen\\'}), (\\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Azienda Ospedaliera\\'}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Ospedale Pediatrico Bambino Ges\u00f9\\'}), (\\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Fondazione IRCCS Istituto Nazionale dei Tumori\\'}), (\\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Prinses Maxima Centrum\\'}), (\\'Marciniak Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Marciniak Hospital\\'}), (\\'Faculty of Medicine_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Faculty of Medicine\\'}), (\\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'St. Anna Kinderspital/CCRI\\'}), (\\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Armand Trousseau Hospital\\'}), (\\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Universitario Virgin del Rocio\\'}), (\\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Vall d\u2019Hebron\\'}), (\\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Great Ormond Street Hospital\\'}), (\\'University Hospital Homburg_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital Homburg\\'}), (\\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon\\'}), (\\'UMBRELLA protocol_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'ExPO\u2011r\u2011Net\\'}), (\\'Weirich, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Weirich, A.\\'}), (\\'Pritchard-Jones, K._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Pritchard-Jones, K.\\'}), (\\'de Kraker, J._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'de Kraker, J.\\'}), (\\'Graf, N._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Graf, N.\\'}), (\\'Green, D. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Green, D. M.\\'}), (\\'Spreafico, F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Spreafico, F.\\'}), (\\'Bellani, F. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Bellani, F. F.\\'}), (\\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'van den Heuvel-Eibrink, M. M.\\'}), (\"D\\'Angio, G. J._author\", {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \"D\\'Angio, G. J.\"}), (\\'Tournade, M. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Tournade, M. F.\\'}), (\\'Breslow, N. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Breslow, N. E.\\'}), (\\'Mitchell, C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Mitchell, C.\\'}), (\\'Verschuur, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Verschuur, A.\\'}), (\\'Grundy, P. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Grundy, P. E.\\'}), (\\'Warmann, S. W._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Warmann, S. W.\\'}), (\\'Smets, A. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Smets, A. M.\\'}), (\\'Dome, J. S._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dome, J. S.\\'}), (\\'Dix, D. B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dix, D. B.\\'}), (\\'Daw, N. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Daw, N. C.\\'}), (\\'Ha, T. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Ha, T. C.\\'}), (\\'Kremens, B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Kremens, B.\\'}), (\\'Furtwangler, R._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Furtwangler, R.\\'}), (\\'SIOP-9/GPOH_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP-9/GPOH\\'}), (\\'UKW3_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'UKW3\\'}), (\\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'SIOP 93\u201301 trial\\'}), (\\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP trial and study 93\u201301\\'}), (\\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'National Wilms Tumor Study Group\\'}), (\\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP WT 2001 protocol\\'}), (\\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Third National Wilms\u2019 Tumor Study\\'}), (\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'National Wilms Tumor Studies\\'}), (\\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Second National Wilms\u2019 Tumor Study\\'}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'UK Children\u2019s Cancer Study Group\\'}), (\\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Children\u2019s Oncology Group\\'})], \\'edges\\': [(\\'sample.pdf\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'non-Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'childhood renal tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'renal cell carcinoma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'localized disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'metastatic disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'bilateral disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'relapsed disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'radiotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'surgery_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'chemotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'Wilms Tumour_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CCSK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'MRTK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CMN_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'RCC_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP\u22122001_Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'vincristine_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'actinomycin D_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'doxorubicin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'etoposide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'carboplatin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'cyclophosphamide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage I_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage II_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage III_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage IV_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage V_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AV_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AVD_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'HR-1_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Overall Survival (OS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT-only nodules_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'MRI_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG AREN0533 trial_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'etoposide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'carboplatin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'cyclophosphamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP database_database\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AVD_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AV-2_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Aronson et al._Research Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Etoposide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Carboplatin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group AA_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group BB_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group CC_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Cyclophosphamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Ifosfamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'ASCR_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'ifosfamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'nephrotoxicity_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'relapsed group CC_patient_group\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'diffuse anaplasia_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'blastemal-type tumors_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'camptothecins_medication_class\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'irinotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'topotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'radiotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'surgical excision_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'stage IV WT_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD150_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD250_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'low-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'CDCV_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'actinomycin-D_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'vincristine_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'doxorubicin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'VP16_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'surgery_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'chemotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'anaplasia_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'actinomycin D_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'vincristine_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'doxorubicin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'carboplatin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'cyclophosphamide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'etoposide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'SIOP\u22122001_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Wilms tumours_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Davila Fajardo et al._author\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'whole-lung irradiation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'proton therapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'dosimetric study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'locoregional disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'metastatic disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'low-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'intermediate-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'high-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage I_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage II_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage III_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'major rupture_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Austria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Italy_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'San Marino_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Iceland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Germany_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bulgaria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Turkey_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Denmark_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Poland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Greece_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Andorra_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belgium_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Serbia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Albania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Moldova_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Lithuania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Latvia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Estonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Luxembourg_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Montenegro_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Croatia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovenia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Macedonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'United Kingdom_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ireland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Spain_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Algeria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Tunisia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Malta_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Morocco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Portugal_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'France_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Monaco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Russia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Finland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Sweden_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Norway_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belarus_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Romania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ukraine_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hungary_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Czech Republic_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovakia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Switzerland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Liechtenstein_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Netherlands_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Munich_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Marciniak Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Faculty of Medicine_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital Homburg_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Weirich, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Pritchard-Jones, K._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'de Kraker, J._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Graf, N._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Green, D. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Spreafico, F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Bellani, F. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \"D\\'Angio, G. J._author\", {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Tournade, M. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Breslow, N. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Mitchell, C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Verschuur, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Grundy, P. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Warmann, S. W._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Smets, A. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dome, J. S._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dix, D. B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Daw, N. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ha, T. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Kremens, B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Furtwangler, R._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP-9/GPOH_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UKW3_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10})]}, {\\'nodes\\': [(\\'vincristine_entity\\', {}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {}), (\\'www.siop-rtsg.eu_entity\\', {}), (\\'stage II_entity\\', {}), (\\'Wilms tumours_entity\\', {}), (\\'Relapsed Wilms Tumor_entity\\', {}), (\\'Davila Fajardo et al._entity\\', {}), (\\'vincristine, actinomycin D, and doxorubicin_entity\\', {}), (\\'SIOP\u22122001 randomized trial_entity\\', {}), (\\'surgery_entity\\', {}), (\\'non-Wilms tumours_entity\\', {}), (\\'actinomycin D_entity\\', {}), (\\'diffuse anaplasia_entity\\', {}), (\\'Synchronous bilateral Wilms tumor_entity\\', {}), (\\'CT-only nodules_entity\\', {}), (\\'relapsed group CC_entity\\', {}), (\\'increased relapse risk_entity\\', {}), (\\'reduced survival_entity\\', {}), (\\'UKW3 trial_entity\\', {}), (\\'chemotherapy_entity\\', {}), (\\'Bilateral Disease (Stage V)_entity\\', {}), (\\'blastemal-type tumors_entity\\', {}), (\\'UMBRELLA protocol_entity\\', {}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', {}), (\\'minimally invasive surgery_entity\\', {}), (\\'VP16_entity\\', {}), (\\'Wilms tumor_entity\\', {}), (\\'anaplasia_entity\\', {}), (\\'radical tumor nephrectomy_entity\\', {}), (\\'Innovative Therapies for Children with Cancer consortium_entity\\', {}), (\\'cumulative doxorubicin dose_entity\\', {}), (\\'etoposide_entity\\', {}), (\\'large-volume tumours_entity\\', {}), (\\'Stage IV_entity\\', {}), (\\'CDCV_entity\\', {}), (\\'SIOP\u2013RTSG_entity\\', {}), (\\'AVD150_entity\\', {}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', {}), (\\'laparoscopic surgery_entity\\', {}), (\\'SIOP\u2212RTSG panel_entity\\', {}), (\\'actinomycin-D_entity\\', {}), (\\'COG AREN0533 trial_entity\\', {}), (\\'cyclophosphamide_entity\\', {}), (\\'carboplatin_entity\\', {}), (\\'UKW\u2011R protocol_entity\\', {}), (\\'Nephron-sparing surgery (NSS)_entity\\', {}), (\\'Adult Wilms Tumors_entity\\', {}), (\\'doxorubicin_entity\\', {}), (\\'NWTS\u20115 relapse protocol_entity\\', {}), (\\'End-stage renal disease (ESRD)_entity\\', {}), (\\'AVD250_entity\\', {}), (\\'Children\u2019s Oncology Group (COG)_entity\\', {}), (\\'blastemal-type Wilms tumour_entity\\', {}), (\\'SIOP\u22122001_entity\\', {}), (\\'radiotherapy_entity\\', {}), (\\'childhood renal tumours_entity\\', {})], \\'edges\\': [(\\'vincristine_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'stage II_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'indicated_for_in_adults\\'}), (\\'Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'Wilms tumours_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated under\\'}), (\\'Relapsed Wilms Tumor_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guided_by\\'}), (\\'Davila Fajardo et al._entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed\\'}), (\\'SIOP\u22122001 randomized trial_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated use in\\'}), (\\'surgery_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'non-Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'actinomycin D_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Synchronous bilateral Wilms tumor_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'instance_of\\'}), (\\'CT-only nodules_entity\\', \\'increased relapse risk_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'reduced survival_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included_in\\'}), (\\'relapsed group CC_entity\\', \\'diffuse anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'blastemal-type tumors_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UKW3 trial_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'UKW3 trial_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'chemotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UMBRELLA protocol_entity\\', \\'COG AREN0533 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses_data_from\\'}), (\\'UMBRELLA protocol_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'advises_treatment_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'Innovative Therapies for Children with Cancer consortium_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborates_with\\'}), (\\'UMBRELLA protocol_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'surgery_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is the standard of\\'}), (\\'UMBRELLA protocol_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guides treatment in\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', \\'UKW3 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\\'minimally invasive surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'anaplasia_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'radical tumor nephrectomy_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'standard_of_care_for\\'}), (\\'Stage IV_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'presents in\\'}), (\\'CDCV_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'VP16_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'aims to improve survival rates of\\'}), (\\'AVD150_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed_by\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'succeeds\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'www.siop-rtsg.eu_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'available_on\\'}), (\\'laparoscopic surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'COG AREN0533 trial_entity\\', \\'cumulative doxorubicin dose_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'evaluates\\'}), (\\'UKW\u2011R protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'Nephron-sparing surgery (NSS)_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'classification_developed_by\\'}), (\\'Adult Wilms Tumors_entity\\', \\'anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'Adult Wilms Tumors_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'doxorubicin_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'doxorubicin_entity\\', \\'large-volume tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'recommended for\\'}), (\\'NWTS\u20115 relapse protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'End-stage renal disease (ESRD)_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'AVD250_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'Children\u2019s Oncology Group (COG)_entity\\', \\'SIOP\u22122001 randomized trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborated with\\'}), (\\'blastemal-type Wilms tumour_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment intensified according to\\'}), (\\'SIOP\u22122001_entity\\', \\'vincristine, actinomycin D, and doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses\\'}), (\\'SIOP\u22122001_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provided_guidelines_for\\'}), (\\'radiotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'radiotherapy_entity\\', \\'SIOP\u2212RTSG panel_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'contact_for_guidance\\'})]}, {\\'nodes\\': [(\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {}), (\\'Marry M. van den Heuvel-Eibrink_entity\\', {})], \\'edges\\': [(\\'Marry M. van den Heuvel-Eibrink_entity\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'affiliated_with\\'})]}, {\\'nodes\\': [(\\'Stage II_entity\\', {}), (\\'AV_entity\\', {}), (\\'Stage III_entity\\', {}), (\\'vincestine and actinomycin D_entity\\', {}), (\\'AVD_entity\\', {})], \\'edges\\': [(\\'Stage II_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AV_entity\\', \\'Stage II_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Stage III_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AVD_entity\\', \\'Stage III_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'SIOP-RTSG 2016_entity\\', {}), (\\'RCC_entity\\', {}), (\\'CMN_entity\\', {})], \\'edges\\': [(\\'RCC_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'}), (\\'CMN_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'})]}, {\\'nodes\\': [(\\'HR-1_entity\\', {}), (\\'High-risk blastemal type Wilms tumour_entity\\', {})], \\'edges\\': [(\\'HR-1_entity\\', \\'High-risk blastemal type Wilms tumour_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'unfavorable prognosis_entity\\', {}), (\\'high-risk characteristics_entity\\', {})], \\'edges\\': [(\\'high-risk characteristics_entity\\', \\'unfavorable prognosis_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'leads_to\\'})]}, {\\'nodes\\': [(\\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {}), (\\'SIOP\u2013RTSG board_entity\\', {})], \\'edges\\': [(\\'SIOP\u2013RTSG board_entity\\', \\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggests\\'})]}, {\\'nodes\\': [(\\'regimen and outcomes_entity\\', {}), (\\'SIOP database_entity\\', {})], \\'edges\\': [(\\'SIOP database_entity\\', \\'regimen and outcomes_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'captures_data_on\\'})]}, {\\'nodes\\': [(\\'Bilateral nephron-sparing surgery (NSS)_entity\\', {}), (\\'Aronson et al._entity\\', {})], \\'edges\\': [(\\'Aronson et al._entity\\', \\'Bilateral nephron-sparing surgery (NSS)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'observed_effectiveness_of\\'})]}, {\\'nodes\\': [(\\'SIOP\u22122001 study_entity\\', {}), (\\'Actinomycin D_entity\\', {}), (\\'Vincristine_entity\\', {})], \\'edges\\': [(\\'SIOP\u22122001 study_entity\\', \\'Vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'}), (\\'SIOP\u22122001 study_entity\\', \\'Actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'})]}, {\\'nodes\\': [(\\'High-dose melphalan_entity\\', {}), (\\'Group AA_entity\\', {}), (\\'Carboplatin_entity\\', {}), (\\'Doxorubicin_entity\\', {}), (\\'Etoposide_entity\\', {}), (\\'Group BB_entity\\', {}), (\\'Cyclophosphamide_entity\\', {}), (\\'Ifosfamide_entity\\', {})], \\'edges\\': [(\\'Group AA_entity\\', \\'Doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Ifosfamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'High-dose melphalan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'})]}, {\\'nodes\\': [(\\'nephrotoxicity_entity\\', {}), (\\'ifosfamide_entity\\', {})], \\'edges\\': [(\\'ifosfamide_entity\\', \\'nephrotoxicity_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'related_to\\'})]}, {\\'nodes\\': [(\\'camptothecins_entity\\', {}), (\\'irinotecan_entity\\', {}), (\\'topotecan_entity\\', {})], \\'edges\\': [(\\'camptothecins_entity\\', \\'irinotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'camptothecins_entity\\', \\'topotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'})]}, {\\'nodes\\': [(\\'Infant Wilms Tumors_entity\\', {}), (\\'nephrectomy_entity\\', {})], \\'edges\\': [(\\'Infant Wilms Tumors_entity\\', \\'nephrectomy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_option\\'})]}, {\\'nodes\\': [(\\'congenital mesoblastic nephroma_entity\\', {}), (\\'surgery alone_entity\\', {})], \\'edges\\': [(\\'congenital mesoblastic nephroma_entity\\', \\'surgery alone_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'alternative chemotherapy_entity\\', {}), (\\'malignant rhabdoid tumors_entity\\', {})], \\'edges\\': [(\\'malignant rhabdoid tumors_entity\\', \\'alternative chemotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'lymph node sampling_entity\\', {}), (\\'accurate staging_entity\\', {})], \\'edges\\': [(\\'lymph node sampling_entity\\', \\'accurate staging_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'purpose_of\\'})]}, {\\'nodes\\': [(\\'COG\u2013NWTS trials_entity\\', {}), (\\'whole-lung irradiation_entity\\', {})], \\'edges\\': [(\\'COG\u2013NWTS trials_entity\\', \\'whole-lung irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'informed_dosage_for\\'})]}, {\\'nodes\\': [(\\'lung metastases_entity\\', {}), (\\'pulmonary radiotherapy_entity\\', {})], \\'edges\\': [(\\'pulmonary radiotherapy_entity\\', \\'lung metastases_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'administered_for\\'})]}, {\\'nodes\\': [(\\'dosimetric study_entity\\', {}), (\\'proton therapy_entity\\', {}), (\\'flank irradiation_entity\\', {})], \\'edges\\': [(\\'dosimetric study_entity\\', \\'proton therapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated\\'}), (\\'proton therapy_entity\\', \\'flank irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggested_for\\'})]}, {\\'nodes\\': [(\\'metastatic disease_entity\\', {}), (\\'radiotherapy guidelines_entity\\', {}), (\\'locoregional disease_entity\\', {})], \\'edges\\': [(\\'radiotherapy guidelines_entity\\', \\'locoregional disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'}), (\\'radiotherapy guidelines_entity\\', \\'metastatic disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'})]}, {\\'nodes\\': [(\\'major rupture_entity\\', {}), (\\'stage III_entity\\', {})], \\'edges\\': [(\\'stage III_entity\\', \\'major rupture_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes_condition\\'})]}, {\\'nodes\\': [(\\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {}), (\\'ExPO\u2011r\u2011Net_entity\\', {})], \\'edges\\': [(\\'ExPO\u2011r\u2011Net_entity\\', \\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is part of\\'})]}, {\\'nodes\\': [(\\'University Hospital of Munich_entity\\', {}), (\\'Germany_entity\\', {}), (\\'University Hospital of Tuebingen_entity\\', {})], \\'edges\\': [(\\'Germany_entity\\', \\'University Hospital of Munich_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Germany_entity\\', \\'University Hospital of Tuebingen_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {}), (\\'Italy_entity\\', {}), (\\'Azienda Ospedaliera_entity\\', {}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {})], \\'edges\\': [(\\'Italy_entity\\', \\'Azienda Ospedaliera_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Netherlands_entity\\', {}), (\\'Prinses Maxima Centrum_entity\\', {})], \\'edges\\': [(\\'Netherlands_entity\\', \\'Prinses Maxima Centrum_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Marciniak Hospital_entity\\', {}), (\\'Poland_entity\\', {}), (\\'Faculty of Medicine_entity\\', {})], \\'edges\\': [(\\'Poland_entity\\', \\'Marciniak Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Poland_entity\\', \\'Faculty of Medicine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'St. Anna Kinderspital/CCRI_entity\\', {}), (\\'Austria_entity\\', {})], \\'edges\\': [(\\'Austria_entity\\', \\'St. Anna Kinderspital/CCRI_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'France_entity\\', {}), (\\'Armand Trousseau Hospital_entity\\', {})], \\'edges\\': [(\\'France_entity\\', \\'Armand Trousseau Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Spain_entity\\', {}), (\\'Hospital Vall d\u2019Hebron_entity\\', {}), (\\'Hospital Universitario Virgin del Rocio_entity\\', {})], \\'edges\\': [(\\'Spain_entity\\', \\'Hospital Universitario Virgin del Rocio_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Spain_entity\\', \\'Hospital Vall d\u2019Hebron_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'United Kingdom_entity\\', {}), (\\'Great Ormond Street Hospital_entity\\', {})], \\'edges\\': [(\\'United Kingdom_entity\\', \\'Great Ormond Street Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Weirich, A._entity\\', {}), (\\'SIOP-9/GPOH_entity\\', {})], \\'edges\\': [(\\'Weirich, A._entity\\', \\'SIOP-9/GPOH_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Pritchard-Jones, K._entity\\', {}), (\\'UKW3_entity\\', {})], \\'edges\\': [(\\'Pritchard-Jones, K._entity\\', \\'UKW3_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed in\\'})]}, {\\'nodes\\': [(\\'SIOP 93\u201301 trial_entity\\', {}), (\\'de Kraker, J._entity\\', {})], \\'edges\\': [(\\'de Kraker, J._entity\\', \\'SIOP 93\u201301 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'SIOP trial and study 93\u201301_entity\\', {}), (\\'Graf, N._entity\\', {})], \\'edges\\': [(\\'Graf, N._entity\\', \\'SIOP trial and study 93\u201301_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Green, D. M._entity\\', {}), (\\'National Wilms Tumor Study Group_entity\\', {})], \\'edges\\': [(\\'Green, D. M._entity\\', \\'National Wilms Tumor Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}, {\\'nodes\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', {}), (\\'SIOP WT 2001 protocol_entity\\', {})], \\'edges\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', \\'SIOP WT 2001 protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Third National Wilms\u2019 Tumor Study_entity\\', {}), (\"D\\'Angio, G. J._entity\", {}), (\\'Second National Wilms\u2019 Tumor Study_entity\\', {})], \\'edges\\': [(\"D\\'Angio, G. J._entity\", \\'Third National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\"D\\'Angio, G. J._entity\", \\'Second National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {}), (\\'Tournade, M. F._entity\\', {}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {})], \\'edges\\': [(\\'Tournade, M. F._entity\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'}), (\\'Tournade, M. F._entity\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Breslow, N. E._entity\\', {}), (\\'National Wilms Tumor Studies_entity\\', {})], \\'edges\\': [(\\'Breslow, N. E._entity\\', \\'National Wilms Tumor Studies_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Mitchell, C._entity\\', {}), (\\'UK Children\u2019s Cancer Study Group_entity\\', {})], \\'edges\\': [(\\'Mitchell, C._entity\\', \\'UK Children\u2019s Cancer Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'under\\'})]}, {\\'nodes\\': [(\\'Daw, N. C._entity\\', {}), (\\'Dix, D. B._entity\\', {}), (\\'Children\u2019s Oncology Group_entity\\', {}), (\\'Grundy, P. E._entity\\', {})], \\'edges\\': [(\\'Daw, N. C._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted under\\'}), (\\'Dix, D. B._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'}), (\\'Grundy, P. E._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}]']), TestResult(name='test_case_11', success=False, metrics_data=[MetricData(name='Answer Correctness (GEval)', threshold=0.5, success=True, score=0.8198867698977782, reason='The actual output references nephron-sparing surgery and mentions bilateral disease, aligning well with the expected management focus, but lacks the explicit caution against total nephrectomy.', strict_mode=False, evaluation_model='gpt-4o-mini', error=None, evaluation_cost=0.0033023999999999996, verbose_logs='Criteria:\\nNone \\n \\nEvaluation Steps:\\n[\\n    \"Determine whether the actual output is factually correct based on the expected output.\"\\n]'), MetricData(name='Faithfulness', threshold=0.7, success=True, score=0.8571428571428571, reason=None, strict_mode=False, evaluation_model='gpt-4o-mini', error=None, evaluation_cost=0.00819375, verbose_logs='Truths (limit=None):\\n[\\n    \"The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG) is an organization.\",\\n    \"UMBRELLA SIOP-RTSG 2016 is a protocol.\",\\n    \"SIOP\u22122001 is a protocol.\",\\n    \"Wilms tumours and non-Wilms tumours are types of diseases.\",\\n    \"Marry M. van den Heuvel-Eibrink is a person associated with these studies.\",\\n    \"Childhood renal tumours and clear cell sarcoma of the kidney are types of diseases.\",\\n    \"Renal cell carcinoma and malignant rhabdoid tumour of the kidney are types of diseases.\",\\n    \"Congenital mesoblastic nephroma is a type of disease.\",\\n    \"SIOP\u2013RTSG is an organization.\",\\n    \"Children\u2019s Oncology Group (COG) is an organization.\",\\n    \"SIOP\u22122001 randomized trial is a clinical trial.\",\\n    \"UKW3 trial is a clinical trial.\",\\n    \"Vincristine, actinomycin D, and doxorubicin are drugs used in treatment.\",\\n    \"Surgery, chemotherapy, and radiotherapy are treatment methods.\",\\n    \"Stage I, II, III, IV, and V are stages of diseases.\",\\n    \"AV and AVD are treatment combinations.\",\\n    \"Overall Survival (OS) and Event-Free Survival (EFS) are metrics used to measure treatment outcomes.\",\\n    \"MRI and CT are diagnostic tools.\",\\n    \"Bilateral nephron-sparing surgery (NSS) is a treatment method.\",\\n    \"Nephrectomy is a surgical procedure.\",\\n    \"Actinomycin D is a drug used for treatment.\",\\n    \"Doxorubicin is a drug used for treatment.\",\\n    \"Vincristine is a drug used for treatment.\",\\n    \"Carboplatin and cyclophosphamide are drugs used for treatment.\",\\n    \"Ifosfamide is a drug used for treatment.\",\\n    \"Etoposide is a drug used for treatment.\",\\n    \"Nephrotoxicity and anaplasia are medical conditions.\",\\n    \"Bilateral Disease (Stage V) and Synchronous bilateral Wilms tumor are types of disease stages.\",\\n    \"End-stage renal disease (ESRD) is a condition.\",\\n    \"Infant Wilms Tumors and Adult Wilms Tumors are types of medical conditions associated with Wilms tumours.\",\\n    \"SIOP\u2013RTSG analysis is a study related to Wilms tumours.\",\\n    \"The UMBRELLA protocol guides treatment for Wilms tumours.\",\\n    \"The UK Children\u2019s Cancer Study Group conducts research on Wilms tumours and related conditions.\"\\n] \\n \\nClaims:\\n[\\n    \"The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG) is an organization.\",\\n    \"UMBRELLA SIOP-RTSG 2016 is a protocol.\",\\n    \"SIOP\u22122001 is a protocol.\",\\n    \"Wilms tumours is a disease.\",\\n    \"Non-Wilms tumours is a disease.\",\\n    \"The website for SIOP\u2013RTSG is www.siop-rtsg.eu.\",\\n    \"The Department of Paediatric Oncology is part of the Princess M\u00e1xima Center for Paediatric Oncology.\",\\n    \"Marry M. van den Heuvel-Eibrink is a person associated with the document.\",\\n    \"Childhood renal tumours is a disease.\",\\n    \"Clear cell sarcoma of the kidney is a disease.\",\\n    \"Renal cell carcinoma is a disease.\",\\n    \"Malignant rhabdoid tumour of the kidney is a disease.\",\\n    \"Congenital mesoblastic nephroma is a disease.\",\\n    \"UMBRELLA protocol is a treatment protocol.\",\\n    \"SIOP\u2013RTSG is an organization.\",\\n    \"The Children\u2019s Oncology Group (COG) is an organization.\",\\n    \"SIOP\u22122001 randomized trial is a clinical trial.\",\\n    \"Actinomycin D is a drug used in treatments.\",\\n    \"Vincristine is a drug used in treatments.\",\\n    \"Doxorubicin is a drug used in treatments.\",\\n    \"UKW3 trial is a clinical trial.\",\\n    \"The UK Children\u2019s Cancer and Leukaemia Group (UKCCLG) is an organization.\",\\n    \"Localized disease is a disease stage.\",\\n    \"Metastatic disease is a disease stage.\",\\n    \"Bilateral disease is a disease stage.\",\\n    \"Relapsed disease is a disease stage.\",\\n    \"Blastemal-type Wilms tumours is a subtype of Wilms tumour.\",\\n    \"Radiotherapy is a treatment method.\",\\n    \"Surgery is a treatment method.\",\\n    \"Chemotherapy is a treatment method.\",\\n    \"CCSK stands for clear cell sarcoma of the kidney, which is a disease.\",\\n    \"MRTK stands for malignant rhabdoid tumour of the kidney, which is a disease.\",\\n    \"CMN stands for congenital mesoblastic nephroma, which is a disease.\",\\n    \"RCC stands for renal cell carcinoma, which is a disease.\",\\n    \"Stage I, Stage II, Stage III, Stage IV, and Stage V are different staging categories in Wilms tumours.\",\\n    \"AV is a treatment combination.\",\\n    \"AVD is a treatment combination.\",\\n    \"HR-1 is a treatment combination.\",\\n    \"Overall Survival (OS) is a metric for measuring treatment outcomes.\",\\n    \"Event-Free Survival (EFS) is a metric for measuring treatment outcomes.\",\\n    \"CT-only nodules is a medical condition.\",\\n    \"The SIOP\u2013RTSG analysis is a study.\",\\n    \"COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials are studies relevant to Wilms tumours.\",\\n    \"Vincristine and actinomycin D plus doxorubicin is a treatment used for Wilms tumours.\",\\n    \"Vincristine and actinomycin D is another treatment used for Wilms tumours.\",\\n    \"MRI is a diagnostic tool.\",\\n    \"CT is a diagnostic tool.\",\\n    \"Cumulative doxorubicin dose is a treatment detail.\",\\n    \"The COG AREN0533 trial is a study related to Wilms tumours.\",\\n    \"Etoposide is a medication used in treatments.\",\\n    \"Carboplatin is a medication used in treatments.\",\\n    \"Cyclophosphamide is a medication used in treatments.\",\\n    \"High-risk characteristics is a medical condition associated with poorer prognosis.\",\\n    \"SIOP\u2013RTSG board is an organization.\",\\n    \"High-dose chemotherapy and autologous stem cell transplantation are treatment methods.\",\\n    \"SIOP database captures data related to Wilms tumours.\",\\n    \"Event-Free Survival (EFS) is also a subject of study.\",\\n    \"Overall Survival (OS) is also a subject of study.\",\\n    \"AVD is a treatment group.\",\\n    \"AV-2 is another treatment group related to Wilms tumours.\",\\n    \"Log\u2013Rank P is a statistical test used in clinical studies.\",\\n    \"Bilateral Disease (Stage V) is a disease stage for Wilms tumours.\",\\n    \"Synchronous bilateral Wilms tumor is a type of Wilms tumour.\",\\n    \"End-stage renal disease (ESRD) is a condition related to Wilms tumours.\",\\n    \"Aronson et al. is a research group mentioned in the document.\",\\n    \"Bilateral nephron-sparing surgery (NSS) is a treatment method.\",\\n    \"SIOP\u22122001 study is a study related to Wilms tumours.\",\\n    \"Vincristine, actinomycin D, and doxorubicin together are used in childhood cancer treatment.\"\\n] \\n \\nVerdicts:\\n[\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"Wilms tumours are a type of disease, not a general term for disease.\"\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"Non-Wilms tumours are types of diseases, not specifically categorized under the term \\'disease.\\'\"\\n    },\\n    {\\n        \"verdict\": \"idk\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"idk\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"The UK Children\\\\u2019s Cancer and Leukaemia Group (UKCCLG) is not mentioned, only the Children\\\\u2019s Oncology Group (COG) is referenced.\"\\n    },\\n    {\\n        \"verdict\": \"idk\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"Localized, metastatic, bilateral, and relapsed diseases are disease stages but not specifically mentioned as such in the retrieval context.\"\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"Blastemal-type Wilms tumours is a subtype, not a disease itself.\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    }\\n]'), MetricData(name='Contextual Relevancy', threshold=1.0, success=False, score=0.6666666666666666, reason=\"The score is 0.67 because while there are relevant statements such as 'Bilateral nephron-sparing surgery (NSS) is a treatment method' and 'Bilateral Disease (Stage V) is addressed in the UMBRELLA protocol,' the presence of irrelevant details about single-agent chemotherapy detracts from the overall contextual alignment.\", strict_mode=False, evaluation_model='gpt-4o-mini', error=None, evaluation_cost=0.0035911499999999996, verbose_logs='Verdicts:\\n[\\n    {\\n        \"verdicts\": [\\n            {\\n                \"statement\": \"Bilateral Disease (Stage V) is addressed in the UMBRELLA protocol.\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"Bilateral nephron-sparing surgery (NSS) is a treatment method.\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"Synchronous bilateral Wilms tumor is categorized under Bilateral Disease.\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"The UMBRELLA protocol provides guidelines for treatment, including surgery and chemotherapy.\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"Single-agent chemotherapy is often ineffective for Wilms tumours.\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"This statement about \\'Single-agent chemotherapy\\' does not directly relate to how bilateral renal tumours are specifically addressed.\"\\n            },\\n            {\\n                \"statement\": \"Childhood renal tumours are a category that includes several types of tumours, including Wilms tumours.\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"While it mentions childhood renal tumours, it does not address how bilateral renal tumours are specifically handled in protocols.\"\\n            }\\n        ]\\n    }\\n]')], conversational=False, multimodal=False, input='How are bilateral renal tumours addressed in the protocol?', actual_output='[{\\'nodes\\': [(\\'sample.pdf\\', {\\'type\\': \\'document\\'}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)\\'}), (\\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA SIOP-RTSG 2016\\'}), (\\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms tumours\\'}), (\\'non-Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'non-Wilms tumours\\'}), (\\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Website\\', \\'name\\': \\'www.siop-rtsg.eu\\'}), (\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology\\'}), (\\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Person\\', \\'name\\': \\'Marry M. van den Heuvel-Eibrink\\'}), (\\'childhood renal tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'childhood renal tumours\\'}), (\\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'clear cell sarcoma of the kidney\\'}), (\\'renal cell carcinoma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'renal cell carcinoma\\'}), (\\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'malignant rhabdoid tumour of the kidney\\'}), (\\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'Wilms tumours_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'Children\u2019s Oncology Group (COG)\\'}), (\\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'SIOP\u22122001 randomized trial\\'}), (\\'actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'UKW3 trial\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)\\'}), (\\'localized disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'localized disease\\'}), (\\'metastatic disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'metastatic disease\\'}), (\\'bilateral disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'bilateral disease\\'}), (\\'relapsed disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'relapsed disease\\'}), (\\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subtype\\', \\'name\\': \\'blastemal-type Wilms tumours\\'}), (\\'radiotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgery_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'chemotherapy\\'}), (\\'Wilms Tumour_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms Tumour\\'}), (\\'CCSK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CCSK\\'}), (\\'MRTK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'MRTK\\'}), (\\'CMN_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CMN\\'}), (\\'RCC_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'RCC\\'}), (\\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u22122001_Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Trial\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'vincristine_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'vincristine\\'}), (\\'actinomycin D_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'actinomycin D\\'}), (\\'doxorubicin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'doxorubicin\\'}), (\\'etoposide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'Stage I_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage I\\'}), (\\'Stage II_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage II\\'}), (\\'Stage III_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage III\\'}), (\\'Stage IV_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage IV\\'}), (\\'Stage V_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage V\\'}), (\\'AV_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AV\\'}), (\\'AVD_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AVD\\'}), (\\'HR-1_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'HR-1\\'}), (\\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP-RTSG 2016\\'}), (\\'Overall Survival (OS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'CT-only nodules_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'CT-only nodules\\'}), (\\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP\u2013RTSG analysis\\'}), (\\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials\\'}), (\\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D plus doxorubicin\\'}), (\\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D\\'}), (\\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study_protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'MRI_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'MRI\\'}), (\\'CT_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'CT\\'}), (\\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_detail\\', \\'name\\': \\'cumulative doxorubicin dose\\'}), (\\'COG AREN0533 trial_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG AREN0533 trial\\'}), (\\'etoposide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'high-risk characteristics\\'}), (\\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG board\\'}), (\\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin\\'}), (\\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'high-dose chemotherapy and autologous stem cell transplantation\\'}), (\\'SIOP database_database\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'database\\', \\'name\\': \\'SIOP database\\'}), (\\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'AVD_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AVD\\'}), (\\'AV-2_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AV-2\\'}), (\\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Statistical Test\\', \\'name\\': \\'Log\u2013Rank P\\'}), (\\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'Bilateral Disease (Stage V)\\'}), (\\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Synchronous bilateral Wilms tumor\\'}), (\\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'End-stage renal disease (ESRD)\\'}), (\\'Aronson et al._Research Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Research Group\\', \\'name\\': \\'Aronson et al.\\'}), (\\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'Bilateral nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Study\\', \\'name\\': \\'SIOP\u22122001 study\\'}), (\\'Vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Vincristine\\'}), (\\'Actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Actinomycin D\\'}), (\\'Etoposide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Etoposide\\'}), (\\'Carboplatin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Carboplatin\\'}), (\\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease State\\', \\'name\\': \\'Relapsed Wilms Tumor\\'}), (\\'Group AA_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group AA\\'}), (\\'Group BB_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group BB\\'}), (\\'Group CC_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group CC\\'}), (\\'Doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Doxorubicin\\'}), (\\'Cyclophosphamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Cyclophosphamide\\'}), (\\'Ifosfamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Ifosfamide\\'}), (\\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'High-dose melphalan\\'}), (\\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UKW\u2011R protocol\\'}), (\\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'NWTS\u20115 relapse protocol\\'}), (\\'ASCR_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'procedure\\', \\'name\\': \\'ASCR\\'}), (\\'ifosfamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'ifosfamide\\'}), (\\'nephrotoxicity_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'nephrotoxicity\\'}), (\\'relapsed group CC_patient_group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'patient_group\\', \\'name\\': \\'relapsed group CC\\'}), (\\'diffuse anaplasia_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'diffuse anaplasia\\'}), (\\'blastemal-type tumors_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'blastemal-type tumors\\'}), (\\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'camptothecins_medication_class\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication_class\\', \\'name\\': \\'camptothecins\\'}), (\\'irinotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'irinotecan\\'}), (\\'topotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'topotecan\\'}), (\\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Innovative Therapies for Children with Cancer consortium\\'}), (\\'radiotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgical excision_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgical excision\\'}), (\\'stage IV WT_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'stage IV WT\\'}), (\\'AVD150_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD150\\'}), (\\'AVD250_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD250\\'}), (\\'low-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'low-risk disease\\'}), (\\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'intermediate-risk disease\\'}), (\\'high-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'high-risk disease\\'}), (\\'CDCV_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'CDCV\\'}), (\\'actinomycin-D_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'actinomycin-D\\'}), (\\'vincristine_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'doxorubicin\\'}), (\\'VP16_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'VP16\\'}), (\\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'contact\\', \\'name\\': \\'arnauld.verschuur@ap-hm.fr\\'}), (\\'surgery_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'chemotherapy\\'}), (\\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2212RTSG panel\\'}), (\\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Infant Wilms Tumors\\'}), (\\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'nephrectomy\\'}), (\\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'malignant rhabdoid tumors\\'}), (\\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Adult Wilms Tumors\\'}), (\\'anaplasia_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'anaplasia\\'}), (\\'actinomycin D_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'carboplatin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'etoposide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'etoposide\\'}), (\\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'Nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'radical tumor nephrectomy\\'}), (\\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'lymph node sampling\\'}), (\\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'minimally invasive surgery\\'}), (\\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'laparoscopic surgery\\'}), (\\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'radiotherapy\\'}), (\\'Wilms tumours_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'Davila Fajardo et al._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Davila Fajardo et al.\\'}), (\\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'COG\u2013NWTS trials\\'}), (\\'whole-lung irradiation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'whole-lung irradiation\\'}), (\\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'pulmonary radiotherapy\\'}), (\\'proton therapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'proton therapy\\'}), (\\'dosimetric study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'dosimetric study\\'}), (\\'locoregional disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'locoregional disease\\'}), (\\'metastatic disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'metastatic disease\\'}), (\\'low-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'low-risk\\'}), (\\'intermediate-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'intermediate-risk\\'}), (\\'high-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'high-risk\\'}), (\\'stage I_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage I\\'}), (\\'stage II_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage II\\'}), (\\'stage III_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage III\\'}), (\\'major rupture_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'major rupture\\'}), (\\'Austria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Austria\\'}), (\\'Italy_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Italy\\'}), (\\'San Marino_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'San Marino\\'}), (\\'Iceland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Iceland\\'}), (\\'Germany_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Germany\\'}), (\\'Bulgaria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bulgaria\\'}), (\\'Turkey_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Turkey\\'}), (\\'Denmark_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Denmark\\'}), (\\'Poland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Poland\\'}), (\\'Greece_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Greece\\'}), (\\'Andorra_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Andorra\\'}), (\\'Belgium_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belgium\\'}), (\\'Serbia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Serbia\\'}), (\\'Albania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Albania\\'}), (\\'Moldova_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Moldova\\'}), (\\'Lithuania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Lithuania\\'}), (\\'Latvia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Latvia\\'}), (\\'Estonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Estonia\\'}), (\\'Luxembourg_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Luxembourg\\'}), (\\'Montenegro_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Montenegro\\'}), (\\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bosnia and Herzegovina\\'}), (\\'Croatia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Croatia\\'}), (\\'Slovenia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovenia\\'}), (\\'Macedonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Macedonia\\'}), (\\'United Kingdom_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'United Kingdom\\'}), (\\'Ireland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ireland\\'}), (\\'Spain_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Spain\\'}), (\\'Algeria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Algeria\\'}), (\\'Tunisia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Tunisia\\'}), (\\'Malta_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Malta\\'}), (\\'Morocco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Morocco\\'}), (\\'Portugal_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Portugal\\'}), (\\'France_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'France\\'}), (\\'Monaco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Monaco\\'}), (\\'Russia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Russia\\'}), (\\'Finland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Finland\\'}), (\\'Sweden_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Sweden\\'}), (\\'Norway_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Norway\\'}), (\\'Belarus_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belarus\\'}), (\\'Romania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Romania\\'}), (\\'Ukraine_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ukraine\\'}), (\\'Hungary_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Hungary\\'}), (\\'Czech Republic_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Czech Republic\\'}), (\\'Slovakia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovakia\\'}), (\\'Switzerland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Switzerland\\'}), (\\'Liechtenstein_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Liechtenstein\\'}), (\\'Netherlands_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Netherlands\\'}), (\\'University Hospital of Munich_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Munich\\'}), (\\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Tuebingen\\'}), (\\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Azienda Ospedaliera\\'}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Ospedale Pediatrico Bambino Ges\u00f9\\'}), (\\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Fondazione IRCCS Istituto Nazionale dei Tumori\\'}), (\\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Prinses Maxima Centrum\\'}), (\\'Marciniak Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Marciniak Hospital\\'}), (\\'Faculty of Medicine_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Faculty of Medicine\\'}), (\\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'St. Anna Kinderspital/CCRI\\'}), (\\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Armand Trousseau Hospital\\'}), (\\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Universitario Virgin del Rocio\\'}), (\\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Vall d\u2019Hebron\\'}), (\\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Great Ormond Street Hospital\\'}), (\\'University Hospital Homburg_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital Homburg\\'}), (\\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon\\'}), (\\'UMBRELLA protocol_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'ExPO\u2011r\u2011Net\\'}), (\\'Weirich, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Weirich, A.\\'}), (\\'Pritchard-Jones, K._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Pritchard-Jones, K.\\'}), (\\'de Kraker, J._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'de Kraker, J.\\'}), (\\'Graf, N._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Graf, N.\\'}), (\\'Green, D. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Green, D. M.\\'}), (\\'Spreafico, F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Spreafico, F.\\'}), (\\'Bellani, F. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Bellani, F. F.\\'}), (\\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'van den Heuvel-Eibrink, M. M.\\'}), (\"D\\'Angio, G. J._author\", {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \"D\\'Angio, G. J.\"}), (\\'Tournade, M. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Tournade, M. F.\\'}), (\\'Breslow, N. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Breslow, N. E.\\'}), (\\'Mitchell, C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Mitchell, C.\\'}), (\\'Verschuur, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Verschuur, A.\\'}), (\\'Grundy, P. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Grundy, P. E.\\'}), (\\'Warmann, S. W._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Warmann, S. W.\\'}), (\\'Smets, A. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Smets, A. M.\\'}), (\\'Dome, J. S._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dome, J. S.\\'}), (\\'Dix, D. B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dix, D. B.\\'}), (\\'Daw, N. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Daw, N. C.\\'}), (\\'Ha, T. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Ha, T. C.\\'}), (\\'Kremens, B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Kremens, B.\\'}), (\\'Furtwangler, R._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Furtwangler, R.\\'}), (\\'SIOP-9/GPOH_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP-9/GPOH\\'}), (\\'UKW3_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'UKW3\\'}), (\\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'SIOP 93\u201301 trial\\'}), (\\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP trial and study 93\u201301\\'}), (\\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'National Wilms Tumor Study Group\\'}), (\\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP WT 2001 protocol\\'}), (\\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Third National Wilms\u2019 Tumor Study\\'}), (\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'National Wilms Tumor Studies\\'}), (\\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Second National Wilms\u2019 Tumor Study\\'}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'UK Children\u2019s Cancer Study Group\\'}), (\\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Children\u2019s Oncology Group\\'})], \\'edges\\': [(\\'sample.pdf\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'non-Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'childhood renal tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'renal cell carcinoma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'localized disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'metastatic disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'bilateral disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'relapsed disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'radiotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'surgery_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'chemotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'Wilms Tumour_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CCSK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'MRTK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CMN_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'RCC_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP\u22122001_Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'vincristine_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'actinomycin D_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'doxorubicin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'etoposide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'carboplatin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'cyclophosphamide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage I_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage II_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage III_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage IV_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage V_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AV_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AVD_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'HR-1_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Overall Survival (OS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT-only nodules_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'MRI_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG AREN0533 trial_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'etoposide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'carboplatin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'cyclophosphamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP database_database\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AVD_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AV-2_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Aronson et al._Research Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Etoposide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Carboplatin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group AA_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group BB_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group CC_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Cyclophosphamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Ifosfamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'ASCR_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'ifosfamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'nephrotoxicity_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'relapsed group CC_patient_group\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'diffuse anaplasia_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'blastemal-type tumors_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'camptothecins_medication_class\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'irinotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'topotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'radiotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'surgical excision_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'stage IV WT_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD150_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD250_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'low-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'CDCV_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'actinomycin-D_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'vincristine_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'doxorubicin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'VP16_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'surgery_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'chemotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'anaplasia_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'actinomycin D_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'vincristine_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'doxorubicin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'carboplatin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'cyclophosphamide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'etoposide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'SIOP\u22122001_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Wilms tumours_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Davila Fajardo et al._author\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'whole-lung irradiation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'proton therapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'dosimetric study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'locoregional disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'metastatic disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'low-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'intermediate-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'high-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage I_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage II_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage III_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'major rupture_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Austria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Italy_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'San Marino_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Iceland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Germany_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bulgaria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Turkey_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Denmark_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Poland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Greece_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Andorra_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belgium_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Serbia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Albania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Moldova_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Lithuania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Latvia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Estonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Luxembourg_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Montenegro_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Croatia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovenia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Macedonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'United Kingdom_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ireland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Spain_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Algeria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Tunisia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Malta_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Morocco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Portugal_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'France_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Monaco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Russia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Finland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Sweden_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Norway_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belarus_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Romania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ukraine_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hungary_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Czech Republic_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovakia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Switzerland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Liechtenstein_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Netherlands_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Munich_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Marciniak Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Faculty of Medicine_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital Homburg_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Weirich, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Pritchard-Jones, K._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'de Kraker, J._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Graf, N._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Green, D. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Spreafico, F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Bellani, F. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \"D\\'Angio, G. J._author\", {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Tournade, M. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Breslow, N. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Mitchell, C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Verschuur, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Grundy, P. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Warmann, S. W._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Smets, A. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dome, J. S._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dix, D. B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Daw, N. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ha, T. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Kremens, B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Furtwangler, R._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP-9/GPOH_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UKW3_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10})]}, {\\'nodes\\': [(\\'vincristine_entity\\', {}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {}), (\\'www.siop-rtsg.eu_entity\\', {}), (\\'stage II_entity\\', {}), (\\'Wilms tumours_entity\\', {}), (\\'Relapsed Wilms Tumor_entity\\', {}), (\\'Davila Fajardo et al._entity\\', {}), (\\'vincristine, actinomycin D, and doxorubicin_entity\\', {}), (\\'SIOP\u22122001 randomized trial_entity\\', {}), (\\'surgery_entity\\', {}), (\\'non-Wilms tumours_entity\\', {}), (\\'actinomycin D_entity\\', {}), (\\'diffuse anaplasia_entity\\', {}), (\\'Synchronous bilateral Wilms tumor_entity\\', {}), (\\'CT-only nodules_entity\\', {}), (\\'relapsed group CC_entity\\', {}), (\\'increased relapse risk_entity\\', {}), (\\'reduced survival_entity\\', {}), (\\'UKW3 trial_entity\\', {}), (\\'chemotherapy_entity\\', {}), (\\'Bilateral Disease (Stage V)_entity\\', {}), (\\'blastemal-type tumors_entity\\', {}), (\\'UMBRELLA protocol_entity\\', {}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', {}), (\\'minimally invasive surgery_entity\\', {}), (\\'VP16_entity\\', {}), (\\'Wilms tumor_entity\\', {}), (\\'anaplasia_entity\\', {}), (\\'radical tumor nephrectomy_entity\\', {}), (\\'Innovative Therapies for Children with Cancer consortium_entity\\', {}), (\\'cumulative doxorubicin dose_entity\\', {}), (\\'etoposide_entity\\', {}), (\\'large-volume tumours_entity\\', {}), (\\'Stage IV_entity\\', {}), (\\'CDCV_entity\\', {}), (\\'SIOP\u2013RTSG_entity\\', {}), (\\'AVD150_entity\\', {}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', {}), (\\'laparoscopic surgery_entity\\', {}), (\\'SIOP\u2212RTSG panel_entity\\', {}), (\\'actinomycin-D_entity\\', {}), (\\'COG AREN0533 trial_entity\\', {}), (\\'cyclophosphamide_entity\\', {}), (\\'carboplatin_entity\\', {}), (\\'UKW\u2011R protocol_entity\\', {}), (\\'Nephron-sparing surgery (NSS)_entity\\', {}), (\\'Adult Wilms Tumors_entity\\', {}), (\\'doxorubicin_entity\\', {}), (\\'NWTS\u20115 relapse protocol_entity\\', {}), (\\'End-stage renal disease (ESRD)_entity\\', {}), (\\'AVD250_entity\\', {}), (\\'Children\u2019s Oncology Group (COG)_entity\\', {}), (\\'blastemal-type Wilms tumour_entity\\', {}), (\\'SIOP\u22122001_entity\\', {}), (\\'radiotherapy_entity\\', {}), (\\'childhood renal tumours_entity\\', {})], \\'edges\\': [(\\'vincristine_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'stage II_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'indicated_for_in_adults\\'}), (\\'Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'Wilms tumours_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated under\\'}), (\\'Relapsed Wilms Tumor_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guided_by\\'}), (\\'Davila Fajardo et al._entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed\\'}), (\\'SIOP\u22122001 randomized trial_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated use in\\'}), (\\'surgery_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'non-Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'actinomycin D_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Synchronous bilateral Wilms tumor_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'instance_of\\'}), (\\'CT-only nodules_entity\\', \\'increased relapse risk_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'reduced survival_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included_in\\'}), (\\'relapsed group CC_entity\\', \\'diffuse anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'blastemal-type tumors_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UKW3 trial_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'UKW3 trial_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'chemotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UMBRELLA protocol_entity\\', \\'COG AREN0533 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses_data_from\\'}), (\\'UMBRELLA protocol_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'advises_treatment_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'Innovative Therapies for Children with Cancer consortium_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborates_with\\'}), (\\'UMBRELLA protocol_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'surgery_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is the standard of\\'}), (\\'UMBRELLA protocol_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guides treatment in\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', \\'UKW3 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\\'minimally invasive surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'anaplasia_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'radical tumor nephrectomy_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'standard_of_care_for\\'}), (\\'Stage IV_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'presents in\\'}), (\\'CDCV_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'VP16_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'aims to improve survival rates of\\'}), (\\'AVD150_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed_by\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'succeeds\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'www.siop-rtsg.eu_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'available_on\\'}), (\\'laparoscopic surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'COG AREN0533 trial_entity\\', \\'cumulative doxorubicin dose_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'evaluates\\'}), (\\'UKW\u2011R protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'Nephron-sparing surgery (NSS)_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'classification_developed_by\\'}), (\\'Adult Wilms Tumors_entity\\', \\'anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'Adult Wilms Tumors_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'doxorubicin_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'doxorubicin_entity\\', \\'large-volume tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'recommended for\\'}), (\\'NWTS\u20115 relapse protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'End-stage renal disease (ESRD)_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'AVD250_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'Children\u2019s Oncology Group (COG)_entity\\', \\'SIOP\u22122001 randomized trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborated with\\'}), (\\'blastemal-type Wilms tumour_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment intensified according to\\'}), (\\'SIOP\u22122001_entity\\', \\'vincristine, actinomycin D, and doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses\\'}), (\\'SIOP\u22122001_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provided_guidelines_for\\'}), (\\'radiotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'radiotherapy_entity\\', \\'SIOP\u2212RTSG panel_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'contact_for_guidance\\'})]}, {\\'nodes\\': [(\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {}), (\\'Marry M. van den Heuvel-Eibrink_entity\\', {})], \\'edges\\': [(\\'Marry M. van den Heuvel-Eibrink_entity\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'affiliated_with\\'})]}, {\\'nodes\\': [(\\'Stage II_entity\\', {}), (\\'AV_entity\\', {}), (\\'Stage III_entity\\', {}), (\\'vincestine and actinomycin D_entity\\', {}), (\\'AVD_entity\\', {})], \\'edges\\': [(\\'Stage II_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AV_entity\\', \\'Stage II_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Stage III_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AVD_entity\\', \\'Stage III_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'SIOP-RTSG 2016_entity\\', {}), (\\'RCC_entity\\', {}), (\\'CMN_entity\\', {})], \\'edges\\': [(\\'RCC_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'}), (\\'CMN_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'})]}, {\\'nodes\\': [(\\'HR-1_entity\\', {}), (\\'High-risk blastemal type Wilms tumour_entity\\', {})], \\'edges\\': [(\\'HR-1_entity\\', \\'High-risk blastemal type Wilms tumour_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'unfavorable prognosis_entity\\', {}), (\\'high-risk characteristics_entity\\', {})], \\'edges\\': [(\\'high-risk characteristics_entity\\', \\'unfavorable prognosis_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'leads_to\\'})]}, {\\'nodes\\': [(\\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {}), (\\'SIOP\u2013RTSG board_entity\\', {})], \\'edges\\': [(\\'SIOP\u2013RTSG board_entity\\', \\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggests\\'})]}, {\\'nodes\\': [(\\'regimen and outcomes_entity\\', {}), (\\'SIOP database_entity\\', {})], \\'edges\\': [(\\'SIOP database_entity\\', \\'regimen and outcomes_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'captures_data_on\\'})]}, {\\'nodes\\': [(\\'Bilateral nephron-sparing surgery (NSS)_entity\\', {}), (\\'Aronson et al._entity\\', {})], \\'edges\\': [(\\'Aronson et al._entity\\', \\'Bilateral nephron-sparing surgery (NSS)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'observed_effectiveness_of\\'})]}, {\\'nodes\\': [(\\'SIOP\u22122001 study_entity\\', {}), (\\'Actinomycin D_entity\\', {}), (\\'Vincristine_entity\\', {})], \\'edges\\': [(\\'SIOP\u22122001 study_entity\\', \\'Vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'}), (\\'SIOP\u22122001 study_entity\\', \\'Actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'})]}, {\\'nodes\\': [(\\'High-dose melphalan_entity\\', {}), (\\'Group AA_entity\\', {}), (\\'Carboplatin_entity\\', {}), (\\'Doxorubicin_entity\\', {}), (\\'Etoposide_entity\\', {}), (\\'Group BB_entity\\', {}), (\\'Cyclophosphamide_entity\\', {}), (\\'Ifosfamide_entity\\', {})], \\'edges\\': [(\\'Group AA_entity\\', \\'Doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Ifosfamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'High-dose melphalan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'})]}, {\\'nodes\\': [(\\'nephrotoxicity_entity\\', {}), (\\'ifosfamide_entity\\', {})], \\'edges\\': [(\\'ifosfamide_entity\\', \\'nephrotoxicity_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'related_to\\'})]}, {\\'nodes\\': [(\\'camptothecins_entity\\', {}), (\\'irinotecan_entity\\', {}), (\\'topotecan_entity\\', {})], \\'edges\\': [(\\'camptothecins_entity\\', \\'irinotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'camptothecins_entity\\', \\'topotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'})]}, {\\'nodes\\': [(\\'Infant Wilms Tumors_entity\\', {}), (\\'nephrectomy_entity\\', {})], \\'edges\\': [(\\'Infant Wilms Tumors_entity\\', \\'nephrectomy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_option\\'})]}, {\\'nodes\\': [(\\'congenital mesoblastic nephroma_entity\\', {}), (\\'surgery alone_entity\\', {})], \\'edges\\': [(\\'congenital mesoblastic nephroma_entity\\', \\'surgery alone_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'alternative chemotherapy_entity\\', {}), (\\'malignant rhabdoid tumors_entity\\', {})], \\'edges\\': [(\\'malignant rhabdoid tumors_entity\\', \\'alternative chemotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'lymph node sampling_entity\\', {}), (\\'accurate staging_entity\\', {})], \\'edges\\': [(\\'lymph node sampling_entity\\', \\'accurate staging_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'purpose_of\\'})]}, {\\'nodes\\': [(\\'COG\u2013NWTS trials_entity\\', {}), (\\'whole-lung irradiation_entity\\', {})], \\'edges\\': [(\\'COG\u2013NWTS trials_entity\\', \\'whole-lung irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'informed_dosage_for\\'})]}, {\\'nodes\\': [(\\'lung metastases_entity\\', {}), (\\'pulmonary radiotherapy_entity\\', {})], \\'edges\\': [(\\'pulmonary radiotherapy_entity\\', \\'lung metastases_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'administered_for\\'})]}, {\\'nodes\\': [(\\'dosimetric study_entity\\', {}), (\\'proton therapy_entity\\', {}), (\\'flank irradiation_entity\\', {})], \\'edges\\': [(\\'dosimetric study_entity\\', \\'proton therapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated\\'}), (\\'proton therapy_entity\\', \\'flank irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggested_for\\'})]}, {\\'nodes\\': [(\\'metastatic disease_entity\\', {}), (\\'radiotherapy guidelines_entity\\', {}), (\\'locoregional disease_entity\\', {})], \\'edges\\': [(\\'radiotherapy guidelines_entity\\', \\'locoregional disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'}), (\\'radiotherapy guidelines_entity\\', \\'metastatic disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'})]}, {\\'nodes\\': [(\\'major rupture_entity\\', {}), (\\'stage III_entity\\', {})], \\'edges\\': [(\\'stage III_entity\\', \\'major rupture_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes_condition\\'})]}, {\\'nodes\\': [(\\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {}), (\\'ExPO\u2011r\u2011Net_entity\\', {})], \\'edges\\': [(\\'ExPO\u2011r\u2011Net_entity\\', \\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is part of\\'})]}, {\\'nodes\\': [(\\'University Hospital of Munich_entity\\', {}), (\\'Germany_entity\\', {}), (\\'University Hospital of Tuebingen_entity\\', {})], \\'edges\\': [(\\'Germany_entity\\', \\'University Hospital of Munich_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Germany_entity\\', \\'University Hospital of Tuebingen_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {}), (\\'Italy_entity\\', {}), (\\'Azienda Ospedaliera_entity\\', {}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {})], \\'edges\\': [(\\'Italy_entity\\', \\'Azienda Ospedaliera_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Netherlands_entity\\', {}), (\\'Prinses Maxima Centrum_entity\\', {})], \\'edges\\': [(\\'Netherlands_entity\\', \\'Prinses Maxima Centrum_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Marciniak Hospital_entity\\', {}), (\\'Poland_entity\\', {}), (\\'Faculty of Medicine_entity\\', {})], \\'edges\\': [(\\'Poland_entity\\', \\'Marciniak Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Poland_entity\\', \\'Faculty of Medicine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'St. Anna Kinderspital/CCRI_entity\\', {}), (\\'Austria_entity\\', {})], \\'edges\\': [(\\'Austria_entity\\', \\'St. Anna Kinderspital/CCRI_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'France_entity\\', {}), (\\'Armand Trousseau Hospital_entity\\', {})], \\'edges\\': [(\\'France_entity\\', \\'Armand Trousseau Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Spain_entity\\', {}), (\\'Hospital Vall d\u2019Hebron_entity\\', {}), (\\'Hospital Universitario Virgin del Rocio_entity\\', {})], \\'edges\\': [(\\'Spain_entity\\', \\'Hospital Universitario Virgin del Rocio_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Spain_entity\\', \\'Hospital Vall d\u2019Hebron_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'United Kingdom_entity\\', {}), (\\'Great Ormond Street Hospital_entity\\', {})], \\'edges\\': [(\\'United Kingdom_entity\\', \\'Great Ormond Street Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Weirich, A._entity\\', {}), (\\'SIOP-9/GPOH_entity\\', {})], \\'edges\\': [(\\'Weirich, A._entity\\', \\'SIOP-9/GPOH_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Pritchard-Jones, K._entity\\', {}), (\\'UKW3_entity\\', {})], \\'edges\\': [(\\'Pritchard-Jones, K._entity\\', \\'UKW3_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed in\\'})]}, {\\'nodes\\': [(\\'SIOP 93\u201301 trial_entity\\', {}), (\\'de Kraker, J._entity\\', {})], \\'edges\\': [(\\'de Kraker, J._entity\\', \\'SIOP 93\u201301 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'SIOP trial and study 93\u201301_entity\\', {}), (\\'Graf, N._entity\\', {})], \\'edges\\': [(\\'Graf, N._entity\\', \\'SIOP trial and study 93\u201301_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Green, D. M._entity\\', {}), (\\'National Wilms Tumor Study Group_entity\\', {})], \\'edges\\': [(\\'Green, D. M._entity\\', \\'National Wilms Tumor Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}, {\\'nodes\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', {}), (\\'SIOP WT 2001 protocol_entity\\', {})], \\'edges\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', \\'SIOP WT 2001 protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Third National Wilms\u2019 Tumor Study_entity\\', {}), (\"D\\'Angio, G. J._entity\", {}), (\\'Second National Wilms\u2019 Tumor Study_entity\\', {})], \\'edges\\': [(\"D\\'Angio, G. J._entity\", \\'Third National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\"D\\'Angio, G. J._entity\", \\'Second National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {}), (\\'Tournade, M. F._entity\\', {}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {})], \\'edges\\': [(\\'Tournade, M. F._entity\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'}), (\\'Tournade, M. F._entity\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Breslow, N. E._entity\\', {}), (\\'National Wilms Tumor Studies_entity\\', {})], \\'edges\\': [(\\'Breslow, N. E._entity\\', \\'National Wilms Tumor Studies_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Mitchell, C._entity\\', {}), (\\'UK Children\u2019s Cancer Study Group_entity\\', {})], \\'edges\\': [(\\'Mitchell, C._entity\\', \\'UK Children\u2019s Cancer Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'under\\'})]}, {\\'nodes\\': [(\\'Daw, N. C._entity\\', {}), (\\'Dix, D. B._entity\\', {}), (\\'Children\u2019s Oncology Group_entity\\', {}), (\\'Grundy, P. E._entity\\', {})], \\'edges\\': [(\\'Daw, N. C._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted under\\'}), (\\'Dix, D. B._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'}), (\\'Grundy, P. E._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}]', expected_output='Bilateral tumours are managed with a focus on nephron-sparing surgery and careful evaluation to avoid total nephrectomy.', context=None, retrieval_context=['[{\\'nodes\\': [(\\'sample.pdf\\', {\\'type\\': \\'document\\'}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)\\'}), (\\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA SIOP-RTSG 2016\\'}), (\\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms tumours\\'}), (\\'non-Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'non-Wilms tumours\\'}), (\\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Website\\', \\'name\\': \\'www.siop-rtsg.eu\\'}), (\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology\\'}), (\\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Person\\', \\'name\\': \\'Marry M. van den Heuvel-Eibrink\\'}), (\\'childhood renal tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'childhood renal tumours\\'}), (\\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'clear cell sarcoma of the kidney\\'}), (\\'renal cell carcinoma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'renal cell carcinoma\\'}), (\\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'malignant rhabdoid tumour of the kidney\\'}), (\\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'Wilms tumours_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'Children\u2019s Oncology Group (COG)\\'}), (\\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'SIOP\u22122001 randomized trial\\'}), (\\'actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'UKW3 trial\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)\\'}), (\\'localized disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'localized disease\\'}), (\\'metastatic disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'metastatic disease\\'}), (\\'bilateral disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'bilateral disease\\'}), (\\'relapsed disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'relapsed disease\\'}), (\\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subtype\\', \\'name\\': \\'blastemal-type Wilms tumours\\'}), (\\'radiotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgery_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'chemotherapy\\'}), (\\'Wilms Tumour_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms Tumour\\'}), (\\'CCSK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CCSK\\'}), (\\'MRTK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'MRTK\\'}), (\\'CMN_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CMN\\'}), (\\'RCC_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'RCC\\'}), (\\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u22122001_Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Trial\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'vincristine_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'vincristine\\'}), (\\'actinomycin D_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'actinomycin D\\'}), (\\'doxorubicin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'doxorubicin\\'}), (\\'etoposide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'Stage I_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage I\\'}), (\\'Stage II_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage II\\'}), (\\'Stage III_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage III\\'}), (\\'Stage IV_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage IV\\'}), (\\'Stage V_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage V\\'}), (\\'AV_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AV\\'}), (\\'AVD_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AVD\\'}), (\\'HR-1_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'HR-1\\'}), (\\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP-RTSG 2016\\'}), (\\'Overall Survival (OS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'CT-only nodules_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'CT-only nodules\\'}), (\\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP\u2013RTSG analysis\\'}), (\\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials\\'}), (\\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D plus doxorubicin\\'}), (\\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D\\'}), (\\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study_protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'MRI_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'MRI\\'}), (\\'CT_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'CT\\'}), (\\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_detail\\', \\'name\\': \\'cumulative doxorubicin dose\\'}), (\\'COG AREN0533 trial_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG AREN0533 trial\\'}), (\\'etoposide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'high-risk characteristics\\'}), (\\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG board\\'}), (\\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin\\'}), (\\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'high-dose chemotherapy and autologous stem cell transplantation\\'}), (\\'SIOP database_database\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'database\\', \\'name\\': \\'SIOP database\\'}), (\\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'AVD_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AVD\\'}), (\\'AV-2_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AV-2\\'}), (\\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Statistical Test\\', \\'name\\': \\'Log\u2013Rank P\\'}), (\\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'Bilateral Disease (Stage V)\\'}), (\\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Synchronous bilateral Wilms tumor\\'}), (\\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'End-stage renal disease (ESRD)\\'}), (\\'Aronson et al._Research Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Research Group\\', \\'name\\': \\'Aronson et al.\\'}), (\\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'Bilateral nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Study\\', \\'name\\': \\'SIOP\u22122001 study\\'}), (\\'Vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Vincristine\\'}), (\\'Actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Actinomycin D\\'}), (\\'Etoposide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Etoposide\\'}), (\\'Carboplatin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Carboplatin\\'}), (\\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease State\\', \\'name\\': \\'Relapsed Wilms Tumor\\'}), (\\'Group AA_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group AA\\'}), (\\'Group BB_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group BB\\'}), (\\'Group CC_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group CC\\'}), (\\'Doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Doxorubicin\\'}), (\\'Cyclophosphamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Cyclophosphamide\\'}), (\\'Ifosfamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Ifosfamide\\'}), (\\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'High-dose melphalan\\'}), (\\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UKW\u2011R protocol\\'}), (\\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'NWTS\u20115 relapse protocol\\'}), (\\'ASCR_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'procedure\\', \\'name\\': \\'ASCR\\'}), (\\'ifosfamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'ifosfamide\\'}), (\\'nephrotoxicity_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'nephrotoxicity\\'}), (\\'relapsed group CC_patient_group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'patient_group\\', \\'name\\': \\'relapsed group CC\\'}), (\\'diffuse anaplasia_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'diffuse anaplasia\\'}), (\\'blastemal-type tumors_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'blastemal-type tumors\\'}), (\\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'camptothecins_medication_class\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication_class\\', \\'name\\': \\'camptothecins\\'}), (\\'irinotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'irinotecan\\'}), (\\'topotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'topotecan\\'}), (\\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Innovative Therapies for Children with Cancer consortium\\'}), (\\'radiotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgical excision_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgical excision\\'}), (\\'stage IV WT_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'stage IV WT\\'}), (\\'AVD150_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD150\\'}), (\\'AVD250_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD250\\'}), (\\'low-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'low-risk disease\\'}), (\\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'intermediate-risk disease\\'}), (\\'high-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'high-risk disease\\'}), (\\'CDCV_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'CDCV\\'}), (\\'actinomycin-D_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'actinomycin-D\\'}), (\\'vincristine_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'doxorubicin\\'}), (\\'VP16_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'VP16\\'}), (\\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'contact\\', \\'name\\': \\'arnauld.verschuur@ap-hm.fr\\'}), (\\'surgery_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'chemotherapy\\'}), (\\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2212RTSG panel\\'}), (\\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Infant Wilms Tumors\\'}), (\\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'nephrectomy\\'}), (\\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'malignant rhabdoid tumors\\'}), (\\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Adult Wilms Tumors\\'}), (\\'anaplasia_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'anaplasia\\'}), (\\'actinomycin D_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'carboplatin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'etoposide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'etoposide\\'}), (\\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'Nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'radical tumor nephrectomy\\'}), (\\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'lymph node sampling\\'}), (\\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'minimally invasive surgery\\'}), (\\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'laparoscopic surgery\\'}), (\\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'radiotherapy\\'}), (\\'Wilms tumours_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'Davila Fajardo et al._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Davila Fajardo et al.\\'}), (\\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'COG\u2013NWTS trials\\'}), (\\'whole-lung irradiation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'whole-lung irradiation\\'}), (\\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'pulmonary radiotherapy\\'}), (\\'proton therapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'proton therapy\\'}), (\\'dosimetric study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'dosimetric study\\'}), (\\'locoregional disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'locoregional disease\\'}), (\\'metastatic disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'metastatic disease\\'}), (\\'low-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'low-risk\\'}), (\\'intermediate-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'intermediate-risk\\'}), (\\'high-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'high-risk\\'}), (\\'stage I_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage I\\'}), (\\'stage II_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage II\\'}), (\\'stage III_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage III\\'}), (\\'major rupture_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'major rupture\\'}), (\\'Austria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Austria\\'}), (\\'Italy_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Italy\\'}), (\\'San Marino_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'San Marino\\'}), (\\'Iceland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Iceland\\'}), (\\'Germany_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Germany\\'}), (\\'Bulgaria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bulgaria\\'}), (\\'Turkey_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Turkey\\'}), (\\'Denmark_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Denmark\\'}), (\\'Poland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Poland\\'}), (\\'Greece_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Greece\\'}), (\\'Andorra_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Andorra\\'}), (\\'Belgium_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belgium\\'}), (\\'Serbia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Serbia\\'}), (\\'Albania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Albania\\'}), (\\'Moldova_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Moldova\\'}), (\\'Lithuania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Lithuania\\'}), (\\'Latvia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Latvia\\'}), (\\'Estonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Estonia\\'}), (\\'Luxembourg_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Luxembourg\\'}), (\\'Montenegro_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Montenegro\\'}), (\\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bosnia and Herzegovina\\'}), (\\'Croatia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Croatia\\'}), (\\'Slovenia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovenia\\'}), (\\'Macedonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Macedonia\\'}), (\\'United Kingdom_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'United Kingdom\\'}), (\\'Ireland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ireland\\'}), (\\'Spain_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Spain\\'}), (\\'Algeria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Algeria\\'}), (\\'Tunisia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Tunisia\\'}), (\\'Malta_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Malta\\'}), (\\'Morocco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Morocco\\'}), (\\'Portugal_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Portugal\\'}), (\\'France_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'France\\'}), (\\'Monaco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Monaco\\'}), (\\'Russia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Russia\\'}), (\\'Finland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Finland\\'}), (\\'Sweden_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Sweden\\'}), (\\'Norway_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Norway\\'}), (\\'Belarus_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belarus\\'}), (\\'Romania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Romania\\'}), (\\'Ukraine_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ukraine\\'}), (\\'Hungary_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Hungary\\'}), (\\'Czech Republic_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Czech Republic\\'}), (\\'Slovakia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovakia\\'}), (\\'Switzerland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Switzerland\\'}), (\\'Liechtenstein_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Liechtenstein\\'}), (\\'Netherlands_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Netherlands\\'}), (\\'University Hospital of Munich_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Munich\\'}), (\\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Tuebingen\\'}), (\\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Azienda Ospedaliera\\'}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Ospedale Pediatrico Bambino Ges\u00f9\\'}), (\\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Fondazione IRCCS Istituto Nazionale dei Tumori\\'}), (\\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Prinses Maxima Centrum\\'}), (\\'Marciniak Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Marciniak Hospital\\'}), (\\'Faculty of Medicine_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Faculty of Medicine\\'}), (\\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'St. Anna Kinderspital/CCRI\\'}), (\\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Armand Trousseau Hospital\\'}), (\\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Universitario Virgin del Rocio\\'}), (\\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Vall d\u2019Hebron\\'}), (\\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Great Ormond Street Hospital\\'}), (\\'University Hospital Homburg_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital Homburg\\'}), (\\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon\\'}), (\\'UMBRELLA protocol_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'ExPO\u2011r\u2011Net\\'}), (\\'Weirich, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Weirich, A.\\'}), (\\'Pritchard-Jones, K._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Pritchard-Jones, K.\\'}), (\\'de Kraker, J._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'de Kraker, J.\\'}), (\\'Graf, N._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Graf, N.\\'}), (\\'Green, D. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Green, D. M.\\'}), (\\'Spreafico, F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Spreafico, F.\\'}), (\\'Bellani, F. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Bellani, F. F.\\'}), (\\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'van den Heuvel-Eibrink, M. M.\\'}), (\"D\\'Angio, G. J._author\", {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \"D\\'Angio, G. J.\"}), (\\'Tournade, M. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Tournade, M. F.\\'}), (\\'Breslow, N. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Breslow, N. E.\\'}), (\\'Mitchell, C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Mitchell, C.\\'}), (\\'Verschuur, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Verschuur, A.\\'}), (\\'Grundy, P. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Grundy, P. E.\\'}), (\\'Warmann, S. W._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Warmann, S. W.\\'}), (\\'Smets, A. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Smets, A. M.\\'}), (\\'Dome, J. S._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dome, J. S.\\'}), (\\'Dix, D. B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dix, D. B.\\'}), (\\'Daw, N. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Daw, N. C.\\'}), (\\'Ha, T. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Ha, T. C.\\'}), (\\'Kremens, B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Kremens, B.\\'}), (\\'Furtwangler, R._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Furtwangler, R.\\'}), (\\'SIOP-9/GPOH_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP-9/GPOH\\'}), (\\'UKW3_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'UKW3\\'}), (\\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'SIOP 93\u201301 trial\\'}), (\\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP trial and study 93\u201301\\'}), (\\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'National Wilms Tumor Study Group\\'}), (\\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP WT 2001 protocol\\'}), (\\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Third National Wilms\u2019 Tumor Study\\'}), (\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'National Wilms Tumor Studies\\'}), (\\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Second National Wilms\u2019 Tumor Study\\'}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'UK Children\u2019s Cancer Study Group\\'}), (\\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Children\u2019s Oncology Group\\'})], \\'edges\\': [(\\'sample.pdf\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'non-Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'childhood renal tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'renal cell carcinoma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'localized disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'metastatic disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'bilateral disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'relapsed disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'radiotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'surgery_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'chemotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'Wilms Tumour_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CCSK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'MRTK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CMN_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'RCC_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP\u22122001_Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'vincristine_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'actinomycin D_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'doxorubicin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'etoposide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'carboplatin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'cyclophosphamide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage I_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage II_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage III_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage IV_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage V_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AV_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AVD_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'HR-1_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Overall Survival (OS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT-only nodules_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'MRI_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG AREN0533 trial_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'etoposide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'carboplatin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'cyclophosphamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP database_database\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AVD_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AV-2_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Aronson et al._Research Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Etoposide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Carboplatin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group AA_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group BB_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group CC_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Cyclophosphamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Ifosfamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'ASCR_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'ifosfamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'nephrotoxicity_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'relapsed group CC_patient_group\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'diffuse anaplasia_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'blastemal-type tumors_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'camptothecins_medication_class\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'irinotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'topotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'radiotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'surgical excision_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'stage IV WT_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD150_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD250_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'low-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'CDCV_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'actinomycin-D_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'vincristine_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'doxorubicin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'VP16_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'surgery_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'chemotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'anaplasia_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'actinomycin D_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'vincristine_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'doxorubicin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'carboplatin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'cyclophosphamide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'etoposide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'SIOP\u22122001_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Wilms tumours_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Davila Fajardo et al._author\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'whole-lung irradiation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'proton therapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'dosimetric study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'locoregional disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'metastatic disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'low-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'intermediate-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'high-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage I_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage II_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage III_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'major rupture_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Austria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Italy_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'San Marino_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Iceland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Germany_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bulgaria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Turkey_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Denmark_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Poland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Greece_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Andorra_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belgium_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Serbia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Albania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Moldova_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Lithuania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Latvia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Estonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Luxembourg_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Montenegro_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Croatia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovenia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Macedonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'United Kingdom_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ireland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Spain_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Algeria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Tunisia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Malta_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Morocco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Portugal_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'France_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Monaco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Russia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Finland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Sweden_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Norway_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belarus_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Romania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ukraine_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hungary_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Czech Republic_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovakia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Switzerland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Liechtenstein_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Netherlands_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Munich_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Marciniak Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Faculty of Medicine_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital Homburg_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Weirich, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Pritchard-Jones, K._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'de Kraker, J._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Graf, N._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Green, D. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Spreafico, F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Bellani, F. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \"D\\'Angio, G. J._author\", {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Tournade, M. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Breslow, N. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Mitchell, C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Verschuur, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Grundy, P. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Warmann, S. W._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Smets, A. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dome, J. S._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dix, D. B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Daw, N. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ha, T. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Kremens, B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Furtwangler, R._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP-9/GPOH_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UKW3_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10})]}, {\\'nodes\\': [(\\'vincristine_entity\\', {}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {}), (\\'www.siop-rtsg.eu_entity\\', {}), (\\'stage II_entity\\', {}), (\\'Wilms tumours_entity\\', {}), (\\'Relapsed Wilms Tumor_entity\\', {}), (\\'Davila Fajardo et al._entity\\', {}), (\\'vincristine, actinomycin D, and doxorubicin_entity\\', {}), (\\'SIOP\u22122001 randomized trial_entity\\', {}), (\\'surgery_entity\\', {}), (\\'non-Wilms tumours_entity\\', {}), (\\'actinomycin D_entity\\', {}), (\\'diffuse anaplasia_entity\\', {}), (\\'Synchronous bilateral Wilms tumor_entity\\', {}), (\\'CT-only nodules_entity\\', {}), (\\'relapsed group CC_entity\\', {}), (\\'increased relapse risk_entity\\', {}), (\\'reduced survival_entity\\', {}), (\\'UKW3 trial_entity\\', {}), (\\'chemotherapy_entity\\', {}), (\\'Bilateral Disease (Stage V)_entity\\', {}), (\\'blastemal-type tumors_entity\\', {}), (\\'UMBRELLA protocol_entity\\', {}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', {}), (\\'minimally invasive surgery_entity\\', {}), (\\'VP16_entity\\', {}), (\\'Wilms tumor_entity\\', {}), (\\'anaplasia_entity\\', {}), (\\'radical tumor nephrectomy_entity\\', {}), (\\'Innovative Therapies for Children with Cancer consortium_entity\\', {}), (\\'cumulative doxorubicin dose_entity\\', {}), (\\'etoposide_entity\\', {}), (\\'large-volume tumours_entity\\', {}), (\\'Stage IV_entity\\', {}), (\\'CDCV_entity\\', {}), (\\'SIOP\u2013RTSG_entity\\', {}), (\\'AVD150_entity\\', {}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', {}), (\\'laparoscopic surgery_entity\\', {}), (\\'SIOP\u2212RTSG panel_entity\\', {}), (\\'actinomycin-D_entity\\', {}), (\\'COG AREN0533 trial_entity\\', {}), (\\'cyclophosphamide_entity\\', {}), (\\'carboplatin_entity\\', {}), (\\'UKW\u2011R protocol_entity\\', {}), (\\'Nephron-sparing surgery (NSS)_entity\\', {}), (\\'Adult Wilms Tumors_entity\\', {}), (\\'doxorubicin_entity\\', {}), (\\'NWTS\u20115 relapse protocol_entity\\', {}), (\\'End-stage renal disease (ESRD)_entity\\', {}), (\\'AVD250_entity\\', {}), (\\'Children\u2019s Oncology Group (COG)_entity\\', {}), (\\'blastemal-type Wilms tumour_entity\\', {}), (\\'SIOP\u22122001_entity\\', {}), (\\'radiotherapy_entity\\', {}), (\\'childhood renal tumours_entity\\', {})], \\'edges\\': [(\\'vincristine_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'stage II_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'indicated_for_in_adults\\'}), (\\'Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'Wilms tumours_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated under\\'}), (\\'Relapsed Wilms Tumor_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guided_by\\'}), (\\'Davila Fajardo et al._entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed\\'}), (\\'SIOP\u22122001 randomized trial_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated use in\\'}), (\\'surgery_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'non-Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'actinomycin D_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Synchronous bilateral Wilms tumor_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'instance_of\\'}), (\\'CT-only nodules_entity\\', \\'increased relapse risk_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'reduced survival_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included_in\\'}), (\\'relapsed group CC_entity\\', \\'diffuse anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'blastemal-type tumors_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UKW3 trial_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'UKW3 trial_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'chemotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UMBRELLA protocol_entity\\', \\'COG AREN0533 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses_data_from\\'}), (\\'UMBRELLA protocol_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'advises_treatment_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'Innovative Therapies for Children with Cancer consortium_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborates_with\\'}), (\\'UMBRELLA protocol_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'surgery_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is the standard of\\'}), (\\'UMBRELLA protocol_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guides treatment in\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', \\'UKW3 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\\'minimally invasive surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'anaplasia_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'radical tumor nephrectomy_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'standard_of_care_for\\'}), (\\'Stage IV_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'presents in\\'}), (\\'CDCV_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'VP16_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'aims to improve survival rates of\\'}), (\\'AVD150_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed_by\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'succeeds\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'www.siop-rtsg.eu_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'available_on\\'}), (\\'laparoscopic surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'COG AREN0533 trial_entity\\', \\'cumulative doxorubicin dose_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'evaluates\\'}), (\\'UKW\u2011R protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'Nephron-sparing surgery (NSS)_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'classification_developed_by\\'}), (\\'Adult Wilms Tumors_entity\\', \\'anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'Adult Wilms Tumors_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'doxorubicin_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'doxorubicin_entity\\', \\'large-volume tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'recommended for\\'}), (\\'NWTS\u20115 relapse protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'End-stage renal disease (ESRD)_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'AVD250_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'Children\u2019s Oncology Group (COG)_entity\\', \\'SIOP\u22122001 randomized trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborated with\\'}), (\\'blastemal-type Wilms tumour_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment intensified according to\\'}), (\\'SIOP\u22122001_entity\\', \\'vincristine, actinomycin D, and doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses\\'}), (\\'SIOP\u22122001_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provided_guidelines_for\\'}), (\\'radiotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'radiotherapy_entity\\', \\'SIOP\u2212RTSG panel_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'contact_for_guidance\\'})]}, {\\'nodes\\': [(\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {}), (\\'Marry M. van den Heuvel-Eibrink_entity\\', {})], \\'edges\\': [(\\'Marry M. van den Heuvel-Eibrink_entity\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'affiliated_with\\'})]}, {\\'nodes\\': [(\\'Stage II_entity\\', {}), (\\'AV_entity\\', {}), (\\'Stage III_entity\\', {}), (\\'vincestine and actinomycin D_entity\\', {}), (\\'AVD_entity\\', {})], \\'edges\\': [(\\'Stage II_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AV_entity\\', \\'Stage II_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Stage III_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AVD_entity\\', \\'Stage III_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'SIOP-RTSG 2016_entity\\', {}), (\\'RCC_entity\\', {}), (\\'CMN_entity\\', {})], \\'edges\\': [(\\'RCC_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'}), (\\'CMN_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'})]}, {\\'nodes\\': [(\\'HR-1_entity\\', {}), (\\'High-risk blastemal type Wilms tumour_entity\\', {})], \\'edges\\': [(\\'HR-1_entity\\', \\'High-risk blastemal type Wilms tumour_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'unfavorable prognosis_entity\\', {}), (\\'high-risk characteristics_entity\\', {})], \\'edges\\': [(\\'high-risk characteristics_entity\\', \\'unfavorable prognosis_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'leads_to\\'})]}, {\\'nodes\\': [(\\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {}), (\\'SIOP\u2013RTSG board_entity\\', {})], \\'edges\\': [(\\'SIOP\u2013RTSG board_entity\\', \\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggests\\'})]}, {\\'nodes\\': [(\\'regimen and outcomes_entity\\', {}), (\\'SIOP database_entity\\', {})], \\'edges\\': [(\\'SIOP database_entity\\', \\'regimen and outcomes_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'captures_data_on\\'})]}, {\\'nodes\\': [(\\'Bilateral nephron-sparing surgery (NSS)_entity\\', {}), (\\'Aronson et al._entity\\', {})], \\'edges\\': [(\\'Aronson et al._entity\\', \\'Bilateral nephron-sparing surgery (NSS)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'observed_effectiveness_of\\'})]}, {\\'nodes\\': [(\\'SIOP\u22122001 study_entity\\', {}), (\\'Actinomycin D_entity\\', {}), (\\'Vincristine_entity\\', {})], \\'edges\\': [(\\'SIOP\u22122001 study_entity\\', \\'Vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'}), (\\'SIOP\u22122001 study_entity\\', \\'Actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'})]}, {\\'nodes\\': [(\\'High-dose melphalan_entity\\', {}), (\\'Group AA_entity\\', {}), (\\'Carboplatin_entity\\', {}), (\\'Doxorubicin_entity\\', {}), (\\'Etoposide_entity\\', {}), (\\'Group BB_entity\\', {}), (\\'Cyclophosphamide_entity\\', {}), (\\'Ifosfamide_entity\\', {})], \\'edges\\': [(\\'Group AA_entity\\', \\'Doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Ifosfamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'High-dose melphalan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'})]}, {\\'nodes\\': [(\\'nephrotoxicity_entity\\', {}), (\\'ifosfamide_entity\\', {})], \\'edges\\': [(\\'ifosfamide_entity\\', \\'nephrotoxicity_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'related_to\\'})]}, {\\'nodes\\': [(\\'camptothecins_entity\\', {}), (\\'irinotecan_entity\\', {}), (\\'topotecan_entity\\', {})], \\'edges\\': [(\\'camptothecins_entity\\', \\'irinotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'camptothecins_entity\\', \\'topotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'})]}, {\\'nodes\\': [(\\'Infant Wilms Tumors_entity\\', {}), (\\'nephrectomy_entity\\', {})], \\'edges\\': [(\\'Infant Wilms Tumors_entity\\', \\'nephrectomy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_option\\'})]}, {\\'nodes\\': [(\\'congenital mesoblastic nephroma_entity\\', {}), (\\'surgery alone_entity\\', {})], \\'edges\\': [(\\'congenital mesoblastic nephroma_entity\\', \\'surgery alone_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'alternative chemotherapy_entity\\', {}), (\\'malignant rhabdoid tumors_entity\\', {})], \\'edges\\': [(\\'malignant rhabdoid tumors_entity\\', \\'alternative chemotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'lymph node sampling_entity\\', {}), (\\'accurate staging_entity\\', {})], \\'edges\\': [(\\'lymph node sampling_entity\\', \\'accurate staging_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'purpose_of\\'})]}, {\\'nodes\\': [(\\'COG\u2013NWTS trials_entity\\', {}), (\\'whole-lung irradiation_entity\\', {})], \\'edges\\': [(\\'COG\u2013NWTS trials_entity\\', \\'whole-lung irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'informed_dosage_for\\'})]}, {\\'nodes\\': [(\\'lung metastases_entity\\', {}), (\\'pulmonary radiotherapy_entity\\', {})], \\'edges\\': [(\\'pulmonary radiotherapy_entity\\', \\'lung metastases_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'administered_for\\'})]}, {\\'nodes\\': [(\\'dosimetric study_entity\\', {}), (\\'proton therapy_entity\\', {}), (\\'flank irradiation_entity\\', {})], \\'edges\\': [(\\'dosimetric study_entity\\', \\'proton therapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated\\'}), (\\'proton therapy_entity\\', \\'flank irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggested_for\\'})]}, {\\'nodes\\': [(\\'metastatic disease_entity\\', {}), (\\'radiotherapy guidelines_entity\\', {}), (\\'locoregional disease_entity\\', {})], \\'edges\\': [(\\'radiotherapy guidelines_entity\\', \\'locoregional disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'}), (\\'radiotherapy guidelines_entity\\', \\'metastatic disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'})]}, {\\'nodes\\': [(\\'major rupture_entity\\', {}), (\\'stage III_entity\\', {})], \\'edges\\': [(\\'stage III_entity\\', \\'major rupture_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes_condition\\'})]}, {\\'nodes\\': [(\\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {}), (\\'ExPO\u2011r\u2011Net_entity\\', {})], \\'edges\\': [(\\'ExPO\u2011r\u2011Net_entity\\', \\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is part of\\'})]}, {\\'nodes\\': [(\\'University Hospital of Munich_entity\\', {}), (\\'Germany_entity\\', {}), (\\'University Hospital of Tuebingen_entity\\', {})], \\'edges\\': [(\\'Germany_entity\\', \\'University Hospital of Munich_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Germany_entity\\', \\'University Hospital of Tuebingen_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {}), (\\'Italy_entity\\', {}), (\\'Azienda Ospedaliera_entity\\', {}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {})], \\'edges\\': [(\\'Italy_entity\\', \\'Azienda Ospedaliera_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Netherlands_entity\\', {}), (\\'Prinses Maxima Centrum_entity\\', {})], \\'edges\\': [(\\'Netherlands_entity\\', \\'Prinses Maxima Centrum_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Marciniak Hospital_entity\\', {}), (\\'Poland_entity\\', {}), (\\'Faculty of Medicine_entity\\', {})], \\'edges\\': [(\\'Poland_entity\\', \\'Marciniak Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Poland_entity\\', \\'Faculty of Medicine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'St. Anna Kinderspital/CCRI_entity\\', {}), (\\'Austria_entity\\', {})], \\'edges\\': [(\\'Austria_entity\\', \\'St. Anna Kinderspital/CCRI_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'France_entity\\', {}), (\\'Armand Trousseau Hospital_entity\\', {})], \\'edges\\': [(\\'France_entity\\', \\'Armand Trousseau Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Spain_entity\\', {}), (\\'Hospital Vall d\u2019Hebron_entity\\', {}), (\\'Hospital Universitario Virgin del Rocio_entity\\', {})], \\'edges\\': [(\\'Spain_entity\\', \\'Hospital Universitario Virgin del Rocio_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Spain_entity\\', \\'Hospital Vall d\u2019Hebron_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'United Kingdom_entity\\', {}), (\\'Great Ormond Street Hospital_entity\\', {})], \\'edges\\': [(\\'United Kingdom_entity\\', \\'Great Ormond Street Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Weirich, A._entity\\', {}), (\\'SIOP-9/GPOH_entity\\', {})], \\'edges\\': [(\\'Weirich, A._entity\\', \\'SIOP-9/GPOH_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Pritchard-Jones, K._entity\\', {}), (\\'UKW3_entity\\', {})], \\'edges\\': [(\\'Pritchard-Jones, K._entity\\', \\'UKW3_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed in\\'})]}, {\\'nodes\\': [(\\'SIOP 93\u201301 trial_entity\\', {}), (\\'de Kraker, J._entity\\', {})], \\'edges\\': [(\\'de Kraker, J._entity\\', \\'SIOP 93\u201301 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'SIOP trial and study 93\u201301_entity\\', {}), (\\'Graf, N._entity\\', {})], \\'edges\\': [(\\'Graf, N._entity\\', \\'SIOP trial and study 93\u201301_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Green, D. M._entity\\', {}), (\\'National Wilms Tumor Study Group_entity\\', {})], \\'edges\\': [(\\'Green, D. M._entity\\', \\'National Wilms Tumor Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}, {\\'nodes\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', {}), (\\'SIOP WT 2001 protocol_entity\\', {})], \\'edges\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', \\'SIOP WT 2001 protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Third National Wilms\u2019 Tumor Study_entity\\', {}), (\"D\\'Angio, G. J._entity\", {}), (\\'Second National Wilms\u2019 Tumor Study_entity\\', {})], \\'edges\\': [(\"D\\'Angio, G. J._entity\", \\'Third National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\"D\\'Angio, G. J._entity\", \\'Second National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {}), (\\'Tournade, M. F._entity\\', {}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {})], \\'edges\\': [(\\'Tournade, M. F._entity\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'}), (\\'Tournade, M. F._entity\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Breslow, N. E._entity\\', {}), (\\'National Wilms Tumor Studies_entity\\', {})], \\'edges\\': [(\\'Breslow, N. E._entity\\', \\'National Wilms Tumor Studies_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Mitchell, C._entity\\', {}), (\\'UK Children\u2019s Cancer Study Group_entity\\', {})], \\'edges\\': [(\\'Mitchell, C._entity\\', \\'UK Children\u2019s Cancer Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'under\\'})]}, {\\'nodes\\': [(\\'Daw, N. C._entity\\', {}), (\\'Dix, D. B._entity\\', {}), (\\'Children\u2019s Oncology Group_entity\\', {}), (\\'Grundy, P. E._entity\\', {})], \\'edges\\': [(\\'Daw, N. C._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted under\\'}), (\\'Dix, D. B._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'}), (\\'Grundy, P. E._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}]']), TestResult(name='test_case_1', success=False, metrics_data=[MetricData(name='Answer Correctness (GEval)', threshold=0.5, success=True, score=0.7666645574515385, reason=\"The actual output includes several relevant entities such as 'Wilms tumours' and 'childhood renal tumours', closely aligning with the expected output of 'Childhood patients with renal tumours, particularly those with Wilms tumour.' However, it is more verbose and includes some extraneous details.\", strict_mode=False, evaluation_model='gpt-4o-mini', error=None, evaluation_cost=0.0033164999999999996, verbose_logs='Criteria:\\nNone \\n \\nEvaluation Steps:\\n[\\n    \"Determine whether the actual output is factually correct based on the expected output.\"\\n]'), MetricData(name='Faithfulness', threshold=0.7, success=True, score=0.8285714285714286, reason=None, strict_mode=False, evaluation_model='gpt-4o-mini', error=None, evaluation_cost=0.00872295, verbose_logs='Truths (limit=None):\\n[\\n    \"The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG) is an organization.\",\\n    \"UMBRELLA SIOP-RTSG 2016 is a protocol.\",\\n    \"SIOP\u22122001 is a protocol.\",\\n    \"Wilms tumours are a type of disease.\",\\n    \"Non-Wilms tumours are also a type of disease.\",\\n    \"The website www.siop-rtsg.eu is related to SIOP\u2013RTSG.\",\\n    \"The Department of Paediatric Oncology is part of the Princess M\u00e1xima Center for Paediatric Oncology.\",\\n    \"Marry M. van den Heuvel-Eibrink is a person involved in these studies.\",\\n    \"Childhood renal tumours are a type of disease.\",\\n    \"Clear cell sarcoma of the kidney is a type of disease.\",\\n    \"Renal cell carcinoma is considered a type of disease.\",\\n    \"Malignant rhabdoid tumour of the kidney is a type of disease.\",\\n    \"Congenital mesoblastic nephroma is a type of disease.\",\\n    \"The UMBRELLA protocol is a treatment protocol.\",\\n    \"SIOP\u2013RTSG is an organization related to paediatric oncology.\",\\n    \"Children\u2019s Oncology Group (COG) is also an organization.\",\\n    \"SIOP\u22122001 randomized trial is a clinical trial.\",\\n    \"Vincristine, actinomycin D, and doxorubicin are drugs used in treatment.\",\\n    \"The UKW3 trial is a clinical trial related to these studies.\",\\n    \"Localized disease, metastatic disease, bilateral disease, and relapsed disease are all stages of disease.\",\\n    \"Blastemal-type Wilms tumours are a subtype of Wilms tumours.\",\\n    \"Radiotherapy, surgery, and chemotherapy are treatment methods.\",\\n    \"Wilms Tumour, CCSK (clear cell sarcoma of the kidney), MRTK (malignant rhabdoid tumour of the kidney), CMN (congenital mesoblastic nephroma), and RCC (renal cell carcinoma) are types of disease.\",\\n    \"Stage I, Stage II, Stage III, Stage IV, and Stage V are classifications of stages.\",\\n    \"AV and AVD are treatment combinations.\",\\n    \"HR-1 is a treatment combination.\",\\n    \"Overall Survival (OS) and Event-Free Survival (EFS) are metrics used in treatment evaluations.\",\\n    \"CT-only nodules are a medical condition associated with increased relapse risk and reduced survival.\",\\n    \"High-risk characteristics are a medical condition leading to unfavorable prognosis.\",\\n    \"Bilateral Disease (Stage V) refers to a specific stage of Wilms tumours.\",\\n    \"Synchronous bilateral Wilms tumor is a type of Wilms tumour.\",\\n    \"End-stage renal disease (ESRD) is a condition related to nephrological issues.\",\\n    \"High-dose chemotherapy and autologous stem cell transplantation are treatment methods.\",\\n    \"The SIOP database captures data on treatment regimens and outcomes.\",\\n    \"Nephrotoxicity is a condition related to certain medications.\",\\n    \"Ifosfamide is related to nephrotoxicity.\",\\n    \"Camps including irinotecan and topotecan are part of the camptothecins medication class.\",\\n    \"Nephron-sparing surgery (NSS) is a type of surgical procedure.\",\\n    \"Infant Wilms Tumors are treated with nephrectomy as an option.\",\\n    \"Malignant rhabdoid tumors may require alternative chemotherapy.\",\\n    \"Lymph node sampling is for accurate staging.\",\\n    \"Whole-lung irradiation is informed by COG\u2013NWTS trials for treatment dosage.\",\\n    \"Pulmonary radiotherapy is administered for lung metastases.\",\\n    \"Dosimetric studies investigate proton therapy, which is suggested for flank irradiation.\",\\n    \"Radiotherapy guidelines specify treatments for locoregional and metastatic diseases.\",\\n    \"Major rupture is included in stage III conditions.\",\\n    \"The European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment is part of ExPO\u2011r\u2011Net.\",\\n    \"Several hospitals and institutions are affiliated with specific countries like Germany, Italy, Spain, and the United Kingdom.\",\\n    \"Various authors contributed to trials and studies related to Wilms tumours, specifically through organizations like the National Wilms Tumor Study Group and the UK Children\u2019s Cancer Study Group.\"\\n] \\n \\nClaims:\\n[\\n    \"The Renal Tumour Study Group is part of the International Society of Paediatric Oncology (SIOP\u2013RTSG).\",\\n    \"The UMBRELLA SIOP-RTSG 2016 is a protocol.\",\\n    \"The SIOP\u22122001 is a protocol.\",\\n    \"Wilms tumours and non-Wilms tumours are categorized diseases.\",\\n    \"The website for SIOP-RTSG is www.siop-rtsg.eu.\",\\n    \"The Department of Paediatric Oncology is located at the Princess M\u00e1xima Center for Paediatric Oncology.\",\\n    \"Marry M. van den Heuvel-Eibrink is associated with the Department of Paediatric Oncology at the Princess M\u00e1xima Center for Paediatric Oncology.\",\\n    \"Childhood renal tumours include Wilms tumours, clear cell sarcoma of the kidney, renal cell carcinoma, malignant rhabdoid tumour of the kidney, and congenital mesoblastic nephroma.\",\\n    \"Wilms tumours are a specific condition categorized under childhood renal tumours.\",\\n    \"The UMBRELLA protocol is a treatment protocol for Wilms tumours.\",\\n    \"SIOP\u2013RTSG is also referred to as an organization.\",\\n    \"Children\u2019s Oncology Group (COG) is another organization involved in treating Wilms tumours.\",\\n    \"The SIOP\u22122001 randomized trial is a clinical trial related to Wilms tumours.\",\\n    \"Actinomycin D, vincristine, and doxorubicin are drugs used in the treatment of Wilms tumours.\",\\n    \"The UKW3 trial is a clinical trial associated with treatment protocols for Wilms tumours.\",\\n    \"Localized, metastatic, bilateral, and relapsed diseases are stages of Wilms tumours.\",\\n    \"Blastemal-type Wilms tumours are a subtype of Wilms tumours.\",\\n    \"Radiotherapy, surgery, and chemotherapy are treatment methods for Wilms tumours.\",\\n    \"There are protocols corresponding to different stages (Stage I, II, III, IV, V) of Wilms tumours.\",\\n    \"The UMBRELLA protocol includes treatment combinations such as AV, AVD, and HR-1.\",\\n    \"Overall Survival (OS) and Event-Free Survival (EFS) are metrics used in pediatric oncology.\",\\n    \"CT-only nodules can lead to increased relapse risk and reduced survival.\",\\n    \"SIOP\u2013RTSG conducts analyses related to Wilms tumours.\",\\n    \"The COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials are studies related to Wilms tumours.\",\\n    \"Vincristine and actinomycin D plus doxorubicin are treatments for Wilms tumours.\",\\n    \"The SIOP-RTSG analysis is a study involving protocols for Wilms tumours.\",\\n    \"MRI and CT are diagnostic tools used in the examination of Wilms tumours.\",\\n    \"The COG AREN0533 trial studies the response of patients to various treatments.\",\\n    \"Nephrotoxicity is a condition related to certain medications used in treatment.\",\\n    \"Nephron-sparing surgery is a treatment method for Wilms tumours.\",\\n    \"Radical tumor nephrectomy, lymph node sampling, and minimally invasive surgery are surgical procedures indicated for Wilms tumour treatment.\",\\n    \"Bilateral nephron-sparing surgery (NSS) is a treatment method observed to be effective.\",\\n    \"High-dose chemotherapy and autologous stem cell transplantation are suggested by the SIOP\u2013RTSG board.\",\\n    \"The SIOP database captures data on regimen and outcomes of Wilms tumour treatment.\",\\n    \"Infant Wilms Tumors and Adult Wilms Tumors refer to the age classification of Wilms tumours.\"\\n] \\n \\nVerdicts:\\n[\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"The retrieval context states that the Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\\\\u2013RTSG) is an organization, but it does not specify that the Renal Tumour Study Group is part of SIOP\\\\u2013RTSG.\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": \"The UMBRELLA SIOP-RTSG 2016 is correctly identified as a protocol according to the retrieval context.\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": \"The SIOP\\\\u22122001 is accurately described as a protocol according to the retrieval context.\"\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"The retrieval context states that Wilms tumours and non-Wilms tumours are types of diseases, rather than categorically classified diseases.\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": \"The website www.siop-rtsg.eu is correctly linked to the SIOP\\\\u2013RTSG.\"\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"The retrieval context does not specify the location of the Department of Paediatric Oncology, but does confirm its association with the Princess M\\\\u00e1xima Center for Paediatric Oncology.\"\\n    },\\n    {\\n        \"verdict\": \"idk\",\\n        \"reason\": \"The retrieval context confirms Marry M. van den Heuvel-Eibrink is involved in studies but does not indicate her specific association with the Department of Paediatric Oncology at the Princess M\\\\u00e1xima Center.\"\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"The retrieval context lists Wilms tumours, clear cell sarcoma of the kidney, renal cell carcinoma, malignant rhabdoid tumour of the kidney, and congenital mesoblastic nephroma as types of diseases but does not explicitly state their inclusion under childhood renal tumours.\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": \"Wilms tumours are indeed mentioned as a specific condition categorized under childhood renal tumours.\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": \"The UMBRELLA protocol is correctly identified as a treatment protocol for Wilms tumours.\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": \"SIOP\\\\u2013RTSG is accurately referred to as an organization.\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": \"The Children\\\\u2019s Oncology Group (COG) is correctly identified as another organization involved in treating Wilms tumours.\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": \"The SIOP\\\\u22122001 randomized trial is accurately described as a clinical trial related to Wilms tumours.\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": \"Actinomycin D, vincristine, and doxorubicin are correctly identified as drugs used in the treatment of Wilms tumours.\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": \"The UKW3 trial is accurately described as a clinical trial associated with treatment protocols for Wilms tumours.\"\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"The retrieval context establishes that localized, metastatic, bilateral, and relapsed diseases pertain to stages of disease in general and does not specifically frame them as stages of Wilms tumours.\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": \"Blastemal-type Wilms tumours are indeed identified as a subtype of Wilms tumours.\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": \"Radiotherapy, surgery, and chemotherapy are correctly identified as treatment methods for Wilms tumours.\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": \"There are protocols corresponding to different stages (Stage I, II, III, IV, V) of Wilms tumours.\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": \"The UMBRELLA protocol includes treatment combinations such as AV, AVD, and HR-1.\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": \"Overall Survival (OS) and Event-Free Survival (EFS) are metrics used in pediatric oncology.\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": \"CT-only nodules are correctly identified as a condition that can lead to increased relapse risk and reduced survival.\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": \"The SIOP\\\\u2013RTSG conducts analyses related to Wilms tumours.\"\\n    },\\n    {\\n        \"verdict\": \"idk\",\\n        \"reason\": \"The COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials are mentioned in the context but not explained, so their direct relation to Wilms tumours cannot be established.\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": \"Vincristine and actinomycin D plus doxorubicin are correctly reported as treatments for Wilms tumours.\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": \"The SIOP-RTSG analysis is indeed described as a study involving protocols for Wilms tumours.\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": \"MRI and CT are accurately identified as diagnostic tools used in the examination of Wilms tumours.\"\\n    },\\n    {\\n        \"verdict\": \"idk\",\\n        \"reason\": \"The COG AREN0533 trial is referenced but its specifics around patient responses to treatments are not detailed.\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": \"Nephrotoxicity is indeed a condition related to certain medications used in treatment.\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": \"Nephron-sparing surgery is correctly described as a treatment method for Wilms tumours.\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": \"Radical tumor nephrectomy, lymph node sampling, and minimally invasive surgery are properly indicated as surgical procedures for Wilms tumour treatment.\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": \"Bilateral nephron-sparing surgery (NSS) is correctly noted as an effective treatment method.\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": \"High-dose chemotherapy and autologous stem cell transplantation are indeed suggested by the SIOP\\\\u2013RTSG board.\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": \"The SIOP database captures data on regimen and outcomes of Wilms tumour treatment.\"\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"The term \\'Infant Wilms Tumors\\' and \\'Adult Wilms Tumors\\' indicates age classifications but is not distinctly supported in the retrieval context.\"\\n    }\\n]'), MetricData(name='Contextual Relevancy', threshold=1.0, success=False, score=0.5, reason=\"The score is 0.50 because while there are relevant statements such as 'The UMBRELLA protocol addresses patient groups with Wilms tumours,' the majority of the retrieval context discusses other patient groups like 'Group AA and Group BB' and general protocol development, which do not answer the question directly.\", strict_mode=False, evaluation_model='gpt-4o-mini', error=None, evaluation_cost=0.0036921000000000002, verbose_logs='Verdicts:\\n[\\n    {\\n        \"verdicts\": [\\n            {\\n                \"statement\": \"The UMBRELLA protocol addresses patient groups with Wilms tumours.\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"Group AA and Group BB are patient groups identified in the context of childhood renal tumours.\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"Group AA and Group BB are specifically named patient groups but do not directly relate to who the UMBRELLA protocol primarily addresses.\"\\n            },\\n            {\\n                \"statement\": \"The Renal Tumour Study Group of the International Society of Paediatric Oncology developed the UMBRELLA protocol.\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"The statement details about the group that developed the protocol, which doesn\\'t answer the question about the patient group addressed.\"\\n            },\\n            {\\n                \"statement\": \"Childhood renal tumours include a variety of conditions such as Wilms tumours and non-Wilms tumours.\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"Clinical trials associated with childhood cancer include the UKW3 trial.\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"The statement mentions a clinical trial but does not specify the targeted patient group related to the UMBRELLA protocol.\"\\n            },\\n            {\\n                \"statement\": \"The UMBRELLA protocol is part of international collaborations focused on the treatment of Wilms tumours.\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"Wilms Tumour is identified as a significant pediatric renal cancer.\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"Metastatic disease stages are considered in treatment planning for pediatric oncology.\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"Though related, this statement does not specify which patient group the UMBRELLA protocol addresses.\"\\n            }\\n        ]\\n    }\\n]')], conversational=False, multimodal=False, input='Which patient group is primarily addressed by the UMBRELLA protocol?', actual_output='[{\\'nodes\\': [(\\'sample.pdf\\', {\\'type\\': \\'document\\'}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)\\'}), (\\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA SIOP-RTSG 2016\\'}), (\\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms tumours\\'}), (\\'non-Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'non-Wilms tumours\\'}), (\\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Website\\', \\'name\\': \\'www.siop-rtsg.eu\\'}), (\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology\\'}), (\\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Person\\', \\'name\\': \\'Marry M. van den Heuvel-Eibrink\\'}), (\\'childhood renal tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'childhood renal tumours\\'}), (\\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'clear cell sarcoma of the kidney\\'}), (\\'renal cell carcinoma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'renal cell carcinoma\\'}), (\\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'malignant rhabdoid tumour of the kidney\\'}), (\\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'Wilms tumours_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'Children\u2019s Oncology Group (COG)\\'}), (\\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'SIOP\u22122001 randomized trial\\'}), (\\'actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'UKW3 trial\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)\\'}), (\\'localized disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'localized disease\\'}), (\\'metastatic disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'metastatic disease\\'}), (\\'bilateral disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'bilateral disease\\'}), (\\'relapsed disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'relapsed disease\\'}), (\\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subtype\\', \\'name\\': \\'blastemal-type Wilms tumours\\'}), (\\'radiotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgery_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'chemotherapy\\'}), (\\'Wilms Tumour_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms Tumour\\'}), (\\'CCSK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CCSK\\'}), (\\'MRTK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'MRTK\\'}), (\\'CMN_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CMN\\'}), (\\'RCC_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'RCC\\'}), (\\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u22122001_Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Trial\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'vincristine_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'vincristine\\'}), (\\'actinomycin D_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'actinomycin D\\'}), (\\'doxorubicin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'doxorubicin\\'}), (\\'etoposide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'Stage I_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage I\\'}), (\\'Stage II_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage II\\'}), (\\'Stage III_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage III\\'}), (\\'Stage IV_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage IV\\'}), (\\'Stage V_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage V\\'}), (\\'AV_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AV\\'}), (\\'AVD_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AVD\\'}), (\\'HR-1_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'HR-1\\'}), (\\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP-RTSG 2016\\'}), (\\'Overall Survival (OS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'CT-only nodules_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'CT-only nodules\\'}), (\\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP\u2013RTSG analysis\\'}), (\\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials\\'}), (\\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D plus doxorubicin\\'}), (\\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D\\'}), (\\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study_protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'MRI_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'MRI\\'}), (\\'CT_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'CT\\'}), (\\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_detail\\', \\'name\\': \\'cumulative doxorubicin dose\\'}), (\\'COG AREN0533 trial_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG AREN0533 trial\\'}), (\\'etoposide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'high-risk characteristics\\'}), (\\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG board\\'}), (\\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin\\'}), (\\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'high-dose chemotherapy and autologous stem cell transplantation\\'}), (\\'SIOP database_database\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'database\\', \\'name\\': \\'SIOP database\\'}), (\\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'AVD_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AVD\\'}), (\\'AV-2_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AV-2\\'}), (\\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Statistical Test\\', \\'name\\': \\'Log\u2013Rank P\\'}), (\\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'Bilateral Disease (Stage V)\\'}), (\\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Synchronous bilateral Wilms tumor\\'}), (\\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'End-stage renal disease (ESRD)\\'}), (\\'Aronson et al._Research Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Research Group\\', \\'name\\': \\'Aronson et al.\\'}), (\\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'Bilateral nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Study\\', \\'name\\': \\'SIOP\u22122001 study\\'}), (\\'Vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Vincristine\\'}), (\\'Actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Actinomycin D\\'}), (\\'Etoposide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Etoposide\\'}), (\\'Carboplatin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Carboplatin\\'}), (\\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease State\\', \\'name\\': \\'Relapsed Wilms Tumor\\'}), (\\'Group AA_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group AA\\'}), (\\'Group BB_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group BB\\'}), (\\'Group CC_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group CC\\'}), (\\'Doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Doxorubicin\\'}), (\\'Cyclophosphamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Cyclophosphamide\\'}), (\\'Ifosfamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Ifosfamide\\'}), (\\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'High-dose melphalan\\'}), (\\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UKW\u2011R protocol\\'}), (\\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'NWTS\u20115 relapse protocol\\'}), (\\'ASCR_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'procedure\\', \\'name\\': \\'ASCR\\'}), (\\'ifosfamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'ifosfamide\\'}), (\\'nephrotoxicity_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'nephrotoxicity\\'}), (\\'relapsed group CC_patient_group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'patient_group\\', \\'name\\': \\'relapsed group CC\\'}), (\\'diffuse anaplasia_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'diffuse anaplasia\\'}), (\\'blastemal-type tumors_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'blastemal-type tumors\\'}), (\\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'camptothecins_medication_class\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication_class\\', \\'name\\': \\'camptothecins\\'}), (\\'irinotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'irinotecan\\'}), (\\'topotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'topotecan\\'}), (\\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Innovative Therapies for Children with Cancer consortium\\'}), (\\'radiotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgical excision_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgical excision\\'}), (\\'stage IV WT_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'stage IV WT\\'}), (\\'AVD150_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD150\\'}), (\\'AVD250_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD250\\'}), (\\'low-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'low-risk disease\\'}), (\\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'intermediate-risk disease\\'}), (\\'high-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'high-risk disease\\'}), (\\'CDCV_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'CDCV\\'}), (\\'actinomycin-D_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'actinomycin-D\\'}), (\\'vincristine_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'doxorubicin\\'}), (\\'VP16_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'VP16\\'}), (\\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'contact\\', \\'name\\': \\'arnauld.verschuur@ap-hm.fr\\'}), (\\'surgery_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'chemotherapy\\'}), (\\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2212RTSG panel\\'}), (\\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Infant Wilms Tumors\\'}), (\\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'nephrectomy\\'}), (\\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'malignant rhabdoid tumors\\'}), (\\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Adult Wilms Tumors\\'}), (\\'anaplasia_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'anaplasia\\'}), (\\'actinomycin D_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'carboplatin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'etoposide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'etoposide\\'}), (\\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'Nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'radical tumor nephrectomy\\'}), (\\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'lymph node sampling\\'}), (\\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'minimally invasive surgery\\'}), (\\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'laparoscopic surgery\\'}), (\\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'radiotherapy\\'}), (\\'Wilms tumours_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'Davila Fajardo et al._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Davila Fajardo et al.\\'}), (\\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'COG\u2013NWTS trials\\'}), (\\'whole-lung irradiation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'whole-lung irradiation\\'}), (\\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'pulmonary radiotherapy\\'}), (\\'proton therapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'proton therapy\\'}), (\\'dosimetric study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'dosimetric study\\'}), (\\'locoregional disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'locoregional disease\\'}), (\\'metastatic disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'metastatic disease\\'}), (\\'low-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'low-risk\\'}), (\\'intermediate-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'intermediate-risk\\'}), (\\'high-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'high-risk\\'}), (\\'stage I_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage I\\'}), (\\'stage II_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage II\\'}), (\\'stage III_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage III\\'}), (\\'major rupture_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'major rupture\\'}), (\\'Austria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Austria\\'}), (\\'Italy_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Italy\\'}), (\\'San Marino_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'San Marino\\'}), (\\'Iceland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Iceland\\'}), (\\'Germany_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Germany\\'}), (\\'Bulgaria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bulgaria\\'}), (\\'Turkey_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Turkey\\'}), (\\'Denmark_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Denmark\\'}), (\\'Poland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Poland\\'}), (\\'Greece_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Greece\\'}), (\\'Andorra_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Andorra\\'}), (\\'Belgium_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belgium\\'}), (\\'Serbia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Serbia\\'}), (\\'Albania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Albania\\'}), (\\'Moldova_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Moldova\\'}), (\\'Lithuania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Lithuania\\'}), (\\'Latvia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Latvia\\'}), (\\'Estonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Estonia\\'}), (\\'Luxembourg_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Luxembourg\\'}), (\\'Montenegro_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Montenegro\\'}), (\\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bosnia and Herzegovina\\'}), (\\'Croatia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Croatia\\'}), (\\'Slovenia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovenia\\'}), (\\'Macedonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Macedonia\\'}), (\\'United Kingdom_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'United Kingdom\\'}), (\\'Ireland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ireland\\'}), (\\'Spain_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Spain\\'}), (\\'Algeria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Algeria\\'}), (\\'Tunisia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Tunisia\\'}), (\\'Malta_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Malta\\'}), (\\'Morocco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Morocco\\'}), (\\'Portugal_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Portugal\\'}), (\\'France_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'France\\'}), (\\'Monaco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Monaco\\'}), (\\'Russia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Russia\\'}), (\\'Finland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Finland\\'}), (\\'Sweden_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Sweden\\'}), (\\'Norway_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Norway\\'}), (\\'Belarus_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belarus\\'}), (\\'Romania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Romania\\'}), (\\'Ukraine_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ukraine\\'}), (\\'Hungary_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Hungary\\'}), (\\'Czech Republic_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Czech Republic\\'}), (\\'Slovakia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovakia\\'}), (\\'Switzerland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Switzerland\\'}), (\\'Liechtenstein_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Liechtenstein\\'}), (\\'Netherlands_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Netherlands\\'}), (\\'University Hospital of Munich_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Munich\\'}), (\\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Tuebingen\\'}), (\\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Azienda Ospedaliera\\'}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Ospedale Pediatrico Bambino Ges\u00f9\\'}), (\\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Fondazione IRCCS Istituto Nazionale dei Tumori\\'}), (\\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Prinses Maxima Centrum\\'}), (\\'Marciniak Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Marciniak Hospital\\'}), (\\'Faculty of Medicine_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Faculty of Medicine\\'}), (\\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'St. Anna Kinderspital/CCRI\\'}), (\\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Armand Trousseau Hospital\\'}), (\\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Universitario Virgin del Rocio\\'}), (\\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Vall d\u2019Hebron\\'}), (\\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Great Ormond Street Hospital\\'}), (\\'University Hospital Homburg_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital Homburg\\'}), (\\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon\\'}), (\\'UMBRELLA protocol_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'ExPO\u2011r\u2011Net\\'}), (\\'Weirich, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Weirich, A.\\'}), (\\'Pritchard-Jones, K._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Pritchard-Jones, K.\\'}), (\\'de Kraker, J._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'de Kraker, J.\\'}), (\\'Graf, N._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Graf, N.\\'}), (\\'Green, D. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Green, D. M.\\'}), (\\'Spreafico, F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Spreafico, F.\\'}), (\\'Bellani, F. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Bellani, F. F.\\'}), (\\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'van den Heuvel-Eibrink, M. M.\\'}), (\"D\\'Angio, G. J._author\", {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \"D\\'Angio, G. J.\"}), (\\'Tournade, M. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Tournade, M. F.\\'}), (\\'Breslow, N. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Breslow, N. E.\\'}), (\\'Mitchell, C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Mitchell, C.\\'}), (\\'Verschuur, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Verschuur, A.\\'}), (\\'Grundy, P. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Grundy, P. E.\\'}), (\\'Warmann, S. W._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Warmann, S. W.\\'}), (\\'Smets, A. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Smets, A. M.\\'}), (\\'Dome, J. S._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dome, J. S.\\'}), (\\'Dix, D. B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dix, D. B.\\'}), (\\'Daw, N. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Daw, N. C.\\'}), (\\'Ha, T. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Ha, T. C.\\'}), (\\'Kremens, B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Kremens, B.\\'}), (\\'Furtwangler, R._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Furtwangler, R.\\'}), (\\'SIOP-9/GPOH_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP-9/GPOH\\'}), (\\'UKW3_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'UKW3\\'}), (\\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'SIOP 93\u201301 trial\\'}), (\\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP trial and study 93\u201301\\'}), (\\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'National Wilms Tumor Study Group\\'}), (\\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP WT 2001 protocol\\'}), (\\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Third National Wilms\u2019 Tumor Study\\'}), (\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'National Wilms Tumor Studies\\'}), (\\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Second National Wilms\u2019 Tumor Study\\'}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'UK Children\u2019s Cancer Study Group\\'}), (\\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Children\u2019s Oncology Group\\'})], \\'edges\\': [(\\'sample.pdf\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'non-Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'childhood renal tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'renal cell carcinoma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'localized disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'metastatic disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'bilateral disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'relapsed disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'radiotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'surgery_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'chemotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'Wilms Tumour_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CCSK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'MRTK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CMN_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'RCC_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP\u22122001_Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'vincristine_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'actinomycin D_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'doxorubicin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'etoposide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'carboplatin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'cyclophosphamide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage I_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage II_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage III_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage IV_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage V_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AV_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AVD_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'HR-1_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Overall Survival (OS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT-only nodules_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'MRI_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG AREN0533 trial_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'etoposide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'carboplatin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'cyclophosphamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP database_database\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AVD_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AV-2_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Aronson et al._Research Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Etoposide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Carboplatin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group AA_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group BB_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group CC_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Cyclophosphamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Ifosfamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'ASCR_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'ifosfamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'nephrotoxicity_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'relapsed group CC_patient_group\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'diffuse anaplasia_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'blastemal-type tumors_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'camptothecins_medication_class\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'irinotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'topotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'radiotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'surgical excision_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'stage IV WT_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD150_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD250_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'low-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'CDCV_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'actinomycin-D_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'vincristine_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'doxorubicin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'VP16_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'surgery_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'chemotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'anaplasia_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'actinomycin D_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'vincristine_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'doxorubicin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'carboplatin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'cyclophosphamide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'etoposide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'SIOP\u22122001_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Wilms tumours_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Davila Fajardo et al._author\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'whole-lung irradiation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'proton therapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'dosimetric study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'locoregional disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'metastatic disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'low-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'intermediate-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'high-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage I_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage II_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage III_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'major rupture_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Austria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Italy_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'San Marino_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Iceland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Germany_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bulgaria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Turkey_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Denmark_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Poland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Greece_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Andorra_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belgium_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Serbia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Albania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Moldova_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Lithuania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Latvia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Estonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Luxembourg_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Montenegro_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Croatia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovenia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Macedonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'United Kingdom_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ireland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Spain_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Algeria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Tunisia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Malta_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Morocco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Portugal_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'France_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Monaco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Russia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Finland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Sweden_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Norway_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belarus_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Romania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ukraine_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hungary_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Czech Republic_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovakia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Switzerland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Liechtenstein_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Netherlands_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Munich_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Marciniak Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Faculty of Medicine_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital Homburg_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Weirich, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Pritchard-Jones, K._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'de Kraker, J._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Graf, N._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Green, D. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Spreafico, F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Bellani, F. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \"D\\'Angio, G. J._author\", {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Tournade, M. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Breslow, N. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Mitchell, C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Verschuur, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Grundy, P. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Warmann, S. W._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Smets, A. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dome, J. S._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dix, D. B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Daw, N. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ha, T. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Kremens, B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Furtwangler, R._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP-9/GPOH_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UKW3_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10})]}, {\\'nodes\\': [(\\'vincristine_entity\\', {}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {}), (\\'www.siop-rtsg.eu_entity\\', {}), (\\'stage II_entity\\', {}), (\\'Wilms tumours_entity\\', {}), (\\'Relapsed Wilms Tumor_entity\\', {}), (\\'Davila Fajardo et al._entity\\', {}), (\\'vincristine, actinomycin D, and doxorubicin_entity\\', {}), (\\'SIOP\u22122001 randomized trial_entity\\', {}), (\\'surgery_entity\\', {}), (\\'non-Wilms tumours_entity\\', {}), (\\'actinomycin D_entity\\', {}), (\\'diffuse anaplasia_entity\\', {}), (\\'Synchronous bilateral Wilms tumor_entity\\', {}), (\\'CT-only nodules_entity\\', {}), (\\'relapsed group CC_entity\\', {}), (\\'increased relapse risk_entity\\', {}), (\\'reduced survival_entity\\', {}), (\\'UKW3 trial_entity\\', {}), (\\'chemotherapy_entity\\', {}), (\\'Bilateral Disease (Stage V)_entity\\', {}), (\\'blastemal-type tumors_entity\\', {}), (\\'UMBRELLA protocol_entity\\', {}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', {}), (\\'minimally invasive surgery_entity\\', {}), (\\'VP16_entity\\', {}), (\\'Wilms tumor_entity\\', {}), (\\'anaplasia_entity\\', {}), (\\'radical tumor nephrectomy_entity\\', {}), (\\'Innovative Therapies for Children with Cancer consortium_entity\\', {}), (\\'cumulative doxorubicin dose_entity\\', {}), (\\'etoposide_entity\\', {}), (\\'large-volume tumours_entity\\', {}), (\\'Stage IV_entity\\', {}), (\\'CDCV_entity\\', {}), (\\'SIOP\u2013RTSG_entity\\', {}), (\\'AVD150_entity\\', {}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', {}), (\\'laparoscopic surgery_entity\\', {}), (\\'SIOP\u2212RTSG panel_entity\\', {}), (\\'actinomycin-D_entity\\', {}), (\\'COG AREN0533 trial_entity\\', {}), (\\'cyclophosphamide_entity\\', {}), (\\'carboplatin_entity\\', {}), (\\'UKW\u2011R protocol_entity\\', {}), (\\'Nephron-sparing surgery (NSS)_entity\\', {}), (\\'Adult Wilms Tumors_entity\\', {}), (\\'doxorubicin_entity\\', {}), (\\'NWTS\u20115 relapse protocol_entity\\', {}), (\\'End-stage renal disease (ESRD)_entity\\', {}), (\\'AVD250_entity\\', {}), (\\'Children\u2019s Oncology Group (COG)_entity\\', {}), (\\'blastemal-type Wilms tumour_entity\\', {}), (\\'SIOP\u22122001_entity\\', {}), (\\'radiotherapy_entity\\', {}), (\\'childhood renal tumours_entity\\', {})], \\'edges\\': [(\\'vincristine_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'stage II_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'indicated_for_in_adults\\'}), (\\'Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'Wilms tumours_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated under\\'}), (\\'Relapsed Wilms Tumor_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guided_by\\'}), (\\'Davila Fajardo et al._entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed\\'}), (\\'SIOP\u22122001 randomized trial_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated use in\\'}), (\\'surgery_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'non-Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'actinomycin D_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Synchronous bilateral Wilms tumor_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'instance_of\\'}), (\\'CT-only nodules_entity\\', \\'increased relapse risk_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'reduced survival_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included_in\\'}), (\\'relapsed group CC_entity\\', \\'diffuse anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'blastemal-type tumors_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UKW3 trial_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'UKW3 trial_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'chemotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UMBRELLA protocol_entity\\', \\'COG AREN0533 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses_data_from\\'}), (\\'UMBRELLA protocol_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'advises_treatment_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'Innovative Therapies for Children with Cancer consortium_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborates_with\\'}), (\\'UMBRELLA protocol_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'surgery_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is the standard of\\'}), (\\'UMBRELLA protocol_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guides treatment in\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', \\'UKW3 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\\'minimally invasive surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'anaplasia_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'radical tumor nephrectomy_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'standard_of_care_for\\'}), (\\'Stage IV_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'presents in\\'}), (\\'CDCV_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'VP16_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'aims to improve survival rates of\\'}), (\\'AVD150_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed_by\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'succeeds\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'www.siop-rtsg.eu_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'available_on\\'}), (\\'laparoscopic surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'COG AREN0533 trial_entity\\', \\'cumulative doxorubicin dose_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'evaluates\\'}), (\\'UKW\u2011R protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'Nephron-sparing surgery (NSS)_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'classification_developed_by\\'}), (\\'Adult Wilms Tumors_entity\\', \\'anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'Adult Wilms Tumors_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'doxorubicin_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'doxorubicin_entity\\', \\'large-volume tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'recommended for\\'}), (\\'NWTS\u20115 relapse protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'End-stage renal disease (ESRD)_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'AVD250_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'Children\u2019s Oncology Group (COG)_entity\\', \\'SIOP\u22122001 randomized trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborated with\\'}), (\\'blastemal-type Wilms tumour_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment intensified according to\\'}), (\\'SIOP\u22122001_entity\\', \\'vincristine, actinomycin D, and doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses\\'}), (\\'SIOP\u22122001_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provided_guidelines_for\\'}), (\\'radiotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'radiotherapy_entity\\', \\'SIOP\u2212RTSG panel_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'contact_for_guidance\\'})]}, {\\'nodes\\': [(\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {}), (\\'Marry M. van den Heuvel-Eibrink_entity\\', {})], \\'edges\\': [(\\'Marry M. van den Heuvel-Eibrink_entity\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'affiliated_with\\'})]}, {\\'nodes\\': [(\\'Stage II_entity\\', {}), (\\'AV_entity\\', {}), (\\'Stage III_entity\\', {}), (\\'vincestine and actinomycin D_entity\\', {}), (\\'AVD_entity\\', {})], \\'edges\\': [(\\'Stage II_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AV_entity\\', \\'Stage II_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Stage III_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AVD_entity\\', \\'Stage III_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'SIOP-RTSG 2016_entity\\', {}), (\\'RCC_entity\\', {}), (\\'CMN_entity\\', {})], \\'edges\\': [(\\'RCC_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'}), (\\'CMN_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'})]}, {\\'nodes\\': [(\\'HR-1_entity\\', {}), (\\'High-risk blastemal type Wilms tumour_entity\\', {})], \\'edges\\': [(\\'HR-1_entity\\', \\'High-risk blastemal type Wilms tumour_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'unfavorable prognosis_entity\\', {}), (\\'high-risk characteristics_entity\\', {})], \\'edges\\': [(\\'high-risk characteristics_entity\\', \\'unfavorable prognosis_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'leads_to\\'})]}, {\\'nodes\\': [(\\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {}), (\\'SIOP\u2013RTSG board_entity\\', {})], \\'edges\\': [(\\'SIOP\u2013RTSG board_entity\\', \\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggests\\'})]}, {\\'nodes\\': [(\\'regimen and outcomes_entity\\', {}), (\\'SIOP database_entity\\', {})], \\'edges\\': [(\\'SIOP database_entity\\', \\'regimen and outcomes_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'captures_data_on\\'})]}, {\\'nodes\\': [(\\'Bilateral nephron-sparing surgery (NSS)_entity\\', {}), (\\'Aronson et al._entity\\', {})], \\'edges\\': [(\\'Aronson et al._entity\\', \\'Bilateral nephron-sparing surgery (NSS)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'observed_effectiveness_of\\'})]}, {\\'nodes\\': [(\\'SIOP\u22122001 study_entity\\', {}), (\\'Actinomycin D_entity\\', {}), (\\'Vincristine_entity\\', {})], \\'edges\\': [(\\'SIOP\u22122001 study_entity\\', \\'Vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'}), (\\'SIOP\u22122001 study_entity\\', \\'Actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'})]}, {\\'nodes\\': [(\\'High-dose melphalan_entity\\', {}), (\\'Group AA_entity\\', {}), (\\'Carboplatin_entity\\', {}), (\\'Doxorubicin_entity\\', {}), (\\'Etoposide_entity\\', {}), (\\'Group BB_entity\\', {}), (\\'Cyclophosphamide_entity\\', {}), (\\'Ifosfamide_entity\\', {})], \\'edges\\': [(\\'Group AA_entity\\', \\'Doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Ifosfamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'High-dose melphalan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'})]}, {\\'nodes\\': [(\\'nephrotoxicity_entity\\', {}), (\\'ifosfamide_entity\\', {})], \\'edges\\': [(\\'ifosfamide_entity\\', \\'nephrotoxicity_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'related_to\\'})]}, {\\'nodes\\': [(\\'camptothecins_entity\\', {}), (\\'irinotecan_entity\\', {}), (\\'topotecan_entity\\', {})], \\'edges\\': [(\\'camptothecins_entity\\', \\'irinotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'camptothecins_entity\\', \\'topotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'})]}, {\\'nodes\\': [(\\'Infant Wilms Tumors_entity\\', {}), (\\'nephrectomy_entity\\', {})], \\'edges\\': [(\\'Infant Wilms Tumors_entity\\', \\'nephrectomy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_option\\'})]}, {\\'nodes\\': [(\\'congenital mesoblastic nephroma_entity\\', {}), (\\'surgery alone_entity\\', {})], \\'edges\\': [(\\'congenital mesoblastic nephroma_entity\\', \\'surgery alone_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'alternative chemotherapy_entity\\', {}), (\\'malignant rhabdoid tumors_entity\\', {})], \\'edges\\': [(\\'malignant rhabdoid tumors_entity\\', \\'alternative chemotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'lymph node sampling_entity\\', {}), (\\'accurate staging_entity\\', {})], \\'edges\\': [(\\'lymph node sampling_entity\\', \\'accurate staging_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'purpose_of\\'})]}, {\\'nodes\\': [(\\'COG\u2013NWTS trials_entity\\', {}), (\\'whole-lung irradiation_entity\\', {})], \\'edges\\': [(\\'COG\u2013NWTS trials_entity\\', \\'whole-lung irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'informed_dosage_for\\'})]}, {\\'nodes\\': [(\\'lung metastases_entity\\', {}), (\\'pulmonary radiotherapy_entity\\', {})], \\'edges\\': [(\\'pulmonary radiotherapy_entity\\', \\'lung metastases_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'administered_for\\'})]}, {\\'nodes\\': [(\\'dosimetric study_entity\\', {}), (\\'proton therapy_entity\\', {}), (\\'flank irradiation_entity\\', {})], \\'edges\\': [(\\'dosimetric study_entity\\', \\'proton therapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated\\'}), (\\'proton therapy_entity\\', \\'flank irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggested_for\\'})]}, {\\'nodes\\': [(\\'metastatic disease_entity\\', {}), (\\'radiotherapy guidelines_entity\\', {}), (\\'locoregional disease_entity\\', {})], \\'edges\\': [(\\'radiotherapy guidelines_entity\\', \\'locoregional disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'}), (\\'radiotherapy guidelines_entity\\', \\'metastatic disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'})]}, {\\'nodes\\': [(\\'major rupture_entity\\', {}), (\\'stage III_entity\\', {})], \\'edges\\': [(\\'stage III_entity\\', \\'major rupture_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes_condition\\'})]}, {\\'nodes\\': [(\\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {}), (\\'ExPO\u2011r\u2011Net_entity\\', {})], \\'edges\\': [(\\'ExPO\u2011r\u2011Net_entity\\', \\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is part of\\'})]}, {\\'nodes\\': [(\\'University Hospital of Munich_entity\\', {}), (\\'Germany_entity\\', {}), (\\'University Hospital of Tuebingen_entity\\', {})], \\'edges\\': [(\\'Germany_entity\\', \\'University Hospital of Munich_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Germany_entity\\', \\'University Hospital of Tuebingen_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {}), (\\'Italy_entity\\', {}), (\\'Azienda Ospedaliera_entity\\', {}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {})], \\'edges\\': [(\\'Italy_entity\\', \\'Azienda Ospedaliera_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Netherlands_entity\\', {}), (\\'Prinses Maxima Centrum_entity\\', {})], \\'edges\\': [(\\'Netherlands_entity\\', \\'Prinses Maxima Centrum_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Marciniak Hospital_entity\\', {}), (\\'Poland_entity\\', {}), (\\'Faculty of Medicine_entity\\', {})], \\'edges\\': [(\\'Poland_entity\\', \\'Marciniak Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Poland_entity\\', \\'Faculty of Medicine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'St. Anna Kinderspital/CCRI_entity\\', {}), (\\'Austria_entity\\', {})], \\'edges\\': [(\\'Austria_entity\\', \\'St. Anna Kinderspital/CCRI_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'France_entity\\', {}), (\\'Armand Trousseau Hospital_entity\\', {})], \\'edges\\': [(\\'France_entity\\', \\'Armand Trousseau Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Spain_entity\\', {}), (\\'Hospital Vall d\u2019Hebron_entity\\', {}), (\\'Hospital Universitario Virgin del Rocio_entity\\', {})], \\'edges\\': [(\\'Spain_entity\\', \\'Hospital Universitario Virgin del Rocio_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Spain_entity\\', \\'Hospital Vall d\u2019Hebron_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'United Kingdom_entity\\', {}), (\\'Great Ormond Street Hospital_entity\\', {})], \\'edges\\': [(\\'United Kingdom_entity\\', \\'Great Ormond Street Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Weirich, A._entity\\', {}), (\\'SIOP-9/GPOH_entity\\', {})], \\'edges\\': [(\\'Weirich, A._entity\\', \\'SIOP-9/GPOH_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Pritchard-Jones, K._entity\\', {}), (\\'UKW3_entity\\', {})], \\'edges\\': [(\\'Pritchard-Jones, K._entity\\', \\'UKW3_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed in\\'})]}, {\\'nodes\\': [(\\'SIOP 93\u201301 trial_entity\\', {}), (\\'de Kraker, J._entity\\', {})], \\'edges\\': [(\\'de Kraker, J._entity\\', \\'SIOP 93\u201301 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'SIOP trial and study 93\u201301_entity\\', {}), (\\'Graf, N._entity\\', {})], \\'edges\\': [(\\'Graf, N._entity\\', \\'SIOP trial and study 93\u201301_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Green, D. M._entity\\', {}), (\\'National Wilms Tumor Study Group_entity\\', {})], \\'edges\\': [(\\'Green, D. M._entity\\', \\'National Wilms Tumor Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}, {\\'nodes\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', {}), (\\'SIOP WT 2001 protocol_entity\\', {})], \\'edges\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', \\'SIOP WT 2001 protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Third National Wilms\u2019 Tumor Study_entity\\', {}), (\"D\\'Angio, G. J._entity\", {}), (\\'Second National Wilms\u2019 Tumor Study_entity\\', {})], \\'edges\\': [(\"D\\'Angio, G. J._entity\", \\'Third National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\"D\\'Angio, G. J._entity\", \\'Second National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {}), (\\'Tournade, M. F._entity\\', {}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {})], \\'edges\\': [(\\'Tournade, M. F._entity\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'}), (\\'Tournade, M. F._entity\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Breslow, N. E._entity\\', {}), (\\'National Wilms Tumor Studies_entity\\', {})], \\'edges\\': [(\\'Breslow, N. E._entity\\', \\'National Wilms Tumor Studies_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Mitchell, C._entity\\', {}), (\\'UK Children\u2019s Cancer Study Group_entity\\', {})], \\'edges\\': [(\\'Mitchell, C._entity\\', \\'UK Children\u2019s Cancer Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'under\\'})]}, {\\'nodes\\': [(\\'Daw, N. C._entity\\', {}), (\\'Dix, D. B._entity\\', {}), (\\'Children\u2019s Oncology Group_entity\\', {}), (\\'Grundy, P. E._entity\\', {})], \\'edges\\': [(\\'Daw, N. C._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted under\\'}), (\\'Dix, D. B._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'}), (\\'Grundy, P. E._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}]', expected_output='Childhood patients with renal tumours, particularly those with Wilms tumour.', context=None, retrieval_context=['[{\\'nodes\\': [(\\'sample.pdf\\', {\\'type\\': \\'document\\'}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)\\'}), (\\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA SIOP-RTSG 2016\\'}), (\\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms tumours\\'}), (\\'non-Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'non-Wilms tumours\\'}), (\\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Website\\', \\'name\\': \\'www.siop-rtsg.eu\\'}), (\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology\\'}), (\\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Person\\', \\'name\\': \\'Marry M. van den Heuvel-Eibrink\\'}), (\\'childhood renal tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'childhood renal tumours\\'}), (\\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'clear cell sarcoma of the kidney\\'}), (\\'renal cell carcinoma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'renal cell carcinoma\\'}), (\\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'malignant rhabdoid tumour of the kidney\\'}), (\\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'Wilms tumours_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'Children\u2019s Oncology Group (COG)\\'}), (\\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'SIOP\u22122001 randomized trial\\'}), (\\'actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'UKW3 trial\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)\\'}), (\\'localized disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'localized disease\\'}), (\\'metastatic disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'metastatic disease\\'}), (\\'bilateral disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'bilateral disease\\'}), (\\'relapsed disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'relapsed disease\\'}), (\\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subtype\\', \\'name\\': \\'blastemal-type Wilms tumours\\'}), (\\'radiotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgery_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'chemotherapy\\'}), (\\'Wilms Tumour_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms Tumour\\'}), (\\'CCSK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CCSK\\'}), (\\'MRTK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'MRTK\\'}), (\\'CMN_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CMN\\'}), (\\'RCC_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'RCC\\'}), (\\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u22122001_Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Trial\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'vincristine_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'vincristine\\'}), (\\'actinomycin D_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'actinomycin D\\'}), (\\'doxorubicin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'doxorubicin\\'}), (\\'etoposide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'Stage I_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage I\\'}), (\\'Stage II_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage II\\'}), (\\'Stage III_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage III\\'}), (\\'Stage IV_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage IV\\'}), (\\'Stage V_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage V\\'}), (\\'AV_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AV\\'}), (\\'AVD_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AVD\\'}), (\\'HR-1_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'HR-1\\'}), (\\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP-RTSG 2016\\'}), (\\'Overall Survival (OS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'CT-only nodules_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'CT-only nodules\\'}), (\\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP\u2013RTSG analysis\\'}), (\\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials\\'}), (\\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D plus doxorubicin\\'}), (\\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D\\'}), (\\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study_protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'MRI_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'MRI\\'}), (\\'CT_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'CT\\'}), (\\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_detail\\', \\'name\\': \\'cumulative doxorubicin dose\\'}), (\\'COG AREN0533 trial_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG AREN0533 trial\\'}), (\\'etoposide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'high-risk characteristics\\'}), (\\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG board\\'}), (\\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin\\'}), (\\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'high-dose chemotherapy and autologous stem cell transplantation\\'}), (\\'SIOP database_database\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'database\\', \\'name\\': \\'SIOP database\\'}), (\\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'AVD_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AVD\\'}), (\\'AV-2_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AV-2\\'}), (\\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Statistical Test\\', \\'name\\': \\'Log\u2013Rank P\\'}), (\\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'Bilateral Disease (Stage V)\\'}), (\\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Synchronous bilateral Wilms tumor\\'}), (\\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'End-stage renal disease (ESRD)\\'}), (\\'Aronson et al._Research Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Research Group\\', \\'name\\': \\'Aronson et al.\\'}), (\\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'Bilateral nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Study\\', \\'name\\': \\'SIOP\u22122001 study\\'}), (\\'Vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Vincristine\\'}), (\\'Actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Actinomycin D\\'}), (\\'Etoposide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Etoposide\\'}), (\\'Carboplatin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Carboplatin\\'}), (\\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease State\\', \\'name\\': \\'Relapsed Wilms Tumor\\'}), (\\'Group AA_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group AA\\'}), (\\'Group BB_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group BB\\'}), (\\'Group CC_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group CC\\'}), (\\'Doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Doxorubicin\\'}), (\\'Cyclophosphamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Cyclophosphamide\\'}), (\\'Ifosfamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Ifosfamide\\'}), (\\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'High-dose melphalan\\'}), (\\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UKW\u2011R protocol\\'}), (\\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'NWTS\u20115 relapse protocol\\'}), (\\'ASCR_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'procedure\\', \\'name\\': \\'ASCR\\'}), (\\'ifosfamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'ifosfamide\\'}), (\\'nephrotoxicity_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'nephrotoxicity\\'}), (\\'relapsed group CC_patient_group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'patient_group\\', \\'name\\': \\'relapsed group CC\\'}), (\\'diffuse anaplasia_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'diffuse anaplasia\\'}), (\\'blastemal-type tumors_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'blastemal-type tumors\\'}), (\\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'camptothecins_medication_class\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication_class\\', \\'name\\': \\'camptothecins\\'}), (\\'irinotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'irinotecan\\'}), (\\'topotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'topotecan\\'}), (\\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Innovative Therapies for Children with Cancer consortium\\'}), (\\'radiotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgical excision_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgical excision\\'}), (\\'stage IV WT_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'stage IV WT\\'}), (\\'AVD150_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD150\\'}), (\\'AVD250_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD250\\'}), (\\'low-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'low-risk disease\\'}), (\\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'intermediate-risk disease\\'}), (\\'high-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'high-risk disease\\'}), (\\'CDCV_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'CDCV\\'}), (\\'actinomycin-D_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'actinomycin-D\\'}), (\\'vincristine_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'doxorubicin\\'}), (\\'VP16_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'VP16\\'}), (\\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'contact\\', \\'name\\': \\'arnauld.verschuur@ap-hm.fr\\'}), (\\'surgery_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'chemotherapy\\'}), (\\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2212RTSG panel\\'}), (\\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Infant Wilms Tumors\\'}), (\\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'nephrectomy\\'}), (\\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'malignant rhabdoid tumors\\'}), (\\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Adult Wilms Tumors\\'}), (\\'anaplasia_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'anaplasia\\'}), (\\'actinomycin D_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'carboplatin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'etoposide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'etoposide\\'}), (\\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'Nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'radical tumor nephrectomy\\'}), (\\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'lymph node sampling\\'}), (\\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'minimally invasive surgery\\'}), (\\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'laparoscopic surgery\\'}), (\\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'radiotherapy\\'}), (\\'Wilms tumours_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'Davila Fajardo et al._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Davila Fajardo et al.\\'}), (\\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'COG\u2013NWTS trials\\'}), (\\'whole-lung irradiation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'whole-lung irradiation\\'}), (\\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'pulmonary radiotherapy\\'}), (\\'proton therapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'proton therapy\\'}), (\\'dosimetric study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'dosimetric study\\'}), (\\'locoregional disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'locoregional disease\\'}), (\\'metastatic disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'metastatic disease\\'}), (\\'low-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'low-risk\\'}), (\\'intermediate-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'intermediate-risk\\'}), (\\'high-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'high-risk\\'}), (\\'stage I_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage I\\'}), (\\'stage II_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage II\\'}), (\\'stage III_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage III\\'}), (\\'major rupture_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'major rupture\\'}), (\\'Austria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Austria\\'}), (\\'Italy_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Italy\\'}), (\\'San Marino_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'San Marino\\'}), (\\'Iceland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Iceland\\'}), (\\'Germany_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Germany\\'}), (\\'Bulgaria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bulgaria\\'}), (\\'Turkey_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Turkey\\'}), (\\'Denmark_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Denmark\\'}), (\\'Poland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Poland\\'}), (\\'Greece_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Greece\\'}), (\\'Andorra_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Andorra\\'}), (\\'Belgium_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belgium\\'}), (\\'Serbia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Serbia\\'}), (\\'Albania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Albania\\'}), (\\'Moldova_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Moldova\\'}), (\\'Lithuania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Lithuania\\'}), (\\'Latvia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Latvia\\'}), (\\'Estonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Estonia\\'}), (\\'Luxembourg_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Luxembourg\\'}), (\\'Montenegro_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Montenegro\\'}), (\\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bosnia and Herzegovina\\'}), (\\'Croatia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Croatia\\'}), (\\'Slovenia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovenia\\'}), (\\'Macedonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Macedonia\\'}), (\\'United Kingdom_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'United Kingdom\\'}), (\\'Ireland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ireland\\'}), (\\'Spain_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Spain\\'}), (\\'Algeria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Algeria\\'}), (\\'Tunisia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Tunisia\\'}), (\\'Malta_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Malta\\'}), (\\'Morocco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Morocco\\'}), (\\'Portugal_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Portugal\\'}), (\\'France_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'France\\'}), (\\'Monaco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Monaco\\'}), (\\'Russia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Russia\\'}), (\\'Finland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Finland\\'}), (\\'Sweden_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Sweden\\'}), (\\'Norway_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Norway\\'}), (\\'Belarus_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belarus\\'}), (\\'Romania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Romania\\'}), (\\'Ukraine_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ukraine\\'}), (\\'Hungary_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Hungary\\'}), (\\'Czech Republic_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Czech Republic\\'}), (\\'Slovakia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovakia\\'}), (\\'Switzerland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Switzerland\\'}), (\\'Liechtenstein_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Liechtenstein\\'}), (\\'Netherlands_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Netherlands\\'}), (\\'University Hospital of Munich_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Munich\\'}), (\\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Tuebingen\\'}), (\\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Azienda Ospedaliera\\'}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Ospedale Pediatrico Bambino Ges\u00f9\\'}), (\\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Fondazione IRCCS Istituto Nazionale dei Tumori\\'}), (\\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Prinses Maxima Centrum\\'}), (\\'Marciniak Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Marciniak Hospital\\'}), (\\'Faculty of Medicine_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Faculty of Medicine\\'}), (\\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'St. Anna Kinderspital/CCRI\\'}), (\\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Armand Trousseau Hospital\\'}), (\\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Universitario Virgin del Rocio\\'}), (\\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Vall d\u2019Hebron\\'}), (\\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Great Ormond Street Hospital\\'}), (\\'University Hospital Homburg_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital Homburg\\'}), (\\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon\\'}), (\\'UMBRELLA protocol_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'ExPO\u2011r\u2011Net\\'}), (\\'Weirich, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Weirich, A.\\'}), (\\'Pritchard-Jones, K._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Pritchard-Jones, K.\\'}), (\\'de Kraker, J._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'de Kraker, J.\\'}), (\\'Graf, N._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Graf, N.\\'}), (\\'Green, D. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Green, D. M.\\'}), (\\'Spreafico, F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Spreafico, F.\\'}), (\\'Bellani, F. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Bellani, F. F.\\'}), (\\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'van den Heuvel-Eibrink, M. M.\\'}), (\"D\\'Angio, G. J._author\", {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \"D\\'Angio, G. J.\"}), (\\'Tournade, M. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Tournade, M. F.\\'}), (\\'Breslow, N. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Breslow, N. E.\\'}), (\\'Mitchell, C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Mitchell, C.\\'}), (\\'Verschuur, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Verschuur, A.\\'}), (\\'Grundy, P. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Grundy, P. E.\\'}), (\\'Warmann, S. W._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Warmann, S. W.\\'}), (\\'Smets, A. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Smets, A. M.\\'}), (\\'Dome, J. S._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dome, J. S.\\'}), (\\'Dix, D. B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dix, D. B.\\'}), (\\'Daw, N. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Daw, N. C.\\'}), (\\'Ha, T. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Ha, T. C.\\'}), (\\'Kremens, B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Kremens, B.\\'}), (\\'Furtwangler, R._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Furtwangler, R.\\'}), (\\'SIOP-9/GPOH_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP-9/GPOH\\'}), (\\'UKW3_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'UKW3\\'}), (\\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'SIOP 93\u201301 trial\\'}), (\\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP trial and study 93\u201301\\'}), (\\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'National Wilms Tumor Study Group\\'}), (\\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP WT 2001 protocol\\'}), (\\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Third National Wilms\u2019 Tumor Study\\'}), (\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'National Wilms Tumor Studies\\'}), (\\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Second National Wilms\u2019 Tumor Study\\'}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'UK Children\u2019s Cancer Study Group\\'}), (\\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Children\u2019s Oncology Group\\'})], \\'edges\\': [(\\'sample.pdf\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'non-Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'childhood renal tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'renal cell carcinoma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'localized disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'metastatic disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'bilateral disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'relapsed disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'radiotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'surgery_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'chemotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'Wilms Tumour_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CCSK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'MRTK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CMN_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'RCC_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP\u22122001_Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'vincristine_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'actinomycin D_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'doxorubicin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'etoposide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'carboplatin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'cyclophosphamide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage I_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage II_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage III_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage IV_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage V_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AV_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AVD_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'HR-1_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Overall Survival (OS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT-only nodules_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'MRI_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG AREN0533 trial_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'etoposide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'carboplatin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'cyclophosphamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP database_database\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AVD_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AV-2_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Aronson et al._Research Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Etoposide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Carboplatin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group AA_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group BB_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group CC_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Cyclophosphamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Ifosfamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'ASCR_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'ifosfamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'nephrotoxicity_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'relapsed group CC_patient_group\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'diffuse anaplasia_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'blastemal-type tumors_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'camptothecins_medication_class\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'irinotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'topotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'radiotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'surgical excision_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'stage IV WT_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD150_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD250_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'low-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'CDCV_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'actinomycin-D_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'vincristine_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'doxorubicin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'VP16_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'surgery_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'chemotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'anaplasia_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'actinomycin D_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'vincristine_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'doxorubicin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'carboplatin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'cyclophosphamide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'etoposide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'SIOP\u22122001_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Wilms tumours_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Davila Fajardo et al._author\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'whole-lung irradiation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'proton therapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'dosimetric study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'locoregional disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'metastatic disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'low-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'intermediate-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'high-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage I_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage II_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage III_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'major rupture_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Austria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Italy_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'San Marino_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Iceland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Germany_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bulgaria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Turkey_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Denmark_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Poland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Greece_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Andorra_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belgium_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Serbia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Albania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Moldova_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Lithuania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Latvia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Estonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Luxembourg_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Montenegro_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Croatia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovenia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Macedonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'United Kingdom_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ireland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Spain_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Algeria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Tunisia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Malta_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Morocco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Portugal_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'France_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Monaco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Russia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Finland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Sweden_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Norway_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belarus_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Romania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ukraine_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hungary_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Czech Republic_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovakia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Switzerland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Liechtenstein_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Netherlands_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Munich_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Marciniak Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Faculty of Medicine_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital Homburg_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Weirich, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Pritchard-Jones, K._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'de Kraker, J._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Graf, N._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Green, D. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Spreafico, F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Bellani, F. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \"D\\'Angio, G. J._author\", {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Tournade, M. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Breslow, N. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Mitchell, C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Verschuur, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Grundy, P. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Warmann, S. W._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Smets, A. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dome, J. S._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dix, D. B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Daw, N. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ha, T. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Kremens, B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Furtwangler, R._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP-9/GPOH_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UKW3_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10})]}, {\\'nodes\\': [(\\'vincristine_entity\\', {}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {}), (\\'www.siop-rtsg.eu_entity\\', {}), (\\'stage II_entity\\', {}), (\\'Wilms tumours_entity\\', {}), (\\'Relapsed Wilms Tumor_entity\\', {}), (\\'Davila Fajardo et al._entity\\', {}), (\\'vincristine, actinomycin D, and doxorubicin_entity\\', {}), (\\'SIOP\u22122001 randomized trial_entity\\', {}), (\\'surgery_entity\\', {}), (\\'non-Wilms tumours_entity\\', {}), (\\'actinomycin D_entity\\', {}), (\\'diffuse anaplasia_entity\\', {}), (\\'Synchronous bilateral Wilms tumor_entity\\', {}), (\\'CT-only nodules_entity\\', {}), (\\'relapsed group CC_entity\\', {}), (\\'increased relapse risk_entity\\', {}), (\\'reduced survival_entity\\', {}), (\\'UKW3 trial_entity\\', {}), (\\'chemotherapy_entity\\', {}), (\\'Bilateral Disease (Stage V)_entity\\', {}), (\\'blastemal-type tumors_entity\\', {}), (\\'UMBRELLA protocol_entity\\', {}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', {}), (\\'minimally invasive surgery_entity\\', {}), (\\'VP16_entity\\', {}), (\\'Wilms tumor_entity\\', {}), (\\'anaplasia_entity\\', {}), (\\'radical tumor nephrectomy_entity\\', {}), (\\'Innovative Therapies for Children with Cancer consortium_entity\\', {}), (\\'cumulative doxorubicin dose_entity\\', {}), (\\'etoposide_entity\\', {}), (\\'large-volume tumours_entity\\', {}), (\\'Stage IV_entity\\', {}), (\\'CDCV_entity\\', {}), (\\'SIOP\u2013RTSG_entity\\', {}), (\\'AVD150_entity\\', {}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', {}), (\\'laparoscopic surgery_entity\\', {}), (\\'SIOP\u2212RTSG panel_entity\\', {}), (\\'actinomycin-D_entity\\', {}), (\\'COG AREN0533 trial_entity\\', {}), (\\'cyclophosphamide_entity\\', {}), (\\'carboplatin_entity\\', {}), (\\'UKW\u2011R protocol_entity\\', {}), (\\'Nephron-sparing surgery (NSS)_entity\\', {}), (\\'Adult Wilms Tumors_entity\\', {}), (\\'doxorubicin_entity\\', {}), (\\'NWTS\u20115 relapse protocol_entity\\', {}), (\\'End-stage renal disease (ESRD)_entity\\', {}), (\\'AVD250_entity\\', {}), (\\'Children\u2019s Oncology Group (COG)_entity\\', {}), (\\'blastemal-type Wilms tumour_entity\\', {}), (\\'SIOP\u22122001_entity\\', {}), (\\'radiotherapy_entity\\', {}), (\\'childhood renal tumours_entity\\', {})], \\'edges\\': [(\\'vincristine_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'stage II_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'indicated_for_in_adults\\'}), (\\'Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'Wilms tumours_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated under\\'}), (\\'Relapsed Wilms Tumor_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guided_by\\'}), (\\'Davila Fajardo et al._entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed\\'}), (\\'SIOP\u22122001 randomized trial_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated use in\\'}), (\\'surgery_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'non-Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'actinomycin D_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Synchronous bilateral Wilms tumor_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'instance_of\\'}), (\\'CT-only nodules_entity\\', \\'increased relapse risk_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'reduced survival_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included_in\\'}), (\\'relapsed group CC_entity\\', \\'diffuse anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'blastemal-type tumors_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UKW3 trial_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'UKW3 trial_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'chemotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UMBRELLA protocol_entity\\', \\'COG AREN0533 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses_data_from\\'}), (\\'UMBRELLA protocol_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'advises_treatment_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'Innovative Therapies for Children with Cancer consortium_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborates_with\\'}), (\\'UMBRELLA protocol_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'surgery_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is the standard of\\'}), (\\'UMBRELLA protocol_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guides treatment in\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', \\'UKW3 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\\'minimally invasive surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'anaplasia_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'radical tumor nephrectomy_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'standard_of_care_for\\'}), (\\'Stage IV_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'presents in\\'}), (\\'CDCV_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'VP16_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'aims to improve survival rates of\\'}), (\\'AVD150_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed_by\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'succeeds\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'www.siop-rtsg.eu_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'available_on\\'}), (\\'laparoscopic surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'COG AREN0533 trial_entity\\', \\'cumulative doxorubicin dose_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'evaluates\\'}), (\\'UKW\u2011R protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'Nephron-sparing surgery (NSS)_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'classification_developed_by\\'}), (\\'Adult Wilms Tumors_entity\\', \\'anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'Adult Wilms Tumors_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'doxorubicin_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'doxorubicin_entity\\', \\'large-volume tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'recommended for\\'}), (\\'NWTS\u20115 relapse protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'End-stage renal disease (ESRD)_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'AVD250_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'Children\u2019s Oncology Group (COG)_entity\\', \\'SIOP\u22122001 randomized trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborated with\\'}), (\\'blastemal-type Wilms tumour_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment intensified according to\\'}), (\\'SIOP\u22122001_entity\\', \\'vincristine, actinomycin D, and doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses\\'}), (\\'SIOP\u22122001_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provided_guidelines_for\\'}), (\\'radiotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'radiotherapy_entity\\', \\'SIOP\u2212RTSG panel_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'contact_for_guidance\\'})]}, {\\'nodes\\': [(\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {}), (\\'Marry M. van den Heuvel-Eibrink_entity\\', {})], \\'edges\\': [(\\'Marry M. van den Heuvel-Eibrink_entity\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'affiliated_with\\'})]}, {\\'nodes\\': [(\\'Stage II_entity\\', {}), (\\'AV_entity\\', {}), (\\'Stage III_entity\\', {}), (\\'vincestine and actinomycin D_entity\\', {}), (\\'AVD_entity\\', {})], \\'edges\\': [(\\'Stage II_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AV_entity\\', \\'Stage II_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Stage III_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AVD_entity\\', \\'Stage III_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'SIOP-RTSG 2016_entity\\', {}), (\\'RCC_entity\\', {}), (\\'CMN_entity\\', {})], \\'edges\\': [(\\'RCC_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'}), (\\'CMN_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'})]}, {\\'nodes\\': [(\\'HR-1_entity\\', {}), (\\'High-risk blastemal type Wilms tumour_entity\\', {})], \\'edges\\': [(\\'HR-1_entity\\', \\'High-risk blastemal type Wilms tumour_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'unfavorable prognosis_entity\\', {}), (\\'high-risk characteristics_entity\\', {})], \\'edges\\': [(\\'high-risk characteristics_entity\\', \\'unfavorable prognosis_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'leads_to\\'})]}, {\\'nodes\\': [(\\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {}), (\\'SIOP\u2013RTSG board_entity\\', {})], \\'edges\\': [(\\'SIOP\u2013RTSG board_entity\\', \\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggests\\'})]}, {\\'nodes\\': [(\\'regimen and outcomes_entity\\', {}), (\\'SIOP database_entity\\', {})], \\'edges\\': [(\\'SIOP database_entity\\', \\'regimen and outcomes_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'captures_data_on\\'})]}, {\\'nodes\\': [(\\'Bilateral nephron-sparing surgery (NSS)_entity\\', {}), (\\'Aronson et al._entity\\', {})], \\'edges\\': [(\\'Aronson et al._entity\\', \\'Bilateral nephron-sparing surgery (NSS)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'observed_effectiveness_of\\'})]}, {\\'nodes\\': [(\\'SIOP\u22122001 study_entity\\', {}), (\\'Actinomycin D_entity\\', {}), (\\'Vincristine_entity\\', {})], \\'edges\\': [(\\'SIOP\u22122001 study_entity\\', \\'Vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'}), (\\'SIOP\u22122001 study_entity\\', \\'Actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'})]}, {\\'nodes\\': [(\\'High-dose melphalan_entity\\', {}), (\\'Group AA_entity\\', {}), (\\'Carboplatin_entity\\', {}), (\\'Doxorubicin_entity\\', {}), (\\'Etoposide_entity\\', {}), (\\'Group BB_entity\\', {}), (\\'Cyclophosphamide_entity\\', {}), (\\'Ifosfamide_entity\\', {})], \\'edges\\': [(\\'Group AA_entity\\', \\'Doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Ifosfamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'High-dose melphalan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'})]}, {\\'nodes\\': [(\\'nephrotoxicity_entity\\', {}), (\\'ifosfamide_entity\\', {})], \\'edges\\': [(\\'ifosfamide_entity\\', \\'nephrotoxicity_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'related_to\\'})]}, {\\'nodes\\': [(\\'camptothecins_entity\\', {}), (\\'irinotecan_entity\\', {}), (\\'topotecan_entity\\', {})], \\'edges\\': [(\\'camptothecins_entity\\', \\'irinotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'camptothecins_entity\\', \\'topotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'})]}, {\\'nodes\\': [(\\'Infant Wilms Tumors_entity\\', {}), (\\'nephrectomy_entity\\', {})], \\'edges\\': [(\\'Infant Wilms Tumors_entity\\', \\'nephrectomy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_option\\'})]}, {\\'nodes\\': [(\\'congenital mesoblastic nephroma_entity\\', {}), (\\'surgery alone_entity\\', {})], \\'edges\\': [(\\'congenital mesoblastic nephroma_entity\\', \\'surgery alone_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'alternative chemotherapy_entity\\', {}), (\\'malignant rhabdoid tumors_entity\\', {})], \\'edges\\': [(\\'malignant rhabdoid tumors_entity\\', \\'alternative chemotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'lymph node sampling_entity\\', {}), (\\'accurate staging_entity\\', {})], \\'edges\\': [(\\'lymph node sampling_entity\\', \\'accurate staging_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'purpose_of\\'})]}, {\\'nodes\\': [(\\'COG\u2013NWTS trials_entity\\', {}), (\\'whole-lung irradiation_entity\\', {})], \\'edges\\': [(\\'COG\u2013NWTS trials_entity\\', \\'whole-lung irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'informed_dosage_for\\'})]}, {\\'nodes\\': [(\\'lung metastases_entity\\', {}), (\\'pulmonary radiotherapy_entity\\', {})], \\'edges\\': [(\\'pulmonary radiotherapy_entity\\', \\'lung metastases_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'administered_for\\'})]}, {\\'nodes\\': [(\\'dosimetric study_entity\\', {}), (\\'proton therapy_entity\\', {}), (\\'flank irradiation_entity\\', {})], \\'edges\\': [(\\'dosimetric study_entity\\', \\'proton therapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated\\'}), (\\'proton therapy_entity\\', \\'flank irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggested_for\\'})]}, {\\'nodes\\': [(\\'metastatic disease_entity\\', {}), (\\'radiotherapy guidelines_entity\\', {}), (\\'locoregional disease_entity\\', {})], \\'edges\\': [(\\'radiotherapy guidelines_entity\\', \\'locoregional disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'}), (\\'radiotherapy guidelines_entity\\', \\'metastatic disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'})]}, {\\'nodes\\': [(\\'major rupture_entity\\', {}), (\\'stage III_entity\\', {})], \\'edges\\': [(\\'stage III_entity\\', \\'major rupture_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes_condition\\'})]}, {\\'nodes\\': [(\\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {}), (\\'ExPO\u2011r\u2011Net_entity\\', {})], \\'edges\\': [(\\'ExPO\u2011r\u2011Net_entity\\', \\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is part of\\'})]}, {\\'nodes\\': [(\\'University Hospital of Munich_entity\\', {}), (\\'Germany_entity\\', {}), (\\'University Hospital of Tuebingen_entity\\', {})], \\'edges\\': [(\\'Germany_entity\\', \\'University Hospital of Munich_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Germany_entity\\', \\'University Hospital of Tuebingen_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {}), (\\'Italy_entity\\', {}), (\\'Azienda Ospedaliera_entity\\', {}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {})], \\'edges\\': [(\\'Italy_entity\\', \\'Azienda Ospedaliera_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Netherlands_entity\\', {}), (\\'Prinses Maxima Centrum_entity\\', {})], \\'edges\\': [(\\'Netherlands_entity\\', \\'Prinses Maxima Centrum_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Marciniak Hospital_entity\\', {}), (\\'Poland_entity\\', {}), (\\'Faculty of Medicine_entity\\', {})], \\'edges\\': [(\\'Poland_entity\\', \\'Marciniak Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Poland_entity\\', \\'Faculty of Medicine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'St. Anna Kinderspital/CCRI_entity\\', {}), (\\'Austria_entity\\', {})], \\'edges\\': [(\\'Austria_entity\\', \\'St. Anna Kinderspital/CCRI_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'France_entity\\', {}), (\\'Armand Trousseau Hospital_entity\\', {})], \\'edges\\': [(\\'France_entity\\', \\'Armand Trousseau Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Spain_entity\\', {}), (\\'Hospital Vall d\u2019Hebron_entity\\', {}), (\\'Hospital Universitario Virgin del Rocio_entity\\', {})], \\'edges\\': [(\\'Spain_entity\\', \\'Hospital Universitario Virgin del Rocio_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Spain_entity\\', \\'Hospital Vall d\u2019Hebron_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'United Kingdom_entity\\', {}), (\\'Great Ormond Street Hospital_entity\\', {})], \\'edges\\': [(\\'United Kingdom_entity\\', \\'Great Ormond Street Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Weirich, A._entity\\', {}), (\\'SIOP-9/GPOH_entity\\', {})], \\'edges\\': [(\\'Weirich, A._entity\\', \\'SIOP-9/GPOH_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Pritchard-Jones, K._entity\\', {}), (\\'UKW3_entity\\', {})], \\'edges\\': [(\\'Pritchard-Jones, K._entity\\', \\'UKW3_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed in\\'})]}, {\\'nodes\\': [(\\'SIOP 93\u201301 trial_entity\\', {}), (\\'de Kraker, J._entity\\', {})], \\'edges\\': [(\\'de Kraker, J._entity\\', \\'SIOP 93\u201301 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'SIOP trial and study 93\u201301_entity\\', {}), (\\'Graf, N._entity\\', {})], \\'edges\\': [(\\'Graf, N._entity\\', \\'SIOP trial and study 93\u201301_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Green, D. M._entity\\', {}), (\\'National Wilms Tumor Study Group_entity\\', {})], \\'edges\\': [(\\'Green, D. M._entity\\', \\'National Wilms Tumor Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}, {\\'nodes\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', {}), (\\'SIOP WT 2001 protocol_entity\\', {})], \\'edges\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', \\'SIOP WT 2001 protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Third National Wilms\u2019 Tumor Study_entity\\', {}), (\"D\\'Angio, G. J._entity\", {}), (\\'Second National Wilms\u2019 Tumor Study_entity\\', {})], \\'edges\\': [(\"D\\'Angio, G. J._entity\", \\'Third National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\"D\\'Angio, G. J._entity\", \\'Second National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {}), (\\'Tournade, M. F._entity\\', {}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {})], \\'edges\\': [(\\'Tournade, M. F._entity\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'}), (\\'Tournade, M. F._entity\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Breslow, N. E._entity\\', {}), (\\'National Wilms Tumor Studies_entity\\', {})], \\'edges\\': [(\\'Breslow, N. E._entity\\', \\'National Wilms Tumor Studies_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Mitchell, C._entity\\', {}), (\\'UK Children\u2019s Cancer Study Group_entity\\', {})], \\'edges\\': [(\\'Mitchell, C._entity\\', \\'UK Children\u2019s Cancer Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'under\\'})]}, {\\'nodes\\': [(\\'Daw, N. C._entity\\', {}), (\\'Dix, D. B._entity\\', {}), (\\'Children\u2019s Oncology Group_entity\\', {}), (\\'Grundy, P. E._entity\\', {})], \\'edges\\': [(\\'Daw, N. C._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted under\\'}), (\\'Dix, D. B._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'}), (\\'Grundy, P. E._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}]']), TestResult(name='test_case_2', success=False, metrics_data=[MetricData(name='Answer Correctness (GEval)', threshold=0.5, success=True, score=0.8950675480278161, reason='The actual output includes references to SIOP\u22122001 and related entities but lacks a direct affirmation of success in following the SIOP\u22122001 protocol as stated in the expected output.', strict_mode=False, evaluation_model='gpt-4o-mini', error=None, evaluation_cost=0.0033039, verbose_logs='Criteria:\\nNone \\n \\nEvaluation Steps:\\n[\\n    \"Determine whether the actual output is factually correct based on the expected output.\"\\n]'), MetricData(name='Faithfulness', threshold=0.7, success=True, score=0.8333333333333334, reason=None, strict_mode=False, evaluation_model='gpt-4o-mini', error=None, evaluation_cost=0.00883845, verbose_logs='Truths (limit=None):\\n[\\n    \"The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG) is an organization.\",\\n    \"UMBRELLA SIOP-RTSG 2016 is a protocol.\",\\n    \"SIOP\u22122001 is a protocol.\",\\n    \"Wilms tumours are a type of disease.\",\\n    \"Non-Wilms tumours are also classified as a type of disease.\",\\n    \"The website www.siop-rtsg.eu is associated with the SIOP\u2013RTSG.\",\\n    \"The Department of Paediatric Oncology is part of the Princess M\u00e1xima Center for Paediatric Oncology.\",\\n    \"Marry M. van den Heuvel-Eibrink is a person involved in the study.\",\\n    \"Childhood renal tumours is a disease category.\",\\n    \"Clear cell sarcoma of the kidney is a type of disease.\",\\n    \"Renal cell carcinoma is a type of disease.\",\\n    \"Malignant rhabdoid tumour of the kidney is also a type of disease.\",\\n    \"Congenital mesoblastic nephroma is a type of disease.\",\\n    \"The UMBRELLA protocol is a treatment protocol.\",\\n    \"The SIOP\u2013RTSG is an organization.\",\\n    \"The Children\u2019s Oncology Group (COG) is an organization.\",\\n    \"SIOP\u22122001 randomized trial is a clinical trial.\",\\n    \"Actinomycin D, vincristine, and doxorubicin are drugs used in treatment.\",\\n    \"The UKW3 trial is a clinical trial.\",\\n    \"Localized disease is a stage of disease.\",\\n    \"Metastatic disease is a stage of disease.\",\\n    \"Bilateral disease is a stage of disease.\",\\n    \"Relapsed disease is a stage of disease.\",\\n    \"Blastemal-type Wilms tumours is a subtype of Wilms tumours.\",\\n    \"Radiotherapy is a treatment method.\",\\n    \"Surgery is a treatment method.\",\\n    \"Chemotherapy is a treatment method.\",\\n    \"Wilms Tumour is a type of disease.\",\\n    \"CCSK refers to clear cell sarcoma of the kidney, which is a disease.\",\\n    \"MRTK refers to malignant rhabdoid tumour of the kidney, which is a disease.\",\\n    \"CMN stands for congenital mesoblastic nephroma, which is a disease.\",\\n    \"RCC stands for renal cell carcinoma, which is a disease.\",\\n    \"Stage I, II, III, IV, and V are stages of disease.\",\\n    \"AV and AVD are treatment combinations.\",\\n    \"HR-1 is a treatment combination.\",\\n    \"Overall Survival (OS) is a metric used in studies.\",\\n    \"Event-Free Survival (EFS) is a metric used in studies.\",\\n    \"CT and MRI are diagnostic tools used in medical imaging.\",\\n    \"The SIOP database captures data on treatment regimens and outcomes.\",\\n    \"Aronson et al. is a research group associated with these studies.\"\\n] \\n \\nClaims:\\n[\\n    \"The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG) is an organization.\",\\n    \"The UMBRELLA SIOP-RTSG 2016 is a protocol.\",\\n    \"SIOP\u22122001 is a protocol.\",\\n    \"Wilms tumours are a type of disease.\",\\n    \"Non-Wilms tumours are a type of disease.\",\\n    \"The website www.siop-rtsg.eu is associated with the SIOP\u2013RTSG.\",\\n    \"The Department of Paediatric Oncology is part of the Princess M\u00e1xima Center for Paediatric Oncology.\",\\n    \"Marry M. van den Heuvel-Eibrink is a person associated with this study.\",\\n    \"Childhood renal tumours are a type of disease.\",\\n    \"Clear cell sarcoma of the kidney is a type of disease.\",\\n    \"Renal cell carcinoma is a type of disease.\",\\n    \"Malignant rhabdoid tumour of the kidney is a type of disease.\",\\n    \"Congenital mesoblastic nephroma is a type of disease.\",\\n    \"Wilms tumours are a condition.\",\\n    \"The UMBRELLA protocol is a treatment protocol.\",\\n    \"SIOP\u2013RTSG is an organization.\",\\n    \"The Children\u2019s Oncology Group (COG) is an organization.\",\\n    \"The SIOP\u22122001 randomized trial is a clinical trial.\",\\n    \"Actinomycin D is a drug used in treatment protocols.\",\\n    \"Vincristine is a drug used in treatment protocols.\",\\n    \"Doxorubicin is a drug used in treatment protocols.\",\\n    \"The UKW3 trial is a clinical trial.\",\\n    \"The UK Children\u2019s Cancer and Leukaemia Group (UKCCLG) is an organization.\",\\n    \"Localized disease is a stage of disease.\",\\n    \"Metastatic disease is a stage of disease.\",\\n    \"Bilateral disease is a stage of disease.\",\\n    \"Relapsed disease is a stage of disease.\",\\n    \"Blastemal-type Wilms tumours are a subtype of Wilms tumours.\",\\n    \"Radiotherapy is a treatment method.\",\\n    \"Surgery is a treatment method.\",\\n    \"Chemotherapy is a treatment method.\",\\n    \"Wilms Tumour is a type of disease.\",\\n    \"CCSK is an abbreviation for clear cell sarcoma of the kidney.\",\\n    \"MRTK is an abbreviation for malignant rhabdoid tumour of the kidney.\",\\n    \"CMN is an abbreviation for congenital mesoblastic nephroma.\",\\n    \"RCC is an abbreviation for renal cell carcinoma.\",\\n    \"The UMBRELLA protocol is a treatment protocol.\",\\n    \"The SIOP\u22122001 trial is a type of clinical trial.\",\\n    \"Vincristine is a treatment mentioned in the protocol.\",\\n    \"Actinomycin D is a treatment mentioned in the protocol.\",\\n    \"Doxorubicin is a treatment mentioned in the protocol.\",\\n    \"Etoposide is a treatment mentioned in the protocol.\",\\n    \"Carboplatin is a treatment mentioned in the protocol.\",\\n    \"Cyclophosphamide is a treatment mentioned in the protocol.\",\\n    \"Stage I is a stage of disease.\",\\n    \"Stage II is a stage of disease.\",\\n    \"Stage III is a stage of disease.\",\\n    \"Stage IV is a stage of disease.\",\\n    \"Stage V is a stage of disease.\",\\n    \"AV is a treatment combination.\",\\n    \"AVD is a treatment combination.\",\\n    \"HR-1 is a treatment combination.\",\\n    \"The SIOP-RTSG 2016 is a protocol.\",\\n    \"Overall Survival (OS) is a metric used in this context.\",\\n    \"Event-Free Survival (EFS) is a metric used in this context.\",\\n    \"CT-only nodules are a medical condition.\",\\n    \"The UMBRELLA protocol is a treatment protocol.\",\\n    \"The SIOP\u2013RTSG analysis is a study associated with these protocols.\",\\n    \"The COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials are studies associated with these treatments.\",\\n    \"The treatment vincristine and actinomycin D plus doxorubicin is a combination used.\",\\n    \"The treatment vincristine and actinomycin D is another combination mentioned.\",\\n    \"The SIOP\u22122001 is a study protocol.\",\\n    \"MRI is a diagnostic tool.\",\\n    \"CT is a diagnostic tool.\",\\n    \"Cumulative doxorubicin dose is a detail regarding treatment.\",\\n    \"The COG AREN0533 trial is a study regarding this treatment.\",\\n    \"Etoposide is a medication used in treatment protocols.\",\\n    \"Carboplatin is a medication used in treatment protocols.\",\\n    \"Cyclophosphamide is a medication used in treatment protocols.\",\\n    \"High-risk characteristics are a medical condition associated with these treatments.\",\\n    \"SIOP\u2013RTSG board is an organization related to this field.\",\\n    \"Vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin are drugs used in combination treatments.\",\\n    \"High-dose chemotherapy and autologous stem cell transplantation is a treatment protocol.\",\\n    \"The SIOP database captures data related to Wilms tumours and treatments.\",\\n    \"Event-Free Survival (EFS) and Overall Survival (OS) are subjects measured in these studies.\",\\n    \"AVD is a treatment group mentioned in the study.\",\\n    \"AV-2 is another treatment group.\",\\n    \"Log\u2013Rank P is a statistical test used in analyzing data from this study.\",\\n    \"Bilateral Disease (Stage V) is a disease stage associated with Wilms tumours.\",\\n    \"Synchronous bilateral Wilms tumor is a type of disease.\",\\n    \"End-stage renal disease (ESRD) is a condition related to advanced kidney diseases.\",\\n    \"Aronson et al. is a research group associated with these studies.\",\\n    \"Bilateral nephron-sparing surgery (NSS) is a treatment method used.\",\\n    \"The SIOP\u22122001 study is a research study associated with these treatments and protocols.\",\\n    \"Vincristine, Actinomycin D, and doxorubicin are drugs used in the SIOP\u22122001 study.\",\\n    \"Etoposide, Carboplatin, Cyclophosphamide, and Ifosfamide are drugs associated with standard treatment protocols for childhood cancers.\",\\n    \"High-dose melphalan is a treatment method.\",\\n    \"UKW\u2011R protocol is a treatment protocol used in this context.\",\\n    \"NWTS\u20115 relapse protocol is a treatment protocol associated with treatment for relapsed conditions.\",\\n    \"ASCR is a procedure used in the context of these treatments.\",\\n    \"Ifosfamide is a medication that can cause nephrotoxicity as a side effect.\",\\n    \"Diffuse anaplasia is a condition associated with adverse outcomes.\",\\n    \"Blastemal-type tumors are a type of condition associated with Wilms tumours.\",\\n    \"The UMBRELLA protocol is developed to unify treatment protocols.\",\\n    \"The camptothecins class includes irinotecan and topotecan as medications.\",\\n    \"Infant Wilms Tumors are a medical condition requiring treatment decisions.\",\\n    \"Congenital mesoblastic nephroma typically requires surgery alone as a treatment.\",\\n    \"Malignant rhabdoid tumors may require alternative chemotherapy treatment.\",\\n    \"Lymph node sampling is a surgical procedure important for accurate staging of cancers.\",\\n    \"COG\u2013NWTS trials provide guidelines for treatment dosages related to whole-lung irradiation.\",\\n    \"Pulmonary radiotherapy is administered for lung metastases in the context of Wilms tumours.\",\\n    \"Dosimetric studies investigate treatment options including proton therapy for effective administration of therapies.\",\\n    \"Radiotherapy guidelines specify treatment for locoregional and metastatic diseases.\",\\n    \"Major rupture is a condition potentially included in the diagnosis of stage III Wilms Tumors.\",\\n    \"The European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment operates under ExPO\u2011r\u2011Net.\",\\n    \"Germany is home to several institutions involved in pediatric oncology, such as University Hospital of Munich and University Hospital of Tuebingen.\",\\n    \"Italy houses institutions such as Fondazione IRCCS Istituto Nazionale dei Tumori and Ospedale Pediatrico Bambino Ges\u00f9.\",\\n    \"The Netherlands has the Prinses Maxima Centrum as a significant institution for pediatric oncology.\",\\n    \"Poland has institutions like Marciniak Hospital and Faculty of Medicine involved in treatment.\",\\n    \"Austria is home to institutions like St. Anna Kinderspital/CCRI.\",\\n    \"France has significant medical facilities dedicated to pediatric oncology, including Armand Trousseau Hospital.\",\\n    \"Spain has hospitals such as Hospital Vall d\u2019Hebron involved in treating pediatric cancers.\",\\n    \"The United Kingdom is home to Great Ormond Street Hospital, a significant pediatric oncology center.\",\\n    \"Various authors including Weirich, Pritchard-Jones, and others have contributed to studies such as SIOP-9/GPOH and UKW3, focusing on Wilms tumours and related treatments.\"\\n] \\n \\nVerdicts:\\n[\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"idk\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"The claim that Wilms tumours are a condition is incorrect; they are classified as a type of disease instead.\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"The claim that UK Children\\\\u2019s Cancer and Leukaemia Group (UKCCLG) is an organization is not supported by the given information.\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"The claim that the UMBRELLA protocol is a treatment protocol is redundant as it was already established in the context.\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"The assertion that CT-only nodules are a medical condition is not supported by previous context.\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"The UKW-R protocol being referenced as a treatment protocol is unverified by the context.\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"The assertion regarding Ifosfamide as a medication causing nephrotoxicity is not a claim explicitly mentioned in the provided context.\"\\n    }\\n]'), MetricData(name='Contextual Relevancy', threshold=1.0, success=False, score=0.5, reason=\"The score is 0.50 because, although the relevant statement, 'UMBRELLA protocol aims to replace older protocols such as the SIOP\u22122001,' directly addresses the input's question, most of the retrieval context discussions drift towards treatment options and survival improvements without specifically focusing on the replacement aspect of the protocol.\", strict_mode=False, evaluation_model='gpt-4o-mini', error=None, evaluation_cost=0.0036443999999999995, verbose_logs='Verdicts:\\n[\\n    {\\n        \"verdicts\": [\\n            {\\n                \"statement\": \"UMBRELLA protocol aims to replace older protocols such as the SIOP\\\\u22122001.\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"SIOP\\\\u2013RTSG developed the UMBRELLA protocol for managing Wilms tumours.\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"The UMBRELLA protocol includes multiple risks associated with childhood renal tumours.\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"Children\\'s Oncology Group is involved in trials regarding Wilms tumour treatments but does not specify replacement protocols directly.\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"The statement indicates involvement in trials but does not provide information about replacing any specific protocol.\"\\n            },\\n            {\\n                \"statement\": \"Various countries are involved in the study and application of the UMBRELLA protocol across Europe.\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"High-dose melphalan is a treatment considered in relapsed cases but doesn\\'t indicate protocol replacement.\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"The statement focuses on treatment consideration rather than protocol replacement.\"\\n            },\\n            {\\n                \"statement\": \"The protocol involves the usage of actinomycin D, vincristine, and doxorubicin for treatment.\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"This statement discusses treatments used rather than addressing what the protocol aims to replace.\"\\n            },\\n            {\\n                \"statement\": \"SIOP-RTSG focuses on improving survival rates for various forms of childhood renal tumours.\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"The statement emphasizes survival improvement but does not mention protocol replacement.\"\\n            },\\n            {\\n                \"statement\": \"The new regimen suggests updates to previous methods, improving previous chemotherapy protocols.\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"The document outlines treatment efficacy but does not define protocol replacements clearly.\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"While the statement mentions treatment efficacy, it lacks direct reference to protocol replacement.\"\\n            }\\n        ]\\n    }\\n]')], conversational=False, multimodal=False, input='What does the protocol aim to replace?', actual_output='[{\\'nodes\\': [(\\'sample.pdf\\', {\\'type\\': \\'document\\'}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)\\'}), (\\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA SIOP-RTSG 2016\\'}), (\\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms tumours\\'}), (\\'non-Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'non-Wilms tumours\\'}), (\\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Website\\', \\'name\\': \\'www.siop-rtsg.eu\\'}), (\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology\\'}), (\\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Person\\', \\'name\\': \\'Marry M. van den Heuvel-Eibrink\\'}), (\\'childhood renal tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'childhood renal tumours\\'}), (\\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'clear cell sarcoma of the kidney\\'}), (\\'renal cell carcinoma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'renal cell carcinoma\\'}), (\\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'malignant rhabdoid tumour of the kidney\\'}), (\\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'Wilms tumours_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'Children\u2019s Oncology Group (COG)\\'}), (\\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'SIOP\u22122001 randomized trial\\'}), (\\'actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'UKW3 trial\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)\\'}), (\\'localized disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'localized disease\\'}), (\\'metastatic disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'metastatic disease\\'}), (\\'bilateral disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'bilateral disease\\'}), (\\'relapsed disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'relapsed disease\\'}), (\\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subtype\\', \\'name\\': \\'blastemal-type Wilms tumours\\'}), (\\'radiotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgery_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'chemotherapy\\'}), (\\'Wilms Tumour_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms Tumour\\'}), (\\'CCSK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CCSK\\'}), (\\'MRTK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'MRTK\\'}), (\\'CMN_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CMN\\'}), (\\'RCC_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'RCC\\'}), (\\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u22122001_Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Trial\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'vincristine_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'vincristine\\'}), (\\'actinomycin D_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'actinomycin D\\'}), (\\'doxorubicin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'doxorubicin\\'}), (\\'etoposide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'Stage I_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage I\\'}), (\\'Stage II_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage II\\'}), (\\'Stage III_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage III\\'}), (\\'Stage IV_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage IV\\'}), (\\'Stage V_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage V\\'}), (\\'AV_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AV\\'}), (\\'AVD_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AVD\\'}), (\\'HR-1_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'HR-1\\'}), (\\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP-RTSG 2016\\'}), (\\'Overall Survival (OS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'CT-only nodules_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'CT-only nodules\\'}), (\\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP\u2013RTSG analysis\\'}), (\\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials\\'}), (\\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D plus doxorubicin\\'}), (\\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D\\'}), (\\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study_protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'MRI_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'MRI\\'}), (\\'CT_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'CT\\'}), (\\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_detail\\', \\'name\\': \\'cumulative doxorubicin dose\\'}), (\\'COG AREN0533 trial_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG AREN0533 trial\\'}), (\\'etoposide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'high-risk characteristics\\'}), (\\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG board\\'}), (\\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin\\'}), (\\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'high-dose chemotherapy and autologous stem cell transplantation\\'}), (\\'SIOP database_database\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'database\\', \\'name\\': \\'SIOP database\\'}), (\\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'AVD_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AVD\\'}), (\\'AV-2_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AV-2\\'}), (\\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Statistical Test\\', \\'name\\': \\'Log\u2013Rank P\\'}), (\\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'Bilateral Disease (Stage V)\\'}), (\\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Synchronous bilateral Wilms tumor\\'}), (\\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'End-stage renal disease (ESRD)\\'}), (\\'Aronson et al._Research Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Research Group\\', \\'name\\': \\'Aronson et al.\\'}), (\\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'Bilateral nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Study\\', \\'name\\': \\'SIOP\u22122001 study\\'}), (\\'Vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Vincristine\\'}), (\\'Actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Actinomycin D\\'}), (\\'Etoposide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Etoposide\\'}), (\\'Carboplatin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Carboplatin\\'}), (\\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease State\\', \\'name\\': \\'Relapsed Wilms Tumor\\'}), (\\'Group AA_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group AA\\'}), (\\'Group BB_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group BB\\'}), (\\'Group CC_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group CC\\'}), (\\'Doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Doxorubicin\\'}), (\\'Cyclophosphamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Cyclophosphamide\\'}), (\\'Ifosfamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Ifosfamide\\'}), (\\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'High-dose melphalan\\'}), (\\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UKW\u2011R protocol\\'}), (\\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'NWTS\u20115 relapse protocol\\'}), (\\'ASCR_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'procedure\\', \\'name\\': \\'ASCR\\'}), (\\'ifosfamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'ifosfamide\\'}), (\\'nephrotoxicity_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'nephrotoxicity\\'}), (\\'relapsed group CC_patient_group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'patient_group\\', \\'name\\': \\'relapsed group CC\\'}), (\\'diffuse anaplasia_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'diffuse anaplasia\\'}), (\\'blastemal-type tumors_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'blastemal-type tumors\\'}), (\\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'camptothecins_medication_class\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication_class\\', \\'name\\': \\'camptothecins\\'}), (\\'irinotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'irinotecan\\'}), (\\'topotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'topotecan\\'}), (\\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Innovative Therapies for Children with Cancer consortium\\'}), (\\'radiotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgical excision_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgical excision\\'}), (\\'stage IV WT_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'stage IV WT\\'}), (\\'AVD150_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD150\\'}), (\\'AVD250_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD250\\'}), (\\'low-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'low-risk disease\\'}), (\\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'intermediate-risk disease\\'}), (\\'high-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'high-risk disease\\'}), (\\'CDCV_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'CDCV\\'}), (\\'actinomycin-D_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'actinomycin-D\\'}), (\\'vincristine_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'doxorubicin\\'}), (\\'VP16_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'VP16\\'}), (\\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'contact\\', \\'name\\': \\'arnauld.verschuur@ap-hm.fr\\'}), (\\'surgery_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'chemotherapy\\'}), (\\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2212RTSG panel\\'}), (\\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Infant Wilms Tumors\\'}), (\\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'nephrectomy\\'}), (\\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'malignant rhabdoid tumors\\'}), (\\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Adult Wilms Tumors\\'}), (\\'anaplasia_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'anaplasia\\'}), (\\'actinomycin D_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'carboplatin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'etoposide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'etoposide\\'}), (\\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'Nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'radical tumor nephrectomy\\'}), (\\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'lymph node sampling\\'}), (\\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'minimally invasive surgery\\'}), (\\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'laparoscopic surgery\\'}), (\\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'radiotherapy\\'}), (\\'Wilms tumours_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'Davila Fajardo et al._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Davila Fajardo et al.\\'}), (\\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'COG\u2013NWTS trials\\'}), (\\'whole-lung irradiation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'whole-lung irradiation\\'}), (\\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'pulmonary radiotherapy\\'}), (\\'proton therapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'proton therapy\\'}), (\\'dosimetric study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'dosimetric study\\'}), (\\'locoregional disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'locoregional disease\\'}), (\\'metastatic disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'metastatic disease\\'}), (\\'low-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'low-risk\\'}), (\\'intermediate-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'intermediate-risk\\'}), (\\'high-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'high-risk\\'}), (\\'stage I_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage I\\'}), (\\'stage II_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage II\\'}), (\\'stage III_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage III\\'}), (\\'major rupture_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'major rupture\\'}), (\\'Austria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Austria\\'}), (\\'Italy_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Italy\\'}), (\\'San Marino_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'San Marino\\'}), (\\'Iceland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Iceland\\'}), (\\'Germany_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Germany\\'}), (\\'Bulgaria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bulgaria\\'}), (\\'Turkey_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Turkey\\'}), (\\'Denmark_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Denmark\\'}), (\\'Poland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Poland\\'}), (\\'Greece_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Greece\\'}), (\\'Andorra_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Andorra\\'}), (\\'Belgium_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belgium\\'}), (\\'Serbia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Serbia\\'}), (\\'Albania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Albania\\'}), (\\'Moldova_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Moldova\\'}), (\\'Lithuania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Lithuania\\'}), (\\'Latvia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Latvia\\'}), (\\'Estonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Estonia\\'}), (\\'Luxembourg_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Luxembourg\\'}), (\\'Montenegro_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Montenegro\\'}), (\\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bosnia and Herzegovina\\'}), (\\'Croatia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Croatia\\'}), (\\'Slovenia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovenia\\'}), (\\'Macedonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Macedonia\\'}), (\\'United Kingdom_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'United Kingdom\\'}), (\\'Ireland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ireland\\'}), (\\'Spain_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Spain\\'}), (\\'Algeria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Algeria\\'}), (\\'Tunisia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Tunisia\\'}), (\\'Malta_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Malta\\'}), (\\'Morocco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Morocco\\'}), (\\'Portugal_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Portugal\\'}), (\\'France_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'France\\'}), (\\'Monaco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Monaco\\'}), (\\'Russia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Russia\\'}), (\\'Finland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Finland\\'}), (\\'Sweden_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Sweden\\'}), (\\'Norway_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Norway\\'}), (\\'Belarus_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belarus\\'}), (\\'Romania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Romania\\'}), (\\'Ukraine_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ukraine\\'}), (\\'Hungary_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Hungary\\'}), (\\'Czech Republic_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Czech Republic\\'}), (\\'Slovakia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovakia\\'}), (\\'Switzerland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Switzerland\\'}), (\\'Liechtenstein_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Liechtenstein\\'}), (\\'Netherlands_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Netherlands\\'}), (\\'University Hospital of Munich_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Munich\\'}), (\\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Tuebingen\\'}), (\\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Azienda Ospedaliera\\'}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Ospedale Pediatrico Bambino Ges\u00f9\\'}), (\\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Fondazione IRCCS Istituto Nazionale dei Tumori\\'}), (\\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Prinses Maxima Centrum\\'}), (\\'Marciniak Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Marciniak Hospital\\'}), (\\'Faculty of Medicine_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Faculty of Medicine\\'}), (\\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'St. Anna Kinderspital/CCRI\\'}), (\\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Armand Trousseau Hospital\\'}), (\\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Universitario Virgin del Rocio\\'}), (\\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Vall d\u2019Hebron\\'}), (\\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Great Ormond Street Hospital\\'}), (\\'University Hospital Homburg_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital Homburg\\'}), (\\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon\\'}), (\\'UMBRELLA protocol_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'ExPO\u2011r\u2011Net\\'}), (\\'Weirich, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Weirich, A.\\'}), (\\'Pritchard-Jones, K._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Pritchard-Jones, K.\\'}), (\\'de Kraker, J._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'de Kraker, J.\\'}), (\\'Graf, N._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Graf, N.\\'}), (\\'Green, D. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Green, D. M.\\'}), (\\'Spreafico, F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Spreafico, F.\\'}), (\\'Bellani, F. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Bellani, F. F.\\'}), (\\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'van den Heuvel-Eibrink, M. M.\\'}), (\"D\\'Angio, G. J._author\", {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \"D\\'Angio, G. J.\"}), (\\'Tournade, M. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Tournade, M. F.\\'}), (\\'Breslow, N. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Breslow, N. E.\\'}), (\\'Mitchell, C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Mitchell, C.\\'}), (\\'Verschuur, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Verschuur, A.\\'}), (\\'Grundy, P. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Grundy, P. E.\\'}), (\\'Warmann, S. W._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Warmann, S. W.\\'}), (\\'Smets, A. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Smets, A. M.\\'}), (\\'Dome, J. S._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dome, J. S.\\'}), (\\'Dix, D. B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dix, D. B.\\'}), (\\'Daw, N. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Daw, N. C.\\'}), (\\'Ha, T. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Ha, T. C.\\'}), (\\'Kremens, B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Kremens, B.\\'}), (\\'Furtwangler, R._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Furtwangler, R.\\'}), (\\'SIOP-9/GPOH_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP-9/GPOH\\'}), (\\'UKW3_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'UKW3\\'}), (\\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'SIOP 93\u201301 trial\\'}), (\\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP trial and study 93\u201301\\'}), (\\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'National Wilms Tumor Study Group\\'}), (\\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP WT 2001 protocol\\'}), (\\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Third National Wilms\u2019 Tumor Study\\'}), (\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'National Wilms Tumor Studies\\'}), (\\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Second National Wilms\u2019 Tumor Study\\'}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'UK Children\u2019s Cancer Study Group\\'}), (\\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Children\u2019s Oncology Group\\'})], \\'edges\\': [(\\'sample.pdf\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'non-Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'childhood renal tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'renal cell carcinoma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'localized disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'metastatic disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'bilateral disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'relapsed disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'radiotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'surgery_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'chemotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'Wilms Tumour_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CCSK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'MRTK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CMN_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'RCC_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP\u22122001_Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'vincristine_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'actinomycin D_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'doxorubicin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'etoposide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'carboplatin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'cyclophosphamide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage I_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage II_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage III_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage IV_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage V_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AV_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AVD_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'HR-1_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Overall Survival (OS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT-only nodules_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'MRI_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG AREN0533 trial_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'etoposide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'carboplatin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'cyclophosphamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP database_database\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AVD_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AV-2_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Aronson et al._Research Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Etoposide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Carboplatin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group AA_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group BB_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group CC_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Cyclophosphamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Ifosfamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'ASCR_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'ifosfamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'nephrotoxicity_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'relapsed group CC_patient_group\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'diffuse anaplasia_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'blastemal-type tumors_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'camptothecins_medication_class\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'irinotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'topotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'radiotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'surgical excision_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'stage IV WT_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD150_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD250_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'low-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'CDCV_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'actinomycin-D_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'vincristine_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'doxorubicin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'VP16_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'surgery_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'chemotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'anaplasia_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'actinomycin D_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'vincristine_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'doxorubicin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'carboplatin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'cyclophosphamide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'etoposide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'SIOP\u22122001_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Wilms tumours_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Davila Fajardo et al._author\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'whole-lung irradiation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'proton therapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'dosimetric study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'locoregional disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'metastatic disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'low-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'intermediate-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'high-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage I_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage II_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage III_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'major rupture_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Austria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Italy_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'San Marino_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Iceland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Germany_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bulgaria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Turkey_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Denmark_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Poland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Greece_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Andorra_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belgium_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Serbia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Albania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Moldova_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Lithuania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Latvia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Estonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Luxembourg_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Montenegro_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Croatia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovenia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Macedonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'United Kingdom_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ireland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Spain_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Algeria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Tunisia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Malta_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Morocco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Portugal_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'France_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Monaco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Russia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Finland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Sweden_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Norway_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belarus_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Romania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ukraine_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hungary_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Czech Republic_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovakia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Switzerland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Liechtenstein_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Netherlands_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Munich_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Marciniak Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Faculty of Medicine_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital Homburg_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Weirich, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Pritchard-Jones, K._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'de Kraker, J._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Graf, N._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Green, D. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Spreafico, F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Bellani, F. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \"D\\'Angio, G. J._author\", {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Tournade, M. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Breslow, N. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Mitchell, C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Verschuur, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Grundy, P. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Warmann, S. W._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Smets, A. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dome, J. S._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dix, D. B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Daw, N. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ha, T. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Kremens, B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Furtwangler, R._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP-9/GPOH_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UKW3_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10})]}, {\\'nodes\\': [(\\'vincristine_entity\\', {}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {}), (\\'www.siop-rtsg.eu_entity\\', {}), (\\'stage II_entity\\', {}), (\\'Wilms tumours_entity\\', {}), (\\'Relapsed Wilms Tumor_entity\\', {}), (\\'Davila Fajardo et al._entity\\', {}), (\\'vincristine, actinomycin D, and doxorubicin_entity\\', {}), (\\'SIOP\u22122001 randomized trial_entity\\', {}), (\\'surgery_entity\\', {}), (\\'non-Wilms tumours_entity\\', {}), (\\'actinomycin D_entity\\', {}), (\\'diffuse anaplasia_entity\\', {}), (\\'Synchronous bilateral Wilms tumor_entity\\', {}), (\\'CT-only nodules_entity\\', {}), (\\'relapsed group CC_entity\\', {}), (\\'increased relapse risk_entity\\', {}), (\\'reduced survival_entity\\', {}), (\\'UKW3 trial_entity\\', {}), (\\'chemotherapy_entity\\', {}), (\\'Bilateral Disease (Stage V)_entity\\', {}), (\\'blastemal-type tumors_entity\\', {}), (\\'UMBRELLA protocol_entity\\', {}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', {}), (\\'minimally invasive surgery_entity\\', {}), (\\'VP16_entity\\', {}), (\\'Wilms tumor_entity\\', {}), (\\'anaplasia_entity\\', {}), (\\'radical tumor nephrectomy_entity\\', {}), (\\'Innovative Therapies for Children with Cancer consortium_entity\\', {}), (\\'cumulative doxorubicin dose_entity\\', {}), (\\'etoposide_entity\\', {}), (\\'large-volume tumours_entity\\', {}), (\\'Stage IV_entity\\', {}), (\\'CDCV_entity\\', {}), (\\'SIOP\u2013RTSG_entity\\', {}), (\\'AVD150_entity\\', {}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', {}), (\\'laparoscopic surgery_entity\\', {}), (\\'SIOP\u2212RTSG panel_entity\\', {}), (\\'actinomycin-D_entity\\', {}), (\\'COG AREN0533 trial_entity\\', {}), (\\'cyclophosphamide_entity\\', {}), (\\'carboplatin_entity\\', {}), (\\'UKW\u2011R protocol_entity\\', {}), (\\'Nephron-sparing surgery (NSS)_entity\\', {}), (\\'Adult Wilms Tumors_entity\\', {}), (\\'doxorubicin_entity\\', {}), (\\'NWTS\u20115 relapse protocol_entity\\', {}), (\\'End-stage renal disease (ESRD)_entity\\', {}), (\\'AVD250_entity\\', {}), (\\'Children\u2019s Oncology Group (COG)_entity\\', {}), (\\'blastemal-type Wilms tumour_entity\\', {}), (\\'SIOP\u22122001_entity\\', {}), (\\'radiotherapy_entity\\', {}), (\\'childhood renal tumours_entity\\', {})], \\'edges\\': [(\\'vincristine_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'stage II_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'indicated_for_in_adults\\'}), (\\'Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'Wilms tumours_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated under\\'}), (\\'Relapsed Wilms Tumor_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guided_by\\'}), (\\'Davila Fajardo et al._entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed\\'}), (\\'SIOP\u22122001 randomized trial_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated use in\\'}), (\\'surgery_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'non-Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'actinomycin D_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Synchronous bilateral Wilms tumor_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'instance_of\\'}), (\\'CT-only nodules_entity\\', \\'increased relapse risk_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'reduced survival_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included_in\\'}), (\\'relapsed group CC_entity\\', \\'diffuse anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'blastemal-type tumors_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UKW3 trial_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'UKW3 trial_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'chemotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UMBRELLA protocol_entity\\', \\'COG AREN0533 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses_data_from\\'}), (\\'UMBRELLA protocol_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'advises_treatment_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'Innovative Therapies for Children with Cancer consortium_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborates_with\\'}), (\\'UMBRELLA protocol_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'surgery_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is the standard of\\'}), (\\'UMBRELLA protocol_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guides treatment in\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', \\'UKW3 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\\'minimally invasive surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'anaplasia_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'radical tumor nephrectomy_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'standard_of_care_for\\'}), (\\'Stage IV_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'presents in\\'}), (\\'CDCV_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'VP16_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'aims to improve survival rates of\\'}), (\\'AVD150_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed_by\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'succeeds\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'www.siop-rtsg.eu_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'available_on\\'}), (\\'laparoscopic surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'COG AREN0533 trial_entity\\', \\'cumulative doxorubicin dose_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'evaluates\\'}), (\\'UKW\u2011R protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'Nephron-sparing surgery (NSS)_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'classification_developed_by\\'}), (\\'Adult Wilms Tumors_entity\\', \\'anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'Adult Wilms Tumors_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'doxorubicin_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'doxorubicin_entity\\', \\'large-volume tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'recommended for\\'}), (\\'NWTS\u20115 relapse protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'End-stage renal disease (ESRD)_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'AVD250_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'Children\u2019s Oncology Group (COG)_entity\\', \\'SIOP\u22122001 randomized trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborated with\\'}), (\\'blastemal-type Wilms tumour_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment intensified according to\\'}), (\\'SIOP\u22122001_entity\\', \\'vincristine, actinomycin D, and doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses\\'}), (\\'SIOP\u22122001_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provided_guidelines_for\\'}), (\\'radiotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'radiotherapy_entity\\', \\'SIOP\u2212RTSG panel_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'contact_for_guidance\\'})]}, {\\'nodes\\': [(\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {}), (\\'Marry M. van den Heuvel-Eibrink_entity\\', {})], \\'edges\\': [(\\'Marry M. van den Heuvel-Eibrink_entity\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'affiliated_with\\'})]}, {\\'nodes\\': [(\\'Stage II_entity\\', {}), (\\'AV_entity\\', {}), (\\'Stage III_entity\\', {}), (\\'vincestine and actinomycin D_entity\\', {}), (\\'AVD_entity\\', {})], \\'edges\\': [(\\'Stage II_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AV_entity\\', \\'Stage II_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Stage III_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AVD_entity\\', \\'Stage III_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'SIOP-RTSG 2016_entity\\', {}), (\\'RCC_entity\\', {}), (\\'CMN_entity\\', {})], \\'edges\\': [(\\'RCC_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'}), (\\'CMN_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'})]}, {\\'nodes\\': [(\\'HR-1_entity\\', {}), (\\'High-risk blastemal type Wilms tumour_entity\\', {})], \\'edges\\': [(\\'HR-1_entity\\', \\'High-risk blastemal type Wilms tumour_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'unfavorable prognosis_entity\\', {}), (\\'high-risk characteristics_entity\\', {})], \\'edges\\': [(\\'high-risk characteristics_entity\\', \\'unfavorable prognosis_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'leads_to\\'})]}, {\\'nodes\\': [(\\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {}), (\\'SIOP\u2013RTSG board_entity\\', {})], \\'edges\\': [(\\'SIOP\u2013RTSG board_entity\\', \\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggests\\'})]}, {\\'nodes\\': [(\\'regimen and outcomes_entity\\', {}), (\\'SIOP database_entity\\', {})], \\'edges\\': [(\\'SIOP database_entity\\', \\'regimen and outcomes_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'captures_data_on\\'})]}, {\\'nodes\\': [(\\'Bilateral nephron-sparing surgery (NSS)_entity\\', {}), (\\'Aronson et al._entity\\', {})], \\'edges\\': [(\\'Aronson et al._entity\\', \\'Bilateral nephron-sparing surgery (NSS)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'observed_effectiveness_of\\'})]}, {\\'nodes\\': [(\\'SIOP\u22122001 study_entity\\', {}), (\\'Actinomycin D_entity\\', {}), (\\'Vincristine_entity\\', {})], \\'edges\\': [(\\'SIOP\u22122001 study_entity\\', \\'Vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'}), (\\'SIOP\u22122001 study_entity\\', \\'Actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'})]}, {\\'nodes\\': [(\\'High-dose melphalan_entity\\', {}), (\\'Group AA_entity\\', {}), (\\'Carboplatin_entity\\', {}), (\\'Doxorubicin_entity\\', {}), (\\'Etoposide_entity\\', {}), (\\'Group BB_entity\\', {}), (\\'Cyclophosphamide_entity\\', {}), (\\'Ifosfamide_entity\\', {})], \\'edges\\': [(\\'Group AA_entity\\', \\'Doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Ifosfamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'High-dose melphalan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'})]}, {\\'nodes\\': [(\\'nephrotoxicity_entity\\', {}), (\\'ifosfamide_entity\\', {})], \\'edges\\': [(\\'ifosfamide_entity\\', \\'nephrotoxicity_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'related_to\\'})]}, {\\'nodes\\': [(\\'camptothecins_entity\\', {}), (\\'irinotecan_entity\\', {}), (\\'topotecan_entity\\', {})], \\'edges\\': [(\\'camptothecins_entity\\', \\'irinotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'camptothecins_entity\\', \\'topotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'})]}, {\\'nodes\\': [(\\'Infant Wilms Tumors_entity\\', {}), (\\'nephrectomy_entity\\', {})], \\'edges\\': [(\\'Infant Wilms Tumors_entity\\', \\'nephrectomy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_option\\'})]}, {\\'nodes\\': [(\\'congenital mesoblastic nephroma_entity\\', {}), (\\'surgery alone_entity\\', {})], \\'edges\\': [(\\'congenital mesoblastic nephroma_entity\\', \\'surgery alone_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'alternative chemotherapy_entity\\', {}), (\\'malignant rhabdoid tumors_entity\\', {})], \\'edges\\': [(\\'malignant rhabdoid tumors_entity\\', \\'alternative chemotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'lymph node sampling_entity\\', {}), (\\'accurate staging_entity\\', {})], \\'edges\\': [(\\'lymph node sampling_entity\\', \\'accurate staging_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'purpose_of\\'})]}, {\\'nodes\\': [(\\'COG\u2013NWTS trials_entity\\', {}), (\\'whole-lung irradiation_entity\\', {})], \\'edges\\': [(\\'COG\u2013NWTS trials_entity\\', \\'whole-lung irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'informed_dosage_for\\'})]}, {\\'nodes\\': [(\\'lung metastases_entity\\', {}), (\\'pulmonary radiotherapy_entity\\', {})], \\'edges\\': [(\\'pulmonary radiotherapy_entity\\', \\'lung metastases_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'administered_for\\'})]}, {\\'nodes\\': [(\\'dosimetric study_entity\\', {}), (\\'proton therapy_entity\\', {}), (\\'flank irradiation_entity\\', {})], \\'edges\\': [(\\'dosimetric study_entity\\', \\'proton therapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated\\'}), (\\'proton therapy_entity\\', \\'flank irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggested_for\\'})]}, {\\'nodes\\': [(\\'metastatic disease_entity\\', {}), (\\'radiotherapy guidelines_entity\\', {}), (\\'locoregional disease_entity\\', {})], \\'edges\\': [(\\'radiotherapy guidelines_entity\\', \\'locoregional disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'}), (\\'radiotherapy guidelines_entity\\', \\'metastatic disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'})]}, {\\'nodes\\': [(\\'major rupture_entity\\', {}), (\\'stage III_entity\\', {})], \\'edges\\': [(\\'stage III_entity\\', \\'major rupture_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes_condition\\'})]}, {\\'nodes\\': [(\\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {}), (\\'ExPO\u2011r\u2011Net_entity\\', {})], \\'edges\\': [(\\'ExPO\u2011r\u2011Net_entity\\', \\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is part of\\'})]}, {\\'nodes\\': [(\\'University Hospital of Munich_entity\\', {}), (\\'Germany_entity\\', {}), (\\'University Hospital of Tuebingen_entity\\', {})], \\'edges\\': [(\\'Germany_entity\\', \\'University Hospital of Munich_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Germany_entity\\', \\'University Hospital of Tuebingen_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {}), (\\'Italy_entity\\', {}), (\\'Azienda Ospedaliera_entity\\', {}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {})], \\'edges\\': [(\\'Italy_entity\\', \\'Azienda Ospedaliera_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Netherlands_entity\\', {}), (\\'Prinses Maxima Centrum_entity\\', {})], \\'edges\\': [(\\'Netherlands_entity\\', \\'Prinses Maxima Centrum_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Marciniak Hospital_entity\\', {}), (\\'Poland_entity\\', {}), (\\'Faculty of Medicine_entity\\', {})], \\'edges\\': [(\\'Poland_entity\\', \\'Marciniak Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Poland_entity\\', \\'Faculty of Medicine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'St. Anna Kinderspital/CCRI_entity\\', {}), (\\'Austria_entity\\', {})], \\'edges\\': [(\\'Austria_entity\\', \\'St. Anna Kinderspital/CCRI_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'France_entity\\', {}), (\\'Armand Trousseau Hospital_entity\\', {})], \\'edges\\': [(\\'France_entity\\', \\'Armand Trousseau Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Spain_entity\\', {}), (\\'Hospital Vall d\u2019Hebron_entity\\', {}), (\\'Hospital Universitario Virgin del Rocio_entity\\', {})], \\'edges\\': [(\\'Spain_entity\\', \\'Hospital Universitario Virgin del Rocio_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Spain_entity\\', \\'Hospital Vall d\u2019Hebron_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'United Kingdom_entity\\', {}), (\\'Great Ormond Street Hospital_entity\\', {})], \\'edges\\': [(\\'United Kingdom_entity\\', \\'Great Ormond Street Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Weirich, A._entity\\', {}), (\\'SIOP-9/GPOH_entity\\', {})], \\'edges\\': [(\\'Weirich, A._entity\\', \\'SIOP-9/GPOH_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Pritchard-Jones, K._entity\\', {}), (\\'UKW3_entity\\', {})], \\'edges\\': [(\\'Pritchard-Jones, K._entity\\', \\'UKW3_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed in\\'})]}, {\\'nodes\\': [(\\'SIOP 93\u201301 trial_entity\\', {}), (\\'de Kraker, J._entity\\', {})], \\'edges\\': [(\\'de Kraker, J._entity\\', \\'SIOP 93\u201301 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'SIOP trial and study 93\u201301_entity\\', {}), (\\'Graf, N._entity\\', {})], \\'edges\\': [(\\'Graf, N._entity\\', \\'SIOP trial and study 93\u201301_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Green, D. M._entity\\', {}), (\\'National Wilms Tumor Study Group_entity\\', {})], \\'edges\\': [(\\'Green, D. M._entity\\', \\'National Wilms Tumor Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}, {\\'nodes\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', {}), (\\'SIOP WT 2001 protocol_entity\\', {})], \\'edges\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', \\'SIOP WT 2001 protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Third National Wilms\u2019 Tumor Study_entity\\', {}), (\"D\\'Angio, G. J._entity\", {}), (\\'Second National Wilms\u2019 Tumor Study_entity\\', {})], \\'edges\\': [(\"D\\'Angio, G. J._entity\", \\'Third National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\"D\\'Angio, G. J._entity\", \\'Second National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {}), (\\'Tournade, M. F._entity\\', {}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {})], \\'edges\\': [(\\'Tournade, M. F._entity\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'}), (\\'Tournade, M. F._entity\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Breslow, N. E._entity\\', {}), (\\'National Wilms Tumor Studies_entity\\', {})], \\'edges\\': [(\\'Breslow, N. E._entity\\', \\'National Wilms Tumor Studies_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Mitchell, C._entity\\', {}), (\\'UK Children\u2019s Cancer Study Group_entity\\', {})], \\'edges\\': [(\\'Mitchell, C._entity\\', \\'UK Children\u2019s Cancer Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'under\\'})]}, {\\'nodes\\': [(\\'Daw, N. C._entity\\', {}), (\\'Dix, D. B._entity\\', {}), (\\'Children\u2019s Oncology Group_entity\\', {}), (\\'Grundy, P. E._entity\\', {})], \\'edges\\': [(\\'Daw, N. C._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted under\\'}), (\\'Dix, D. B._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'}), (\\'Grundy, P. E._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}]', expected_output='It succeeds the SIOP\u22122001 protocol.', context=None, retrieval_context=['[{\\'nodes\\': [(\\'sample.pdf\\', {\\'type\\': \\'document\\'}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)\\'}), (\\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA SIOP-RTSG 2016\\'}), (\\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms tumours\\'}), (\\'non-Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'non-Wilms tumours\\'}), (\\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Website\\', \\'name\\': \\'www.siop-rtsg.eu\\'}), (\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology\\'}), (\\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Person\\', \\'name\\': \\'Marry M. van den Heuvel-Eibrink\\'}), (\\'childhood renal tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'childhood renal tumours\\'}), (\\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'clear cell sarcoma of the kidney\\'}), (\\'renal cell carcinoma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'renal cell carcinoma\\'}), (\\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'malignant rhabdoid tumour of the kidney\\'}), (\\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'Wilms tumours_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'Children\u2019s Oncology Group (COG)\\'}), (\\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'SIOP\u22122001 randomized trial\\'}), (\\'actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'UKW3 trial\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)\\'}), (\\'localized disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'localized disease\\'}), (\\'metastatic disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'metastatic disease\\'}), (\\'bilateral disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'bilateral disease\\'}), (\\'relapsed disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'relapsed disease\\'}), (\\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subtype\\', \\'name\\': \\'blastemal-type Wilms tumours\\'}), (\\'radiotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgery_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'chemotherapy\\'}), (\\'Wilms Tumour_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms Tumour\\'}), (\\'CCSK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CCSK\\'}), (\\'MRTK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'MRTK\\'}), (\\'CMN_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CMN\\'}), (\\'RCC_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'RCC\\'}), (\\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u22122001_Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Trial\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'vincristine_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'vincristine\\'}), (\\'actinomycin D_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'actinomycin D\\'}), (\\'doxorubicin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'doxorubicin\\'}), (\\'etoposide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'Stage I_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage I\\'}), (\\'Stage II_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage II\\'}), (\\'Stage III_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage III\\'}), (\\'Stage IV_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage IV\\'}), (\\'Stage V_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage V\\'}), (\\'AV_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AV\\'}), (\\'AVD_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AVD\\'}), (\\'HR-1_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'HR-1\\'}), (\\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP-RTSG 2016\\'}), (\\'Overall Survival (OS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'CT-only nodules_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'CT-only nodules\\'}), (\\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP\u2013RTSG analysis\\'}), (\\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials\\'}), (\\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D plus doxorubicin\\'}), (\\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D\\'}), (\\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study_protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'MRI_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'MRI\\'}), (\\'CT_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'CT\\'}), (\\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_detail\\', \\'name\\': \\'cumulative doxorubicin dose\\'}), (\\'COG AREN0533 trial_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG AREN0533 trial\\'}), (\\'etoposide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'high-risk characteristics\\'}), (\\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG board\\'}), (\\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin\\'}), (\\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'high-dose chemotherapy and autologous stem cell transplantation\\'}), (\\'SIOP database_database\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'database\\', \\'name\\': \\'SIOP database\\'}), (\\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'AVD_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AVD\\'}), (\\'AV-2_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AV-2\\'}), (\\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Statistical Test\\', \\'name\\': \\'Log\u2013Rank P\\'}), (\\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'Bilateral Disease (Stage V)\\'}), (\\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Synchronous bilateral Wilms tumor\\'}), (\\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'End-stage renal disease (ESRD)\\'}), (\\'Aronson et al._Research Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Research Group\\', \\'name\\': \\'Aronson et al.\\'}), (\\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'Bilateral nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Study\\', \\'name\\': \\'SIOP\u22122001 study\\'}), (\\'Vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Vincristine\\'}), (\\'Actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Actinomycin D\\'}), (\\'Etoposide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Etoposide\\'}), (\\'Carboplatin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Carboplatin\\'}), (\\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease State\\', \\'name\\': \\'Relapsed Wilms Tumor\\'}), (\\'Group AA_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group AA\\'}), (\\'Group BB_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group BB\\'}), (\\'Group CC_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group CC\\'}), (\\'Doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Doxorubicin\\'}), (\\'Cyclophosphamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Cyclophosphamide\\'}), (\\'Ifosfamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Ifosfamide\\'}), (\\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'High-dose melphalan\\'}), (\\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UKW\u2011R protocol\\'}), (\\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'NWTS\u20115 relapse protocol\\'}), (\\'ASCR_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'procedure\\', \\'name\\': \\'ASCR\\'}), (\\'ifosfamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'ifosfamide\\'}), (\\'nephrotoxicity_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'nephrotoxicity\\'}), (\\'relapsed group CC_patient_group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'patient_group\\', \\'name\\': \\'relapsed group CC\\'}), (\\'diffuse anaplasia_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'diffuse anaplasia\\'}), (\\'blastemal-type tumors_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'blastemal-type tumors\\'}), (\\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'camptothecins_medication_class\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication_class\\', \\'name\\': \\'camptothecins\\'}), (\\'irinotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'irinotecan\\'}), (\\'topotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'topotecan\\'}), (\\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Innovative Therapies for Children with Cancer consortium\\'}), (\\'radiotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgical excision_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgical excision\\'}), (\\'stage IV WT_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'stage IV WT\\'}), (\\'AVD150_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD150\\'}), (\\'AVD250_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD250\\'}), (\\'low-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'low-risk disease\\'}), (\\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'intermediate-risk disease\\'}), (\\'high-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'high-risk disease\\'}), (\\'CDCV_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'CDCV\\'}), (\\'actinomycin-D_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'actinomycin-D\\'}), (\\'vincristine_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'doxorubicin\\'}), (\\'VP16_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'VP16\\'}), (\\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'contact\\', \\'name\\': \\'arnauld.verschuur@ap-hm.fr\\'}), (\\'surgery_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'chemotherapy\\'}), (\\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2212RTSG panel\\'}), (\\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Infant Wilms Tumors\\'}), (\\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'nephrectomy\\'}), (\\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'malignant rhabdoid tumors\\'}), (\\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Adult Wilms Tumors\\'}), (\\'anaplasia_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'anaplasia\\'}), (\\'actinomycin D_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'carboplatin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'etoposide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'etoposide\\'}), (\\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'Nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'radical tumor nephrectomy\\'}), (\\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'lymph node sampling\\'}), (\\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'minimally invasive surgery\\'}), (\\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'laparoscopic surgery\\'}), (\\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'radiotherapy\\'}), (\\'Wilms tumours_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'Davila Fajardo et al._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Davila Fajardo et al.\\'}), (\\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'COG\u2013NWTS trials\\'}), (\\'whole-lung irradiation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'whole-lung irradiation\\'}), (\\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'pulmonary radiotherapy\\'}), (\\'proton therapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'proton therapy\\'}), (\\'dosimetric study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'dosimetric study\\'}), (\\'locoregional disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'locoregional disease\\'}), (\\'metastatic disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'metastatic disease\\'}), (\\'low-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'low-risk\\'}), (\\'intermediate-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'intermediate-risk\\'}), (\\'high-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'high-risk\\'}), (\\'stage I_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage I\\'}), (\\'stage II_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage II\\'}), (\\'stage III_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage III\\'}), (\\'major rupture_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'major rupture\\'}), (\\'Austria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Austria\\'}), (\\'Italy_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Italy\\'}), (\\'San Marino_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'San Marino\\'}), (\\'Iceland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Iceland\\'}), (\\'Germany_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Germany\\'}), (\\'Bulgaria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bulgaria\\'}), (\\'Turkey_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Turkey\\'}), (\\'Denmark_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Denmark\\'}), (\\'Poland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Poland\\'}), (\\'Greece_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Greece\\'}), (\\'Andorra_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Andorra\\'}), (\\'Belgium_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belgium\\'}), (\\'Serbia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Serbia\\'}), (\\'Albania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Albania\\'}), (\\'Moldova_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Moldova\\'}), (\\'Lithuania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Lithuania\\'}), (\\'Latvia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Latvia\\'}), (\\'Estonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Estonia\\'}), (\\'Luxembourg_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Luxembourg\\'}), (\\'Montenegro_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Montenegro\\'}), (\\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bosnia and Herzegovina\\'}), (\\'Croatia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Croatia\\'}), (\\'Slovenia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovenia\\'}), (\\'Macedonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Macedonia\\'}), (\\'United Kingdom_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'United Kingdom\\'}), (\\'Ireland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ireland\\'}), (\\'Spain_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Spain\\'}), (\\'Algeria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Algeria\\'}), (\\'Tunisia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Tunisia\\'}), (\\'Malta_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Malta\\'}), (\\'Morocco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Morocco\\'}), (\\'Portugal_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Portugal\\'}), (\\'France_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'France\\'}), (\\'Monaco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Monaco\\'}), (\\'Russia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Russia\\'}), (\\'Finland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Finland\\'}), (\\'Sweden_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Sweden\\'}), (\\'Norway_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Norway\\'}), (\\'Belarus_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belarus\\'}), (\\'Romania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Romania\\'}), (\\'Ukraine_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ukraine\\'}), (\\'Hungary_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Hungary\\'}), (\\'Czech Republic_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Czech Republic\\'}), (\\'Slovakia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovakia\\'}), (\\'Switzerland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Switzerland\\'}), (\\'Liechtenstein_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Liechtenstein\\'}), (\\'Netherlands_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Netherlands\\'}), (\\'University Hospital of Munich_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Munich\\'}), (\\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Tuebingen\\'}), (\\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Azienda Ospedaliera\\'}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Ospedale Pediatrico Bambino Ges\u00f9\\'}), (\\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Fondazione IRCCS Istituto Nazionale dei Tumori\\'}), (\\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Prinses Maxima Centrum\\'}), (\\'Marciniak Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Marciniak Hospital\\'}), (\\'Faculty of Medicine_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Faculty of Medicine\\'}), (\\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'St. Anna Kinderspital/CCRI\\'}), (\\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Armand Trousseau Hospital\\'}), (\\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Universitario Virgin del Rocio\\'}), (\\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Vall d\u2019Hebron\\'}), (\\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Great Ormond Street Hospital\\'}), (\\'University Hospital Homburg_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital Homburg\\'}), (\\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon\\'}), (\\'UMBRELLA protocol_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'ExPO\u2011r\u2011Net\\'}), (\\'Weirich, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Weirich, A.\\'}), (\\'Pritchard-Jones, K._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Pritchard-Jones, K.\\'}), (\\'de Kraker, J._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'de Kraker, J.\\'}), (\\'Graf, N._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Graf, N.\\'}), (\\'Green, D. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Green, D. M.\\'}), (\\'Spreafico, F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Spreafico, F.\\'}), (\\'Bellani, F. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Bellani, F. F.\\'}), (\\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'van den Heuvel-Eibrink, M. M.\\'}), (\"D\\'Angio, G. J._author\", {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \"D\\'Angio, G. J.\"}), (\\'Tournade, M. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Tournade, M. F.\\'}), (\\'Breslow, N. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Breslow, N. E.\\'}), (\\'Mitchell, C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Mitchell, C.\\'}), (\\'Verschuur, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Verschuur, A.\\'}), (\\'Grundy, P. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Grundy, P. E.\\'}), (\\'Warmann, S. W._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Warmann, S. W.\\'}), (\\'Smets, A. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Smets, A. M.\\'}), (\\'Dome, J. S._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dome, J. S.\\'}), (\\'Dix, D. B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dix, D. B.\\'}), (\\'Daw, N. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Daw, N. C.\\'}), (\\'Ha, T. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Ha, T. C.\\'}), (\\'Kremens, B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Kremens, B.\\'}), (\\'Furtwangler, R._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Furtwangler, R.\\'}), (\\'SIOP-9/GPOH_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP-9/GPOH\\'}), (\\'UKW3_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'UKW3\\'}), (\\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'SIOP 93\u201301 trial\\'}), (\\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP trial and study 93\u201301\\'}), (\\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'National Wilms Tumor Study Group\\'}), (\\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP WT 2001 protocol\\'}), (\\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Third National Wilms\u2019 Tumor Study\\'}), (\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'National Wilms Tumor Studies\\'}), (\\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Second National Wilms\u2019 Tumor Study\\'}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'UK Children\u2019s Cancer Study Group\\'}), (\\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Children\u2019s Oncology Group\\'})], \\'edges\\': [(\\'sample.pdf\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'non-Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'childhood renal tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'renal cell carcinoma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'localized disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'metastatic disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'bilateral disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'relapsed disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'radiotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'surgery_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'chemotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'Wilms Tumour_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CCSK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'MRTK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CMN_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'RCC_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP\u22122001_Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'vincristine_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'actinomycin D_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'doxorubicin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'etoposide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'carboplatin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'cyclophosphamide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage I_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage II_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage III_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage IV_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage V_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AV_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AVD_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'HR-1_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Overall Survival (OS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT-only nodules_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'MRI_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG AREN0533 trial_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'etoposide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'carboplatin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'cyclophosphamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP database_database\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AVD_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AV-2_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Aronson et al._Research Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Etoposide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Carboplatin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group AA_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group BB_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group CC_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Cyclophosphamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Ifosfamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'ASCR_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'ifosfamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'nephrotoxicity_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'relapsed group CC_patient_group\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'diffuse anaplasia_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'blastemal-type tumors_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'camptothecins_medication_class\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'irinotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'topotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'radiotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'surgical excision_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'stage IV WT_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD150_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD250_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'low-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'CDCV_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'actinomycin-D_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'vincristine_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'doxorubicin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'VP16_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'surgery_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'chemotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'anaplasia_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'actinomycin D_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'vincristine_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'doxorubicin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'carboplatin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'cyclophosphamide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'etoposide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'SIOP\u22122001_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Wilms tumours_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Davila Fajardo et al._author\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'whole-lung irradiation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'proton therapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'dosimetric study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'locoregional disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'metastatic disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'low-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'intermediate-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'high-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage I_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage II_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage III_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'major rupture_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Austria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Italy_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'San Marino_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Iceland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Germany_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bulgaria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Turkey_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Denmark_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Poland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Greece_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Andorra_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belgium_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Serbia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Albania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Moldova_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Lithuania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Latvia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Estonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Luxembourg_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Montenegro_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Croatia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovenia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Macedonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'United Kingdom_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ireland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Spain_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Algeria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Tunisia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Malta_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Morocco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Portugal_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'France_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Monaco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Russia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Finland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Sweden_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Norway_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belarus_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Romania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ukraine_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hungary_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Czech Republic_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovakia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Switzerland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Liechtenstein_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Netherlands_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Munich_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Marciniak Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Faculty of Medicine_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital Homburg_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Weirich, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Pritchard-Jones, K._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'de Kraker, J._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Graf, N._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Green, D. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Spreafico, F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Bellani, F. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \"D\\'Angio, G. J._author\", {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Tournade, M. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Breslow, N. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Mitchell, C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Verschuur, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Grundy, P. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Warmann, S. W._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Smets, A. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dome, J. S._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dix, D. B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Daw, N. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ha, T. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Kremens, B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Furtwangler, R._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP-9/GPOH_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UKW3_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10})]}, {\\'nodes\\': [(\\'vincristine_entity\\', {}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {}), (\\'www.siop-rtsg.eu_entity\\', {}), (\\'stage II_entity\\', {}), (\\'Wilms tumours_entity\\', {}), (\\'Relapsed Wilms Tumor_entity\\', {}), (\\'Davila Fajardo et al._entity\\', {}), (\\'vincristine, actinomycin D, and doxorubicin_entity\\', {}), (\\'SIOP\u22122001 randomized trial_entity\\', {}), (\\'surgery_entity\\', {}), (\\'non-Wilms tumours_entity\\', {}), (\\'actinomycin D_entity\\', {}), (\\'diffuse anaplasia_entity\\', {}), (\\'Synchronous bilateral Wilms tumor_entity\\', {}), (\\'CT-only nodules_entity\\', {}), (\\'relapsed group CC_entity\\', {}), (\\'increased relapse risk_entity\\', {}), (\\'reduced survival_entity\\', {}), (\\'UKW3 trial_entity\\', {}), (\\'chemotherapy_entity\\', {}), (\\'Bilateral Disease (Stage V)_entity\\', {}), (\\'blastemal-type tumors_entity\\', {}), (\\'UMBRELLA protocol_entity\\', {}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', {}), (\\'minimally invasive surgery_entity\\', {}), (\\'VP16_entity\\', {}), (\\'Wilms tumor_entity\\', {}), (\\'anaplasia_entity\\', {}), (\\'radical tumor nephrectomy_entity\\', {}), (\\'Innovative Therapies for Children with Cancer consortium_entity\\', {}), (\\'cumulative doxorubicin dose_entity\\', {}), (\\'etoposide_entity\\', {}), (\\'large-volume tumours_entity\\', {}), (\\'Stage IV_entity\\', {}), (\\'CDCV_entity\\', {}), (\\'SIOP\u2013RTSG_entity\\', {}), (\\'AVD150_entity\\', {}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', {}), (\\'laparoscopic surgery_entity\\', {}), (\\'SIOP\u2212RTSG panel_entity\\', {}), (\\'actinomycin-D_entity\\', {}), (\\'COG AREN0533 trial_entity\\', {}), (\\'cyclophosphamide_entity\\', {}), (\\'carboplatin_entity\\', {}), (\\'UKW\u2011R protocol_entity\\', {}), (\\'Nephron-sparing surgery (NSS)_entity\\', {}), (\\'Adult Wilms Tumors_entity\\', {}), (\\'doxorubicin_entity\\', {}), (\\'NWTS\u20115 relapse protocol_entity\\', {}), (\\'End-stage renal disease (ESRD)_entity\\', {}), (\\'AVD250_entity\\', {}), (\\'Children\u2019s Oncology Group (COG)_entity\\', {}), (\\'blastemal-type Wilms tumour_entity\\', {}), (\\'SIOP\u22122001_entity\\', {}), (\\'radiotherapy_entity\\', {}), (\\'childhood renal tumours_entity\\', {})], \\'edges\\': [(\\'vincristine_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'stage II_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'indicated_for_in_adults\\'}), (\\'Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'Wilms tumours_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated under\\'}), (\\'Relapsed Wilms Tumor_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guided_by\\'}), (\\'Davila Fajardo et al._entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed\\'}), (\\'SIOP\u22122001 randomized trial_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated use in\\'}), (\\'surgery_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'non-Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'actinomycin D_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Synchronous bilateral Wilms tumor_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'instance_of\\'}), (\\'CT-only nodules_entity\\', \\'increased relapse risk_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'reduced survival_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included_in\\'}), (\\'relapsed group CC_entity\\', \\'diffuse anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'blastemal-type tumors_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UKW3 trial_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'UKW3 trial_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'chemotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UMBRELLA protocol_entity\\', \\'COG AREN0533 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses_data_from\\'}), (\\'UMBRELLA protocol_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'advises_treatment_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'Innovative Therapies for Children with Cancer consortium_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborates_with\\'}), (\\'UMBRELLA protocol_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'surgery_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is the standard of\\'}), (\\'UMBRELLA protocol_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guides treatment in\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', \\'UKW3 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\\'minimally invasive surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'anaplasia_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'radical tumor nephrectomy_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'standard_of_care_for\\'}), (\\'Stage IV_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'presents in\\'}), (\\'CDCV_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'VP16_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'aims to improve survival rates of\\'}), (\\'AVD150_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed_by\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'succeeds\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'www.siop-rtsg.eu_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'available_on\\'}), (\\'laparoscopic surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'COG AREN0533 trial_entity\\', \\'cumulative doxorubicin dose_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'evaluates\\'}), (\\'UKW\u2011R protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'Nephron-sparing surgery (NSS)_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'classification_developed_by\\'}), (\\'Adult Wilms Tumors_entity\\', \\'anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'Adult Wilms Tumors_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'doxorubicin_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'doxorubicin_entity\\', \\'large-volume tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'recommended for\\'}), (\\'NWTS\u20115 relapse protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'End-stage renal disease (ESRD)_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'AVD250_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'Children\u2019s Oncology Group (COG)_entity\\', \\'SIOP\u22122001 randomized trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborated with\\'}), (\\'blastemal-type Wilms tumour_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment intensified according to\\'}), (\\'SIOP\u22122001_entity\\', \\'vincristine, actinomycin D, and doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses\\'}), (\\'SIOP\u22122001_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provided_guidelines_for\\'}), (\\'radiotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'radiotherapy_entity\\', \\'SIOP\u2212RTSG panel_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'contact_for_guidance\\'})]}, {\\'nodes\\': [(\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {}), (\\'Marry M. van den Heuvel-Eibrink_entity\\', {})], \\'edges\\': [(\\'Marry M. van den Heuvel-Eibrink_entity\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'affiliated_with\\'})]}, {\\'nodes\\': [(\\'Stage II_entity\\', {}), (\\'AV_entity\\', {}), (\\'Stage III_entity\\', {}), (\\'vincestine and actinomycin D_entity\\', {}), (\\'AVD_entity\\', {})], \\'edges\\': [(\\'Stage II_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AV_entity\\', \\'Stage II_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Stage III_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AVD_entity\\', \\'Stage III_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'SIOP-RTSG 2016_entity\\', {}), (\\'RCC_entity\\', {}), (\\'CMN_entity\\', {})], \\'edges\\': [(\\'RCC_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'}), (\\'CMN_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'})]}, {\\'nodes\\': [(\\'HR-1_entity\\', {}), (\\'High-risk blastemal type Wilms tumour_entity\\', {})], \\'edges\\': [(\\'HR-1_entity\\', \\'High-risk blastemal type Wilms tumour_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'unfavorable prognosis_entity\\', {}), (\\'high-risk characteristics_entity\\', {})], \\'edges\\': [(\\'high-risk characteristics_entity\\', \\'unfavorable prognosis_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'leads_to\\'})]}, {\\'nodes\\': [(\\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {}), (\\'SIOP\u2013RTSG board_entity\\', {})], \\'edges\\': [(\\'SIOP\u2013RTSG board_entity\\', \\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggests\\'})]}, {\\'nodes\\': [(\\'regimen and outcomes_entity\\', {}), (\\'SIOP database_entity\\', {})], \\'edges\\': [(\\'SIOP database_entity\\', \\'regimen and outcomes_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'captures_data_on\\'})]}, {\\'nodes\\': [(\\'Bilateral nephron-sparing surgery (NSS)_entity\\', {}), (\\'Aronson et al._entity\\', {})], \\'edges\\': [(\\'Aronson et al._entity\\', \\'Bilateral nephron-sparing surgery (NSS)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'observed_effectiveness_of\\'})]}, {\\'nodes\\': [(\\'SIOP\u22122001 study_entity\\', {}), (\\'Actinomycin D_entity\\', {}), (\\'Vincristine_entity\\', {})], \\'edges\\': [(\\'SIOP\u22122001 study_entity\\', \\'Vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'}), (\\'SIOP\u22122001 study_entity\\', \\'Actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'})]}, {\\'nodes\\': [(\\'High-dose melphalan_entity\\', {}), (\\'Group AA_entity\\', {}), (\\'Carboplatin_entity\\', {}), (\\'Doxorubicin_entity\\', {}), (\\'Etoposide_entity\\', {}), (\\'Group BB_entity\\', {}), (\\'Cyclophosphamide_entity\\', {}), (\\'Ifosfamide_entity\\', {})], \\'edges\\': [(\\'Group AA_entity\\', \\'Doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Ifosfamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'High-dose melphalan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'})]}, {\\'nodes\\': [(\\'nephrotoxicity_entity\\', {}), (\\'ifosfamide_entity\\', {})], \\'edges\\': [(\\'ifosfamide_entity\\', \\'nephrotoxicity_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'related_to\\'})]}, {\\'nodes\\': [(\\'camptothecins_entity\\', {}), (\\'irinotecan_entity\\', {}), (\\'topotecan_entity\\', {})], \\'edges\\': [(\\'camptothecins_entity\\', \\'irinotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'camptothecins_entity\\', \\'topotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'})]}, {\\'nodes\\': [(\\'Infant Wilms Tumors_entity\\', {}), (\\'nephrectomy_entity\\', {})], \\'edges\\': [(\\'Infant Wilms Tumors_entity\\', \\'nephrectomy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_option\\'})]}, {\\'nodes\\': [(\\'congenital mesoblastic nephroma_entity\\', {}), (\\'surgery alone_entity\\', {})], \\'edges\\': [(\\'congenital mesoblastic nephroma_entity\\', \\'surgery alone_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'alternative chemotherapy_entity\\', {}), (\\'malignant rhabdoid tumors_entity\\', {})], \\'edges\\': [(\\'malignant rhabdoid tumors_entity\\', \\'alternative chemotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'lymph node sampling_entity\\', {}), (\\'accurate staging_entity\\', {})], \\'edges\\': [(\\'lymph node sampling_entity\\', \\'accurate staging_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'purpose_of\\'})]}, {\\'nodes\\': [(\\'COG\u2013NWTS trials_entity\\', {}), (\\'whole-lung irradiation_entity\\', {})], \\'edges\\': [(\\'COG\u2013NWTS trials_entity\\', \\'whole-lung irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'informed_dosage_for\\'})]}, {\\'nodes\\': [(\\'lung metastases_entity\\', {}), (\\'pulmonary radiotherapy_entity\\', {})], \\'edges\\': [(\\'pulmonary radiotherapy_entity\\', \\'lung metastases_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'administered_for\\'})]}, {\\'nodes\\': [(\\'dosimetric study_entity\\', {}), (\\'proton therapy_entity\\', {}), (\\'flank irradiation_entity\\', {})], \\'edges\\': [(\\'dosimetric study_entity\\', \\'proton therapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated\\'}), (\\'proton therapy_entity\\', \\'flank irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggested_for\\'})]}, {\\'nodes\\': [(\\'metastatic disease_entity\\', {}), (\\'radiotherapy guidelines_entity\\', {}), (\\'locoregional disease_entity\\', {})], \\'edges\\': [(\\'radiotherapy guidelines_entity\\', \\'locoregional disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'}), (\\'radiotherapy guidelines_entity\\', \\'metastatic disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'})]}, {\\'nodes\\': [(\\'major rupture_entity\\', {}), (\\'stage III_entity\\', {})], \\'edges\\': [(\\'stage III_entity\\', \\'major rupture_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes_condition\\'})]}, {\\'nodes\\': [(\\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {}), (\\'ExPO\u2011r\u2011Net_entity\\', {})], \\'edges\\': [(\\'ExPO\u2011r\u2011Net_entity\\', \\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is part of\\'})]}, {\\'nodes\\': [(\\'University Hospital of Munich_entity\\', {}), (\\'Germany_entity\\', {}), (\\'University Hospital of Tuebingen_entity\\', {})], \\'edges\\': [(\\'Germany_entity\\', \\'University Hospital of Munich_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Germany_entity\\', \\'University Hospital of Tuebingen_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {}), (\\'Italy_entity\\', {}), (\\'Azienda Ospedaliera_entity\\', {}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {})], \\'edges\\': [(\\'Italy_entity\\', \\'Azienda Ospedaliera_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Netherlands_entity\\', {}), (\\'Prinses Maxima Centrum_entity\\', {})], \\'edges\\': [(\\'Netherlands_entity\\', \\'Prinses Maxima Centrum_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Marciniak Hospital_entity\\', {}), (\\'Poland_entity\\', {}), (\\'Faculty of Medicine_entity\\', {})], \\'edges\\': [(\\'Poland_entity\\', \\'Marciniak Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Poland_entity\\', \\'Faculty of Medicine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'St. Anna Kinderspital/CCRI_entity\\', {}), (\\'Austria_entity\\', {})], \\'edges\\': [(\\'Austria_entity\\', \\'St. Anna Kinderspital/CCRI_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'France_entity\\', {}), (\\'Armand Trousseau Hospital_entity\\', {})], \\'edges\\': [(\\'France_entity\\', \\'Armand Trousseau Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Spain_entity\\', {}), (\\'Hospital Vall d\u2019Hebron_entity\\', {}), (\\'Hospital Universitario Virgin del Rocio_entity\\', {})], \\'edges\\': [(\\'Spain_entity\\', \\'Hospital Universitario Virgin del Rocio_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Spain_entity\\', \\'Hospital Vall d\u2019Hebron_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'United Kingdom_entity\\', {}), (\\'Great Ormond Street Hospital_entity\\', {})], \\'edges\\': [(\\'United Kingdom_entity\\', \\'Great Ormond Street Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Weirich, A._entity\\', {}), (\\'SIOP-9/GPOH_entity\\', {})], \\'edges\\': [(\\'Weirich, A._entity\\', \\'SIOP-9/GPOH_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Pritchard-Jones, K._entity\\', {}), (\\'UKW3_entity\\', {})], \\'edges\\': [(\\'Pritchard-Jones, K._entity\\', \\'UKW3_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed in\\'})]}, {\\'nodes\\': [(\\'SIOP 93\u201301 trial_entity\\', {}), (\\'de Kraker, J._entity\\', {})], \\'edges\\': [(\\'de Kraker, J._entity\\', \\'SIOP 93\u201301 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'SIOP trial and study 93\u201301_entity\\', {}), (\\'Graf, N._entity\\', {})], \\'edges\\': [(\\'Graf, N._entity\\', \\'SIOP trial and study 93\u201301_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Green, D. M._entity\\', {}), (\\'National Wilms Tumor Study Group_entity\\', {})], \\'edges\\': [(\\'Green, D. M._entity\\', \\'National Wilms Tumor Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}, {\\'nodes\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', {}), (\\'SIOP WT 2001 protocol_entity\\', {})], \\'edges\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', \\'SIOP WT 2001 protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Third National Wilms\u2019 Tumor Study_entity\\', {}), (\"D\\'Angio, G. J._entity\", {}), (\\'Second National Wilms\u2019 Tumor Study_entity\\', {})], \\'edges\\': [(\"D\\'Angio, G. J._entity\", \\'Third National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\"D\\'Angio, G. J._entity\", \\'Second National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {}), (\\'Tournade, M. F._entity\\', {}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {})], \\'edges\\': [(\\'Tournade, M. F._entity\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'}), (\\'Tournade, M. F._entity\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Breslow, N. E._entity\\', {}), (\\'National Wilms Tumor Studies_entity\\', {})], \\'edges\\': [(\\'Breslow, N. E._entity\\', \\'National Wilms Tumor Studies_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Mitchell, C._entity\\', {}), (\\'UK Children\u2019s Cancer Study Group_entity\\', {})], \\'edges\\': [(\\'Mitchell, C._entity\\', \\'UK Children\u2019s Cancer Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'under\\'})]}, {\\'nodes\\': [(\\'Daw, N. C._entity\\', {}), (\\'Dix, D. B._entity\\', {}), (\\'Children\u2019s Oncology Group_entity\\', {}), (\\'Grundy, P. E._entity\\', {})], \\'edges\\': [(\\'Daw, N. C._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted under\\'}), (\\'Dix, D. B._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'}), (\\'Grundy, P. E._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}]']), TestResult(name='test_case_0', success=False, metrics_data=[MetricData(name='Answer Correctness (GEval)', threshold=0.5, success=True, score=0.5895358976648775, reason='The actual output includes relevant information about the UMBRELLA protocol and its connections to childhood renal tumors and international collaboration, but it lacks explicit focus on standardization in diagnosis and treatment.', strict_mode=False, evaluation_model='gpt-4o-mini', error=None, evaluation_cost=0.0033053999999999996, verbose_logs='Criteria:\\nNone \\n \\nEvaluation Steps:\\n[\\n    \"Determine whether the actual output is factually correct based on the expected output.\"\\n]'), MetricData(name='Faithfulness', threshold=0.7, success=True, score=0.9487179487179487, reason=None, strict_mode=False, evaluation_model='gpt-4o-mini', error=None, evaluation_cost=0.00940575, verbose_logs='Truths (limit=None):\\n[\\n    \"The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG) is an organization.\",\\n    \"UMBRELLA SIOP-RTSG 2016 is a protocol.\",\\n    \"SIOP\u22122001 is a protocol.\",\\n    \"Wilms tumours are a type of disease.\",\\n    \"Non-Wilms tumours are a type of disease.\",\\n    \"The website for SIOP\u2013RTSG is www.siop-rtsg.eu.\",\\n    \"The Department of Paediatric Oncology is part of the Princess M\u00e1xima Center for Paediatric Oncology.\",\\n    \"Marry M. van den Heuvel-Eibrink is a person affiliated with the Department of Paediatric Oncology.\",\\n    \"Childhood renal tumours are a type of disease.\",\\n    \"Clear cell sarcoma of the kidney is a type of disease.\",\\n    \"Renal cell carcinoma is a type of disease.\",\\n    \"Malignant rhabdoid tumour of the kidney is a type of disease.\",\\n    \"Congenital mesoblastic nephroma is a type of disease.\",\\n    \"Wilms tumours are classified as a condition.\",\\n    \"The UMBRELLA protocol is a treatment protocol.\",\\n    \"SIOP\u2013RTSG is an organization.\",\\n    \"Children\u2019s Oncology Group (COG) is an organization.\",\\n    \"SIOP\u22122001 randomized trial is a clinical trial.\",\\n    \"Actinomycin D is a drug.\",\\n    \"Vincristine is a drug.\",\\n    \"Doxorubicin is a drug.\",\\n    \"UKW3 trial is a clinical trial.\",\\n    \"UK Children\u2019s Cancer and Leukaemia Group (UKCCLG) is an organization.\",\\n    \"Localized disease is a stage of disease.\",\\n    \"Metastatic disease is a stage of disease.\",\\n    \"Bilateral disease is a stage of disease.\",\\n    \"Relapsed disease is a stage of disease.\",\\n    \"Blastemal-type Wilms tumours is a subtype of Wilms tumours.\",\\n    \"Radiotherapy is a treatment method.\",\\n    \"Surgery is a treatment method.\",\\n    \"Chemotherapy is a treatment method.\",\\n    \"Wilms Tumour is a type of disease.\",\\n    \"CCSK is a type of disease.\",\\n    \"MRTK is a type of disease.\",\\n    \"CMN is a type of disease.\",\\n    \"RCC is a type of disease.\",\\n    \"The UMBRELLA protocol is also classified as a protocol.\",\\n    \"SIOP\u22122001 is classified as a trial.\",\\n    \"Vincristine is used as treatment.\",\\n    \"Actinomycin D is used as treatment.\",\\n    \"Doxorubicin is used as treatment.\",\\n    \"Etoposide is used as treatment.\",\\n    \"Carboplatin is used as treatment.\",\\n    \"Cyclophosphamide is used as treatment.\",\\n    \"Stage I is a stage of disease.\",\\n    \"Stage II is a stage of disease.\",\\n    \"Stage III is a stage of disease.\",\\n    \"Stage IV is a stage of disease.\",\\n    \"Stage V is a stage of disease.\",\\n    \"AV is a treatment combination.\",\\n    \"AVD is a treatment combination.\",\\n    \"HR-1 is a treatment combination.\",\\n    \"SIOP-RTSG 2016 is a protocol.\",\\n    \"Overall Survival (OS) is a metric used in oncology.\",\\n    \"Event-Free Survival (EFS) is a metric used in oncology.\",\\n    \"CT-only nodules are a medical condition.\",\\n    \"The SIOP\u2013RTSG analysis is a study.\",\\n    \"COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials are studies.\",\\n    \"Vincristine and actinomycin D plus doxorubicin is a treatment regimen.\",\\n    \"Vincristine and actinomycin D is a treatment regimen.\",\\n    \"MRI is a diagnostic tool.\",\\n    \"CT is a diagnostic tool.\",\\n    \"Cumulative doxorubicin dose is a treatment detail.\",\\n    \"Etoposide is a medication.\",\\n    \"Carboplatin is a medication.\",\\n    \"Cyclophosphamide is a medication.\",\\n    \"High-risk characteristics denote a medical condition.\",\\n    \"SIOP\u2013RTSG board is an organization.\",\\n    \"High-dose chemotherapy and autologous stem cell transplantation is a treatment method.\",\\n    \"SIOP database captures data for studies.\",\\n    \"Event-Free Survival (EFS) and Overall Survival (OS) are key subjects in oncology studies.\",\\n    \"AVD is a treatment group.\",\\n    \"AV-2 is a treatment group.\",\\n    \"Log\u2013Rank P is a statistical test.\",\\n    \"Bilateral Disease (Stage V) is a disease stage.\",\\n    \"Synchronous bilateral Wilms tumor is a type of disease.\",\\n    \"End-stage renal disease (ESRD) is a condition.\",\\n    \"Bilateral nephron-sparing surgery (NSS) is a treatment method.\",\\n    \"The SIOP\u22122001 study is an important oncology study.\",\\n    \"Vincristine, Actinomycin D, and Doxorubicin are notable drugs.\",\\n    \"Nephrotoxicity is a condition.\",\\n    \"Diffuse anaplasia is a condition.\",\\n    \"Blastemal-type tumors are a medical condition.\",\\n    \"Irinotecan and Topotecan are medications that belong to the class of camptothecins.\",\\n    \"Minimally invasive surgery, laparoscopic surgery, and nephron-sparing surgery are types of surgical procedure.\",\\n    \"Wilms tumours can require different treatment protocols based on classification and type.\"\\n] \\n \\nClaims:\\n[\\n    \"The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG) is an organization.\",\\n    \"The UMBRELLA SIOP-RTSG 2016 is a protocol.\",\\n    \"The SIOP\u22122001 is a protocol.\",\\n    \"Wilms tumours are a type of disease.\",\\n    \"Non-Wilms tumours are a type of disease.\",\\n    \"The website www.siop-rtsg.eu is associated with SIOP-RTSG.\",\\n    \"The Department of Paediatric Oncology is part of the Princess M\u00e1xima Center for Paediatric Oncology.\",\\n    \"Marry M. van den Heuvel-Eibrink is a person associated with SIOP\u2013RTSG.\",\\n    \"Childhood renal tumours refer to a group of diseases.\",\\n    \"Clear cell sarcoma of the kidney is a type of disease.\",\\n    \"Renal cell carcinoma is a type of disease.\",\\n    \"Malignant rhabdoid tumour of the kidney is a type of disease.\",\\n    \"Congenital mesoblastic nephroma is a type of disease.\",\\n    \"Wilms tumours are a medical condition.\",\\n    \"The umbrella protocol is a treatment protocol.\",\\n    \"SIOP\u2013RTSG is an organization associated with Wilms tumours.\",\\n    \"The Children\u2019s Oncology Group (COG) is an organization.\",\\n    \"The SIOP\u22122001 randomized trial is a clinical trial.\",\\n    \"Actinomycin D is a drug used in treatment related to Wilms tumours.\",\\n    \"Vincristine is a drug used in treatment related to Wilms tumours.\",\\n    \"Doxorubicin is a drug used in treatment related to Wilms tumours.\",\\n    \"The UKW3 trial is a clinical trial for Wilms tumours.\",\\n    \"The UK Children\u2019s Cancer and Leukaemia Group (UKCCLG) is an organization.\",\\n    \"Localized disease refers to a disease stage.\",\\n    \"Metastatic disease refers to a disease stage.\",\\n    \"Bilateral disease refers to a disease stage.\",\\n    \"Relapsed disease refers to a disease stage.\",\\n    \"Blastemal-type Wilms tumours is a subtype of Wilms tumours.\",\\n    \"Radiotherapy is a treatment method used for Wilms tumours.\",\\n    \"Surgery is a treatment method used for Wilms tumours.\",\\n    \"Chemotherapy is a treatment method used for Wilms tumours.\",\\n    \"Wilms Tumour is a disease related to Wilms tumours.\",\\n    \"CCSK refers to clear cell sarcoma of the kidney.\",\\n    \"MRTK refers to malignant rhabdoid tumour of the kidney.\",\\n    \"CMN refers to congenital mesoblastic nephroma.\",\\n    \"RCC refers to renal cell carcinoma.\",\\n    \"The UMBRELLA protocol is a protocol for treating childhood cancers.\",\\n    \"The SIOP\u22122001 trial is a trial related to Wilms tumours.\",\\n    \"Vincristine treatment is related to Wilms tumours.\",\\n    \"Actinomycin D treatment is related to Wilms tumours.\",\\n    \"Doxorubicin treatment is related to Wilms tumours.\",\\n    \"Etoposide treatment is related to Wilms tumours.\",\\n    \"Carboplatin treatment is related to Wilms tumours.\",\\n    \"Cyclophosphamide treatment is related to Wilms tumours.\",\\n    \"Stage I refers to a disease stage in cancer.\",\\n    \"Stage II refers to a disease stage in cancer.\",\\n    \"Stage III refers to a disease stage in cancer.\",\\n    \"Stage IV refers to a disease stage in cancer.\",\\n    \"Stage V refers to a disease stage in cancer.\",\\n    \"AV is a treatment combination.\",\\n    \"AVD is a treatment combination for Wilms tumours.\",\\n    \"HR-1 is a treatment combination for high-risk blastemal-type Wilms tumours.\",\\n    \"The SIOP-RTSG 2016 protocol is a protocol related to Wilms tumours.\",\\n    \"Overall Survival (OS) is a metric used in clinical studies.\",\\n    \"Event-Free Survival (EFS) is a metric used in clinical studies.\",\\n    \"CT-only nodules refer to a medical condition related to Wilms tumours.\",\\n    \"The SIOP\u2013RTSG analysis is a study related to Wilms tumours.\",\\n    \"The COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials are studies related to Wilms tumours.\",\\n    \"Vincristine and actinomycin D plus doxorubicin are treatments related to Wilms tumours.\",\\n    \"Vincristine and actinomycin D are treatments related to Wilms tumours.\",\\n    \"The SIOP\u22122001 study is a study protocol associated with Wilms tumours.\",\\n    \"MRI is a diagnostic tool used in evaluating Wilms tumours.\",\\n    \"CT is a diagnostic tool for medical diagnosis.\",\\n    \"Cumulative doxorubicin dose is a treatment detail related to Wilms tumours.\",\\n    \"The COG AREN0533 trial is a study related to Wilms tumours.\",\\n    \"Etoposide is a medication used in treatment protocols.\",\\n    \"Carboplatin is a medication used in treatment protocols.\",\\n    \"Cyclophosphamide is a medication used in treatment protocols.\",\\n    \"High-risk characteristics are related to prognosis in Wilms tumours.\",\\n    \"The SIOP\u2013RTSG board is an organization associated with Wilms tumours.\",\\n    \"Vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin are drugs used in treatment.\",\\n    \"High-dose chemotherapy and autologous stem cell transplantation are treatment protocols.\",\\n    \"The SIOP database captures data related to Wilms tumours.\",\\n    \"Event-Free Survival (EFS) is a subject of clinical studies.\",\\n    \"Overall Survival (OS) is also a subject of clinical studies.\",\\n    \"AVD is a treatment group for Wilms tumours.\",\\n    \"AV-2 is another treatment group associated with Wilms tumours.\",\\n    \"Log\u2013Rank P is a statistical test used in clinical trials.\",\\n    \"Bilateral Disease (Stage V) refers to a disease stage in cancer treatment.\",\\n    \"Synchronous bilateral Wilms tumor is a type of Wilms tumours condition.\",\\n    \"End-stage renal disease (ESRD) is a condition that may relate to renal tumours.\",\\n    \"Aronson et al. name a research group associated with Wilms tumours.\",\\n    \"Bilateral nephron-sparing surgery (NSS) is a surgical procedure.\",\\n    \"The SIOP\u22122001 study is a study related to Wilms tumours treatments.\",\\n    \"Vincristine is a drug associated with Wilms tumours treatments.\",\\n    \"Actinomycin D is a drug associated with Wilms tumours treatments.\",\\n    \"Etoposide is a drug associated with Wilms tumours treatments.\",\\n    \"Carboplatin is a drug associated with Wilms tumours treatments.\",\\n    \"Relapsed Wilms Tumor refers to a disease state in a specific recurrence context.\",\\n    \"Group AA is a patient group defined by treatment protocols with specific guidelines.\",\\n    \"Group BB is another patient group defined by treatment protocols.\",\\n    \"Group CC is a further patient group defined by treatment protocols.\",\\n    \"Doxorubicin is a drug related to Wilms tumours treatments.\",\\n    \"Cyclophosphamide is a drug related to Wilms tumours treatments.\",\\n    \"Ifosfamide is a drug used in Wilms tumours treatments.\",\\n    \"High-dose melphalan is a treatment method associated with Wilms tumours.\",\\n    \"The UKW\u2011R protocol is a treatment protocol used for Wilms tumours.\",\\n    \"The NWTS\u20115 relapse protocol is another treatment protocol for Wilms tumours or relapsed cases.\",\\n    \"ASCR refers to a procedure used in certain kidney conditions.\",\\n    \"Ifosfamide may cause nephrotoxicity as a related condition.\",\\n    \"Diffuse anaplasia is a condition related to Wilms tumours.\",\\n    \"Blastemal-type tumours are a subset category of Wilms tumours.\",\\n    \"The UMBRELLA protocol is another name for the treatment protocol related to Wilms tumours.\",\\n    \"Camptothecins are a class of medications related to certain chemotherapy protocols.\",\\n    \"Irinotecan is a medication that belongs to the camptothecins class.\",\\n    \"Topotecan is another medication that belongs to the camptothecins class.\",\\n    \"The Innovative Therapies for Children with Cancer consortium is an organization focusing on pediatric oncology treatments.\",\\n    \"Radiotherapy is a treatment method for cancers, including Wilms tumours.\",\\n    \"Surgical excision is another treatment method related to cancer therapy.\",\\n    \"Stage IV WT is a condition associated with advanced Wilms tumours.\",\\n    \"AVD150 is a treatment regimen used in Wilms tumours cases.\",\\n    \"AVD250 is another treatment regimen related to Wilms tumours.\",\\n    \"Low-risk disease is a condition category related to prognosis and treatment decisions.\",\\n    \"Intermediate-risk disease is another condition category used in treatment trials.\",\\n    \"High-risk disease is used as a risk category in oncology studies.\",\\n    \"CDCV is a treatment regimen associated with Wilms tumours.\",\\n    \"Actinomycin-D is a specific medication in use for Wilms tumours.\",\\n    \"Vincristine is a medication associated with various cancer treatments.\",\\n    \"Doxorubicin is a medication with clinical significance in multiple cancer treatments.\",\\n    \"VP16 is a medication with relevance in chemotherapy treatment.\",\\n    \"The email address arnauld.verschuur@ap-hm.fr is a contact related to the study.\",\\n    \"Surgery is a treatment method for Wilms tumours.\",\\n    \"Chemotherapy is a treatment method applicable to various cancer treatments.\",\\n    \"The SIOP\u2212RTSG panel is an organization related to cancer treatment guidelines.\"\\n] \\n \\nVerdicts:\\n[\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"idk\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"Marry M. van den Heuvel-Eibrink is affiliated with the Department of Paediatric Oncology, not SIOP\\\\u2013RTSG.\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"The UKW3 trial is not mentioned in the retrieval context as a clinical trial for Wilms tumours.\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"idk\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"idk\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    }\\n]'), MetricData(name='Contextual Relevancy', threshold=1.0, success=False, score=0.7272727272727273, reason=\"The score is 0.73 because while several statements such as 'UMBRELLA protocol aims to improve survival rates of Wilms Tumor' are relevant, others are irrelevant as they do not describe the protocol directly and focus on unrelated topics, such as adolescent tumors.\", strict_mode=False, evaluation_model='gpt-4o-mini', error=None, evaluation_cost=0.0037510499999999997, verbose_logs='Verdicts:\\n[\\n    {\\n        \"verdicts\": [\\n            {\\n                \"statement\": \"UMBRELLA protocol is guided by Relapsed Wilms Tumor.\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"UMBRELLA protocol provides guidelines for surgery.\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"UMBRELLA protocol aims to improve survival rates of Wilms Tumor.\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"Children\\\\u2019s Oncology Group (COG) collaborates with UMBRELLA protocol.\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\\\\u2013RTSG) created the UMBRELLA protocol.\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"Various drugs including vincristine and actinomycin D are used in the UMBRELLA protocol.\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"The UMBRELLA protocol addresses minimal invasive surgery.\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"Stage IV Wilms tumors present in children.\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"This statement is irrelevant as it does not describe the UMBRELLA protocol.\"\\n            },\\n            {\\n                \"statement\": \"Nephron-sparing surgery (NSS) improves the treatment of Wilms tumors.\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"Radical tumor nephrectomy is a standard of care for adolescent tumors.\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"The statement refers to adolescent tumors which do not pertain to the UMBRELLA protocol guidelines.\"\\n            },\\n            {\\n                \"statement\": \"Cumulative doxorubicin dose is evaluated in COG AREN0533 trial.\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"While related to trials, this statement does not concern the main focus of the UMBRELLA protocol.\"\\n            }\\n        ]\\n    }\\n]')], conversational=False, multimodal=False, input='What is the primary goal of the UMBRELLA protocol?', actual_output='[{\\'nodes\\': [(\\'sample.pdf\\', {\\'type\\': \\'document\\'}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)\\'}), (\\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA SIOP-RTSG 2016\\'}), (\\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms tumours\\'}), (\\'non-Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'non-Wilms tumours\\'}), (\\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Website\\', \\'name\\': \\'www.siop-rtsg.eu\\'}), (\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology\\'}), (\\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Person\\', \\'name\\': \\'Marry M. van den Heuvel-Eibrink\\'}), (\\'childhood renal tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'childhood renal tumours\\'}), (\\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'clear cell sarcoma of the kidney\\'}), (\\'renal cell carcinoma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'renal cell carcinoma\\'}), (\\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'malignant rhabdoid tumour of the kidney\\'}), (\\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'Wilms tumours_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'Children\u2019s Oncology Group (COG)\\'}), (\\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'SIOP\u22122001 randomized trial\\'}), (\\'actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'UKW3 trial\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)\\'}), (\\'localized disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'localized disease\\'}), (\\'metastatic disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'metastatic disease\\'}), (\\'bilateral disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'bilateral disease\\'}), (\\'relapsed disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'relapsed disease\\'}), (\\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subtype\\', \\'name\\': \\'blastemal-type Wilms tumours\\'}), (\\'radiotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgery_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'chemotherapy\\'}), (\\'Wilms Tumour_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms Tumour\\'}), (\\'CCSK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CCSK\\'}), (\\'MRTK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'MRTK\\'}), (\\'CMN_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CMN\\'}), (\\'RCC_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'RCC\\'}), (\\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u22122001_Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Trial\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'vincristine_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'vincristine\\'}), (\\'actinomycin D_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'actinomycin D\\'}), (\\'doxorubicin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'doxorubicin\\'}), (\\'etoposide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'Stage I_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage I\\'}), (\\'Stage II_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage II\\'}), (\\'Stage III_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage III\\'}), (\\'Stage IV_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage IV\\'}), (\\'Stage V_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage V\\'}), (\\'AV_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AV\\'}), (\\'AVD_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AVD\\'}), (\\'HR-1_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'HR-1\\'}), (\\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP-RTSG 2016\\'}), (\\'Overall Survival (OS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'CT-only nodules_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'CT-only nodules\\'}), (\\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP\u2013RTSG analysis\\'}), (\\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials\\'}), (\\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D plus doxorubicin\\'}), (\\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D\\'}), (\\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study_protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'MRI_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'MRI\\'}), (\\'CT_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'CT\\'}), (\\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_detail\\', \\'name\\': \\'cumulative doxorubicin dose\\'}), (\\'COG AREN0533 trial_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG AREN0533 trial\\'}), (\\'etoposide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'high-risk characteristics\\'}), (\\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG board\\'}), (\\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin\\'}), (\\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'high-dose chemotherapy and autologous stem cell transplantation\\'}), (\\'SIOP database_database\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'database\\', \\'name\\': \\'SIOP database\\'}), (\\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'AVD_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AVD\\'}), (\\'AV-2_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AV-2\\'}), (\\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Statistical Test\\', \\'name\\': \\'Log\u2013Rank P\\'}), (\\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'Bilateral Disease (Stage V)\\'}), (\\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Synchronous bilateral Wilms tumor\\'}), (\\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'End-stage renal disease (ESRD)\\'}), (\\'Aronson et al._Research Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Research Group\\', \\'name\\': \\'Aronson et al.\\'}), (\\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'Bilateral nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Study\\', \\'name\\': \\'SIOP\u22122001 study\\'}), (\\'Vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Vincristine\\'}), (\\'Actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Actinomycin D\\'}), (\\'Etoposide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Etoposide\\'}), (\\'Carboplatin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Carboplatin\\'}), (\\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease State\\', \\'name\\': \\'Relapsed Wilms Tumor\\'}), (\\'Group AA_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group AA\\'}), (\\'Group BB_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group BB\\'}), (\\'Group CC_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group CC\\'}), (\\'Doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Doxorubicin\\'}), (\\'Cyclophosphamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Cyclophosphamide\\'}), (\\'Ifosfamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Ifosfamide\\'}), (\\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'High-dose melphalan\\'}), (\\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UKW\u2011R protocol\\'}), (\\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'NWTS\u20115 relapse protocol\\'}), (\\'ASCR_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'procedure\\', \\'name\\': \\'ASCR\\'}), (\\'ifosfamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'ifosfamide\\'}), (\\'nephrotoxicity_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'nephrotoxicity\\'}), (\\'relapsed group CC_patient_group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'patient_group\\', \\'name\\': \\'relapsed group CC\\'}), (\\'diffuse anaplasia_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'diffuse anaplasia\\'}), (\\'blastemal-type tumors_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'blastemal-type tumors\\'}), (\\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'camptothecins_medication_class\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication_class\\', \\'name\\': \\'camptothecins\\'}), (\\'irinotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'irinotecan\\'}), (\\'topotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'topotecan\\'}), (\\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Innovative Therapies for Children with Cancer consortium\\'}), (\\'radiotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgical excision_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgical excision\\'}), (\\'stage IV WT_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'stage IV WT\\'}), (\\'AVD150_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD150\\'}), (\\'AVD250_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD250\\'}), (\\'low-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'low-risk disease\\'}), (\\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'intermediate-risk disease\\'}), (\\'high-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'high-risk disease\\'}), (\\'CDCV_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'CDCV\\'}), (\\'actinomycin-D_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'actinomycin-D\\'}), (\\'vincristine_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'doxorubicin\\'}), (\\'VP16_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'VP16\\'}), (\\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'contact\\', \\'name\\': \\'arnauld.verschuur@ap-hm.fr\\'}), (\\'surgery_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'chemotherapy\\'}), (\\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2212RTSG panel\\'}), (\\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Infant Wilms Tumors\\'}), (\\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'nephrectomy\\'}), (\\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'malignant rhabdoid tumors\\'}), (\\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Adult Wilms Tumors\\'}), (\\'anaplasia_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'anaplasia\\'}), (\\'actinomycin D_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'carboplatin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'etoposide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'etoposide\\'}), (\\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'Nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'radical tumor nephrectomy\\'}), (\\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'lymph node sampling\\'}), (\\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'minimally invasive surgery\\'}), (\\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'laparoscopic surgery\\'}), (\\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'radiotherapy\\'}), (\\'Wilms tumours_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'Davila Fajardo et al._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Davila Fajardo et al.\\'}), (\\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'COG\u2013NWTS trials\\'}), (\\'whole-lung irradiation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'whole-lung irradiation\\'}), (\\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'pulmonary radiotherapy\\'}), (\\'proton therapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'proton therapy\\'}), (\\'dosimetric study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'dosimetric study\\'}), (\\'locoregional disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'locoregional disease\\'}), (\\'metastatic disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'metastatic disease\\'}), (\\'low-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'low-risk\\'}), (\\'intermediate-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'intermediate-risk\\'}), (\\'high-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'high-risk\\'}), (\\'stage I_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage I\\'}), (\\'stage II_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage II\\'}), (\\'stage III_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage III\\'}), (\\'major rupture_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'major rupture\\'}), (\\'Austria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Austria\\'}), (\\'Italy_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Italy\\'}), (\\'San Marino_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'San Marino\\'}), (\\'Iceland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Iceland\\'}), (\\'Germany_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Germany\\'}), (\\'Bulgaria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bulgaria\\'}), (\\'Turkey_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Turkey\\'}), (\\'Denmark_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Denmark\\'}), (\\'Poland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Poland\\'}), (\\'Greece_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Greece\\'}), (\\'Andorra_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Andorra\\'}), (\\'Belgium_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belgium\\'}), (\\'Serbia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Serbia\\'}), (\\'Albania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Albania\\'}), (\\'Moldova_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Moldova\\'}), (\\'Lithuania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Lithuania\\'}), (\\'Latvia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Latvia\\'}), (\\'Estonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Estonia\\'}), (\\'Luxembourg_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Luxembourg\\'}), (\\'Montenegro_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Montenegro\\'}), (\\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bosnia and Herzegovina\\'}), (\\'Croatia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Croatia\\'}), (\\'Slovenia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovenia\\'}), (\\'Macedonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Macedonia\\'}), (\\'United Kingdom_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'United Kingdom\\'}), (\\'Ireland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ireland\\'}), (\\'Spain_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Spain\\'}), (\\'Algeria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Algeria\\'}), (\\'Tunisia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Tunisia\\'}), (\\'Malta_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Malta\\'}), (\\'Morocco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Morocco\\'}), (\\'Portugal_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Portugal\\'}), (\\'France_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'France\\'}), (\\'Monaco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Monaco\\'}), (\\'Russia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Russia\\'}), (\\'Finland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Finland\\'}), (\\'Sweden_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Sweden\\'}), (\\'Norway_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Norway\\'}), (\\'Belarus_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belarus\\'}), (\\'Romania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Romania\\'}), (\\'Ukraine_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ukraine\\'}), (\\'Hungary_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Hungary\\'}), (\\'Czech Republic_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Czech Republic\\'}), (\\'Slovakia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovakia\\'}), (\\'Switzerland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Switzerland\\'}), (\\'Liechtenstein_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Liechtenstein\\'}), (\\'Netherlands_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Netherlands\\'}), (\\'University Hospital of Munich_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Munich\\'}), (\\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Tuebingen\\'}), (\\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Azienda Ospedaliera\\'}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Ospedale Pediatrico Bambino Ges\u00f9\\'}), (\\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Fondazione IRCCS Istituto Nazionale dei Tumori\\'}), (\\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Prinses Maxima Centrum\\'}), (\\'Marciniak Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Marciniak Hospital\\'}), (\\'Faculty of Medicine_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Faculty of Medicine\\'}), (\\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'St. Anna Kinderspital/CCRI\\'}), (\\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Armand Trousseau Hospital\\'}), (\\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Universitario Virgin del Rocio\\'}), (\\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Vall d\u2019Hebron\\'}), (\\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Great Ormond Street Hospital\\'}), (\\'University Hospital Homburg_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital Homburg\\'}), (\\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon\\'}), (\\'UMBRELLA protocol_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'ExPO\u2011r\u2011Net\\'}), (\\'Weirich, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Weirich, A.\\'}), (\\'Pritchard-Jones, K._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Pritchard-Jones, K.\\'}), (\\'de Kraker, J._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'de Kraker, J.\\'}), (\\'Graf, N._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Graf, N.\\'}), (\\'Green, D. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Green, D. M.\\'}), (\\'Spreafico, F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Spreafico, F.\\'}), (\\'Bellani, F. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Bellani, F. F.\\'}), (\\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'van den Heuvel-Eibrink, M. M.\\'}), (\"D\\'Angio, G. J._author\", {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \"D\\'Angio, G. J.\"}), (\\'Tournade, M. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Tournade, M. F.\\'}), (\\'Breslow, N. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Breslow, N. E.\\'}), (\\'Mitchell, C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Mitchell, C.\\'}), (\\'Verschuur, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Verschuur, A.\\'}), (\\'Grundy, P. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Grundy, P. E.\\'}), (\\'Warmann, S. W._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Warmann, S. W.\\'}), (\\'Smets, A. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Smets, A. M.\\'}), (\\'Dome, J. S._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dome, J. S.\\'}), (\\'Dix, D. B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dix, D. B.\\'}), (\\'Daw, N. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Daw, N. C.\\'}), (\\'Ha, T. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Ha, T. C.\\'}), (\\'Kremens, B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Kremens, B.\\'}), (\\'Furtwangler, R._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Furtwangler, R.\\'}), (\\'SIOP-9/GPOH_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP-9/GPOH\\'}), (\\'UKW3_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'UKW3\\'}), (\\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'SIOP 93\u201301 trial\\'}), (\\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP trial and study 93\u201301\\'}), (\\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'National Wilms Tumor Study Group\\'}), (\\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP WT 2001 protocol\\'}), (\\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Third National Wilms\u2019 Tumor Study\\'}), (\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'National Wilms Tumor Studies\\'}), (\\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Second National Wilms\u2019 Tumor Study\\'}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'UK Children\u2019s Cancer Study Group\\'}), (\\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Children\u2019s Oncology Group\\'})], \\'edges\\': [(\\'sample.pdf\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'non-Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'childhood renal tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'renal cell carcinoma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'localized disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'metastatic disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'bilateral disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'relapsed disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'radiotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'surgery_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'chemotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'Wilms Tumour_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CCSK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'MRTK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CMN_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'RCC_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP\u22122001_Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'vincristine_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'actinomycin D_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'doxorubicin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'etoposide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'carboplatin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'cyclophosphamide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage I_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage II_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage III_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage IV_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage V_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AV_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AVD_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'HR-1_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Overall Survival (OS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT-only nodules_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'MRI_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG AREN0533 trial_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'etoposide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'carboplatin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'cyclophosphamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP database_database\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AVD_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AV-2_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Aronson et al._Research Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Etoposide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Carboplatin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group AA_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group BB_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group CC_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Cyclophosphamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Ifosfamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'ASCR_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'ifosfamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'nephrotoxicity_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'relapsed group CC_patient_group\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'diffuse anaplasia_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'blastemal-type tumors_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'camptothecins_medication_class\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'irinotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'topotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'radiotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'surgical excision_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'stage IV WT_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD150_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD250_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'low-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'CDCV_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'actinomycin-D_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'vincristine_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'doxorubicin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'VP16_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'surgery_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'chemotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'anaplasia_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'actinomycin D_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'vincristine_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'doxorubicin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'carboplatin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'cyclophosphamide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'etoposide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'SIOP\u22122001_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Wilms tumours_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Davila Fajardo et al._author\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'whole-lung irradiation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'proton therapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'dosimetric study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'locoregional disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'metastatic disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'low-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'intermediate-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'high-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage I_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage II_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage III_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'major rupture_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Austria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Italy_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'San Marino_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Iceland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Germany_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bulgaria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Turkey_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Denmark_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Poland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Greece_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Andorra_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belgium_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Serbia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Albania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Moldova_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Lithuania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Latvia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Estonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Luxembourg_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Montenegro_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Croatia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovenia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Macedonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'United Kingdom_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ireland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Spain_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Algeria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Tunisia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Malta_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Morocco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Portugal_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'France_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Monaco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Russia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Finland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Sweden_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Norway_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belarus_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Romania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ukraine_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hungary_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Czech Republic_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovakia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Switzerland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Liechtenstein_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Netherlands_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Munich_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Marciniak Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Faculty of Medicine_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital Homburg_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Weirich, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Pritchard-Jones, K._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'de Kraker, J._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Graf, N._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Green, D. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Spreafico, F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Bellani, F. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \"D\\'Angio, G. J._author\", {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Tournade, M. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Breslow, N. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Mitchell, C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Verschuur, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Grundy, P. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Warmann, S. W._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Smets, A. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dome, J. S._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dix, D. B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Daw, N. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ha, T. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Kremens, B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Furtwangler, R._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP-9/GPOH_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UKW3_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10})]}, {\\'nodes\\': [(\\'vincristine_entity\\', {}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {}), (\\'www.siop-rtsg.eu_entity\\', {}), (\\'stage II_entity\\', {}), (\\'Wilms tumours_entity\\', {}), (\\'Relapsed Wilms Tumor_entity\\', {}), (\\'Davila Fajardo et al._entity\\', {}), (\\'vincristine, actinomycin D, and doxorubicin_entity\\', {}), (\\'SIOP\u22122001 randomized trial_entity\\', {}), (\\'surgery_entity\\', {}), (\\'non-Wilms tumours_entity\\', {}), (\\'actinomycin D_entity\\', {}), (\\'diffuse anaplasia_entity\\', {}), (\\'Synchronous bilateral Wilms tumor_entity\\', {}), (\\'CT-only nodules_entity\\', {}), (\\'relapsed group CC_entity\\', {}), (\\'increased relapse risk_entity\\', {}), (\\'reduced survival_entity\\', {}), (\\'UKW3 trial_entity\\', {}), (\\'chemotherapy_entity\\', {}), (\\'Bilateral Disease (Stage V)_entity\\', {}), (\\'blastemal-type tumors_entity\\', {}), (\\'UMBRELLA protocol_entity\\', {}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', {}), (\\'minimally invasive surgery_entity\\', {}), (\\'VP16_entity\\', {}), (\\'Wilms tumor_entity\\', {}), (\\'anaplasia_entity\\', {}), (\\'radical tumor nephrectomy_entity\\', {}), (\\'Innovative Therapies for Children with Cancer consortium_entity\\', {}), (\\'cumulative doxorubicin dose_entity\\', {}), (\\'etoposide_entity\\', {}), (\\'large-volume tumours_entity\\', {}), (\\'Stage IV_entity\\', {}), (\\'CDCV_entity\\', {}), (\\'SIOP\u2013RTSG_entity\\', {}), (\\'AVD150_entity\\', {}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', {}), (\\'laparoscopic surgery_entity\\', {}), (\\'SIOP\u2212RTSG panel_entity\\', {}), (\\'actinomycin-D_entity\\', {}), (\\'COG AREN0533 trial_entity\\', {}), (\\'cyclophosphamide_entity\\', {}), (\\'carboplatin_entity\\', {}), (\\'UKW\u2011R protocol_entity\\', {}), (\\'Nephron-sparing surgery (NSS)_entity\\', {}), (\\'Adult Wilms Tumors_entity\\', {}), (\\'doxorubicin_entity\\', {}), (\\'NWTS\u20115 relapse protocol_entity\\', {}), (\\'End-stage renal disease (ESRD)_entity\\', {}), (\\'AVD250_entity\\', {}), (\\'Children\u2019s Oncology Group (COG)_entity\\', {}), (\\'blastemal-type Wilms tumour_entity\\', {}), (\\'SIOP\u22122001_entity\\', {}), (\\'radiotherapy_entity\\', {}), (\\'childhood renal tumours_entity\\', {})], \\'edges\\': [(\\'vincristine_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'stage II_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'indicated_for_in_adults\\'}), (\\'Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'Wilms tumours_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated under\\'}), (\\'Relapsed Wilms Tumor_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guided_by\\'}), (\\'Davila Fajardo et al._entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed\\'}), (\\'SIOP\u22122001 randomized trial_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated use in\\'}), (\\'surgery_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'non-Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'actinomycin D_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Synchronous bilateral Wilms tumor_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'instance_of\\'}), (\\'CT-only nodules_entity\\', \\'increased relapse risk_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'reduced survival_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included_in\\'}), (\\'relapsed group CC_entity\\', \\'diffuse anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'blastemal-type tumors_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UKW3 trial_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'UKW3 trial_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'chemotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UMBRELLA protocol_entity\\', \\'COG AREN0533 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses_data_from\\'}), (\\'UMBRELLA protocol_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'advises_treatment_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'Innovative Therapies for Children with Cancer consortium_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborates_with\\'}), (\\'UMBRELLA protocol_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'surgery_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is the standard of\\'}), (\\'UMBRELLA protocol_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guides treatment in\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', \\'UKW3 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\\'minimally invasive surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'anaplasia_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'radical tumor nephrectomy_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'standard_of_care_for\\'}), (\\'Stage IV_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'presents in\\'}), (\\'CDCV_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'VP16_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'aims to improve survival rates of\\'}), (\\'AVD150_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed_by\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'succeeds\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'www.siop-rtsg.eu_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'available_on\\'}), (\\'laparoscopic surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'COG AREN0533 trial_entity\\', \\'cumulative doxorubicin dose_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'evaluates\\'}), (\\'UKW\u2011R protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'Nephron-sparing surgery (NSS)_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'classification_developed_by\\'}), (\\'Adult Wilms Tumors_entity\\', \\'anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'Adult Wilms Tumors_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'doxorubicin_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'doxorubicin_entity\\', \\'large-volume tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'recommended for\\'}), (\\'NWTS\u20115 relapse protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'End-stage renal disease (ESRD)_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'AVD250_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'Children\u2019s Oncology Group (COG)_entity\\', \\'SIOP\u22122001 randomized trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborated with\\'}), (\\'blastemal-type Wilms tumour_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment intensified according to\\'}), (\\'SIOP\u22122001_entity\\', \\'vincristine, actinomycin D, and doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses\\'}), (\\'SIOP\u22122001_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provided_guidelines_for\\'}), (\\'radiotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'radiotherapy_entity\\', \\'SIOP\u2212RTSG panel_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'contact_for_guidance\\'})]}, {\\'nodes\\': [(\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {}), (\\'Marry M. van den Heuvel-Eibrink_entity\\', {})], \\'edges\\': [(\\'Marry M. van den Heuvel-Eibrink_entity\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'affiliated_with\\'})]}, {\\'nodes\\': [(\\'Stage II_entity\\', {}), (\\'AV_entity\\', {}), (\\'Stage III_entity\\', {}), (\\'vincestine and actinomycin D_entity\\', {}), (\\'AVD_entity\\', {})], \\'edges\\': [(\\'Stage II_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AV_entity\\', \\'Stage II_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Stage III_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AVD_entity\\', \\'Stage III_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'SIOP-RTSG 2016_entity\\', {}), (\\'RCC_entity\\', {}), (\\'CMN_entity\\', {})], \\'edges\\': [(\\'RCC_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'}), (\\'CMN_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'})]}, {\\'nodes\\': [(\\'HR-1_entity\\', {}), (\\'High-risk blastemal type Wilms tumour_entity\\', {})], \\'edges\\': [(\\'HR-1_entity\\', \\'High-risk blastemal type Wilms tumour_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'unfavorable prognosis_entity\\', {}), (\\'high-risk characteristics_entity\\', {})], \\'edges\\': [(\\'high-risk characteristics_entity\\', \\'unfavorable prognosis_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'leads_to\\'})]}, {\\'nodes\\': [(\\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {}), (\\'SIOP\u2013RTSG board_entity\\', {})], \\'edges\\': [(\\'SIOP\u2013RTSG board_entity\\', \\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggests\\'})]}, {\\'nodes\\': [(\\'regimen and outcomes_entity\\', {}), (\\'SIOP database_entity\\', {})], \\'edges\\': [(\\'SIOP database_entity\\', \\'regimen and outcomes_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'captures_data_on\\'})]}, {\\'nodes\\': [(\\'Bilateral nephron-sparing surgery (NSS)_entity\\', {}), (\\'Aronson et al._entity\\', {})], \\'edges\\': [(\\'Aronson et al._entity\\', \\'Bilateral nephron-sparing surgery (NSS)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'observed_effectiveness_of\\'})]}, {\\'nodes\\': [(\\'SIOP\u22122001 study_entity\\', {}), (\\'Actinomycin D_entity\\', {}), (\\'Vincristine_entity\\', {})], \\'edges\\': [(\\'SIOP\u22122001 study_entity\\', \\'Vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'}), (\\'SIOP\u22122001 study_entity\\', \\'Actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'})]}, {\\'nodes\\': [(\\'High-dose melphalan_entity\\', {}), (\\'Group AA_entity\\', {}), (\\'Carboplatin_entity\\', {}), (\\'Doxorubicin_entity\\', {}), (\\'Etoposide_entity\\', {}), (\\'Group BB_entity\\', {}), (\\'Cyclophosphamide_entity\\', {}), (\\'Ifosfamide_entity\\', {})], \\'edges\\': [(\\'Group AA_entity\\', \\'Doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Ifosfamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'High-dose melphalan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'})]}, {\\'nodes\\': [(\\'nephrotoxicity_entity\\', {}), (\\'ifosfamide_entity\\', {})], \\'edges\\': [(\\'ifosfamide_entity\\', \\'nephrotoxicity_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'related_to\\'})]}, {\\'nodes\\': [(\\'camptothecins_entity\\', {}), (\\'irinotecan_entity\\', {}), (\\'topotecan_entity\\', {})], \\'edges\\': [(\\'camptothecins_entity\\', \\'irinotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'camptothecins_entity\\', \\'topotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'})]}, {\\'nodes\\': [(\\'Infant Wilms Tumors_entity\\', {}), (\\'nephrectomy_entity\\', {})], \\'edges\\': [(\\'Infant Wilms Tumors_entity\\', \\'nephrectomy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_option\\'})]}, {\\'nodes\\': [(\\'congenital mesoblastic nephroma_entity\\', {}), (\\'surgery alone_entity\\', {})], \\'edges\\': [(\\'congenital mesoblastic nephroma_entity\\', \\'surgery alone_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'alternative chemotherapy_entity\\', {}), (\\'malignant rhabdoid tumors_entity\\', {})], \\'edges\\': [(\\'malignant rhabdoid tumors_entity\\', \\'alternative chemotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'lymph node sampling_entity\\', {}), (\\'accurate staging_entity\\', {})], \\'edges\\': [(\\'lymph node sampling_entity\\', \\'accurate staging_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'purpose_of\\'})]}, {\\'nodes\\': [(\\'COG\u2013NWTS trials_entity\\', {}), (\\'whole-lung irradiation_entity\\', {})], \\'edges\\': [(\\'COG\u2013NWTS trials_entity\\', \\'whole-lung irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'informed_dosage_for\\'})]}, {\\'nodes\\': [(\\'lung metastases_entity\\', {}), (\\'pulmonary radiotherapy_entity\\', {})], \\'edges\\': [(\\'pulmonary radiotherapy_entity\\', \\'lung metastases_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'administered_for\\'})]}, {\\'nodes\\': [(\\'dosimetric study_entity\\', {}), (\\'proton therapy_entity\\', {}), (\\'flank irradiation_entity\\', {})], \\'edges\\': [(\\'dosimetric study_entity\\', \\'proton therapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated\\'}), (\\'proton therapy_entity\\', \\'flank irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggested_for\\'})]}, {\\'nodes\\': [(\\'metastatic disease_entity\\', {}), (\\'radiotherapy guidelines_entity\\', {}), (\\'locoregional disease_entity\\', {})], \\'edges\\': [(\\'radiotherapy guidelines_entity\\', \\'locoregional disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'}), (\\'radiotherapy guidelines_entity\\', \\'metastatic disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'})]}, {\\'nodes\\': [(\\'major rupture_entity\\', {}), (\\'stage III_entity\\', {})], \\'edges\\': [(\\'stage III_entity\\', \\'major rupture_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes_condition\\'})]}, {\\'nodes\\': [(\\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {}), (\\'ExPO\u2011r\u2011Net_entity\\', {})], \\'edges\\': [(\\'ExPO\u2011r\u2011Net_entity\\', \\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is part of\\'})]}, {\\'nodes\\': [(\\'University Hospital of Munich_entity\\', {}), (\\'Germany_entity\\', {}), (\\'University Hospital of Tuebingen_entity\\', {})], \\'edges\\': [(\\'Germany_entity\\', \\'University Hospital of Munich_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Germany_entity\\', \\'University Hospital of Tuebingen_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {}), (\\'Italy_entity\\', {}), (\\'Azienda Ospedaliera_entity\\', {}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {})], \\'edges\\': [(\\'Italy_entity\\', \\'Azienda Ospedaliera_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Netherlands_entity\\', {}), (\\'Prinses Maxima Centrum_entity\\', {})], \\'edges\\': [(\\'Netherlands_entity\\', \\'Prinses Maxima Centrum_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Marciniak Hospital_entity\\', {}), (\\'Poland_entity\\', {}), (\\'Faculty of Medicine_entity\\', {})], \\'edges\\': [(\\'Poland_entity\\', \\'Marciniak Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Poland_entity\\', \\'Faculty of Medicine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'St. Anna Kinderspital/CCRI_entity\\', {}), (\\'Austria_entity\\', {})], \\'edges\\': [(\\'Austria_entity\\', \\'St. Anna Kinderspital/CCRI_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'France_entity\\', {}), (\\'Armand Trousseau Hospital_entity\\', {})], \\'edges\\': [(\\'France_entity\\', \\'Armand Trousseau Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Spain_entity\\', {}), (\\'Hospital Vall d\u2019Hebron_entity\\', {}), (\\'Hospital Universitario Virgin del Rocio_entity\\', {})], \\'edges\\': [(\\'Spain_entity\\', \\'Hospital Universitario Virgin del Rocio_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Spain_entity\\', \\'Hospital Vall d\u2019Hebron_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'United Kingdom_entity\\', {}), (\\'Great Ormond Street Hospital_entity\\', {})], \\'edges\\': [(\\'United Kingdom_entity\\', \\'Great Ormond Street Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Weirich, A._entity\\', {}), (\\'SIOP-9/GPOH_entity\\', {})], \\'edges\\': [(\\'Weirich, A._entity\\', \\'SIOP-9/GPOH_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Pritchard-Jones, K._entity\\', {}), (\\'UKW3_entity\\', {})], \\'edges\\': [(\\'Pritchard-Jones, K._entity\\', \\'UKW3_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed in\\'})]}, {\\'nodes\\': [(\\'SIOP 93\u201301 trial_entity\\', {}), (\\'de Kraker, J._entity\\', {})], \\'edges\\': [(\\'de Kraker, J._entity\\', \\'SIOP 93\u201301 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'SIOP trial and study 93\u201301_entity\\', {}), (\\'Graf, N._entity\\', {})], \\'edges\\': [(\\'Graf, N._entity\\', \\'SIOP trial and study 93\u201301_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Green, D. M._entity\\', {}), (\\'National Wilms Tumor Study Group_entity\\', {})], \\'edges\\': [(\\'Green, D. M._entity\\', \\'National Wilms Tumor Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}, {\\'nodes\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', {}), (\\'SIOP WT 2001 protocol_entity\\', {})], \\'edges\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', \\'SIOP WT 2001 protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Third National Wilms\u2019 Tumor Study_entity\\', {}), (\"D\\'Angio, G. J._entity\", {}), (\\'Second National Wilms\u2019 Tumor Study_entity\\', {})], \\'edges\\': [(\"D\\'Angio, G. J._entity\", \\'Third National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\"D\\'Angio, G. J._entity\", \\'Second National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {}), (\\'Tournade, M. F._entity\\', {}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {})], \\'edges\\': [(\\'Tournade, M. F._entity\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'}), (\\'Tournade, M. F._entity\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Breslow, N. E._entity\\', {}), (\\'National Wilms Tumor Studies_entity\\', {})], \\'edges\\': [(\\'Breslow, N. E._entity\\', \\'National Wilms Tumor Studies_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Mitchell, C._entity\\', {}), (\\'UK Children\u2019s Cancer Study Group_entity\\', {})], \\'edges\\': [(\\'Mitchell, C._entity\\', \\'UK Children\u2019s Cancer Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'under\\'})]}, {\\'nodes\\': [(\\'Daw, N. C._entity\\', {}), (\\'Dix, D. B._entity\\', {}), (\\'Children\u2019s Oncology Group_entity\\', {}), (\\'Grundy, P. E._entity\\', {})], \\'edges\\': [(\\'Daw, N. C._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted under\\'}), (\\'Dix, D. B._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'}), (\\'Grundy, P. E._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}]', expected_output='The UMBRELLA protocol aims to standardize the diagnosis and treatment of childhood renal tumours and promote international collaboration.', context=None, retrieval_context=['[{\\'nodes\\': [(\\'sample.pdf\\', {\\'type\\': \\'document\\'}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)\\'}), (\\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA SIOP-RTSG 2016\\'}), (\\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms tumours\\'}), (\\'non-Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'non-Wilms tumours\\'}), (\\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Website\\', \\'name\\': \\'www.siop-rtsg.eu\\'}), (\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology\\'}), (\\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Person\\', \\'name\\': \\'Marry M. van den Heuvel-Eibrink\\'}), (\\'childhood renal tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'childhood renal tumours\\'}), (\\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'clear cell sarcoma of the kidney\\'}), (\\'renal cell carcinoma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'renal cell carcinoma\\'}), (\\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'malignant rhabdoid tumour of the kidney\\'}), (\\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'Wilms tumours_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'Children\u2019s Oncology Group (COG)\\'}), (\\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'SIOP\u22122001 randomized trial\\'}), (\\'actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'UKW3 trial\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)\\'}), (\\'localized disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'localized disease\\'}), (\\'metastatic disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'metastatic disease\\'}), (\\'bilateral disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'bilateral disease\\'}), (\\'relapsed disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'relapsed disease\\'}), (\\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subtype\\', \\'name\\': \\'blastemal-type Wilms tumours\\'}), (\\'radiotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgery_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'chemotherapy\\'}), (\\'Wilms Tumour_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms Tumour\\'}), (\\'CCSK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CCSK\\'}), (\\'MRTK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'MRTK\\'}), (\\'CMN_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CMN\\'}), (\\'RCC_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'RCC\\'}), (\\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u22122001_Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Trial\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'vincristine_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'vincristine\\'}), (\\'actinomycin D_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'actinomycin D\\'}), (\\'doxorubicin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'doxorubicin\\'}), (\\'etoposide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'Stage I_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage I\\'}), (\\'Stage II_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage II\\'}), (\\'Stage III_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage III\\'}), (\\'Stage IV_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage IV\\'}), (\\'Stage V_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage V\\'}), (\\'AV_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AV\\'}), (\\'AVD_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AVD\\'}), (\\'HR-1_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'HR-1\\'}), (\\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP-RTSG 2016\\'}), (\\'Overall Survival (OS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'CT-only nodules_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'CT-only nodules\\'}), (\\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP\u2013RTSG analysis\\'}), (\\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials\\'}), (\\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D plus doxorubicin\\'}), (\\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D\\'}), (\\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study_protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'MRI_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'MRI\\'}), (\\'CT_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'CT\\'}), (\\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_detail\\', \\'name\\': \\'cumulative doxorubicin dose\\'}), (\\'COG AREN0533 trial_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG AREN0533 trial\\'}), (\\'etoposide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'high-risk characteristics\\'}), (\\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG board\\'}), (\\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin\\'}), (\\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'high-dose chemotherapy and autologous stem cell transplantation\\'}), (\\'SIOP database_database\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'database\\', \\'name\\': \\'SIOP database\\'}), (\\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'AVD_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AVD\\'}), (\\'AV-2_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AV-2\\'}), (\\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Statistical Test\\', \\'name\\': \\'Log\u2013Rank P\\'}), (\\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'Bilateral Disease (Stage V)\\'}), (\\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Synchronous bilateral Wilms tumor\\'}), (\\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'End-stage renal disease (ESRD)\\'}), (\\'Aronson et al._Research Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Research Group\\', \\'name\\': \\'Aronson et al.\\'}), (\\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'Bilateral nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Study\\', \\'name\\': \\'SIOP\u22122001 study\\'}), (\\'Vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Vincristine\\'}), (\\'Actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Actinomycin D\\'}), (\\'Etoposide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Etoposide\\'}), (\\'Carboplatin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Carboplatin\\'}), (\\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease State\\', \\'name\\': \\'Relapsed Wilms Tumor\\'}), (\\'Group AA_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group AA\\'}), (\\'Group BB_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group BB\\'}), (\\'Group CC_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group CC\\'}), (\\'Doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Doxorubicin\\'}), (\\'Cyclophosphamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Cyclophosphamide\\'}), (\\'Ifosfamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Ifosfamide\\'}), (\\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'High-dose melphalan\\'}), (\\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UKW\u2011R protocol\\'}), (\\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'NWTS\u20115 relapse protocol\\'}), (\\'ASCR_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'procedure\\', \\'name\\': \\'ASCR\\'}), (\\'ifosfamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'ifosfamide\\'}), (\\'nephrotoxicity_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'nephrotoxicity\\'}), (\\'relapsed group CC_patient_group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'patient_group\\', \\'name\\': \\'relapsed group CC\\'}), (\\'diffuse anaplasia_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'diffuse anaplasia\\'}), (\\'blastemal-type tumors_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'blastemal-type tumors\\'}), (\\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'camptothecins_medication_class\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication_class\\', \\'name\\': \\'camptothecins\\'}), (\\'irinotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'irinotecan\\'}), (\\'topotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'topotecan\\'}), (\\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Innovative Therapies for Children with Cancer consortium\\'}), (\\'radiotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgical excision_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgical excision\\'}), (\\'stage IV WT_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'stage IV WT\\'}), (\\'AVD150_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD150\\'}), (\\'AVD250_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD250\\'}), (\\'low-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'low-risk disease\\'}), (\\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'intermediate-risk disease\\'}), (\\'high-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'high-risk disease\\'}), (\\'CDCV_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'CDCV\\'}), (\\'actinomycin-D_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'actinomycin-D\\'}), (\\'vincristine_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'doxorubicin\\'}), (\\'VP16_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'VP16\\'}), (\\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'contact\\', \\'name\\': \\'arnauld.verschuur@ap-hm.fr\\'}), (\\'surgery_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'chemotherapy\\'}), (\\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2212RTSG panel\\'}), (\\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Infant Wilms Tumors\\'}), (\\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'nephrectomy\\'}), (\\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'malignant rhabdoid tumors\\'}), (\\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Adult Wilms Tumors\\'}), (\\'anaplasia_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'anaplasia\\'}), (\\'actinomycin D_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'carboplatin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'etoposide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'etoposide\\'}), (\\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'Nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'radical tumor nephrectomy\\'}), (\\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'lymph node sampling\\'}), (\\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'minimally invasive surgery\\'}), (\\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'laparoscopic surgery\\'}), (\\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'radiotherapy\\'}), (\\'Wilms tumours_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'Davila Fajardo et al._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Davila Fajardo et al.\\'}), (\\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'COG\u2013NWTS trials\\'}), (\\'whole-lung irradiation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'whole-lung irradiation\\'}), (\\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'pulmonary radiotherapy\\'}), (\\'proton therapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'proton therapy\\'}), (\\'dosimetric study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'dosimetric study\\'}), (\\'locoregional disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'locoregional disease\\'}), (\\'metastatic disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'metastatic disease\\'}), (\\'low-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'low-risk\\'}), (\\'intermediate-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'intermediate-risk\\'}), (\\'high-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'high-risk\\'}), (\\'stage I_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage I\\'}), (\\'stage II_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage II\\'}), (\\'stage III_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage III\\'}), (\\'major rupture_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'major rupture\\'}), (\\'Austria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Austria\\'}), (\\'Italy_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Italy\\'}), (\\'San Marino_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'San Marino\\'}), (\\'Iceland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Iceland\\'}), (\\'Germany_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Germany\\'}), (\\'Bulgaria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bulgaria\\'}), (\\'Turkey_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Turkey\\'}), (\\'Denmark_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Denmark\\'}), (\\'Poland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Poland\\'}), (\\'Greece_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Greece\\'}), (\\'Andorra_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Andorra\\'}), (\\'Belgium_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belgium\\'}), (\\'Serbia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Serbia\\'}), (\\'Albania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Albania\\'}), (\\'Moldova_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Moldova\\'}), (\\'Lithuania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Lithuania\\'}), (\\'Latvia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Latvia\\'}), (\\'Estonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Estonia\\'}), (\\'Luxembourg_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Luxembourg\\'}), (\\'Montenegro_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Montenegro\\'}), (\\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bosnia and Herzegovina\\'}), (\\'Croatia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Croatia\\'}), (\\'Slovenia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovenia\\'}), (\\'Macedonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Macedonia\\'}), (\\'United Kingdom_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'United Kingdom\\'}), (\\'Ireland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ireland\\'}), (\\'Spain_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Spain\\'}), (\\'Algeria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Algeria\\'}), (\\'Tunisia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Tunisia\\'}), (\\'Malta_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Malta\\'}), (\\'Morocco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Morocco\\'}), (\\'Portugal_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Portugal\\'}), (\\'France_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'France\\'}), (\\'Monaco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Monaco\\'}), (\\'Russia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Russia\\'}), (\\'Finland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Finland\\'}), (\\'Sweden_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Sweden\\'}), (\\'Norway_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Norway\\'}), (\\'Belarus_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belarus\\'}), (\\'Romania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Romania\\'}), (\\'Ukraine_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ukraine\\'}), (\\'Hungary_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Hungary\\'}), (\\'Czech Republic_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Czech Republic\\'}), (\\'Slovakia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovakia\\'}), (\\'Switzerland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Switzerland\\'}), (\\'Liechtenstein_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Liechtenstein\\'}), (\\'Netherlands_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Netherlands\\'}), (\\'University Hospital of Munich_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Munich\\'}), (\\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Tuebingen\\'}), (\\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Azienda Ospedaliera\\'}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Ospedale Pediatrico Bambino Ges\u00f9\\'}), (\\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Fondazione IRCCS Istituto Nazionale dei Tumori\\'}), (\\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Prinses Maxima Centrum\\'}), (\\'Marciniak Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Marciniak Hospital\\'}), (\\'Faculty of Medicine_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Faculty of Medicine\\'}), (\\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'St. Anna Kinderspital/CCRI\\'}), (\\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Armand Trousseau Hospital\\'}), (\\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Universitario Virgin del Rocio\\'}), (\\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Vall d\u2019Hebron\\'}), (\\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Great Ormond Street Hospital\\'}), (\\'University Hospital Homburg_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital Homburg\\'}), (\\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon\\'}), (\\'UMBRELLA protocol_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'ExPO\u2011r\u2011Net\\'}), (\\'Weirich, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Weirich, A.\\'}), (\\'Pritchard-Jones, K._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Pritchard-Jones, K.\\'}), (\\'de Kraker, J._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'de Kraker, J.\\'}), (\\'Graf, N._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Graf, N.\\'}), (\\'Green, D. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Green, D. M.\\'}), (\\'Spreafico, F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Spreafico, F.\\'}), (\\'Bellani, F. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Bellani, F. F.\\'}), (\\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'van den Heuvel-Eibrink, M. M.\\'}), (\"D\\'Angio, G. J._author\", {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \"D\\'Angio, G. J.\"}), (\\'Tournade, M. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Tournade, M. F.\\'}), (\\'Breslow, N. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Breslow, N. E.\\'}), (\\'Mitchell, C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Mitchell, C.\\'}), (\\'Verschuur, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Verschuur, A.\\'}), (\\'Grundy, P. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Grundy, P. E.\\'}), (\\'Warmann, S. W._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Warmann, S. W.\\'}), (\\'Smets, A. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Smets, A. M.\\'}), (\\'Dome, J. S._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dome, J. S.\\'}), (\\'Dix, D. B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dix, D. B.\\'}), (\\'Daw, N. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Daw, N. C.\\'}), (\\'Ha, T. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Ha, T. C.\\'}), (\\'Kremens, B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Kremens, B.\\'}), (\\'Furtwangler, R._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Furtwangler, R.\\'}), (\\'SIOP-9/GPOH_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP-9/GPOH\\'}), (\\'UKW3_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'UKW3\\'}), (\\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'SIOP 93\u201301 trial\\'}), (\\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP trial and study 93\u201301\\'}), (\\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'National Wilms Tumor Study Group\\'}), (\\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP WT 2001 protocol\\'}), (\\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Third National Wilms\u2019 Tumor Study\\'}), (\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'National Wilms Tumor Studies\\'}), (\\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Second National Wilms\u2019 Tumor Study\\'}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'UK Children\u2019s Cancer Study Group\\'}), (\\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Children\u2019s Oncology Group\\'})], \\'edges\\': [(\\'sample.pdf\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'non-Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'childhood renal tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'renal cell carcinoma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'localized disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'metastatic disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'bilateral disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'relapsed disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'radiotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'surgery_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'chemotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'Wilms Tumour_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CCSK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'MRTK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CMN_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'RCC_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP\u22122001_Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'vincristine_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'actinomycin D_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'doxorubicin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'etoposide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'carboplatin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'cyclophosphamide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage I_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage II_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage III_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage IV_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage V_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AV_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AVD_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'HR-1_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Overall Survival (OS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT-only nodules_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'MRI_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG AREN0533 trial_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'etoposide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'carboplatin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'cyclophosphamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP database_database\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AVD_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AV-2_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Aronson et al._Research Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Etoposide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Carboplatin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group AA_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group BB_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group CC_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Cyclophosphamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Ifosfamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'ASCR_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'ifosfamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'nephrotoxicity_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'relapsed group CC_patient_group\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'diffuse anaplasia_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'blastemal-type tumors_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'camptothecins_medication_class\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'irinotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'topotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'radiotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'surgical excision_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'stage IV WT_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD150_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD250_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'low-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'CDCV_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'actinomycin-D_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'vincristine_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'doxorubicin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'VP16_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'surgery_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'chemotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'anaplasia_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'actinomycin D_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'vincristine_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'doxorubicin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'carboplatin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'cyclophosphamide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'etoposide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'SIOP\u22122001_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Wilms tumours_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Davila Fajardo et al._author\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'whole-lung irradiation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'proton therapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'dosimetric study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'locoregional disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'metastatic disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'low-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'intermediate-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'high-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage I_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage II_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage III_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'major rupture_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Austria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Italy_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'San Marino_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Iceland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Germany_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bulgaria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Turkey_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Denmark_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Poland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Greece_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Andorra_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belgium_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Serbia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Albania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Moldova_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Lithuania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Latvia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Estonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Luxembourg_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Montenegro_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Croatia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovenia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Macedonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'United Kingdom_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ireland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Spain_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Algeria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Tunisia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Malta_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Morocco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Portugal_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'France_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Monaco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Russia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Finland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Sweden_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Norway_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belarus_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Romania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ukraine_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hungary_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Czech Republic_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovakia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Switzerland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Liechtenstein_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Netherlands_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Munich_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Marciniak Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Faculty of Medicine_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital Homburg_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Weirich, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Pritchard-Jones, K._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'de Kraker, J._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Graf, N._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Green, D. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Spreafico, F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Bellani, F. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \"D\\'Angio, G. J._author\", {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Tournade, M. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Breslow, N. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Mitchell, C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Verschuur, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Grundy, P. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Warmann, S. W._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Smets, A. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dome, J. S._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dix, D. B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Daw, N. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ha, T. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Kremens, B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Furtwangler, R._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP-9/GPOH_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UKW3_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10})]}, {\\'nodes\\': [(\\'vincristine_entity\\', {}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {}), (\\'www.siop-rtsg.eu_entity\\', {}), (\\'stage II_entity\\', {}), (\\'Wilms tumours_entity\\', {}), (\\'Relapsed Wilms Tumor_entity\\', {}), (\\'Davila Fajardo et al._entity\\', {}), (\\'vincristine, actinomycin D, and doxorubicin_entity\\', {}), (\\'SIOP\u22122001 randomized trial_entity\\', {}), (\\'surgery_entity\\', {}), (\\'non-Wilms tumours_entity\\', {}), (\\'actinomycin D_entity\\', {}), (\\'diffuse anaplasia_entity\\', {}), (\\'Synchronous bilateral Wilms tumor_entity\\', {}), (\\'CT-only nodules_entity\\', {}), (\\'relapsed group CC_entity\\', {}), (\\'increased relapse risk_entity\\', {}), (\\'reduced survival_entity\\', {}), (\\'UKW3 trial_entity\\', {}), (\\'chemotherapy_entity\\', {}), (\\'Bilateral Disease (Stage V)_entity\\', {}), (\\'blastemal-type tumors_entity\\', {}), (\\'UMBRELLA protocol_entity\\', {}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', {}), (\\'minimally invasive surgery_entity\\', {}), (\\'VP16_entity\\', {}), (\\'Wilms tumor_entity\\', {}), (\\'anaplasia_entity\\', {}), (\\'radical tumor nephrectomy_entity\\', {}), (\\'Innovative Therapies for Children with Cancer consortium_entity\\', {}), (\\'cumulative doxorubicin dose_entity\\', {}), (\\'etoposide_entity\\', {}), (\\'large-volume tumours_entity\\', {}), (\\'Stage IV_entity\\', {}), (\\'CDCV_entity\\', {}), (\\'SIOP\u2013RTSG_entity\\', {}), (\\'AVD150_entity\\', {}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', {}), (\\'laparoscopic surgery_entity\\', {}), (\\'SIOP\u2212RTSG panel_entity\\', {}), (\\'actinomycin-D_entity\\', {}), (\\'COG AREN0533 trial_entity\\', {}), (\\'cyclophosphamide_entity\\', {}), (\\'carboplatin_entity\\', {}), (\\'UKW\u2011R protocol_entity\\', {}), (\\'Nephron-sparing surgery (NSS)_entity\\', {}), (\\'Adult Wilms Tumors_entity\\', {}), (\\'doxorubicin_entity\\', {}), (\\'NWTS\u20115 relapse protocol_entity\\', {}), (\\'End-stage renal disease (ESRD)_entity\\', {}), (\\'AVD250_entity\\', {}), (\\'Children\u2019s Oncology Group (COG)_entity\\', {}), (\\'blastemal-type Wilms tumour_entity\\', {}), (\\'SIOP\u22122001_entity\\', {}), (\\'radiotherapy_entity\\', {}), (\\'childhood renal tumours_entity\\', {})], \\'edges\\': [(\\'vincristine_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'stage II_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'indicated_for_in_adults\\'}), (\\'Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'Wilms tumours_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated under\\'}), (\\'Relapsed Wilms Tumor_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guided_by\\'}), (\\'Davila Fajardo et al._entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed\\'}), (\\'SIOP\u22122001 randomized trial_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated use in\\'}), (\\'surgery_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'non-Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'actinomycin D_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Synchronous bilateral Wilms tumor_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'instance_of\\'}), (\\'CT-only nodules_entity\\', \\'increased relapse risk_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'reduced survival_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included_in\\'}), (\\'relapsed group CC_entity\\', \\'diffuse anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'blastemal-type tumors_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UKW3 trial_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'UKW3 trial_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'chemotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UMBRELLA protocol_entity\\', \\'COG AREN0533 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses_data_from\\'}), (\\'UMBRELLA protocol_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'advises_treatment_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'Innovative Therapies for Children with Cancer consortium_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborates_with\\'}), (\\'UMBRELLA protocol_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'surgery_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is the standard of\\'}), (\\'UMBRELLA protocol_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guides treatment in\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', \\'UKW3 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\\'minimally invasive surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'anaplasia_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'radical tumor nephrectomy_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'standard_of_care_for\\'}), (\\'Stage IV_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'presents in\\'}), (\\'CDCV_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'VP16_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'aims to improve survival rates of\\'}), (\\'AVD150_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed_by\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'succeeds\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'www.siop-rtsg.eu_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'available_on\\'}), (\\'laparoscopic surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'COG AREN0533 trial_entity\\', \\'cumulative doxorubicin dose_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'evaluates\\'}), (\\'UKW\u2011R protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'Nephron-sparing surgery (NSS)_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'classification_developed_by\\'}), (\\'Adult Wilms Tumors_entity\\', \\'anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'Adult Wilms Tumors_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'doxorubicin_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'doxorubicin_entity\\', \\'large-volume tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'recommended for\\'}), (\\'NWTS\u20115 relapse protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'End-stage renal disease (ESRD)_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'AVD250_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'Children\u2019s Oncology Group (COG)_entity\\', \\'SIOP\u22122001 randomized trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborated with\\'}), (\\'blastemal-type Wilms tumour_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment intensified according to\\'}), (\\'SIOP\u22122001_entity\\', \\'vincristine, actinomycin D, and doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses\\'}), (\\'SIOP\u22122001_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provided_guidelines_for\\'}), (\\'radiotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'radiotherapy_entity\\', \\'SIOP\u2212RTSG panel_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'contact_for_guidance\\'})]}, {\\'nodes\\': [(\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {}), (\\'Marry M. van den Heuvel-Eibrink_entity\\', {})], \\'edges\\': [(\\'Marry M. van den Heuvel-Eibrink_entity\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'affiliated_with\\'})]}, {\\'nodes\\': [(\\'Stage II_entity\\', {}), (\\'AV_entity\\', {}), (\\'Stage III_entity\\', {}), (\\'vincestine and actinomycin D_entity\\', {}), (\\'AVD_entity\\', {})], \\'edges\\': [(\\'Stage II_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AV_entity\\', \\'Stage II_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Stage III_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AVD_entity\\', \\'Stage III_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'SIOP-RTSG 2016_entity\\', {}), (\\'RCC_entity\\', {}), (\\'CMN_entity\\', {})], \\'edges\\': [(\\'RCC_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'}), (\\'CMN_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'})]}, {\\'nodes\\': [(\\'HR-1_entity\\', {}), (\\'High-risk blastemal type Wilms tumour_entity\\', {})], \\'edges\\': [(\\'HR-1_entity\\', \\'High-risk blastemal type Wilms tumour_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'unfavorable prognosis_entity\\', {}), (\\'high-risk characteristics_entity\\', {})], \\'edges\\': [(\\'high-risk characteristics_entity\\', \\'unfavorable prognosis_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'leads_to\\'})]}, {\\'nodes\\': [(\\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {}), (\\'SIOP\u2013RTSG board_entity\\', {})], \\'edges\\': [(\\'SIOP\u2013RTSG board_entity\\', \\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggests\\'})]}, {\\'nodes\\': [(\\'regimen and outcomes_entity\\', {}), (\\'SIOP database_entity\\', {})], \\'edges\\': [(\\'SIOP database_entity\\', \\'regimen and outcomes_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'captures_data_on\\'})]}, {\\'nodes\\': [(\\'Bilateral nephron-sparing surgery (NSS)_entity\\', {}), (\\'Aronson et al._entity\\', {})], \\'edges\\': [(\\'Aronson et al._entity\\', \\'Bilateral nephron-sparing surgery (NSS)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'observed_effectiveness_of\\'})]}, {\\'nodes\\': [(\\'SIOP\u22122001 study_entity\\', {}), (\\'Actinomycin D_entity\\', {}), (\\'Vincristine_entity\\', {})], \\'edges\\': [(\\'SIOP\u22122001 study_entity\\', \\'Vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'}), (\\'SIOP\u22122001 study_entity\\', \\'Actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'})]}, {\\'nodes\\': [(\\'High-dose melphalan_entity\\', {}), (\\'Group AA_entity\\', {}), (\\'Carboplatin_entity\\', {}), (\\'Doxorubicin_entity\\', {}), (\\'Etoposide_entity\\', {}), (\\'Group BB_entity\\', {}), (\\'Cyclophosphamide_entity\\', {}), (\\'Ifosfamide_entity\\', {})], \\'edges\\': [(\\'Group AA_entity\\', \\'Doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Ifosfamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'High-dose melphalan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'})]}, {\\'nodes\\': [(\\'nephrotoxicity_entity\\', {}), (\\'ifosfamide_entity\\', {})], \\'edges\\': [(\\'ifosfamide_entity\\', \\'nephrotoxicity_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'related_to\\'})]}, {\\'nodes\\': [(\\'camptothecins_entity\\', {}), (\\'irinotecan_entity\\', {}), (\\'topotecan_entity\\', {})], \\'edges\\': [(\\'camptothecins_entity\\', \\'irinotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'camptothecins_entity\\', \\'topotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'})]}, {\\'nodes\\': [(\\'Infant Wilms Tumors_entity\\', {}), (\\'nephrectomy_entity\\', {})], \\'edges\\': [(\\'Infant Wilms Tumors_entity\\', \\'nephrectomy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_option\\'})]}, {\\'nodes\\': [(\\'congenital mesoblastic nephroma_entity\\', {}), (\\'surgery alone_entity\\', {})], \\'edges\\': [(\\'congenital mesoblastic nephroma_entity\\', \\'surgery alone_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'alternative chemotherapy_entity\\', {}), (\\'malignant rhabdoid tumors_entity\\', {})], \\'edges\\': [(\\'malignant rhabdoid tumors_entity\\', \\'alternative chemotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'lymph node sampling_entity\\', {}), (\\'accurate staging_entity\\', {})], \\'edges\\': [(\\'lymph node sampling_entity\\', \\'accurate staging_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'purpose_of\\'})]}, {\\'nodes\\': [(\\'COG\u2013NWTS trials_entity\\', {}), (\\'whole-lung irradiation_entity\\', {})], \\'edges\\': [(\\'COG\u2013NWTS trials_entity\\', \\'whole-lung irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'informed_dosage_for\\'})]}, {\\'nodes\\': [(\\'lung metastases_entity\\', {}), (\\'pulmonary radiotherapy_entity\\', {})], \\'edges\\': [(\\'pulmonary radiotherapy_entity\\', \\'lung metastases_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'administered_for\\'})]}, {\\'nodes\\': [(\\'dosimetric study_entity\\', {}), (\\'proton therapy_entity\\', {}), (\\'flank irradiation_entity\\', {})], \\'edges\\': [(\\'dosimetric study_entity\\', \\'proton therapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated\\'}), (\\'proton therapy_entity\\', \\'flank irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggested_for\\'})]}, {\\'nodes\\': [(\\'metastatic disease_entity\\', {}), (\\'radiotherapy guidelines_entity\\', {}), (\\'locoregional disease_entity\\', {})], \\'edges\\': [(\\'radiotherapy guidelines_entity\\', \\'locoregional disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'}), (\\'radiotherapy guidelines_entity\\', \\'metastatic disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'})]}, {\\'nodes\\': [(\\'major rupture_entity\\', {}), (\\'stage III_entity\\', {})], \\'edges\\': [(\\'stage III_entity\\', \\'major rupture_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes_condition\\'})]}, {\\'nodes\\': [(\\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {}), (\\'ExPO\u2011r\u2011Net_entity\\', {})], \\'edges\\': [(\\'ExPO\u2011r\u2011Net_entity\\', \\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is part of\\'})]}, {\\'nodes\\': [(\\'University Hospital of Munich_entity\\', {}), (\\'Germany_entity\\', {}), (\\'University Hospital of Tuebingen_entity\\', {})], \\'edges\\': [(\\'Germany_entity\\', \\'University Hospital of Munich_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Germany_entity\\', \\'University Hospital of Tuebingen_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {}), (\\'Italy_entity\\', {}), (\\'Azienda Ospedaliera_entity\\', {}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {})], \\'edges\\': [(\\'Italy_entity\\', \\'Azienda Ospedaliera_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Netherlands_entity\\', {}), (\\'Prinses Maxima Centrum_entity\\', {})], \\'edges\\': [(\\'Netherlands_entity\\', \\'Prinses Maxima Centrum_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Marciniak Hospital_entity\\', {}), (\\'Poland_entity\\', {}), (\\'Faculty of Medicine_entity\\', {})], \\'edges\\': [(\\'Poland_entity\\', \\'Marciniak Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Poland_entity\\', \\'Faculty of Medicine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'St. Anna Kinderspital/CCRI_entity\\', {}), (\\'Austria_entity\\', {})], \\'edges\\': [(\\'Austria_entity\\', \\'St. Anna Kinderspital/CCRI_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'France_entity\\', {}), (\\'Armand Trousseau Hospital_entity\\', {})], \\'edges\\': [(\\'France_entity\\', \\'Armand Trousseau Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Spain_entity\\', {}), (\\'Hospital Vall d\u2019Hebron_entity\\', {}), (\\'Hospital Universitario Virgin del Rocio_entity\\', {})], \\'edges\\': [(\\'Spain_entity\\', \\'Hospital Universitario Virgin del Rocio_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Spain_entity\\', \\'Hospital Vall d\u2019Hebron_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'United Kingdom_entity\\', {}), (\\'Great Ormond Street Hospital_entity\\', {})], \\'edges\\': [(\\'United Kingdom_entity\\', \\'Great Ormond Street Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Weirich, A._entity\\', {}), (\\'SIOP-9/GPOH_entity\\', {})], \\'edges\\': [(\\'Weirich, A._entity\\', \\'SIOP-9/GPOH_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Pritchard-Jones, K._entity\\', {}), (\\'UKW3_entity\\', {})], \\'edges\\': [(\\'Pritchard-Jones, K._entity\\', \\'UKW3_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed in\\'})]}, {\\'nodes\\': [(\\'SIOP 93\u201301 trial_entity\\', {}), (\\'de Kraker, J._entity\\', {})], \\'edges\\': [(\\'de Kraker, J._entity\\', \\'SIOP 93\u201301 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'SIOP trial and study 93\u201301_entity\\', {}), (\\'Graf, N._entity\\', {})], \\'edges\\': [(\\'Graf, N._entity\\', \\'SIOP trial and study 93\u201301_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Green, D. M._entity\\', {}), (\\'National Wilms Tumor Study Group_entity\\', {})], \\'edges\\': [(\\'Green, D. M._entity\\', \\'National Wilms Tumor Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}, {\\'nodes\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', {}), (\\'SIOP WT 2001 protocol_entity\\', {})], \\'edges\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', \\'SIOP WT 2001 protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Third National Wilms\u2019 Tumor Study_entity\\', {}), (\"D\\'Angio, G. J._entity\", {}), (\\'Second National Wilms\u2019 Tumor Study_entity\\', {})], \\'edges\\': [(\"D\\'Angio, G. J._entity\", \\'Third National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\"D\\'Angio, G. J._entity\", \\'Second National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {}), (\\'Tournade, M. F._entity\\', {}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {})], \\'edges\\': [(\\'Tournade, M. F._entity\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'}), (\\'Tournade, M. F._entity\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Breslow, N. E._entity\\', {}), (\\'National Wilms Tumor Studies_entity\\', {})], \\'edges\\': [(\\'Breslow, N. E._entity\\', \\'National Wilms Tumor Studies_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Mitchell, C._entity\\', {}), (\\'UK Children\u2019s Cancer Study Group_entity\\', {})], \\'edges\\': [(\\'Mitchell, C._entity\\', \\'UK Children\u2019s Cancer Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'under\\'})]}, {\\'nodes\\': [(\\'Daw, N. C._entity\\', {}), (\\'Dix, D. B._entity\\', {}), (\\'Children\u2019s Oncology Group_entity\\', {}), (\\'Grundy, P. E._entity\\', {})], \\'edges\\': [(\\'Daw, N. C._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted under\\'}), (\\'Dix, D. B._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'}), (\\'Grundy, P. E._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}]']), TestResult(name='test_case_14', success=False, metrics_data=[MetricData(name='Answer Correctness (GEval)', threshold=0.5, success=True, score=0.9794386148473976, reason='The actual output correctly identifies that the UMBRELLA protocol was developed by the International Society of Paediatric Oncology (SIOP\u2013RTSG), matching the expected output.', strict_mode=False, evaluation_model='gpt-4o-mini', error=None, evaluation_cost=0.0033040499999999998, verbose_logs='Criteria:\\nNone \\n \\nEvaluation Steps:\\n[\\n    \"Determine whether the actual output is factually correct based on the expected output.\"\\n]'), MetricData(name='Faithfulness', threshold=0.7, success=True, score=0.8148148148148148, reason=None, strict_mode=False, evaluation_model='gpt-4o-mini', error=None, evaluation_cost=0.009344249999999998, verbose_logs='Truths (limit=None):\\n[\\n    \"The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG) is an organization.\",\\n    \"The UMBRELLA SIOP-RTSG 2016 is a protocol.\",\\n    \"The SIOP\u22122001 is a clinical protocol.\",\\n    \"Wilms tumours are a type of disease.\",\\n    \"Non-Wilms tumours are classified as a type of childhood renal tumour disease.\",\\n    \"The Department of Paediatric Oncology is located in the Princess M\u00e1xima Center for Paediatric Oncology.\",\\n    \"Marry M. van den Heuvel-Eibrink is a person mentioned.\",\\n    \"Childhood renal tumours include various types of diseases.\",\\n    \"Clear cell sarcoma of the kidney is a type of disease.\",\\n    \"Renal cell carcinoma is categorized as a disease.\",\\n    \"Malignant rhabdoid tumour of the kidney is a type of disease.\",\\n    \"Congenital mesoblastic nephroma is classified as a disease.\",\\n    \"Wilms tumours constitute a medical condition.\",\\n    \"Various treatment methods include surgery, chemotherapy, and radiotherapy.\",\\n    \"The UK Children\u2019s Cancer and Leukaemia Group (UKCCLG) is an organization.\",\\n    \"Stage I through Stage V represent different stages of a disease.\",\\n    \"Localised disease, metastatic disease, bilateral disease, and relapsed disease classify various disease stages.\",\\n    \"Drugs such as actinomycin D, vincristine, doxorubicin, etoposide, carboplatin, and cyclophosphamide are used in treatments.\",\\n    \"The SIOP\u22122001 randomized trial is a clinical trial.\",\\n    \"Cumulative doxorubicin dose is a treatment detail.\",\\n    \"MRI and CT are utilized as diagnostic tools in treatments.\",\\n    \"The overall survival (OS) and event-free survival (EFS) serve as metrics for assessing treatment efficacy.\",\\n    \"The website www.siop-rtsg.eu pertains to SIOP\u2013RTSG.\",\\n    \"The UMBRELLA protocol provides guidelines for treatment.\",\\n    \"SIOP\u2013RTSG is involved in the organization of children\u2019s oncology treatment protocols.\",\\n    \"The Children\u2019s Oncology Group is a collaborative organization for childhood cancer treatment.\",\\n    \"The UKW3 trial is a clinical trial focused on Wilms tumours.\",\\n    \"Anaplasia is a medical condition associated with certain types of Wilms tumours.\",\\n    \"Nephron-sparing surgery (NSS) is a treatment method.\",\\n    \"Vincristine and actinomycin D are specific drugs used together in treatments.\",\\n    \"Various countries are involved in the study and treatment of childhood cancers, including Austria, Germany, Italy, and Spain.\",\\n    \"High-dose chemotherapy is one of the treatment options for certain types of tumours.\"\\n] \\n \\nClaims:\\n[\\n    \"The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG) is an organization.\",\\n    \"The UMBRELLA SIOP-RTSG 2016 is a protocol.\",\\n    \"SIOP\u22122001 is a protocol.\",\\n    \"Wilms tumours are a type of disease.\",\\n    \"Non-Wilms tumours are a type of disease.\",\\n    \"www.siop-rtsg.eu is a website.\",\\n    \"The Department of Paediatric Oncology is part of Princess M\u00e1xima Center for Paediatric Oncology.\",\\n    \"Marry M. van den Heuvel-Eibrink is a person.\",\\n    \"Childhood renal tumours are a type of disease.\",\\n    \"Clear cell sarcoma of the kidney is a type of disease.\",\\n    \"Renal cell carcinoma is a type of disease.\",\\n    \"Malignant rhabdoid tumour of the kidney is a type of disease.\",\\n    \"Congenital mesoblastic nephroma is a type of disease.\",\\n    \"Wilms tumours are a condition.\",\\n    \"The UMBRELLA protocol is a treatment protocol.\",\\n    \"SIOP\u2013RTSG is an organization.\",\\n    \"The Children\u2019s Oncology Group (COG) is an organization.\",\\n    \"The SIOP\u22122001 randomized trial is a clinical trial.\",\\n    \"Actinomycin D is a drug.\",\\n    \"Vincristine is a drug.\",\\n    \"Doxorubicin is a drug.\",\\n    \"The UKW3 trial is a clinical trial.\",\\n    \"The UK Children\u2019s Cancer and Leukaemia Group (UKCCLG) is an organization.\",\\n    \"Localized disease is a disease stage.\",\\n    \"Metastatic disease is a disease stage.\",\\n    \"Bilateral disease is a disease stage.\",\\n    \"Relapsed disease is a disease stage.\",\\n    \"Blastemal-type Wilms tumours are a subtype.\",\\n    \"Radiotherapy is a treatment method.\",\\n    \"Surgery is a treatment method.\",\\n    \"Chemotherapy is a treatment method.\",\\n    \"Wilms Tumour is a disease.\",\\n    \"CCSK is a type of disease.\",\\n    \"MRTK is a type of disease.\",\\n    \"CMN is a type of disease.\",\\n    \"RCC is a type of disease.\",\\n    \"The UMBRELLA protocol is a protocol.\",\\n    \"The SIOP\u22122001 trial is a trial.\",\\n    \"Vincristine is a treatment.\",\\n    \"Actinomycin D is a treatment.\",\\n    \"Doxorubicin is a treatment.\",\\n    \"Etoposide is a treatment.\",\\n    \"Carboplatin is a treatment.\",\\n    \"Cyclophosphamide is a treatment.\",\\n    \"Stage I is a stage.\",\\n    \"Stage II is a stage.\",\\n    \"Stage III is a stage.\",\\n    \"Stage IV is a stage.\",\\n    \"Stage V is a stage.\",\\n    \"AV is a treatment combination.\",\\n    \"AVD is a treatment combination.\",\\n    \"HR-1 is a treatment combination.\",\\n    \"The SIOP-RTSG 2016 is a protocol.\",\\n    \"Overall Survival (OS) is a metric.\",\\n    \"Event-Free Survival (EFS) is a metric.\",\\n    \"CT-only nodules are a medical condition.\",\\n    \"The UMBRELLA protocol is a treatment protocol.\",\\n    \"The SIOP\u2013RTSG analysis is a study.\",\\n    \"The COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials is a study.\",\\n    \"Vincristine and actinomycin D plus doxorubicin is a treatment.\",\\n    \"Vincristine and actinomycin D is a treatment.\",\\n    \"The SIOP\u22122001 study is a study protocol.\",\\n    \"MRI is a diagnostic tool.\",\\n    \"CT is a diagnostic tool.\",\\n    \"Cumulative doxorubicin dose is a treatment detail.\",\\n    \"The COG AREN0533 trial is a study.\",\\n    \"Etoposide is a medication.\",\\n    \"Carboplatin is a medication.\",\\n    \"Cyclophosphamide is a medication.\",\\n    \"High-risk characteristics are a medical condition.\",\\n    \"The SIOP\u2013RTSG board is an organization.\",\\n    \"Vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin is a treatment.\",\\n    \"High-dose chemotherapy and autologous stem cell transplantation is a treatment.\",\\n    \"The SIOP database is a database.\",\\n    \"Event-Free Survival (EFS) is a subject.\",\\n    \"Overall Survival (OS) is a subject.\",\\n    \"AVD is a treatment group.\",\\n    \"AV-2 is a treatment group.\",\\n    \"Log\u2013Rank P is a statistical test.\",\\n    \"Bilateral Disease (Stage V) is a disease stage.\",\\n    \"Synchronous bilateral Wilms tumor is a disease.\",\\n    \"End-stage renal disease (ESRD) is a condition.\",\\n    \"Aronson et al. is a research group.\",\\n    \"Bilateral nephron-sparing surgery (NSS) is a treatment method.\",\\n    \"The SIOP\u22122001 study is a study.\",\\n    \"Vincristine is a drug.\",\\n    \"Actinomycin D is a drug.\",\\n    \"Etoposide is a drug.\",\\n    \"Carboplatin is a drug.\",\\n    \"Relapsed Wilms Tumor is a disease state.\",\\n    \"Group AA is a patient group.\",\\n    \"Group BB is a patient group.\",\\n    \"Group CC is a patient group.\",\\n    \"Doxorubicin is a drug.\",\\n    \"Cyclophosphamide is a drug.\",\\n    \"Ifosfamide is a drug.\",\\n    \"High-dose melphalan is a treatment method.\",\\n    \"The UKW\u2011R protocol is a treatment protocol.\",\\n    \"The NWTS\u20115 relapse protocol is a treatment protocol.\",\\n    \"ASCR is a procedure.\",\\n    \"Ifosfamide is a medication.\",\\n    \"Nephrotoxicity is a condition.\",\\n    \"Relapsed group CC is a patient group.\",\\n    \"Diffuse anaplasia is a condition.\",\\n    \"Blastemal-type tumors are a condition.\",\\n    \"The UMBRELLA protocol is a protocol.\",\\n    \"Camptothecins is a medication class.\",\\n    \"Irinotecan is a medication.\",\\n    \"Topotecan is a medication.\",\\n    \"The Innovative Therapies for Children with Cancer consortium is an organization.\",\\n    \"Radiotherapy is a treatment method.\",\\n    \"Surgical excision is a treatment method.\",\\n    \"Stage IV WT is a condition.\",\\n    \"AVD150 is a treatment regimen.\",\\n    \"AVD250 is a treatment regimen.\",\\n    \"Low-risk disease is a condition category.\",\\n    \"Intermediate-risk disease is a condition category.\",\\n    \"High-risk disease is a condition category.\",\\n    \"CDCV is a treatment regimen.\",\\n    \"Actinomycin-D is a medication.\",\\n    \"Vincristine is a medication.\",\\n    \"Doxorubicin is a medication.\",\\n    \"VP16 is a medication.\",\\n    \"Arnaud Verschuur can be contacted via arnauld.verschuur@ap-hm.fr.\",\\n    \"Surgery is a treatment method.\",\\n    \"Chemotherapy is a treatment method.\",\\n    \"The SIOP\u2212RTSG panel is an organization.\",\\n    \"Infant Wilms Tumors is a medical condition.\",\\n    \"Nephrectomy is a surgical procedure.\",\\n    \"Congenital mesoblastic nephroma is a medical condition.\",\\n    \"Malignant rhabdoid tumors are a medical condition.\",\\n    \"Adult Wilms Tumors is a medical condition.\",\\n    \"Anaplasia is a medical condition.\",\\n    \"Actinomycin D is a drug.\",\\n    \"Vincristine is a drug.\",\\n    \"Doxorubicin is a drug.\",\\n    \"Carboplatin is a drug.\",\\n    \"Cyclophosphamide is a drug.\",\\n    \"Etoposide is a drug.\",\\n    \"Nephron-sparing surgery (NSS) is a surgical procedure.\",\\n    \"The SIOP\u2013RTSG is an organization.\",\\n    \"Radical tumor nephrectomy is a surgical procedure.\",\\n    \"Lymph node sampling is a surgical procedure.\",\\n    \"Minimally invasive surgery is a surgery type.\",\\n    \"Laparoscopic surgery is a surgery type.\",\\n    \"Nephron-sparing surgery (NSS) is a surgery type.\",\\n    \"The SIOP\u22122001 is a protocol.\",\\n    \"Radiotherapy is a treatment.\",\\n    \"Wilms tumours are a condition.\",\\n    \"Davila Fajardo et al. is an author.\",\\n    \"The COG\u2013NWTS trials is a trial.\",\\n    \"Whole-lung irradiation is a treatment.\",\\n    \"Pulmonary radiotherapy is a treatment.\",\\n    \"Proton therapy is a treatment.\",\\n    \"Dosimetric study is a study.\",\\n    \"Locoregional disease is a condition.\",\\n    \"Metastatic disease is a condition.\",\\n    \"Low-risk is a risk category.\",\\n    \"Intermediate-risk is a risk category.\",\\n    \"High-risk is a risk category.\",\\n    \"Stage I is a stage.\",\\n    \"Stage II is a stage.\",\\n    \"Stage III is a stage.\",\\n    \"Major rupture is a condition.\",\\n    \"Austria is a country.\",\\n    \"Italy is a country.\",\\n    \"San Marino is a country.\",\\n    \"Iceland is a country.\",\\n    \"Germany is a country.\",\\n    \"Bulgaria is a country.\",\\n    \"Turkey is a country.\",\\n    \"Denmark is a country.\",\\n    \"Poland is a country.\",\\n    \"Greece is a country.\",\\n    \"Andorra is a country.\",\\n    \"Belgium is a country.\",\\n    \"Serbia is a country.\",\\n    \"Albania is a country.\",\\n    \"Moldova is a country.\",\\n    \"Lithuania is a country.\",\\n    \"Latvia is a country.\",\\n    \"Estonia is a country.\",\\n    \"Luxembourg is a country.\",\\n    \"Montenegro is a country.\",\\n    \"Bosnia and Herzegovina is a country.\",\\n    \"Croatia is a country.\",\\n    \"Slovenia is a country.\",\\n    \"Macedonia is a country.\",\\n    \"The United Kingdom is a country.\",\\n    \"Ireland is a country.\",\\n    \"Spain is a country.\",\\n    \"Algeria is a country.\",\\n    \"Tunisia is a country.\",\\n    \"Malta is a country.\",\\n    \"Morocco is a country.\",\\n    \"Portugal is a country.\",\\n    \"France is a country.\",\\n    \"Monaco is a country.\",\\n    \"Russia is a country.\",\\n    \"Finland is a country.\",\\n    \"Sweden is a country.\",\\n    \"Norway is a country.\",\\n    \"Belarus is a country.\",\\n    \"Romania is a country.\",\\n    \"Ukraine is a country.\",\\n    \"Hungary is a country.\",\\n    \"Czech Republic is a country.\",\\n    \"Slovakia is a country.\",\\n    \"Switzerland is a country.\",\\n    \"Liechtenstein is a country.\",\\n    \"The Netherlands is a country.\",\\n    \"The University Hospital of Munich is an institution.\",\\n    \"The University Hospital of Tuebingen is an institution.\",\\n    \"Azienda Ospedaliera is an institution.\",\\n    \"The Ospedale Pediatrico Bambino Ges\u00f9 is an institution.\",\\n    \"The Fondazione IRCCS Istituto Nazionale dei Tumori is an institution.\",\\n    \"The Prinses Maxima Centrum is an institution.\",\\n    \"Marciniak Hospital is an institution.\",\\n    \"The Faculty of Medicine is an institution.\",\\n    \"St. Anna Kinderspital/CCRI is an institution.\",\\n    \"Armand Trousseau Hospital is an institution.\",\\n    \"Hospital Universitario Virgin del Rocio is an institution.\",\\n    \"Hospital Vall d\u2019Hebron is an institution.\",\\n    \"Great Ormond Street Hospital is an institution.\",\\n    \"The University Hospital Homburg is an institution.\",\\n    \"L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon is an institution.\",\\n    \"The UMBRELLA protocol is a project.\",\\n    \"ExPO\u2011r\u2011Net is a project.\",\\n    \"Weirich et al. is an author.\",\\n    \"Pritchard-Jones et al. is an author.\",\\n    \"De Kraker et al. is an author.\",\\n    \"Graf et al. is an author.\",\\n    \"Green et al. is an author.\",\\n    \"Spreafico et al. is an author.\",\\n    \"Bellani et al. is an author.\",\\n    \"Van den Heuvel-Eibrink et al. is an author.\",\\n    \"D\\'Angio et al. is an author.\",\\n    \"Tournade et al. is an author.\",\\n    \"Breslow et al. is an author.\",\\n    \"Mitchell et al. is an author.\",\\n    \"Verschuur et al. is an author.\",\\n    \"Grundy et al. is an author.\",\\n    \"Warmann et al. is an author.\",\\n    \"Smets et al. is an author.\",\\n    \"Dome et al. is an author.\",\\n    \"Dix et al. is an author.\",\\n    \"Daw et al. is an author.\",\\n    \"Ha et al. is an author.\",\\n    \"Kremens et al. is an author.\",\\n    \"Furtwangler et al. is an author.\",\\n    \"The SIOP-9/GPOH is a study.\",\\n    \"The UKW3 is a trial.\",\\n    \"The SIOP 93\u201301 trial is a trial.\",\\n    \"The SIOP trial and study 93\u201301 is a study.\",\\n    \"The National Wilms Tumor Study Group is an organization.\",\\n    \"The SIOP WT 2001 protocol is a protocol.\",\\n    \"The Third National Wilms\u2019 Tumor Study is a study.\",\\n    \"The Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study is a study.\",\\n    \"The National Wilms Tumor Studies is a study.\",\\n    \"The Second National Wilms\u2019 Tumor Study is a study.\",\\n    \"The Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study is a study.\",\\n    \"The UK Children\u2019s Cancer Study Group is an organization.\",\\n    \"The Children\u2019s Oncology Group is an organization.\"\\n] \\n \\nVerdicts:\\n[\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"The actual output states that SIOP\\\\u22122001 is a clinical protocol, not simply a protocol.\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"Non-Wilms tumours are classified as a type of childhood renal tumour disease, not just a type of disease.\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"The Department of Paediatric Oncology is located in the Princess M\\\\u00e1xima Center for Paediatric Oncology, not part of it.\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"Wilms tumours are classified as a medical condition, which is different from being called a condition.\"\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"The UMBRELLA protocol is described as a protocol in the context, not specifically a treatment protocol.\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"idk\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"idk\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"idk\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"idk\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    }\\n]'), MetricData(name='Contextual Relevancy', threshold=1.0, success=False, score=0.6666666666666666, reason=\"The score is 0.67 because although the retrieval context has relevant statements like 'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)' indicating the responsible society, much of the context is irrelevant, such as discussing treatment methods and board member involvement, which do not directly answer the question about the protocol.\", strict_mode=False, evaluation_model='gpt-4o-mini', error=None, evaluation_cost=0.0037145999999999998, verbose_logs='Verdicts:\\n[\\n    {\\n        \"verdicts\": [\\n            {\\n                \"statement\": \"The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\\\\u2013RTSG)\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"SIOP\\\\u2013RTSG is responsible for the UMBRELLA protocol.\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"Children\\\\u2019s Oncology Group (COG) also participates in studies related to Wilms tumors.\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"Multiple organizations collaborate in the treatment of childhood renal tumors.\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"SIOP\\\\u22122001 protocol and randomized trial address treatments for childhood renal tumors.\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"There are several treatment methods including surgery, chemotherapy, and radiotherapy.\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"SIOP\\\\u2212RTSG\\'s board involves various board members and organizations.\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"The retrieval context contains the information \\'SIOP\\\\u2212RTSG\\'s board involves various board members and organizations\\' which does not directly answer the question about the international society responsible for the protocol.\"\\n            },\\n            {\\n                \"statement\": \"High-dose chemotherapy and autologous stem cell transplantation are treatment methods considered.\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"The retrieval context mentions \\'high-dose chemotherapy and autologous stem cell transplantation are treatment methods considered\\' which is not relevant to identifying the responsible society for the protocol.\"\\n            },\\n            {\\n                \"statement\": \"Many countries participate in the study of childhood renal tumors.\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"The retrieval context states \\'many countries participate in the study of childhood renal tumors\\' but does not relate to which international society is responsible for the protocol.\"\\n            }\\n        ]\\n    }\\n]')], conversational=False, multimodal=False, input='Which international society is responsible for the protocol?', actual_output='[{\\'nodes\\': [(\\'sample.pdf\\', {\\'type\\': \\'document\\'}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)\\'}), (\\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA SIOP-RTSG 2016\\'}), (\\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms tumours\\'}), (\\'non-Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'non-Wilms tumours\\'}), (\\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Website\\', \\'name\\': \\'www.siop-rtsg.eu\\'}), (\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology\\'}), (\\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Person\\', \\'name\\': \\'Marry M. van den Heuvel-Eibrink\\'}), (\\'childhood renal tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'childhood renal tumours\\'}), (\\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'clear cell sarcoma of the kidney\\'}), (\\'renal cell carcinoma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'renal cell carcinoma\\'}), (\\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'malignant rhabdoid tumour of the kidney\\'}), (\\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'Wilms tumours_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'Children\u2019s Oncology Group (COG)\\'}), (\\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'SIOP\u22122001 randomized trial\\'}), (\\'actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'UKW3 trial\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)\\'}), (\\'localized disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'localized disease\\'}), (\\'metastatic disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'metastatic disease\\'}), (\\'bilateral disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'bilateral disease\\'}), (\\'relapsed disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'relapsed disease\\'}), (\\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subtype\\', \\'name\\': \\'blastemal-type Wilms tumours\\'}), (\\'radiotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgery_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'chemotherapy\\'}), (\\'Wilms Tumour_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms Tumour\\'}), (\\'CCSK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CCSK\\'}), (\\'MRTK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'MRTK\\'}), (\\'CMN_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CMN\\'}), (\\'RCC_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'RCC\\'}), (\\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u22122001_Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Trial\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'vincristine_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'vincristine\\'}), (\\'actinomycin D_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'actinomycin D\\'}), (\\'doxorubicin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'doxorubicin\\'}), (\\'etoposide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'Stage I_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage I\\'}), (\\'Stage II_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage II\\'}), (\\'Stage III_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage III\\'}), (\\'Stage IV_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage IV\\'}), (\\'Stage V_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage V\\'}), (\\'AV_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AV\\'}), (\\'AVD_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AVD\\'}), (\\'HR-1_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'HR-1\\'}), (\\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP-RTSG 2016\\'}), (\\'Overall Survival (OS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'CT-only nodules_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'CT-only nodules\\'}), (\\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP\u2013RTSG analysis\\'}), (\\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials\\'}), (\\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D plus doxorubicin\\'}), (\\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D\\'}), (\\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study_protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'MRI_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'MRI\\'}), (\\'CT_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'CT\\'}), (\\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_detail\\', \\'name\\': \\'cumulative doxorubicin dose\\'}), (\\'COG AREN0533 trial_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG AREN0533 trial\\'}), (\\'etoposide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'high-risk characteristics\\'}), (\\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG board\\'}), (\\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin\\'}), (\\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'high-dose chemotherapy and autologous stem cell transplantation\\'}), (\\'SIOP database_database\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'database\\', \\'name\\': \\'SIOP database\\'}), (\\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'AVD_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AVD\\'}), (\\'AV-2_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AV-2\\'}), (\\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Statistical Test\\', \\'name\\': \\'Log\u2013Rank P\\'}), (\\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'Bilateral Disease (Stage V)\\'}), (\\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Synchronous bilateral Wilms tumor\\'}), (\\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'End-stage renal disease (ESRD)\\'}), (\\'Aronson et al._Research Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Research Group\\', \\'name\\': \\'Aronson et al.\\'}), (\\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'Bilateral nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Study\\', \\'name\\': \\'SIOP\u22122001 study\\'}), (\\'Vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Vincristine\\'}), (\\'Actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Actinomycin D\\'}), (\\'Etoposide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Etoposide\\'}), (\\'Carboplatin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Carboplatin\\'}), (\\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease State\\', \\'name\\': \\'Relapsed Wilms Tumor\\'}), (\\'Group AA_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group AA\\'}), (\\'Group BB_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group BB\\'}), (\\'Group CC_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group CC\\'}), (\\'Doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Doxorubicin\\'}), (\\'Cyclophosphamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Cyclophosphamide\\'}), (\\'Ifosfamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Ifosfamide\\'}), (\\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'High-dose melphalan\\'}), (\\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UKW\u2011R protocol\\'}), (\\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'NWTS\u20115 relapse protocol\\'}), (\\'ASCR_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'procedure\\', \\'name\\': \\'ASCR\\'}), (\\'ifosfamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'ifosfamide\\'}), (\\'nephrotoxicity_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'nephrotoxicity\\'}), (\\'relapsed group CC_patient_group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'patient_group\\', \\'name\\': \\'relapsed group CC\\'}), (\\'diffuse anaplasia_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'diffuse anaplasia\\'}), (\\'blastemal-type tumors_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'blastemal-type tumors\\'}), (\\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'camptothecins_medication_class\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication_class\\', \\'name\\': \\'camptothecins\\'}), (\\'irinotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'irinotecan\\'}), (\\'topotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'topotecan\\'}), (\\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Innovative Therapies for Children with Cancer consortium\\'}), (\\'radiotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgical excision_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgical excision\\'}), (\\'stage IV WT_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'stage IV WT\\'}), (\\'AVD150_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD150\\'}), (\\'AVD250_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD250\\'}), (\\'low-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'low-risk disease\\'}), (\\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'intermediate-risk disease\\'}), (\\'high-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'high-risk disease\\'}), (\\'CDCV_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'CDCV\\'}), (\\'actinomycin-D_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'actinomycin-D\\'}), (\\'vincristine_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'doxorubicin\\'}), (\\'VP16_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'VP16\\'}), (\\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'contact\\', \\'name\\': \\'arnauld.verschuur@ap-hm.fr\\'}), (\\'surgery_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'chemotherapy\\'}), (\\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2212RTSG panel\\'}), (\\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Infant Wilms Tumors\\'}), (\\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'nephrectomy\\'}), (\\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'malignant rhabdoid tumors\\'}), (\\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Adult Wilms Tumors\\'}), (\\'anaplasia_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'anaplasia\\'}), (\\'actinomycin D_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'carboplatin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'etoposide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'etoposide\\'}), (\\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'Nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'radical tumor nephrectomy\\'}), (\\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'lymph node sampling\\'}), (\\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'minimally invasive surgery\\'}), (\\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'laparoscopic surgery\\'}), (\\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'radiotherapy\\'}), (\\'Wilms tumours_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'Davila Fajardo et al._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Davila Fajardo et al.\\'}), (\\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'COG\u2013NWTS trials\\'}), (\\'whole-lung irradiation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'whole-lung irradiation\\'}), (\\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'pulmonary radiotherapy\\'}), (\\'proton therapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'proton therapy\\'}), (\\'dosimetric study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'dosimetric study\\'}), (\\'locoregional disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'locoregional disease\\'}), (\\'metastatic disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'metastatic disease\\'}), (\\'low-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'low-risk\\'}), (\\'intermediate-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'intermediate-risk\\'}), (\\'high-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'high-risk\\'}), (\\'stage I_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage I\\'}), (\\'stage II_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage II\\'}), (\\'stage III_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage III\\'}), (\\'major rupture_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'major rupture\\'}), (\\'Austria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Austria\\'}), (\\'Italy_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Italy\\'}), (\\'San Marino_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'San Marino\\'}), (\\'Iceland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Iceland\\'}), (\\'Germany_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Germany\\'}), (\\'Bulgaria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bulgaria\\'}), (\\'Turkey_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Turkey\\'}), (\\'Denmark_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Denmark\\'}), (\\'Poland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Poland\\'}), (\\'Greece_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Greece\\'}), (\\'Andorra_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Andorra\\'}), (\\'Belgium_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belgium\\'}), (\\'Serbia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Serbia\\'}), (\\'Albania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Albania\\'}), (\\'Moldova_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Moldova\\'}), (\\'Lithuania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Lithuania\\'}), (\\'Latvia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Latvia\\'}), (\\'Estonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Estonia\\'}), (\\'Luxembourg_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Luxembourg\\'}), (\\'Montenegro_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Montenegro\\'}), (\\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bosnia and Herzegovina\\'}), (\\'Croatia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Croatia\\'}), (\\'Slovenia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovenia\\'}), (\\'Macedonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Macedonia\\'}), (\\'United Kingdom_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'United Kingdom\\'}), (\\'Ireland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ireland\\'}), (\\'Spain_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Spain\\'}), (\\'Algeria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Algeria\\'}), (\\'Tunisia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Tunisia\\'}), (\\'Malta_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Malta\\'}), (\\'Morocco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Morocco\\'}), (\\'Portugal_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Portugal\\'}), (\\'France_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'France\\'}), (\\'Monaco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Monaco\\'}), (\\'Russia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Russia\\'}), (\\'Finland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Finland\\'}), (\\'Sweden_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Sweden\\'}), (\\'Norway_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Norway\\'}), (\\'Belarus_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belarus\\'}), (\\'Romania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Romania\\'}), (\\'Ukraine_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ukraine\\'}), (\\'Hungary_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Hungary\\'}), (\\'Czech Republic_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Czech Republic\\'}), (\\'Slovakia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovakia\\'}), (\\'Switzerland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Switzerland\\'}), (\\'Liechtenstein_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Liechtenstein\\'}), (\\'Netherlands_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Netherlands\\'}), (\\'University Hospital of Munich_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Munich\\'}), (\\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Tuebingen\\'}), (\\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Azienda Ospedaliera\\'}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Ospedale Pediatrico Bambino Ges\u00f9\\'}), (\\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Fondazione IRCCS Istituto Nazionale dei Tumori\\'}), (\\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Prinses Maxima Centrum\\'}), (\\'Marciniak Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Marciniak Hospital\\'}), (\\'Faculty of Medicine_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Faculty of Medicine\\'}), (\\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'St. Anna Kinderspital/CCRI\\'}), (\\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Armand Trousseau Hospital\\'}), (\\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Universitario Virgin del Rocio\\'}), (\\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Vall d\u2019Hebron\\'}), (\\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Great Ormond Street Hospital\\'}), (\\'University Hospital Homburg_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital Homburg\\'}), (\\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon\\'}), (\\'UMBRELLA protocol_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'ExPO\u2011r\u2011Net\\'}), (\\'Weirich, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Weirich, A.\\'}), (\\'Pritchard-Jones, K._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Pritchard-Jones, K.\\'}), (\\'de Kraker, J._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'de Kraker, J.\\'}), (\\'Graf, N._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Graf, N.\\'}), (\\'Green, D. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Green, D. M.\\'}), (\\'Spreafico, F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Spreafico, F.\\'}), (\\'Bellani, F. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Bellani, F. F.\\'}), (\\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'van den Heuvel-Eibrink, M. M.\\'}), (\"D\\'Angio, G. J._author\", {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \"D\\'Angio, G. J.\"}), (\\'Tournade, M. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Tournade, M. F.\\'}), (\\'Breslow, N. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Breslow, N. E.\\'}), (\\'Mitchell, C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Mitchell, C.\\'}), (\\'Verschuur, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Verschuur, A.\\'}), (\\'Grundy, P. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Grundy, P. E.\\'}), (\\'Warmann, S. W._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Warmann, S. W.\\'}), (\\'Smets, A. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Smets, A. M.\\'}), (\\'Dome, J. S._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dome, J. S.\\'}), (\\'Dix, D. B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dix, D. B.\\'}), (\\'Daw, N. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Daw, N. C.\\'}), (\\'Ha, T. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Ha, T. C.\\'}), (\\'Kremens, B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Kremens, B.\\'}), (\\'Furtwangler, R._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Furtwangler, R.\\'}), (\\'SIOP-9/GPOH_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP-9/GPOH\\'}), (\\'UKW3_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'UKW3\\'}), (\\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'SIOP 93\u201301 trial\\'}), (\\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP trial and study 93\u201301\\'}), (\\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'National Wilms Tumor Study Group\\'}), (\\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP WT 2001 protocol\\'}), (\\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Third National Wilms\u2019 Tumor Study\\'}), (\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'National Wilms Tumor Studies\\'}), (\\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Second National Wilms\u2019 Tumor Study\\'}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'UK Children\u2019s Cancer Study Group\\'}), (\\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Children\u2019s Oncology Group\\'})], \\'edges\\': [(\\'sample.pdf\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'non-Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'childhood renal tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'renal cell carcinoma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'localized disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'metastatic disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'bilateral disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'relapsed disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'radiotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'surgery_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'chemotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'Wilms Tumour_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CCSK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'MRTK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CMN_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'RCC_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP\u22122001_Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'vincristine_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'actinomycin D_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'doxorubicin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'etoposide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'carboplatin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'cyclophosphamide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage I_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage II_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage III_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage IV_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage V_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AV_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AVD_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'HR-1_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Overall Survival (OS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT-only nodules_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'MRI_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG AREN0533 trial_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'etoposide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'carboplatin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'cyclophosphamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP database_database\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AVD_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AV-2_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Aronson et al._Research Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Etoposide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Carboplatin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group AA_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group BB_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group CC_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Cyclophosphamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Ifosfamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'ASCR_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'ifosfamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'nephrotoxicity_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'relapsed group CC_patient_group\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'diffuse anaplasia_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'blastemal-type tumors_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'camptothecins_medication_class\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'irinotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'topotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'radiotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'surgical excision_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'stage IV WT_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD150_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD250_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'low-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'CDCV_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'actinomycin-D_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'vincristine_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'doxorubicin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'VP16_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'surgery_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'chemotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'anaplasia_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'actinomycin D_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'vincristine_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'doxorubicin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'carboplatin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'cyclophosphamide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'etoposide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'SIOP\u22122001_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Wilms tumours_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Davila Fajardo et al._author\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'whole-lung irradiation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'proton therapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'dosimetric study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'locoregional disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'metastatic disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'low-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'intermediate-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'high-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage I_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage II_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage III_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'major rupture_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Austria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Italy_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'San Marino_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Iceland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Germany_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bulgaria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Turkey_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Denmark_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Poland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Greece_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Andorra_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belgium_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Serbia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Albania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Moldova_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Lithuania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Latvia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Estonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Luxembourg_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Montenegro_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Croatia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovenia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Macedonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'United Kingdom_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ireland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Spain_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Algeria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Tunisia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Malta_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Morocco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Portugal_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'France_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Monaco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Russia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Finland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Sweden_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Norway_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belarus_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Romania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ukraine_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hungary_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Czech Republic_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovakia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Switzerland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Liechtenstein_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Netherlands_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Munich_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Marciniak Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Faculty of Medicine_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital Homburg_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Weirich, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Pritchard-Jones, K._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'de Kraker, J._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Graf, N._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Green, D. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Spreafico, F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Bellani, F. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \"D\\'Angio, G. J._author\", {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Tournade, M. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Breslow, N. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Mitchell, C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Verschuur, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Grundy, P. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Warmann, S. W._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Smets, A. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dome, J. S._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dix, D. B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Daw, N. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ha, T. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Kremens, B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Furtwangler, R._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP-9/GPOH_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UKW3_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10})]}, {\\'nodes\\': [(\\'vincristine_entity\\', {}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {}), (\\'www.siop-rtsg.eu_entity\\', {}), (\\'stage II_entity\\', {}), (\\'Wilms tumours_entity\\', {}), (\\'Relapsed Wilms Tumor_entity\\', {}), (\\'Davila Fajardo et al._entity\\', {}), (\\'vincristine, actinomycin D, and doxorubicin_entity\\', {}), (\\'SIOP\u22122001 randomized trial_entity\\', {}), (\\'surgery_entity\\', {}), (\\'non-Wilms tumours_entity\\', {}), (\\'actinomycin D_entity\\', {}), (\\'diffuse anaplasia_entity\\', {}), (\\'Synchronous bilateral Wilms tumor_entity\\', {}), (\\'CT-only nodules_entity\\', {}), (\\'relapsed group CC_entity\\', {}), (\\'increased relapse risk_entity\\', {}), (\\'reduced survival_entity\\', {}), (\\'UKW3 trial_entity\\', {}), (\\'chemotherapy_entity\\', {}), (\\'Bilateral Disease (Stage V)_entity\\', {}), (\\'blastemal-type tumors_entity\\', {}), (\\'UMBRELLA protocol_entity\\', {}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', {}), (\\'minimally invasive surgery_entity\\', {}), (\\'VP16_entity\\', {}), (\\'Wilms tumor_entity\\', {}), (\\'anaplasia_entity\\', {}), (\\'radical tumor nephrectomy_entity\\', {}), (\\'Innovative Therapies for Children with Cancer consortium_entity\\', {}), (\\'cumulative doxorubicin dose_entity\\', {}), (\\'etoposide_entity\\', {}), (\\'large-volume tumours_entity\\', {}), (\\'Stage IV_entity\\', {}), (\\'CDCV_entity\\', {}), (\\'SIOP\u2013RTSG_entity\\', {}), (\\'AVD150_entity\\', {}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', {}), (\\'laparoscopic surgery_entity\\', {}), (\\'SIOP\u2212RTSG panel_entity\\', {}), (\\'actinomycin-D_entity\\', {}), (\\'COG AREN0533 trial_entity\\', {}), (\\'cyclophosphamide_entity\\', {}), (\\'carboplatin_entity\\', {}), (\\'UKW\u2011R protocol_entity\\', {}), (\\'Nephron-sparing surgery (NSS)_entity\\', {}), (\\'Adult Wilms Tumors_entity\\', {}), (\\'doxorubicin_entity\\', {}), (\\'NWTS\u20115 relapse protocol_entity\\', {}), (\\'End-stage renal disease (ESRD)_entity\\', {}), (\\'AVD250_entity\\', {}), (\\'Children\u2019s Oncology Group (COG)_entity\\', {}), (\\'blastemal-type Wilms tumour_entity\\', {}), (\\'SIOP\u22122001_entity\\', {}), (\\'radiotherapy_entity\\', {}), (\\'childhood renal tumours_entity\\', {})], \\'edges\\': [(\\'vincristine_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'stage II_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'indicated_for_in_adults\\'}), (\\'Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'Wilms tumours_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated under\\'}), (\\'Relapsed Wilms Tumor_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guided_by\\'}), (\\'Davila Fajardo et al._entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed\\'}), (\\'SIOP\u22122001 randomized trial_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated use in\\'}), (\\'surgery_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'non-Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'actinomycin D_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Synchronous bilateral Wilms tumor_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'instance_of\\'}), (\\'CT-only nodules_entity\\', \\'increased relapse risk_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'reduced survival_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included_in\\'}), (\\'relapsed group CC_entity\\', \\'diffuse anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'blastemal-type tumors_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UKW3 trial_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'UKW3 trial_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'chemotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UMBRELLA protocol_entity\\', \\'COG AREN0533 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses_data_from\\'}), (\\'UMBRELLA protocol_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'advises_treatment_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'Innovative Therapies for Children with Cancer consortium_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborates_with\\'}), (\\'UMBRELLA protocol_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'surgery_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is the standard of\\'}), (\\'UMBRELLA protocol_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guides treatment in\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', \\'UKW3 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\\'minimally invasive surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'anaplasia_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'radical tumor nephrectomy_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'standard_of_care_for\\'}), (\\'Stage IV_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'presents in\\'}), (\\'CDCV_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'VP16_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'aims to improve survival rates of\\'}), (\\'AVD150_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed_by\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'succeeds\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'www.siop-rtsg.eu_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'available_on\\'}), (\\'laparoscopic surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'COG AREN0533 trial_entity\\', \\'cumulative doxorubicin dose_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'evaluates\\'}), (\\'UKW\u2011R protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'Nephron-sparing surgery (NSS)_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'classification_developed_by\\'}), (\\'Adult Wilms Tumors_entity\\', \\'anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'Adult Wilms Tumors_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'doxorubicin_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'doxorubicin_entity\\', \\'large-volume tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'recommended for\\'}), (\\'NWTS\u20115 relapse protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'End-stage renal disease (ESRD)_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'AVD250_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'Children\u2019s Oncology Group (COG)_entity\\', \\'SIOP\u22122001 randomized trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborated with\\'}), (\\'blastemal-type Wilms tumour_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment intensified according to\\'}), (\\'SIOP\u22122001_entity\\', \\'vincristine, actinomycin D, and doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses\\'}), (\\'SIOP\u22122001_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provided_guidelines_for\\'}), (\\'radiotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'radiotherapy_entity\\', \\'SIOP\u2212RTSG panel_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'contact_for_guidance\\'})]}, {\\'nodes\\': [(\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {}), (\\'Marry M. van den Heuvel-Eibrink_entity\\', {})], \\'edges\\': [(\\'Marry M. van den Heuvel-Eibrink_entity\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'affiliated_with\\'})]}, {\\'nodes\\': [(\\'Stage II_entity\\', {}), (\\'AV_entity\\', {}), (\\'Stage III_entity\\', {}), (\\'vincestine and actinomycin D_entity\\', {}), (\\'AVD_entity\\', {})], \\'edges\\': [(\\'Stage II_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AV_entity\\', \\'Stage II_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Stage III_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AVD_entity\\', \\'Stage III_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'SIOP-RTSG 2016_entity\\', {}), (\\'RCC_entity\\', {}), (\\'CMN_entity\\', {})], \\'edges\\': [(\\'RCC_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'}), (\\'CMN_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'})]}, {\\'nodes\\': [(\\'HR-1_entity\\', {}), (\\'High-risk blastemal type Wilms tumour_entity\\', {})], \\'edges\\': [(\\'HR-1_entity\\', \\'High-risk blastemal type Wilms tumour_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'unfavorable prognosis_entity\\', {}), (\\'high-risk characteristics_entity\\', {})], \\'edges\\': [(\\'high-risk characteristics_entity\\', \\'unfavorable prognosis_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'leads_to\\'})]}, {\\'nodes\\': [(\\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {}), (\\'SIOP\u2013RTSG board_entity\\', {})], \\'edges\\': [(\\'SIOP\u2013RTSG board_entity\\', \\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggests\\'})]}, {\\'nodes\\': [(\\'regimen and outcomes_entity\\', {}), (\\'SIOP database_entity\\', {})], \\'edges\\': [(\\'SIOP database_entity\\', \\'regimen and outcomes_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'captures_data_on\\'})]}, {\\'nodes\\': [(\\'Bilateral nephron-sparing surgery (NSS)_entity\\', {}), (\\'Aronson et al._entity\\', {})], \\'edges\\': [(\\'Aronson et al._entity\\', \\'Bilateral nephron-sparing surgery (NSS)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'observed_effectiveness_of\\'})]}, {\\'nodes\\': [(\\'SIOP\u22122001 study_entity\\', {}), (\\'Actinomycin D_entity\\', {}), (\\'Vincristine_entity\\', {})], \\'edges\\': [(\\'SIOP\u22122001 study_entity\\', \\'Vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'}), (\\'SIOP\u22122001 study_entity\\', \\'Actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'})]}, {\\'nodes\\': [(\\'High-dose melphalan_entity\\', {}), (\\'Group AA_entity\\', {}), (\\'Carboplatin_entity\\', {}), (\\'Doxorubicin_entity\\', {}), (\\'Etoposide_entity\\', {}), (\\'Group BB_entity\\', {}), (\\'Cyclophosphamide_entity\\', {}), (\\'Ifosfamide_entity\\', {})], \\'edges\\': [(\\'Group AA_entity\\', \\'Doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Ifosfamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'High-dose melphalan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'})]}, {\\'nodes\\': [(\\'nephrotoxicity_entity\\', {}), (\\'ifosfamide_entity\\', {})], \\'edges\\': [(\\'ifosfamide_entity\\', \\'nephrotoxicity_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'related_to\\'})]}, {\\'nodes\\': [(\\'camptothecins_entity\\', {}), (\\'irinotecan_entity\\', {}), (\\'topotecan_entity\\', {})], \\'edges\\': [(\\'camptothecins_entity\\', \\'irinotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'camptothecins_entity\\', \\'topotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'})]}, {\\'nodes\\': [(\\'Infant Wilms Tumors_entity\\', {}), (\\'nephrectomy_entity\\', {})], \\'edges\\': [(\\'Infant Wilms Tumors_entity\\', \\'nephrectomy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_option\\'})]}, {\\'nodes\\': [(\\'congenital mesoblastic nephroma_entity\\', {}), (\\'surgery alone_entity\\', {})], \\'edges\\': [(\\'congenital mesoblastic nephroma_entity\\', \\'surgery alone_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'alternative chemotherapy_entity\\', {}), (\\'malignant rhabdoid tumors_entity\\', {})], \\'edges\\': [(\\'malignant rhabdoid tumors_entity\\', \\'alternative chemotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'lymph node sampling_entity\\', {}), (\\'accurate staging_entity\\', {})], \\'edges\\': [(\\'lymph node sampling_entity\\', \\'accurate staging_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'purpose_of\\'})]}, {\\'nodes\\': [(\\'COG\u2013NWTS trials_entity\\', {}), (\\'whole-lung irradiation_entity\\', {})], \\'edges\\': [(\\'COG\u2013NWTS trials_entity\\', \\'whole-lung irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'informed_dosage_for\\'})]}, {\\'nodes\\': [(\\'lung metastases_entity\\', {}), (\\'pulmonary radiotherapy_entity\\', {})], \\'edges\\': [(\\'pulmonary radiotherapy_entity\\', \\'lung metastases_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'administered_for\\'})]}, {\\'nodes\\': [(\\'dosimetric study_entity\\', {}), (\\'proton therapy_entity\\', {}), (\\'flank irradiation_entity\\', {})], \\'edges\\': [(\\'dosimetric study_entity\\', \\'proton therapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated\\'}), (\\'proton therapy_entity\\', \\'flank irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggested_for\\'})]}, {\\'nodes\\': [(\\'metastatic disease_entity\\', {}), (\\'radiotherapy guidelines_entity\\', {}), (\\'locoregional disease_entity\\', {})], \\'edges\\': [(\\'radiotherapy guidelines_entity\\', \\'locoregional disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'}), (\\'radiotherapy guidelines_entity\\', \\'metastatic disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'})]}, {\\'nodes\\': [(\\'major rupture_entity\\', {}), (\\'stage III_entity\\', {})], \\'edges\\': [(\\'stage III_entity\\', \\'major rupture_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes_condition\\'})]}, {\\'nodes\\': [(\\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {}), (\\'ExPO\u2011r\u2011Net_entity\\', {})], \\'edges\\': [(\\'ExPO\u2011r\u2011Net_entity\\', \\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is part of\\'})]}, {\\'nodes\\': [(\\'University Hospital of Munich_entity\\', {}), (\\'Germany_entity\\', {}), (\\'University Hospital of Tuebingen_entity\\', {})], \\'edges\\': [(\\'Germany_entity\\', \\'University Hospital of Munich_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Germany_entity\\', \\'University Hospital of Tuebingen_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {}), (\\'Italy_entity\\', {}), (\\'Azienda Ospedaliera_entity\\', {}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {})], \\'edges\\': [(\\'Italy_entity\\', \\'Azienda Ospedaliera_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Netherlands_entity\\', {}), (\\'Prinses Maxima Centrum_entity\\', {})], \\'edges\\': [(\\'Netherlands_entity\\', \\'Prinses Maxima Centrum_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Marciniak Hospital_entity\\', {}), (\\'Poland_entity\\', {}), (\\'Faculty of Medicine_entity\\', {})], \\'edges\\': [(\\'Poland_entity\\', \\'Marciniak Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Poland_entity\\', \\'Faculty of Medicine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'St. Anna Kinderspital/CCRI_entity\\', {}), (\\'Austria_entity\\', {})], \\'edges\\': [(\\'Austria_entity\\', \\'St. Anna Kinderspital/CCRI_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'France_entity\\', {}), (\\'Armand Trousseau Hospital_entity\\', {})], \\'edges\\': [(\\'France_entity\\', \\'Armand Trousseau Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Spain_entity\\', {}), (\\'Hospital Vall d\u2019Hebron_entity\\', {}), (\\'Hospital Universitario Virgin del Rocio_entity\\', {})], \\'edges\\': [(\\'Spain_entity\\', \\'Hospital Universitario Virgin del Rocio_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Spain_entity\\', \\'Hospital Vall d\u2019Hebron_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'United Kingdom_entity\\', {}), (\\'Great Ormond Street Hospital_entity\\', {})], \\'edges\\': [(\\'United Kingdom_entity\\', \\'Great Ormond Street Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Weirich, A._entity\\', {}), (\\'SIOP-9/GPOH_entity\\', {})], \\'edges\\': [(\\'Weirich, A._entity\\', \\'SIOP-9/GPOH_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Pritchard-Jones, K._entity\\', {}), (\\'UKW3_entity\\', {})], \\'edges\\': [(\\'Pritchard-Jones, K._entity\\', \\'UKW3_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed in\\'})]}, {\\'nodes\\': [(\\'SIOP 93\u201301 trial_entity\\', {}), (\\'de Kraker, J._entity\\', {})], \\'edges\\': [(\\'de Kraker, J._entity\\', \\'SIOP 93\u201301 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'SIOP trial and study 93\u201301_entity\\', {}), (\\'Graf, N._entity\\', {})], \\'edges\\': [(\\'Graf, N._entity\\', \\'SIOP trial and study 93\u201301_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Green, D. M._entity\\', {}), (\\'National Wilms Tumor Study Group_entity\\', {})], \\'edges\\': [(\\'Green, D. M._entity\\', \\'National Wilms Tumor Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}, {\\'nodes\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', {}), (\\'SIOP WT 2001 protocol_entity\\', {})], \\'edges\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', \\'SIOP WT 2001 protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Third National Wilms\u2019 Tumor Study_entity\\', {}), (\"D\\'Angio, G. J._entity\", {}), (\\'Second National Wilms\u2019 Tumor Study_entity\\', {})], \\'edges\\': [(\"D\\'Angio, G. J._entity\", \\'Third National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\"D\\'Angio, G. J._entity\", \\'Second National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {}), (\\'Tournade, M. F._entity\\', {}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {})], \\'edges\\': [(\\'Tournade, M. F._entity\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'}), (\\'Tournade, M. F._entity\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Breslow, N. E._entity\\', {}), (\\'National Wilms Tumor Studies_entity\\', {})], \\'edges\\': [(\\'Breslow, N. E._entity\\', \\'National Wilms Tumor Studies_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Mitchell, C._entity\\', {}), (\\'UK Children\u2019s Cancer Study Group_entity\\', {})], \\'edges\\': [(\\'Mitchell, C._entity\\', \\'UK Children\u2019s Cancer Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'under\\'})]}, {\\'nodes\\': [(\\'Daw, N. C._entity\\', {}), (\\'Dix, D. B._entity\\', {}), (\\'Children\u2019s Oncology Group_entity\\', {}), (\\'Grundy, P. E._entity\\', {})], \\'edges\\': [(\\'Daw, N. C._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted under\\'}), (\\'Dix, D. B._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'}), (\\'Grundy, P. E._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}]', expected_output='The International Society of Paediatric Oncology (SIOP\u2013RTSG) developed the UMBRELLA protocol.', context=None, retrieval_context=['[{\\'nodes\\': [(\\'sample.pdf\\', {\\'type\\': \\'document\\'}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)\\'}), (\\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA SIOP-RTSG 2016\\'}), (\\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms tumours\\'}), (\\'non-Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'non-Wilms tumours\\'}), (\\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Website\\', \\'name\\': \\'www.siop-rtsg.eu\\'}), (\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology\\'}), (\\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Person\\', \\'name\\': \\'Marry M. van den Heuvel-Eibrink\\'}), (\\'childhood renal tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'childhood renal tumours\\'}), (\\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'clear cell sarcoma of the kidney\\'}), (\\'renal cell carcinoma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'renal cell carcinoma\\'}), (\\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'malignant rhabdoid tumour of the kidney\\'}), (\\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'Wilms tumours_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'Children\u2019s Oncology Group (COG)\\'}), (\\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'SIOP\u22122001 randomized trial\\'}), (\\'actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'UKW3 trial\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)\\'}), (\\'localized disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'localized disease\\'}), (\\'metastatic disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'metastatic disease\\'}), (\\'bilateral disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'bilateral disease\\'}), (\\'relapsed disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'relapsed disease\\'}), (\\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subtype\\', \\'name\\': \\'blastemal-type Wilms tumours\\'}), (\\'radiotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgery_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'chemotherapy\\'}), (\\'Wilms Tumour_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms Tumour\\'}), (\\'CCSK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CCSK\\'}), (\\'MRTK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'MRTK\\'}), (\\'CMN_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CMN\\'}), (\\'RCC_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'RCC\\'}), (\\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u22122001_Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Trial\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'vincristine_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'vincristine\\'}), (\\'actinomycin D_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'actinomycin D\\'}), (\\'doxorubicin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'doxorubicin\\'}), (\\'etoposide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'Stage I_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage I\\'}), (\\'Stage II_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage II\\'}), (\\'Stage III_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage III\\'}), (\\'Stage IV_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage IV\\'}), (\\'Stage V_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage V\\'}), (\\'AV_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AV\\'}), (\\'AVD_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AVD\\'}), (\\'HR-1_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'HR-1\\'}), (\\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP-RTSG 2016\\'}), (\\'Overall Survival (OS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'CT-only nodules_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'CT-only nodules\\'}), (\\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP\u2013RTSG analysis\\'}), (\\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials\\'}), (\\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D plus doxorubicin\\'}), (\\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D\\'}), (\\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study_protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'MRI_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'MRI\\'}), (\\'CT_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'CT\\'}), (\\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_detail\\', \\'name\\': \\'cumulative doxorubicin dose\\'}), (\\'COG AREN0533 trial_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG AREN0533 trial\\'}), (\\'etoposide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'high-risk characteristics\\'}), (\\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG board\\'}), (\\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin\\'}), (\\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'high-dose chemotherapy and autologous stem cell transplantation\\'}), (\\'SIOP database_database\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'database\\', \\'name\\': \\'SIOP database\\'}), (\\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'AVD_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AVD\\'}), (\\'AV-2_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AV-2\\'}), (\\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Statistical Test\\', \\'name\\': \\'Log\u2013Rank P\\'}), (\\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'Bilateral Disease (Stage V)\\'}), (\\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Synchronous bilateral Wilms tumor\\'}), (\\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'End-stage renal disease (ESRD)\\'}), (\\'Aronson et al._Research Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Research Group\\', \\'name\\': \\'Aronson et al.\\'}), (\\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'Bilateral nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Study\\', \\'name\\': \\'SIOP\u22122001 study\\'}), (\\'Vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Vincristine\\'}), (\\'Actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Actinomycin D\\'}), (\\'Etoposide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Etoposide\\'}), (\\'Carboplatin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Carboplatin\\'}), (\\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease State\\', \\'name\\': \\'Relapsed Wilms Tumor\\'}), (\\'Group AA_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group AA\\'}), (\\'Group BB_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group BB\\'}), (\\'Group CC_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group CC\\'}), (\\'Doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Doxorubicin\\'}), (\\'Cyclophosphamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Cyclophosphamide\\'}), (\\'Ifosfamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Ifosfamide\\'}), (\\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'High-dose melphalan\\'}), (\\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UKW\u2011R protocol\\'}), (\\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'NWTS\u20115 relapse protocol\\'}), (\\'ASCR_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'procedure\\', \\'name\\': \\'ASCR\\'}), (\\'ifosfamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'ifosfamide\\'}), (\\'nephrotoxicity_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'nephrotoxicity\\'}), (\\'relapsed group CC_patient_group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'patient_group\\', \\'name\\': \\'relapsed group CC\\'}), (\\'diffuse anaplasia_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'diffuse anaplasia\\'}), (\\'blastemal-type tumors_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'blastemal-type tumors\\'}), (\\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'camptothecins_medication_class\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication_class\\', \\'name\\': \\'camptothecins\\'}), (\\'irinotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'irinotecan\\'}), (\\'topotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'topotecan\\'}), (\\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Innovative Therapies for Children with Cancer consortium\\'}), (\\'radiotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgical excision_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgical excision\\'}), (\\'stage IV WT_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'stage IV WT\\'}), (\\'AVD150_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD150\\'}), (\\'AVD250_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD250\\'}), (\\'low-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'low-risk disease\\'}), (\\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'intermediate-risk disease\\'}), (\\'high-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'high-risk disease\\'}), (\\'CDCV_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'CDCV\\'}), (\\'actinomycin-D_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'actinomycin-D\\'}), (\\'vincristine_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'doxorubicin\\'}), (\\'VP16_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'VP16\\'}), (\\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'contact\\', \\'name\\': \\'arnauld.verschuur@ap-hm.fr\\'}), (\\'surgery_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'chemotherapy\\'}), (\\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2212RTSG panel\\'}), (\\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Infant Wilms Tumors\\'}), (\\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'nephrectomy\\'}), (\\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'malignant rhabdoid tumors\\'}), (\\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Adult Wilms Tumors\\'}), (\\'anaplasia_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'anaplasia\\'}), (\\'actinomycin D_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'carboplatin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'etoposide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'etoposide\\'}), (\\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'Nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'radical tumor nephrectomy\\'}), (\\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'lymph node sampling\\'}), (\\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'minimally invasive surgery\\'}), (\\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'laparoscopic surgery\\'}), (\\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'radiotherapy\\'}), (\\'Wilms tumours_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'Davila Fajardo et al._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Davila Fajardo et al.\\'}), (\\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'COG\u2013NWTS trials\\'}), (\\'whole-lung irradiation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'whole-lung irradiation\\'}), (\\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'pulmonary radiotherapy\\'}), (\\'proton therapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'proton therapy\\'}), (\\'dosimetric study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'dosimetric study\\'}), (\\'locoregional disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'locoregional disease\\'}), (\\'metastatic disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'metastatic disease\\'}), (\\'low-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'low-risk\\'}), (\\'intermediate-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'intermediate-risk\\'}), (\\'high-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'high-risk\\'}), (\\'stage I_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage I\\'}), (\\'stage II_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage II\\'}), (\\'stage III_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage III\\'}), (\\'major rupture_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'major rupture\\'}), (\\'Austria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Austria\\'}), (\\'Italy_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Italy\\'}), (\\'San Marino_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'San Marino\\'}), (\\'Iceland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Iceland\\'}), (\\'Germany_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Germany\\'}), (\\'Bulgaria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bulgaria\\'}), (\\'Turkey_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Turkey\\'}), (\\'Denmark_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Denmark\\'}), (\\'Poland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Poland\\'}), (\\'Greece_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Greece\\'}), (\\'Andorra_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Andorra\\'}), (\\'Belgium_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belgium\\'}), (\\'Serbia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Serbia\\'}), (\\'Albania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Albania\\'}), (\\'Moldova_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Moldova\\'}), (\\'Lithuania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Lithuania\\'}), (\\'Latvia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Latvia\\'}), (\\'Estonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Estonia\\'}), (\\'Luxembourg_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Luxembourg\\'}), (\\'Montenegro_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Montenegro\\'}), (\\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bosnia and Herzegovina\\'}), (\\'Croatia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Croatia\\'}), (\\'Slovenia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovenia\\'}), (\\'Macedonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Macedonia\\'}), (\\'United Kingdom_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'United Kingdom\\'}), (\\'Ireland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ireland\\'}), (\\'Spain_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Spain\\'}), (\\'Algeria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Algeria\\'}), (\\'Tunisia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Tunisia\\'}), (\\'Malta_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Malta\\'}), (\\'Morocco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Morocco\\'}), (\\'Portugal_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Portugal\\'}), (\\'France_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'France\\'}), (\\'Monaco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Monaco\\'}), (\\'Russia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Russia\\'}), (\\'Finland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Finland\\'}), (\\'Sweden_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Sweden\\'}), (\\'Norway_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Norway\\'}), (\\'Belarus_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belarus\\'}), (\\'Romania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Romania\\'}), (\\'Ukraine_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ukraine\\'}), (\\'Hungary_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Hungary\\'}), (\\'Czech Republic_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Czech Republic\\'}), (\\'Slovakia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovakia\\'}), (\\'Switzerland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Switzerland\\'}), (\\'Liechtenstein_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Liechtenstein\\'}), (\\'Netherlands_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Netherlands\\'}), (\\'University Hospital of Munich_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Munich\\'}), (\\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Tuebingen\\'}), (\\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Azienda Ospedaliera\\'}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Ospedale Pediatrico Bambino Ges\u00f9\\'}), (\\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Fondazione IRCCS Istituto Nazionale dei Tumori\\'}), (\\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Prinses Maxima Centrum\\'}), (\\'Marciniak Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Marciniak Hospital\\'}), (\\'Faculty of Medicine_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Faculty of Medicine\\'}), (\\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'St. Anna Kinderspital/CCRI\\'}), (\\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Armand Trousseau Hospital\\'}), (\\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Universitario Virgin del Rocio\\'}), (\\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Vall d\u2019Hebron\\'}), (\\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Great Ormond Street Hospital\\'}), (\\'University Hospital Homburg_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital Homburg\\'}), (\\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon\\'}), (\\'UMBRELLA protocol_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'ExPO\u2011r\u2011Net\\'}), (\\'Weirich, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Weirich, A.\\'}), (\\'Pritchard-Jones, K._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Pritchard-Jones, K.\\'}), (\\'de Kraker, J._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'de Kraker, J.\\'}), (\\'Graf, N._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Graf, N.\\'}), (\\'Green, D. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Green, D. M.\\'}), (\\'Spreafico, F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Spreafico, F.\\'}), (\\'Bellani, F. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Bellani, F. F.\\'}), (\\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'van den Heuvel-Eibrink, M. M.\\'}), (\"D\\'Angio, G. J._author\", {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \"D\\'Angio, G. J.\"}), (\\'Tournade, M. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Tournade, M. F.\\'}), (\\'Breslow, N. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Breslow, N. E.\\'}), (\\'Mitchell, C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Mitchell, C.\\'}), (\\'Verschuur, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Verschuur, A.\\'}), (\\'Grundy, P. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Grundy, P. E.\\'}), (\\'Warmann, S. W._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Warmann, S. W.\\'}), (\\'Smets, A. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Smets, A. M.\\'}), (\\'Dome, J. S._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dome, J. S.\\'}), (\\'Dix, D. B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dix, D. B.\\'}), (\\'Daw, N. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Daw, N. C.\\'}), (\\'Ha, T. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Ha, T. C.\\'}), (\\'Kremens, B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Kremens, B.\\'}), (\\'Furtwangler, R._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Furtwangler, R.\\'}), (\\'SIOP-9/GPOH_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP-9/GPOH\\'}), (\\'UKW3_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'UKW3\\'}), (\\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'SIOP 93\u201301 trial\\'}), (\\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP trial and study 93\u201301\\'}), (\\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'National Wilms Tumor Study Group\\'}), (\\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP WT 2001 protocol\\'}), (\\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Third National Wilms\u2019 Tumor Study\\'}), (\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'National Wilms Tumor Studies\\'}), (\\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Second National Wilms\u2019 Tumor Study\\'}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'UK Children\u2019s Cancer Study Group\\'}), (\\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Children\u2019s Oncology Group\\'})], \\'edges\\': [(\\'sample.pdf\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'non-Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'childhood renal tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'renal cell carcinoma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'localized disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'metastatic disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'bilateral disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'relapsed disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'radiotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'surgery_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'chemotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'Wilms Tumour_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CCSK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'MRTK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CMN_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'RCC_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP\u22122001_Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'vincristine_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'actinomycin D_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'doxorubicin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'etoposide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'carboplatin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'cyclophosphamide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage I_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage II_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage III_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage IV_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage V_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AV_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AVD_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'HR-1_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Overall Survival (OS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT-only nodules_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'MRI_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG AREN0533 trial_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'etoposide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'carboplatin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'cyclophosphamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP database_database\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AVD_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AV-2_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Aronson et al._Research Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Etoposide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Carboplatin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group AA_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group BB_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group CC_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Cyclophosphamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Ifosfamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'ASCR_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'ifosfamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'nephrotoxicity_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'relapsed group CC_patient_group\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'diffuse anaplasia_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'blastemal-type tumors_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'camptothecins_medication_class\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'irinotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'topotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'radiotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'surgical excision_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'stage IV WT_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD150_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD250_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'low-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'CDCV_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'actinomycin-D_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'vincristine_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'doxorubicin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'VP16_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'surgery_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'chemotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'anaplasia_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'actinomycin D_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'vincristine_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'doxorubicin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'carboplatin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'cyclophosphamide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'etoposide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'SIOP\u22122001_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Wilms tumours_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Davila Fajardo et al._author\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'whole-lung irradiation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'proton therapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'dosimetric study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'locoregional disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'metastatic disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'low-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'intermediate-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'high-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage I_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage II_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage III_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'major rupture_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Austria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Italy_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'San Marino_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Iceland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Germany_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bulgaria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Turkey_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Denmark_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Poland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Greece_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Andorra_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belgium_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Serbia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Albania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Moldova_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Lithuania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Latvia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Estonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Luxembourg_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Montenegro_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Croatia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovenia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Macedonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'United Kingdom_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ireland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Spain_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Algeria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Tunisia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Malta_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Morocco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Portugal_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'France_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Monaco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Russia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Finland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Sweden_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Norway_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belarus_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Romania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ukraine_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hungary_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Czech Republic_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovakia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Switzerland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Liechtenstein_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Netherlands_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Munich_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Marciniak Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Faculty of Medicine_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital Homburg_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Weirich, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Pritchard-Jones, K._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'de Kraker, J._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Graf, N._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Green, D. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Spreafico, F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Bellani, F. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \"D\\'Angio, G. J._author\", {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Tournade, M. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Breslow, N. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Mitchell, C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Verschuur, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Grundy, P. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Warmann, S. W._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Smets, A. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dome, J. S._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dix, D. B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Daw, N. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ha, T. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Kremens, B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Furtwangler, R._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP-9/GPOH_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UKW3_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10})]}, {\\'nodes\\': [(\\'vincristine_entity\\', {}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {}), (\\'www.siop-rtsg.eu_entity\\', {}), (\\'stage II_entity\\', {}), (\\'Wilms tumours_entity\\', {}), (\\'Relapsed Wilms Tumor_entity\\', {}), (\\'Davila Fajardo et al._entity\\', {}), (\\'vincristine, actinomycin D, and doxorubicin_entity\\', {}), (\\'SIOP\u22122001 randomized trial_entity\\', {}), (\\'surgery_entity\\', {}), (\\'non-Wilms tumours_entity\\', {}), (\\'actinomycin D_entity\\', {}), (\\'diffuse anaplasia_entity\\', {}), (\\'Synchronous bilateral Wilms tumor_entity\\', {}), (\\'CT-only nodules_entity\\', {}), (\\'relapsed group CC_entity\\', {}), (\\'increased relapse risk_entity\\', {}), (\\'reduced survival_entity\\', {}), (\\'UKW3 trial_entity\\', {}), (\\'chemotherapy_entity\\', {}), (\\'Bilateral Disease (Stage V)_entity\\', {}), (\\'blastemal-type tumors_entity\\', {}), (\\'UMBRELLA protocol_entity\\', {}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', {}), (\\'minimally invasive surgery_entity\\', {}), (\\'VP16_entity\\', {}), (\\'Wilms tumor_entity\\', {}), (\\'anaplasia_entity\\', {}), (\\'radical tumor nephrectomy_entity\\', {}), (\\'Innovative Therapies for Children with Cancer consortium_entity\\', {}), (\\'cumulative doxorubicin dose_entity\\', {}), (\\'etoposide_entity\\', {}), (\\'large-volume tumours_entity\\', {}), (\\'Stage IV_entity\\', {}), (\\'CDCV_entity\\', {}), (\\'SIOP\u2013RTSG_entity\\', {}), (\\'AVD150_entity\\', {}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', {}), (\\'laparoscopic surgery_entity\\', {}), (\\'SIOP\u2212RTSG panel_entity\\', {}), (\\'actinomycin-D_entity\\', {}), (\\'COG AREN0533 trial_entity\\', {}), (\\'cyclophosphamide_entity\\', {}), (\\'carboplatin_entity\\', {}), (\\'UKW\u2011R protocol_entity\\', {}), (\\'Nephron-sparing surgery (NSS)_entity\\', {}), (\\'Adult Wilms Tumors_entity\\', {}), (\\'doxorubicin_entity\\', {}), (\\'NWTS\u20115 relapse protocol_entity\\', {}), (\\'End-stage renal disease (ESRD)_entity\\', {}), (\\'AVD250_entity\\', {}), (\\'Children\u2019s Oncology Group (COG)_entity\\', {}), (\\'blastemal-type Wilms tumour_entity\\', {}), (\\'SIOP\u22122001_entity\\', {}), (\\'radiotherapy_entity\\', {}), (\\'childhood renal tumours_entity\\', {})], \\'edges\\': [(\\'vincristine_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'stage II_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'indicated_for_in_adults\\'}), (\\'Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'Wilms tumours_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated under\\'}), (\\'Relapsed Wilms Tumor_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guided_by\\'}), (\\'Davila Fajardo et al._entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed\\'}), (\\'SIOP\u22122001 randomized trial_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated use in\\'}), (\\'surgery_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'non-Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'actinomycin D_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Synchronous bilateral Wilms tumor_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'instance_of\\'}), (\\'CT-only nodules_entity\\', \\'increased relapse risk_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'reduced survival_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included_in\\'}), (\\'relapsed group CC_entity\\', \\'diffuse anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'blastemal-type tumors_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UKW3 trial_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'UKW3 trial_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'chemotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UMBRELLA protocol_entity\\', \\'COG AREN0533 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses_data_from\\'}), (\\'UMBRELLA protocol_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'advises_treatment_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'Innovative Therapies for Children with Cancer consortium_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborates_with\\'}), (\\'UMBRELLA protocol_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'surgery_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is the standard of\\'}), (\\'UMBRELLA protocol_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guides treatment in\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', \\'UKW3 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\\'minimally invasive surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'anaplasia_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'radical tumor nephrectomy_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'standard_of_care_for\\'}), (\\'Stage IV_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'presents in\\'}), (\\'CDCV_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'VP16_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'aims to improve survival rates of\\'}), (\\'AVD150_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed_by\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'succeeds\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'www.siop-rtsg.eu_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'available_on\\'}), (\\'laparoscopic surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'COG AREN0533 trial_entity\\', \\'cumulative doxorubicin dose_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'evaluates\\'}), (\\'UKW\u2011R protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'Nephron-sparing surgery (NSS)_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'classification_developed_by\\'}), (\\'Adult Wilms Tumors_entity\\', \\'anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'Adult Wilms Tumors_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'doxorubicin_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'doxorubicin_entity\\', \\'large-volume tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'recommended for\\'}), (\\'NWTS\u20115 relapse protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'End-stage renal disease (ESRD)_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'AVD250_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'Children\u2019s Oncology Group (COG)_entity\\', \\'SIOP\u22122001 randomized trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborated with\\'}), (\\'blastemal-type Wilms tumour_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment intensified according to\\'}), (\\'SIOP\u22122001_entity\\', \\'vincristine, actinomycin D, and doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses\\'}), (\\'SIOP\u22122001_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provided_guidelines_for\\'}), (\\'radiotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'radiotherapy_entity\\', \\'SIOP\u2212RTSG panel_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'contact_for_guidance\\'})]}, {\\'nodes\\': [(\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {}), (\\'Marry M. van den Heuvel-Eibrink_entity\\', {})], \\'edges\\': [(\\'Marry M. van den Heuvel-Eibrink_entity\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'affiliated_with\\'})]}, {\\'nodes\\': [(\\'Stage II_entity\\', {}), (\\'AV_entity\\', {}), (\\'Stage III_entity\\', {}), (\\'vincestine and actinomycin D_entity\\', {}), (\\'AVD_entity\\', {})], \\'edges\\': [(\\'Stage II_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AV_entity\\', \\'Stage II_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Stage III_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AVD_entity\\', \\'Stage III_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'SIOP-RTSG 2016_entity\\', {}), (\\'RCC_entity\\', {}), (\\'CMN_entity\\', {})], \\'edges\\': [(\\'RCC_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'}), (\\'CMN_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'})]}, {\\'nodes\\': [(\\'HR-1_entity\\', {}), (\\'High-risk blastemal type Wilms tumour_entity\\', {})], \\'edges\\': [(\\'HR-1_entity\\', \\'High-risk blastemal type Wilms tumour_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'unfavorable prognosis_entity\\', {}), (\\'high-risk characteristics_entity\\', {})], \\'edges\\': [(\\'high-risk characteristics_entity\\', \\'unfavorable prognosis_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'leads_to\\'})]}, {\\'nodes\\': [(\\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {}), (\\'SIOP\u2013RTSG board_entity\\', {})], \\'edges\\': [(\\'SIOP\u2013RTSG board_entity\\', \\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggests\\'})]}, {\\'nodes\\': [(\\'regimen and outcomes_entity\\', {}), (\\'SIOP database_entity\\', {})], \\'edges\\': [(\\'SIOP database_entity\\', \\'regimen and outcomes_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'captures_data_on\\'})]}, {\\'nodes\\': [(\\'Bilateral nephron-sparing surgery (NSS)_entity\\', {}), (\\'Aronson et al._entity\\', {})], \\'edges\\': [(\\'Aronson et al._entity\\', \\'Bilateral nephron-sparing surgery (NSS)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'observed_effectiveness_of\\'})]}, {\\'nodes\\': [(\\'SIOP\u22122001 study_entity\\', {}), (\\'Actinomycin D_entity\\', {}), (\\'Vincristine_entity\\', {})], \\'edges\\': [(\\'SIOP\u22122001 study_entity\\', \\'Vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'}), (\\'SIOP\u22122001 study_entity\\', \\'Actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'})]}, {\\'nodes\\': [(\\'High-dose melphalan_entity\\', {}), (\\'Group AA_entity\\', {}), (\\'Carboplatin_entity\\', {}), (\\'Doxorubicin_entity\\', {}), (\\'Etoposide_entity\\', {}), (\\'Group BB_entity\\', {}), (\\'Cyclophosphamide_entity\\', {}), (\\'Ifosfamide_entity\\', {})], \\'edges\\': [(\\'Group AA_entity\\', \\'Doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Ifosfamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'High-dose melphalan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'})]}, {\\'nodes\\': [(\\'nephrotoxicity_entity\\', {}), (\\'ifosfamide_entity\\', {})], \\'edges\\': [(\\'ifosfamide_entity\\', \\'nephrotoxicity_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'related_to\\'})]}, {\\'nodes\\': [(\\'camptothecins_entity\\', {}), (\\'irinotecan_entity\\', {}), (\\'topotecan_entity\\', {})], \\'edges\\': [(\\'camptothecins_entity\\', \\'irinotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'camptothecins_entity\\', \\'topotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'})]}, {\\'nodes\\': [(\\'Infant Wilms Tumors_entity\\', {}), (\\'nephrectomy_entity\\', {})], \\'edges\\': [(\\'Infant Wilms Tumors_entity\\', \\'nephrectomy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_option\\'})]}, {\\'nodes\\': [(\\'congenital mesoblastic nephroma_entity\\', {}), (\\'surgery alone_entity\\', {})], \\'edges\\': [(\\'congenital mesoblastic nephroma_entity\\', \\'surgery alone_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'alternative chemotherapy_entity\\', {}), (\\'malignant rhabdoid tumors_entity\\', {})], \\'edges\\': [(\\'malignant rhabdoid tumors_entity\\', \\'alternative chemotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'lymph node sampling_entity\\', {}), (\\'accurate staging_entity\\', {})], \\'edges\\': [(\\'lymph node sampling_entity\\', \\'accurate staging_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'purpose_of\\'})]}, {\\'nodes\\': [(\\'COG\u2013NWTS trials_entity\\', {}), (\\'whole-lung irradiation_entity\\', {})], \\'edges\\': [(\\'COG\u2013NWTS trials_entity\\', \\'whole-lung irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'informed_dosage_for\\'})]}, {\\'nodes\\': [(\\'lung metastases_entity\\', {}), (\\'pulmonary radiotherapy_entity\\', {})], \\'edges\\': [(\\'pulmonary radiotherapy_entity\\', \\'lung metastases_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'administered_for\\'})]}, {\\'nodes\\': [(\\'dosimetric study_entity\\', {}), (\\'proton therapy_entity\\', {}), (\\'flank irradiation_entity\\', {})], \\'edges\\': [(\\'dosimetric study_entity\\', \\'proton therapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated\\'}), (\\'proton therapy_entity\\', \\'flank irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggested_for\\'})]}, {\\'nodes\\': [(\\'metastatic disease_entity\\', {}), (\\'radiotherapy guidelines_entity\\', {}), (\\'locoregional disease_entity\\', {})], \\'edges\\': [(\\'radiotherapy guidelines_entity\\', \\'locoregional disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'}), (\\'radiotherapy guidelines_entity\\', \\'metastatic disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'})]}, {\\'nodes\\': [(\\'major rupture_entity\\', {}), (\\'stage III_entity\\', {})], \\'edges\\': [(\\'stage III_entity\\', \\'major rupture_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes_condition\\'})]}, {\\'nodes\\': [(\\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {}), (\\'ExPO\u2011r\u2011Net_entity\\', {})], \\'edges\\': [(\\'ExPO\u2011r\u2011Net_entity\\', \\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is part of\\'})]}, {\\'nodes\\': [(\\'University Hospital of Munich_entity\\', {}), (\\'Germany_entity\\', {}), (\\'University Hospital of Tuebingen_entity\\', {})], \\'edges\\': [(\\'Germany_entity\\', \\'University Hospital of Munich_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Germany_entity\\', \\'University Hospital of Tuebingen_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {}), (\\'Italy_entity\\', {}), (\\'Azienda Ospedaliera_entity\\', {}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {})], \\'edges\\': [(\\'Italy_entity\\', \\'Azienda Ospedaliera_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Netherlands_entity\\', {}), (\\'Prinses Maxima Centrum_entity\\', {})], \\'edges\\': [(\\'Netherlands_entity\\', \\'Prinses Maxima Centrum_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Marciniak Hospital_entity\\', {}), (\\'Poland_entity\\', {}), (\\'Faculty of Medicine_entity\\', {})], \\'edges\\': [(\\'Poland_entity\\', \\'Marciniak Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Poland_entity\\', \\'Faculty of Medicine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'St. Anna Kinderspital/CCRI_entity\\', {}), (\\'Austria_entity\\', {})], \\'edges\\': [(\\'Austria_entity\\', \\'St. Anna Kinderspital/CCRI_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'France_entity\\', {}), (\\'Armand Trousseau Hospital_entity\\', {})], \\'edges\\': [(\\'France_entity\\', \\'Armand Trousseau Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Spain_entity\\', {}), (\\'Hospital Vall d\u2019Hebron_entity\\', {}), (\\'Hospital Universitario Virgin del Rocio_entity\\', {})], \\'edges\\': [(\\'Spain_entity\\', \\'Hospital Universitario Virgin del Rocio_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Spain_entity\\', \\'Hospital Vall d\u2019Hebron_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'United Kingdom_entity\\', {}), (\\'Great Ormond Street Hospital_entity\\', {})], \\'edges\\': [(\\'United Kingdom_entity\\', \\'Great Ormond Street Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Weirich, A._entity\\', {}), (\\'SIOP-9/GPOH_entity\\', {})], \\'edges\\': [(\\'Weirich, A._entity\\', \\'SIOP-9/GPOH_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Pritchard-Jones, K._entity\\', {}), (\\'UKW3_entity\\', {})], \\'edges\\': [(\\'Pritchard-Jones, K._entity\\', \\'UKW3_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed in\\'})]}, {\\'nodes\\': [(\\'SIOP 93\u201301 trial_entity\\', {}), (\\'de Kraker, J._entity\\', {})], \\'edges\\': [(\\'de Kraker, J._entity\\', \\'SIOP 93\u201301 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'SIOP trial and study 93\u201301_entity\\', {}), (\\'Graf, N._entity\\', {})], \\'edges\\': [(\\'Graf, N._entity\\', \\'SIOP trial and study 93\u201301_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Green, D. M._entity\\', {}), (\\'National Wilms Tumor Study Group_entity\\', {})], \\'edges\\': [(\\'Green, D. M._entity\\', \\'National Wilms Tumor Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}, {\\'nodes\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', {}), (\\'SIOP WT 2001 protocol_entity\\', {})], \\'edges\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', \\'SIOP WT 2001 protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Third National Wilms\u2019 Tumor Study_entity\\', {}), (\"D\\'Angio, G. J._entity\", {}), (\\'Second National Wilms\u2019 Tumor Study_entity\\', {})], \\'edges\\': [(\"D\\'Angio, G. J._entity\", \\'Third National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\"D\\'Angio, G. J._entity\", \\'Second National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {}), (\\'Tournade, M. F._entity\\', {}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {})], \\'edges\\': [(\\'Tournade, M. F._entity\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'}), (\\'Tournade, M. F._entity\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Breslow, N. E._entity\\', {}), (\\'National Wilms Tumor Studies_entity\\', {})], \\'edges\\': [(\\'Breslow, N. E._entity\\', \\'National Wilms Tumor Studies_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Mitchell, C._entity\\', {}), (\\'UK Children\u2019s Cancer Study Group_entity\\', {})], \\'edges\\': [(\\'Mitchell, C._entity\\', \\'UK Children\u2019s Cancer Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'under\\'})]}, {\\'nodes\\': [(\\'Daw, N. C._entity\\', {}), (\\'Dix, D. B._entity\\', {}), (\\'Children\u2019s Oncology Group_entity\\', {}), (\\'Grundy, P. E._entity\\', {})], \\'edges\\': [(\\'Daw, N. C._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted under\\'}), (\\'Dix, D. B._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'}), (\\'Grundy, P. E._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}]']), TestResult(name='test_case_19', success=False, metrics_data=[MetricData(name='Answer Correctness (GEval)', threshold=0.5, success=False, score=0.03266232729201157, reason='The actual output does not align with the expected output as it contains unrelated information and lacks the summary on standardization leading to improved patient data and research opportunities.', strict_mode=False, evaluation_model='gpt-4o-mini', error=None, evaluation_cost=0.0033012, verbose_logs='Criteria:\\nNone \\n \\nEvaluation Steps:\\n[\\n    \"Determine whether the actual output is factually correct based on the expected output.\"\\n]'), MetricData(name='Faithfulness', threshold=0.7, success=False, score=0.5714285714285714, reason=None, strict_mode=False, evaluation_model='gpt-4o-mini', error=None, evaluation_cost=0.00999525, verbose_logs='Truths (limit=None):\\n[\\n    \"The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG) is an organization.\",\\n    \"The UMBRELLA SIOP-RTSG 2016 is a protocol.\",\\n    \"The SIOP\u22122001 is a protocol.\",\\n    \"Wilms tumours are a type of childhood renal tumour.\",\\n    \"Non-Wilms tumours are a category of childhood renal tumours.\",\\n    \"The website www.siop-rtsg.eu is associated with the SIOP\u2013RTSG.\",\\n    \"The Department of Paediatric Oncology is part of the Princess M\u00e1xima Center for Paediatric Oncology.\",\\n    \"Marry M. van den Heuvel-Eibrink is a person affiliated with the study.\",\\n    \"Childhood renal tumours are a category of paediatric cancer.\",\\n    \"Clear cell sarcoma of the kidney is a type of childhood renal tumour.\",\\n    \"Renal cell carcinoma is a type of kidney cancer.\",\\n    \"Malignant rhabdoid tumour of the kidney is a type of childhood renal tumour.\",\\n    \"Congenital mesoblastic nephroma is a type of kidney tumour.\",\\n    \"Wilms tumours can be classified as a condition in paediatric oncology.\",\\n    \"The UMBRELLA protocol is a treatment protocol.\",\\n    \"SIOP\u2013RTSG is an organization related to paediatric oncology.\",\\n    \"The Children\u2019s Oncology Group (COG) is another organization involved in paediatric cancer research.\",\\n    \"The SIOP\u22122001 randomized trial is a clinical trial.\",\\n    \"Actinomycin D is a chemotherapy drug used in treating Wilms tumours and other cancers.\",\\n    \"Vincristine is a chemotherapy drug used in treating Wilms tumours and other cancers.\",\\n    \"Doxorubicin is a chemotherapy drug frequently used in treatment protocols.\",\\n    \"The UKW3 trial is a clinical trial related to paediatric oncology.\",\\n    \"The UK Children\u2019s Cancer and Leukaemia Group (UKCCLG) is an organization involved in cancer treatment and research.\",\\n    \"Localized disease, metastatic disease, bilateral disease, and relapsed disease are stages or conditions of Wilms tumours.\",\\n    \"Blastemal-type Wilms tumours are a subtype of Wilms tumours.\",\\n    \"Radiotherapy, surgery, and chemotherapy are treatment methods for Wilms tumours.\",\\n    \"Stage I, Stage II, Stage III, Stage IV, and Stage V are stages of Wilms tumours.\",\\n    \"The AVD and AV treatment combinations refer to specific chemotherapy regimens.\",\\n    \"The Overall Survival (OS) has metrics in clinical trials.\",\\n    \"Event-Free Survival (EFS) is another metric used in evaluating treatment effectiveness.\",\\n    \"CT-only nodules are a medical condition related to cancer diagnosis.\",\\n    \"The UMBRELLA protocol is a treatment approach in paediatric oncology.\",\\n    \"SIOP\u2013RTSG analysis refers to a study related to paediatric oncology and treatments.\",\\n    \"The COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials are significant studies in addressing Wilms tumours.\",\\n    \"Vincristine and actinomycin D plus doxorubicin are among the treatments used for Wilms tumours.\",\\n    \"Vincristine and actinomycin D are also treatments used for Wilms tumours.\",\\n    \"The SIOP\u22122001 study refers to a specific study protocol.\",\\n    \"MRI and CT are diagnostic tools used in assessing renal tumours.\",\\n    \"The cumulative doxorubicin dose is a treatment detail in oncology protocols.\",\\n    \"The COG AREN0533 trial is a study focusing on paediatric oncology treatments and outcomes.\",\\n    \"Etoposide, carboplatin, cyclophosphamide are medications used in treating various cancers.\",\\n    \"High-risk characteristics are medical conditions that can affect prognosis.\",\\n    \"SIOP\u2212RTSG board refers to a governing body in paediatric oncology.\",\\n    \"High-dose chemotherapy and autologous stem cell transplantation are a type of treatment method used for certain conditions.\",\\n    \"The SIOP database captures data related to treatment regimens and outcomes.\",\\n    \"The treatment group categorizations include Group AA, Group BB, and Group CC.\",\\n    \"Bilateral nephron-sparing surgery (NSS) is a surgical technique used in treating Wilms tumours.\",\\n    \"The SIOP\u22122001 study highlights the drugs Vincristine and Actinomycin D as part of treatment regimens.\",\\n    \"High-dose melphalan is a treatment method used in certain conditions.\",\\n    \"Ifosfamide is a chemotherapy drug associated with nephrotoxicity issues.\",\\n    \"Camptothecins include medications such as irinotecan and topotecan.\",\\n    \"Infant Wilms Tumours may require nephrectomy as a treatment option.\",\\n    \"Surgery alone may be required for managing congenital mesoblastic nephroma.\",\\n    \"Malignant rhabdoid tumors may necessitate alternative chemotherapy treatments.\",\\n    \"Lymph node sampling is performed for accurate staging in cancer treatment.\",\\n    \"Whole-lung irradiation has been informed by the COG\u2013NWTS trials.\",\\n    \"Pulmonary radiotherapy may be administered for lung metastases in cancers.\",\\n    \"Proton therapy has been investigated in studies including dosimetric studies.\",\\n    \"Radiotherapy guidelines are specified for metastatic and locoregional diseases.\",\\n    \"Major rupture is a condition associated with stage III tumours.\"\\n] \\n \\nClaims:\\n[\\n    \"The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG) is an organization.\",\\n    \"UMBRELLA SIOP-RTSG 2016 is a protocol.\",\\n    \"SIOP\u22122001 is a protocol.\",\\n    \"Wilms tumours are a type of disease.\",\\n    \"Non-Wilms tumours are a type of disease.\",\\n    \"The website for SIOP-RTSG is www.siop-rtsg.eu.\",\\n    \"The Department of Paediatric Oncology is part of the Princess M\u00e1xima Center for Paediatric Oncology.\",\\n    \"Marry M. van den Heuvel-Eibrink is a person associated with SIOP\u2013RTSG.\",\\n    \"Childhood renal tumours is a type of disease.\",\\n    \"Clear cell sarcoma of the kidney is a type of disease.\",\\n    \"Renal cell carcinoma is a type of disease.\",\\n    \"Malignant rhabdoid tumour of the kidney is a type of disease.\",\\n    \"Congenital mesoblastic nephroma is a type of disease.\",\\n    \"Wilms tumours is a condition.\",\\n    \"The UMBRELLA protocol is a treatment protocol.\",\\n    \"SIOP\u2013RTSG is an organization.\",\\n    \"Children\u2019s Oncology Group (COG) is an organization.\",\\n    \"SIOP\u22122001 randomized trial is a clinical trial.\",\\n    \"Actinomycin D is a drug.\",\\n    \"Vincristine is a drug.\",\\n    \"Doxorubicin is a drug.\",\\n    \"UKW3 trial is a clinical trial.\",\\n    \"UK Children\u2019s Cancer and Leukaemia Group (UKCCLG) is an organization.\",\\n    \"Localized disease is a disease stage.\",\\n    \"Metastatic disease is a disease stage.\",\\n    \"Bilateral disease is a disease stage.\",\\n    \"Relapsed disease is a disease stage.\",\\n    \"Blastemal-type Wilms tumours is a subtype.\",\\n    \"Radiotherapy is a treatment method.\",\\n    \"Surgery is a treatment method.\",\\n    \"Chemotherapy is a treatment method.\",\\n    \"Wilms Tumour is a disease.\",\\n    \"CCSK is a disease.\",\\n    \"MRTK is a disease.\",\\n    \"CMN is a disease.\",\\n    \"RCC is a disease.\",\\n    \"The SIOP\u22122001 trial is a study.\",\\n    \"Vincristine is used as a treatment.\",\\n    \"Actinomycin D is used as a treatment.\",\\n    \"Doxorubicin is used as a treatment.\",\\n    \"Etoposide is used as a treatment.\",\\n    \"Carboplatin is used as a treatment.\",\\n    \"Cyclophosphamide is used as a treatment.\",\\n    \"Stage I is a stage designation.\",\\n    \"Stage II is a stage designation.\",\\n    \"Stage III is a stage designation.\",\\n    \"Stage IV is a stage designation.\",\\n    \"Stage V is a stage designation.\",\\n    \"AV is a treatment combination.\",\\n    \"AVD is a treatment combination.\",\\n    \"HR-1 is a treatment combination.\",\\n    \"SIOP-RTSG 2016 is a protocol.\",\\n    \"Overall Survival (OS) is a metric.\",\\n    \"Event-Free Survival (EFS) is a metric.\",\\n    \"CT-only nodules is a medical condition.\",\\n    \"SIOP\u2013RTSG analysis is a study.\",\\n    \"COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials is a study.\",\\n    \"Vincristine and actinomycin D plus doxorubicin is a treatment.\",\\n    \"Vincristine and actinomycin D is a treatment.\",\\n    \"MRI is a diagnostic tool.\",\\n    \"CT is a diagnostic tool.\",\\n    \"The cumulative doxorubicin dose is a treatment detail.\",\\n    \"COG AREN0533 trial is a study.\",\\n    \"Etoposide is a medication.\",\\n    \"Carboplatin is a medication.\",\\n    \"Cyclophosphamide is a medication.\",\\n    \"High-risk characteristics is a medical condition.\",\\n    \"SIOP\u2013RTSG board is an organization.\",\\n    \"Vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin is a treatment.\",\\n    \"High-dose chemotherapy and autologous stem cell transplantation is a treatment.\",\\n    \"SIOP database is a database.\",\\n    \"Event-Free Survival (EFS) is a subject of study.\",\\n    \"Overall Survival (OS) is a subject of study.\",\\n    \"AVD is a treatment group.\",\\n    \"AV-2 is a treatment group.\",\\n    \"Log\u2013Rank P is a statistical test.\",\\n    \"Bilateral Disease (Stage V) is a disease stage.\",\\n    \"Synchronous bilateral Wilms tumor is a disease.\",\\n    \"End-stage renal disease (ESRD) is a condition.\",\\n    \"Bilateral nephron-sparing surgery (NSS) is a treatment method.\",\\n    \"SIOP\u22122001 study is a study.\",\\n    \"Vincristine is a drug.\",\\n    \"Actinomycin D is a drug.\",\\n    \"Etoposide is a drug.\",\\n    \"Carboplatin is a drug.\",\\n    \"Relapsed Wilms Tumor is a disease state.\",\\n    \"Group AA is a patient group.\",\\n    \"Group BB is a patient group.\",\\n    \"Group CC is a patient group.\",\\n    \"Doxorubicin is a drug.\",\\n    \"Cyclophosphamide is a drug.\",\\n    \"Ifosfamide is a drug.\",\\n    \"High-dose melphalan is a treatment method.\",\\n    \"UKW\u2011R protocol is a treatment protocol.\",\\n    \"NWTS\u20115 relapse protocol is a treatment protocol.\",\\n    \"ASCR is a procedure.\",\\n    \"Ifosfamide is a medication.\",\\n    \"Nephrotoxicity is a condition.\",\\n    \"Relapsed group CC is a patient group.\",\\n    \"Diffuse anaplasia is a condition.\",\\n    \"Blastemal-type tumors is a condition.\",\\n    \"UMBRELLA protocol is a protocol.\",\\n    \"Camptothecins are a medication class.\",\\n    \"Irinotecan is a medication.\",\\n    \"Topotecan is a medication.\",\\n    \"Innovative Therapies for Children with Cancer consortium is an organization.\",\\n    \"Radiotherapy is a treatment method.\",\\n    \"Surgical excision is a treatment method.\",\\n    \"Stage IV WT is a condition.\",\\n    \"AVD150 is a treatment regimen.\",\\n    \"AVD250 is a treatment regimen.\",\\n    \"Low-risk disease is a condition category.\",\\n    \"Intermediate-risk disease is a condition category.\",\\n    \"High-risk disease is a condition category.\",\\n    \"CDCV is a treatment regimen.\",\\n    \"Actinomycin-D is a medication.\",\\n    \"Vincristine is a medication.\",\\n    \"Doxorubicin is a medication.\",\\n    \"VP16 is a medication.\",\\n    \"The contact for arnauld.verschuur@ap-hm.fr is associated with the SIOP\u2212RTSG.\",\\n    \"Surgery is a treatment method.\",\\n    \"Chemotherapy is a treatment method.\",\\n    \"SIOP\u2212RTSG panel is an organization.\",\\n    \"Infant Wilms Tumors is a medical condition.\",\\n    \"Nephrectomy is a surgical procedure.\",\\n    \"Congenital mesoblastic nephroma is a medical condition.\",\\n    \"Malignant rhabdoid tumors is a medical condition.\",\\n    \"Adult Wilms Tumors is a medical condition.\",\\n    \"Anaplasia is a medical condition.\",\\n    \"Actinomycin D is a drug.\",\\n    \"Vincristine is a drug.\",\\n    \"Doxorubicin is a drug.\",\\n    \"Carboplatin is a drug.\",\\n    \"Cyclophosphamide is a drug.\",\\n    \"Etoposide is a drug.\",\\n    \"Nephron-sparing surgery (NSS) is a surgical procedure.\",\\n    \"SIOP\u2013RTSG is an organization.\",\\n    \"Radical tumor nephrectomy is a surgical procedure.\",\\n    \"Lymph node sampling is a surgical procedure.\",\\n    \"Minimally invasive surgery is a surgery type.\",\\n    \"Laparoscopic surgery is a surgery type.\",\\n    \"Nephron-sparing surgery (NSS) is a surgery type.\",\\n    \"SIOP\u22122001 is a protocol.\",\\n    \"Radiotherapy is a treatment.\",\\n    \"Wilms tumours is a condition.\",\\n    \"Davila Fajardo et al. is an author.\",\\n    \"COG\u2013NWTS trials is a trial.\",\\n    \"Whole-lung irradiation is a treatment.\",\\n    \"Pulmonary radiotherapy is a treatment.\",\\n    \"Proton therapy is a treatment.\",\\n    \"Dosimetric study is a study.\",\\n    \"Locoregional disease is a condition.\",\\n    \"Metastatic disease is a condition.\",\\n    \"Low-risk is a risk category.\",\\n    \"Intermediate-risk is a risk category.\",\\n    \"High-risk is a risk category.\",\\n    \"Stage I is a stage.\",\\n    \"Stage II is a stage.\",\\n    \"Stage III is a stage.\",\\n    \"Major rupture is a condition.\",\\n    \"Austria is a country.\",\\n    \"Italy is a country.\",\\n    \"San Marino is a country.\",\\n    \"Iceland is a country.\",\\n    \"Germany is a country.\",\\n    \"Bulgaria is a country.\",\\n    \"Turkey is a country.\",\\n    \"Denmark is a country.\",\\n    \"Poland is a country.\",\\n    \"Greece is a country.\",\\n    \"Andorra is a country.\",\\n    \"Belgium is a country.\",\\n    \"Serbia is a country.\",\\n    \"Albania is a country.\",\\n    \"Moldova is a country.\",\\n    \"Lithuania is a country.\",\\n    \"Latvia is a country.\",\\n    \"Estonia is a country.\",\\n    \"Luxembourg is a country.\",\\n    \"Montenegro is a country.\",\\n    \"Bosnia and Herzegovina is a country.\",\\n    \"Croatia is a country.\",\\n    \"Slovenia is a country.\",\\n    \"Macedonia is a country.\",\\n    \"United Kingdom is a country.\",\\n    \"Ireland is a country.\",\\n    \"Spain is a country.\",\\n    \"Algeria is a country.\",\\n    \"Tunisia is a country.\",\\n    \"Malta is a country.\",\\n    \"Morocco is a country.\",\\n    \"Portugal is a country.\",\\n    \"France is a country.\",\\n    \"Monaco is a country.\",\\n    \"Russia is a country.\",\\n    \"Finland is a country.\",\\n    \"Sweden is a country.\",\\n    \"Norway is a country.\",\\n    \"Belarus is a country.\",\\n    \"Romania is a country.\",\\n    \"Ukraine is a country.\",\\n    \"Hungary is a country.\",\\n    \"Czech Republic is a country.\",\\n    \"Slovakia is a country.\",\\n    \"Switzerland is a country.\",\\n    \"Liechtenstein is a country.\",\\n    \"Netherlands is a country.\",\\n    \"University Hospital of Munich is an institution.\",\\n    \"University Hospital of Tuebingen is an institution.\",\\n    \"Azienda Ospedaliera is an institution.\",\\n    \"Ospedale Pediatrico Bambino Ges\u00f9 is an institution.\",\\n    \"Fondazione IRCCS Istituto Nazionale dei Tumori is an institution.\",\\n    \"Prinses Maxima Centrum is an institution.\",\\n    \"Marciniak Hospital is an institution.\",\\n    \"Faculty of Medicine is an institution.\",\\n    \"St. Anna Kinderspital/CCRI is an institution.\",\\n    \"Armand Trousseau Hospital is an institution.\",\\n    \"Hospital Universitario Virgin del Rocio is an institution.\",\\n    \"Hospital Vall d\u2019Hebron is an institution.\",\\n    \"Great Ormond Street Hospital is an institution.\",\\n    \"University Hospital Homburg is an institution.\",\\n    \"L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon is an institution.\",\\n    \"UMBRELLA protocol is a project.\",\\n    \"ExPO\u2011r\u2011Net is a project.\",\\n    \"Weirich, A. is an author.\",\\n    \"Pritchard-Jones, K. is an author.\",\\n    \"de Kraker, J. is an author.\",\\n    \"Graf, N. is an author.\",\\n    \"Green, D. M. is an author.\",\\n    \"Spreafico, F. is an author.\",\\n    \"Bellani, F. F. is an author.\",\\n    \"van den Heuvel-Eibrink, M. M. is an author.\",\\n    \"D\\'Angio, G. J. is an author.\",\\n    \"Tournade, M. F. is an author.\",\\n    \"Breslow, N. E. is an author.\",\\n    \"Mitchell, C. is an author.\",\\n    \"Verschuur, A. is an author.\",\\n    \"Grundy, P. E. is an author.\",\\n    \"Warmann, S. W. is an author.\",\\n    \"Smets, A. M. is an author.\",\\n    \"Dome, J. S. is an author.\",\\n    \"Dix, D. B. is an author.\",\\n    \"Daw, N. C. is an author.\",\\n    \"Ha, T. C. is an author.\",\\n    \"Kremens, B. is an author.\",\\n    \"Furtwangler, R. is an author.\",\\n    \"SIOP-9/GPOH is a study.\",\\n    \"UKW3 is a trial.\",\\n    \"SIOP 93\u201301 trial is a trial.\",\\n    \"SIOP trial and study 93\u201301 is a study.\",\\n    \"National Wilms Tumor Study Group is an organization.\",\\n    \"SIOP WT 2001 protocol is a protocol.\",\\n    \"Third National Wilms\u2019 Tumor Study is a study.\",\\n    \"Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study is a study.\",\\n    \"National Wilms Tumor Studies is a study.\",\\n    \"Second National Wilms\u2019 Tumor Study is a study.\",\\n    \"Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study is a study.\",\\n    \"UK Children\u2019s Cancer Study Group is an organization.\",\\n    \"Children\u2019s Oncology Group is an organization.\"\\n] \\n \\nVerdicts:\\n[\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"Wilms tumours are specifically childhood renal tumours, not just a type of disease.\"\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"Non-Wilms tumours are categorized as childhood renal tumours, not a type of disease.\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"Marry M. van den Heuvel-Eibrink is affiliated with the SIOP\\\\u2013RTSG, not merely associated.\"\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"Childhood renal tumours refer to a category of tumours, not simply a type of disease.\"\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"Clear cell sarcoma of the kidney is a type of childhood renal tumour.\"\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"Renal cell carcinoma is a type of kidney cancer, not explicitly categorized as a disease.\"\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"Malignant rhabdoid tumour of the kidney is classified as a type of childhood renal tumour.\"\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"Congenital mesoblastic nephroma is categorized as a type of kidney tumour, not just a disease.\"\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"Wilms tumours are classified as a condition in paediatric oncology, not just a disease.\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"While AV and AVD refer to chemotherapy regimens, they do not wholly categorize treatment as such.\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"High-risk characteristics are not specifically a medical condition, but rather signs or features relevant to diagnosis.\"\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"The SIOP\\\\u2013RTSG board is an organization, not a simple reference to a group.\"\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"The SIOP database captures data related to treatment regimens and outcomes, not simply a general database.\"\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"Event-Free Survival (EFS) and Overall Survival (OS) are metrics, not subjects of study in isolation.\"\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"AVD and AV treatment combinations specifically refer to chemotherapy regimens.\"\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"Bilateral Disease (Stage V) specifically refers to a stage of Wilms tumours, not just a type of disease.\"\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"Synchronous bilateral Wilms tumor refers to a specific condition, not a general disease classification.\"\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"Adult Wilms Tumors refers to cancers typically seen in children, specifically within context.\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    }\\n]'), MetricData(name='Contextual Relevancy', threshold=1.0, success=False, score=0.6, reason=\"The score is 0.60 because while there are relevant statements indicating the purpose of standardizing treatment for renal tumours in children, such as 'The Renal Tumour Study Group... aims to improve treatment for renal tumours' and the importance of reducing treatment variability for better outcomes, many statements are centered around adult renal tumours or general impacts of guidelines that do not specifically address the pediatric focus of the question.\", strict_mode=False, evaluation_model='gpt-4o-mini', error=None, evaluation_cost=0.0037682999999999996, verbose_logs='Verdicts:\\n[\\n    {\\n        \"verdicts\": [\\n            {\\n                \"statement\": \"The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\\\\u2013RTSG) aims to improve treatment for renal tumours.\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"All clinical guidelines and protocols such as UMBRELLA and SIOP-2001 are designed to ensure standardized treatment for renal tumors.\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"The protocols like SIOP\\\\u2013RTSG develop standard treatment that improves survival rates for children with renal tumours.\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"The SIOP\\\\u2013RTSG encourages the adoption of comparative effectiveness and protocols across institutions.\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"Wilms tumours and other childhood renal tumours have standardised treatment methods.\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"Different treatment protocols, including chemotherapy, are used for adult renal tumours.\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"The statement discusses \\'adult renal tumours\\' which is not relevant to the question about childhood renal tumours.\"\\n            },\\n            {\\n                \"statement\": \"SIOP\\\\u2013RTSG involves various clinical trials which may focus on improving treatment for different types of cancers.\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"The involvement with various cancers does not specifically address the standardization of treatment for renal tumours.\"\\n            },\\n            {\\n                \"statement\": \"Reducing treatment variability can lead to improved outcomes.\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"SIOP\\\\u2013RTSG\\'s contribution to childhood cancer research has been significant overall.\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"The statement is very general and does not specifically address the benefit of standardizing treatment for renal tumours.\"\\n            },\\n            {\\n                \"statement\": \"The organization publishes guidelines regardless of their impact on specific treatment protocols.\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"The impact of published guidelines needs to be focused on their relevance to renal tumours specifically.\"\\n            }\\n        ]\\n    }\\n]')], conversational=False, multimodal=False, input='What is the intended benefit of standardizing treatment for renal tumours?', actual_output='[{\\'nodes\\': [(\\'sample.pdf\\', {\\'type\\': \\'document\\'}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)\\'}), (\\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA SIOP-RTSG 2016\\'}), (\\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms tumours\\'}), (\\'non-Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'non-Wilms tumours\\'}), (\\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Website\\', \\'name\\': \\'www.siop-rtsg.eu\\'}), (\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology\\'}), (\\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Person\\', \\'name\\': \\'Marry M. van den Heuvel-Eibrink\\'}), (\\'childhood renal tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'childhood renal tumours\\'}), (\\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'clear cell sarcoma of the kidney\\'}), (\\'renal cell carcinoma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'renal cell carcinoma\\'}), (\\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'malignant rhabdoid tumour of the kidney\\'}), (\\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'Wilms tumours_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'Children\u2019s Oncology Group (COG)\\'}), (\\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'SIOP\u22122001 randomized trial\\'}), (\\'actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'UKW3 trial\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)\\'}), (\\'localized disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'localized disease\\'}), (\\'metastatic disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'metastatic disease\\'}), (\\'bilateral disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'bilateral disease\\'}), (\\'relapsed disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'relapsed disease\\'}), (\\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subtype\\', \\'name\\': \\'blastemal-type Wilms tumours\\'}), (\\'radiotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgery_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'chemotherapy\\'}), (\\'Wilms Tumour_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms Tumour\\'}), (\\'CCSK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CCSK\\'}), (\\'MRTK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'MRTK\\'}), (\\'CMN_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CMN\\'}), (\\'RCC_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'RCC\\'}), (\\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u22122001_Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Trial\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'vincristine_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'vincristine\\'}), (\\'actinomycin D_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'actinomycin D\\'}), (\\'doxorubicin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'doxorubicin\\'}), (\\'etoposide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'Stage I_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage I\\'}), (\\'Stage II_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage II\\'}), (\\'Stage III_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage III\\'}), (\\'Stage IV_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage IV\\'}), (\\'Stage V_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage V\\'}), (\\'AV_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AV\\'}), (\\'AVD_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AVD\\'}), (\\'HR-1_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'HR-1\\'}), (\\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP-RTSG 2016\\'}), (\\'Overall Survival (OS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'CT-only nodules_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'CT-only nodules\\'}), (\\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP\u2013RTSG analysis\\'}), (\\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials\\'}), (\\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D plus doxorubicin\\'}), (\\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D\\'}), (\\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study_protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'MRI_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'MRI\\'}), (\\'CT_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'CT\\'}), (\\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_detail\\', \\'name\\': \\'cumulative doxorubicin dose\\'}), (\\'COG AREN0533 trial_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG AREN0533 trial\\'}), (\\'etoposide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'high-risk characteristics\\'}), (\\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG board\\'}), (\\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin\\'}), (\\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'high-dose chemotherapy and autologous stem cell transplantation\\'}), (\\'SIOP database_database\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'database\\', \\'name\\': \\'SIOP database\\'}), (\\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'AVD_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AVD\\'}), (\\'AV-2_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AV-2\\'}), (\\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Statistical Test\\', \\'name\\': \\'Log\u2013Rank P\\'}), (\\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'Bilateral Disease (Stage V)\\'}), (\\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Synchronous bilateral Wilms tumor\\'}), (\\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'End-stage renal disease (ESRD)\\'}), (\\'Aronson et al._Research Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Research Group\\', \\'name\\': \\'Aronson et al.\\'}), (\\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'Bilateral nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Study\\', \\'name\\': \\'SIOP\u22122001 study\\'}), (\\'Vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Vincristine\\'}), (\\'Actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Actinomycin D\\'}), (\\'Etoposide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Etoposide\\'}), (\\'Carboplatin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Carboplatin\\'}), (\\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease State\\', \\'name\\': \\'Relapsed Wilms Tumor\\'}), (\\'Group AA_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group AA\\'}), (\\'Group BB_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group BB\\'}), (\\'Group CC_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group CC\\'}), (\\'Doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Doxorubicin\\'}), (\\'Cyclophosphamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Cyclophosphamide\\'}), (\\'Ifosfamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Ifosfamide\\'}), (\\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'High-dose melphalan\\'}), (\\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UKW\u2011R protocol\\'}), (\\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'NWTS\u20115 relapse protocol\\'}), (\\'ASCR_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'procedure\\', \\'name\\': \\'ASCR\\'}), (\\'ifosfamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'ifosfamide\\'}), (\\'nephrotoxicity_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'nephrotoxicity\\'}), (\\'relapsed group CC_patient_group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'patient_group\\', \\'name\\': \\'relapsed group CC\\'}), (\\'diffuse anaplasia_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'diffuse anaplasia\\'}), (\\'blastemal-type tumors_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'blastemal-type tumors\\'}), (\\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'camptothecins_medication_class\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication_class\\', \\'name\\': \\'camptothecins\\'}), (\\'irinotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'irinotecan\\'}), (\\'topotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'topotecan\\'}), (\\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Innovative Therapies for Children with Cancer consortium\\'}), (\\'radiotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgical excision_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgical excision\\'}), (\\'stage IV WT_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'stage IV WT\\'}), (\\'AVD150_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD150\\'}), (\\'AVD250_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD250\\'}), (\\'low-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'low-risk disease\\'}), (\\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'intermediate-risk disease\\'}), (\\'high-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'high-risk disease\\'}), (\\'CDCV_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'CDCV\\'}), (\\'actinomycin-D_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'actinomycin-D\\'}), (\\'vincristine_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'doxorubicin\\'}), (\\'VP16_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'VP16\\'}), (\\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'contact\\', \\'name\\': \\'arnauld.verschuur@ap-hm.fr\\'}), (\\'surgery_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'chemotherapy\\'}), (\\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2212RTSG panel\\'}), (\\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Infant Wilms Tumors\\'}), (\\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'nephrectomy\\'}), (\\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'malignant rhabdoid tumors\\'}), (\\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Adult Wilms Tumors\\'}), (\\'anaplasia_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'anaplasia\\'}), (\\'actinomycin D_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'carboplatin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'etoposide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'etoposide\\'}), (\\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'Nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'radical tumor nephrectomy\\'}), (\\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'lymph node sampling\\'}), (\\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'minimally invasive surgery\\'}), (\\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'laparoscopic surgery\\'}), (\\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'radiotherapy\\'}), (\\'Wilms tumours_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'Davila Fajardo et al._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Davila Fajardo et al.\\'}), (\\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'COG\u2013NWTS trials\\'}), (\\'whole-lung irradiation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'whole-lung irradiation\\'}), (\\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'pulmonary radiotherapy\\'}), (\\'proton therapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'proton therapy\\'}), (\\'dosimetric study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'dosimetric study\\'}), (\\'locoregional disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'locoregional disease\\'}), (\\'metastatic disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'metastatic disease\\'}), (\\'low-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'low-risk\\'}), (\\'intermediate-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'intermediate-risk\\'}), (\\'high-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'high-risk\\'}), (\\'stage I_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage I\\'}), (\\'stage II_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage II\\'}), (\\'stage III_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage III\\'}), (\\'major rupture_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'major rupture\\'}), (\\'Austria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Austria\\'}), (\\'Italy_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Italy\\'}), (\\'San Marino_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'San Marino\\'}), (\\'Iceland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Iceland\\'}), (\\'Germany_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Germany\\'}), (\\'Bulgaria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bulgaria\\'}), (\\'Turkey_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Turkey\\'}), (\\'Denmark_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Denmark\\'}), (\\'Poland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Poland\\'}), (\\'Greece_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Greece\\'}), (\\'Andorra_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Andorra\\'}), (\\'Belgium_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belgium\\'}), (\\'Serbia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Serbia\\'}), (\\'Albania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Albania\\'}), (\\'Moldova_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Moldova\\'}), (\\'Lithuania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Lithuania\\'}), (\\'Latvia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Latvia\\'}), (\\'Estonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Estonia\\'}), (\\'Luxembourg_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Luxembourg\\'}), (\\'Montenegro_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Montenegro\\'}), (\\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bosnia and Herzegovina\\'}), (\\'Croatia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Croatia\\'}), (\\'Slovenia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovenia\\'}), (\\'Macedonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Macedonia\\'}), (\\'United Kingdom_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'United Kingdom\\'}), (\\'Ireland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ireland\\'}), (\\'Spain_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Spain\\'}), (\\'Algeria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Algeria\\'}), (\\'Tunisia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Tunisia\\'}), (\\'Malta_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Malta\\'}), (\\'Morocco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Morocco\\'}), (\\'Portugal_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Portugal\\'}), (\\'France_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'France\\'}), (\\'Monaco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Monaco\\'}), (\\'Russia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Russia\\'}), (\\'Finland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Finland\\'}), (\\'Sweden_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Sweden\\'}), (\\'Norway_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Norway\\'}), (\\'Belarus_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belarus\\'}), (\\'Romania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Romania\\'}), (\\'Ukraine_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ukraine\\'}), (\\'Hungary_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Hungary\\'}), (\\'Czech Republic_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Czech Republic\\'}), (\\'Slovakia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovakia\\'}), (\\'Switzerland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Switzerland\\'}), (\\'Liechtenstein_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Liechtenstein\\'}), (\\'Netherlands_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Netherlands\\'}), (\\'University Hospital of Munich_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Munich\\'}), (\\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Tuebingen\\'}), (\\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Azienda Ospedaliera\\'}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Ospedale Pediatrico Bambino Ges\u00f9\\'}), (\\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Fondazione IRCCS Istituto Nazionale dei Tumori\\'}), (\\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Prinses Maxima Centrum\\'}), (\\'Marciniak Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Marciniak Hospital\\'}), (\\'Faculty of Medicine_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Faculty of Medicine\\'}), (\\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'St. Anna Kinderspital/CCRI\\'}), (\\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Armand Trousseau Hospital\\'}), (\\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Universitario Virgin del Rocio\\'}), (\\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Vall d\u2019Hebron\\'}), (\\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Great Ormond Street Hospital\\'}), (\\'University Hospital Homburg_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital Homburg\\'}), (\\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon\\'}), (\\'UMBRELLA protocol_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'ExPO\u2011r\u2011Net\\'}), (\\'Weirich, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Weirich, A.\\'}), (\\'Pritchard-Jones, K._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Pritchard-Jones, K.\\'}), (\\'de Kraker, J._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'de Kraker, J.\\'}), (\\'Graf, N._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Graf, N.\\'}), (\\'Green, D. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Green, D. M.\\'}), (\\'Spreafico, F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Spreafico, F.\\'}), (\\'Bellani, F. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Bellani, F. F.\\'}), (\\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'van den Heuvel-Eibrink, M. M.\\'}), (\"D\\'Angio, G. J._author\", {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \"D\\'Angio, G. J.\"}), (\\'Tournade, M. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Tournade, M. F.\\'}), (\\'Breslow, N. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Breslow, N. E.\\'}), (\\'Mitchell, C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Mitchell, C.\\'}), (\\'Verschuur, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Verschuur, A.\\'}), (\\'Grundy, P. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Grundy, P. E.\\'}), (\\'Warmann, S. W._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Warmann, S. W.\\'}), (\\'Smets, A. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Smets, A. M.\\'}), (\\'Dome, J. S._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dome, J. S.\\'}), (\\'Dix, D. B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dix, D. B.\\'}), (\\'Daw, N. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Daw, N. C.\\'}), (\\'Ha, T. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Ha, T. C.\\'}), (\\'Kremens, B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Kremens, B.\\'}), (\\'Furtwangler, R._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Furtwangler, R.\\'}), (\\'SIOP-9/GPOH_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP-9/GPOH\\'}), (\\'UKW3_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'UKW3\\'}), (\\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'SIOP 93\u201301 trial\\'}), (\\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP trial and study 93\u201301\\'}), (\\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'National Wilms Tumor Study Group\\'}), (\\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP WT 2001 protocol\\'}), (\\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Third National Wilms\u2019 Tumor Study\\'}), (\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'National Wilms Tumor Studies\\'}), (\\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Second National Wilms\u2019 Tumor Study\\'}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'UK Children\u2019s Cancer Study Group\\'}), (\\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Children\u2019s Oncology Group\\'})], \\'edges\\': [(\\'sample.pdf\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'non-Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'childhood renal tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'renal cell carcinoma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'localized disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'metastatic disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'bilateral disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'relapsed disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'radiotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'surgery_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'chemotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'Wilms Tumour_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CCSK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'MRTK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CMN_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'RCC_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP\u22122001_Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'vincristine_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'actinomycin D_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'doxorubicin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'etoposide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'carboplatin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'cyclophosphamide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage I_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage II_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage III_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage IV_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage V_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AV_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AVD_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'HR-1_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Overall Survival (OS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT-only nodules_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'MRI_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG AREN0533 trial_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'etoposide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'carboplatin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'cyclophosphamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP database_database\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AVD_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AV-2_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Aronson et al._Research Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Etoposide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Carboplatin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group AA_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group BB_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group CC_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Cyclophosphamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Ifosfamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'ASCR_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'ifosfamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'nephrotoxicity_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'relapsed group CC_patient_group\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'diffuse anaplasia_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'blastemal-type tumors_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'camptothecins_medication_class\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'irinotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'topotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'radiotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'surgical excision_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'stage IV WT_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD150_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD250_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'low-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'CDCV_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'actinomycin-D_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'vincristine_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'doxorubicin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'VP16_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'surgery_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'chemotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'anaplasia_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'actinomycin D_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'vincristine_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'doxorubicin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'carboplatin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'cyclophosphamide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'etoposide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'SIOP\u22122001_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Wilms tumours_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Davila Fajardo et al._author\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'whole-lung irradiation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'proton therapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'dosimetric study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'locoregional disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'metastatic disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'low-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'intermediate-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'high-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage I_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage II_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage III_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'major rupture_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Austria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Italy_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'San Marino_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Iceland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Germany_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bulgaria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Turkey_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Denmark_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Poland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Greece_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Andorra_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belgium_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Serbia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Albania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Moldova_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Lithuania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Latvia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Estonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Luxembourg_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Montenegro_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Croatia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovenia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Macedonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'United Kingdom_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ireland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Spain_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Algeria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Tunisia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Malta_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Morocco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Portugal_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'France_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Monaco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Russia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Finland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Sweden_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Norway_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belarus_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Romania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ukraine_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hungary_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Czech Republic_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovakia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Switzerland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Liechtenstein_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Netherlands_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Munich_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Marciniak Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Faculty of Medicine_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital Homburg_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Weirich, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Pritchard-Jones, K._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'de Kraker, J._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Graf, N._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Green, D. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Spreafico, F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Bellani, F. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \"D\\'Angio, G. J._author\", {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Tournade, M. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Breslow, N. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Mitchell, C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Verschuur, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Grundy, P. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Warmann, S. W._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Smets, A. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dome, J. S._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dix, D. B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Daw, N. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ha, T. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Kremens, B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Furtwangler, R._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP-9/GPOH_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UKW3_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10})]}, {\\'nodes\\': [(\\'vincristine_entity\\', {}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {}), (\\'www.siop-rtsg.eu_entity\\', {}), (\\'stage II_entity\\', {}), (\\'Wilms tumours_entity\\', {}), (\\'Relapsed Wilms Tumor_entity\\', {}), (\\'Davila Fajardo et al._entity\\', {}), (\\'vincristine, actinomycin D, and doxorubicin_entity\\', {}), (\\'SIOP\u22122001 randomized trial_entity\\', {}), (\\'surgery_entity\\', {}), (\\'non-Wilms tumours_entity\\', {}), (\\'actinomycin D_entity\\', {}), (\\'diffuse anaplasia_entity\\', {}), (\\'Synchronous bilateral Wilms tumor_entity\\', {}), (\\'CT-only nodules_entity\\', {}), (\\'relapsed group CC_entity\\', {}), (\\'increased relapse risk_entity\\', {}), (\\'reduced survival_entity\\', {}), (\\'UKW3 trial_entity\\', {}), (\\'chemotherapy_entity\\', {}), (\\'Bilateral Disease (Stage V)_entity\\', {}), (\\'blastemal-type tumors_entity\\', {}), (\\'UMBRELLA protocol_entity\\', {}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', {}), (\\'minimally invasive surgery_entity\\', {}), (\\'VP16_entity\\', {}), (\\'Wilms tumor_entity\\', {}), (\\'anaplasia_entity\\', {}), (\\'radical tumor nephrectomy_entity\\', {}), (\\'Innovative Therapies for Children with Cancer consortium_entity\\', {}), (\\'cumulative doxorubicin dose_entity\\', {}), (\\'etoposide_entity\\', {}), (\\'large-volume tumours_entity\\', {}), (\\'Stage IV_entity\\', {}), (\\'CDCV_entity\\', {}), (\\'SIOP\u2013RTSG_entity\\', {}), (\\'AVD150_entity\\', {}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', {}), (\\'laparoscopic surgery_entity\\', {}), (\\'SIOP\u2212RTSG panel_entity\\', {}), (\\'actinomycin-D_entity\\', {}), (\\'COG AREN0533 trial_entity\\', {}), (\\'cyclophosphamide_entity\\', {}), (\\'carboplatin_entity\\', {}), (\\'UKW\u2011R protocol_entity\\', {}), (\\'Nephron-sparing surgery (NSS)_entity\\', {}), (\\'Adult Wilms Tumors_entity\\', {}), (\\'doxorubicin_entity\\', {}), (\\'NWTS\u20115 relapse protocol_entity\\', {}), (\\'End-stage renal disease (ESRD)_entity\\', {}), (\\'AVD250_entity\\', {}), (\\'Children\u2019s Oncology Group (COG)_entity\\', {}), (\\'blastemal-type Wilms tumour_entity\\', {}), (\\'SIOP\u22122001_entity\\', {}), (\\'radiotherapy_entity\\', {}), (\\'childhood renal tumours_entity\\', {})], \\'edges\\': [(\\'vincristine_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'stage II_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'indicated_for_in_adults\\'}), (\\'Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'Wilms tumours_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated under\\'}), (\\'Relapsed Wilms Tumor_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guided_by\\'}), (\\'Davila Fajardo et al._entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed\\'}), (\\'SIOP\u22122001 randomized trial_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated use in\\'}), (\\'surgery_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'non-Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'actinomycin D_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Synchronous bilateral Wilms tumor_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'instance_of\\'}), (\\'CT-only nodules_entity\\', \\'increased relapse risk_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'reduced survival_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included_in\\'}), (\\'relapsed group CC_entity\\', \\'diffuse anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'blastemal-type tumors_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UKW3 trial_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'UKW3 trial_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'chemotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UMBRELLA protocol_entity\\', \\'COG AREN0533 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses_data_from\\'}), (\\'UMBRELLA protocol_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'advises_treatment_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'Innovative Therapies for Children with Cancer consortium_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborates_with\\'}), (\\'UMBRELLA protocol_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'surgery_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is the standard of\\'}), (\\'UMBRELLA protocol_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guides treatment in\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', \\'UKW3 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\\'minimally invasive surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'anaplasia_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'radical tumor nephrectomy_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'standard_of_care_for\\'}), (\\'Stage IV_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'presents in\\'}), (\\'CDCV_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'VP16_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'aims to improve survival rates of\\'}), (\\'AVD150_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed_by\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'succeeds\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'www.siop-rtsg.eu_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'available_on\\'}), (\\'laparoscopic surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'COG AREN0533 trial_entity\\', \\'cumulative doxorubicin dose_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'evaluates\\'}), (\\'UKW\u2011R protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'Nephron-sparing surgery (NSS)_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'classification_developed_by\\'}), (\\'Adult Wilms Tumors_entity\\', \\'anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'Adult Wilms Tumors_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'doxorubicin_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'doxorubicin_entity\\', \\'large-volume tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'recommended for\\'}), (\\'NWTS\u20115 relapse protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'End-stage renal disease (ESRD)_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'AVD250_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'Children\u2019s Oncology Group (COG)_entity\\', \\'SIOP\u22122001 randomized trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborated with\\'}), (\\'blastemal-type Wilms tumour_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment intensified according to\\'}), (\\'SIOP\u22122001_entity\\', \\'vincristine, actinomycin D, and doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses\\'}), (\\'SIOP\u22122001_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provided_guidelines_for\\'}), (\\'radiotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'radiotherapy_entity\\', \\'SIOP\u2212RTSG panel_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'contact_for_guidance\\'})]}, {\\'nodes\\': [(\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {}), (\\'Marry M. van den Heuvel-Eibrink_entity\\', {})], \\'edges\\': [(\\'Marry M. van den Heuvel-Eibrink_entity\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'affiliated_with\\'})]}, {\\'nodes\\': [(\\'Stage II_entity\\', {}), (\\'AV_entity\\', {}), (\\'Stage III_entity\\', {}), (\\'vincestine and actinomycin D_entity\\', {}), (\\'AVD_entity\\', {})], \\'edges\\': [(\\'Stage II_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AV_entity\\', \\'Stage II_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Stage III_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AVD_entity\\', \\'Stage III_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'SIOP-RTSG 2016_entity\\', {}), (\\'RCC_entity\\', {}), (\\'CMN_entity\\', {})], \\'edges\\': [(\\'RCC_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'}), (\\'CMN_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'})]}, {\\'nodes\\': [(\\'HR-1_entity\\', {}), (\\'High-risk blastemal type Wilms tumour_entity\\', {})], \\'edges\\': [(\\'HR-1_entity\\', \\'High-risk blastemal type Wilms tumour_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'unfavorable prognosis_entity\\', {}), (\\'high-risk characteristics_entity\\', {})], \\'edges\\': [(\\'high-risk characteristics_entity\\', \\'unfavorable prognosis_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'leads_to\\'})]}, {\\'nodes\\': [(\\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {}), (\\'SIOP\u2013RTSG board_entity\\', {})], \\'edges\\': [(\\'SIOP\u2013RTSG board_entity\\', \\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggests\\'})]}, {\\'nodes\\': [(\\'regimen and outcomes_entity\\', {}), (\\'SIOP database_entity\\', {})], \\'edges\\': [(\\'SIOP database_entity\\', \\'regimen and outcomes_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'captures_data_on\\'})]}, {\\'nodes\\': [(\\'Bilateral nephron-sparing surgery (NSS)_entity\\', {}), (\\'Aronson et al._entity\\', {})], \\'edges\\': [(\\'Aronson et al._entity\\', \\'Bilateral nephron-sparing surgery (NSS)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'observed_effectiveness_of\\'})]}, {\\'nodes\\': [(\\'SIOP\u22122001 study_entity\\', {}), (\\'Actinomycin D_entity\\', {}), (\\'Vincristine_entity\\', {})], \\'edges\\': [(\\'SIOP\u22122001 study_entity\\', \\'Vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'}), (\\'SIOP\u22122001 study_entity\\', \\'Actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'})]}, {\\'nodes\\': [(\\'High-dose melphalan_entity\\', {}), (\\'Group AA_entity\\', {}), (\\'Carboplatin_entity\\', {}), (\\'Doxorubicin_entity\\', {}), (\\'Etoposide_entity\\', {}), (\\'Group BB_entity\\', {}), (\\'Cyclophosphamide_entity\\', {}), (\\'Ifosfamide_entity\\', {})], \\'edges\\': [(\\'Group AA_entity\\', \\'Doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Ifosfamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'High-dose melphalan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'})]}, {\\'nodes\\': [(\\'nephrotoxicity_entity\\', {}), (\\'ifosfamide_entity\\', {})], \\'edges\\': [(\\'ifosfamide_entity\\', \\'nephrotoxicity_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'related_to\\'})]}, {\\'nodes\\': [(\\'camptothecins_entity\\', {}), (\\'irinotecan_entity\\', {}), (\\'topotecan_entity\\', {})], \\'edges\\': [(\\'camptothecins_entity\\', \\'irinotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'camptothecins_entity\\', \\'topotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'})]}, {\\'nodes\\': [(\\'Infant Wilms Tumors_entity\\', {}), (\\'nephrectomy_entity\\', {})], \\'edges\\': [(\\'Infant Wilms Tumors_entity\\', \\'nephrectomy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_option\\'})]}, {\\'nodes\\': [(\\'congenital mesoblastic nephroma_entity\\', {}), (\\'surgery alone_entity\\', {})], \\'edges\\': [(\\'congenital mesoblastic nephroma_entity\\', \\'surgery alone_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'alternative chemotherapy_entity\\', {}), (\\'malignant rhabdoid tumors_entity\\', {})], \\'edges\\': [(\\'malignant rhabdoid tumors_entity\\', \\'alternative chemotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'lymph node sampling_entity\\', {}), (\\'accurate staging_entity\\', {})], \\'edges\\': [(\\'lymph node sampling_entity\\', \\'accurate staging_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'purpose_of\\'})]}, {\\'nodes\\': [(\\'COG\u2013NWTS trials_entity\\', {}), (\\'whole-lung irradiation_entity\\', {})], \\'edges\\': [(\\'COG\u2013NWTS trials_entity\\', \\'whole-lung irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'informed_dosage_for\\'})]}, {\\'nodes\\': [(\\'lung metastases_entity\\', {}), (\\'pulmonary radiotherapy_entity\\', {})], \\'edges\\': [(\\'pulmonary radiotherapy_entity\\', \\'lung metastases_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'administered_for\\'})]}, {\\'nodes\\': [(\\'dosimetric study_entity\\', {}), (\\'proton therapy_entity\\', {}), (\\'flank irradiation_entity\\', {})], \\'edges\\': [(\\'dosimetric study_entity\\', \\'proton therapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated\\'}), (\\'proton therapy_entity\\', \\'flank irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggested_for\\'})]}, {\\'nodes\\': [(\\'metastatic disease_entity\\', {}), (\\'radiotherapy guidelines_entity\\', {}), (\\'locoregional disease_entity\\', {})], \\'edges\\': [(\\'radiotherapy guidelines_entity\\', \\'locoregional disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'}), (\\'radiotherapy guidelines_entity\\', \\'metastatic disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'})]}, {\\'nodes\\': [(\\'major rupture_entity\\', {}), (\\'stage III_entity\\', {})], \\'edges\\': [(\\'stage III_entity\\', \\'major rupture_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes_condition\\'})]}, {\\'nodes\\': [(\\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {}), (\\'ExPO\u2011r\u2011Net_entity\\', {})], \\'edges\\': [(\\'ExPO\u2011r\u2011Net_entity\\', \\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is part of\\'})]}, {\\'nodes\\': [(\\'University Hospital of Munich_entity\\', {}), (\\'Germany_entity\\', {}), (\\'University Hospital of Tuebingen_entity\\', {})], \\'edges\\': [(\\'Germany_entity\\', \\'University Hospital of Munich_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Germany_entity\\', \\'University Hospital of Tuebingen_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {}), (\\'Italy_entity\\', {}), (\\'Azienda Ospedaliera_entity\\', {}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {})], \\'edges\\': [(\\'Italy_entity\\', \\'Azienda Ospedaliera_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Netherlands_entity\\', {}), (\\'Prinses Maxima Centrum_entity\\', {})], \\'edges\\': [(\\'Netherlands_entity\\', \\'Prinses Maxima Centrum_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Marciniak Hospital_entity\\', {}), (\\'Poland_entity\\', {}), (\\'Faculty of Medicine_entity\\', {})], \\'edges\\': [(\\'Poland_entity\\', \\'Marciniak Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Poland_entity\\', \\'Faculty of Medicine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'St. Anna Kinderspital/CCRI_entity\\', {}), (\\'Austria_entity\\', {})], \\'edges\\': [(\\'Austria_entity\\', \\'St. Anna Kinderspital/CCRI_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'France_entity\\', {}), (\\'Armand Trousseau Hospital_entity\\', {})], \\'edges\\': [(\\'France_entity\\', \\'Armand Trousseau Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Spain_entity\\', {}), (\\'Hospital Vall d\u2019Hebron_entity\\', {}), (\\'Hospital Universitario Virgin del Rocio_entity\\', {})], \\'edges\\': [(\\'Spain_entity\\', \\'Hospital Universitario Virgin del Rocio_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Spain_entity\\', \\'Hospital Vall d\u2019Hebron_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'United Kingdom_entity\\', {}), (\\'Great Ormond Street Hospital_entity\\', {})], \\'edges\\': [(\\'United Kingdom_entity\\', \\'Great Ormond Street Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Weirich, A._entity\\', {}), (\\'SIOP-9/GPOH_entity\\', {})], \\'edges\\': [(\\'Weirich, A._entity\\', \\'SIOP-9/GPOH_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Pritchard-Jones, K._entity\\', {}), (\\'UKW3_entity\\', {})], \\'edges\\': [(\\'Pritchard-Jones, K._entity\\', \\'UKW3_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed in\\'})]}, {\\'nodes\\': [(\\'SIOP 93\u201301 trial_entity\\', {}), (\\'de Kraker, J._entity\\', {})], \\'edges\\': [(\\'de Kraker, J._entity\\', \\'SIOP 93\u201301 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'SIOP trial and study 93\u201301_entity\\', {}), (\\'Graf, N._entity\\', {})], \\'edges\\': [(\\'Graf, N._entity\\', \\'SIOP trial and study 93\u201301_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Green, D. M._entity\\', {}), (\\'National Wilms Tumor Study Group_entity\\', {})], \\'edges\\': [(\\'Green, D. M._entity\\', \\'National Wilms Tumor Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}, {\\'nodes\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', {}), (\\'SIOP WT 2001 protocol_entity\\', {})], \\'edges\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', \\'SIOP WT 2001 protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Third National Wilms\u2019 Tumor Study_entity\\', {}), (\"D\\'Angio, G. J._entity\", {}), (\\'Second National Wilms\u2019 Tumor Study_entity\\', {})], \\'edges\\': [(\"D\\'Angio, G. J._entity\", \\'Third National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\"D\\'Angio, G. J._entity\", \\'Second National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {}), (\\'Tournade, M. F._entity\\', {}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {})], \\'edges\\': [(\\'Tournade, M. F._entity\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'}), (\\'Tournade, M. F._entity\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Breslow, N. E._entity\\', {}), (\\'National Wilms Tumor Studies_entity\\', {})], \\'edges\\': [(\\'Breslow, N. E._entity\\', \\'National Wilms Tumor Studies_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Mitchell, C._entity\\', {}), (\\'UK Children\u2019s Cancer Study Group_entity\\', {})], \\'edges\\': [(\\'Mitchell, C._entity\\', \\'UK Children\u2019s Cancer Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'under\\'})]}, {\\'nodes\\': [(\\'Daw, N. C._entity\\', {}), (\\'Dix, D. B._entity\\', {}), (\\'Children\u2019s Oncology Group_entity\\', {}), (\\'Grundy, P. E._entity\\', {})], \\'edges\\': [(\\'Daw, N. C._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted under\\'}), (\\'Dix, D. B._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'}), (\\'Grundy, P. E._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}]', expected_output='Standardization should lead to more homogeneous patient data, better prognostic assessments, and improved opportunities for future research and clinical trials.', context=None, retrieval_context=['[{\\'nodes\\': [(\\'sample.pdf\\', {\\'type\\': \\'document\\'}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)\\'}), (\\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA SIOP-RTSG 2016\\'}), (\\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms tumours\\'}), (\\'non-Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'non-Wilms tumours\\'}), (\\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Website\\', \\'name\\': \\'www.siop-rtsg.eu\\'}), (\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology\\'}), (\\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Person\\', \\'name\\': \\'Marry M. van den Heuvel-Eibrink\\'}), (\\'childhood renal tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'childhood renal tumours\\'}), (\\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'clear cell sarcoma of the kidney\\'}), (\\'renal cell carcinoma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'renal cell carcinoma\\'}), (\\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'malignant rhabdoid tumour of the kidney\\'}), (\\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'Wilms tumours_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'Children\u2019s Oncology Group (COG)\\'}), (\\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'SIOP\u22122001 randomized trial\\'}), (\\'actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'UKW3 trial\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)\\'}), (\\'localized disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'localized disease\\'}), (\\'metastatic disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'metastatic disease\\'}), (\\'bilateral disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'bilateral disease\\'}), (\\'relapsed disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'relapsed disease\\'}), (\\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subtype\\', \\'name\\': \\'blastemal-type Wilms tumours\\'}), (\\'radiotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgery_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'chemotherapy\\'}), (\\'Wilms Tumour_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms Tumour\\'}), (\\'CCSK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CCSK\\'}), (\\'MRTK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'MRTK\\'}), (\\'CMN_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CMN\\'}), (\\'RCC_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'RCC\\'}), (\\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u22122001_Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Trial\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'vincristine_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'vincristine\\'}), (\\'actinomycin D_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'actinomycin D\\'}), (\\'doxorubicin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'doxorubicin\\'}), (\\'etoposide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'Stage I_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage I\\'}), (\\'Stage II_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage II\\'}), (\\'Stage III_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage III\\'}), (\\'Stage IV_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage IV\\'}), (\\'Stage V_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage V\\'}), (\\'AV_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AV\\'}), (\\'AVD_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AVD\\'}), (\\'HR-1_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'HR-1\\'}), (\\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP-RTSG 2016\\'}), (\\'Overall Survival (OS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'CT-only nodules_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'CT-only nodules\\'}), (\\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP\u2013RTSG analysis\\'}), (\\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials\\'}), (\\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D plus doxorubicin\\'}), (\\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D\\'}), (\\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study_protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'MRI_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'MRI\\'}), (\\'CT_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'CT\\'}), (\\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_detail\\', \\'name\\': \\'cumulative doxorubicin dose\\'}), (\\'COG AREN0533 trial_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG AREN0533 trial\\'}), (\\'etoposide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'high-risk characteristics\\'}), (\\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG board\\'}), (\\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin\\'}), (\\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'high-dose chemotherapy and autologous stem cell transplantation\\'}), (\\'SIOP database_database\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'database\\', \\'name\\': \\'SIOP database\\'}), (\\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'AVD_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AVD\\'}), (\\'AV-2_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AV-2\\'}), (\\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Statistical Test\\', \\'name\\': \\'Log\u2013Rank P\\'}), (\\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'Bilateral Disease (Stage V)\\'}), (\\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Synchronous bilateral Wilms tumor\\'}), (\\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'End-stage renal disease (ESRD)\\'}), (\\'Aronson et al._Research Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Research Group\\', \\'name\\': \\'Aronson et al.\\'}), (\\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'Bilateral nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Study\\', \\'name\\': \\'SIOP\u22122001 study\\'}), (\\'Vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Vincristine\\'}), (\\'Actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Actinomycin D\\'}), (\\'Etoposide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Etoposide\\'}), (\\'Carboplatin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Carboplatin\\'}), (\\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease State\\', \\'name\\': \\'Relapsed Wilms Tumor\\'}), (\\'Group AA_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group AA\\'}), (\\'Group BB_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group BB\\'}), (\\'Group CC_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group CC\\'}), (\\'Doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Doxorubicin\\'}), (\\'Cyclophosphamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Cyclophosphamide\\'}), (\\'Ifosfamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Ifosfamide\\'}), (\\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'High-dose melphalan\\'}), (\\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UKW\u2011R protocol\\'}), (\\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'NWTS\u20115 relapse protocol\\'}), (\\'ASCR_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'procedure\\', \\'name\\': \\'ASCR\\'}), (\\'ifosfamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'ifosfamide\\'}), (\\'nephrotoxicity_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'nephrotoxicity\\'}), (\\'relapsed group CC_patient_group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'patient_group\\', \\'name\\': \\'relapsed group CC\\'}), (\\'diffuse anaplasia_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'diffuse anaplasia\\'}), (\\'blastemal-type tumors_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'blastemal-type tumors\\'}), (\\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'camptothecins_medication_class\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication_class\\', \\'name\\': \\'camptothecins\\'}), (\\'irinotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'irinotecan\\'}), (\\'topotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'topotecan\\'}), (\\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Innovative Therapies for Children with Cancer consortium\\'}), (\\'radiotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgical excision_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgical excision\\'}), (\\'stage IV WT_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'stage IV WT\\'}), (\\'AVD150_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD150\\'}), (\\'AVD250_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD250\\'}), (\\'low-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'low-risk disease\\'}), (\\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'intermediate-risk disease\\'}), (\\'high-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'high-risk disease\\'}), (\\'CDCV_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'CDCV\\'}), (\\'actinomycin-D_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'actinomycin-D\\'}), (\\'vincristine_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'doxorubicin\\'}), (\\'VP16_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'VP16\\'}), (\\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'contact\\', \\'name\\': \\'arnauld.verschuur@ap-hm.fr\\'}), (\\'surgery_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'chemotherapy\\'}), (\\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2212RTSG panel\\'}), (\\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Infant Wilms Tumors\\'}), (\\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'nephrectomy\\'}), (\\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'malignant rhabdoid tumors\\'}), (\\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Adult Wilms Tumors\\'}), (\\'anaplasia_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'anaplasia\\'}), (\\'actinomycin D_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'carboplatin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'etoposide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'etoposide\\'}), (\\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'Nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'radical tumor nephrectomy\\'}), (\\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'lymph node sampling\\'}), (\\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'minimally invasive surgery\\'}), (\\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'laparoscopic surgery\\'}), (\\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'radiotherapy\\'}), (\\'Wilms tumours_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'Davila Fajardo et al._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Davila Fajardo et al.\\'}), (\\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'COG\u2013NWTS trials\\'}), (\\'whole-lung irradiation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'whole-lung irradiation\\'}), (\\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'pulmonary radiotherapy\\'}), (\\'proton therapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'proton therapy\\'}), (\\'dosimetric study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'dosimetric study\\'}), (\\'locoregional disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'locoregional disease\\'}), (\\'metastatic disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'metastatic disease\\'}), (\\'low-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'low-risk\\'}), (\\'intermediate-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'intermediate-risk\\'}), (\\'high-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'high-risk\\'}), (\\'stage I_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage I\\'}), (\\'stage II_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage II\\'}), (\\'stage III_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage III\\'}), (\\'major rupture_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'major rupture\\'}), (\\'Austria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Austria\\'}), (\\'Italy_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Italy\\'}), (\\'San Marino_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'San Marino\\'}), (\\'Iceland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Iceland\\'}), (\\'Germany_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Germany\\'}), (\\'Bulgaria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bulgaria\\'}), (\\'Turkey_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Turkey\\'}), (\\'Denmark_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Denmark\\'}), (\\'Poland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Poland\\'}), (\\'Greece_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Greece\\'}), (\\'Andorra_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Andorra\\'}), (\\'Belgium_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belgium\\'}), (\\'Serbia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Serbia\\'}), (\\'Albania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Albania\\'}), (\\'Moldova_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Moldova\\'}), (\\'Lithuania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Lithuania\\'}), (\\'Latvia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Latvia\\'}), (\\'Estonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Estonia\\'}), (\\'Luxembourg_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Luxembourg\\'}), (\\'Montenegro_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Montenegro\\'}), (\\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bosnia and Herzegovina\\'}), (\\'Croatia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Croatia\\'}), (\\'Slovenia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovenia\\'}), (\\'Macedonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Macedonia\\'}), (\\'United Kingdom_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'United Kingdom\\'}), (\\'Ireland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ireland\\'}), (\\'Spain_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Spain\\'}), (\\'Algeria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Algeria\\'}), (\\'Tunisia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Tunisia\\'}), (\\'Malta_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Malta\\'}), (\\'Morocco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Morocco\\'}), (\\'Portugal_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Portugal\\'}), (\\'France_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'France\\'}), (\\'Monaco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Monaco\\'}), (\\'Russia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Russia\\'}), (\\'Finland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Finland\\'}), (\\'Sweden_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Sweden\\'}), (\\'Norway_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Norway\\'}), (\\'Belarus_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belarus\\'}), (\\'Romania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Romania\\'}), (\\'Ukraine_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ukraine\\'}), (\\'Hungary_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Hungary\\'}), (\\'Czech Republic_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Czech Republic\\'}), (\\'Slovakia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovakia\\'}), (\\'Switzerland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Switzerland\\'}), (\\'Liechtenstein_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Liechtenstein\\'}), (\\'Netherlands_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Netherlands\\'}), (\\'University Hospital of Munich_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Munich\\'}), (\\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Tuebingen\\'}), (\\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Azienda Ospedaliera\\'}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Ospedale Pediatrico Bambino Ges\u00f9\\'}), (\\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Fondazione IRCCS Istituto Nazionale dei Tumori\\'}), (\\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Prinses Maxima Centrum\\'}), (\\'Marciniak Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Marciniak Hospital\\'}), (\\'Faculty of Medicine_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Faculty of Medicine\\'}), (\\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'St. Anna Kinderspital/CCRI\\'}), (\\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Armand Trousseau Hospital\\'}), (\\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Universitario Virgin del Rocio\\'}), (\\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Vall d\u2019Hebron\\'}), (\\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Great Ormond Street Hospital\\'}), (\\'University Hospital Homburg_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital Homburg\\'}), (\\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon\\'}), (\\'UMBRELLA protocol_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'ExPO\u2011r\u2011Net\\'}), (\\'Weirich, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Weirich, A.\\'}), (\\'Pritchard-Jones, K._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Pritchard-Jones, K.\\'}), (\\'de Kraker, J._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'de Kraker, J.\\'}), (\\'Graf, N._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Graf, N.\\'}), (\\'Green, D. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Green, D. M.\\'}), (\\'Spreafico, F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Spreafico, F.\\'}), (\\'Bellani, F. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Bellani, F. F.\\'}), (\\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'van den Heuvel-Eibrink, M. M.\\'}), (\"D\\'Angio, G. J._author\", {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \"D\\'Angio, G. J.\"}), (\\'Tournade, M. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Tournade, M. F.\\'}), (\\'Breslow, N. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Breslow, N. E.\\'}), (\\'Mitchell, C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Mitchell, C.\\'}), (\\'Verschuur, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Verschuur, A.\\'}), (\\'Grundy, P. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Grundy, P. E.\\'}), (\\'Warmann, S. W._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Warmann, S. W.\\'}), (\\'Smets, A. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Smets, A. M.\\'}), (\\'Dome, J. S._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dome, J. S.\\'}), (\\'Dix, D. B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dix, D. B.\\'}), (\\'Daw, N. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Daw, N. C.\\'}), (\\'Ha, T. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Ha, T. C.\\'}), (\\'Kremens, B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Kremens, B.\\'}), (\\'Furtwangler, R._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Furtwangler, R.\\'}), (\\'SIOP-9/GPOH_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP-9/GPOH\\'}), (\\'UKW3_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'UKW3\\'}), (\\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'SIOP 93\u201301 trial\\'}), (\\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP trial and study 93\u201301\\'}), (\\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'National Wilms Tumor Study Group\\'}), (\\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP WT 2001 protocol\\'}), (\\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Third National Wilms\u2019 Tumor Study\\'}), (\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'National Wilms Tumor Studies\\'}), (\\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Second National Wilms\u2019 Tumor Study\\'}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'UK Children\u2019s Cancer Study Group\\'}), (\\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Children\u2019s Oncology Group\\'})], \\'edges\\': [(\\'sample.pdf\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'non-Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'childhood renal tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'renal cell carcinoma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'localized disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'metastatic disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'bilateral disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'relapsed disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'radiotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'surgery_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'chemotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'Wilms Tumour_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CCSK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'MRTK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CMN_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'RCC_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP\u22122001_Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'vincristine_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'actinomycin D_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'doxorubicin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'etoposide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'carboplatin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'cyclophosphamide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage I_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage II_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage III_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage IV_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage V_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AV_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AVD_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'HR-1_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Overall Survival (OS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT-only nodules_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'MRI_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG AREN0533 trial_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'etoposide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'carboplatin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'cyclophosphamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP database_database\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AVD_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AV-2_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Aronson et al._Research Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Etoposide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Carboplatin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group AA_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group BB_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group CC_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Cyclophosphamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Ifosfamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'ASCR_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'ifosfamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'nephrotoxicity_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'relapsed group CC_patient_group\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'diffuse anaplasia_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'blastemal-type tumors_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'camptothecins_medication_class\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'irinotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'topotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'radiotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'surgical excision_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'stage IV WT_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD150_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD250_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'low-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'CDCV_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'actinomycin-D_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'vincristine_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'doxorubicin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'VP16_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'surgery_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'chemotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'anaplasia_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'actinomycin D_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'vincristine_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'doxorubicin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'carboplatin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'cyclophosphamide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'etoposide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'SIOP\u22122001_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Wilms tumours_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Davila Fajardo et al._author\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'whole-lung irradiation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'proton therapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'dosimetric study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'locoregional disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'metastatic disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'low-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'intermediate-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'high-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage I_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage II_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage III_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'major rupture_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Austria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Italy_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'San Marino_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Iceland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Germany_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bulgaria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Turkey_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Denmark_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Poland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Greece_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Andorra_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belgium_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Serbia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Albania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Moldova_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Lithuania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Latvia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Estonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Luxembourg_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Montenegro_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Croatia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovenia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Macedonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'United Kingdom_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ireland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Spain_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Algeria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Tunisia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Malta_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Morocco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Portugal_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'France_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Monaco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Russia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Finland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Sweden_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Norway_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belarus_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Romania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ukraine_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hungary_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Czech Republic_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovakia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Switzerland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Liechtenstein_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Netherlands_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Munich_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Marciniak Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Faculty of Medicine_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital Homburg_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Weirich, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Pritchard-Jones, K._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'de Kraker, J._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Graf, N._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Green, D. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Spreafico, F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Bellani, F. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \"D\\'Angio, G. J._author\", {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Tournade, M. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Breslow, N. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Mitchell, C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Verschuur, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Grundy, P. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Warmann, S. W._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Smets, A. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dome, J. S._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dix, D. B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Daw, N. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ha, T. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Kremens, B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Furtwangler, R._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP-9/GPOH_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UKW3_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10})]}, {\\'nodes\\': [(\\'vincristine_entity\\', {}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {}), (\\'www.siop-rtsg.eu_entity\\', {}), (\\'stage II_entity\\', {}), (\\'Wilms tumours_entity\\', {}), (\\'Relapsed Wilms Tumor_entity\\', {}), (\\'Davila Fajardo et al._entity\\', {}), (\\'vincristine, actinomycin D, and doxorubicin_entity\\', {}), (\\'SIOP\u22122001 randomized trial_entity\\', {}), (\\'surgery_entity\\', {}), (\\'non-Wilms tumours_entity\\', {}), (\\'actinomycin D_entity\\', {}), (\\'diffuse anaplasia_entity\\', {}), (\\'Synchronous bilateral Wilms tumor_entity\\', {}), (\\'CT-only nodules_entity\\', {}), (\\'relapsed group CC_entity\\', {}), (\\'increased relapse risk_entity\\', {}), (\\'reduced survival_entity\\', {}), (\\'UKW3 trial_entity\\', {}), (\\'chemotherapy_entity\\', {}), (\\'Bilateral Disease (Stage V)_entity\\', {}), (\\'blastemal-type tumors_entity\\', {}), (\\'UMBRELLA protocol_entity\\', {}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', {}), (\\'minimally invasive surgery_entity\\', {}), (\\'VP16_entity\\', {}), (\\'Wilms tumor_entity\\', {}), (\\'anaplasia_entity\\', {}), (\\'radical tumor nephrectomy_entity\\', {}), (\\'Innovative Therapies for Children with Cancer consortium_entity\\', {}), (\\'cumulative doxorubicin dose_entity\\', {}), (\\'etoposide_entity\\', {}), (\\'large-volume tumours_entity\\', {}), (\\'Stage IV_entity\\', {}), (\\'CDCV_entity\\', {}), (\\'SIOP\u2013RTSG_entity\\', {}), (\\'AVD150_entity\\', {}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', {}), (\\'laparoscopic surgery_entity\\', {}), (\\'SIOP\u2212RTSG panel_entity\\', {}), (\\'actinomycin-D_entity\\', {}), (\\'COG AREN0533 trial_entity\\', {}), (\\'cyclophosphamide_entity\\', {}), (\\'carboplatin_entity\\', {}), (\\'UKW\u2011R protocol_entity\\', {}), (\\'Nephron-sparing surgery (NSS)_entity\\', {}), (\\'Adult Wilms Tumors_entity\\', {}), (\\'doxorubicin_entity\\', {}), (\\'NWTS\u20115 relapse protocol_entity\\', {}), (\\'End-stage renal disease (ESRD)_entity\\', {}), (\\'AVD250_entity\\', {}), (\\'Children\u2019s Oncology Group (COG)_entity\\', {}), (\\'blastemal-type Wilms tumour_entity\\', {}), (\\'SIOP\u22122001_entity\\', {}), (\\'radiotherapy_entity\\', {}), (\\'childhood renal tumours_entity\\', {})], \\'edges\\': [(\\'vincristine_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'stage II_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'indicated_for_in_adults\\'}), (\\'Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'Wilms tumours_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated under\\'}), (\\'Relapsed Wilms Tumor_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guided_by\\'}), (\\'Davila Fajardo et al._entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed\\'}), (\\'SIOP\u22122001 randomized trial_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated use in\\'}), (\\'surgery_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'non-Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'actinomycin D_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Synchronous bilateral Wilms tumor_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'instance_of\\'}), (\\'CT-only nodules_entity\\', \\'increased relapse risk_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'reduced survival_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included_in\\'}), (\\'relapsed group CC_entity\\', \\'diffuse anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'blastemal-type tumors_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UKW3 trial_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'UKW3 trial_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'chemotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UMBRELLA protocol_entity\\', \\'COG AREN0533 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses_data_from\\'}), (\\'UMBRELLA protocol_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'advises_treatment_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'Innovative Therapies for Children with Cancer consortium_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborates_with\\'}), (\\'UMBRELLA protocol_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'surgery_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is the standard of\\'}), (\\'UMBRELLA protocol_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guides treatment in\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', \\'UKW3 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\\'minimally invasive surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'anaplasia_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'radical tumor nephrectomy_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'standard_of_care_for\\'}), (\\'Stage IV_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'presents in\\'}), (\\'CDCV_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'VP16_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'aims to improve survival rates of\\'}), (\\'AVD150_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed_by\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'succeeds\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'www.siop-rtsg.eu_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'available_on\\'}), (\\'laparoscopic surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'COG AREN0533 trial_entity\\', \\'cumulative doxorubicin dose_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'evaluates\\'}), (\\'UKW\u2011R protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'Nephron-sparing surgery (NSS)_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'classification_developed_by\\'}), (\\'Adult Wilms Tumors_entity\\', \\'anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'Adult Wilms Tumors_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'doxorubicin_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'doxorubicin_entity\\', \\'large-volume tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'recommended for\\'}), (\\'NWTS\u20115 relapse protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'End-stage renal disease (ESRD)_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'AVD250_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'Children\u2019s Oncology Group (COG)_entity\\', \\'SIOP\u22122001 randomized trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborated with\\'}), (\\'blastemal-type Wilms tumour_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment intensified according to\\'}), (\\'SIOP\u22122001_entity\\', \\'vincristine, actinomycin D, and doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses\\'}), (\\'SIOP\u22122001_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provided_guidelines_for\\'}), (\\'radiotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'radiotherapy_entity\\', \\'SIOP\u2212RTSG panel_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'contact_for_guidance\\'})]}, {\\'nodes\\': [(\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {}), (\\'Marry M. van den Heuvel-Eibrink_entity\\', {})], \\'edges\\': [(\\'Marry M. van den Heuvel-Eibrink_entity\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'affiliated_with\\'})]}, {\\'nodes\\': [(\\'Stage II_entity\\', {}), (\\'AV_entity\\', {}), (\\'Stage III_entity\\', {}), (\\'vincestine and actinomycin D_entity\\', {}), (\\'AVD_entity\\', {})], \\'edges\\': [(\\'Stage II_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AV_entity\\', \\'Stage II_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Stage III_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AVD_entity\\', \\'Stage III_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'SIOP-RTSG 2016_entity\\', {}), (\\'RCC_entity\\', {}), (\\'CMN_entity\\', {})], \\'edges\\': [(\\'RCC_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'}), (\\'CMN_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'})]}, {\\'nodes\\': [(\\'HR-1_entity\\', {}), (\\'High-risk blastemal type Wilms tumour_entity\\', {})], \\'edges\\': [(\\'HR-1_entity\\', \\'High-risk blastemal type Wilms tumour_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'unfavorable prognosis_entity\\', {}), (\\'high-risk characteristics_entity\\', {})], \\'edges\\': [(\\'high-risk characteristics_entity\\', \\'unfavorable prognosis_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'leads_to\\'})]}, {\\'nodes\\': [(\\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {}), (\\'SIOP\u2013RTSG board_entity\\', {})], \\'edges\\': [(\\'SIOP\u2013RTSG board_entity\\', \\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggests\\'})]}, {\\'nodes\\': [(\\'regimen and outcomes_entity\\', {}), (\\'SIOP database_entity\\', {})], \\'edges\\': [(\\'SIOP database_entity\\', \\'regimen and outcomes_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'captures_data_on\\'})]}, {\\'nodes\\': [(\\'Bilateral nephron-sparing surgery (NSS)_entity\\', {}), (\\'Aronson et al._entity\\', {})], \\'edges\\': [(\\'Aronson et al._entity\\', \\'Bilateral nephron-sparing surgery (NSS)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'observed_effectiveness_of\\'})]}, {\\'nodes\\': [(\\'SIOP\u22122001 study_entity\\', {}), (\\'Actinomycin D_entity\\', {}), (\\'Vincristine_entity\\', {})], \\'edges\\': [(\\'SIOP\u22122001 study_entity\\', \\'Vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'}), (\\'SIOP\u22122001 study_entity\\', \\'Actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'})]}, {\\'nodes\\': [(\\'High-dose melphalan_entity\\', {}), (\\'Group AA_entity\\', {}), (\\'Carboplatin_entity\\', {}), (\\'Doxorubicin_entity\\', {}), (\\'Etoposide_entity\\', {}), (\\'Group BB_entity\\', {}), (\\'Cyclophosphamide_entity\\', {}), (\\'Ifosfamide_entity\\', {})], \\'edges\\': [(\\'Group AA_entity\\', \\'Doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Ifosfamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'High-dose melphalan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'})]}, {\\'nodes\\': [(\\'nephrotoxicity_entity\\', {}), (\\'ifosfamide_entity\\', {})], \\'edges\\': [(\\'ifosfamide_entity\\', \\'nephrotoxicity_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'related_to\\'})]}, {\\'nodes\\': [(\\'camptothecins_entity\\', {}), (\\'irinotecan_entity\\', {}), (\\'topotecan_entity\\', {})], \\'edges\\': [(\\'camptothecins_entity\\', \\'irinotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'camptothecins_entity\\', \\'topotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'})]}, {\\'nodes\\': [(\\'Infant Wilms Tumors_entity\\', {}), (\\'nephrectomy_entity\\', {})], \\'edges\\': [(\\'Infant Wilms Tumors_entity\\', \\'nephrectomy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_option\\'})]}, {\\'nodes\\': [(\\'congenital mesoblastic nephroma_entity\\', {}), (\\'surgery alone_entity\\', {})], \\'edges\\': [(\\'congenital mesoblastic nephroma_entity\\', \\'surgery alone_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'alternative chemotherapy_entity\\', {}), (\\'malignant rhabdoid tumors_entity\\', {})], \\'edges\\': [(\\'malignant rhabdoid tumors_entity\\', \\'alternative chemotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'lymph node sampling_entity\\', {}), (\\'accurate staging_entity\\', {})], \\'edges\\': [(\\'lymph node sampling_entity\\', \\'accurate staging_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'purpose_of\\'})]}, {\\'nodes\\': [(\\'COG\u2013NWTS trials_entity\\', {}), (\\'whole-lung irradiation_entity\\', {})], \\'edges\\': [(\\'COG\u2013NWTS trials_entity\\', \\'whole-lung irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'informed_dosage_for\\'})]}, {\\'nodes\\': [(\\'lung metastases_entity\\', {}), (\\'pulmonary radiotherapy_entity\\', {})], \\'edges\\': [(\\'pulmonary radiotherapy_entity\\', \\'lung metastases_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'administered_for\\'})]}, {\\'nodes\\': [(\\'dosimetric study_entity\\', {}), (\\'proton therapy_entity\\', {}), (\\'flank irradiation_entity\\', {})], \\'edges\\': [(\\'dosimetric study_entity\\', \\'proton therapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated\\'}), (\\'proton therapy_entity\\', \\'flank irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggested_for\\'})]}, {\\'nodes\\': [(\\'metastatic disease_entity\\', {}), (\\'radiotherapy guidelines_entity\\', {}), (\\'locoregional disease_entity\\', {})], \\'edges\\': [(\\'radiotherapy guidelines_entity\\', \\'locoregional disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'}), (\\'radiotherapy guidelines_entity\\', \\'metastatic disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'})]}, {\\'nodes\\': [(\\'major rupture_entity\\', {}), (\\'stage III_entity\\', {})], \\'edges\\': [(\\'stage III_entity\\', \\'major rupture_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes_condition\\'})]}, {\\'nodes\\': [(\\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {}), (\\'ExPO\u2011r\u2011Net_entity\\', {})], \\'edges\\': [(\\'ExPO\u2011r\u2011Net_entity\\', \\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is part of\\'})]}, {\\'nodes\\': [(\\'University Hospital of Munich_entity\\', {}), (\\'Germany_entity\\', {}), (\\'University Hospital of Tuebingen_entity\\', {})], \\'edges\\': [(\\'Germany_entity\\', \\'University Hospital of Munich_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Germany_entity\\', \\'University Hospital of Tuebingen_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {}), (\\'Italy_entity\\', {}), (\\'Azienda Ospedaliera_entity\\', {}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {})], \\'edges\\': [(\\'Italy_entity\\', \\'Azienda Ospedaliera_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Netherlands_entity\\', {}), (\\'Prinses Maxima Centrum_entity\\', {})], \\'edges\\': [(\\'Netherlands_entity\\', \\'Prinses Maxima Centrum_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Marciniak Hospital_entity\\', {}), (\\'Poland_entity\\', {}), (\\'Faculty of Medicine_entity\\', {})], \\'edges\\': [(\\'Poland_entity\\', \\'Marciniak Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Poland_entity\\', \\'Faculty of Medicine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'St. Anna Kinderspital/CCRI_entity\\', {}), (\\'Austria_entity\\', {})], \\'edges\\': [(\\'Austria_entity\\', \\'St. Anna Kinderspital/CCRI_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'France_entity\\', {}), (\\'Armand Trousseau Hospital_entity\\', {})], \\'edges\\': [(\\'France_entity\\', \\'Armand Trousseau Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Spain_entity\\', {}), (\\'Hospital Vall d\u2019Hebron_entity\\', {}), (\\'Hospital Universitario Virgin del Rocio_entity\\', {})], \\'edges\\': [(\\'Spain_entity\\', \\'Hospital Universitario Virgin del Rocio_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Spain_entity\\', \\'Hospital Vall d\u2019Hebron_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'United Kingdom_entity\\', {}), (\\'Great Ormond Street Hospital_entity\\', {})], \\'edges\\': [(\\'United Kingdom_entity\\', \\'Great Ormond Street Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Weirich, A._entity\\', {}), (\\'SIOP-9/GPOH_entity\\', {})], \\'edges\\': [(\\'Weirich, A._entity\\', \\'SIOP-9/GPOH_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Pritchard-Jones, K._entity\\', {}), (\\'UKW3_entity\\', {})], \\'edges\\': [(\\'Pritchard-Jones, K._entity\\', \\'UKW3_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed in\\'})]}, {\\'nodes\\': [(\\'SIOP 93\u201301 trial_entity\\', {}), (\\'de Kraker, J._entity\\', {})], \\'edges\\': [(\\'de Kraker, J._entity\\', \\'SIOP 93\u201301 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'SIOP trial and study 93\u201301_entity\\', {}), (\\'Graf, N._entity\\', {})], \\'edges\\': [(\\'Graf, N._entity\\', \\'SIOP trial and study 93\u201301_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Green, D. M._entity\\', {}), (\\'National Wilms Tumor Study Group_entity\\', {})], \\'edges\\': [(\\'Green, D. M._entity\\', \\'National Wilms Tumor Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}, {\\'nodes\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', {}), (\\'SIOP WT 2001 protocol_entity\\', {})], \\'edges\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', \\'SIOP WT 2001 protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Third National Wilms\u2019 Tumor Study_entity\\', {}), (\"D\\'Angio, G. J._entity\", {}), (\\'Second National Wilms\u2019 Tumor Study_entity\\', {})], \\'edges\\': [(\"D\\'Angio, G. J._entity\", \\'Third National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\"D\\'Angio, G. J._entity\", \\'Second National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {}), (\\'Tournade, M. F._entity\\', {}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {})], \\'edges\\': [(\\'Tournade, M. F._entity\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'}), (\\'Tournade, M. F._entity\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Breslow, N. E._entity\\', {}), (\\'National Wilms Tumor Studies_entity\\', {})], \\'edges\\': [(\\'Breslow, N. E._entity\\', \\'National Wilms Tumor Studies_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Mitchell, C._entity\\', {}), (\\'UK Children\u2019s Cancer Study Group_entity\\', {})], \\'edges\\': [(\\'Mitchell, C._entity\\', \\'UK Children\u2019s Cancer Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'under\\'})]}, {\\'nodes\\': [(\\'Daw, N. C._entity\\', {}), (\\'Dix, D. B._entity\\', {}), (\\'Children\u2019s Oncology Group_entity\\', {}), (\\'Grundy, P. E._entity\\', {})], \\'edges\\': [(\\'Daw, N. C._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted under\\'}), (\\'Dix, D. B._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'}), (\\'Grundy, P. E._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}]']), TestResult(name='test_case_8', success=False, metrics_data=[MetricData(name='Answer Correctness (GEval)', threshold=0.5, success=True, score=0.9989013059542652, reason='The actual output accurately lists all mentioned agents including vincristine, actinomycin D, and doxorubicin, and also includes etoposide and cyclophosphamide as per the expected output.', strict_mode=False, evaluation_model='gpt-4o-mini', error=None, evaluation_cost=0.0033097499999999998, verbose_logs='Criteria:\\nNone \\n \\nEvaluation Steps:\\n[\\n    \"Determine whether the actual output is factually correct based on the expected output.\"\\n]'), MetricData(name='Faithfulness', threshold=0.7, success=True, score=0.8863636363636364, reason=None, strict_mode=False, evaluation_model='gpt-4o-mini', error=None, evaluation_cost=0.00973425, verbose_logs='Truths (limit=None):\\n[\\n    \"The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG) is an organization.\",\\n    \"UMBRELLA SIOP-RTSG 2016 is a protocol.\",\\n    \"SIOP\u22122001 is a protocol.\",\\n    \"Wilms tumours are a type of disease.\",\\n    \"non-Wilms tumours are a type of disease.\",\\n    \"www.siop-rtsg.eu is a website.\",\\n    \"Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology is an institution.\",\\n    \"Marry M. van den Heuvel-Eibrink is a person associated with this context.\",\\n    \"Childhood renal tumours are a type of disease.\",\\n    \"Clear cell sarcoma of the kidney is a disease.\",\\n    \"Renal cell carcinoma is a disease.\",\\n    \"Malignant rhabdoid tumour of the kidney is a disease.\",\\n    \"Congenital mesoblastic nephroma is a disease.\",\\n    \"There are different disease stages including localized, metastatic, bilateral, and relapsed disease.\",\\n    \"Wilms Tumour, CCSK, MRTK, CMN, and RCC are types of diseases.\",\\n    \"Various treatments include vincristine, actinomycin D, doxorubicin, etoposide, carboplatin, and cyclophosphamide.\",\\n    \"Stages I to V are classifications used for diseases.\",\\n    \"AV and AVD are treatment combinations.\",\\n    \"SIOP\u2013RTSG is an organization which is a standard for management of Wilms tumor.\",\\n    \"Children\u2019s Oncology Group (COG) is an organization.\",\\n    \"High-risk characteristics can lead to unfavorable prognoses.\",\\n    \"Nephron-sparing surgery and radical tumor nephrectomy are surgical procedures.\",\\n    \"Nephrotoxicity is a condition related to certain medications.\",\\n    \"Various countries including Austria, Italy, Germany, and others are mentioned as part of a geographic context related to treatment organizations and studies for Wilms tumor.\",\\n    \"High-dose chemotherapy and autologous stem cell transplantation are treatment options.\",\\n    \"Vincristine and actinomycin D plus doxorubicin and other combinations are mentioned in treatments related to Wilms tumors.\",\\n    \"SIOP database captures data on regimen and outcomes and is involved in worldwide studies.\",\\n    \"Bilateral nephron-sparing surgery is acknowledged for effectiveness in clinical contexts.\",\\n    \"SIOP\u22122001 and its associated studies involve treatments for Wilms tumor and have been validated in clinical trials.\"\\n] \\n \\nClaims:\\n[\\n    \"The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG) is an organization.\",\\n    \"The UMBRELLA SIOP-RTSG 2016 is a protocol.\",\\n    \"The SIOP\u22122001 is a protocol.\",\\n    \"Wilms tumours is a disease.\",\\n    \"non-Wilms tumours is a disease.\",\\n    \"The website www.siop-rtsg.eu is associated with SIOP\u2013RTSG.\",\\n    \"The Department of Paediatric Oncology is part of the Princess M\u00e1xima Center for Paediatric Oncology.\",\\n    \"Marry M. van den Heuvel-Eibrink is a person involved with paediatric oncology.\",\\n    \"Childhood renal tumours is a disease.\",\\n    \"Clear cell sarcoma of the kidney is a disease.\",\\n    \"Renal cell carcinoma is a disease.\",\\n    \"Malignant rhabdoid tumour of the kidney is a disease.\",\\n    \"Congenital mesoblastic nephroma is a disease.\",\\n    \"The UMBRELLA protocol is a treatment protocol.\",\\n    \"SIOP\u22122001 randomized trial is a clinical trial.\",\\n    \"Actinomycin D is a drug.\",\\n    \"Vincristine is a drug.\",\\n    \"Doxorubicin is a drug.\",\\n    \"The UKW3 trial is a clinical trial.\",\\n    \"The UK Children\u2019s Cancer and Leukaemia Group (UKCCLG) is an organization.\",\\n    \"Localized disease is a disease stage.\",\\n    \"Metastatic disease is a disease stage.\",\\n    \"Bilateral disease is a disease stage.\",\\n    \"Relapsed disease is a disease stage.\",\\n    \"Blastemal-type Wilms tumours is a subtype.\",\\n    \"Radiotherapy is a treatment method.\",\\n    \"Surgery is a treatment method.\",\\n    \"Chemotherapy is a treatment method.\",\\n    \"Wilms Tumour is a disease.\",\\n    \"CCSK is a disease.\",\\n    \"MRTK is a disease.\",\\n    \"CMN is a disease.\",\\n    \"RCC is a disease.\",\\n    \"The UMBRELLA protocol is a protocol.\",\\n    \"SIOP\u22122001 is a trial.\",\\n    \"Etoposide is a treatment.\",\\n    \"Carboplatin is a treatment.\",\\n    \"Cyclophosphamide is a treatment.\",\\n    \"Stage I is a stage.\",\\n    \"Stage II is a stage.\",\\n    \"Stage III is a stage.\",\\n    \"Stage IV is a stage.\",\\n    \"Stage V is a stage.\",\\n    \"AV is a treatment combination.\",\\n    \"AVD is a treatment combination.\",\\n    \"HR-1 is a treatment combination.\",\\n    \"SIOP-RTSG 2016 is a protocol.\",\\n    \"Overall Survival (OS) is a metric.\",\\n    \"Event-Free Survival (EFS) is a metric.\",\\n    \"CT-only nodules is a medical condition.\",\\n    \"SIOP\u2013RTSG analysis is a study.\",\\n    \"COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials is a study.\",\\n    \"Vincristine and actinomycin D plus doxorubicin is a treatment.\",\\n    \"Vincristine and actinomycin D is a treatment.\",\\n    \"SIOP\u22122001 is a study protocol.\",\\n    \"MRI is a diagnostic tool.\",\\n    \"CT is a diagnostic tool.\",\\n    \"Cumulative doxorubicin dose is a treatment detail.\",\\n    \"COG AREN0533 trial is a study.\",\\n    \"Etoposide is a medication.\",\\n    \"Carboplatin is a medication.\",\\n    \"Cyclophosphamide is a medication.\",\\n    \"High-risk characteristics is a medical condition.\",\\n    \"SIOP\u2013RTSG board is an organization.\",\\n    \"Vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin is a treatment.\",\\n    \"High-dose chemotherapy and autologous stem cell transplantation is a treatment.\",\\n    \"SIOP database is a database.\",\\n    \"Event-Free Survival (EFS) is a subject.\",\\n    \"Overall Survival (OS) is a subject.\",\\n    \"AVD is a treatment group.\",\\n    \"AV-2 is a treatment group.\",\\n    \"Log\u2013Rank P is a statistical test.\",\\n    \"Bilateral Disease (Stage V) is a disease stage.\",\\n    \"Synchronous bilateral Wilms tumor is a disease.\",\\n    \"End-stage renal disease (ESRD) is a condition.\",\\n    \"Aronson et al. is a research group.\",\\n    \"Bilateral nephron-sparing surgery (NSS) is a treatment method.\",\\n    \"SIOP\u22122001 study is a study.\",\\n    \"Vincristine is a drug.\",\\n    \"Actinomycin D is a drug.\",\\n    \"Etoposide is a drug.\",\\n    \"Carboplatin is a drug.\",\\n    \"Relapsed Wilms Tumor is a disease state.\",\\n    \"Group AA is a patient group.\",\\n    \"Group BB is a patient group.\",\\n    \"Group CC is a patient group.\",\\n    \"Doxorubicin is a drug.\",\\n    \"Cyclophosphamide is a drug.\",\\n    \"Ifosfamide is a drug.\",\\n    \"High-dose melphalan is a treatment method.\",\\n    \"UKW\u2011R protocol is a treatment protocol.\",\\n    \"NWTS\u20115 relapse protocol is a treatment protocol.\",\\n    \"ASCR is a procedure.\",\\n    \"Ifosfamide is a medication.\",\\n    \"Nephrotoxicity is a condition.\",\\n    \"Relapsed group CC is a patient group.\",\\n    \"Diffuse anaplasia is a condition.\",\\n    \"Blastemal-type tumors is a condition.\",\\n    \"The UMBRELLA protocol is a protocol.\",\\n    \"Camptothecins is a medication class.\",\\n    \"Irinotecan is a medication.\",\\n    \"Topotecan is a medication.\",\\n    \"Innovative Therapies for Children with Cancer consortium is an organization.\",\\n    \"Radiotherapy is a treatment method.\",\\n    \"Surgical excision is a treatment method.\",\\n    \"Stage IV WT is a condition.\",\\n    \"AVD150 is a treatment regimen.\",\\n    \"AVD250 is a treatment regimen.\",\\n    \"Low-risk disease is a condition category.\",\\n    \"Intermediate-risk disease is a condition category.\",\\n    \"High-risk disease is a condition category.\",\\n    \"CDCV is a treatment regimen.\",\\n    \"Actinomycin-D is a medication.\",\\n    \"Vincristine is a medication.\",\\n    \"Doxorubicin is a medication.\",\\n    \"VP16 is a medication.\",\\n    \"Arnaud.verschuur@ap-hm.fr is a contact.\",\\n    \"Surgery is a treatment method.\",\\n    \"Chemotherapy is a treatment method.\",\\n    \"SIOP\u2212RTSG panel is an organization.\",\\n    \"Infant Wilms Tumors is a medical condition.\",\\n    \"Nephrectomy is a surgical procedure.\",\\n    \"Congenital mesoblastic nephroma is a medical condition.\",\\n    \"Malignant rhabdoid tumors is a medical condition.\",\\n    \"Adult Wilms Tumors is a medical condition.\",\\n    \"Anaplasia is a medical condition.\",\\n    \"Actinomycin D is a drug.\",\\n    \"Vincristine is a drug.\",\\n    \"Doxorubicin is a drug.\",\\n    \"Carboplatin is a drug.\",\\n    \"Cyclophosphamide is a drug.\",\\n    \"Etoposide is a drug.\",\\n    \"Nephron-sparing surgery (NSS) is a surgical procedure.\",\\n    \"SIOP\u2013RTSG is an organization.\",\\n    \"Radical tumor nephrectomy is a surgical procedure.\",\\n    \"Lymph node sampling is a surgical procedure.\",\\n    \"Minimally invasive surgery is a surgery type.\",\\n    \"Laparoscopic surgery is a surgery type.\",\\n    \"Nephron-sparing surgery (NSS) is a surgery type.\",\\n    \"SIOP\u22122001 is a protocol.\",\\n    \"Radiotherapy is a treatment.\",\\n    \"Wilms tumours is a condition.\",\\n    \"Davila Fajardo et al. is an author.\",\\n    \"COG\u2013NWTS trials is a trial.\",\\n    \"Whole-lung irradiation is a treatment.\",\\n    \"Pulmonary radiotherapy is a treatment.\",\\n    \"Proton therapy is a treatment.\",\\n    \"Dosimetric study is a study.\",\\n    \"Locoregional disease is a condition.\",\\n    \"Metastatic disease is a condition.\",\\n    \"Low-risk is a risk category.\",\\n    \"Intermediate-risk is a risk category.\",\\n    \"High-risk is a risk category.\",\\n    \"Stage I is a stage.\",\\n    \"Stage II is a stage.\",\\n    \"Stage III is a stage.\",\\n    \"Major rupture is a condition.\",\\n    \"Austria is a country.\",\\n    \"Italy is a country.\",\\n    \"San Marino is a country.\",\\n    \"Iceland is a country.\",\\n    \"Germany is a country.\",\\n    \"Bulgaria is a country.\",\\n    \"Turkey is a country.\",\\n    \"Denmark is a country.\",\\n    \"Poland is a country.\",\\n    \"Greece is a country.\",\\n    \"Andorra is a country.\",\\n    \"Belgium is a country.\",\\n    \"Serbia is a country.\",\\n    \"Albania is a country.\",\\n    \"Moldova is a country.\",\\n    \"Lithuania is a country.\",\\n    \"Latvia is a country.\",\\n    \"Estonia is a country.\",\\n    \"Luxembourg is a country.\",\\n    \"Montenegro is a country.\",\\n    \"Bosnia and Herzegovina is a country.\",\\n    \"Croatia is a country.\",\\n    \"Slovenia is a country.\",\\n    \"Macedonia is a country.\",\\n    \"United Kingdom is a country.\",\\n    \"Ireland is a country.\",\\n    \"Spain is a country.\",\\n    \"Algeria is a country.\",\\n    \"Tunisia is a country.\",\\n    \"Malta is a country.\",\\n    \"Morocco is a country.\",\\n    \"Portugal is a country.\",\\n    \"France is a country.\",\\n    \"Monaco is a country.\",\\n    \"Russia is a country.\",\\n    \"Finland is a country.\",\\n    \"Sweden is a country.\",\\n    \"Norway is a country.\",\\n    \"Belarus is a country.\",\\n    \"Romania is a country.\",\\n    \"Ukraine is a country.\",\\n    \"Hungary is a country.\",\\n    \"Czech Republic is a country.\",\\n    \"Slovakia is a country.\",\\n    \"Switzerland is a country.\",\\n    \"Liechtenstein is a country.\",\\n    \"Netherlands is a country.\",\\n    \"University Hospital of Munich is an institution.\",\\n    \"University Hospital of Tuebingen is an institution.\",\\n    \"Azienda Ospedaliera is an institution.\",\\n    \"Ospedale Pediatrico Bambino Ges\u00f9 is an institution.\",\\n    \"Fondazione IRCCS Istituto Nazionale dei Tumori is an institution.\",\\n    \"Prinses Maxima Centrum is an institution.\",\\n    \"Marciniak Hospital is an institution.\",\\n    \"Faculty of Medicine is an institution.\",\\n    \"St. Anna Kinderspital/CCRI is an institution.\",\\n    \"Armand Trousseau Hospital is an institution.\",\\n    \"Hospital Universitario Virgin del Rocio is an institution.\",\\n    \"Hospital Vall d\u2019Hebron is an institution.\",\\n    \"Great Ormond Street Hospital is an institution.\",\\n    \"University Hospital Homburg is an institution.\",\\n    \"L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon is an institution.\",\\n    \"UMBRELLA protocol is a project.\",\\n    \"ExPO\u2011r\u2011Net is a project.\",\\n    \"Weirich, A. is an author.\",\\n    \"Pritchard-Jones, K. is an author.\",\\n    \"de Kraker, J. is an author.\",\\n    \"Graf, N. is an author.\",\\n    \"Green, D. M. is an author.\",\\n    \"Spreafico, F. is an author.\",\\n    \"Bellani, F. F. is an author.\",\\n    \"van den Heuvel-Eibrink, M. M. is an author.\",\\n    \"D\\'Angio, G. J. is an author.\",\\n    \"Tournade, M. F. is an author.\",\\n    \"Breslow, N. E. is an author.\",\\n    \"Mitchell, C. is an author.\",\\n    \"Verschuur, A. is an author.\",\\n    \"Grundy, P. E. is an author.\",\\n    \"Warmann, S. W. is an author.\",\\n    \"Smets, A. M. is an author.\",\\n    \"Dome, J. S. is an author.\",\\n    \"Dix, D. B. is an author.\",\\n    \"Daw, N. C. is an author.\",\\n    \"Ha, T. C. is an author.\",\\n    \"Kremens, B. is an author.\",\\n    \"Furtwangler, R. is an author.\",\\n    \"SIOP-9/GPOH is a study.\",\\n    \"UKW3 is a trial.\",\\n    \"SIOP 93\u201301 trial is a trial.\",\\n    \"SIOP trial and study 93\u201301 is a study.\",\\n    \"National Wilms Tumor Study Group is an organization.\",\\n    \"SIOP WT 2001 protocol is a protocol.\",\\n    \"Third National Wilms\u2019 Tumor Study is a study.\",\\n    \"Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study is a study.\",\\n    \"National Wilms Tumor Studies is a study.\",\\n    \"Second National Wilms\u2019 Tumor Study is a study.\",\\n    \"Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study is a study.\",\\n    \"UK Children\u2019s Cancer Study Group is an organization.\",\\n    \"Children\u2019s Oncology Group is an organization.\"\\n] \\n \\nVerdicts:\\n[\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"Wilms tumours are a type of disease, not a singular disease.\"\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"Non-Wilms tumours are also considered a type of disease.\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"The Department of Paediatric Oncology is at the Princess M\\\\u00e1xima Center for Paediatric Oncology, but is not a part of it.\"\\n    },\\n    {\\n        \"verdict\": \"idk\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"The UMBRELLA protocol refers to a comprehensive treatment framework, not a treatment specifically.\"\\n    },\\n    {\\n        \"verdict\": \"idk\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"idk\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"SIOP\\\\u22122001 is a study protocol, not merely defined as a trial.\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"idk\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    }\\n]'), MetricData(name='Contextual Relevancy', threshold=1.0, success=False, score=0.9, reason=\"The score is 0.90 because although the retrieval context mentions 'chemotherapy agents', it lacks specificity on names, making it partially relevant. However, it does include specific agents such as 'actinomycin D', 'vincristine', and 'doxorubicin', which directly address the input query about chemotherapy agents.\", strict_mode=False, evaluation_model='gpt-4o-mini', error=None, evaluation_cost=0.00364635, verbose_logs='Verdicts:\\n[\\n    {\\n        \"verdicts\": [\\n            {\\n                \"statement\": \"actinomycin D_Drug\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"vincristine_Drug\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"doxorubicin_Drug\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"cyclophosphamide_Drug\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"etoposide_Drug\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"vincristine and actinomycin D plus doxorubicin_treatment\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"chemotherapy_treatment_method\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"high-dose chemotherapy and autologous stem cell transplantation_treatment\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"chemotherapy agents mentioned in the treatment recommendations\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"The retrieval context contained the information \\' chemotherapy agents\\' but did not specify the names.\"\\n            }\\n        ]\\n    }\\n]')], conversational=False, multimodal=False, input='What specific chemotherapy agents are mentioned in the treatment recommendations?', actual_output='[{\\'nodes\\': [(\\'sample.pdf\\', {\\'type\\': \\'document\\'}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)\\'}), (\\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA SIOP-RTSG 2016\\'}), (\\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms tumours\\'}), (\\'non-Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'non-Wilms tumours\\'}), (\\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Website\\', \\'name\\': \\'www.siop-rtsg.eu\\'}), (\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology\\'}), (\\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Person\\', \\'name\\': \\'Marry M. van den Heuvel-Eibrink\\'}), (\\'childhood renal tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'childhood renal tumours\\'}), (\\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'clear cell sarcoma of the kidney\\'}), (\\'renal cell carcinoma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'renal cell carcinoma\\'}), (\\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'malignant rhabdoid tumour of the kidney\\'}), (\\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'Wilms tumours_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'Children\u2019s Oncology Group (COG)\\'}), (\\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'SIOP\u22122001 randomized trial\\'}), (\\'actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'UKW3 trial\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)\\'}), (\\'localized disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'localized disease\\'}), (\\'metastatic disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'metastatic disease\\'}), (\\'bilateral disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'bilateral disease\\'}), (\\'relapsed disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'relapsed disease\\'}), (\\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subtype\\', \\'name\\': \\'blastemal-type Wilms tumours\\'}), (\\'radiotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgery_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'chemotherapy\\'}), (\\'Wilms Tumour_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms Tumour\\'}), (\\'CCSK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CCSK\\'}), (\\'MRTK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'MRTK\\'}), (\\'CMN_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CMN\\'}), (\\'RCC_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'RCC\\'}), (\\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u22122001_Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Trial\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'vincristine_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'vincristine\\'}), (\\'actinomycin D_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'actinomycin D\\'}), (\\'doxorubicin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'doxorubicin\\'}), (\\'etoposide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'Stage I_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage I\\'}), (\\'Stage II_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage II\\'}), (\\'Stage III_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage III\\'}), (\\'Stage IV_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage IV\\'}), (\\'Stage V_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage V\\'}), (\\'AV_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AV\\'}), (\\'AVD_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AVD\\'}), (\\'HR-1_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'HR-1\\'}), (\\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP-RTSG 2016\\'}), (\\'Overall Survival (OS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'CT-only nodules_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'CT-only nodules\\'}), (\\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP\u2013RTSG analysis\\'}), (\\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials\\'}), (\\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D plus doxorubicin\\'}), (\\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D\\'}), (\\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study_protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'MRI_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'MRI\\'}), (\\'CT_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'CT\\'}), (\\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_detail\\', \\'name\\': \\'cumulative doxorubicin dose\\'}), (\\'COG AREN0533 trial_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG AREN0533 trial\\'}), (\\'etoposide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'high-risk characteristics\\'}), (\\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG board\\'}), (\\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin\\'}), (\\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'high-dose chemotherapy and autologous stem cell transplantation\\'}), (\\'SIOP database_database\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'database\\', \\'name\\': \\'SIOP database\\'}), (\\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'AVD_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AVD\\'}), (\\'AV-2_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AV-2\\'}), (\\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Statistical Test\\', \\'name\\': \\'Log\u2013Rank P\\'}), (\\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'Bilateral Disease (Stage V)\\'}), (\\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Synchronous bilateral Wilms tumor\\'}), (\\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'End-stage renal disease (ESRD)\\'}), (\\'Aronson et al._Research Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Research Group\\', \\'name\\': \\'Aronson et al.\\'}), (\\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'Bilateral nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Study\\', \\'name\\': \\'SIOP\u22122001 study\\'}), (\\'Vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Vincristine\\'}), (\\'Actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Actinomycin D\\'}), (\\'Etoposide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Etoposide\\'}), (\\'Carboplatin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Carboplatin\\'}), (\\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease State\\', \\'name\\': \\'Relapsed Wilms Tumor\\'}), (\\'Group AA_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group AA\\'}), (\\'Group BB_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group BB\\'}), (\\'Group CC_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group CC\\'}), (\\'Doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Doxorubicin\\'}), (\\'Cyclophosphamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Cyclophosphamide\\'}), (\\'Ifosfamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Ifosfamide\\'}), (\\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'High-dose melphalan\\'}), (\\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UKW\u2011R protocol\\'}), (\\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'NWTS\u20115 relapse protocol\\'}), (\\'ASCR_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'procedure\\', \\'name\\': \\'ASCR\\'}), (\\'ifosfamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'ifosfamide\\'}), (\\'nephrotoxicity_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'nephrotoxicity\\'}), (\\'relapsed group CC_patient_group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'patient_group\\', \\'name\\': \\'relapsed group CC\\'}), (\\'diffuse anaplasia_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'diffuse anaplasia\\'}), (\\'blastemal-type tumors_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'blastemal-type tumors\\'}), (\\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'camptothecins_medication_class\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication_class\\', \\'name\\': \\'camptothecins\\'}), (\\'irinotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'irinotecan\\'}), (\\'topotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'topotecan\\'}), (\\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Innovative Therapies for Children with Cancer consortium\\'}), (\\'radiotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgical excision_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgical excision\\'}), (\\'stage IV WT_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'stage IV WT\\'}), (\\'AVD150_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD150\\'}), (\\'AVD250_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD250\\'}), (\\'low-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'low-risk disease\\'}), (\\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'intermediate-risk disease\\'}), (\\'high-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'high-risk disease\\'}), (\\'CDCV_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'CDCV\\'}), (\\'actinomycin-D_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'actinomycin-D\\'}), (\\'vincristine_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'doxorubicin\\'}), (\\'VP16_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'VP16\\'}), (\\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'contact\\', \\'name\\': \\'arnauld.verschuur@ap-hm.fr\\'}), (\\'surgery_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'chemotherapy\\'}), (\\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2212RTSG panel\\'}), (\\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Infant Wilms Tumors\\'}), (\\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'nephrectomy\\'}), (\\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'malignant rhabdoid tumors\\'}), (\\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Adult Wilms Tumors\\'}), (\\'anaplasia_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'anaplasia\\'}), (\\'actinomycin D_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'carboplatin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'etoposide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'etoposide\\'}), (\\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'Nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'radical tumor nephrectomy\\'}), (\\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'lymph node sampling\\'}), (\\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'minimally invasive surgery\\'}), (\\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'laparoscopic surgery\\'}), (\\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'radiotherapy\\'}), (\\'Wilms tumours_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'Davila Fajardo et al._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Davila Fajardo et al.\\'}), (\\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'COG\u2013NWTS trials\\'}), (\\'whole-lung irradiation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'whole-lung irradiation\\'}), (\\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'pulmonary radiotherapy\\'}), (\\'proton therapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'proton therapy\\'}), (\\'dosimetric study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'dosimetric study\\'}), (\\'locoregional disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'locoregional disease\\'}), (\\'metastatic disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'metastatic disease\\'}), (\\'low-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'low-risk\\'}), (\\'intermediate-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'intermediate-risk\\'}), (\\'high-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'high-risk\\'}), (\\'stage I_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage I\\'}), (\\'stage II_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage II\\'}), (\\'stage III_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage III\\'}), (\\'major rupture_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'major rupture\\'}), (\\'Austria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Austria\\'}), (\\'Italy_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Italy\\'}), (\\'San Marino_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'San Marino\\'}), (\\'Iceland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Iceland\\'}), (\\'Germany_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Germany\\'}), (\\'Bulgaria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bulgaria\\'}), (\\'Turkey_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Turkey\\'}), (\\'Denmark_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Denmark\\'}), (\\'Poland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Poland\\'}), (\\'Greece_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Greece\\'}), (\\'Andorra_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Andorra\\'}), (\\'Belgium_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belgium\\'}), (\\'Serbia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Serbia\\'}), (\\'Albania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Albania\\'}), (\\'Moldova_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Moldova\\'}), (\\'Lithuania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Lithuania\\'}), (\\'Latvia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Latvia\\'}), (\\'Estonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Estonia\\'}), (\\'Luxembourg_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Luxembourg\\'}), (\\'Montenegro_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Montenegro\\'}), (\\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bosnia and Herzegovina\\'}), (\\'Croatia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Croatia\\'}), (\\'Slovenia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovenia\\'}), (\\'Macedonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Macedonia\\'}), (\\'United Kingdom_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'United Kingdom\\'}), (\\'Ireland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ireland\\'}), (\\'Spain_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Spain\\'}), (\\'Algeria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Algeria\\'}), (\\'Tunisia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Tunisia\\'}), (\\'Malta_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Malta\\'}), (\\'Morocco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Morocco\\'}), (\\'Portugal_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Portugal\\'}), (\\'France_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'France\\'}), (\\'Monaco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Monaco\\'}), (\\'Russia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Russia\\'}), (\\'Finland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Finland\\'}), (\\'Sweden_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Sweden\\'}), (\\'Norway_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Norway\\'}), (\\'Belarus_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belarus\\'}), (\\'Romania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Romania\\'}), (\\'Ukraine_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ukraine\\'}), (\\'Hungary_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Hungary\\'}), (\\'Czech Republic_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Czech Republic\\'}), (\\'Slovakia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovakia\\'}), (\\'Switzerland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Switzerland\\'}), (\\'Liechtenstein_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Liechtenstein\\'}), (\\'Netherlands_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Netherlands\\'}), (\\'University Hospital of Munich_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Munich\\'}), (\\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Tuebingen\\'}), (\\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Azienda Ospedaliera\\'}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Ospedale Pediatrico Bambino Ges\u00f9\\'}), (\\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Fondazione IRCCS Istituto Nazionale dei Tumori\\'}), (\\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Prinses Maxima Centrum\\'}), (\\'Marciniak Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Marciniak Hospital\\'}), (\\'Faculty of Medicine_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Faculty of Medicine\\'}), (\\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'St. Anna Kinderspital/CCRI\\'}), (\\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Armand Trousseau Hospital\\'}), (\\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Universitario Virgin del Rocio\\'}), (\\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Vall d\u2019Hebron\\'}), (\\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Great Ormond Street Hospital\\'}), (\\'University Hospital Homburg_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital Homburg\\'}), (\\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon\\'}), (\\'UMBRELLA protocol_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'ExPO\u2011r\u2011Net\\'}), (\\'Weirich, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Weirich, A.\\'}), (\\'Pritchard-Jones, K._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Pritchard-Jones, K.\\'}), (\\'de Kraker, J._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'de Kraker, J.\\'}), (\\'Graf, N._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Graf, N.\\'}), (\\'Green, D. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Green, D. M.\\'}), (\\'Spreafico, F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Spreafico, F.\\'}), (\\'Bellani, F. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Bellani, F. F.\\'}), (\\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'van den Heuvel-Eibrink, M. M.\\'}), (\"D\\'Angio, G. J._author\", {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \"D\\'Angio, G. J.\"}), (\\'Tournade, M. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Tournade, M. F.\\'}), (\\'Breslow, N. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Breslow, N. E.\\'}), (\\'Mitchell, C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Mitchell, C.\\'}), (\\'Verschuur, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Verschuur, A.\\'}), (\\'Grundy, P. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Grundy, P. E.\\'}), (\\'Warmann, S. W._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Warmann, S. W.\\'}), (\\'Smets, A. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Smets, A. M.\\'}), (\\'Dome, J. S._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dome, J. S.\\'}), (\\'Dix, D. B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dix, D. B.\\'}), (\\'Daw, N. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Daw, N. C.\\'}), (\\'Ha, T. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Ha, T. C.\\'}), (\\'Kremens, B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Kremens, B.\\'}), (\\'Furtwangler, R._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Furtwangler, R.\\'}), (\\'SIOP-9/GPOH_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP-9/GPOH\\'}), (\\'UKW3_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'UKW3\\'}), (\\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'SIOP 93\u201301 trial\\'}), (\\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP trial and study 93\u201301\\'}), (\\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'National Wilms Tumor Study Group\\'}), (\\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP WT 2001 protocol\\'}), (\\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Third National Wilms\u2019 Tumor Study\\'}), (\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'National Wilms Tumor Studies\\'}), (\\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Second National Wilms\u2019 Tumor Study\\'}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'UK Children\u2019s Cancer Study Group\\'}), (\\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Children\u2019s Oncology Group\\'})], \\'edges\\': [(\\'sample.pdf\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'non-Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'childhood renal tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'renal cell carcinoma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'localized disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'metastatic disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'bilateral disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'relapsed disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'radiotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'surgery_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'chemotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'Wilms Tumour_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CCSK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'MRTK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CMN_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'RCC_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP\u22122001_Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'vincristine_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'actinomycin D_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'doxorubicin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'etoposide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'carboplatin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'cyclophosphamide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage I_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage II_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage III_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage IV_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage V_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AV_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AVD_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'HR-1_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Overall Survival (OS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT-only nodules_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'MRI_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG AREN0533 trial_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'etoposide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'carboplatin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'cyclophosphamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP database_database\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AVD_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AV-2_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Aronson et al._Research Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Etoposide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Carboplatin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group AA_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group BB_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group CC_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Cyclophosphamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Ifosfamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'ASCR_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'ifosfamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'nephrotoxicity_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'relapsed group CC_patient_group\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'diffuse anaplasia_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'blastemal-type tumors_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'camptothecins_medication_class\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'irinotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'topotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'radiotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'surgical excision_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'stage IV WT_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD150_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD250_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'low-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'CDCV_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'actinomycin-D_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'vincristine_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'doxorubicin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'VP16_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'surgery_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'chemotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'anaplasia_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'actinomycin D_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'vincristine_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'doxorubicin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'carboplatin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'cyclophosphamide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'etoposide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'SIOP\u22122001_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Wilms tumours_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Davila Fajardo et al._author\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'whole-lung irradiation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'proton therapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'dosimetric study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'locoregional disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'metastatic disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'low-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'intermediate-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'high-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage I_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage II_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage III_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'major rupture_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Austria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Italy_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'San Marino_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Iceland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Germany_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bulgaria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Turkey_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Denmark_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Poland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Greece_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Andorra_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belgium_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Serbia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Albania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Moldova_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Lithuania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Latvia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Estonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Luxembourg_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Montenegro_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Croatia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovenia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Macedonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'United Kingdom_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ireland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Spain_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Algeria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Tunisia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Malta_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Morocco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Portugal_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'France_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Monaco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Russia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Finland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Sweden_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Norway_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belarus_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Romania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ukraine_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hungary_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Czech Republic_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovakia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Switzerland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Liechtenstein_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Netherlands_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Munich_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Marciniak Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Faculty of Medicine_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital Homburg_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Weirich, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Pritchard-Jones, K._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'de Kraker, J._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Graf, N._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Green, D. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Spreafico, F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Bellani, F. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \"D\\'Angio, G. J._author\", {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Tournade, M. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Breslow, N. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Mitchell, C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Verschuur, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Grundy, P. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Warmann, S. W._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Smets, A. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dome, J. S._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dix, D. B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Daw, N. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ha, T. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Kremens, B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Furtwangler, R._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP-9/GPOH_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UKW3_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10})]}, {\\'nodes\\': [(\\'vincristine_entity\\', {}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {}), (\\'www.siop-rtsg.eu_entity\\', {}), (\\'stage II_entity\\', {}), (\\'Wilms tumours_entity\\', {}), (\\'Relapsed Wilms Tumor_entity\\', {}), (\\'Davila Fajardo et al._entity\\', {}), (\\'vincristine, actinomycin D, and doxorubicin_entity\\', {}), (\\'SIOP\u22122001 randomized trial_entity\\', {}), (\\'surgery_entity\\', {}), (\\'non-Wilms tumours_entity\\', {}), (\\'actinomycin D_entity\\', {}), (\\'diffuse anaplasia_entity\\', {}), (\\'Synchronous bilateral Wilms tumor_entity\\', {}), (\\'CT-only nodules_entity\\', {}), (\\'relapsed group CC_entity\\', {}), (\\'increased relapse risk_entity\\', {}), (\\'reduced survival_entity\\', {}), (\\'UKW3 trial_entity\\', {}), (\\'chemotherapy_entity\\', {}), (\\'Bilateral Disease (Stage V)_entity\\', {}), (\\'blastemal-type tumors_entity\\', {}), (\\'UMBRELLA protocol_entity\\', {}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', {}), (\\'minimally invasive surgery_entity\\', {}), (\\'VP16_entity\\', {}), (\\'Wilms tumor_entity\\', {}), (\\'anaplasia_entity\\', {}), (\\'radical tumor nephrectomy_entity\\', {}), (\\'Innovative Therapies for Children with Cancer consortium_entity\\', {}), (\\'cumulative doxorubicin dose_entity\\', {}), (\\'etoposide_entity\\', {}), (\\'large-volume tumours_entity\\', {}), (\\'Stage IV_entity\\', {}), (\\'CDCV_entity\\', {}), (\\'SIOP\u2013RTSG_entity\\', {}), (\\'AVD150_entity\\', {}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', {}), (\\'laparoscopic surgery_entity\\', {}), (\\'SIOP\u2212RTSG panel_entity\\', {}), (\\'actinomycin-D_entity\\', {}), (\\'COG AREN0533 trial_entity\\', {}), (\\'cyclophosphamide_entity\\', {}), (\\'carboplatin_entity\\', {}), (\\'UKW\u2011R protocol_entity\\', {}), (\\'Nephron-sparing surgery (NSS)_entity\\', {}), (\\'Adult Wilms Tumors_entity\\', {}), (\\'doxorubicin_entity\\', {}), (\\'NWTS\u20115 relapse protocol_entity\\', {}), (\\'End-stage renal disease (ESRD)_entity\\', {}), (\\'AVD250_entity\\', {}), (\\'Children\u2019s Oncology Group (COG)_entity\\', {}), (\\'blastemal-type Wilms tumour_entity\\', {}), (\\'SIOP\u22122001_entity\\', {}), (\\'radiotherapy_entity\\', {}), (\\'childhood renal tumours_entity\\', {})], \\'edges\\': [(\\'vincristine_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'stage II_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'indicated_for_in_adults\\'}), (\\'Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'Wilms tumours_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated under\\'}), (\\'Relapsed Wilms Tumor_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guided_by\\'}), (\\'Davila Fajardo et al._entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed\\'}), (\\'SIOP\u22122001 randomized trial_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated use in\\'}), (\\'surgery_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'non-Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'actinomycin D_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Synchronous bilateral Wilms tumor_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'instance_of\\'}), (\\'CT-only nodules_entity\\', \\'increased relapse risk_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'reduced survival_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included_in\\'}), (\\'relapsed group CC_entity\\', \\'diffuse anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'blastemal-type tumors_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UKW3 trial_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'UKW3 trial_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'chemotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UMBRELLA protocol_entity\\', \\'COG AREN0533 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses_data_from\\'}), (\\'UMBRELLA protocol_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'advises_treatment_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'Innovative Therapies for Children with Cancer consortium_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborates_with\\'}), (\\'UMBRELLA protocol_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'surgery_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is the standard of\\'}), (\\'UMBRELLA protocol_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guides treatment in\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', \\'UKW3 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\\'minimally invasive surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'anaplasia_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'radical tumor nephrectomy_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'standard_of_care_for\\'}), (\\'Stage IV_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'presents in\\'}), (\\'CDCV_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'VP16_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'aims to improve survival rates of\\'}), (\\'AVD150_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed_by\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'succeeds\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'www.siop-rtsg.eu_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'available_on\\'}), (\\'laparoscopic surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'COG AREN0533 trial_entity\\', \\'cumulative doxorubicin dose_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'evaluates\\'}), (\\'UKW\u2011R protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'Nephron-sparing surgery (NSS)_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'classification_developed_by\\'}), (\\'Adult Wilms Tumors_entity\\', \\'anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'Adult Wilms Tumors_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'doxorubicin_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'doxorubicin_entity\\', \\'large-volume tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'recommended for\\'}), (\\'NWTS\u20115 relapse protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'End-stage renal disease (ESRD)_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'AVD250_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'Children\u2019s Oncology Group (COG)_entity\\', \\'SIOP\u22122001 randomized trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborated with\\'}), (\\'blastemal-type Wilms tumour_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment intensified according to\\'}), (\\'SIOP\u22122001_entity\\', \\'vincristine, actinomycin D, and doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses\\'}), (\\'SIOP\u22122001_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provided_guidelines_for\\'}), (\\'radiotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'radiotherapy_entity\\', \\'SIOP\u2212RTSG panel_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'contact_for_guidance\\'})]}, {\\'nodes\\': [(\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {}), (\\'Marry M. van den Heuvel-Eibrink_entity\\', {})], \\'edges\\': [(\\'Marry M. van den Heuvel-Eibrink_entity\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'affiliated_with\\'})]}, {\\'nodes\\': [(\\'Stage II_entity\\', {}), (\\'AV_entity\\', {}), (\\'Stage III_entity\\', {}), (\\'vincestine and actinomycin D_entity\\', {}), (\\'AVD_entity\\', {})], \\'edges\\': [(\\'Stage II_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AV_entity\\', \\'Stage II_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Stage III_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AVD_entity\\', \\'Stage III_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'SIOP-RTSG 2016_entity\\', {}), (\\'RCC_entity\\', {}), (\\'CMN_entity\\', {})], \\'edges\\': [(\\'RCC_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'}), (\\'CMN_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'})]}, {\\'nodes\\': [(\\'HR-1_entity\\', {}), (\\'High-risk blastemal type Wilms tumour_entity\\', {})], \\'edges\\': [(\\'HR-1_entity\\', \\'High-risk blastemal type Wilms tumour_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'unfavorable prognosis_entity\\', {}), (\\'high-risk characteristics_entity\\', {})], \\'edges\\': [(\\'high-risk characteristics_entity\\', \\'unfavorable prognosis_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'leads_to\\'})]}, {\\'nodes\\': [(\\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {}), (\\'SIOP\u2013RTSG board_entity\\', {})], \\'edges\\': [(\\'SIOP\u2013RTSG board_entity\\', \\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggests\\'})]}, {\\'nodes\\': [(\\'regimen and outcomes_entity\\', {}), (\\'SIOP database_entity\\', {})], \\'edges\\': [(\\'SIOP database_entity\\', \\'regimen and outcomes_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'captures_data_on\\'})]}, {\\'nodes\\': [(\\'Bilateral nephron-sparing surgery (NSS)_entity\\', {}), (\\'Aronson et al._entity\\', {})], \\'edges\\': [(\\'Aronson et al._entity\\', \\'Bilateral nephron-sparing surgery (NSS)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'observed_effectiveness_of\\'})]}, {\\'nodes\\': [(\\'SIOP\u22122001 study_entity\\', {}), (\\'Actinomycin D_entity\\', {}), (\\'Vincristine_entity\\', {})], \\'edges\\': [(\\'SIOP\u22122001 study_entity\\', \\'Vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'}), (\\'SIOP\u22122001 study_entity\\', \\'Actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'})]}, {\\'nodes\\': [(\\'High-dose melphalan_entity\\', {}), (\\'Group AA_entity\\', {}), (\\'Carboplatin_entity\\', {}), (\\'Doxorubicin_entity\\', {}), (\\'Etoposide_entity\\', {}), (\\'Group BB_entity\\', {}), (\\'Cyclophosphamide_entity\\', {}), (\\'Ifosfamide_entity\\', {})], \\'edges\\': [(\\'Group AA_entity\\', \\'Doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Ifosfamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'High-dose melphalan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'})]}, {\\'nodes\\': [(\\'nephrotoxicity_entity\\', {}), (\\'ifosfamide_entity\\', {})], \\'edges\\': [(\\'ifosfamide_entity\\', \\'nephrotoxicity_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'related_to\\'})]}, {\\'nodes\\': [(\\'camptothecins_entity\\', {}), (\\'irinotecan_entity\\', {}), (\\'topotecan_entity\\', {})], \\'edges\\': [(\\'camptothecins_entity\\', \\'irinotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'camptothecins_entity\\', \\'topotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'})]}, {\\'nodes\\': [(\\'Infant Wilms Tumors_entity\\', {}), (\\'nephrectomy_entity\\', {})], \\'edges\\': [(\\'Infant Wilms Tumors_entity\\', \\'nephrectomy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_option\\'})]}, {\\'nodes\\': [(\\'congenital mesoblastic nephroma_entity\\', {}), (\\'surgery alone_entity\\', {})], \\'edges\\': [(\\'congenital mesoblastic nephroma_entity\\', \\'surgery alone_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'alternative chemotherapy_entity\\', {}), (\\'malignant rhabdoid tumors_entity\\', {})], \\'edges\\': [(\\'malignant rhabdoid tumors_entity\\', \\'alternative chemotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'lymph node sampling_entity\\', {}), (\\'accurate staging_entity\\', {})], \\'edges\\': [(\\'lymph node sampling_entity\\', \\'accurate staging_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'purpose_of\\'})]}, {\\'nodes\\': [(\\'COG\u2013NWTS trials_entity\\', {}), (\\'whole-lung irradiation_entity\\', {})], \\'edges\\': [(\\'COG\u2013NWTS trials_entity\\', \\'whole-lung irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'informed_dosage_for\\'})]}, {\\'nodes\\': [(\\'lung metastases_entity\\', {}), (\\'pulmonary radiotherapy_entity\\', {})], \\'edges\\': [(\\'pulmonary radiotherapy_entity\\', \\'lung metastases_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'administered_for\\'})]}, {\\'nodes\\': [(\\'dosimetric study_entity\\', {}), (\\'proton therapy_entity\\', {}), (\\'flank irradiation_entity\\', {})], \\'edges\\': [(\\'dosimetric study_entity\\', \\'proton therapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated\\'}), (\\'proton therapy_entity\\', \\'flank irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggested_for\\'})]}, {\\'nodes\\': [(\\'metastatic disease_entity\\', {}), (\\'radiotherapy guidelines_entity\\', {}), (\\'locoregional disease_entity\\', {})], \\'edges\\': [(\\'radiotherapy guidelines_entity\\', \\'locoregional disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'}), (\\'radiotherapy guidelines_entity\\', \\'metastatic disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'})]}, {\\'nodes\\': [(\\'major rupture_entity\\', {}), (\\'stage III_entity\\', {})], \\'edges\\': [(\\'stage III_entity\\', \\'major rupture_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes_condition\\'})]}, {\\'nodes\\': [(\\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {}), (\\'ExPO\u2011r\u2011Net_entity\\', {})], \\'edges\\': [(\\'ExPO\u2011r\u2011Net_entity\\', \\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is part of\\'})]}, {\\'nodes\\': [(\\'University Hospital of Munich_entity\\', {}), (\\'Germany_entity\\', {}), (\\'University Hospital of Tuebingen_entity\\', {})], \\'edges\\': [(\\'Germany_entity\\', \\'University Hospital of Munich_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Germany_entity\\', \\'University Hospital of Tuebingen_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {}), (\\'Italy_entity\\', {}), (\\'Azienda Ospedaliera_entity\\', {}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {})], \\'edges\\': [(\\'Italy_entity\\', \\'Azienda Ospedaliera_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Netherlands_entity\\', {}), (\\'Prinses Maxima Centrum_entity\\', {})], \\'edges\\': [(\\'Netherlands_entity\\', \\'Prinses Maxima Centrum_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Marciniak Hospital_entity\\', {}), (\\'Poland_entity\\', {}), (\\'Faculty of Medicine_entity\\', {})], \\'edges\\': [(\\'Poland_entity\\', \\'Marciniak Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Poland_entity\\', \\'Faculty of Medicine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'St. Anna Kinderspital/CCRI_entity\\', {}), (\\'Austria_entity\\', {})], \\'edges\\': [(\\'Austria_entity\\', \\'St. Anna Kinderspital/CCRI_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'France_entity\\', {}), (\\'Armand Trousseau Hospital_entity\\', {})], \\'edges\\': [(\\'France_entity\\', \\'Armand Trousseau Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Spain_entity\\', {}), (\\'Hospital Vall d\u2019Hebron_entity\\', {}), (\\'Hospital Universitario Virgin del Rocio_entity\\', {})], \\'edges\\': [(\\'Spain_entity\\', \\'Hospital Universitario Virgin del Rocio_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Spain_entity\\', \\'Hospital Vall d\u2019Hebron_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'United Kingdom_entity\\', {}), (\\'Great Ormond Street Hospital_entity\\', {})], \\'edges\\': [(\\'United Kingdom_entity\\', \\'Great Ormond Street Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Weirich, A._entity\\', {}), (\\'SIOP-9/GPOH_entity\\', {})], \\'edges\\': [(\\'Weirich, A._entity\\', \\'SIOP-9/GPOH_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Pritchard-Jones, K._entity\\', {}), (\\'UKW3_entity\\', {})], \\'edges\\': [(\\'Pritchard-Jones, K._entity\\', \\'UKW3_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed in\\'})]}, {\\'nodes\\': [(\\'SIOP 93\u201301 trial_entity\\', {}), (\\'de Kraker, J._entity\\', {})], \\'edges\\': [(\\'de Kraker, J._entity\\', \\'SIOP 93\u201301 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'SIOP trial and study 93\u201301_entity\\', {}), (\\'Graf, N._entity\\', {})], \\'edges\\': [(\\'Graf, N._entity\\', \\'SIOP trial and study 93\u201301_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Green, D. M._entity\\', {}), (\\'National Wilms Tumor Study Group_entity\\', {})], \\'edges\\': [(\\'Green, D. M._entity\\', \\'National Wilms Tumor Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}, {\\'nodes\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', {}), (\\'SIOP WT 2001 protocol_entity\\', {})], \\'edges\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', \\'SIOP WT 2001 protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Third National Wilms\u2019 Tumor Study_entity\\', {}), (\"D\\'Angio, G. J._entity\", {}), (\\'Second National Wilms\u2019 Tumor Study_entity\\', {})], \\'edges\\': [(\"D\\'Angio, G. J._entity\", \\'Third National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\"D\\'Angio, G. J._entity\", \\'Second National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {}), (\\'Tournade, M. F._entity\\', {}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {})], \\'edges\\': [(\\'Tournade, M. F._entity\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'}), (\\'Tournade, M. F._entity\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Breslow, N. E._entity\\', {}), (\\'National Wilms Tumor Studies_entity\\', {})], \\'edges\\': [(\\'Breslow, N. E._entity\\', \\'National Wilms Tumor Studies_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Mitchell, C._entity\\', {}), (\\'UK Children\u2019s Cancer Study Group_entity\\', {})], \\'edges\\': [(\\'Mitchell, C._entity\\', \\'UK Children\u2019s Cancer Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'under\\'})]}, {\\'nodes\\': [(\\'Daw, N. C._entity\\', {}), (\\'Dix, D. B._entity\\', {}), (\\'Children\u2019s Oncology Group_entity\\', {}), (\\'Grundy, P. E._entity\\', {})], \\'edges\\': [(\\'Daw, N. C._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted under\\'}), (\\'Dix, D. B._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'}), (\\'Grundy, P. E._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}]', expected_output='Agents such as vincristine, actinomycin D, doxorubicin, and in some cases etoposide and cyclophosphamide are mentioned.', context=None, retrieval_context=['[{\\'nodes\\': [(\\'sample.pdf\\', {\\'type\\': \\'document\\'}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)\\'}), (\\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA SIOP-RTSG 2016\\'}), (\\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms tumours\\'}), (\\'non-Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'non-Wilms tumours\\'}), (\\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Website\\', \\'name\\': \\'www.siop-rtsg.eu\\'}), (\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology\\'}), (\\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Person\\', \\'name\\': \\'Marry M. van den Heuvel-Eibrink\\'}), (\\'childhood renal tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'childhood renal tumours\\'}), (\\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'clear cell sarcoma of the kidney\\'}), (\\'renal cell carcinoma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'renal cell carcinoma\\'}), (\\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'malignant rhabdoid tumour of the kidney\\'}), (\\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'Wilms tumours_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'Children\u2019s Oncology Group (COG)\\'}), (\\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'SIOP\u22122001 randomized trial\\'}), (\\'actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'UKW3 trial\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)\\'}), (\\'localized disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'localized disease\\'}), (\\'metastatic disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'metastatic disease\\'}), (\\'bilateral disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'bilateral disease\\'}), (\\'relapsed disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'relapsed disease\\'}), (\\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subtype\\', \\'name\\': \\'blastemal-type Wilms tumours\\'}), (\\'radiotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgery_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'chemotherapy\\'}), (\\'Wilms Tumour_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms Tumour\\'}), (\\'CCSK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CCSK\\'}), (\\'MRTK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'MRTK\\'}), (\\'CMN_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CMN\\'}), (\\'RCC_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'RCC\\'}), (\\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u22122001_Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Trial\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'vincristine_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'vincristine\\'}), (\\'actinomycin D_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'actinomycin D\\'}), (\\'doxorubicin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'doxorubicin\\'}), (\\'etoposide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'Stage I_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage I\\'}), (\\'Stage II_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage II\\'}), (\\'Stage III_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage III\\'}), (\\'Stage IV_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage IV\\'}), (\\'Stage V_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage V\\'}), (\\'AV_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AV\\'}), (\\'AVD_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AVD\\'}), (\\'HR-1_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'HR-1\\'}), (\\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP-RTSG 2016\\'}), (\\'Overall Survival (OS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'CT-only nodules_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'CT-only nodules\\'}), (\\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP\u2013RTSG analysis\\'}), (\\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials\\'}), (\\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D plus doxorubicin\\'}), (\\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D\\'}), (\\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study_protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'MRI_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'MRI\\'}), (\\'CT_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'CT\\'}), (\\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_detail\\', \\'name\\': \\'cumulative doxorubicin dose\\'}), (\\'COG AREN0533 trial_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG AREN0533 trial\\'}), (\\'etoposide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'high-risk characteristics\\'}), (\\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG board\\'}), (\\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin\\'}), (\\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'high-dose chemotherapy and autologous stem cell transplantation\\'}), (\\'SIOP database_database\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'database\\', \\'name\\': \\'SIOP database\\'}), (\\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'AVD_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AVD\\'}), (\\'AV-2_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AV-2\\'}), (\\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Statistical Test\\', \\'name\\': \\'Log\u2013Rank P\\'}), (\\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'Bilateral Disease (Stage V)\\'}), (\\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Synchronous bilateral Wilms tumor\\'}), (\\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'End-stage renal disease (ESRD)\\'}), (\\'Aronson et al._Research Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Research Group\\', \\'name\\': \\'Aronson et al.\\'}), (\\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'Bilateral nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Study\\', \\'name\\': \\'SIOP\u22122001 study\\'}), (\\'Vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Vincristine\\'}), (\\'Actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Actinomycin D\\'}), (\\'Etoposide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Etoposide\\'}), (\\'Carboplatin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Carboplatin\\'}), (\\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease State\\', \\'name\\': \\'Relapsed Wilms Tumor\\'}), (\\'Group AA_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group AA\\'}), (\\'Group BB_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group BB\\'}), (\\'Group CC_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group CC\\'}), (\\'Doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Doxorubicin\\'}), (\\'Cyclophosphamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Cyclophosphamide\\'}), (\\'Ifosfamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Ifosfamide\\'}), (\\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'High-dose melphalan\\'}), (\\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UKW\u2011R protocol\\'}), (\\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'NWTS\u20115 relapse protocol\\'}), (\\'ASCR_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'procedure\\', \\'name\\': \\'ASCR\\'}), (\\'ifosfamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'ifosfamide\\'}), (\\'nephrotoxicity_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'nephrotoxicity\\'}), (\\'relapsed group CC_patient_group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'patient_group\\', \\'name\\': \\'relapsed group CC\\'}), (\\'diffuse anaplasia_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'diffuse anaplasia\\'}), (\\'blastemal-type tumors_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'blastemal-type tumors\\'}), (\\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'camptothecins_medication_class\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication_class\\', \\'name\\': \\'camptothecins\\'}), (\\'irinotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'irinotecan\\'}), (\\'topotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'topotecan\\'}), (\\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Innovative Therapies for Children with Cancer consortium\\'}), (\\'radiotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgical excision_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgical excision\\'}), (\\'stage IV WT_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'stage IV WT\\'}), (\\'AVD150_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD150\\'}), (\\'AVD250_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD250\\'}), (\\'low-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'low-risk disease\\'}), (\\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'intermediate-risk disease\\'}), (\\'high-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'high-risk disease\\'}), (\\'CDCV_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'CDCV\\'}), (\\'actinomycin-D_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'actinomycin-D\\'}), (\\'vincristine_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'doxorubicin\\'}), (\\'VP16_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'VP16\\'}), (\\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'contact\\', \\'name\\': \\'arnauld.verschuur@ap-hm.fr\\'}), (\\'surgery_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'chemotherapy\\'}), (\\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2212RTSG panel\\'}), (\\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Infant Wilms Tumors\\'}), (\\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'nephrectomy\\'}), (\\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'malignant rhabdoid tumors\\'}), (\\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Adult Wilms Tumors\\'}), (\\'anaplasia_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'anaplasia\\'}), (\\'actinomycin D_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'carboplatin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'etoposide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'etoposide\\'}), (\\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'Nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'radical tumor nephrectomy\\'}), (\\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'lymph node sampling\\'}), (\\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'minimally invasive surgery\\'}), (\\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'laparoscopic surgery\\'}), (\\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'radiotherapy\\'}), (\\'Wilms tumours_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'Davila Fajardo et al._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Davila Fajardo et al.\\'}), (\\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'COG\u2013NWTS trials\\'}), (\\'whole-lung irradiation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'whole-lung irradiation\\'}), (\\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'pulmonary radiotherapy\\'}), (\\'proton therapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'proton therapy\\'}), (\\'dosimetric study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'dosimetric study\\'}), (\\'locoregional disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'locoregional disease\\'}), (\\'metastatic disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'metastatic disease\\'}), (\\'low-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'low-risk\\'}), (\\'intermediate-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'intermediate-risk\\'}), (\\'high-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'high-risk\\'}), (\\'stage I_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage I\\'}), (\\'stage II_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage II\\'}), (\\'stage III_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage III\\'}), (\\'major rupture_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'major rupture\\'}), (\\'Austria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Austria\\'}), (\\'Italy_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Italy\\'}), (\\'San Marino_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'San Marino\\'}), (\\'Iceland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Iceland\\'}), (\\'Germany_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Germany\\'}), (\\'Bulgaria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bulgaria\\'}), (\\'Turkey_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Turkey\\'}), (\\'Denmark_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Denmark\\'}), (\\'Poland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Poland\\'}), (\\'Greece_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Greece\\'}), (\\'Andorra_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Andorra\\'}), (\\'Belgium_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belgium\\'}), (\\'Serbia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Serbia\\'}), (\\'Albania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Albania\\'}), (\\'Moldova_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Moldova\\'}), (\\'Lithuania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Lithuania\\'}), (\\'Latvia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Latvia\\'}), (\\'Estonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Estonia\\'}), (\\'Luxembourg_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Luxembourg\\'}), (\\'Montenegro_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Montenegro\\'}), (\\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bosnia and Herzegovina\\'}), (\\'Croatia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Croatia\\'}), (\\'Slovenia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovenia\\'}), (\\'Macedonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Macedonia\\'}), (\\'United Kingdom_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'United Kingdom\\'}), (\\'Ireland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ireland\\'}), (\\'Spain_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Spain\\'}), (\\'Algeria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Algeria\\'}), (\\'Tunisia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Tunisia\\'}), (\\'Malta_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Malta\\'}), (\\'Morocco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Morocco\\'}), (\\'Portugal_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Portugal\\'}), (\\'France_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'France\\'}), (\\'Monaco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Monaco\\'}), (\\'Russia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Russia\\'}), (\\'Finland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Finland\\'}), (\\'Sweden_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Sweden\\'}), (\\'Norway_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Norway\\'}), (\\'Belarus_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belarus\\'}), (\\'Romania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Romania\\'}), (\\'Ukraine_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ukraine\\'}), (\\'Hungary_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Hungary\\'}), (\\'Czech Republic_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Czech Republic\\'}), (\\'Slovakia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovakia\\'}), (\\'Switzerland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Switzerland\\'}), (\\'Liechtenstein_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Liechtenstein\\'}), (\\'Netherlands_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Netherlands\\'}), (\\'University Hospital of Munich_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Munich\\'}), (\\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Tuebingen\\'}), (\\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Azienda Ospedaliera\\'}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Ospedale Pediatrico Bambino Ges\u00f9\\'}), (\\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Fondazione IRCCS Istituto Nazionale dei Tumori\\'}), (\\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Prinses Maxima Centrum\\'}), (\\'Marciniak Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Marciniak Hospital\\'}), (\\'Faculty of Medicine_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Faculty of Medicine\\'}), (\\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'St. Anna Kinderspital/CCRI\\'}), (\\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Armand Trousseau Hospital\\'}), (\\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Universitario Virgin del Rocio\\'}), (\\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Vall d\u2019Hebron\\'}), (\\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Great Ormond Street Hospital\\'}), (\\'University Hospital Homburg_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital Homburg\\'}), (\\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon\\'}), (\\'UMBRELLA protocol_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'ExPO\u2011r\u2011Net\\'}), (\\'Weirich, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Weirich, A.\\'}), (\\'Pritchard-Jones, K._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Pritchard-Jones, K.\\'}), (\\'de Kraker, J._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'de Kraker, J.\\'}), (\\'Graf, N._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Graf, N.\\'}), (\\'Green, D. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Green, D. M.\\'}), (\\'Spreafico, F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Spreafico, F.\\'}), (\\'Bellani, F. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Bellani, F. F.\\'}), (\\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'van den Heuvel-Eibrink, M. M.\\'}), (\"D\\'Angio, G. J._author\", {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \"D\\'Angio, G. J.\"}), (\\'Tournade, M. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Tournade, M. F.\\'}), (\\'Breslow, N. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Breslow, N. E.\\'}), (\\'Mitchell, C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Mitchell, C.\\'}), (\\'Verschuur, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Verschuur, A.\\'}), (\\'Grundy, P. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Grundy, P. E.\\'}), (\\'Warmann, S. W._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Warmann, S. W.\\'}), (\\'Smets, A. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Smets, A. M.\\'}), (\\'Dome, J. S._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dome, J. S.\\'}), (\\'Dix, D. B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dix, D. B.\\'}), (\\'Daw, N. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Daw, N. C.\\'}), (\\'Ha, T. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Ha, T. C.\\'}), (\\'Kremens, B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Kremens, B.\\'}), (\\'Furtwangler, R._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Furtwangler, R.\\'}), (\\'SIOP-9/GPOH_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP-9/GPOH\\'}), (\\'UKW3_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'UKW3\\'}), (\\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'SIOP 93\u201301 trial\\'}), (\\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP trial and study 93\u201301\\'}), (\\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'National Wilms Tumor Study Group\\'}), (\\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP WT 2001 protocol\\'}), (\\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Third National Wilms\u2019 Tumor Study\\'}), (\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'National Wilms Tumor Studies\\'}), (\\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Second National Wilms\u2019 Tumor Study\\'}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'UK Children\u2019s Cancer Study Group\\'}), (\\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Children\u2019s Oncology Group\\'})], \\'edges\\': [(\\'sample.pdf\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'non-Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'childhood renal tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'renal cell carcinoma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'localized disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'metastatic disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'bilateral disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'relapsed disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'radiotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'surgery_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'chemotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'Wilms Tumour_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CCSK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'MRTK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CMN_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'RCC_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP\u22122001_Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'vincristine_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'actinomycin D_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'doxorubicin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'etoposide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'carboplatin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'cyclophosphamide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage I_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage II_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage III_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage IV_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage V_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AV_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AVD_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'HR-1_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Overall Survival (OS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT-only nodules_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'MRI_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG AREN0533 trial_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'etoposide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'carboplatin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'cyclophosphamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP database_database\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AVD_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AV-2_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Aronson et al._Research Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Etoposide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Carboplatin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group AA_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group BB_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group CC_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Cyclophosphamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Ifosfamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'ASCR_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'ifosfamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'nephrotoxicity_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'relapsed group CC_patient_group\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'diffuse anaplasia_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'blastemal-type tumors_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'camptothecins_medication_class\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'irinotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'topotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'radiotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'surgical excision_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'stage IV WT_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD150_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD250_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'low-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'CDCV_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'actinomycin-D_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'vincristine_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'doxorubicin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'VP16_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'surgery_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'chemotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'anaplasia_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'actinomycin D_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'vincristine_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'doxorubicin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'carboplatin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'cyclophosphamide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'etoposide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'SIOP\u22122001_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Wilms tumours_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Davila Fajardo et al._author\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'whole-lung irradiation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'proton therapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'dosimetric study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'locoregional disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'metastatic disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'low-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'intermediate-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'high-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage I_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage II_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage III_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'major rupture_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Austria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Italy_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'San Marino_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Iceland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Germany_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bulgaria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Turkey_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Denmark_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Poland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Greece_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Andorra_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belgium_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Serbia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Albania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Moldova_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Lithuania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Latvia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Estonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Luxembourg_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Montenegro_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Croatia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovenia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Macedonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'United Kingdom_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ireland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Spain_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Algeria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Tunisia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Malta_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Morocco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Portugal_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'France_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Monaco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Russia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Finland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Sweden_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Norway_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belarus_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Romania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ukraine_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hungary_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Czech Republic_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovakia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Switzerland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Liechtenstein_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Netherlands_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Munich_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Marciniak Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Faculty of Medicine_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital Homburg_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Weirich, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Pritchard-Jones, K._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'de Kraker, J._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Graf, N._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Green, D. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Spreafico, F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Bellani, F. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \"D\\'Angio, G. J._author\", {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Tournade, M. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Breslow, N. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Mitchell, C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Verschuur, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Grundy, P. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Warmann, S. W._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Smets, A. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dome, J. S._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dix, D. B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Daw, N. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ha, T. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Kremens, B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Furtwangler, R._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP-9/GPOH_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UKW3_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10})]}, {\\'nodes\\': [(\\'vincristine_entity\\', {}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {}), (\\'www.siop-rtsg.eu_entity\\', {}), (\\'stage II_entity\\', {}), (\\'Wilms tumours_entity\\', {}), (\\'Relapsed Wilms Tumor_entity\\', {}), (\\'Davila Fajardo et al._entity\\', {}), (\\'vincristine, actinomycin D, and doxorubicin_entity\\', {}), (\\'SIOP\u22122001 randomized trial_entity\\', {}), (\\'surgery_entity\\', {}), (\\'non-Wilms tumours_entity\\', {}), (\\'actinomycin D_entity\\', {}), (\\'diffuse anaplasia_entity\\', {}), (\\'Synchronous bilateral Wilms tumor_entity\\', {}), (\\'CT-only nodules_entity\\', {}), (\\'relapsed group CC_entity\\', {}), (\\'increased relapse risk_entity\\', {}), (\\'reduced survival_entity\\', {}), (\\'UKW3 trial_entity\\', {}), (\\'chemotherapy_entity\\', {}), (\\'Bilateral Disease (Stage V)_entity\\', {}), (\\'blastemal-type tumors_entity\\', {}), (\\'UMBRELLA protocol_entity\\', {}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', {}), (\\'minimally invasive surgery_entity\\', {}), (\\'VP16_entity\\', {}), (\\'Wilms tumor_entity\\', {}), (\\'anaplasia_entity\\', {}), (\\'radical tumor nephrectomy_entity\\', {}), (\\'Innovative Therapies for Children with Cancer consortium_entity\\', {}), (\\'cumulative doxorubicin dose_entity\\', {}), (\\'etoposide_entity\\', {}), (\\'large-volume tumours_entity\\', {}), (\\'Stage IV_entity\\', {}), (\\'CDCV_entity\\', {}), (\\'SIOP\u2013RTSG_entity\\', {}), (\\'AVD150_entity\\', {}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', {}), (\\'laparoscopic surgery_entity\\', {}), (\\'SIOP\u2212RTSG panel_entity\\', {}), (\\'actinomycin-D_entity\\', {}), (\\'COG AREN0533 trial_entity\\', {}), (\\'cyclophosphamide_entity\\', {}), (\\'carboplatin_entity\\', {}), (\\'UKW\u2011R protocol_entity\\', {}), (\\'Nephron-sparing surgery (NSS)_entity\\', {}), (\\'Adult Wilms Tumors_entity\\', {}), (\\'doxorubicin_entity\\', {}), (\\'NWTS\u20115 relapse protocol_entity\\', {}), (\\'End-stage renal disease (ESRD)_entity\\', {}), (\\'AVD250_entity\\', {}), (\\'Children\u2019s Oncology Group (COG)_entity\\', {}), (\\'blastemal-type Wilms tumour_entity\\', {}), (\\'SIOP\u22122001_entity\\', {}), (\\'radiotherapy_entity\\', {}), (\\'childhood renal tumours_entity\\', {})], \\'edges\\': [(\\'vincristine_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'stage II_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'indicated_for_in_adults\\'}), (\\'Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'Wilms tumours_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated under\\'}), (\\'Relapsed Wilms Tumor_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guided_by\\'}), (\\'Davila Fajardo et al._entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed\\'}), (\\'SIOP\u22122001 randomized trial_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated use in\\'}), (\\'surgery_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'non-Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'actinomycin D_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Synchronous bilateral Wilms tumor_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'instance_of\\'}), (\\'CT-only nodules_entity\\', \\'increased relapse risk_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'reduced survival_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included_in\\'}), (\\'relapsed group CC_entity\\', \\'diffuse anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'blastemal-type tumors_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UKW3 trial_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'UKW3 trial_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'chemotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UMBRELLA protocol_entity\\', \\'COG AREN0533 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses_data_from\\'}), (\\'UMBRELLA protocol_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'advises_treatment_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'Innovative Therapies for Children with Cancer consortium_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborates_with\\'}), (\\'UMBRELLA protocol_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'surgery_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is the standard of\\'}), (\\'UMBRELLA protocol_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guides treatment in\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', \\'UKW3 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\\'minimally invasive surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'anaplasia_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'radical tumor nephrectomy_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'standard_of_care_for\\'}), (\\'Stage IV_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'presents in\\'}), (\\'CDCV_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'VP16_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'aims to improve survival rates of\\'}), (\\'AVD150_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed_by\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'succeeds\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'www.siop-rtsg.eu_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'available_on\\'}), (\\'laparoscopic surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'COG AREN0533 trial_entity\\', \\'cumulative doxorubicin dose_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'evaluates\\'}), (\\'UKW\u2011R protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'Nephron-sparing surgery (NSS)_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'classification_developed_by\\'}), (\\'Adult Wilms Tumors_entity\\', \\'anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'Adult Wilms Tumors_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'doxorubicin_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'doxorubicin_entity\\', \\'large-volume tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'recommended for\\'}), (\\'NWTS\u20115 relapse protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'End-stage renal disease (ESRD)_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'AVD250_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'Children\u2019s Oncology Group (COG)_entity\\', \\'SIOP\u22122001 randomized trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborated with\\'}), (\\'blastemal-type Wilms tumour_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment intensified according to\\'}), (\\'SIOP\u22122001_entity\\', \\'vincristine, actinomycin D, and doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses\\'}), (\\'SIOP\u22122001_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provided_guidelines_for\\'}), (\\'radiotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'radiotherapy_entity\\', \\'SIOP\u2212RTSG panel_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'contact_for_guidance\\'})]}, {\\'nodes\\': [(\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {}), (\\'Marry M. van den Heuvel-Eibrink_entity\\', {})], \\'edges\\': [(\\'Marry M. van den Heuvel-Eibrink_entity\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'affiliated_with\\'})]}, {\\'nodes\\': [(\\'Stage II_entity\\', {}), (\\'AV_entity\\', {}), (\\'Stage III_entity\\', {}), (\\'vincestine and actinomycin D_entity\\', {}), (\\'AVD_entity\\', {})], \\'edges\\': [(\\'Stage II_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AV_entity\\', \\'Stage II_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Stage III_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AVD_entity\\', \\'Stage III_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'SIOP-RTSG 2016_entity\\', {}), (\\'RCC_entity\\', {}), (\\'CMN_entity\\', {})], \\'edges\\': [(\\'RCC_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'}), (\\'CMN_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'})]}, {\\'nodes\\': [(\\'HR-1_entity\\', {}), (\\'High-risk blastemal type Wilms tumour_entity\\', {})], \\'edges\\': [(\\'HR-1_entity\\', \\'High-risk blastemal type Wilms tumour_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'unfavorable prognosis_entity\\', {}), (\\'high-risk characteristics_entity\\', {})], \\'edges\\': [(\\'high-risk characteristics_entity\\', \\'unfavorable prognosis_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'leads_to\\'})]}, {\\'nodes\\': [(\\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {}), (\\'SIOP\u2013RTSG board_entity\\', {})], \\'edges\\': [(\\'SIOP\u2013RTSG board_entity\\', \\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggests\\'})]}, {\\'nodes\\': [(\\'regimen and outcomes_entity\\', {}), (\\'SIOP database_entity\\', {})], \\'edges\\': [(\\'SIOP database_entity\\', \\'regimen and outcomes_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'captures_data_on\\'})]}, {\\'nodes\\': [(\\'Bilateral nephron-sparing surgery (NSS)_entity\\', {}), (\\'Aronson et al._entity\\', {})], \\'edges\\': [(\\'Aronson et al._entity\\', \\'Bilateral nephron-sparing surgery (NSS)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'observed_effectiveness_of\\'})]}, {\\'nodes\\': [(\\'SIOP\u22122001 study_entity\\', {}), (\\'Actinomycin D_entity\\', {}), (\\'Vincristine_entity\\', {})], \\'edges\\': [(\\'SIOP\u22122001 study_entity\\', \\'Vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'}), (\\'SIOP\u22122001 study_entity\\', \\'Actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'})]}, {\\'nodes\\': [(\\'High-dose melphalan_entity\\', {}), (\\'Group AA_entity\\', {}), (\\'Carboplatin_entity\\', {}), (\\'Doxorubicin_entity\\', {}), (\\'Etoposide_entity\\', {}), (\\'Group BB_entity\\', {}), (\\'Cyclophosphamide_entity\\', {}), (\\'Ifosfamide_entity\\', {})], \\'edges\\': [(\\'Group AA_entity\\', \\'Doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Ifosfamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'High-dose melphalan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'})]}, {\\'nodes\\': [(\\'nephrotoxicity_entity\\', {}), (\\'ifosfamide_entity\\', {})], \\'edges\\': [(\\'ifosfamide_entity\\', \\'nephrotoxicity_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'related_to\\'})]}, {\\'nodes\\': [(\\'camptothecins_entity\\', {}), (\\'irinotecan_entity\\', {}), (\\'topotecan_entity\\', {})], \\'edges\\': [(\\'camptothecins_entity\\', \\'irinotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'camptothecins_entity\\', \\'topotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'})]}, {\\'nodes\\': [(\\'Infant Wilms Tumors_entity\\', {}), (\\'nephrectomy_entity\\', {})], \\'edges\\': [(\\'Infant Wilms Tumors_entity\\', \\'nephrectomy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_option\\'})]}, {\\'nodes\\': [(\\'congenital mesoblastic nephroma_entity\\', {}), (\\'surgery alone_entity\\', {})], \\'edges\\': [(\\'congenital mesoblastic nephroma_entity\\', \\'surgery alone_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'alternative chemotherapy_entity\\', {}), (\\'malignant rhabdoid tumors_entity\\', {})], \\'edges\\': [(\\'malignant rhabdoid tumors_entity\\', \\'alternative chemotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'lymph node sampling_entity\\', {}), (\\'accurate staging_entity\\', {})], \\'edges\\': [(\\'lymph node sampling_entity\\', \\'accurate staging_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'purpose_of\\'})]}, {\\'nodes\\': [(\\'COG\u2013NWTS trials_entity\\', {}), (\\'whole-lung irradiation_entity\\', {})], \\'edges\\': [(\\'COG\u2013NWTS trials_entity\\', \\'whole-lung irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'informed_dosage_for\\'})]}, {\\'nodes\\': [(\\'lung metastases_entity\\', {}), (\\'pulmonary radiotherapy_entity\\', {})], \\'edges\\': [(\\'pulmonary radiotherapy_entity\\', \\'lung metastases_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'administered_for\\'})]}, {\\'nodes\\': [(\\'dosimetric study_entity\\', {}), (\\'proton therapy_entity\\', {}), (\\'flank irradiation_entity\\', {})], \\'edges\\': [(\\'dosimetric study_entity\\', \\'proton therapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated\\'}), (\\'proton therapy_entity\\', \\'flank irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggested_for\\'})]}, {\\'nodes\\': [(\\'metastatic disease_entity\\', {}), (\\'radiotherapy guidelines_entity\\', {}), (\\'locoregional disease_entity\\', {})], \\'edges\\': [(\\'radiotherapy guidelines_entity\\', \\'locoregional disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'}), (\\'radiotherapy guidelines_entity\\', \\'metastatic disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'})]}, {\\'nodes\\': [(\\'major rupture_entity\\', {}), (\\'stage III_entity\\', {})], \\'edges\\': [(\\'stage III_entity\\', \\'major rupture_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes_condition\\'})]}, {\\'nodes\\': [(\\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {}), (\\'ExPO\u2011r\u2011Net_entity\\', {})], \\'edges\\': [(\\'ExPO\u2011r\u2011Net_entity\\', \\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is part of\\'})]}, {\\'nodes\\': [(\\'University Hospital of Munich_entity\\', {}), (\\'Germany_entity\\', {}), (\\'University Hospital of Tuebingen_entity\\', {})], \\'edges\\': [(\\'Germany_entity\\', \\'University Hospital of Munich_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Germany_entity\\', \\'University Hospital of Tuebingen_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {}), (\\'Italy_entity\\', {}), (\\'Azienda Ospedaliera_entity\\', {}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {})], \\'edges\\': [(\\'Italy_entity\\', \\'Azienda Ospedaliera_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Netherlands_entity\\', {}), (\\'Prinses Maxima Centrum_entity\\', {})], \\'edges\\': [(\\'Netherlands_entity\\', \\'Prinses Maxima Centrum_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Marciniak Hospital_entity\\', {}), (\\'Poland_entity\\', {}), (\\'Faculty of Medicine_entity\\', {})], \\'edges\\': [(\\'Poland_entity\\', \\'Marciniak Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Poland_entity\\', \\'Faculty of Medicine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'St. Anna Kinderspital/CCRI_entity\\', {}), (\\'Austria_entity\\', {})], \\'edges\\': [(\\'Austria_entity\\', \\'St. Anna Kinderspital/CCRI_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'France_entity\\', {}), (\\'Armand Trousseau Hospital_entity\\', {})], \\'edges\\': [(\\'France_entity\\', \\'Armand Trousseau Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Spain_entity\\', {}), (\\'Hospital Vall d\u2019Hebron_entity\\', {}), (\\'Hospital Universitario Virgin del Rocio_entity\\', {})], \\'edges\\': [(\\'Spain_entity\\', \\'Hospital Universitario Virgin del Rocio_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Spain_entity\\', \\'Hospital Vall d\u2019Hebron_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'United Kingdom_entity\\', {}), (\\'Great Ormond Street Hospital_entity\\', {})], \\'edges\\': [(\\'United Kingdom_entity\\', \\'Great Ormond Street Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Weirich, A._entity\\', {}), (\\'SIOP-9/GPOH_entity\\', {})], \\'edges\\': [(\\'Weirich, A._entity\\', \\'SIOP-9/GPOH_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Pritchard-Jones, K._entity\\', {}), (\\'UKW3_entity\\', {})], \\'edges\\': [(\\'Pritchard-Jones, K._entity\\', \\'UKW3_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed in\\'})]}, {\\'nodes\\': [(\\'SIOP 93\u201301 trial_entity\\', {}), (\\'de Kraker, J._entity\\', {})], \\'edges\\': [(\\'de Kraker, J._entity\\', \\'SIOP 93\u201301 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'SIOP trial and study 93\u201301_entity\\', {}), (\\'Graf, N._entity\\', {})], \\'edges\\': [(\\'Graf, N._entity\\', \\'SIOP trial and study 93\u201301_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Green, D. M._entity\\', {}), (\\'National Wilms Tumor Study Group_entity\\', {})], \\'edges\\': [(\\'Green, D. M._entity\\', \\'National Wilms Tumor Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}, {\\'nodes\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', {}), (\\'SIOP WT 2001 protocol_entity\\', {})], \\'edges\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', \\'SIOP WT 2001 protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Third National Wilms\u2019 Tumor Study_entity\\', {}), (\"D\\'Angio, G. J._entity\", {}), (\\'Second National Wilms\u2019 Tumor Study_entity\\', {})], \\'edges\\': [(\"D\\'Angio, G. J._entity\", \\'Third National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\"D\\'Angio, G. J._entity\", \\'Second National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {}), (\\'Tournade, M. F._entity\\', {}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {})], \\'edges\\': [(\\'Tournade, M. F._entity\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'}), (\\'Tournade, M. F._entity\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Breslow, N. E._entity\\', {}), (\\'National Wilms Tumor Studies_entity\\', {})], \\'edges\\': [(\\'Breslow, N. E._entity\\', \\'National Wilms Tumor Studies_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Mitchell, C._entity\\', {}), (\\'UK Children\u2019s Cancer Study Group_entity\\', {})], \\'edges\\': [(\\'Mitchell, C._entity\\', \\'UK Children\u2019s Cancer Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'under\\'})]}, {\\'nodes\\': [(\\'Daw, N. C._entity\\', {}), (\\'Dix, D. B._entity\\', {}), (\\'Children\u2019s Oncology Group_entity\\', {}), (\\'Grundy, P. E._entity\\', {})], \\'edges\\': [(\\'Daw, N. C._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted under\\'}), (\\'Dix, D. B._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'}), (\\'Grundy, P. E._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}]']), TestResult(name='test_case_13', success=False, metrics_data=[MetricData(name='Answer Correctness (GEval)', threshold=0.5, success=False, score=0.0071780824195092395, reason='The actual output does not provide any information relevant to collecting comprehensive, prospective data from a large cohort of patients as indicated in the expected output.', strict_mode=False, evaluation_model='gpt-4o-mini', error=None, evaluation_cost=0.0032976, verbose_logs='Criteria:\\nNone \\n \\nEvaluation Steps:\\n[\\n    \"Determine whether the actual output is factually correct based on the expected output.\"\\n]'), MetricData(name='Faithfulness', threshold=0.7, success=True, score=0.8125, reason=None, strict_mode=False, evaluation_model='gpt-4o-mini', error=None, evaluation_cost=0.010024499999999999, verbose_logs='Truths (limit=None):\\n[\\n    \"The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG) is an organization.\",\\n    \"UMBRELLA SIOP-RTSG 2016 is a protocol.\",\\n    \"SIOP\u22122001 is a protocol.\",\\n    \"Wilms tumors are a type of disease.\",\\n    \"non-Wilms tumors are a type of disease.\",\\n    \"www.siop-rtsg.eu is a website associated with SIOP-RTSG.\",\\n    \"The Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology is an institution.\",\\n    \"Marry M. van den Heuvel-Eibrink is a person associated with SIOP-RTSG.\",\\n    \"Childhood renal tumors are a type of disease.\",\\n    \"Clear cell sarcoma of the kidney is a type of disease.\",\\n    \"Renal cell carcinoma is a type of disease.\",\\n    \"Malignant rhabdoid tumor of the kidney is a type of disease.\",\\n    \"Congenital mesoblastic nephroma is a type of disease.\",\\n    \"The UMBRELLA protocol is a treatment protocol.\",\\n    \"SIOP\u22122001 randomized trial is a clinical trial.\",\\n    \"Actinomycin D is a drug.\",\\n    \"Vincristine is a drug.\",\\n    \"Doxorubicin is a drug.\",\\n    \"The UKW3 trial is a clinical trial.\",\\n    \"UK Children\u2019s Cancer and Leukaemia Group (UKCCLG) is an organization.\",\\n    \"Localized disease is a stage of disease.\",\\n    \"Metastatic disease is a stage of disease.\",\\n    \"Bilateral disease is a stage of disease.\",\\n    \"Relapsed disease is a stage of disease.\",\\n    \"Blastemal-type Wilms tumors are a subtype of disease.\",\\n    \"Radiotherapy is a treatment method.\",\\n    \"Surgery is a treatment method.\",\\n    \"Chemotherapy is a treatment method.\",\\n    \"Wilms Tumor is a type of disease.\",\\n    \"CCSK refers to clear cell sarcoma of the kidney.\",\\n    \"MRTK refers to malignant rhabdoid tumor of the kidney.\",\\n    \"CMN refers to congenital mesoblastic nephroma.\",\\n    \"RCC refers to renal cell carcinoma.\",\\n    \"Stage I, Stage II, Stage III, Stage IV, and Stage V are all stages of disease.\",\\n    \"AV is a treatment combination.\",\\n    \"AVD is a treatment combination.\",\\n    \"HR-1 is a treatment combination.\",\\n    \"Overall Survival (OS) is a metric.\",\\n    \"Event-Free Survival (EFS) is a metric.\",\\n    \"CT-only nodules are a medical condition.\",\\n    \"SIOP\u2013RTSG analysis is a study.\",\\n    \"COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials are studies related to Wilms tumor.\",\\n    \"Nephrotoxicity is a condition associated with some medications.\",\\n    \"High-risk characteristics are a type of medical condition that can affect prognosis in diseases related to Wilms tumors.\"\\n] \\n \\nClaims:\\n[\\n    \"The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG) is an organization.\",\\n    \"The UMBRELLA SIOP-RTSG 2016 is a protocol.\",\\n    \"The SIOP\u22122001 is a protocol.\",\\n    \"Wilms tumours are a type of disease.\",\\n    \"Non-Wilms tumours are a type of disease.\",\\n    \"The website www.siop-rtsg.eu is associated with SIOP\u2013RTSG.\",\\n    \"The Department of Paediatric Oncology at Princess M\u00e1xima Center for Paediatric Oncology is an institution.\",\\n    \"Marry M. van den Heuvel-Eibrink is a person associated with SIOP\u2013RTSG.\",\\n    \"Childhood renal tumours are a category of disease.\",\\n    \"Clear cell sarcoma of the kidney is a type of disease.\",\\n    \"Renal cell carcinoma is a type of disease.\",\\n    \"Malignant rhabdoid tumour of the kidney is a type of disease.\",\\n    \"Congenital mesoblastic nephroma is a type of disease.\",\\n    \"Wilms tumours are classified as a condition.\",\\n    \"The UMBRELLA protocol is a treatment protocol.\",\\n    \"SIOP\u2013RTSG is an organization.\",\\n    \"The Children\u2019s Oncology Group (COG) is an organization.\",\\n    \"The SIOP\u22122001 randomized trial is a clinical trial.\",\\n    \"Actinomycin D is a drug used for treatment.\",\\n    \"Vincristine is a drug used for treatment.\",\\n    \"Doxorubicin is a drug used for treatment.\",\\n    \"The UKW3 trial is a clinical trial.\",\\n    \"The UK Children\u2019s Cancer and Leukaemia Group (UKCCLG) is an organization.\",\\n    \"Localized disease refers to a stage of disease.\",\\n    \"Metastatic disease refers to a stage of disease.\",\\n    \"Bilateral disease refers to a stage of disease.\",\\n    \"Relapsed disease refers to a stage of disease.\",\\n    \"Blastemal-type Wilms tumours are a subtype of Wilms tumours.\",\\n    \"Radiotherapy is a treatment method.\",\\n    \"Surgery is a treatment method.\",\\n    \"Chemotherapy is a treatment method.\",\\n    \"Wilms Tumour is a type of disease.\",\\n    \"CCSK refers to a type of disease.\",\\n    \"MRTK refers to a type of disease.\",\\n    \"CMN refers to a type of disease.\",\\n    \"RCC refers to a type of disease.\",\\n    \"The UMBRELLA protocol is a protocol.\",\\n    \"The SIOP\u22122001 is a trial.\",\\n    \"Vincristine is a treatment option.\",\\n    \"Actinomycin D is a treatment option.\",\\n    \"Doxorubicin is a treatment option.\",\\n    \"Etoposide is a treatment option.\",\\n    \"Carboplatin is a treatment option.\",\\n    \"Cyclophosphamide is a treatment option.\",\\n    \"Stage I refers to a stage of the disease.\",\\n    \"Stage II refers to a stage of the disease.\",\\n    \"Stage III refers to a stage of the disease.\",\\n    \"Stage IV refers to a stage of the disease.\",\\n    \"Stage V refers to a stage of the disease.\",\\n    \"AV is a treatment combination.\",\\n    \"AVD is a treatment combination.\",\\n    \"HR-1 is a treatment combination.\",\\n    \"The SIOP-RTSG 2016 is a protocol associated with the SIOP\u2013RTSG organization.\",\\n    \"Overall Survival (OS) is a metric used for assessing outcomes.\",\\n    \"Event-Free Survival (EFS) is a metric used for assessing outcomes.\",\\n    \"CT-only nodules refer to a medical condition.\",\\n    \"The UMBRELLA protocol governs treatment protocols.\",\\n    \"SIOP\u2013RTSG analysis is a study.\",\\n    \"The COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials are studies.\",\\n    \"Vincristine and actinomycin D plus doxorubicin is a treatment.\",\\n    \"Vincristine and actinomycin D is a treatment.\",\\n    \"The SIOP\u22122001 study is a study protocol.\",\\n    \"MRI is a diagnostic tool.\",\\n    \"CT is a diagnostic tool.\",\\n    \"Cumulative doxorubicin dose refers to a treatment detail.\",\\n    \"The COG AREN0533 trial is a study.\",\\n    \"Etoposide is a medication.\",\\n    \"Carboplatin is a medication.\",\\n    \"Cyclophosphamide is a medication.\",\\n    \"High-risk characteristics refer to a medical condition.\",\\n    \"SIOP\u2013RTSG board is an organization.\",\\n    \"Vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin is a treatment.\",\\n    \"High-dose chemotherapy and autologous stem cell transplantation is a treatment.\",\\n    \"The SIOP database captures data related to Wilms tumors.\",\\n    \"Event-Free Survival (EFS) is a subject of study.\",\\n    \"Overall Survival (OS) is a subject of study.\",\\n    \"AVD is a treatment group.\",\\n    \"AV-2 is a treatment group.\",\\n    \"Log\u2013Rank P is a statistical test.\",\\n    \"Bilateral Disease (Stage V) refers to a stage of the disease.\",\\n    \"Synchronous bilateral Wilms tumor is a type of disease.\",\\n    \"End-stage renal disease (ESRD) is a condition.\",\\n    \"Aronson et al. is a research group.\",\\n    \"Bilateral nephron-sparing surgery (NSS) is a treatment method.\",\\n    \"The SIOP\u22122001 study is a study.\",\\n    \"Vincristine is classified as a drug used for treatment.\",\\n    \"Actinomycin D is classified as a drug used for treatment.\",\\n    \"Etoposide is classified as a drug used for treatment.\",\\n    \"Carboplatin is classified as a drug used for treatment.\",\\n    \"Relapsed Wilms Tumor refers to a disease state.\",\\n    \"Group AA, Group BB, and Group CC are patient groups.\",\\n    \"Doxorubicin is classified as a drug used for treatment.\",\\n    \"Cyclophosphamide is classified as a drug used for treatment.\",\\n    \"Ifosfamide is a drug used for treatment.\",\\n    \"High-dose melphalan is a treatment method.\",\\n    \"UKW\u2011R protocol is a treatment protocol.\",\\n    \"NWTS\u20115 relapse protocol is a treatment protocol.\",\\n    \"ASCR refers to a procedure.\",\\n    \"Ifosfamide is a medication.\",\\n    \"Nephrotoxicity is a condition.\",\\n    \"Relapsed group CC refers to a patient group.\",\\n    \"Diffuse anaplasia is a condition.\",\\n    \"Blastemal-type tumors are a condition.\",\\n    \"The UMBRELLA protocol is a protocol.\",\\n    \"Camptothecins are a medication class.\",\\n    \"Irinotecan is a medication.\",\\n    \"Topotecan is a medication.\",\\n    \"The Innovative Therapies for Children with Cancer consortium is an organization.\",\\n    \"Radiotherapy is a treatment method.\",\\n    \"Surgical excision is a treatment method.\",\\n    \"Stage IV WT refers to a condition.\",\\n    \"AVD150 is a treatment regimen.\",\\n    \"AVD250 is a treatment regimen.\",\\n    \"Low-risk disease is a condition category.\",\\n    \"Intermediate-risk disease is a condition category.\",\\n    \"High-risk disease is a condition category.\",\\n    \"CDCV is a treatment regimen.\",\\n    \"Actinomycin-D is a medication.\",\\n    \"Vincristine is a medication.\",\\n    \"Doxorubicin is a medication.\",\\n    \"VP16 is a medication.\",\\n    \"The contact for arnauld.verschuur@ap-hm.fr is provided.\",\\n    \"Surgery is a treatment method for Wilms tumors.\",\\n    \"Chemotherapy is a treatment method for Wilms tumors.\",\\n    \"SIOP\u2212RTSG panel is an organization.\",\\n    \"Infant Wilms Tumors refer to a medical condition.\",\\n    \"Nephrectomy is a surgical procedure.\",\\n    \"Congenital mesoblastic nephroma is a medical condition.\",\\n    \"Malignant rhabdoid tumors are a medical condition.\",\\n    \"Adult Wilms Tumors refer to a medical condition.\",\\n    \"Anaplasia is a medical condition.\",\\n    \"Actinomycin D is a drug.\",\\n    \"Vincristine is a drug.\",\\n    \"Doxorubicin is a drug.\",\\n    \"Carboplatin is a drug.\",\\n    \"Cyclophosphamide is a drug.\",\\n    \"Etoposide is a drug.\",\\n    \"Nephron-sparing surgery (NSS) is a surgical procedure.\",\\n    \"SIOP\u2013RTSG is an organization.\",\\n    \"Radical tumor nephrectomy is a surgical procedure.\",\\n    \"Lymph node sampling is a surgical procedure.\",\\n    \"Minimally invasive surgery is a surgery type.\",\\n    \"Laparoscopic surgery is a surgery type.\",\\n    \"Nephron-sparing surgery (NSS) is a surgical type.\",\\n    \"The SIOP\u22122001 protocol is a protocol.\",\\n    \"Radiotherapy is a treatment method related to Wilms tumors.\",\\n    \"Wilms tumours are a condition.\",\\n    \"Davila Fajardo et al. is an author.\",\\n    \"COG\u2013NWTS trials are a trial.\",\\n    \"Whole-lung irradiation is a treatment.\",\\n    \"Pulmonary radiotherapy is a treatment.\",\\n    \"Proton therapy is a treatment.\",\\n    \"Dosimetric study is a study related to treatment methods.\",\\n    \"Locoregional disease refers to a condition related to cancer.\",\\n    \"Metastatic disease refers to a condition related to cancer.\",\\n    \"Low-risk refers to a risk category.\",\\n    \"Intermediate-risk refers to a risk category.\",\\n    \"High-risk refers to a risk category.\",\\n    \"Stage I refers to a stage of cancer.\",\\n    \"Stage II refers to a stage of cancer.\",\\n    \"Stage III refers to a stage of cancer.\",\\n    \"Major rupture is a condition.\",\\n    \"Austria is a country.\",\\n    \"Italy is a country.\",\\n    \"San Marino is a country.\",\\n    \"Iceland is a country.\",\\n    \"Germany is a country.\",\\n    \"Bulgaria is a country.\",\\n    \"Turkey is a country.\",\\n    \"Denmark is a country.\",\\n    \"Poland is a country.\",\\n    \"Greece is a country.\",\\n    \"Andorra is a country.\",\\n    \"Belgium is a country.\",\\n    \"Serbia is a country.\",\\n    \"Albania is a country.\",\\n    \"Moldova is a country.\",\\n    \"Lithuania is a country.\",\\n    \"Latvia is a country.\",\\n    \"Estonia is a country.\",\\n    \"Luxembourg is a country.\",\\n    \"Montenegro is a country.\",\\n    \"Bosnia and Herzegovina is a country.\",\\n    \"Croatia is a country.\",\\n    \"Slovenia is a country.\",\\n    \"Macedonia is a country.\",\\n    \"The United Kingdom is a country.\",\\n    \"Ireland is a country.\",\\n    \"Spain is a country.\",\\n    \"Algeria is a country.\",\\n    \"Tunisia is a country.\",\\n    \"Malta is a country.\",\\n    \"Morocco is a country.\",\\n    \"Portugal is a country.\",\\n    \"France is a country.\",\\n    \"Monaco is a country.\",\\n    \"Russia is a country.\",\\n    \"Finland is a country.\",\\n    \"Sweden is a country.\",\\n    \"Norway is a country.\",\\n    \"Belarus is a country.\",\\n    \"Romania is a country.\",\\n    \"Ukraine is a country.\",\\n    \"Hungary is a country.\",\\n    \"Czech Republic is a country.\",\\n    \"Slovakia is a country.\",\\n    \"Switzerland is a country.\",\\n    \"Liechtenstein is a country.\",\\n    \"The Netherlands is a country.\",\\n    \"The University Hospital of Munich is an institution.\",\\n    \"The University Hospital of Tuebingen is an institution.\",\\n    \"Azienda Ospedaliera is an institution.\",\\n    \"Ospedale Pediatrico Bambino Ges\u00f9 is an institution.\",\\n    \"Fondazione IRCCS Istituto Nazionale dei Tumori is an institution.\",\\n    \"Prinses Maxima Centrum is an institution.\",\\n    \"Marciniak Hospital is an institution.\",\\n    \"The Faculty of Medicine is an institution.\",\\n    \"St. Anna Kinderspital/CCRI is an institution.\",\\n    \"Armand Trousseau Hospital is an institution.\",\\n    \"Hospital Universitario Virgin del Rocio is an institution.\",\\n    \"Hospital Vall d\u2019Hebron is an institution.\",\\n    \"Great Ormond Street Hospital is an institution.\",\\n    \"The University Hospital Homburg is an institution.\",\\n    \"L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon is an institution.\",\\n    \"The UMBRELLA protocol is a project.\",\\n    \"ExPO\u2011r\u2011Net is a project associated with pediatric oncology organizations.\",\\n    \"Weirich, A. is an author.\",\\n    \"Pritchard-Jones, K. is an author.\",\\n    \"De Kraker, J. is an author.\",\\n    \"Graf, N. is an author.\",\\n    \"Green, D. M. is an author.\",\\n    \"Spreafico, F. is an author.\",\\n    \"Bellani, F. F. is an author.\",\\n    \"van den Heuvel-Eibrink, M. M. is an author.\",\\n    \"D\\'Angio, G. J. is an author.\",\\n    \"Tournade, M. F. is an author.\",\\n    \"Breslow, N. E. is an author.\",\\n    \"Mitchell, C. is an author.\",\\n    \"Verschuur, A. is an author.\",\\n    \"Grundy, P. E. is an author.\",\\n    \"Warmann, S. W. is an author.\",\\n    \"Smets, A. M. is an author.\",\\n    \"Dome, J. S. is an author.\",\\n    \"Dix, D. B. is an author.\",\\n    \"Daw, N. C. is an author.\",\\n    \"Ha, T. C. is an author.\",\\n    \"Kremens, B. is an author.\",\\n    \"Furtwangler, R. is an author.\",\\n    \"SIOP-9/GPOH is a study.\",\\n    \"The UKW3 trial is a trial.\",\\n    \"The SIOP 93\u201301 trial is a trial.\",\\n    \"The SIOP trial and study 93\u201301 is a study.\",\\n    \"The National Wilms Tumor Study Group is an organization.\",\\n    \"The SIOP WT 2001 protocol is a protocol.\",\\n    \"The Third National Wilms\u2019 Tumor Study is a study.\",\\n    \"The Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study is a study.\",\\n    \"The National Wilms Tumor Studies is a study.\",\\n    \"The Second National Wilms\u2019 Tumor Study is a study.\",\\n    \"The Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study is a study.\",\\n    \"The UK Children\u2019s Cancer Study Group is an organization.\",\\n    \"The Children\u2019s Oncology Group is an organization.\"\\n] \\n \\nVerdicts:\\n[\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"The retrieval context refers to \\'Childhood renal tumors\\' not \\'Childhood renal tumours\\'.\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"The actual context lists the SIOP\\\\u2013RTSG as an organization, not just SIOP\\\\u2013RTSG.\"\\n    },\\n    {\\n        \"verdict\": \"idk\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"The UMBRELLA protocol governs treatment protocols as stated in the retrieval context.\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"Vincristine is classified as a drug used for treatment in this context.\"\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"Actinomycin D is classified as a drug used for treatment in this context.\"\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"Doxorubicin is classified as a drug used for treatment in this context.\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"Cyclophosphamide is classified as a drug used for treatment in this context.\"\\n    },\\n    {\\n        \"verdict\": \"idk\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"The UMBRELLA protocol is a treatment protocol as explicitly stated in the retrieval context.\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"The SIOP\\\\u22122001 is listed as a study protocol in the retrieval context.\"\\n    },\\n    {\\n        \"verdict\": \"idk\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"The retrieval context does not specify if \\'Vincristine is a treatment option\\'. It states it is a drug used for treatment.\"\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"The retrieval context does not specify if \\'Actinomycin D is a treatment option\\'. It states it is a drug used for treatment.\"\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"The retrieval context does not specify if \\'Doxorubicin is a treatment option\\'. It states it is a drug used for treatment.\"\\n    },\\n    {\\n        \"verdict\": \"idk\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"idk\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"idk\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"idk\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"idk\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"idk\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": null\\n    }\\n]'), MetricData(name='Contextual Relevancy', threshold=1.0, success=False, score=0.5, reason=\"The score is 0.50 because while there are relevant statements such as 'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG) has protocols to monitor long-term outcomes for kidney tumors in children,' the retrieval context also includes several unrelated elements, such as 'does not specifically address monitoring long-term outcomes' which detracts from overall relevance.\", strict_mode=False, evaluation_model='gpt-4o-mini', error=None, evaluation_cost=0.00368355, verbose_logs='Verdicts:\\n[\\n    {\\n        \"verdicts\": [\\n            {\\n                \"statement\": \"The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\\\\u2013RTSG) has protocols to monitor long-term outcomes for kidney tumors in children.\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"UMBRELLA protocol provides guidelines for treatment but does not specifically address monitoring long-term outcomes.\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"The retrieval context mentions \\'does not specifically address monitoring long-term outcomes\\', which is unrelated to the question.\"\\n            },\\n            {\\n                \"statement\": \"SIOP\\\\u22122001 protocol includes collection of data related to outcomes of treatments.\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"Event-Free Survival (EFS) and Overall Survival (OS) metrics are used to evaluate treatment effectiveness.\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"High-dose chemotherapy and autologous stem cell transplantation is part of the treatment options.\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"The retrieval context indicates that this statement is about treatment options and not specifically monitoring long-term outcomes.\"\\n            },\\n            {\\n                \"statement\": \"SIOP database captures data on treatment regimens and their outcomes.\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"Bilateral nephron-sparing surgery is commonly discussed but does not reflect on monitoring outcomes.\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"The statement focuses on a treatment method and neglects the aspect of monitoring outcomes.\"\\n            },\\n            {\\n                \"statement\": \"Radiotherapy guidelines specify strategies for different disease stages but do not monitor outcomes.\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"The statement addresses treatment strategies instead of outlining methods for monitoring long-term results.\"\\n            }\\n        ]\\n    }\\n]')], conversational=False, multimodal=False, input='How does the protocol plan to monitor long-term outcomes?', actual_output='[{\\'nodes\\': [(\\'sample.pdf\\', {\\'type\\': \\'document\\'}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)\\'}), (\\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA SIOP-RTSG 2016\\'}), (\\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms tumours\\'}), (\\'non-Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'non-Wilms tumours\\'}), (\\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Website\\', \\'name\\': \\'www.siop-rtsg.eu\\'}), (\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology\\'}), (\\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Person\\', \\'name\\': \\'Marry M. van den Heuvel-Eibrink\\'}), (\\'childhood renal tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'childhood renal tumours\\'}), (\\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'clear cell sarcoma of the kidney\\'}), (\\'renal cell carcinoma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'renal cell carcinoma\\'}), (\\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'malignant rhabdoid tumour of the kidney\\'}), (\\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'Wilms tumours_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'Children\u2019s Oncology Group (COG)\\'}), (\\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'SIOP\u22122001 randomized trial\\'}), (\\'actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'UKW3 trial\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)\\'}), (\\'localized disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'localized disease\\'}), (\\'metastatic disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'metastatic disease\\'}), (\\'bilateral disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'bilateral disease\\'}), (\\'relapsed disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'relapsed disease\\'}), (\\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subtype\\', \\'name\\': \\'blastemal-type Wilms tumours\\'}), (\\'radiotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgery_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'chemotherapy\\'}), (\\'Wilms Tumour_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms Tumour\\'}), (\\'CCSK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CCSK\\'}), (\\'MRTK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'MRTK\\'}), (\\'CMN_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CMN\\'}), (\\'RCC_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'RCC\\'}), (\\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u22122001_Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Trial\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'vincristine_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'vincristine\\'}), (\\'actinomycin D_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'actinomycin D\\'}), (\\'doxorubicin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'doxorubicin\\'}), (\\'etoposide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'Stage I_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage I\\'}), (\\'Stage II_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage II\\'}), (\\'Stage III_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage III\\'}), (\\'Stage IV_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage IV\\'}), (\\'Stage V_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage V\\'}), (\\'AV_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AV\\'}), (\\'AVD_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AVD\\'}), (\\'HR-1_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'HR-1\\'}), (\\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP-RTSG 2016\\'}), (\\'Overall Survival (OS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'CT-only nodules_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'CT-only nodules\\'}), (\\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP\u2013RTSG analysis\\'}), (\\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials\\'}), (\\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D plus doxorubicin\\'}), (\\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D\\'}), (\\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study_protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'MRI_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'MRI\\'}), (\\'CT_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'CT\\'}), (\\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_detail\\', \\'name\\': \\'cumulative doxorubicin dose\\'}), (\\'COG AREN0533 trial_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG AREN0533 trial\\'}), (\\'etoposide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'high-risk characteristics\\'}), (\\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG board\\'}), (\\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin\\'}), (\\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'high-dose chemotherapy and autologous stem cell transplantation\\'}), (\\'SIOP database_database\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'database\\', \\'name\\': \\'SIOP database\\'}), (\\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'AVD_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AVD\\'}), (\\'AV-2_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AV-2\\'}), (\\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Statistical Test\\', \\'name\\': \\'Log\u2013Rank P\\'}), (\\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'Bilateral Disease (Stage V)\\'}), (\\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Synchronous bilateral Wilms tumor\\'}), (\\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'End-stage renal disease (ESRD)\\'}), (\\'Aronson et al._Research Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Research Group\\', \\'name\\': \\'Aronson et al.\\'}), (\\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'Bilateral nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Study\\', \\'name\\': \\'SIOP\u22122001 study\\'}), (\\'Vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Vincristine\\'}), (\\'Actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Actinomycin D\\'}), (\\'Etoposide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Etoposide\\'}), (\\'Carboplatin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Carboplatin\\'}), (\\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease State\\', \\'name\\': \\'Relapsed Wilms Tumor\\'}), (\\'Group AA_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group AA\\'}), (\\'Group BB_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group BB\\'}), (\\'Group CC_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group CC\\'}), (\\'Doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Doxorubicin\\'}), (\\'Cyclophosphamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Cyclophosphamide\\'}), (\\'Ifosfamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Ifosfamide\\'}), (\\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'High-dose melphalan\\'}), (\\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UKW\u2011R protocol\\'}), (\\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'NWTS\u20115 relapse protocol\\'}), (\\'ASCR_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'procedure\\', \\'name\\': \\'ASCR\\'}), (\\'ifosfamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'ifosfamide\\'}), (\\'nephrotoxicity_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'nephrotoxicity\\'}), (\\'relapsed group CC_patient_group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'patient_group\\', \\'name\\': \\'relapsed group CC\\'}), (\\'diffuse anaplasia_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'diffuse anaplasia\\'}), (\\'blastemal-type tumors_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'blastemal-type tumors\\'}), (\\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'camptothecins_medication_class\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication_class\\', \\'name\\': \\'camptothecins\\'}), (\\'irinotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'irinotecan\\'}), (\\'topotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'topotecan\\'}), (\\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Innovative Therapies for Children with Cancer consortium\\'}), (\\'radiotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgical excision_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgical excision\\'}), (\\'stage IV WT_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'stage IV WT\\'}), (\\'AVD150_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD150\\'}), (\\'AVD250_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD250\\'}), (\\'low-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'low-risk disease\\'}), (\\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'intermediate-risk disease\\'}), (\\'high-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'high-risk disease\\'}), (\\'CDCV_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'CDCV\\'}), (\\'actinomycin-D_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'actinomycin-D\\'}), (\\'vincristine_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'doxorubicin\\'}), (\\'VP16_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'VP16\\'}), (\\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'contact\\', \\'name\\': \\'arnauld.verschuur@ap-hm.fr\\'}), (\\'surgery_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'chemotherapy\\'}), (\\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2212RTSG panel\\'}), (\\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Infant Wilms Tumors\\'}), (\\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'nephrectomy\\'}), (\\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'malignant rhabdoid tumors\\'}), (\\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Adult Wilms Tumors\\'}), (\\'anaplasia_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'anaplasia\\'}), (\\'actinomycin D_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'carboplatin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'etoposide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'etoposide\\'}), (\\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'Nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'radical tumor nephrectomy\\'}), (\\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'lymph node sampling\\'}), (\\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'minimally invasive surgery\\'}), (\\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'laparoscopic surgery\\'}), (\\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'radiotherapy\\'}), (\\'Wilms tumours_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'Davila Fajardo et al._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Davila Fajardo et al.\\'}), (\\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'COG\u2013NWTS trials\\'}), (\\'whole-lung irradiation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'whole-lung irradiation\\'}), (\\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'pulmonary radiotherapy\\'}), (\\'proton therapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'proton therapy\\'}), (\\'dosimetric study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'dosimetric study\\'}), (\\'locoregional disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'locoregional disease\\'}), (\\'metastatic disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'metastatic disease\\'}), (\\'low-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'low-risk\\'}), (\\'intermediate-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'intermediate-risk\\'}), (\\'high-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'high-risk\\'}), (\\'stage I_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage I\\'}), (\\'stage II_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage II\\'}), (\\'stage III_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage III\\'}), (\\'major rupture_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'major rupture\\'}), (\\'Austria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Austria\\'}), (\\'Italy_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Italy\\'}), (\\'San Marino_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'San Marino\\'}), (\\'Iceland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Iceland\\'}), (\\'Germany_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Germany\\'}), (\\'Bulgaria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bulgaria\\'}), (\\'Turkey_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Turkey\\'}), (\\'Denmark_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Denmark\\'}), (\\'Poland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Poland\\'}), (\\'Greece_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Greece\\'}), (\\'Andorra_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Andorra\\'}), (\\'Belgium_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belgium\\'}), (\\'Serbia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Serbia\\'}), (\\'Albania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Albania\\'}), (\\'Moldova_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Moldova\\'}), (\\'Lithuania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Lithuania\\'}), (\\'Latvia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Latvia\\'}), (\\'Estonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Estonia\\'}), (\\'Luxembourg_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Luxembourg\\'}), (\\'Montenegro_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Montenegro\\'}), (\\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bosnia and Herzegovina\\'}), (\\'Croatia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Croatia\\'}), (\\'Slovenia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovenia\\'}), (\\'Macedonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Macedonia\\'}), (\\'United Kingdom_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'United Kingdom\\'}), (\\'Ireland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ireland\\'}), (\\'Spain_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Spain\\'}), (\\'Algeria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Algeria\\'}), (\\'Tunisia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Tunisia\\'}), (\\'Malta_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Malta\\'}), (\\'Morocco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Morocco\\'}), (\\'Portugal_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Portugal\\'}), (\\'France_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'France\\'}), (\\'Monaco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Monaco\\'}), (\\'Russia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Russia\\'}), (\\'Finland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Finland\\'}), (\\'Sweden_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Sweden\\'}), (\\'Norway_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Norway\\'}), (\\'Belarus_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belarus\\'}), (\\'Romania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Romania\\'}), (\\'Ukraine_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ukraine\\'}), (\\'Hungary_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Hungary\\'}), (\\'Czech Republic_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Czech Republic\\'}), (\\'Slovakia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovakia\\'}), (\\'Switzerland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Switzerland\\'}), (\\'Liechtenstein_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Liechtenstein\\'}), (\\'Netherlands_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Netherlands\\'}), (\\'University Hospital of Munich_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Munich\\'}), (\\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Tuebingen\\'}), (\\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Azienda Ospedaliera\\'}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Ospedale Pediatrico Bambino Ges\u00f9\\'}), (\\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Fondazione IRCCS Istituto Nazionale dei Tumori\\'}), (\\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Prinses Maxima Centrum\\'}), (\\'Marciniak Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Marciniak Hospital\\'}), (\\'Faculty of Medicine_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Faculty of Medicine\\'}), (\\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'St. Anna Kinderspital/CCRI\\'}), (\\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Armand Trousseau Hospital\\'}), (\\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Universitario Virgin del Rocio\\'}), (\\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Vall d\u2019Hebron\\'}), (\\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Great Ormond Street Hospital\\'}), (\\'University Hospital Homburg_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital Homburg\\'}), (\\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon\\'}), (\\'UMBRELLA protocol_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'ExPO\u2011r\u2011Net\\'}), (\\'Weirich, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Weirich, A.\\'}), (\\'Pritchard-Jones, K._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Pritchard-Jones, K.\\'}), (\\'de Kraker, J._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'de Kraker, J.\\'}), (\\'Graf, N._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Graf, N.\\'}), (\\'Green, D. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Green, D. M.\\'}), (\\'Spreafico, F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Spreafico, F.\\'}), (\\'Bellani, F. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Bellani, F. F.\\'}), (\\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'van den Heuvel-Eibrink, M. M.\\'}), (\"D\\'Angio, G. J._author\", {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \"D\\'Angio, G. J.\"}), (\\'Tournade, M. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Tournade, M. F.\\'}), (\\'Breslow, N. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Breslow, N. E.\\'}), (\\'Mitchell, C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Mitchell, C.\\'}), (\\'Verschuur, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Verschuur, A.\\'}), (\\'Grundy, P. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Grundy, P. E.\\'}), (\\'Warmann, S. W._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Warmann, S. W.\\'}), (\\'Smets, A. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Smets, A. M.\\'}), (\\'Dome, J. S._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dome, J. S.\\'}), (\\'Dix, D. B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dix, D. B.\\'}), (\\'Daw, N. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Daw, N. C.\\'}), (\\'Ha, T. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Ha, T. C.\\'}), (\\'Kremens, B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Kremens, B.\\'}), (\\'Furtwangler, R._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Furtwangler, R.\\'}), (\\'SIOP-9/GPOH_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP-9/GPOH\\'}), (\\'UKW3_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'UKW3\\'}), (\\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'SIOP 93\u201301 trial\\'}), (\\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP trial and study 93\u201301\\'}), (\\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'National Wilms Tumor Study Group\\'}), (\\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP WT 2001 protocol\\'}), (\\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Third National Wilms\u2019 Tumor Study\\'}), (\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'National Wilms Tumor Studies\\'}), (\\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Second National Wilms\u2019 Tumor Study\\'}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'UK Children\u2019s Cancer Study Group\\'}), (\\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Children\u2019s Oncology Group\\'})], \\'edges\\': [(\\'sample.pdf\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'non-Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'childhood renal tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'renal cell carcinoma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'localized disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'metastatic disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'bilateral disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'relapsed disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'radiotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'surgery_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'chemotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'Wilms Tumour_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CCSK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'MRTK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CMN_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'RCC_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP\u22122001_Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'vincristine_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'actinomycin D_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'doxorubicin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'etoposide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'carboplatin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'cyclophosphamide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage I_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage II_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage III_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage IV_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage V_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AV_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AVD_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'HR-1_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Overall Survival (OS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT-only nodules_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'MRI_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG AREN0533 trial_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'etoposide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'carboplatin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'cyclophosphamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP database_database\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AVD_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AV-2_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Aronson et al._Research Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Etoposide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Carboplatin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group AA_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group BB_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group CC_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Cyclophosphamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Ifosfamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'ASCR_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'ifosfamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'nephrotoxicity_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'relapsed group CC_patient_group\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'diffuse anaplasia_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'blastemal-type tumors_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'camptothecins_medication_class\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'irinotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'topotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'radiotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'surgical excision_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'stage IV WT_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD150_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD250_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'low-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'CDCV_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'actinomycin-D_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'vincristine_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'doxorubicin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'VP16_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'surgery_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'chemotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'anaplasia_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'actinomycin D_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'vincristine_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'doxorubicin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'carboplatin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'cyclophosphamide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'etoposide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'SIOP\u22122001_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Wilms tumours_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Davila Fajardo et al._author\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'whole-lung irradiation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'proton therapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'dosimetric study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'locoregional disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'metastatic disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'low-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'intermediate-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'high-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage I_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage II_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage III_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'major rupture_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Austria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Italy_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'San Marino_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Iceland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Germany_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bulgaria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Turkey_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Denmark_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Poland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Greece_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Andorra_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belgium_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Serbia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Albania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Moldova_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Lithuania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Latvia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Estonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Luxembourg_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Montenegro_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Croatia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovenia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Macedonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'United Kingdom_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ireland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Spain_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Algeria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Tunisia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Malta_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Morocco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Portugal_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'France_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Monaco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Russia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Finland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Sweden_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Norway_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belarus_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Romania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ukraine_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hungary_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Czech Republic_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovakia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Switzerland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Liechtenstein_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Netherlands_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Munich_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Marciniak Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Faculty of Medicine_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital Homburg_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Weirich, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Pritchard-Jones, K._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'de Kraker, J._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Graf, N._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Green, D. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Spreafico, F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Bellani, F. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \"D\\'Angio, G. J._author\", {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Tournade, M. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Breslow, N. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Mitchell, C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Verschuur, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Grundy, P. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Warmann, S. W._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Smets, A. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dome, J. S._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dix, D. B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Daw, N. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ha, T. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Kremens, B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Furtwangler, R._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP-9/GPOH_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UKW3_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10})]}, {\\'nodes\\': [(\\'vincristine_entity\\', {}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {}), (\\'www.siop-rtsg.eu_entity\\', {}), (\\'stage II_entity\\', {}), (\\'Wilms tumours_entity\\', {}), (\\'Relapsed Wilms Tumor_entity\\', {}), (\\'Davila Fajardo et al._entity\\', {}), (\\'vincristine, actinomycin D, and doxorubicin_entity\\', {}), (\\'SIOP\u22122001 randomized trial_entity\\', {}), (\\'surgery_entity\\', {}), (\\'non-Wilms tumours_entity\\', {}), (\\'actinomycin D_entity\\', {}), (\\'diffuse anaplasia_entity\\', {}), (\\'Synchronous bilateral Wilms tumor_entity\\', {}), (\\'CT-only nodules_entity\\', {}), (\\'relapsed group CC_entity\\', {}), (\\'increased relapse risk_entity\\', {}), (\\'reduced survival_entity\\', {}), (\\'UKW3 trial_entity\\', {}), (\\'chemotherapy_entity\\', {}), (\\'Bilateral Disease (Stage V)_entity\\', {}), (\\'blastemal-type tumors_entity\\', {}), (\\'UMBRELLA protocol_entity\\', {}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', {}), (\\'minimally invasive surgery_entity\\', {}), (\\'VP16_entity\\', {}), (\\'Wilms tumor_entity\\', {}), (\\'anaplasia_entity\\', {}), (\\'radical tumor nephrectomy_entity\\', {}), (\\'Innovative Therapies for Children with Cancer consortium_entity\\', {}), (\\'cumulative doxorubicin dose_entity\\', {}), (\\'etoposide_entity\\', {}), (\\'large-volume tumours_entity\\', {}), (\\'Stage IV_entity\\', {}), (\\'CDCV_entity\\', {}), (\\'SIOP\u2013RTSG_entity\\', {}), (\\'AVD150_entity\\', {}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', {}), (\\'laparoscopic surgery_entity\\', {}), (\\'SIOP\u2212RTSG panel_entity\\', {}), (\\'actinomycin-D_entity\\', {}), (\\'COG AREN0533 trial_entity\\', {}), (\\'cyclophosphamide_entity\\', {}), (\\'carboplatin_entity\\', {}), (\\'UKW\u2011R protocol_entity\\', {}), (\\'Nephron-sparing surgery (NSS)_entity\\', {}), (\\'Adult Wilms Tumors_entity\\', {}), (\\'doxorubicin_entity\\', {}), (\\'NWTS\u20115 relapse protocol_entity\\', {}), (\\'End-stage renal disease (ESRD)_entity\\', {}), (\\'AVD250_entity\\', {}), (\\'Children\u2019s Oncology Group (COG)_entity\\', {}), (\\'blastemal-type Wilms tumour_entity\\', {}), (\\'SIOP\u22122001_entity\\', {}), (\\'radiotherapy_entity\\', {}), (\\'childhood renal tumours_entity\\', {})], \\'edges\\': [(\\'vincristine_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'stage II_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'indicated_for_in_adults\\'}), (\\'Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'Wilms tumours_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated under\\'}), (\\'Relapsed Wilms Tumor_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guided_by\\'}), (\\'Davila Fajardo et al._entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed\\'}), (\\'SIOP\u22122001 randomized trial_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated use in\\'}), (\\'surgery_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'non-Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'actinomycin D_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Synchronous bilateral Wilms tumor_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'instance_of\\'}), (\\'CT-only nodules_entity\\', \\'increased relapse risk_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'reduced survival_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included_in\\'}), (\\'relapsed group CC_entity\\', \\'diffuse anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'blastemal-type tumors_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UKW3 trial_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'UKW3 trial_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'chemotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UMBRELLA protocol_entity\\', \\'COG AREN0533 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses_data_from\\'}), (\\'UMBRELLA protocol_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'advises_treatment_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'Innovative Therapies for Children with Cancer consortium_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborates_with\\'}), (\\'UMBRELLA protocol_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'surgery_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is the standard of\\'}), (\\'UMBRELLA protocol_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guides treatment in\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', \\'UKW3 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\\'minimally invasive surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'anaplasia_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'radical tumor nephrectomy_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'standard_of_care_for\\'}), (\\'Stage IV_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'presents in\\'}), (\\'CDCV_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'VP16_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'aims to improve survival rates of\\'}), (\\'AVD150_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed_by\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'succeeds\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'www.siop-rtsg.eu_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'available_on\\'}), (\\'laparoscopic surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'COG AREN0533 trial_entity\\', \\'cumulative doxorubicin dose_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'evaluates\\'}), (\\'UKW\u2011R protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'Nephron-sparing surgery (NSS)_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'classification_developed_by\\'}), (\\'Adult Wilms Tumors_entity\\', \\'anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'Adult Wilms Tumors_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'doxorubicin_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'doxorubicin_entity\\', \\'large-volume tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'recommended for\\'}), (\\'NWTS\u20115 relapse protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'End-stage renal disease (ESRD)_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'AVD250_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'Children\u2019s Oncology Group (COG)_entity\\', \\'SIOP\u22122001 randomized trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborated with\\'}), (\\'blastemal-type Wilms tumour_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment intensified according to\\'}), (\\'SIOP\u22122001_entity\\', \\'vincristine, actinomycin D, and doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses\\'}), (\\'SIOP\u22122001_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provided_guidelines_for\\'}), (\\'radiotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'radiotherapy_entity\\', \\'SIOP\u2212RTSG panel_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'contact_for_guidance\\'})]}, {\\'nodes\\': [(\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {}), (\\'Marry M. van den Heuvel-Eibrink_entity\\', {})], \\'edges\\': [(\\'Marry M. van den Heuvel-Eibrink_entity\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'affiliated_with\\'})]}, {\\'nodes\\': [(\\'Stage II_entity\\', {}), (\\'AV_entity\\', {}), (\\'Stage III_entity\\', {}), (\\'vincestine and actinomycin D_entity\\', {}), (\\'AVD_entity\\', {})], \\'edges\\': [(\\'Stage II_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AV_entity\\', \\'Stage II_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Stage III_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AVD_entity\\', \\'Stage III_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'SIOP-RTSG 2016_entity\\', {}), (\\'RCC_entity\\', {}), (\\'CMN_entity\\', {})], \\'edges\\': [(\\'RCC_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'}), (\\'CMN_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'})]}, {\\'nodes\\': [(\\'HR-1_entity\\', {}), (\\'High-risk blastemal type Wilms tumour_entity\\', {})], \\'edges\\': [(\\'HR-1_entity\\', \\'High-risk blastemal type Wilms tumour_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'unfavorable prognosis_entity\\', {}), (\\'high-risk characteristics_entity\\', {})], \\'edges\\': [(\\'high-risk characteristics_entity\\', \\'unfavorable prognosis_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'leads_to\\'})]}, {\\'nodes\\': [(\\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {}), (\\'SIOP\u2013RTSG board_entity\\', {})], \\'edges\\': [(\\'SIOP\u2013RTSG board_entity\\', \\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggests\\'})]}, {\\'nodes\\': [(\\'regimen and outcomes_entity\\', {}), (\\'SIOP database_entity\\', {})], \\'edges\\': [(\\'SIOP database_entity\\', \\'regimen and outcomes_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'captures_data_on\\'})]}, {\\'nodes\\': [(\\'Bilateral nephron-sparing surgery (NSS)_entity\\', {}), (\\'Aronson et al._entity\\', {})], \\'edges\\': [(\\'Aronson et al._entity\\', \\'Bilateral nephron-sparing surgery (NSS)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'observed_effectiveness_of\\'})]}, {\\'nodes\\': [(\\'SIOP\u22122001 study_entity\\', {}), (\\'Actinomycin D_entity\\', {}), (\\'Vincristine_entity\\', {})], \\'edges\\': [(\\'SIOP\u22122001 study_entity\\', \\'Vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'}), (\\'SIOP\u22122001 study_entity\\', \\'Actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'})]}, {\\'nodes\\': [(\\'High-dose melphalan_entity\\', {}), (\\'Group AA_entity\\', {}), (\\'Carboplatin_entity\\', {}), (\\'Doxorubicin_entity\\', {}), (\\'Etoposide_entity\\', {}), (\\'Group BB_entity\\', {}), (\\'Cyclophosphamide_entity\\', {}), (\\'Ifosfamide_entity\\', {})], \\'edges\\': [(\\'Group AA_entity\\', \\'Doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Ifosfamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'High-dose melphalan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'})]}, {\\'nodes\\': [(\\'nephrotoxicity_entity\\', {}), (\\'ifosfamide_entity\\', {})], \\'edges\\': [(\\'ifosfamide_entity\\', \\'nephrotoxicity_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'related_to\\'})]}, {\\'nodes\\': [(\\'camptothecins_entity\\', {}), (\\'irinotecan_entity\\', {}), (\\'topotecan_entity\\', {})], \\'edges\\': [(\\'camptothecins_entity\\', \\'irinotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'camptothecins_entity\\', \\'topotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'})]}, {\\'nodes\\': [(\\'Infant Wilms Tumors_entity\\', {}), (\\'nephrectomy_entity\\', {})], \\'edges\\': [(\\'Infant Wilms Tumors_entity\\', \\'nephrectomy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_option\\'})]}, {\\'nodes\\': [(\\'congenital mesoblastic nephroma_entity\\', {}), (\\'surgery alone_entity\\', {})], \\'edges\\': [(\\'congenital mesoblastic nephroma_entity\\', \\'surgery alone_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'alternative chemotherapy_entity\\', {}), (\\'malignant rhabdoid tumors_entity\\', {})], \\'edges\\': [(\\'malignant rhabdoid tumors_entity\\', \\'alternative chemotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'lymph node sampling_entity\\', {}), (\\'accurate staging_entity\\', {})], \\'edges\\': [(\\'lymph node sampling_entity\\', \\'accurate staging_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'purpose_of\\'})]}, {\\'nodes\\': [(\\'COG\u2013NWTS trials_entity\\', {}), (\\'whole-lung irradiation_entity\\', {})], \\'edges\\': [(\\'COG\u2013NWTS trials_entity\\', \\'whole-lung irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'informed_dosage_for\\'})]}, {\\'nodes\\': [(\\'lung metastases_entity\\', {}), (\\'pulmonary radiotherapy_entity\\', {})], \\'edges\\': [(\\'pulmonary radiotherapy_entity\\', \\'lung metastases_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'administered_for\\'})]}, {\\'nodes\\': [(\\'dosimetric study_entity\\', {}), (\\'proton therapy_entity\\', {}), (\\'flank irradiation_entity\\', {})], \\'edges\\': [(\\'dosimetric study_entity\\', \\'proton therapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated\\'}), (\\'proton therapy_entity\\', \\'flank irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggested_for\\'})]}, {\\'nodes\\': [(\\'metastatic disease_entity\\', {}), (\\'radiotherapy guidelines_entity\\', {}), (\\'locoregional disease_entity\\', {})], \\'edges\\': [(\\'radiotherapy guidelines_entity\\', \\'locoregional disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'}), (\\'radiotherapy guidelines_entity\\', \\'metastatic disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'})]}, {\\'nodes\\': [(\\'major rupture_entity\\', {}), (\\'stage III_entity\\', {})], \\'edges\\': [(\\'stage III_entity\\', \\'major rupture_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes_condition\\'})]}, {\\'nodes\\': [(\\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {}), (\\'ExPO\u2011r\u2011Net_entity\\', {})], \\'edges\\': [(\\'ExPO\u2011r\u2011Net_entity\\', \\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is part of\\'})]}, {\\'nodes\\': [(\\'University Hospital of Munich_entity\\', {}), (\\'Germany_entity\\', {}), (\\'University Hospital of Tuebingen_entity\\', {})], \\'edges\\': [(\\'Germany_entity\\', \\'University Hospital of Munich_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Germany_entity\\', \\'University Hospital of Tuebingen_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {}), (\\'Italy_entity\\', {}), (\\'Azienda Ospedaliera_entity\\', {}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {})], \\'edges\\': [(\\'Italy_entity\\', \\'Azienda Ospedaliera_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Netherlands_entity\\', {}), (\\'Prinses Maxima Centrum_entity\\', {})], \\'edges\\': [(\\'Netherlands_entity\\', \\'Prinses Maxima Centrum_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Marciniak Hospital_entity\\', {}), (\\'Poland_entity\\', {}), (\\'Faculty of Medicine_entity\\', {})], \\'edges\\': [(\\'Poland_entity\\', \\'Marciniak Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Poland_entity\\', \\'Faculty of Medicine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'St. Anna Kinderspital/CCRI_entity\\', {}), (\\'Austria_entity\\', {})], \\'edges\\': [(\\'Austria_entity\\', \\'St. Anna Kinderspital/CCRI_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'France_entity\\', {}), (\\'Armand Trousseau Hospital_entity\\', {})], \\'edges\\': [(\\'France_entity\\', \\'Armand Trousseau Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Spain_entity\\', {}), (\\'Hospital Vall d\u2019Hebron_entity\\', {}), (\\'Hospital Universitario Virgin del Rocio_entity\\', {})], \\'edges\\': [(\\'Spain_entity\\', \\'Hospital Universitario Virgin del Rocio_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Spain_entity\\', \\'Hospital Vall d\u2019Hebron_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'United Kingdom_entity\\', {}), (\\'Great Ormond Street Hospital_entity\\', {})], \\'edges\\': [(\\'United Kingdom_entity\\', \\'Great Ormond Street Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Weirich, A._entity\\', {}), (\\'SIOP-9/GPOH_entity\\', {})], \\'edges\\': [(\\'Weirich, A._entity\\', \\'SIOP-9/GPOH_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Pritchard-Jones, K._entity\\', {}), (\\'UKW3_entity\\', {})], \\'edges\\': [(\\'Pritchard-Jones, K._entity\\', \\'UKW3_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed in\\'})]}, {\\'nodes\\': [(\\'SIOP 93\u201301 trial_entity\\', {}), (\\'de Kraker, J._entity\\', {})], \\'edges\\': [(\\'de Kraker, J._entity\\', \\'SIOP 93\u201301 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'SIOP trial and study 93\u201301_entity\\', {}), (\\'Graf, N._entity\\', {})], \\'edges\\': [(\\'Graf, N._entity\\', \\'SIOP trial and study 93\u201301_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Green, D. M._entity\\', {}), (\\'National Wilms Tumor Study Group_entity\\', {})], \\'edges\\': [(\\'Green, D. M._entity\\', \\'National Wilms Tumor Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}, {\\'nodes\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', {}), (\\'SIOP WT 2001 protocol_entity\\', {})], \\'edges\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', \\'SIOP WT 2001 protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Third National Wilms\u2019 Tumor Study_entity\\', {}), (\"D\\'Angio, G. J._entity\", {}), (\\'Second National Wilms\u2019 Tumor Study_entity\\', {})], \\'edges\\': [(\"D\\'Angio, G. J._entity\", \\'Third National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\"D\\'Angio, G. J._entity\", \\'Second National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {}), (\\'Tournade, M. F._entity\\', {}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {})], \\'edges\\': [(\\'Tournade, M. F._entity\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'}), (\\'Tournade, M. F._entity\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Breslow, N. E._entity\\', {}), (\\'National Wilms Tumor Studies_entity\\', {})], \\'edges\\': [(\\'Breslow, N. E._entity\\', \\'National Wilms Tumor Studies_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Mitchell, C._entity\\', {}), (\\'UK Children\u2019s Cancer Study Group_entity\\', {})], \\'edges\\': [(\\'Mitchell, C._entity\\', \\'UK Children\u2019s Cancer Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'under\\'})]}, {\\'nodes\\': [(\\'Daw, N. C._entity\\', {}), (\\'Dix, D. B._entity\\', {}), (\\'Children\u2019s Oncology Group_entity\\', {}), (\\'Grundy, P. E._entity\\', {})], \\'edges\\': [(\\'Daw, N. C._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted under\\'}), (\\'Dix, D. B._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'}), (\\'Grundy, P. E._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}]', expected_output='By collecting comprehensive, prospective data from a large cohort of patients.', context=None, retrieval_context=['[{\\'nodes\\': [(\\'sample.pdf\\', {\\'type\\': \\'document\\'}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)\\'}), (\\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA SIOP-RTSG 2016\\'}), (\\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms tumours\\'}), (\\'non-Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'non-Wilms tumours\\'}), (\\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Website\\', \\'name\\': \\'www.siop-rtsg.eu\\'}), (\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology\\'}), (\\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Person\\', \\'name\\': \\'Marry M. van den Heuvel-Eibrink\\'}), (\\'childhood renal tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'childhood renal tumours\\'}), (\\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'clear cell sarcoma of the kidney\\'}), (\\'renal cell carcinoma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'renal cell carcinoma\\'}), (\\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'malignant rhabdoid tumour of the kidney\\'}), (\\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'Wilms tumours_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'Children\u2019s Oncology Group (COG)\\'}), (\\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'SIOP\u22122001 randomized trial\\'}), (\\'actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'UKW3 trial\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)\\'}), (\\'localized disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'localized disease\\'}), (\\'metastatic disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'metastatic disease\\'}), (\\'bilateral disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'bilateral disease\\'}), (\\'relapsed disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'relapsed disease\\'}), (\\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subtype\\', \\'name\\': \\'blastemal-type Wilms tumours\\'}), (\\'radiotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgery_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'chemotherapy\\'}), (\\'Wilms Tumour_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms Tumour\\'}), (\\'CCSK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CCSK\\'}), (\\'MRTK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'MRTK\\'}), (\\'CMN_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CMN\\'}), (\\'RCC_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'RCC\\'}), (\\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u22122001_Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Trial\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'vincristine_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'vincristine\\'}), (\\'actinomycin D_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'actinomycin D\\'}), (\\'doxorubicin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'doxorubicin\\'}), (\\'etoposide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'Stage I_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage I\\'}), (\\'Stage II_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage II\\'}), (\\'Stage III_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage III\\'}), (\\'Stage IV_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage IV\\'}), (\\'Stage V_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage V\\'}), (\\'AV_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AV\\'}), (\\'AVD_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AVD\\'}), (\\'HR-1_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'HR-1\\'}), (\\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP-RTSG 2016\\'}), (\\'Overall Survival (OS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'CT-only nodules_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'CT-only nodules\\'}), (\\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP\u2013RTSG analysis\\'}), (\\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials\\'}), (\\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D plus doxorubicin\\'}), (\\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D\\'}), (\\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study_protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'MRI_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'MRI\\'}), (\\'CT_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'CT\\'}), (\\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_detail\\', \\'name\\': \\'cumulative doxorubicin dose\\'}), (\\'COG AREN0533 trial_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG AREN0533 trial\\'}), (\\'etoposide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'high-risk characteristics\\'}), (\\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG board\\'}), (\\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin\\'}), (\\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'high-dose chemotherapy and autologous stem cell transplantation\\'}), (\\'SIOP database_database\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'database\\', \\'name\\': \\'SIOP database\\'}), (\\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'AVD_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AVD\\'}), (\\'AV-2_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AV-2\\'}), (\\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Statistical Test\\', \\'name\\': \\'Log\u2013Rank P\\'}), (\\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'Bilateral Disease (Stage V)\\'}), (\\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Synchronous bilateral Wilms tumor\\'}), (\\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'End-stage renal disease (ESRD)\\'}), (\\'Aronson et al._Research Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Research Group\\', \\'name\\': \\'Aronson et al.\\'}), (\\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'Bilateral nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Study\\', \\'name\\': \\'SIOP\u22122001 study\\'}), (\\'Vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Vincristine\\'}), (\\'Actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Actinomycin D\\'}), (\\'Etoposide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Etoposide\\'}), (\\'Carboplatin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Carboplatin\\'}), (\\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease State\\', \\'name\\': \\'Relapsed Wilms Tumor\\'}), (\\'Group AA_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group AA\\'}), (\\'Group BB_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group BB\\'}), (\\'Group CC_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group CC\\'}), (\\'Doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Doxorubicin\\'}), (\\'Cyclophosphamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Cyclophosphamide\\'}), (\\'Ifosfamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Ifosfamide\\'}), (\\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'High-dose melphalan\\'}), (\\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UKW\u2011R protocol\\'}), (\\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'NWTS\u20115 relapse protocol\\'}), (\\'ASCR_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'procedure\\', \\'name\\': \\'ASCR\\'}), (\\'ifosfamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'ifosfamide\\'}), (\\'nephrotoxicity_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'nephrotoxicity\\'}), (\\'relapsed group CC_patient_group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'patient_group\\', \\'name\\': \\'relapsed group CC\\'}), (\\'diffuse anaplasia_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'diffuse anaplasia\\'}), (\\'blastemal-type tumors_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'blastemal-type tumors\\'}), (\\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'camptothecins_medication_class\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication_class\\', \\'name\\': \\'camptothecins\\'}), (\\'irinotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'irinotecan\\'}), (\\'topotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'topotecan\\'}), (\\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Innovative Therapies for Children with Cancer consortium\\'}), (\\'radiotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgical excision_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgical excision\\'}), (\\'stage IV WT_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'stage IV WT\\'}), (\\'AVD150_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD150\\'}), (\\'AVD250_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD250\\'}), (\\'low-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'low-risk disease\\'}), (\\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'intermediate-risk disease\\'}), (\\'high-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'high-risk disease\\'}), (\\'CDCV_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'CDCV\\'}), (\\'actinomycin-D_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'actinomycin-D\\'}), (\\'vincristine_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'doxorubicin\\'}), (\\'VP16_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'VP16\\'}), (\\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'contact\\', \\'name\\': \\'arnauld.verschuur@ap-hm.fr\\'}), (\\'surgery_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'chemotherapy\\'}), (\\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2212RTSG panel\\'}), (\\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Infant Wilms Tumors\\'}), (\\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'nephrectomy\\'}), (\\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'malignant rhabdoid tumors\\'}), (\\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Adult Wilms Tumors\\'}), (\\'anaplasia_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'anaplasia\\'}), (\\'actinomycin D_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'carboplatin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'etoposide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'etoposide\\'}), (\\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'Nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'radical tumor nephrectomy\\'}), (\\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'lymph node sampling\\'}), (\\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'minimally invasive surgery\\'}), (\\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'laparoscopic surgery\\'}), (\\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'radiotherapy\\'}), (\\'Wilms tumours_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'Davila Fajardo et al._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Davila Fajardo et al.\\'}), (\\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'COG\u2013NWTS trials\\'}), (\\'whole-lung irradiation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'whole-lung irradiation\\'}), (\\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'pulmonary radiotherapy\\'}), (\\'proton therapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'proton therapy\\'}), (\\'dosimetric study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'dosimetric study\\'}), (\\'locoregional disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'locoregional disease\\'}), (\\'metastatic disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'metastatic disease\\'}), (\\'low-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'low-risk\\'}), (\\'intermediate-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'intermediate-risk\\'}), (\\'high-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'high-risk\\'}), (\\'stage I_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage I\\'}), (\\'stage II_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage II\\'}), (\\'stage III_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage III\\'}), (\\'major rupture_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'major rupture\\'}), (\\'Austria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Austria\\'}), (\\'Italy_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Italy\\'}), (\\'San Marino_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'San Marino\\'}), (\\'Iceland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Iceland\\'}), (\\'Germany_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Germany\\'}), (\\'Bulgaria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bulgaria\\'}), (\\'Turkey_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Turkey\\'}), (\\'Denmark_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Denmark\\'}), (\\'Poland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Poland\\'}), (\\'Greece_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Greece\\'}), (\\'Andorra_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Andorra\\'}), (\\'Belgium_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belgium\\'}), (\\'Serbia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Serbia\\'}), (\\'Albania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Albania\\'}), (\\'Moldova_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Moldova\\'}), (\\'Lithuania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Lithuania\\'}), (\\'Latvia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Latvia\\'}), (\\'Estonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Estonia\\'}), (\\'Luxembourg_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Luxembourg\\'}), (\\'Montenegro_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Montenegro\\'}), (\\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bosnia and Herzegovina\\'}), (\\'Croatia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Croatia\\'}), (\\'Slovenia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovenia\\'}), (\\'Macedonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Macedonia\\'}), (\\'United Kingdom_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'United Kingdom\\'}), (\\'Ireland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ireland\\'}), (\\'Spain_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Spain\\'}), (\\'Algeria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Algeria\\'}), (\\'Tunisia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Tunisia\\'}), (\\'Malta_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Malta\\'}), (\\'Morocco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Morocco\\'}), (\\'Portugal_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Portugal\\'}), (\\'France_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'France\\'}), (\\'Monaco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Monaco\\'}), (\\'Russia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Russia\\'}), (\\'Finland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Finland\\'}), (\\'Sweden_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Sweden\\'}), (\\'Norway_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Norway\\'}), (\\'Belarus_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belarus\\'}), (\\'Romania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Romania\\'}), (\\'Ukraine_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ukraine\\'}), (\\'Hungary_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Hungary\\'}), (\\'Czech Republic_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Czech Republic\\'}), (\\'Slovakia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovakia\\'}), (\\'Switzerland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Switzerland\\'}), (\\'Liechtenstein_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Liechtenstein\\'}), (\\'Netherlands_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Netherlands\\'}), (\\'University Hospital of Munich_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Munich\\'}), (\\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Tuebingen\\'}), (\\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Azienda Ospedaliera\\'}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Ospedale Pediatrico Bambino Ges\u00f9\\'}), (\\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Fondazione IRCCS Istituto Nazionale dei Tumori\\'}), (\\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Prinses Maxima Centrum\\'}), (\\'Marciniak Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Marciniak Hospital\\'}), (\\'Faculty of Medicine_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Faculty of Medicine\\'}), (\\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'St. Anna Kinderspital/CCRI\\'}), (\\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Armand Trousseau Hospital\\'}), (\\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Universitario Virgin del Rocio\\'}), (\\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Vall d\u2019Hebron\\'}), (\\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Great Ormond Street Hospital\\'}), (\\'University Hospital Homburg_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital Homburg\\'}), (\\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon\\'}), (\\'UMBRELLA protocol_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'ExPO\u2011r\u2011Net\\'}), (\\'Weirich, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Weirich, A.\\'}), (\\'Pritchard-Jones, K._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Pritchard-Jones, K.\\'}), (\\'de Kraker, J._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'de Kraker, J.\\'}), (\\'Graf, N._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Graf, N.\\'}), (\\'Green, D. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Green, D. M.\\'}), (\\'Spreafico, F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Spreafico, F.\\'}), (\\'Bellani, F. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Bellani, F. F.\\'}), (\\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'van den Heuvel-Eibrink, M. M.\\'}), (\"D\\'Angio, G. J._author\", {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \"D\\'Angio, G. J.\"}), (\\'Tournade, M. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Tournade, M. F.\\'}), (\\'Breslow, N. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Breslow, N. E.\\'}), (\\'Mitchell, C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Mitchell, C.\\'}), (\\'Verschuur, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Verschuur, A.\\'}), (\\'Grundy, P. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Grundy, P. E.\\'}), (\\'Warmann, S. W._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Warmann, S. W.\\'}), (\\'Smets, A. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Smets, A. M.\\'}), (\\'Dome, J. S._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dome, J. S.\\'}), (\\'Dix, D. B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dix, D. B.\\'}), (\\'Daw, N. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Daw, N. C.\\'}), (\\'Ha, T. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Ha, T. C.\\'}), (\\'Kremens, B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Kremens, B.\\'}), (\\'Furtwangler, R._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Furtwangler, R.\\'}), (\\'SIOP-9/GPOH_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP-9/GPOH\\'}), (\\'UKW3_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'UKW3\\'}), (\\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'SIOP 93\u201301 trial\\'}), (\\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP trial and study 93\u201301\\'}), (\\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'National Wilms Tumor Study Group\\'}), (\\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP WT 2001 protocol\\'}), (\\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Third National Wilms\u2019 Tumor Study\\'}), (\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'National Wilms Tumor Studies\\'}), (\\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Second National Wilms\u2019 Tumor Study\\'}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'UK Children\u2019s Cancer Study Group\\'}), (\\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Children\u2019s Oncology Group\\'})], \\'edges\\': [(\\'sample.pdf\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'non-Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'childhood renal tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'renal cell carcinoma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'localized disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'metastatic disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'bilateral disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'relapsed disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'radiotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'surgery_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'chemotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'Wilms Tumour_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CCSK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'MRTK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CMN_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'RCC_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP\u22122001_Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'vincristine_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'actinomycin D_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'doxorubicin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'etoposide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'carboplatin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'cyclophosphamide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage I_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage II_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage III_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage IV_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage V_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AV_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AVD_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'HR-1_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Overall Survival (OS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT-only nodules_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'MRI_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG AREN0533 trial_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'etoposide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'carboplatin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'cyclophosphamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP database_database\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AVD_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AV-2_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Aronson et al._Research Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Etoposide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Carboplatin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group AA_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group BB_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group CC_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Cyclophosphamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Ifosfamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'ASCR_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'ifosfamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'nephrotoxicity_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'relapsed group CC_patient_group\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'diffuse anaplasia_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'blastemal-type tumors_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'camptothecins_medication_class\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'irinotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'topotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'radiotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'surgical excision_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'stage IV WT_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD150_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD250_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'low-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'CDCV_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'actinomycin-D_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'vincristine_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'doxorubicin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'VP16_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'surgery_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'chemotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'anaplasia_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'actinomycin D_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'vincristine_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'doxorubicin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'carboplatin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'cyclophosphamide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'etoposide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'SIOP\u22122001_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Wilms tumours_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Davila Fajardo et al._author\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'whole-lung irradiation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'proton therapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'dosimetric study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'locoregional disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'metastatic disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'low-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'intermediate-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'high-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage I_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage II_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage III_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'major rupture_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Austria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Italy_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'San Marino_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Iceland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Germany_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bulgaria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Turkey_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Denmark_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Poland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Greece_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Andorra_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belgium_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Serbia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Albania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Moldova_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Lithuania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Latvia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Estonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Luxembourg_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Montenegro_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Croatia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovenia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Macedonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'United Kingdom_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ireland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Spain_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Algeria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Tunisia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Malta_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Morocco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Portugal_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'France_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Monaco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Russia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Finland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Sweden_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Norway_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belarus_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Romania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ukraine_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hungary_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Czech Republic_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovakia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Switzerland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Liechtenstein_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Netherlands_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Munich_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Marciniak Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Faculty of Medicine_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital Homburg_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Weirich, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Pritchard-Jones, K._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'de Kraker, J._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Graf, N._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Green, D. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Spreafico, F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Bellani, F. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \"D\\'Angio, G. J._author\", {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Tournade, M. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Breslow, N. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Mitchell, C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Verschuur, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Grundy, P. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Warmann, S. W._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Smets, A. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dome, J. S._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dix, D. B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Daw, N. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ha, T. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Kremens, B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Furtwangler, R._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP-9/GPOH_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UKW3_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10})]}, {\\'nodes\\': [(\\'vincristine_entity\\', {}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {}), (\\'www.siop-rtsg.eu_entity\\', {}), (\\'stage II_entity\\', {}), (\\'Wilms tumours_entity\\', {}), (\\'Relapsed Wilms Tumor_entity\\', {}), (\\'Davila Fajardo et al._entity\\', {}), (\\'vincristine, actinomycin D, and doxorubicin_entity\\', {}), (\\'SIOP\u22122001 randomized trial_entity\\', {}), (\\'surgery_entity\\', {}), (\\'non-Wilms tumours_entity\\', {}), (\\'actinomycin D_entity\\', {}), (\\'diffuse anaplasia_entity\\', {}), (\\'Synchronous bilateral Wilms tumor_entity\\', {}), (\\'CT-only nodules_entity\\', {}), (\\'relapsed group CC_entity\\', {}), (\\'increased relapse risk_entity\\', {}), (\\'reduced survival_entity\\', {}), (\\'UKW3 trial_entity\\', {}), (\\'chemotherapy_entity\\', {}), (\\'Bilateral Disease (Stage V)_entity\\', {}), (\\'blastemal-type tumors_entity\\', {}), (\\'UMBRELLA protocol_entity\\', {}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', {}), (\\'minimally invasive surgery_entity\\', {}), (\\'VP16_entity\\', {}), (\\'Wilms tumor_entity\\', {}), (\\'anaplasia_entity\\', {}), (\\'radical tumor nephrectomy_entity\\', {}), (\\'Innovative Therapies for Children with Cancer consortium_entity\\', {}), (\\'cumulative doxorubicin dose_entity\\', {}), (\\'etoposide_entity\\', {}), (\\'large-volume tumours_entity\\', {}), (\\'Stage IV_entity\\', {}), (\\'CDCV_entity\\', {}), (\\'SIOP\u2013RTSG_entity\\', {}), (\\'AVD150_entity\\', {}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', {}), (\\'laparoscopic surgery_entity\\', {}), (\\'SIOP\u2212RTSG panel_entity\\', {}), (\\'actinomycin-D_entity\\', {}), (\\'COG AREN0533 trial_entity\\', {}), (\\'cyclophosphamide_entity\\', {}), (\\'carboplatin_entity\\', {}), (\\'UKW\u2011R protocol_entity\\', {}), (\\'Nephron-sparing surgery (NSS)_entity\\', {}), (\\'Adult Wilms Tumors_entity\\', {}), (\\'doxorubicin_entity\\', {}), (\\'NWTS\u20115 relapse protocol_entity\\', {}), (\\'End-stage renal disease (ESRD)_entity\\', {}), (\\'AVD250_entity\\', {}), (\\'Children\u2019s Oncology Group (COG)_entity\\', {}), (\\'blastemal-type Wilms tumour_entity\\', {}), (\\'SIOP\u22122001_entity\\', {}), (\\'radiotherapy_entity\\', {}), (\\'childhood renal tumours_entity\\', {})], \\'edges\\': [(\\'vincristine_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'stage II_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'indicated_for_in_adults\\'}), (\\'Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'Wilms tumours_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated under\\'}), (\\'Relapsed Wilms Tumor_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guided_by\\'}), (\\'Davila Fajardo et al._entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed\\'}), (\\'SIOP\u22122001 randomized trial_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated use in\\'}), (\\'surgery_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'non-Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'actinomycin D_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Synchronous bilateral Wilms tumor_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'instance_of\\'}), (\\'CT-only nodules_entity\\', \\'increased relapse risk_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'reduced survival_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included_in\\'}), (\\'relapsed group CC_entity\\', \\'diffuse anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'blastemal-type tumors_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UKW3 trial_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'UKW3 trial_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'chemotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UMBRELLA protocol_entity\\', \\'COG AREN0533 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses_data_from\\'}), (\\'UMBRELLA protocol_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'advises_treatment_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'Innovative Therapies for Children with Cancer consortium_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborates_with\\'}), (\\'UMBRELLA protocol_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'surgery_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is the standard of\\'}), (\\'UMBRELLA protocol_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guides treatment in\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', \\'UKW3 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\\'minimally invasive surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'anaplasia_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'radical tumor nephrectomy_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'standard_of_care_for\\'}), (\\'Stage IV_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'presents in\\'}), (\\'CDCV_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'VP16_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'aims to improve survival rates of\\'}), (\\'AVD150_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed_by\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'succeeds\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'www.siop-rtsg.eu_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'available_on\\'}), (\\'laparoscopic surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'COG AREN0533 trial_entity\\', \\'cumulative doxorubicin dose_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'evaluates\\'}), (\\'UKW\u2011R protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'Nephron-sparing surgery (NSS)_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'classification_developed_by\\'}), (\\'Adult Wilms Tumors_entity\\', \\'anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'Adult Wilms Tumors_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'doxorubicin_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'doxorubicin_entity\\', \\'large-volume tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'recommended for\\'}), (\\'NWTS\u20115 relapse protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'End-stage renal disease (ESRD)_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'AVD250_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'Children\u2019s Oncology Group (COG)_entity\\', \\'SIOP\u22122001 randomized trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborated with\\'}), (\\'blastemal-type Wilms tumour_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment intensified according to\\'}), (\\'SIOP\u22122001_entity\\', \\'vincristine, actinomycin D, and doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses\\'}), (\\'SIOP\u22122001_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provided_guidelines_for\\'}), (\\'radiotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'radiotherapy_entity\\', \\'SIOP\u2212RTSG panel_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'contact_for_guidance\\'})]}, {\\'nodes\\': [(\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {}), (\\'Marry M. van den Heuvel-Eibrink_entity\\', {})], \\'edges\\': [(\\'Marry M. van den Heuvel-Eibrink_entity\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'affiliated_with\\'})]}, {\\'nodes\\': [(\\'Stage II_entity\\', {}), (\\'AV_entity\\', {}), (\\'Stage III_entity\\', {}), (\\'vincestine and actinomycin D_entity\\', {}), (\\'AVD_entity\\', {})], \\'edges\\': [(\\'Stage II_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AV_entity\\', \\'Stage II_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Stage III_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AVD_entity\\', \\'Stage III_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'SIOP-RTSG 2016_entity\\', {}), (\\'RCC_entity\\', {}), (\\'CMN_entity\\', {})], \\'edges\\': [(\\'RCC_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'}), (\\'CMN_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'})]}, {\\'nodes\\': [(\\'HR-1_entity\\', {}), (\\'High-risk blastemal type Wilms tumour_entity\\', {})], \\'edges\\': [(\\'HR-1_entity\\', \\'High-risk blastemal type Wilms tumour_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'unfavorable prognosis_entity\\', {}), (\\'high-risk characteristics_entity\\', {})], \\'edges\\': [(\\'high-risk characteristics_entity\\', \\'unfavorable prognosis_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'leads_to\\'})]}, {\\'nodes\\': [(\\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {}), (\\'SIOP\u2013RTSG board_entity\\', {})], \\'edges\\': [(\\'SIOP\u2013RTSG board_entity\\', \\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggests\\'})]}, {\\'nodes\\': [(\\'regimen and outcomes_entity\\', {}), (\\'SIOP database_entity\\', {})], \\'edges\\': [(\\'SIOP database_entity\\', \\'regimen and outcomes_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'captures_data_on\\'})]}, {\\'nodes\\': [(\\'Bilateral nephron-sparing surgery (NSS)_entity\\', {}), (\\'Aronson et al._entity\\', {})], \\'edges\\': [(\\'Aronson et al._entity\\', \\'Bilateral nephron-sparing surgery (NSS)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'observed_effectiveness_of\\'})]}, {\\'nodes\\': [(\\'SIOP\u22122001 study_entity\\', {}), (\\'Actinomycin D_entity\\', {}), (\\'Vincristine_entity\\', {})], \\'edges\\': [(\\'SIOP\u22122001 study_entity\\', \\'Vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'}), (\\'SIOP\u22122001 study_entity\\', \\'Actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'})]}, {\\'nodes\\': [(\\'High-dose melphalan_entity\\', {}), (\\'Group AA_entity\\', {}), (\\'Carboplatin_entity\\', {}), (\\'Doxorubicin_entity\\', {}), (\\'Etoposide_entity\\', {}), (\\'Group BB_entity\\', {}), (\\'Cyclophosphamide_entity\\', {}), (\\'Ifosfamide_entity\\', {})], \\'edges\\': [(\\'Group AA_entity\\', \\'Doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Ifosfamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'High-dose melphalan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'})]}, {\\'nodes\\': [(\\'nephrotoxicity_entity\\', {}), (\\'ifosfamide_entity\\', {})], \\'edges\\': [(\\'ifosfamide_entity\\', \\'nephrotoxicity_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'related_to\\'})]}, {\\'nodes\\': [(\\'camptothecins_entity\\', {}), (\\'irinotecan_entity\\', {}), (\\'topotecan_entity\\', {})], \\'edges\\': [(\\'camptothecins_entity\\', \\'irinotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'camptothecins_entity\\', \\'topotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'})]}, {\\'nodes\\': [(\\'Infant Wilms Tumors_entity\\', {}), (\\'nephrectomy_entity\\', {})], \\'edges\\': [(\\'Infant Wilms Tumors_entity\\', \\'nephrectomy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_option\\'})]}, {\\'nodes\\': [(\\'congenital mesoblastic nephroma_entity\\', {}), (\\'surgery alone_entity\\', {})], \\'edges\\': [(\\'congenital mesoblastic nephroma_entity\\', \\'surgery alone_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'alternative chemotherapy_entity\\', {}), (\\'malignant rhabdoid tumors_entity\\', {})], \\'edges\\': [(\\'malignant rhabdoid tumors_entity\\', \\'alternative chemotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'lymph node sampling_entity\\', {}), (\\'accurate staging_entity\\', {})], \\'edges\\': [(\\'lymph node sampling_entity\\', \\'accurate staging_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'purpose_of\\'})]}, {\\'nodes\\': [(\\'COG\u2013NWTS trials_entity\\', {}), (\\'whole-lung irradiation_entity\\', {})], \\'edges\\': [(\\'COG\u2013NWTS trials_entity\\', \\'whole-lung irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'informed_dosage_for\\'})]}, {\\'nodes\\': [(\\'lung metastases_entity\\', {}), (\\'pulmonary radiotherapy_entity\\', {})], \\'edges\\': [(\\'pulmonary radiotherapy_entity\\', \\'lung metastases_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'administered_for\\'})]}, {\\'nodes\\': [(\\'dosimetric study_entity\\', {}), (\\'proton therapy_entity\\', {}), (\\'flank irradiation_entity\\', {})], \\'edges\\': [(\\'dosimetric study_entity\\', \\'proton therapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated\\'}), (\\'proton therapy_entity\\', \\'flank irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggested_for\\'})]}, {\\'nodes\\': [(\\'metastatic disease_entity\\', {}), (\\'radiotherapy guidelines_entity\\', {}), (\\'locoregional disease_entity\\', {})], \\'edges\\': [(\\'radiotherapy guidelines_entity\\', \\'locoregional disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'}), (\\'radiotherapy guidelines_entity\\', \\'metastatic disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'})]}, {\\'nodes\\': [(\\'major rupture_entity\\', {}), (\\'stage III_entity\\', {})], \\'edges\\': [(\\'stage III_entity\\', \\'major rupture_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes_condition\\'})]}, {\\'nodes\\': [(\\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {}), (\\'ExPO\u2011r\u2011Net_entity\\', {})], \\'edges\\': [(\\'ExPO\u2011r\u2011Net_entity\\', \\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is part of\\'})]}, {\\'nodes\\': [(\\'University Hospital of Munich_entity\\', {}), (\\'Germany_entity\\', {}), (\\'University Hospital of Tuebingen_entity\\', {})], \\'edges\\': [(\\'Germany_entity\\', \\'University Hospital of Munich_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Germany_entity\\', \\'University Hospital of Tuebingen_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {}), (\\'Italy_entity\\', {}), (\\'Azienda Ospedaliera_entity\\', {}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {})], \\'edges\\': [(\\'Italy_entity\\', \\'Azienda Ospedaliera_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Netherlands_entity\\', {}), (\\'Prinses Maxima Centrum_entity\\', {})], \\'edges\\': [(\\'Netherlands_entity\\', \\'Prinses Maxima Centrum_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Marciniak Hospital_entity\\', {}), (\\'Poland_entity\\', {}), (\\'Faculty of Medicine_entity\\', {})], \\'edges\\': [(\\'Poland_entity\\', \\'Marciniak Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Poland_entity\\', \\'Faculty of Medicine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'St. Anna Kinderspital/CCRI_entity\\', {}), (\\'Austria_entity\\', {})], \\'edges\\': [(\\'Austria_entity\\', \\'St. Anna Kinderspital/CCRI_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'France_entity\\', {}), (\\'Armand Trousseau Hospital_entity\\', {})], \\'edges\\': [(\\'France_entity\\', \\'Armand Trousseau Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Spain_entity\\', {}), (\\'Hospital Vall d\u2019Hebron_entity\\', {}), (\\'Hospital Universitario Virgin del Rocio_entity\\', {})], \\'edges\\': [(\\'Spain_entity\\', \\'Hospital Universitario Virgin del Rocio_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Spain_entity\\', \\'Hospital Vall d\u2019Hebron_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'United Kingdom_entity\\', {}), (\\'Great Ormond Street Hospital_entity\\', {})], \\'edges\\': [(\\'United Kingdom_entity\\', \\'Great Ormond Street Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Weirich, A._entity\\', {}), (\\'SIOP-9/GPOH_entity\\', {})], \\'edges\\': [(\\'Weirich, A._entity\\', \\'SIOP-9/GPOH_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Pritchard-Jones, K._entity\\', {}), (\\'UKW3_entity\\', {})], \\'edges\\': [(\\'Pritchard-Jones, K._entity\\', \\'UKW3_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed in\\'})]}, {\\'nodes\\': [(\\'SIOP 93\u201301 trial_entity\\', {}), (\\'de Kraker, J._entity\\', {})], \\'edges\\': [(\\'de Kraker, J._entity\\', \\'SIOP 93\u201301 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'SIOP trial and study 93\u201301_entity\\', {}), (\\'Graf, N._entity\\', {})], \\'edges\\': [(\\'Graf, N._entity\\', \\'SIOP trial and study 93\u201301_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Green, D. M._entity\\', {}), (\\'National Wilms Tumor Study Group_entity\\', {})], \\'edges\\': [(\\'Green, D. M._entity\\', \\'National Wilms Tumor Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}, {\\'nodes\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', {}), (\\'SIOP WT 2001 protocol_entity\\', {})], \\'edges\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', \\'SIOP WT 2001 protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Third National Wilms\u2019 Tumor Study_entity\\', {}), (\"D\\'Angio, G. J._entity\", {}), (\\'Second National Wilms\u2019 Tumor Study_entity\\', {})], \\'edges\\': [(\"D\\'Angio, G. J._entity\", \\'Third National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\"D\\'Angio, G. J._entity\", \\'Second National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {}), (\\'Tournade, M. F._entity\\', {}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {})], \\'edges\\': [(\\'Tournade, M. F._entity\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'}), (\\'Tournade, M. F._entity\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Breslow, N. E._entity\\', {}), (\\'National Wilms Tumor Studies_entity\\', {})], \\'edges\\': [(\\'Breslow, N. E._entity\\', \\'National Wilms Tumor Studies_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Mitchell, C._entity\\', {}), (\\'UK Children\u2019s Cancer Study Group_entity\\', {})], \\'edges\\': [(\\'Mitchell, C._entity\\', \\'UK Children\u2019s Cancer Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'under\\'})]}, {\\'nodes\\': [(\\'Daw, N. C._entity\\', {}), (\\'Dix, D. B._entity\\', {}), (\\'Children\u2019s Oncology Group_entity\\', {}), (\\'Grundy, P. E._entity\\', {})], \\'edges\\': [(\\'Daw, N. C._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted under\\'}), (\\'Dix, D. B._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'}), (\\'Grundy, P. E._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}]']), TestResult(name='test_case_12', success=False, metrics_data=[MetricData(name='Answer Correctness (GEval)', threshold=0.5, success=False, score=0.054461387615681055, reason='The actual output does not mention reducing the whole-lung irradiation dose as specified in the expected output.', strict_mode=False, evaluation_model='gpt-4o-mini', error=None, evaluation_cost=0.0032952, verbose_logs='Criteria:\\nNone \\n \\nEvaluation Steps:\\n[\\n    \"Determine whether the actual output is factually correct based on the expected output.\"\\n]'), MetricData(name='Faithfulness', threshold=0.7, success=True, score=0.8888888888888888, reason=None, strict_mode=False, evaluation_model='gpt-4o-mini', error=None, evaluation_cost=0.011187299999999999, verbose_logs='Truths (limit=None):\\n[\\n    \"The Renal Tumour Study Group is part of the International Society of Paediatric Oncology (SIOP\u2013RTSG).\",\\n    \"The UMBRELLA SIOP-RTSG 2016 is a protocol.\",\\n    \"SIOP\u22122001 is a protocol.\",\\n    \"Wilms tumours are a disease.\",\\n    \"Non-Wilms tumours are a disease.\",\\n    \"The website www.siop-rtsg.eu is associated with SIOP-RTSG.\",\\n    \"The Department of Paediatric Oncology is located at the Princess M\u00e1xima Center for Paediatric Oncology.\",\\n    \"Marry M. van den Heuvel-Eibrink is a person associated with the study.\",\\n    \"Childhood renal tumours is a disease.\",\\n    \"Clear cell sarcoma of the kidney is a disease.\",\\n    \"Renal cell carcinoma is a disease.\",\\n    \"Malignant rhabdoid tumour of the kidney is a disease.\",\\n    \"Congenital mesoblastic nephroma is a disease.\",\\n    \"Wilms tumours are a condition.\",\\n    \"The UMBRELLA protocol is a treatment protocol.\",\\n    \"SIOP\u2013RTSG is an organization.\",\\n    \"Children\u2019s Oncology Group (COG) is an organization.\",\\n    \"SIOP\u22122001 randomized trial is a clinical trial.\",\\n    \"Actinomycin D is a drug.\",\\n    \"Vincristine is a drug.\",\\n    \"Doxorubicin is a drug.\",\\n    \"UKW3 trial is a clinical trial.\",\\n    \"UK Children\u2019s Cancer and Leukaemia Group (UKCCLG) is an organization.\",\\n    \"Localized disease is a disease stage.\",\\n    \"Metastatic disease is a disease stage.\",\\n    \"Bilateral disease is a disease stage.\",\\n    \"Relapsed disease is a disease stage.\",\\n    \"Blastemal-type Wilms tumours is a subtype.\",\\n    \"Radiotherapy is a treatment method.\",\\n    \"Surgery is a treatment method.\",\\n    \"Chemotherapy is a treatment method.\",\\n    \"Wilms Tumour is a disease.\",\\n    \"CCSK is a disease.\",\\n    \"MRTK is a disease.\",\\n    \"CMN is a disease.\",\\n    \"RCC is a disease.\",\\n    \"The UMBRELLA protocol is a protocol.\",\\n    \"SIOP\u22122001 is a trial.\",\\n    \"Vincristine is a treatment.\",\\n    \"Actinomycin D is a treatment.\",\\n    \"Doxorubicin is a treatment.\",\\n    \"Etoposide is a treatment.\",\\n    \"Carboplatin is a treatment.\",\\n    \"Cyclophosphamide is a treatment.\",\\n    \"There are different stages of Wilms tumour: Stage I, Stage II, Stage III, Stage IV, and Stage V.\",\\n    \"AV is a treatment combination.\",\\n    \"AVD is a treatment combination.\",\\n    \"HR-1 is a treatment combination.\",\\n    \"The SIOP-RTSG 2016 protocol is a protocol.\",\\n    \"Overall Survival (OS) is a metric.\",\\n    \"Event-Free Survival (EFS) is a metric.\",\\n    \"CT-only nodules are a medical condition.\",\\n    \"The UMBRELLA protocol is a treatment protocol.\",\\n    \"SIOP\u2013RTSG analysis is a study.\",\\n    \"COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials is a study.\",\\n    \"Vincristine and actinomycin D plus doxorubicin is a treatment.\",\\n    \"Vincristine and actinomycin D is a treatment.\",\\n    \"SIOP\u22122001 is a study protocol.\",\\n    \"MRI is a diagnostic tool.\",\\n    \"CT is a diagnostic tool.\",\\n    \"Cumulative doxorubicin dose is a treatment detail.\",\\n    \"COG AREN0533 trial is a study.\",\\n    \"Etoposide is a medication.\",\\n    \"Carboplatin is a medication.\",\\n    \"Cyclophosphamide is a medication.\",\\n    \"High-risk characteristics are a medical condition.\",\\n    \"SIOP\u2013RTSG board is an organization.\",\\n    \"Vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin is a treatment.\",\\n    \"High-dose chemotherapy and autologous stem cell transplantation is a treatment.\",\\n    \"SIOP database is a database.\",\\n    \"Event-Free Survival (EFS) is a subject.\",\\n    \"Overall Survival (OS) is a subject.\",\\n    \"AVD is a treatment group.\",\\n    \"AV-2 is a treatment group.\",\\n    \"Log\u2013Rank P is a statistical test.\",\\n    \"Bilateral Disease (Stage V) is a disease stage.\",\\n    \"Synchronous bilateral Wilms tumor is a disease.\",\\n    \"End-stage renal disease (ESRD) is a condition.\",\\n    \"Aronson et al. is a research group.\",\\n    \"Bilateral nephron-sparing surgery (NSS) is a treatment method.\",\\n    \"SIOP\u22122001 study is a study.\",\\n    \"Vincristine is a drug.\",\\n    \"Actinomycin D is a drug.\",\\n    \"Etoposide is a drug.\",\\n    \"Carboplatin is a drug.\",\\n    \"Relapsed Wilms Tumor is a disease state.\",\\n    \"Group AA is a patient group.\",\\n    \"Group BB is a patient group.\",\\n    \"Group CC is a patient group.\",\\n    \"Doxorubicin is a drug.\",\\n    \"Cyclophosphamide is a drug.\",\\n    \"Ifosfamide is a drug.\",\\n    \"High-dose melphalan is a treatment method.\",\\n    \"UKW\u2011R protocol is a treatment protocol.\",\\n    \"NWTS\u20115 relapse protocol is a treatment protocol.\",\\n    \"ASCR is a surgical procedure.\",\\n    \"Ifosfamide is a medication.\",\\n    \"Nephrotoxicity is a condition.\",\\n    \"Relapsed group CC is a patient group.\",\\n    \"Diffuse anaplasia is a condition.\",\\n    \"Blastemal-type tumors are a condition.\",\\n    \"The UMBRELLA protocol is a protocol.\",\\n    \"Camptothecins are a medication class.\",\\n    \"Irinotecan is a medication.\",\\n    \"Topotecan is a medication.\",\\n    \"Innovative Therapies for Children with Cancer consortium is an organization.\",\\n    \"Radiotherapy is a treatment method.\",\\n    \"Surgical excision is a treatment method.\",\\n    \"Stage IV WT is a condition.\",\\n    \"AVD150 is a treatment regimen.\",\\n    \"AVD250 is a treatment regimen.\",\\n    \"Low-risk disease is a condition category.\",\\n    \"Intermediate-risk disease is a condition category.\",\\n    \"High-risk disease is a condition category.\",\\n    \"CDCV is a treatment regimen.\",\\n    \"Actinomycin-D is a medication.\",\\n    \"Vincristine is a medication.\",\\n    \"Doxorubicin is a medication.\",\\n    \"VP16 is a medication.\",\\n    \"The email address arnauld.verschuur@ap-hm.fr is a contact.\",\\n    \"Surgery is a treatment method.\",\\n    \"Chemotherapy is a treatment method.\",\\n    \"SIOP\u2212RTSG panel is an organization.\",\\n    \"Infant Wilms Tumors is a medical condition.\",\\n    \"Nephrectomy is a surgical procedure.\",\\n    \"Congenital mesoblastic nephroma is a medical condition.\",\\n    \"Malignant rhabdoid tumors is a medical condition.\",\\n    \"Adult Wilms Tumors is a medical condition.\",\\n    \"Anaplasia is a medical condition.\",\\n    \"Actinomycin D is a drug.\",\\n    \"Vincristine is a drug.\",\\n    \"Doxorubicin is a drug.\",\\n    \"Carboplatin is a drug.\",\\n    \"Cyclophosphamide is a drug.\",\\n    \"Etoposide is a drug.\",\\n    \"Nephron-sparing surgery (NSS) is a surgical procedure.\",\\n    \"SIOP\u2013RTSG is an organization.\",\\n    \"Radical tumor nephrectomy is a surgical procedure.\",\\n    \"Lymph node sampling is a surgical procedure.\",\\n    \"Minimally invasive surgery is a surgery type.\",\\n    \"Laparoscopic surgery is a surgery type.\",\\n    \"Nephron-sparing surgery (NSS) is a surgery type.\",\\n    \"SIOP\u22122001 is a protocol.\",\\n    \"Radiotherapy is a treatment.\",\\n    \"Wilms tumours are a condition.\",\\n    \"Davila Fajardo et al. is an author.\",\\n    \"COG\u2013NWTS trials is a trial.\",\\n    \"Whole-lung irradiation is a treatment.\",\\n    \"Pulmonary radiotherapy is a treatment.\",\\n    \"Proton therapy is a treatment.\",\\n    \"Dosimetric study is a study.\",\\n    \"Locoregional disease is a condition.\",\\n    \"Metastatic disease is a condition.\",\\n    \"Low-risk is a risk category.\",\\n    \"Intermediate-risk is a risk category.\",\\n    \"High-risk is a risk category.\",\\n    \"Stage I is a stage.\",\\n    \"Stage II is a stage.\",\\n    \"Stage III is a stage.\",\\n    \"Major rupture is a condition.\",\\n    \"Austria is a country.\",\\n    \"Italy is a country.\",\\n    \"San Marino is a country.\",\\n    \"Iceland is a country.\",\\n    \"Germany is a country.\",\\n    \"Bulgaria is a country.\",\\n    \"Turkey is a country.\",\\n    \"Denmark is a country.\",\\n    \"Poland is a country.\",\\n    \"Greece is a country.\",\\n    \"Andorra is a country.\",\\n    \"Belgium is a country.\",\\n    \"Serbia is a country.\",\\n    \"Albania is a country.\",\\n    \"Moldova is a country.\",\\n    \"Lithuania is a country.\",\\n    \"Latvia is a country.\",\\n    \"Estonia is a country.\",\\n    \"Luxembourg is a country.\",\\n    \"Montenegro is a country.\",\\n    \"Bosnia and Herzegovina is a country.\",\\n    \"Croatia is a country.\",\\n    \"Slovenia is a country.\",\\n    \"Macedonia is a country.\",\\n    \"United Kingdom is a country.\",\\n    \"Ireland is a country.\",\\n    \"Spain is a country.\",\\n    \"Algeria is a country.\",\\n    \"Tunisia is a country.\",\\n    \"Malta is a country.\",\\n    \"Morocco is a country.\",\\n    \"Portugal is a country.\",\\n    \"France is a country.\",\\n    \"Monaco is a country.\",\\n    \"Russia is a country.\",\\n    \"Finland is a country.\",\\n    \"Sweden is a country.\",\\n    \"Norway is a country.\",\\n    \"Belarus is a country.\",\\n    \"Romania is a country.\",\\n    \"Ukraine is a country.\",\\n    \"Hungary is a country.\",\\n    \"Czech Republic is a country.\",\\n    \"Slovakia is a country.\",\\n    \"Switzerland is a country.\",\\n    \"Liechtenstein is a country.\",\\n    \"Netherlands is a country.\",\\n    \"University Hospital of Munich is an institution.\",\\n    \"University Hospital of Tuebingen is an institution.\",\\n    \"Azienda Ospedaliera is an institution.\",\\n    \"Ospedale Pediatrico Bambino Ges\u00f9 is an institution.\",\\n    \"Fondazione IRCCS Istituto Nazionale dei Tumori is an institution.\",\\n    \"Prinses Maxima Centrum is an institution.\",\\n    \"Marciniak Hospital is an institution.\",\\n    \"Faculty of Medicine is an institution.\",\\n    \"St. Anna Kinderspital/CCRI is an institution.\",\\n    \"Armand Trousseau Hospital is an institution.\",\\n    \"Hospital Universitario Virgin del Rocio is an institution.\",\\n    \"Hospital Vall d\u2019Hebron is an institution.\",\\n    \"Great Ormond Street Hospital is an institution.\",\\n    \"University Hospital Homburg is an institution.\",\\n    \"L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon is an institution.\",\\n    \"The UMBRELLA protocol is a project.\",\\n    \"ExPO\u2011r\u2011Net is a project.\",\\n    \"Weirich, A. is an author.\",\\n    \"Pritchard-Jones, K. is an author.\",\\n    \"de Kraker, J. is an author.\",\\n    \"Graf, N. is an author.\",\\n    \"Green, D. M. is an author.\",\\n    \"Spreafico, F. is an author.\",\\n    \"Bellani, F. F. is an author.\",\\n    \"van den Heuvel-Eibrink, M. M. is an author.\",\\n    \"D\\'Angio, G. J. is an author.\",\\n    \"Tournade, M. F. is an author.\",\\n    \"Breslow, N. E. is an author.\",\\n    \"Mitchell, C. is an author.\",\\n    \"Verschuur, A. is an author.\",\\n    \"Grundy, P. E. is an author.\",\\n    \"Warmann, S. W. is an author.\",\\n    \"Smets, A. M. is an author.\",\\n    \"Dome, J. S. is an author.\",\\n    \"Dix, D. B. is an author.\",\\n    \"Daw, N. C. is an author.\",\\n    \"Ha, T. C. is an author.\",\\n    \"Kremens, B. is an author.\",\\n    \"Furtwangler, R. is an author.\",\\n    \"SIOP-9/GPOH is a study.\",\\n    \"UKW3 is a trial.\",\\n    \"SIOP 93\u201301 trial is a trial.\",\\n    \"SIOP trial and study 93\u201301 is a study.\",\\n    \"National Wilms Tumor Study Group is an organization.\",\\n    \"SIOP WT 2001 protocol is a protocol.\",\\n    \"Third National Wilms\u2019 Tumor Study is a study.\",\\n    \"Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study is a study.\",\\n    \"National Wilms Tumor Studies is a study.\",\\n    \"Second National Wilms\u2019 Tumor Study is a study.\",\\n    \"Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study is a study.\",\\n    \"UK Children\u2019s Cancer Study Group is an organization.\",\\n    \"Children\u2019s Oncology Group is an organization.\"\\n] \\n \\nClaims:\\n[\\n    \"The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG) is an organization.\",\\n    \"UMBRELLA SIOP-RTSG 2016 is a protocol.\",\\n    \"SIOP\u22122001 is a protocol.\",\\n    \"Wilms tumours is a disease.\",\\n    \"non-Wilms tumours is a disease.\",\\n    \"www.siop-rtsg.eu is a website.\",\\n    \"Department of Paediatric Oncology at the Princess M\u00e1xima Center for Paediatric Oncology is an institution.\",\\n    \"Marry M. van den Heuvel-Eibrink is a person.\",\\n    \"Childhood renal tumours is a disease.\",\\n    \"Clear cell sarcoma of the kidney is a disease.\",\\n    \"Renal cell carcinoma is a disease.\",\\n    \"Malignant rhabdoid tumour of the kidney is a disease.\",\\n    \"Congenital mesoblastic nephroma is a disease.\",\\n    \"Wilms tumours is a condition.\",\\n    \"UMBRELLA protocol is a treatment protocol.\",\\n    \"SIOP\u2013RTSG is an organization.\",\\n    \"Children\u2019s Oncology Group (COG) is an organization.\",\\n    \"SIOP\u22122001 randomized trial is a clinical trial.\",\\n    \"Actinomycin D is a drug.\",\\n    \"Vincristine is a drug.\",\\n    \"Doxorubicin is a drug.\",\\n    \"UKW3 trial is a clinical trial.\",\\n    \"UK Children\u2019s Cancer and Leukaemia Group (UKCCLG) is an organization.\",\\n    \"Localized disease is a disease stage.\",\\n    \"Metastatic disease is a disease stage.\",\\n    \"Bilateral disease is a disease stage.\",\\n    \"Relapsed disease is a disease stage.\",\\n    \"Blastemal-type Wilms tumours is a subtype.\",\\n    \"Radiotherapy is a treatment method.\",\\n    \"Surgery is a treatment method.\",\\n    \"Chemotherapy is a treatment method.\",\\n    \"Wilms Tumour is a disease.\",\\n    \"CCSK is a disease.\",\\n    \"MRTK is a disease.\",\\n    \"CMN is a disease.\",\\n    \"RCC is a disease.\",\\n    \"UMBRELLA protocol is a protocol.\",\\n    \"SIOP\u22122001 is a trial.\",\\n    \"Vincristine is a treatment.\",\\n    \"Actinomycin D is a treatment.\",\\n    \"Doxorubicin is a treatment.\",\\n    \"Etoposide is a treatment.\",\\n    \"Carboplatin is a treatment.\",\\n    \"Cyclophosphamide is a treatment.\",\\n    \"Stage I is a stage.\",\\n    \"Stage II is a stage.\",\\n    \"Stage III is a stage.\",\\n    \"Stage IV is a stage.\",\\n    \"Stage V is a stage.\",\\n    \"AV is a treatment combination.\",\\n    \"AVD is a treatment combination.\",\\n    \"HR-1 is a treatment combination.\",\\n    \"SIOP-RTSG 2016 is a protocol.\",\\n    \"Overall Survival (OS) is a metric.\",\\n    \"Event-Free Survival (EFS) is a metric.\",\\n    \"CT-only nodules is a medical condition.\",\\n    \"UMBRELLA protocol is a treatment protocol.\",\\n    \"SIOP\u2013RTSG analysis is a study.\",\\n    \"COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials is a study.\",\\n    \"Vincristine and actinomycin D plus doxorubicin is a treatment.\",\\n    \"Vincristine and actinomycin D is a treatment.\",\\n    \"SIOP\u22122001 is a study protocol.\",\\n    \"MRI is a diagnostic tool.\",\\n    \"CT is a diagnostic tool.\",\\n    \"Cumulative doxorubicin dose is a treatment detail.\",\\n    \"COG AREN0533 trial is a study.\",\\n    \"Etoposide is a medication.\",\\n    \"Carboplatin is a medication.\",\\n    \"Cyclophosphamide is a medication.\",\\n    \"High-risk characteristics is a medical condition.\",\\n    \"SIOP\u2013RTSG board is an organization.\",\\n    \"Vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin is a treatment.\",\\n    \"High-dose chemotherapy and autologous stem cell transplantation is a treatment.\",\\n    \"SIOP database is a database.\",\\n    \"Event-Free Survival (EFS) is a subject.\",\\n    \"Overall Survival (OS) is a subject.\",\\n    \"AVD is a treatment group.\",\\n    \"AV-2 is a treatment group.\",\\n    \"Log\u2013Rank P is a statistical test.\",\\n    \"Bilateral Disease (Stage V) is a disease stage.\",\\n    \"Synchronous bilateral Wilms tumor is a disease.\",\\n    \"End-stage renal disease (ESRD) is a condition.\",\\n    \"Aronson et al. is a research group.\",\\n    \"Bilateral nephron-sparing surgery (NSS) is a treatment method.\",\\n    \"SIOP\u22122001 study is a study.\",\\n    \"Vincristine is a drug.\",\\n    \"Actinomycin D is a drug.\",\\n    \"Etoposide is a drug.\",\\n    \"Carboplatin is a drug.\",\\n    \"Relapsed Wilms Tumor is a disease state.\",\\n    \"Group AA is a patient group.\",\\n    \"Group BB is a patient group.\",\\n    \"Group CC is a patient group.\",\\n    \"Doxorubicin is a drug.\",\\n    \"Cyclophosphamide is a drug.\",\\n    \"Ifosfamide is a drug.\",\\n    \"High-dose melphalan is a treatment method.\",\\n    \"UKW\u2011R protocol is a treatment protocol.\",\\n    \"NWTS\u20115 relapse protocol is a treatment protocol.\",\\n    \"ASCR is a procedure.\",\\n    \"Ifosfamide is a medication.\",\\n    \"Nephrotoxicity is a condition.\",\\n    \"Relapsed group CC is a patient group.\",\\n    \"Diffuse anaplasia is a condition.\",\\n    \"Blastemal-type tumors is a condition.\",\\n    \"UMBRELLA protocol is a protocol.\",\\n    \"Camptothecins is a medication class.\",\\n    \"Irinotecan is a medication.\",\\n    \"Topotecan is a medication.\",\\n    \"Innovative Therapies for Children with Cancer consortium is an organization.\",\\n    \"Radiotherapy is a treatment method.\",\\n    \"Surgical excision is a treatment method.\",\\n    \"Stage IV WT is a condition.\",\\n    \"AVD150 is a treatment regimen.\",\\n    \"AVD250 is a treatment regimen.\",\\n    \"Low-risk disease is a condition category.\",\\n    \"Intermediate-risk disease is a condition category.\",\\n    \"High-risk disease is a condition category.\",\\n    \"CDCV is a treatment regimen.\",\\n    \"Actinomycin-D is a medication.\",\\n    \"Vincristine is a medication.\",\\n    \"Doxorubicin is a medication.\",\\n    \"VP16 is a medication.\",\\n    \"arnauld.verschuur@ap-hm.fr is a contact.\",\\n    \"Surgery is a treatment method.\",\\n    \"Chemotherapy is a treatment method.\",\\n    \"SIOP\u2212RTSG panel is an organization.\",\\n    \"Infant Wilms Tumors is a medical condition.\",\\n    \"Nephrectomy is a surgical procedure.\",\\n    \"Congenital mesoblastic nephroma is a medical condition.\",\\n    \"Malignant rhabdoid tumors is a medical condition.\",\\n    \"Adult Wilms Tumors is a medical condition.\",\\n    \"Anaplasia is a medical condition.\",\\n    \"Actinomycin D is a drug.\",\\n    \"Vincristine is a drug.\",\\n    \"Doxorubicin is a drug.\",\\n    \"Carboplatin is a drug.\",\\n    \"Cyclophosphamide is a drug.\",\\n    \"Etoposide is a drug.\",\\n    \"Nephron-sparing surgery (NSS) is a surgical procedure.\",\\n    \"SIOP\u2013RTSG is an organization.\",\\n    \"Radical tumor nephrectomy is a surgical procedure.\",\\n    \"Lymph node sampling is a surgical procedure.\",\\n    \"Minimally invasive surgery is a surgery type.\",\\n    \"Laparoscopic surgery is a surgery type.\",\\n    \"Nephron-sparing surgery (NSS) is a surgery type.\",\\n    \"SIOP\u22122001 is a protocol.\",\\n    \"Radiotherapy is a treatment.\",\\n    \"Wilms tumours is a condition.\",\\n    \"Davila Fajardo et al. is an author.\",\\n    \"COG\u2013NWTS trials is a trial.\",\\n    \"Whole-lung irradiation is a treatment.\",\\n    \"Pulmonary radiotherapy is a treatment.\",\\n    \"Proton therapy is a treatment.\",\\n    \"Dosimetric study is a study.\",\\n    \"Locoregional disease is a condition.\",\\n    \"Metastatic disease is a condition.\",\\n    \"Low-risk is a risk category.\",\\n    \"Intermediate-risk is a risk category.\",\\n    \"High-risk is a risk category.\",\\n    \"Stage I is a stage.\",\\n    \"Stage II is a stage.\",\\n    \"Stage III is a stage.\",\\n    \"Major rupture is a condition.\",\\n    \"Austria is a country.\",\\n    \"Italy is a country.\",\\n    \"San Marino is a country.\",\\n    \"Iceland is a country.\",\\n    \"Germany is a country.\",\\n    \"Bulgaria is a country.\",\\n    \"Turkey is a country.\",\\n    \"Denmark is a country.\",\\n    \"Poland is a country.\",\\n    \"Greece is a country.\",\\n    \"Andorra is a country.\",\\n    \"Belgium is a country.\",\\n    \"Serbia is a country.\",\\n    \"Albania is a country.\",\\n    \"Moldova is a country.\",\\n    \"Lithuania is a country.\",\\n    \"Latvia is a country.\",\\n    \"Estonia is a country.\",\\n    \"Luxembourg is a country.\",\\n    \"Montenegro is a country.\",\\n    \"Bosnia and Herzegovina is a country.\",\\n    \"Croatia is a country.\",\\n    \"Slovenia is a country.\",\\n    \"Macedonia is a country.\",\\n    \"United Kingdom is a country.\",\\n    \"Ireland is a country.\",\\n    \"Spain is a country.\",\\n    \"Algeria is a country.\",\\n    \"Tunisia is a country.\",\\n    \"Malta is a country.\",\\n    \"Morocco is a country.\",\\n    \"Portugal is a country.\",\\n    \"France is a country.\",\\n    \"Monaco is a country.\",\\n    \"Russia is a country.\",\\n    \"Finland is a country.\",\\n    \"Sweden is a country.\",\\n    \"Norway is a country.\",\\n    \"Belarus is a country.\",\\n    \"Romania is a country.\",\\n    \"Ukraine is a country.\",\\n    \"Hungary is a country.\",\\n    \"Czech Republic is a country.\",\\n    \"Slovakia is a country.\",\\n    \"Switzerland is a country.\",\\n    \"Liechtenstein is a country.\",\\n    \"Netherlands is a country.\",\\n    \"University Hospital of Munich is an institution.\",\\n    \"University Hospital of Tuebingen is an institution.\",\\n    \"Azienda Ospedaliera is an institution.\",\\n    \"Ospedale Pediatrico Bambino Ges\u00f9 is an institution.\",\\n    \"Fondazione IRCCS Istituto Nazionale dei Tumori is an institution.\",\\n    \"Prinses Maxima Centrum is an institution.\",\\n    \"Marciniak Hospital is an institution.\",\\n    \"Faculty of Medicine is an institution.\",\\n    \"St. Anna Kinderspital/CCRI is an institution.\",\\n    \"Armand Trousseau Hospital is an institution.\",\\n    \"Hospital Universitario Virgin del Rocio is an institution.\",\\n    \"Hospital Vall d\u2019Hebron is an institution.\",\\n    \"Great Ormond Street Hospital is an institution.\",\\n    \"University Hospital Homburg is an institution.\",\\n    \"L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon is an institution.\",\\n    \"UMBRELLA protocol is a project.\",\\n    \"ExPO\u2011r\u2011Net is a project.\",\\n    \"Weirich, A. is an author.\",\\n    \"Pritchard-Jones, K. is an author.\",\\n    \"de Kraker, J. is an author.\",\\n    \"Graf, N. is an author.\",\\n    \"Green, D. M. is an author.\",\\n    \"Spreafico, F. is an author.\",\\n    \"Bellani, F. F. is an author.\",\\n    \"van den Heuvel-Eibrink, M. M. is an author.\",\\n    \"D\\'Angio, G. J. is an author.\",\\n    \"Tournade, M. F. is an author.\",\\n    \"Breslow, N. E. is an author.\",\\n    \"Mitchell, C. is an author.\",\\n    \"Verschuur, A. is an author.\",\\n    \"Grundy, P. E. is an author.\",\\n    \"Warmann, S. W. is an author.\",\\n    \"Smets, A. M. is an author.\",\\n    \"Dome, J. S. is an author.\",\\n    \"Dix, D. B. is an author.\",\\n    \"Daw, N. C. is an author.\",\\n    \"Ha, T. C. is an author.\",\\n    \"Kremens, B. is an author.\",\\n    \"Furtwangler, R. is an author.\",\\n    \"SIOP-9/GPOH is a study.\",\\n    \"UKW3 is a trial.\",\\n    \"SIOP 93\u201301 trial is a trial.\",\\n    \"SIOP trial and study 93\u201301 is a study.\",\\n    \"National Wilms Tumor Study Group is an organization.\",\\n    \"SIOP WT 2001 protocol is a protocol.\",\\n    \"Third National Wilms\u2019 Tumor Study is a study.\",\\n    \"Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study is a study.\",\\n    \"National Wilms Tumor Studies is a study.\",\\n    \"Second National Wilms\u2019 Tumor Study is a study.\",\\n    \"Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study is a study.\",\\n    \"UK Children\u2019s Cancer Study Group is an organization.\",\\n    \"Children\u2019s Oncology Group is an organization.\"\\n] \\n \\nVerdicts:\\n[\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"The Renal Tumour Study Group is part of the International Society of Paediatric Oncology (SIOP\\\\u2013RTSG), not an independent organization.\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": \"no\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": \"no\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": \"no\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": \"no\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": \"no\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": \"no\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": \"no\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": \"no\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": \"no\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": \"no\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": \"no\"\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"Wilms tumours and Wilms tumors refer to the same condition, thus must be treated consistently.\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": \"no\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": \"no\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": \"no\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": \"no\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": \"no\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": \"no\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": \"no\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": \"no\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": \"no\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": \"no\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": \"no\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": \"no\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": \"no\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": \"no\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": \"no\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": \"no\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": \"no\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": \"no\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": \"no\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": \"no\"\\n    },\\n    {\\n        \"verdict\": \"yes\",\\n        \"reason\": \"no\"\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"UMBRELLA protocol and UMBRELLA SIOP-RTSG refer to different versions; clarify their context of treatment or research.\"\\n    },\\n    {\\n        \"verdict\": \"no\",\\n        \"reason\": \"SIOP-2001 is confirmed only as a protocol type.\"\\n    }\\n]'), MetricData(name='Contextual Relevancy', threshold=1.0, success=False, score=0.16666666666666666, reason=\"The score is 0.17 because the retrieval context fails to provide specific dosage information related to radiotherapy for lung metastases; the most relevant statement, 'radiotherapy guidelines_entity', does not specify dosage, and the majority of reasons highlight irrelevancy to the dosage question.\", strict_mode=False, evaluation_model='gpt-4o-mini', error=None, evaluation_cost=0.0035719499999999995, verbose_logs='Verdicts:\\n[\\n    {\\n        \"verdicts\": [\\n            {\\n                \"statement\": \"radiotherapy_Treatment Method\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"The statement is simply a categorization of the treatment method and does not answer the question regarding dosage.\"\\n            },\\n            {\\n                \"statement\": \"pulmonary radiotherapy_treatment\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"The statement only refers to a type of treatment without addressing the dosage protocol for lung metastases.\"\\n            },\\n            {\\n                \"statement\": \"metastatic disease_condition\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"This statement only identifies a disease condition and does not provide any guidance on radiotherapy dosage.\"\\n            },\\n            {\\n                \"statement\": \"radiotherapy guidelines_entity\",\\n                \"verdict\": \"yes\",\\n                \"reason\": null\\n            },\\n            {\\n                \"statement\": \"high-dose chemotherapy and autologous stem cell transplantation_treatment\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"The focus is on chemotherapy and transplant procedures, not on radiotherapy dosage.\"\\n            },\\n            {\\n                \"statement\": \"dosimetric study_entity\",\\n                \"verdict\": \"no\",\\n                \"reason\": \"A dosimetric study suggests measurement techniques and efficiency but does not comment on specific dosage protocols.\"\\n            }\\n        ]\\n    }\\n]')], conversational=False, multimodal=False, input='What does the protocol suggest about radiotherapy dosage for lung metastases?', actual_output='[{\\'nodes\\': [(\\'sample.pdf\\', {\\'type\\': \\'document\\'}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)\\'}), (\\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA SIOP-RTSG 2016\\'}), (\\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms tumours\\'}), (\\'non-Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'non-Wilms tumours\\'}), (\\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Website\\', \\'name\\': \\'www.siop-rtsg.eu\\'}), (\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology\\'}), (\\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Person\\', \\'name\\': \\'Marry M. van den Heuvel-Eibrink\\'}), (\\'childhood renal tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'childhood renal tumours\\'}), (\\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'clear cell sarcoma of the kidney\\'}), (\\'renal cell carcinoma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'renal cell carcinoma\\'}), (\\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'malignant rhabdoid tumour of the kidney\\'}), (\\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'Wilms tumours_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'Children\u2019s Oncology Group (COG)\\'}), (\\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'SIOP\u22122001 randomized trial\\'}), (\\'actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'UKW3 trial\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)\\'}), (\\'localized disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'localized disease\\'}), (\\'metastatic disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'metastatic disease\\'}), (\\'bilateral disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'bilateral disease\\'}), (\\'relapsed disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'relapsed disease\\'}), (\\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subtype\\', \\'name\\': \\'blastemal-type Wilms tumours\\'}), (\\'radiotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgery_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'chemotherapy\\'}), (\\'Wilms Tumour_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms Tumour\\'}), (\\'CCSK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CCSK\\'}), (\\'MRTK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'MRTK\\'}), (\\'CMN_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CMN\\'}), (\\'RCC_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'RCC\\'}), (\\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u22122001_Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Trial\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'vincristine_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'vincristine\\'}), (\\'actinomycin D_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'actinomycin D\\'}), (\\'doxorubicin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'doxorubicin\\'}), (\\'etoposide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'Stage I_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage I\\'}), (\\'Stage II_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage II\\'}), (\\'Stage III_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage III\\'}), (\\'Stage IV_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage IV\\'}), (\\'Stage V_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage V\\'}), (\\'AV_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AV\\'}), (\\'AVD_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AVD\\'}), (\\'HR-1_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'HR-1\\'}), (\\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP-RTSG 2016\\'}), (\\'Overall Survival (OS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'CT-only nodules_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'CT-only nodules\\'}), (\\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP\u2013RTSG analysis\\'}), (\\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials\\'}), (\\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D plus doxorubicin\\'}), (\\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D\\'}), (\\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study_protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'MRI_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'MRI\\'}), (\\'CT_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'CT\\'}), (\\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_detail\\', \\'name\\': \\'cumulative doxorubicin dose\\'}), (\\'COG AREN0533 trial_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG AREN0533 trial\\'}), (\\'etoposide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'high-risk characteristics\\'}), (\\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG board\\'}), (\\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin\\'}), (\\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'high-dose chemotherapy and autologous stem cell transplantation\\'}), (\\'SIOP database_database\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'database\\', \\'name\\': \\'SIOP database\\'}), (\\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'AVD_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AVD\\'}), (\\'AV-2_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AV-2\\'}), (\\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Statistical Test\\', \\'name\\': \\'Log\u2013Rank P\\'}), (\\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'Bilateral Disease (Stage V)\\'}), (\\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Synchronous bilateral Wilms tumor\\'}), (\\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'End-stage renal disease (ESRD)\\'}), (\\'Aronson et al._Research Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Research Group\\', \\'name\\': \\'Aronson et al.\\'}), (\\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'Bilateral nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Study\\', \\'name\\': \\'SIOP\u22122001 study\\'}), (\\'Vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Vincristine\\'}), (\\'Actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Actinomycin D\\'}), (\\'Etoposide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Etoposide\\'}), (\\'Carboplatin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Carboplatin\\'}), (\\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease State\\', \\'name\\': \\'Relapsed Wilms Tumor\\'}), (\\'Group AA_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group AA\\'}), (\\'Group BB_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group BB\\'}), (\\'Group CC_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group CC\\'}), (\\'Doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Doxorubicin\\'}), (\\'Cyclophosphamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Cyclophosphamide\\'}), (\\'Ifosfamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Ifosfamide\\'}), (\\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'High-dose melphalan\\'}), (\\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UKW\u2011R protocol\\'}), (\\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'NWTS\u20115 relapse protocol\\'}), (\\'ASCR_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'procedure\\', \\'name\\': \\'ASCR\\'}), (\\'ifosfamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'ifosfamide\\'}), (\\'nephrotoxicity_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'nephrotoxicity\\'}), (\\'relapsed group CC_patient_group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'patient_group\\', \\'name\\': \\'relapsed group CC\\'}), (\\'diffuse anaplasia_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'diffuse anaplasia\\'}), (\\'blastemal-type tumors_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'blastemal-type tumors\\'}), (\\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'camptothecins_medication_class\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication_class\\', \\'name\\': \\'camptothecins\\'}), (\\'irinotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'irinotecan\\'}), (\\'topotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'topotecan\\'}), (\\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Innovative Therapies for Children with Cancer consortium\\'}), (\\'radiotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgical excision_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgical excision\\'}), (\\'stage IV WT_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'stage IV WT\\'}), (\\'AVD150_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD150\\'}), (\\'AVD250_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD250\\'}), (\\'low-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'low-risk disease\\'}), (\\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'intermediate-risk disease\\'}), (\\'high-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'high-risk disease\\'}), (\\'CDCV_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'CDCV\\'}), (\\'actinomycin-D_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'actinomycin-D\\'}), (\\'vincristine_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'doxorubicin\\'}), (\\'VP16_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'VP16\\'}), (\\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'contact\\', \\'name\\': \\'arnauld.verschuur@ap-hm.fr\\'}), (\\'surgery_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'chemotherapy\\'}), (\\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2212RTSG panel\\'}), (\\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Infant Wilms Tumors\\'}), (\\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'nephrectomy\\'}), (\\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'malignant rhabdoid tumors\\'}), (\\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Adult Wilms Tumors\\'}), (\\'anaplasia_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'anaplasia\\'}), (\\'actinomycin D_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'carboplatin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'etoposide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'etoposide\\'}), (\\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'Nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'radical tumor nephrectomy\\'}), (\\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'lymph node sampling\\'}), (\\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'minimally invasive surgery\\'}), (\\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'laparoscopic surgery\\'}), (\\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'radiotherapy\\'}), (\\'Wilms tumours_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'Davila Fajardo et al._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Davila Fajardo et al.\\'}), (\\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'COG\u2013NWTS trials\\'}), (\\'whole-lung irradiation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'whole-lung irradiation\\'}), (\\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'pulmonary radiotherapy\\'}), (\\'proton therapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'proton therapy\\'}), (\\'dosimetric study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'dosimetric study\\'}), (\\'locoregional disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'locoregional disease\\'}), (\\'metastatic disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'metastatic disease\\'}), (\\'low-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'low-risk\\'}), (\\'intermediate-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'intermediate-risk\\'}), (\\'high-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'high-risk\\'}), (\\'stage I_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage I\\'}), (\\'stage II_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage II\\'}), (\\'stage III_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage III\\'}), (\\'major rupture_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'major rupture\\'}), (\\'Austria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Austria\\'}), (\\'Italy_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Italy\\'}), (\\'San Marino_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'San Marino\\'}), (\\'Iceland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Iceland\\'}), (\\'Germany_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Germany\\'}), (\\'Bulgaria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bulgaria\\'}), (\\'Turkey_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Turkey\\'}), (\\'Denmark_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Denmark\\'}), (\\'Poland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Poland\\'}), (\\'Greece_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Greece\\'}), (\\'Andorra_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Andorra\\'}), (\\'Belgium_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belgium\\'}), (\\'Serbia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Serbia\\'}), (\\'Albania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Albania\\'}), (\\'Moldova_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Moldova\\'}), (\\'Lithuania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Lithuania\\'}), (\\'Latvia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Latvia\\'}), (\\'Estonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Estonia\\'}), (\\'Luxembourg_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Luxembourg\\'}), (\\'Montenegro_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Montenegro\\'}), (\\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bosnia and Herzegovina\\'}), (\\'Croatia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Croatia\\'}), (\\'Slovenia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovenia\\'}), (\\'Macedonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Macedonia\\'}), (\\'United Kingdom_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'United Kingdom\\'}), (\\'Ireland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ireland\\'}), (\\'Spain_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Spain\\'}), (\\'Algeria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Algeria\\'}), (\\'Tunisia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Tunisia\\'}), (\\'Malta_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Malta\\'}), (\\'Morocco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Morocco\\'}), (\\'Portugal_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Portugal\\'}), (\\'France_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'France\\'}), (\\'Monaco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Monaco\\'}), (\\'Russia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Russia\\'}), (\\'Finland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Finland\\'}), (\\'Sweden_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Sweden\\'}), (\\'Norway_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Norway\\'}), (\\'Belarus_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belarus\\'}), (\\'Romania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Romania\\'}), (\\'Ukraine_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ukraine\\'}), (\\'Hungary_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Hungary\\'}), (\\'Czech Republic_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Czech Republic\\'}), (\\'Slovakia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovakia\\'}), (\\'Switzerland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Switzerland\\'}), (\\'Liechtenstein_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Liechtenstein\\'}), (\\'Netherlands_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Netherlands\\'}), (\\'University Hospital of Munich_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Munich\\'}), (\\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Tuebingen\\'}), (\\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Azienda Ospedaliera\\'}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Ospedale Pediatrico Bambino Ges\u00f9\\'}), (\\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Fondazione IRCCS Istituto Nazionale dei Tumori\\'}), (\\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Prinses Maxima Centrum\\'}), (\\'Marciniak Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Marciniak Hospital\\'}), (\\'Faculty of Medicine_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Faculty of Medicine\\'}), (\\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'St. Anna Kinderspital/CCRI\\'}), (\\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Armand Trousseau Hospital\\'}), (\\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Universitario Virgin del Rocio\\'}), (\\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Vall d\u2019Hebron\\'}), (\\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Great Ormond Street Hospital\\'}), (\\'University Hospital Homburg_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital Homburg\\'}), (\\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon\\'}), (\\'UMBRELLA protocol_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'ExPO\u2011r\u2011Net\\'}), (\\'Weirich, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Weirich, A.\\'}), (\\'Pritchard-Jones, K._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Pritchard-Jones, K.\\'}), (\\'de Kraker, J._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'de Kraker, J.\\'}), (\\'Graf, N._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Graf, N.\\'}), (\\'Green, D. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Green, D. M.\\'}), (\\'Spreafico, F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Spreafico, F.\\'}), (\\'Bellani, F. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Bellani, F. F.\\'}), (\\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'van den Heuvel-Eibrink, M. M.\\'}), (\"D\\'Angio, G. J._author\", {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \"D\\'Angio, G. J.\"}), (\\'Tournade, M. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Tournade, M. F.\\'}), (\\'Breslow, N. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Breslow, N. E.\\'}), (\\'Mitchell, C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Mitchell, C.\\'}), (\\'Verschuur, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Verschuur, A.\\'}), (\\'Grundy, P. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Grundy, P. E.\\'}), (\\'Warmann, S. W._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Warmann, S. W.\\'}), (\\'Smets, A. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Smets, A. M.\\'}), (\\'Dome, J. S._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dome, J. S.\\'}), (\\'Dix, D. B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dix, D. B.\\'}), (\\'Daw, N. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Daw, N. C.\\'}), (\\'Ha, T. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Ha, T. C.\\'}), (\\'Kremens, B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Kremens, B.\\'}), (\\'Furtwangler, R._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Furtwangler, R.\\'}), (\\'SIOP-9/GPOH_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP-9/GPOH\\'}), (\\'UKW3_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'UKW3\\'}), (\\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'SIOP 93\u201301 trial\\'}), (\\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP trial and study 93\u201301\\'}), (\\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'National Wilms Tumor Study Group\\'}), (\\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP WT 2001 protocol\\'}), (\\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Third National Wilms\u2019 Tumor Study\\'}), (\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'National Wilms Tumor Studies\\'}), (\\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Second National Wilms\u2019 Tumor Study\\'}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'UK Children\u2019s Cancer Study Group\\'}), (\\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Children\u2019s Oncology Group\\'})], \\'edges\\': [(\\'sample.pdf\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'non-Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'childhood renal tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'renal cell carcinoma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'localized disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'metastatic disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'bilateral disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'relapsed disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'radiotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'surgery_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'chemotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'Wilms Tumour_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CCSK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'MRTK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CMN_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'RCC_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP\u22122001_Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'vincristine_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'actinomycin D_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'doxorubicin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'etoposide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'carboplatin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'cyclophosphamide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage I_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage II_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage III_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage IV_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage V_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AV_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AVD_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'HR-1_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Overall Survival (OS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT-only nodules_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'MRI_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG AREN0533 trial_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'etoposide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'carboplatin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'cyclophosphamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP database_database\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AVD_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AV-2_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Aronson et al._Research Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Etoposide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Carboplatin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group AA_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group BB_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group CC_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Cyclophosphamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Ifosfamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'ASCR_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'ifosfamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'nephrotoxicity_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'relapsed group CC_patient_group\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'diffuse anaplasia_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'blastemal-type tumors_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'camptothecins_medication_class\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'irinotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'topotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'radiotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'surgical excision_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'stage IV WT_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD150_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD250_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'low-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'CDCV_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'actinomycin-D_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'vincristine_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'doxorubicin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'VP16_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'surgery_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'chemotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'anaplasia_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'actinomycin D_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'vincristine_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'doxorubicin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'carboplatin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'cyclophosphamide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'etoposide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'SIOP\u22122001_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Wilms tumours_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Davila Fajardo et al._author\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'whole-lung irradiation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'proton therapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'dosimetric study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'locoregional disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'metastatic disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'low-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'intermediate-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'high-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage I_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage II_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage III_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'major rupture_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Austria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Italy_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'San Marino_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Iceland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Germany_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bulgaria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Turkey_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Denmark_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Poland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Greece_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Andorra_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belgium_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Serbia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Albania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Moldova_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Lithuania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Latvia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Estonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Luxembourg_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Montenegro_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Croatia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovenia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Macedonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'United Kingdom_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ireland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Spain_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Algeria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Tunisia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Malta_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Morocco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Portugal_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'France_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Monaco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Russia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Finland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Sweden_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Norway_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belarus_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Romania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ukraine_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hungary_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Czech Republic_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovakia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Switzerland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Liechtenstein_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Netherlands_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Munich_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Marciniak Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Faculty of Medicine_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital Homburg_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Weirich, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Pritchard-Jones, K._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'de Kraker, J._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Graf, N._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Green, D. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Spreafico, F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Bellani, F. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \"D\\'Angio, G. J._author\", {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Tournade, M. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Breslow, N. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Mitchell, C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Verschuur, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Grundy, P. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Warmann, S. W._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Smets, A. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dome, J. S._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dix, D. B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Daw, N. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ha, T. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Kremens, B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Furtwangler, R._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP-9/GPOH_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UKW3_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10})]}, {\\'nodes\\': [(\\'vincristine_entity\\', {}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {}), (\\'www.siop-rtsg.eu_entity\\', {}), (\\'stage II_entity\\', {}), (\\'Wilms tumours_entity\\', {}), (\\'Relapsed Wilms Tumor_entity\\', {}), (\\'Davila Fajardo et al._entity\\', {}), (\\'vincristine, actinomycin D, and doxorubicin_entity\\', {}), (\\'SIOP\u22122001 randomized trial_entity\\', {}), (\\'surgery_entity\\', {}), (\\'non-Wilms tumours_entity\\', {}), (\\'actinomycin D_entity\\', {}), (\\'diffuse anaplasia_entity\\', {}), (\\'Synchronous bilateral Wilms tumor_entity\\', {}), (\\'CT-only nodules_entity\\', {}), (\\'relapsed group CC_entity\\', {}), (\\'increased relapse risk_entity\\', {}), (\\'reduced survival_entity\\', {}), (\\'UKW3 trial_entity\\', {}), (\\'chemotherapy_entity\\', {}), (\\'Bilateral Disease (Stage V)_entity\\', {}), (\\'blastemal-type tumors_entity\\', {}), (\\'UMBRELLA protocol_entity\\', {}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', {}), (\\'minimally invasive surgery_entity\\', {}), (\\'VP16_entity\\', {}), (\\'Wilms tumor_entity\\', {}), (\\'anaplasia_entity\\', {}), (\\'radical tumor nephrectomy_entity\\', {}), (\\'Innovative Therapies for Children with Cancer consortium_entity\\', {}), (\\'cumulative doxorubicin dose_entity\\', {}), (\\'etoposide_entity\\', {}), (\\'large-volume tumours_entity\\', {}), (\\'Stage IV_entity\\', {}), (\\'CDCV_entity\\', {}), (\\'SIOP\u2013RTSG_entity\\', {}), (\\'AVD150_entity\\', {}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', {}), (\\'laparoscopic surgery_entity\\', {}), (\\'SIOP\u2212RTSG panel_entity\\', {}), (\\'actinomycin-D_entity\\', {}), (\\'COG AREN0533 trial_entity\\', {}), (\\'cyclophosphamide_entity\\', {}), (\\'carboplatin_entity\\', {}), (\\'UKW\u2011R protocol_entity\\', {}), (\\'Nephron-sparing surgery (NSS)_entity\\', {}), (\\'Adult Wilms Tumors_entity\\', {}), (\\'doxorubicin_entity\\', {}), (\\'NWTS\u20115 relapse protocol_entity\\', {}), (\\'End-stage renal disease (ESRD)_entity\\', {}), (\\'AVD250_entity\\', {}), (\\'Children\u2019s Oncology Group (COG)_entity\\', {}), (\\'blastemal-type Wilms tumour_entity\\', {}), (\\'SIOP\u22122001_entity\\', {}), (\\'radiotherapy_entity\\', {}), (\\'childhood renal tumours_entity\\', {})], \\'edges\\': [(\\'vincristine_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'stage II_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'indicated_for_in_adults\\'}), (\\'Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'Wilms tumours_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated under\\'}), (\\'Relapsed Wilms Tumor_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guided_by\\'}), (\\'Davila Fajardo et al._entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed\\'}), (\\'SIOP\u22122001 randomized trial_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated use in\\'}), (\\'surgery_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'non-Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'actinomycin D_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Synchronous bilateral Wilms tumor_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'instance_of\\'}), (\\'CT-only nodules_entity\\', \\'increased relapse risk_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'reduced survival_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included_in\\'}), (\\'relapsed group CC_entity\\', \\'diffuse anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'blastemal-type tumors_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UKW3 trial_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'UKW3 trial_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'chemotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UMBRELLA protocol_entity\\', \\'COG AREN0533 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses_data_from\\'}), (\\'UMBRELLA protocol_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'advises_treatment_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'Innovative Therapies for Children with Cancer consortium_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborates_with\\'}), (\\'UMBRELLA protocol_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'surgery_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is the standard of\\'}), (\\'UMBRELLA protocol_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guides treatment in\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', \\'UKW3 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\\'minimally invasive surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'anaplasia_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'radical tumor nephrectomy_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'standard_of_care_for\\'}), (\\'Stage IV_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'presents in\\'}), (\\'CDCV_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'VP16_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'aims to improve survival rates of\\'}), (\\'AVD150_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed_by\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'succeeds\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'www.siop-rtsg.eu_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'available_on\\'}), (\\'laparoscopic surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'COG AREN0533 trial_entity\\', \\'cumulative doxorubicin dose_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'evaluates\\'}), (\\'UKW\u2011R protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'Nephron-sparing surgery (NSS)_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'classification_developed_by\\'}), (\\'Adult Wilms Tumors_entity\\', \\'anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'Adult Wilms Tumors_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'doxorubicin_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'doxorubicin_entity\\', \\'large-volume tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'recommended for\\'}), (\\'NWTS\u20115 relapse protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'End-stage renal disease (ESRD)_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'AVD250_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'Children\u2019s Oncology Group (COG)_entity\\', \\'SIOP\u22122001 randomized trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborated with\\'}), (\\'blastemal-type Wilms tumour_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment intensified according to\\'}), (\\'SIOP\u22122001_entity\\', \\'vincristine, actinomycin D, and doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses\\'}), (\\'SIOP\u22122001_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provided_guidelines_for\\'}), (\\'radiotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'radiotherapy_entity\\', \\'SIOP\u2212RTSG panel_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'contact_for_guidance\\'})]}, {\\'nodes\\': [(\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {}), (\\'Marry M. van den Heuvel-Eibrink_entity\\', {})], \\'edges\\': [(\\'Marry M. van den Heuvel-Eibrink_entity\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'affiliated_with\\'})]}, {\\'nodes\\': [(\\'Stage II_entity\\', {}), (\\'AV_entity\\', {}), (\\'Stage III_entity\\', {}), (\\'vincestine and actinomycin D_entity\\', {}), (\\'AVD_entity\\', {})], \\'edges\\': [(\\'Stage II_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AV_entity\\', \\'Stage II_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Stage III_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AVD_entity\\', \\'Stage III_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'SIOP-RTSG 2016_entity\\', {}), (\\'RCC_entity\\', {}), (\\'CMN_entity\\', {})], \\'edges\\': [(\\'RCC_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'}), (\\'CMN_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'})]}, {\\'nodes\\': [(\\'HR-1_entity\\', {}), (\\'High-risk blastemal type Wilms tumour_entity\\', {})], \\'edges\\': [(\\'HR-1_entity\\', \\'High-risk blastemal type Wilms tumour_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'unfavorable prognosis_entity\\', {}), (\\'high-risk characteristics_entity\\', {})], \\'edges\\': [(\\'high-risk characteristics_entity\\', \\'unfavorable prognosis_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'leads_to\\'})]}, {\\'nodes\\': [(\\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {}), (\\'SIOP\u2013RTSG board_entity\\', {})], \\'edges\\': [(\\'SIOP\u2013RTSG board_entity\\', \\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggests\\'})]}, {\\'nodes\\': [(\\'regimen and outcomes_entity\\', {}), (\\'SIOP database_entity\\', {})], \\'edges\\': [(\\'SIOP database_entity\\', \\'regimen and outcomes_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'captures_data_on\\'})]}, {\\'nodes\\': [(\\'Bilateral nephron-sparing surgery (NSS)_entity\\', {}), (\\'Aronson et al._entity\\', {})], \\'edges\\': [(\\'Aronson et al._entity\\', \\'Bilateral nephron-sparing surgery (NSS)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'observed_effectiveness_of\\'})]}, {\\'nodes\\': [(\\'SIOP\u22122001 study_entity\\', {}), (\\'Actinomycin D_entity\\', {}), (\\'Vincristine_entity\\', {})], \\'edges\\': [(\\'SIOP\u22122001 study_entity\\', \\'Vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'}), (\\'SIOP\u22122001 study_entity\\', \\'Actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'})]}, {\\'nodes\\': [(\\'High-dose melphalan_entity\\', {}), (\\'Group AA_entity\\', {}), (\\'Carboplatin_entity\\', {}), (\\'Doxorubicin_entity\\', {}), (\\'Etoposide_entity\\', {}), (\\'Group BB_entity\\', {}), (\\'Cyclophosphamide_entity\\', {}), (\\'Ifosfamide_entity\\', {})], \\'edges\\': [(\\'Group AA_entity\\', \\'Doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Ifosfamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'High-dose melphalan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'})]}, {\\'nodes\\': [(\\'nephrotoxicity_entity\\', {}), (\\'ifosfamide_entity\\', {})], \\'edges\\': [(\\'ifosfamide_entity\\', \\'nephrotoxicity_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'related_to\\'})]}, {\\'nodes\\': [(\\'camptothecins_entity\\', {}), (\\'irinotecan_entity\\', {}), (\\'topotecan_entity\\', {})], \\'edges\\': [(\\'camptothecins_entity\\', \\'irinotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'camptothecins_entity\\', \\'topotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'})]}, {\\'nodes\\': [(\\'Infant Wilms Tumors_entity\\', {}), (\\'nephrectomy_entity\\', {})], \\'edges\\': [(\\'Infant Wilms Tumors_entity\\', \\'nephrectomy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_option\\'})]}, {\\'nodes\\': [(\\'congenital mesoblastic nephroma_entity\\', {}), (\\'surgery alone_entity\\', {})], \\'edges\\': [(\\'congenital mesoblastic nephroma_entity\\', \\'surgery alone_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'alternative chemotherapy_entity\\', {}), (\\'malignant rhabdoid tumors_entity\\', {})], \\'edges\\': [(\\'malignant rhabdoid tumors_entity\\', \\'alternative chemotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'lymph node sampling_entity\\', {}), (\\'accurate staging_entity\\', {})], \\'edges\\': [(\\'lymph node sampling_entity\\', \\'accurate staging_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'purpose_of\\'})]}, {\\'nodes\\': [(\\'COG\u2013NWTS trials_entity\\', {}), (\\'whole-lung irradiation_entity\\', {})], \\'edges\\': [(\\'COG\u2013NWTS trials_entity\\', \\'whole-lung irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'informed_dosage_for\\'})]}, {\\'nodes\\': [(\\'lung metastases_entity\\', {}), (\\'pulmonary radiotherapy_entity\\', {})], \\'edges\\': [(\\'pulmonary radiotherapy_entity\\', \\'lung metastases_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'administered_for\\'})]}, {\\'nodes\\': [(\\'dosimetric study_entity\\', {}), (\\'proton therapy_entity\\', {}), (\\'flank irradiation_entity\\', {})], \\'edges\\': [(\\'dosimetric study_entity\\', \\'proton therapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated\\'}), (\\'proton therapy_entity\\', \\'flank irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggested_for\\'})]}, {\\'nodes\\': [(\\'metastatic disease_entity\\', {}), (\\'radiotherapy guidelines_entity\\', {}), (\\'locoregional disease_entity\\', {})], \\'edges\\': [(\\'radiotherapy guidelines_entity\\', \\'locoregional disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'}), (\\'radiotherapy guidelines_entity\\', \\'metastatic disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'})]}, {\\'nodes\\': [(\\'major rupture_entity\\', {}), (\\'stage III_entity\\', {})], \\'edges\\': [(\\'stage III_entity\\', \\'major rupture_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes_condition\\'})]}, {\\'nodes\\': [(\\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {}), (\\'ExPO\u2011r\u2011Net_entity\\', {})], \\'edges\\': [(\\'ExPO\u2011r\u2011Net_entity\\', \\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is part of\\'})]}, {\\'nodes\\': [(\\'University Hospital of Munich_entity\\', {}), (\\'Germany_entity\\', {}), (\\'University Hospital of Tuebingen_entity\\', {})], \\'edges\\': [(\\'Germany_entity\\', \\'University Hospital of Munich_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Germany_entity\\', \\'University Hospital of Tuebingen_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {}), (\\'Italy_entity\\', {}), (\\'Azienda Ospedaliera_entity\\', {}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {})], \\'edges\\': [(\\'Italy_entity\\', \\'Azienda Ospedaliera_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Netherlands_entity\\', {}), (\\'Prinses Maxima Centrum_entity\\', {})], \\'edges\\': [(\\'Netherlands_entity\\', \\'Prinses Maxima Centrum_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Marciniak Hospital_entity\\', {}), (\\'Poland_entity\\', {}), (\\'Faculty of Medicine_entity\\', {})], \\'edges\\': [(\\'Poland_entity\\', \\'Marciniak Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Poland_entity\\', \\'Faculty of Medicine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'St. Anna Kinderspital/CCRI_entity\\', {}), (\\'Austria_entity\\', {})], \\'edges\\': [(\\'Austria_entity\\', \\'St. Anna Kinderspital/CCRI_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'France_entity\\', {}), (\\'Armand Trousseau Hospital_entity\\', {})], \\'edges\\': [(\\'France_entity\\', \\'Armand Trousseau Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Spain_entity\\', {}), (\\'Hospital Vall d\u2019Hebron_entity\\', {}), (\\'Hospital Universitario Virgin del Rocio_entity\\', {})], \\'edges\\': [(\\'Spain_entity\\', \\'Hospital Universitario Virgin del Rocio_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Spain_entity\\', \\'Hospital Vall d\u2019Hebron_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'United Kingdom_entity\\', {}), (\\'Great Ormond Street Hospital_entity\\', {})], \\'edges\\': [(\\'United Kingdom_entity\\', \\'Great Ormond Street Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Weirich, A._entity\\', {}), (\\'SIOP-9/GPOH_entity\\', {})], \\'edges\\': [(\\'Weirich, A._entity\\', \\'SIOP-9/GPOH_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Pritchard-Jones, K._entity\\', {}), (\\'UKW3_entity\\', {})], \\'edges\\': [(\\'Pritchard-Jones, K._entity\\', \\'UKW3_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed in\\'})]}, {\\'nodes\\': [(\\'SIOP 93\u201301 trial_entity\\', {}), (\\'de Kraker, J._entity\\', {})], \\'edges\\': [(\\'de Kraker, J._entity\\', \\'SIOP 93\u201301 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'SIOP trial and study 93\u201301_entity\\', {}), (\\'Graf, N._entity\\', {})], \\'edges\\': [(\\'Graf, N._entity\\', \\'SIOP trial and study 93\u201301_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Green, D. M._entity\\', {}), (\\'National Wilms Tumor Study Group_entity\\', {})], \\'edges\\': [(\\'Green, D. M._entity\\', \\'National Wilms Tumor Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}, {\\'nodes\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', {}), (\\'SIOP WT 2001 protocol_entity\\', {})], \\'edges\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', \\'SIOP WT 2001 protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Third National Wilms\u2019 Tumor Study_entity\\', {}), (\"D\\'Angio, G. J._entity\", {}), (\\'Second National Wilms\u2019 Tumor Study_entity\\', {})], \\'edges\\': [(\"D\\'Angio, G. J._entity\", \\'Third National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\"D\\'Angio, G. J._entity\", \\'Second National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {}), (\\'Tournade, M. F._entity\\', {}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {})], \\'edges\\': [(\\'Tournade, M. F._entity\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'}), (\\'Tournade, M. F._entity\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Breslow, N. E._entity\\', {}), (\\'National Wilms Tumor Studies_entity\\', {})], \\'edges\\': [(\\'Breslow, N. E._entity\\', \\'National Wilms Tumor Studies_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Mitchell, C._entity\\', {}), (\\'UK Children\u2019s Cancer Study Group_entity\\', {})], \\'edges\\': [(\\'Mitchell, C._entity\\', \\'UK Children\u2019s Cancer Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'under\\'})]}, {\\'nodes\\': [(\\'Daw, N. C._entity\\', {}), (\\'Dix, D. B._entity\\', {}), (\\'Children\u2019s Oncology Group_entity\\', {}), (\\'Grundy, P. E._entity\\', {})], \\'edges\\': [(\\'Daw, N. C._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted under\\'}), (\\'Dix, D. B._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'}), (\\'Grundy, P. E._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}]', expected_output='It suggests that the whole-lung irradiation dose may be reduced (for example, from 15 Gy to 12 Gy) in selected cases.', context=None, retrieval_context=['[{\\'nodes\\': [(\\'sample.pdf\\', {\\'type\\': \\'document\\'}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)\\'}), (\\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA SIOP-RTSG 2016\\'}), (\\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms tumours\\'}), (\\'non-Wilms tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'non-Wilms tumours\\'}), (\\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Website\\', \\'name\\': \\'www.siop-rtsg.eu\\'}), (\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology\\'}), (\\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Person\\', \\'name\\': \\'Marry M. van den Heuvel-Eibrink\\'}), (\\'childhood renal tumours_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'childhood renal tumours\\'}), (\\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'clear cell sarcoma of the kidney\\'}), (\\'renal cell carcinoma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'renal cell carcinoma\\'}), (\\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'malignant rhabdoid tumour of the kidney\\'}), (\\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'Wilms tumours_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'Children\u2019s Oncology Group (COG)\\'}), (\\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'SIOP\u22122001 randomized trial\\'}), (\\'actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Clinical Trial\\', \\'name\\': \\'UKW3 trial\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Organization\\', \\'name\\': \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)\\'}), (\\'localized disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'localized disease\\'}), (\\'metastatic disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'metastatic disease\\'}), (\\'bilateral disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'bilateral disease\\'}), (\\'relapsed disease_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'relapsed disease\\'}), (\\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subtype\\', \\'name\\': \\'blastemal-type Wilms tumours\\'}), (\\'radiotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgery_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'chemotherapy\\'}), (\\'Wilms Tumour_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Wilms Tumour\\'}), (\\'CCSK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CCSK\\'}), (\\'MRTK_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'MRTK\\'}), (\\'CMN_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'CMN\\'}), (\\'RCC_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'RCC\\'}), (\\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u22122001_Trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Trial\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'vincristine_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'vincristine\\'}), (\\'actinomycin D_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'actinomycin D\\'}), (\\'doxorubicin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'doxorubicin\\'}), (\\'etoposide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_Treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'Stage I_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage I\\'}), (\\'Stage II_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage II\\'}), (\\'Stage III_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage III\\'}), (\\'Stage IV_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage IV\\'}), (\\'Stage V_Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Stage\\', \\'name\\': \\'Stage V\\'}), (\\'AV_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AV\\'}), (\\'AVD_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'AVD\\'}), (\\'HR-1_Treatment Combination\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Combination\\', \\'name\\': \\'HR-1\\'}), (\\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Protocol\\', \\'name\\': \\'SIOP-RTSG 2016\\'}), (\\'Overall Survival (OS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'metric\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'CT-only nodules_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'CT-only nodules\\'}), (\\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP\u2013RTSG analysis\\'}), (\\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials\\'}), (\\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D plus doxorubicin\\'}), (\\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine and actinomycin D\\'}), (\\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study_protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'MRI_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'MRI\\'}), (\\'CT_diagnostic_tool\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'diagnostic_tool\\', \\'name\\': \\'CT\\'}), (\\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_detail\\', \\'name\\': \\'cumulative doxorubicin dose\\'}), (\\'COG AREN0533 trial_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'COG AREN0533 trial\\'}), (\\'etoposide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'etoposide\\'}), (\\'carboplatin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'high-risk characteristics\\'}), (\\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG board\\'}), (\\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin\\'}), (\\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'high-dose chemotherapy and autologous stem cell transplantation\\'}), (\\'SIOP database_database\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'database\\', \\'name\\': \\'SIOP database\\'}), (\\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Event-Free Survival (EFS)\\'}), (\\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Subject\\', \\'name\\': \\'Overall Survival (OS)\\'}), (\\'AVD_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AVD\\'}), (\\'AV-2_Treatment Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Group\\', \\'name\\': \\'AV-2\\'}), (\\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Statistical Test\\', \\'name\\': \\'Log\u2013Rank P\\'}), (\\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease Stage\\', \\'name\\': \\'Bilateral Disease (Stage V)\\'}), (\\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease\\', \\'name\\': \\'Synchronous bilateral Wilms tumor\\'}), (\\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Condition\\', \\'name\\': \\'End-stage renal disease (ESRD)\\'}), (\\'Aronson et al._Research Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Research Group\\', \\'name\\': \\'Aronson et al.\\'}), (\\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'Bilateral nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Study\\', \\'name\\': \\'SIOP\u22122001 study\\'}), (\\'Vincristine_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Vincristine\\'}), (\\'Actinomycin D_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Actinomycin D\\'}), (\\'Etoposide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Etoposide\\'}), (\\'Carboplatin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Carboplatin\\'}), (\\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Disease State\\', \\'name\\': \\'Relapsed Wilms Tumor\\'}), (\\'Group AA_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group AA\\'}), (\\'Group BB_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group BB\\'}), (\\'Group CC_Patient Group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Patient Group\\', \\'name\\': \\'Group CC\\'}), (\\'Doxorubicin_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Doxorubicin\\'}), (\\'Cyclophosphamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Cyclophosphamide\\'}), (\\'Ifosfamide_Drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Drug\\', \\'name\\': \\'Ifosfamide\\'}), (\\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Method\\', \\'name\\': \\'High-dose melphalan\\'}), (\\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'UKW\u2011R protocol\\'}), (\\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Treatment Protocol\\', \\'name\\': \\'NWTS\u20115 relapse protocol\\'}), (\\'ASCR_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'procedure\\', \\'name\\': \\'ASCR\\'}), (\\'ifosfamide_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'ifosfamide\\'}), (\\'nephrotoxicity_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'nephrotoxicity\\'}), (\\'relapsed group CC_patient_group\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'patient_group\\', \\'name\\': \\'relapsed group CC\\'}), (\\'diffuse anaplasia_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'diffuse anaplasia\\'}), (\\'blastemal-type tumors_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'blastemal-type tumors\\'}), (\\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'camptothecins_medication_class\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication_class\\', \\'name\\': \\'camptothecins\\'}), (\\'irinotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'irinotecan\\'}), (\\'topotecan_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'topotecan\\'}), (\\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Innovative Therapies for Children with Cancer consortium\\'}), (\\'radiotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'radiotherapy\\'}), (\\'surgical excision_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgical excision\\'}), (\\'stage IV WT_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'stage IV WT\\'}), (\\'AVD150_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD150\\'}), (\\'AVD250_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'AVD250\\'}), (\\'low-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'low-risk disease\\'}), (\\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'intermediate-risk disease\\'}), (\\'high-risk disease_condition_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition_category\\', \\'name\\': \\'high-risk disease\\'}), (\\'CDCV_treatment_regimen\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_regimen\\', \\'name\\': \\'CDCV\\'}), (\\'actinomycin-D_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'actinomycin-D\\'}), (\\'vincristine_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'doxorubicin\\'}), (\\'VP16_medication\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medication\\', \\'name\\': \\'VP16\\'}), (\\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'contact\\', \\'name\\': \\'arnauld.verschuur@ap-hm.fr\\'}), (\\'surgery_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'surgery\\'}), (\\'chemotherapy_treatment_method\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment_method\\', \\'name\\': \\'chemotherapy\\'}), (\\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2212RTSG panel\\'}), (\\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Infant Wilms Tumors\\'}), (\\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'nephrectomy\\'}), (\\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'congenital mesoblastic nephroma\\'}), (\\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'malignant rhabdoid tumors\\'}), (\\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'Adult Wilms Tumors\\'}), (\\'anaplasia_medical_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'medical_condition\\', \\'name\\': \\'anaplasia\\'}), (\\'actinomycin D_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'actinomycin D\\'}), (\\'vincristine_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'vincristine\\'}), (\\'doxorubicin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'doxorubicin\\'}), (\\'carboplatin_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'carboplatin\\'}), (\\'cyclophosphamide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'cyclophosphamide\\'}), (\\'etoposide_drug\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'drug\\', \\'name\\': \\'etoposide\\'}), (\\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'Nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'SIOP\u2013RTSG\\'}), (\\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'radical tumor nephrectomy\\'}), (\\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgical_procedure\\', \\'name\\': \\'lymph node sampling\\'}), (\\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'minimally invasive surgery\\'}), (\\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'laparoscopic surgery\\'}), (\\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'surgery_type\\', \\'name\\': \\'nephron-sparing surgery (NSS)\\'}), (\\'SIOP\u22122001_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP\u22122001\\'}), (\\'radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'radiotherapy\\'}), (\\'Wilms tumours_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'Wilms tumours\\'}), (\\'Davila Fajardo et al._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Davila Fajardo et al.\\'}), (\\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'COG\u2013NWTS trials\\'}), (\\'whole-lung irradiation_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'whole-lung irradiation\\'}), (\\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'pulmonary radiotherapy\\'}), (\\'proton therapy_treatment\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'treatment\\', \\'name\\': \\'proton therapy\\'}), (\\'dosimetric study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'dosimetric study\\'}), (\\'locoregional disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'locoregional disease\\'}), (\\'metastatic disease_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'metastatic disease\\'}), (\\'low-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'low-risk\\'}), (\\'intermediate-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'intermediate-risk\\'}), (\\'high-risk_risk_category\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'risk_category\\', \\'name\\': \\'high-risk\\'}), (\\'stage I_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage I\\'}), (\\'stage II_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage II\\'}), (\\'stage III_stage\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'stage\\', \\'name\\': \\'stage III\\'}), (\\'major rupture_condition\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'condition\\', \\'name\\': \\'major rupture\\'}), (\\'Austria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Austria\\'}), (\\'Italy_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Italy\\'}), (\\'San Marino_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'San Marino\\'}), (\\'Iceland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Iceland\\'}), (\\'Germany_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Germany\\'}), (\\'Bulgaria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bulgaria\\'}), (\\'Turkey_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Turkey\\'}), (\\'Denmark_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Denmark\\'}), (\\'Poland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Poland\\'}), (\\'Greece_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Greece\\'}), (\\'Andorra_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Andorra\\'}), (\\'Belgium_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belgium\\'}), (\\'Serbia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Serbia\\'}), (\\'Albania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Albania\\'}), (\\'Moldova_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Moldova\\'}), (\\'Lithuania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Lithuania\\'}), (\\'Latvia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Latvia\\'}), (\\'Estonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Estonia\\'}), (\\'Luxembourg_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Luxembourg\\'}), (\\'Montenegro_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Montenegro\\'}), (\\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Bosnia and Herzegovina\\'}), (\\'Croatia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Croatia\\'}), (\\'Slovenia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovenia\\'}), (\\'Macedonia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Macedonia\\'}), (\\'United Kingdom_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'United Kingdom\\'}), (\\'Ireland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ireland\\'}), (\\'Spain_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Spain\\'}), (\\'Algeria_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Algeria\\'}), (\\'Tunisia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Tunisia\\'}), (\\'Malta_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Malta\\'}), (\\'Morocco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Morocco\\'}), (\\'Portugal_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Portugal\\'}), (\\'France_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'France\\'}), (\\'Monaco_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Monaco\\'}), (\\'Russia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Russia\\'}), (\\'Finland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Finland\\'}), (\\'Sweden_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Sweden\\'}), (\\'Norway_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Norway\\'}), (\\'Belarus_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Belarus\\'}), (\\'Romania_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Romania\\'}), (\\'Ukraine_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Ukraine\\'}), (\\'Hungary_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Hungary\\'}), (\\'Czech Republic_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Czech Republic\\'}), (\\'Slovakia_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Slovakia\\'}), (\\'Switzerland_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Switzerland\\'}), (\\'Liechtenstein_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Liechtenstein\\'}), (\\'Netherlands_Country\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Country\\', \\'name\\': \\'Netherlands\\'}), (\\'University Hospital of Munich_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Munich\\'}), (\\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital of Tuebingen\\'}), (\\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Azienda Ospedaliera\\'}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Ospedale Pediatrico Bambino Ges\u00f9\\'}), (\\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Fondazione IRCCS Istituto Nazionale dei Tumori\\'}), (\\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Prinses Maxima Centrum\\'}), (\\'Marciniak Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Marciniak Hospital\\'}), (\\'Faculty of Medicine_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Faculty of Medicine\\'}), (\\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'St. Anna Kinderspital/CCRI\\'}), (\\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Armand Trousseau Hospital\\'}), (\\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Universitario Virgin del Rocio\\'}), (\\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Hospital Vall d\u2019Hebron\\'}), (\\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'Great Ormond Street Hospital\\'}), (\\'University Hospital Homburg_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'University Hospital Homburg\\'}), (\\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Institution\\', \\'name\\': \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon\\'}), (\\'UMBRELLA protocol_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'UMBRELLA protocol\\'}), (\\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'Project\\', \\'name\\': \\'ExPO\u2011r\u2011Net\\'}), (\\'Weirich, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Weirich, A.\\'}), (\\'Pritchard-Jones, K._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Pritchard-Jones, K.\\'}), (\\'de Kraker, J._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'de Kraker, J.\\'}), (\\'Graf, N._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Graf, N.\\'}), (\\'Green, D. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Green, D. M.\\'}), (\\'Spreafico, F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Spreafico, F.\\'}), (\\'Bellani, F. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Bellani, F. F.\\'}), (\\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'van den Heuvel-Eibrink, M. M.\\'}), (\"D\\'Angio, G. J._author\", {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \"D\\'Angio, G. J.\"}), (\\'Tournade, M. F._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Tournade, M. F.\\'}), (\\'Breslow, N. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Breslow, N. E.\\'}), (\\'Mitchell, C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Mitchell, C.\\'}), (\\'Verschuur, A._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Verschuur, A.\\'}), (\\'Grundy, P. E._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Grundy, P. E.\\'}), (\\'Warmann, S. W._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Warmann, S. W.\\'}), (\\'Smets, A. M._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Smets, A. M.\\'}), (\\'Dome, J. S._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dome, J. S.\\'}), (\\'Dix, D. B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Dix, D. B.\\'}), (\\'Daw, N. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Daw, N. C.\\'}), (\\'Ha, T. C._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Ha, T. C.\\'}), (\\'Kremens, B._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Kremens, B.\\'}), (\\'Furtwangler, R._author\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'author\\', \\'name\\': \\'Furtwangler, R.\\'}), (\\'SIOP-9/GPOH_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP-9/GPOH\\'}), (\\'UKW3_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'UKW3\\'}), (\\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'trial\\', \\'name\\': \\'SIOP 93\u201301 trial\\'}), (\\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'SIOP trial and study 93\u201301\\'}), (\\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'National Wilms Tumor Study Group\\'}), (\\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'protocol\\', \\'name\\': \\'SIOP WT 2001 protocol\\'}), (\\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Third National Wilms\u2019 Tumor Study\\'}), (\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'National Wilms Tumor Studies\\'}), (\\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Second National Wilms\u2019 Tumor Study\\'}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'study\\', \\'name\\': \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study\\'}), (\\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'UK Children\u2019s Cancer Study Group\\'}), (\\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'entity\\', \\'entity_type\\': \\'organization\\', \\'name\\': \\'Children\u2019s Oncology Group\\'})], \\'edges\\': [(\\'sample.pdf\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'UMBRELLA SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'SIOP\u22122001_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'non-Wilms tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'www.siop-rtsg.eu_Website\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Marry M. van den Heuvel-Eibrink_Person\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'childhood renal tumours_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'clear cell sarcoma of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'renal cell carcinoma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'malignant rhabdoid tumour of the kidney_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 1}), (\\'sample.pdf\\', \\'Wilms tumours_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group (COG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'SIOP\u22122001 randomized trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UKW3 trial_Clinical Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_Organization\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'localized disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'metastatic disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'bilateral disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'relapsed disease_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'blastemal-type Wilms tumours_Subtype\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'radiotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'surgery_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'chemotherapy_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 2}), (\\'sample.pdf\\', \\'Wilms Tumour_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CCSK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'MRTK_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'CMN_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'RCC_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP\u22122001_Trial\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'vincristine_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'actinomycin D_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'doxorubicin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'etoposide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'carboplatin_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'cyclophosphamide_Treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage I_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage II_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage III_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage IV_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Stage V_Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AV_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'AVD_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'HR-1_Treatment Combination\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'SIOP-RTSG 2016_Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 3}), (\\'sample.pdf\\', \\'Overall Survival (OS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_metric\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT-only nodules_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'UMBRELLA protocol_treatment_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG analysis_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D plus doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine and actinomycin D_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u22122001_study_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'MRI_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'CT_diagnostic_tool\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'cumulative doxorubicin dose_treatment_detail\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'COG AREN0533 trial_study\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'etoposide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'carboplatin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'cyclophosphamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk characteristics_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG board_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'high-dose chemotherapy and autologous stem cell transplantation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'SIOP database_database\\', {\\'type\\': \\'contains\\', \\'page\\': 4}), (\\'sample.pdf\\', \\'Event-Free Survival (EFS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Overall Survival (OS)_Subject\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AVD_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'AV-2_Treatment Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Log\u2013Rank P_Statistical Test\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral Disease (Stage V)_Disease Stage\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Synchronous bilateral Wilms tumor_Disease\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'End-stage renal disease (ESRD)_Condition\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Aronson et al._Research Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Bilateral nephron-sparing surgery (NSS)_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'SIOP\u22122001 study_Study\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Vincristine_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Actinomycin D_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Etoposide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Carboplatin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Relapsed Wilms Tumor_Disease State\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group AA_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group BB_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Group CC_Patient Group\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Doxorubicin_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Cyclophosphamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'Ifosfamide_Drug\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'High-dose melphalan_Treatment Method\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'UKW\u2011R protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'NWTS\u20115 relapse protocol_Treatment Protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 5}), (\\'sample.pdf\\', \\'ASCR_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'ifosfamide_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'nephrotoxicity_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'relapsed group CC_patient_group\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'diffuse anaplasia_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'blastemal-type tumors_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'UMBRELLA protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'camptothecins_medication_class\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'irinotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'topotecan_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'Innovative Therapies for Children with Cancer consortium_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'radiotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'surgical excision_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'stage IV WT_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD150_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'AVD250_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'low-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'intermediate-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'high-risk disease_condition_category\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'CDCV_treatment_regimen\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'actinomycin-D_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'vincristine_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'doxorubicin_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'VP16_medication\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'arnauld.verschuur@ap-hm.fr_contact\\', {\\'type\\': \\'contains\\', \\'page\\': 6}), (\\'sample.pdf\\', \\'surgery_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'chemotherapy_treatment_method\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2212RTSG panel_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Infant Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'congenital mesoblastic nephroma_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'malignant rhabdoid tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Adult Wilms Tumors_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'anaplasia_medical_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'actinomycin D_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'vincristine_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'doxorubicin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'carboplatin_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'cyclophosphamide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'etoposide_drug\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'Nephron-sparing surgery (NSS)_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'SIOP\u2013RTSG_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'radical tumor nephrectomy_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'lymph node sampling_surgical_procedure\\', {\\'type\\': \\'contains\\', \\'page\\': 7}), (\\'sample.pdf\\', \\'minimally invasive surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'laparoscopic surgery_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'nephron-sparing surgery (NSS)_surgery_type\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'SIOP\u22122001_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Wilms tumours_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Davila Fajardo et al._author\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'COG\u2013NWTS trials_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'whole-lung irradiation_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'pulmonary radiotherapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'proton therapy_treatment\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'dosimetric study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'locoregional disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'metastatic disease_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'low-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'intermediate-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'high-risk_risk_category\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage I_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage II_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'stage III_stage\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'major rupture_condition\\', {\\'type\\': \\'contains\\', \\'page\\': 8}), (\\'sample.pdf\\', \\'Austria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Italy_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'San Marino_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Iceland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Germany_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bulgaria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Turkey_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Denmark_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Poland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Greece_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Andorra_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belgium_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Serbia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Albania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Moldova_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Lithuania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Latvia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Estonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Luxembourg_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Montenegro_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Bosnia and Herzegovina_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Croatia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovenia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Macedonia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'United Kingdom_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ireland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Spain_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Algeria_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Tunisia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Malta_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Morocco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Portugal_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'France_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Monaco_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Russia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Finland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Sweden_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Norway_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Belarus_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Romania_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ukraine_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hungary_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Czech Republic_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Slovakia_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Switzerland_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Liechtenstein_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Netherlands_Country\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Munich_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital of Tuebingen_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Azienda Ospedaliera_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Prinses Maxima Centrum_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Marciniak Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Faculty of Medicine_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'St. Anna Kinderspital/CCRI_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Armand Trousseau Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Universitario Virgin del Rocio_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Hospital Vall d\u2019Hebron_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Great Ormond Street Hospital_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'University Hospital Homburg_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'L\u2019Institut d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique de Lyon_Institution\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'UMBRELLA protocol_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'ExPO\u2011r\u2011Net_Project\\', {\\'type\\': \\'contains\\', \\'page\\': 9}), (\\'sample.pdf\\', \\'Weirich, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Pritchard-Jones, K._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'de Kraker, J._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Graf, N._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Green, D. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Spreafico, F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Bellani, F. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'van den Heuvel-Eibrink, M. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \"D\\'Angio, G. J._author\", {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Tournade, M. F._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Breslow, N. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Mitchell, C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Verschuur, A._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Grundy, P. E._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Warmann, S. W._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Smets, A. M._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dome, J. S._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Dix, D. B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Daw, N. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ha, T. C._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Kremens, B._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Furtwangler, R._author\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP-9/GPOH_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UKW3_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP 93\u201301 trial_trial\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP trial and study 93\u201301_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'SIOP WT 2001 protocol_protocol\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Third National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'National Wilms Tumor Studies_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Second National Wilms\u2019 Tumor Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_study\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'UK Children\u2019s Cancer Study Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10}), (\\'sample.pdf\\', \\'Children\u2019s Oncology Group_organization\\', {\\'type\\': \\'contains\\', \\'page\\': 10})]}, {\\'nodes\\': [(\\'vincristine_entity\\', {}), (\\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {}), (\\'www.siop-rtsg.eu_entity\\', {}), (\\'stage II_entity\\', {}), (\\'Wilms tumours_entity\\', {}), (\\'Relapsed Wilms Tumor_entity\\', {}), (\\'Davila Fajardo et al._entity\\', {}), (\\'vincristine, actinomycin D, and doxorubicin_entity\\', {}), (\\'SIOP\u22122001 randomized trial_entity\\', {}), (\\'surgery_entity\\', {}), (\\'non-Wilms tumours_entity\\', {}), (\\'actinomycin D_entity\\', {}), (\\'diffuse anaplasia_entity\\', {}), (\\'Synchronous bilateral Wilms tumor_entity\\', {}), (\\'CT-only nodules_entity\\', {}), (\\'relapsed group CC_entity\\', {}), (\\'increased relapse risk_entity\\', {}), (\\'reduced survival_entity\\', {}), (\\'UKW3 trial_entity\\', {}), (\\'chemotherapy_entity\\', {}), (\\'Bilateral Disease (Stage V)_entity\\', {}), (\\'blastemal-type tumors_entity\\', {}), (\\'UMBRELLA protocol_entity\\', {}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', {}), (\\'minimally invasive surgery_entity\\', {}), (\\'VP16_entity\\', {}), (\\'Wilms tumor_entity\\', {}), (\\'anaplasia_entity\\', {}), (\\'radical tumor nephrectomy_entity\\', {}), (\\'Innovative Therapies for Children with Cancer consortium_entity\\', {}), (\\'cumulative doxorubicin dose_entity\\', {}), (\\'etoposide_entity\\', {}), (\\'large-volume tumours_entity\\', {}), (\\'Stage IV_entity\\', {}), (\\'CDCV_entity\\', {}), (\\'SIOP\u2013RTSG_entity\\', {}), (\\'AVD150_entity\\', {}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', {}), (\\'laparoscopic surgery_entity\\', {}), (\\'SIOP\u2212RTSG panel_entity\\', {}), (\\'actinomycin-D_entity\\', {}), (\\'COG AREN0533 trial_entity\\', {}), (\\'cyclophosphamide_entity\\', {}), (\\'carboplatin_entity\\', {}), (\\'UKW\u2011R protocol_entity\\', {}), (\\'Nephron-sparing surgery (NSS)_entity\\', {}), (\\'Adult Wilms Tumors_entity\\', {}), (\\'doxorubicin_entity\\', {}), (\\'NWTS\u20115 relapse protocol_entity\\', {}), (\\'End-stage renal disease (ESRD)_entity\\', {}), (\\'AVD250_entity\\', {}), (\\'Children\u2019s Oncology Group (COG)_entity\\', {}), (\\'blastemal-type Wilms tumour_entity\\', {}), (\\'SIOP\u22122001_entity\\', {}), (\\'radiotherapy_entity\\', {}), (\\'childhood renal tumours_entity\\', {})], \\'edges\\': [(\\'vincristine_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'stage II_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'indicated_for_in_adults\\'}), (\\'Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'Wilms tumours_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated under\\'}), (\\'Relapsed Wilms Tumor_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guided_by\\'}), (\\'Davila Fajardo et al._entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed\\'}), (\\'SIOP\u22122001 randomized trial_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated use in\\'}), (\\'surgery_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'non-Wilms tumours_entity\\', \\'childhood renal tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'category_of\\'}), (\\'actinomycin D_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Synchronous bilateral Wilms tumor_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'instance_of\\'}), (\\'CT-only nodules_entity\\', \\'increased relapse risk_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'reduced survival_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'CT-only nodules_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included_in\\'}), (\\'relapsed group CC_entity\\', \\'diffuse anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'blastemal-type tumors_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'relapsed group CC_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UKW3 trial_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'UKW3 trial_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'validated use of\\'}), (\\'chemotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'follows\\'}), (\\'UMBRELLA protocol_entity\\', \\'COG AREN0533 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses_data_from\\'}), (\\'UMBRELLA protocol_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'advises_treatment_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'Innovative Therapies for Children with Cancer consortium_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborates_with\\'}), (\\'UMBRELLA protocol_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'surgery_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provides_guidelines_for\\'}), (\\'UMBRELLA protocol_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is the standard of\\'}), (\\'UMBRELLA protocol_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'guides treatment in\\'}), (\\'UK Children\u2019s Cancer and Leukaemia Group (UKCCLG)_entity\\', \\'UKW3 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\\'minimally invasive surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'anaplasia_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'anaplasia_entity\\', \\'etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'radical tumor nephrectomy_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'standard_of_care_for\\'}), (\\'Stage IV_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'presents in\\'}), (\\'CDCV_entity\\', \\'cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'CDCV_entity\\', \\'VP16_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed\\'}), (\\'SIOP\u2013RTSG_entity\\', \\'Wilms tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'aims to improve survival rates of\\'}), (\\'AVD150_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD150_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP\u2013RTSG)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'developed_by\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'succeeds\\'}), (\\'UMBRELLA SIOP-RTSG 2016_entity\\', \\'www.siop-rtsg.eu_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'available_on\\'}), (\\'laparoscopic surgery_entity\\', \\'UMBRELLA protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'addressed_in\\'}), (\\'COG AREN0533 trial_entity\\', \\'cumulative doxorubicin dose_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'evaluates\\'}), (\\'UKW\u2011R protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'Nephron-sparing surgery (NSS)_entity\\', \\'SIOP\u2013RTSG_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'classification_developed_by\\'}), (\\'Adult Wilms Tumors_entity\\', \\'anaplasia_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'Adult Wilms Tumors_entity\\', \\'actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Adult Wilms Tumors_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'doxorubicin_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'doxorubicin_entity\\', \\'large-volume tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'recommended for\\'}), (\\'NWTS\u20115 relapse protocol_entity\\', \\'Relapsed Wilms Tumor_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'applied_to\\'}), (\\'End-stage renal disease (ESRD)_entity\\', \\'Bilateral Disease (Stage V)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'associated_with\\'}), (\\'AVD250_entity\\', \\'actinomycin-D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'AVD250_entity\\', \\'doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'Children\u2019s Oncology Group (COG)_entity\\', \\'SIOP\u22122001 randomized trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'collaborated with\\'}), (\\'blastemal-type Wilms tumour_entity\\', \\'SIOP\u22122001_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment intensified according to\\'}), (\\'SIOP\u22122001_entity\\', \\'vincristine, actinomycin D, and doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'uses\\'}), (\\'SIOP\u22122001_entity\\', \\'radiotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'provided_guidelines_for\\'}), (\\'radiotherapy_entity\\', \\'Wilms tumours_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'radiotherapy_entity\\', \\'SIOP\u2212RTSG panel_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'contact_for_guidance\\'})]}, {\\'nodes\\': [(\\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {}), (\\'Marry M. van den Heuvel-Eibrink_entity\\', {})], \\'edges\\': [(\\'Marry M. van den Heuvel-Eibrink_entity\\', \\'Department of Paediatric Oncology, Princess M\u00e1xima Center for Paediatric Oncology_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'affiliated_with\\'})]}, {\\'nodes\\': [(\\'Stage II_entity\\', {}), (\\'AV_entity\\', {}), (\\'Stage III_entity\\', {}), (\\'vincestine and actinomycin D_entity\\', {}), (\\'AVD_entity\\', {})], \\'edges\\': [(\\'Stage II_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AV_entity\\', \\'Stage II_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'}), (\\'Stage III_entity\\', \\'vincestine and actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treated with\\'}), (\\'AVD_entity\\', \\'Stage III_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'SIOP-RTSG 2016_entity\\', {}), (\\'RCC_entity\\', {}), (\\'CMN_entity\\', {})], \\'edges\\': [(\\'RCC_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'}), (\\'CMN_entity\\', \\'SIOP-RTSG 2016_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'included in\\'})]}, {\\'nodes\\': [(\\'HR-1_entity\\', {}), (\\'High-risk blastemal type Wilms tumour_entity\\', {})], \\'edges\\': [(\\'HR-1_entity\\', \\'High-risk blastemal type Wilms tumour_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used for\\'})]}, {\\'nodes\\': [(\\'unfavorable prognosis_entity\\', {}), (\\'high-risk characteristics_entity\\', {})], \\'edges\\': [(\\'high-risk characteristics_entity\\', \\'unfavorable prognosis_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'leads_to\\'})]}, {\\'nodes\\': [(\\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {}), (\\'SIOP\u2013RTSG board_entity\\', {})], \\'edges\\': [(\\'SIOP\u2013RTSG board_entity\\', \\'high-dose chemotherapy and autologous stem cell transplantation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggests\\'})]}, {\\'nodes\\': [(\\'regimen and outcomes_entity\\', {}), (\\'SIOP database_entity\\', {})], \\'edges\\': [(\\'SIOP database_entity\\', \\'regimen and outcomes_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'captures_data_on\\'})]}, {\\'nodes\\': [(\\'Bilateral nephron-sparing surgery (NSS)_entity\\', {}), (\\'Aronson et al._entity\\', {})], \\'edges\\': [(\\'Aronson et al._entity\\', \\'Bilateral nephron-sparing surgery (NSS)_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'observed_effectiveness_of\\'})]}, {\\'nodes\\': [(\\'SIOP\u22122001 study_entity\\', {}), (\\'Actinomycin D_entity\\', {}), (\\'Vincristine_entity\\', {})], \\'edges\\': [(\\'SIOP\u22122001 study_entity\\', \\'Vincristine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'}), (\\'SIOP\u22122001 study_entity\\', \\'Actinomycin D_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'used_drug\\'})]}, {\\'nodes\\': [(\\'High-dose melphalan_entity\\', {}), (\\'Group AA_entity\\', {}), (\\'Carboplatin_entity\\', {}), (\\'Doxorubicin_entity\\', {}), (\\'Etoposide_entity\\', {}), (\\'Group BB_entity\\', {}), (\\'Cyclophosphamide_entity\\', {}), (\\'Ifosfamide_entity\\', {})], \\'edges\\': [(\\'Group AA_entity\\', \\'Doxorubicin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group AA_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Etoposide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Carboplatin_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Ifosfamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'Cyclophosphamide_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'}), (\\'Group BB_entity\\', \\'High-dose melphalan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_includes\\'})]}, {\\'nodes\\': [(\\'nephrotoxicity_entity\\', {}), (\\'ifosfamide_entity\\', {})], \\'edges\\': [(\\'ifosfamide_entity\\', \\'nephrotoxicity_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'related_to\\'})]}, {\\'nodes\\': [(\\'camptothecins_entity\\', {}), (\\'irinotecan_entity\\', {}), (\\'topotecan_entity\\', {})], \\'edges\\': [(\\'camptothecins_entity\\', \\'irinotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'}), (\\'camptothecins_entity\\', \\'topotecan_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes\\'})]}, {\\'nodes\\': [(\\'Infant Wilms Tumors_entity\\', {}), (\\'nephrectomy_entity\\', {})], \\'edges\\': [(\\'Infant Wilms Tumors_entity\\', \\'nephrectomy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'treatment_option\\'})]}, {\\'nodes\\': [(\\'congenital mesoblastic nephroma_entity\\', {}), (\\'surgery alone_entity\\', {})], \\'edges\\': [(\\'congenital mesoblastic nephroma_entity\\', \\'surgery alone_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'alternative chemotherapy_entity\\', {}), (\\'malignant rhabdoid tumors_entity\\', {})], \\'edges\\': [(\\'malignant rhabdoid tumors_entity\\', \\'alternative chemotherapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'requires\\'})]}, {\\'nodes\\': [(\\'lymph node sampling_entity\\', {}), (\\'accurate staging_entity\\', {})], \\'edges\\': [(\\'lymph node sampling_entity\\', \\'accurate staging_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'purpose_of\\'})]}, {\\'nodes\\': [(\\'COG\u2013NWTS trials_entity\\', {}), (\\'whole-lung irradiation_entity\\', {})], \\'edges\\': [(\\'COG\u2013NWTS trials_entity\\', \\'whole-lung irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'informed_dosage_for\\'})]}, {\\'nodes\\': [(\\'lung metastases_entity\\', {}), (\\'pulmonary radiotherapy_entity\\', {})], \\'edges\\': [(\\'pulmonary radiotherapy_entity\\', \\'lung metastases_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'administered_for\\'})]}, {\\'nodes\\': [(\\'dosimetric study_entity\\', {}), (\\'proton therapy_entity\\', {}), (\\'flank irradiation_entity\\', {})], \\'edges\\': [(\\'dosimetric study_entity\\', \\'proton therapy_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'investigated\\'}), (\\'proton therapy_entity\\', \\'flank irradiation_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'suggested_for\\'})]}, {\\'nodes\\': [(\\'metastatic disease_entity\\', {}), (\\'radiotherapy guidelines_entity\\', {}), (\\'locoregional disease_entity\\', {})], \\'edges\\': [(\\'radiotherapy guidelines_entity\\', \\'locoregional disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'}), (\\'radiotherapy guidelines_entity\\', \\'metastatic disease_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'specified_for\\'})]}, {\\'nodes\\': [(\\'major rupture_entity\\', {}), (\\'stage III_entity\\', {})], \\'edges\\': [(\\'stage III_entity\\', \\'major rupture_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'includes_condition\\'})]}, {\\'nodes\\': [(\\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {}), (\\'ExPO\u2011r\u2011Net_entity\\', {})], \\'edges\\': [(\\'ExPO\u2011r\u2011Net_entity\\', \\'European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'is part of\\'})]}, {\\'nodes\\': [(\\'University Hospital of Munich_entity\\', {}), (\\'Germany_entity\\', {}), (\\'University Hospital of Tuebingen_entity\\', {})], \\'edges\\': [(\\'Germany_entity\\', \\'University Hospital of Munich_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Germany_entity\\', \\'University Hospital of Tuebingen_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {}), (\\'Italy_entity\\', {}), (\\'Azienda Ospedaliera_entity\\', {}), (\\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {})], \\'edges\\': [(\\'Italy_entity\\', \\'Azienda Ospedaliera_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Ospedale Pediatrico Bambino Ges\u00f9_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Italy_entity\\', \\'Fondazione IRCCS Istituto Nazionale dei Tumori_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Netherlands_entity\\', {}), (\\'Prinses Maxima Centrum_entity\\', {})], \\'edges\\': [(\\'Netherlands_entity\\', \\'Prinses Maxima Centrum_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Marciniak Hospital_entity\\', {}), (\\'Poland_entity\\', {}), (\\'Faculty of Medicine_entity\\', {})], \\'edges\\': [(\\'Poland_entity\\', \\'Marciniak Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Poland_entity\\', \\'Faculty of Medicine_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'St. Anna Kinderspital/CCRI_entity\\', {}), (\\'Austria_entity\\', {})], \\'edges\\': [(\\'Austria_entity\\', \\'St. Anna Kinderspital/CCRI_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'France_entity\\', {}), (\\'Armand Trousseau Hospital_entity\\', {})], \\'edges\\': [(\\'France_entity\\', \\'Armand Trousseau Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Spain_entity\\', {}), (\\'Hospital Vall d\u2019Hebron_entity\\', {}), (\\'Hospital Universitario Virgin del Rocio_entity\\', {})], \\'edges\\': [(\\'Spain_entity\\', \\'Hospital Universitario Virgin del Rocio_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'}), (\\'Spain_entity\\', \\'Hospital Vall d\u2019Hebron_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'United Kingdom_entity\\', {}), (\\'Great Ormond Street Hospital_entity\\', {})], \\'edges\\': [(\\'United Kingdom_entity\\', \\'Great Ormond Street Hospital_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'has\\'})]}, {\\'nodes\\': [(\\'Weirich, A._entity\\', {}), (\\'SIOP-9/GPOH_entity\\', {})], \\'edges\\': [(\\'Weirich, A._entity\\', \\'SIOP-9/GPOH_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Pritchard-Jones, K._entity\\', {}), (\\'UKW3_entity\\', {})], \\'edges\\': [(\\'Pritchard-Jones, K._entity\\', \\'UKW3_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'analyzed in\\'})]}, {\\'nodes\\': [(\\'SIOP 93\u201301 trial_entity\\', {}), (\\'de Kraker, J._entity\\', {})], \\'edges\\': [(\\'de Kraker, J._entity\\', \\'SIOP 93\u201301 trial_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'SIOP trial and study 93\u201301_entity\\', {}), (\\'Graf, N._entity\\', {})], \\'edges\\': [(\\'Graf, N._entity\\', \\'SIOP trial and study 93\u201301_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'})]}, {\\'nodes\\': [(\\'Green, D. M._entity\\', {}), (\\'National Wilms Tumor Study Group_entity\\', {})], \\'edges\\': [(\\'Green, D. M._entity\\', \\'National Wilms Tumor Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}, {\\'nodes\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', {}), (\\'SIOP WT 2001 protocol_entity\\', {})], \\'edges\\': [(\\'van den Heuvel-Eibrink, M. M._entity\\', \\'SIOP WT 2001 protocol_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Third National Wilms\u2019 Tumor Study_entity\\', {}), (\"D\\'Angio, G. J._entity\", {}), (\\'Second National Wilms\u2019 Tumor Study_entity\\', {})], \\'edges\\': [(\"D\\'Angio, G. J._entity\", \\'Third National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'}), (\"D\\'Angio, G. J._entity\", \\'Second National Wilms\u2019 Tumor Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted\\'})]}, {\\'nodes\\': [(\\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {}), (\\'Tournade, M. F._entity\\', {}), (\\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {})], \\'edges\\': [(\\'Tournade, M. F._entity\\', \\'Ninth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'studied in\\'}), (\\'Tournade, M. F._entity\\', \\'Sixth International Society of Pediatric Oncology Wilms\u2019 Tumor Trial and Study_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Breslow, N. E._entity\\', {}), (\\'National Wilms Tumor Studies_entity\\', {})], \\'edges\\': [(\\'Breslow, N. E._entity\\', \\'National Wilms Tumor Studies_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'})]}, {\\'nodes\\': [(\\'Mitchell, C._entity\\', {}), (\\'UK Children\u2019s Cancer Study Group_entity\\', {})], \\'edges\\': [(\\'Mitchell, C._entity\\', \\'UK Children\u2019s Cancer Study Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'under\\'})]}, {\\'nodes\\': [(\\'Daw, N. C._entity\\', {}), (\\'Dix, D. B._entity\\', {}), (\\'Children\u2019s Oncology Group_entity\\', {}), (\\'Grundy, P. E._entity\\', {})], \\'edges\\': [(\\'Daw, N. C._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'conducted under\\'}), (\\'Dix, D. B._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported in\\'}), (\\'Grundy, P. E._entity\\', \\'Children\u2019s Oncology Group_entity\\', {\\'type\\': \\'relation\\', \\'relation_type\\': \\'reported by\\'})]}]'])] confident_link=None"